FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU SENNERBY, L
   THOMSEN, P
AF SENNERBY, L
   THOMSEN, P
TI TISSUE-RESPONSE TO TITANIUM IMPLANTS IN EXPERIMENTAL ANTIGEN-INDUCED
   ARTHRITIS
SO BIOMATERIALS
LA English
DT Article
DE TITANIUM; JOINT; ARTHRITIS; MORPHOLOGY
ID RABBIT KNEE JOINTS; REPLACEMENT
AB The healing of threaded, non-alloyed titanium implants in bone was studied in an experimental model of monoarticular arthritis in New Zealand white rabbits. Immunization with bovine serum albumin (BSA) and repeated intra-articular injections with BSA elicited an immune response and clinical signs of inflammation. Implants were inserted and 6 wk after surgery, with full weight-bearing, the rabbits were killed by perfusion fixation. Light microscopic morphometry showed that the cartilage was thinner and the subchondral bone had a lower density in the arthritic joints compared to the control side. The titanium implants in the arthritic joints had a lesser degree of mineralized bone-implant contact and surrounding bone than the implants inserted in control joints. The present study shows that the healing of titanium implants in the rabbit knee joint is impaired in experimental immunologic arthritis. This model may be useful for the study of biomaterial-tissue interactions under pathological conditions.
C1 UNIV GOTHENBURG,DEPT ANAT,S-41312 GOTHENBURG,SWEDEN.
RP SENNERBY, L (reprint author), UNIV GOTHENBURG,DEPT HANDICAP RES,BIOMAT GRP,BRUNNSGATAN 2,S-41312 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1988, J PROSTHET DENT, V60, P75, DOI 10.1016/0022-3913(88)90355-1
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   BRATTSTROM J, 1963, ACTA RHEUMATOL SCAND, V9, P102
   CARLSSON LV, 1989, THESIS U GOTHENBURG
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DONATH K, 1984, FORTSCHR ZAHNARZTL I, V1, P55
   GREAVES M, 1974, J EXP MED, V140, P1, DOI 10.1084/jem.140.1.1
   HAGERT CG, 1986, SCAND J PLAST RECONS, V20, P207, DOI 10.3109/02844318609006321
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   LINDER L, 1990, ACTA ORTHOP SCAND, V61, P87
   LUNDBORG G, 1992, TISSUE INTEGRATION IN ORAL, ORTHOPEDIC, AND MAXILLOFACIAL RECONSTRUCTION, P287
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   ROSTLUND TV, 1990, THESIS U GOTHENBURG
   SENNERBY L, 1992, J MATER SCI-MATER M, V3, P262, DOI 10.1007/BF00705291
   SENNERBY L, 1992, International Journal of Oral and Maxillofacial Implants, V7, P62
   Sennerby L, 1991, CLIN ORAL IMPLAN RES, V2, P103, DOI 10.1034/j.1600-0501.1991.020302.x
   SENNERBY L, IN PRESS J MATER SCI
   SHAPIRO F, 1982, J BONE JOINT SURG AM, V64, P639, DOI 10.2106/00004623-198264050-00001
   Soballe K, 1991, J Arthroplasty, V6, P307, DOI 10.1016/S0883-5403(06)80181-6
   THOMSEN P, 1985, SCAND J RHEUMATOL, V14, P239, DOI 10.3109/03009748509100401
   THOMSEN P, 1987, ACTA ORTHOP SCAND, V58, P265, DOI 10.3109/17453678709146481
   THOMSEN P, 1989, BRANEMARK OSSEOINTEG, P25
   Tjellstrom A, 1989, BRANEMARK OSSEOINTEG, P235
   WOODS CG, 1970, ANN RHEUM DIS, V29, P138, DOI 10.1136/ard.29.2.138
NR 26
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1993
VL 14
IS 6
BP 413
EP 422
DI 10.1016/0142-9612(93)90143-P
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LC035
UT WOS:A1993LC03500003
PM 8507787
DA 2018-10-20
ER

PT J
AU DARQUY, S
   HONIGER, J
   PUEYO, M
   CAPRON, F
   POITOUT, V
   REACH, G
   COLLIER, C
   MUSCAT, E
AF DARQUY, S
   HONIGER, J
   PUEYO, M
   CAPRON, F
   POITOUT, V
   REACH, G
   COLLIER, C
   MUSCAT, E
TI USE OF A BIOCOMPATIBLE BIOMATERIAL (AN69) FOR MICROENCAPSULATION OF
   ISLETS OF LANGERHANS
SO DIABETES
LA English
DT Meeting Abstract
RI Darquy, Sylviane/M-7858-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1660 DUKE ST, ALEXANDRIA, VA 22314
SN 0012-1797
J9 DIABETES
JI Diabetes
PD MAY
PY 1993
VL 42
SU 1
BP A139
EP A139
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA KZ626
UT WOS:A1993KZ62600433
DA 2018-10-20
ER

PT J
AU GUO, W
   WILLEN, R
   ANDERSSON, R
   PARSSON, H
   LIU, X
   JOHANSSON, K
   BENGMARK, S
AF GUO, W
   WILLEN, R
   ANDERSSON, R
   PARSSON, H
   LIU, X
   JOHANSSON, K
   BENGMARK, S
TI MORPHOLOGICAL RESPONSE OF THE PERITONEUM AND SPLEEN TO INTRAPERITONEAL
   BIOMATERIALS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE INTRAPERITONEAL IMPLANTATION; PERITONEUM; SPLEEN; MICROSCOPY; SCANNING;
   MORPHOLOGY
ID BIOCOMPATIBILITY; INTERLEUKIN-1; MACROPHAGE
AB The present study was performed to evaluate the morphological response of the peritoneum and spleen to biomaterials. Silicone elastomer, knitted dacron or rubber was implanted, respectively, into a rat's peritoneal cavity and the morphology of the peritoneum and spleen was studied at 4 hours and on the lst, 4th, 7th and 21st day after surgery. The morphological changes were identical among groups with different implanted materials. After intraperitoneal implantation of biomaterials from 4 hours and on, an infiltration of inflammatory cells was found in the slackened edematous superficial part of the peritoneum. Also noted in the spleen were stasis, vessel dilatation and fibrin deposition. With the help of scanning electron microscopy, a marked denudation and separation of the mesothelial cells, with infiltration of inflammatory cells, were observed. Peripheral leucocytes significantly increased in number one day after intraperitoneal implantation. Three weeks after intraperitoneal implantation, the materials were completely encapsulated and the morphological aberration of the peritoneum and spleen disappeared. The findings reveal the consequence and the resolution of the host-biomaterial interaction, which could contribute to the explaination of various pathophysiological alterations, including the translocation of enteric bacteria and the development of infectious complications after intraperitoneal biomaterial implantation.
C1 LUND UNIV,DEPT SURG,S-22185 LUND,SWEDEN.
   LUND UNIV,DEPT PATHOL,S-22185 LUND,SWEDEN.
   LUND UNIV,DEPT ZOOL,S-22185 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSSON R, 1990, SCAND J GASTROENTERO, V25, P405, DOI 10.3109/00365529009095507
   BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405
   BRUCK SD, 1990, INT J ARTIF ORGANS, V13, P469
   DAVIDSOHN I, 1969, CLIN DIAGNOSIS LABOR, P155
   DIPAOLO N, 1986, NEPHRON, V44, P204, DOI 10.1159/000183987
   DOBBIE JW, 1989, BLOOD PURIFICAT, V7, P74, DOI 10.1159/000169580
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   GUO W, 1993, IN PRESS J SURG RES
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P215
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   LLENDE M, 1986, J SURG RES, V40, P85, DOI 10.1016/0022-4804(86)90149-6
   MANENTI A, 1991, Pathologica (Genoa), V83, P65
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MEACHIM G, 1982, BIOMATERIALS, V3, P213, DOI 10.1016/0142-9612(82)90022-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Norgren L, 1990, Ann Vasc Surg, V4, P575, DOI 10.1016/S0890-5096(06)60842-X
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   TIGHE D, 1989, CLIN SCI, V76, P269, DOI 10.1042/cs0760269
   VERGER C, 1983, KIDNEY INT, V23, P823, DOI 10.1038/ki.1983.101
   VOLK HW, 1990, EUR SURG RES, V22, P347, DOI 10.1159/000129121
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 24
TC 27
Z9 27
U1 1
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAY
PY 1993
VL 16
IS 5
BP 276
EP 284
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA LM845
UT WOS:A1993LM84500008
PM 8354587
DA 2018-10-20
ER

PT J
AU BASLE, MF
   REBEL, A
   GRIZON, F
   DACULSI, G
   PASSUTI, N
   FILMON, R
AF BASLE, MF
   REBEL, A
   GRIZON, F
   DACULSI, G
   PASSUTI, N
   FILMON, R
TI CELLULAR-RESPONSE TO CALCIUM-PHOSPHATE CERAMICS IMPLANTED IN RABBIT BONE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SOFT-TISSUE RESPONSES; OSTEOCLAST-LIKE CELLS; MARROW CULTURES;
   HYDROXYLAPATITE INTERFACE; MULTINUCLEATED CELLS; PROGENITOR CELLS;
   CRYSTALS; GENERATION; PARTICLES; RATS
AB Two hydroxyapatite ceramics, synthesized by sintering from bovine bone and from a mixture of phosphate tricalcium and natural hydroxyapatite, were implanted in bone sites in rabbits. From day 7 after implantation, osteoblast-like cells were visible with thin layers of new bone on both biomaterials. Histomorphometry showed progressive increase in volume and surface of newly formed bone. Signs of cell-dependent resorption were visible at the surface of biomaterials and newly formed bone. There was a progressive decrease in relative volume and trabecular thickness of the biomaterials. Resorption of biomaterials appears to involve two cell types: multinucleated giant cells and osteoclast-like cells. The multinucleated giant cells observed had neither tartrate resistant acid phosphatase activity (TRAP) nor a ruffled border. Vesicles and vacuoles containing crystals observed in these cells suggest phagocytosis of biomaterials. The number of these cells decreased after day 14 following implantation. The osteoclast-like cells were TRAP positive. The structured modification and the TRAP activity demonstrated in the subjacent biomaterial suggest that the dissolution of the implant may be associated to an extracellular enzymatic activity of these cells. Electron microscopy revealed a clear zone and cytoplasmic membrane infolding in these cells, suggesting a ruffled border differentiation. The number of these cells increased with delay after implantation. It was concluded that the implantation of calcium phosphate ceramics in bone leads to new bone formation as well as to resorption of the biomaterials. The mechanism of resorption appears to associate crystal endocytosis by multinucleated giant cells and more classical resorption by osteoclast-like cells.
C1 FAC CHIRURG DENTAIRE, RECH TISSUS CALCIFIES & BIOMAT LAB, F-44042 NANTES 01, FRANCE.
   UNIV ANGERS, SERV COMMUN MICROSCOPIE ELECTRON, F-49045 ANGERS, FRANCE.
RP BASLE, MF (reprint author), FAC MED ANGERS, HISTOL & EMBRYOL LAB, ETUDE & RECH TISSU OSSEUX GRP, RUE HAUTE RECULEE, F-49045 ANGERS, FRANCE.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BAGI CM, 1991, CLIN ORTHOP RELAT R, P257
   BOYDE A, 1984, BRIT DENT J, V156, P216, DOI 10.1038/sj.bdj.4805313
   Caplan AI, 1987, BONE MINERAL RES, P117
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DEGROOT K, BIOCERAMICS CALCIUM
   DONATH K, 1989, 1ST P INT S CER MED, P96
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   EVANS RW, 1984, ARTHRITIS RHEUM, V27, P829, DOI 10.1002/art.1780270717
   EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384
   FROUM SJ, 1982, J PERIODONTOL, V53, P719, DOI 10.1902/jop.1982.53.12.719
   FULLER K, 1987, J CELL PHYSIOL, V132, P441, DOI 10.1002/jcp.1041320306
   GLOWACKI J, 1986, J BONE MINER RES, V1, P327
   GLOWACKI J, 1986, CALCIFIED TISSUE INT, V39, P97, DOI 10.1007/BF02553297
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   HAGENAARS CE, 1989, BONE MINER, V6, P179, DOI 10.1016/0169-6009(89)90049-4
   HALL BK, 1971, CLIN ORTHOP RELAT R, V71, P249
   Ham AW, 1930, J BONE JOINT SURG, V12, P827
   HATTERSLEY G, 1989, ENDOCRINOLOGY, V125, P1606, DOI 10.1210/endo-125-3-1606
   HENCH LL, 1989, 1ST P INT S CER MED, P27
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOLTROP ME, 1979, CALCIFIED TISSUE INT, V27, P129, DOI 10.1007/BF02441175
   HOLTROP ME, 1982, CALCIFIED TISSUE INT, V34, P488, DOI 10.1007/BF02411290
   HOOGENDOORN HA, 1987, ADV BIOMATER, V7, P81
   HUBBARD WG, 1974, THESIS MILWAUKEE
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   JONES SJ, 1977, CELL TISSUE RES, V185, P387
   KRUKOWSKI M, 1982, CALCIFIED TISSUE INT, V34, P474, DOI 10.1007/BF02411288
   KUKITA T, 1989, LAB INVEST, V60, P532
   KURIHARA N, 1989, BLOOD, V74, P1295
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   MARKS SC, 1991, J BONE MINER RES, V6, P395
   MARQUIS PM, 1990, ADV BIOMAT, V9, P243
   MCDAVID PT, 1979, J DENT RES, V58, P1478, DOI 10.1177/00220345790580050901
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MINKIN C, 1982, CALCIF TISSUE RES, V17, P57
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   MODDERMAN WE, 1991, BONE, V12, P81, DOI 10.1016/8756-3282(91)90004-3
   MOSKOW BS, 1983, J PERIODONTOL, V54, P455, DOI 10.1902/jop.1983.54.8.455
   MUNDY GR, 1987, BONE MINERAL RES ANN, V5, P209
   NOLAN P, 1991, J ANAT, V174, P97
   OGISO M, 1982, ADV BIOMATER, V3, P59
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1990, 2ND P INT S CER MED, P65
   OKUMURA M, 1991, CELL MATER, V1, P29
   OSDOBY P, 1982, J EXP ZOOL, V224, P331, DOI 10.1002/jez.1402240306
   OWENS JL, 1986, CALCIFIED TISSUE INT, V38, P170, DOI 10.1007/BF02556877
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PARFITT AM, BONE HISTOMORPHOMETR, P53
   PASSUTI N, 1990, ADV BIOMAT, V9, P255
   PIERCE AM, 1991, ELECTRON MICROSC REV, V4, P1, DOI 10.1016/0892-0354(91)90015-5
   ROODMAN GD, 1985, P NATL ACAD SCI USA, V82, P8213, DOI 10.1073/pnas.82.23.8213
   SHAPIRO F, 1988, J BONE JOINT SURG AM, V70A, P1067, DOI 10.2106/00004623-198870070-00016
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   SMINIA T, 1986, CALCIFIED TISSUE INT, V39, P263, DOI 10.1007/BF02555216
   TAKAHASHI N, 1986, J CLIN INVEST, V78, P894, DOI 10.1172/JCI112677
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   USHIDA T, 1990, 2ND P INT S CER MED, P33
   WEBBER D, 1990, J BONE MINER RES, V5, P401, DOI 10.1002/jbmr.5650050414
NR 62
TC 30
Z9 30
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1993
VL 4
IS 3
BP 273
EP 280
DI 10.1007/BF00122280
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LR926
UT WOS:A1993LR92600009
DA 2018-10-20
ER

PT J
AU LEGEAY, G
   PONCINEPAILLARD, F
AF LEGEAY, G
   PONCINEPAILLARD, F
TI SURFACE-TREATMENT AND BIOMATERIAL
SO VIDE-SCIENCE TECHNIQUE ET APPLICATIONS
LA English
DT Article
AB Biomaterial can be defined as material with specific use in biological surroundings. Therefore, beyond toxicity aspects, biocompatibility is mainly due to adhesion phenomena (mechanical anchoring, dipole-dipole and acid-base interactions...). Only few molecular layers are concerned. Common materials treatment , such as cold plasma and radiation methods, leads largely to a modification of the surface chemistry which, for biological applications, must be taken into account. Different examples are given.
RP LEGEAY, G (reprint author), IRAP,AVE O MESSIAEN,F-72000 LE MANS,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC FRANCAISE DU VID
PI PARIS
PA 19 RUE DU RENARD, 75004 PARIS, FRANCE
SN 1266-0167
J9 VIDE
JI Vide-Sci. Techn. Appl.
PD MAY-JUL
PY 1993
VL 49
IS 267
BP 161
EP 170
PG 10
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA LX240
UT WOS:A1993LX24000001
DA 2018-10-20
ER

PT J
AU CHUARD, C
   VAUDAUX, P
   WALDVOGEL, FA
   LEW, DP
AF CHUARD, C
   VAUDAUX, P
   WALDVOGEL, FA
   LEW, DP
TI SUSCEPTIBILITY OF STAPHYLOCOCCUS-AUREUS GROWING ON FIBRONECTIN-COATED
   SURFACES TO BACTERICIDAL ANTIBIOTICS
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID FOREIGN-BODY INFECTION; COAGULASE-NEGATIVE STAPHYLOCOCCI; GROWTH-RATE;
   PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL AGENTS; RESISTANCE; BIOFILMS;
   ADHERENCE; CIPROFLOXACIN; COMBINATION
AB Several recent studies have shown that bacteria either grown in vitro as adherent biofilms or recovered from infected prosthetic devices have decreased susceptibilities to antimicrobial killing. To further study the microbial and environmental factors responsible for this decreased antibiotic susceptibility, we developed an in vitro model of surface-adherent Staphylococcus aureus growing on polymethylmethacrylate coverslips coated with pure fibronectin. After exponential growth for 4 h, the population of fibronectin-attached S. aureus remained constant for a further 48-h period, as evaluated by CFU counts of organisms quantitatively removed from the coverslips. At selected time points, surface-bound organisms were exposed to bactericidal concentrations of either oxacillin, vancomycin, fleroxacin, or gentamicin in short-term (0.5 to 2 h) or long-term (24 h) killing assays. Whereas at 2 h surface-growing organisms were still optimally killed by all antimicrobial agents, at 4 and 24 h attached bacteria expressed markedly altered susceptibilities to these agents. The decrease in susceptibility was moderate for fleroxacin, more important for oxacillin and vancomycin, and extensive for gentamicin. When surface-attached S. aureus was compared with bacteria grown in a fluid phase, both populations showed a parallel time-dependent decrease in their susceptibilities to either oxacillin, vancomycin, or fleroxacin. In contrast, attached organisms became considerably more resistant to gentamicin than suspended bacteria did. Subpopulations of organisms spontaneously released from coverslips during antibiotic exposure also showed markedly reduced susceptibilities to antimicrobial killing. This simple model of S. aureus colonization of in vitro fibronectin-coated surfaces might represent a useful approach to the study of the physiological and biochemical changes that underlie the decreased antibiotic susceptibilities of biomaterial-attached organisms.
RP CHUARD, C (reprint author), UNIV GENEVA,HOP CANTONAL,DIV INFECT DIS,CH-1211 GENEVA 4,SWITZERLAND.
CR ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824
   ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   BISNO AL, 1989, INFECTIONS ASS INDWE, P93
   Brause BD, 1989, INFECT ASS INDWELLIN, P111
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   BROWN MRW, 1990, ANTIMICROB AGENTS CH, V34, P1623, DOI 10.1128/AAC.34.9.1623
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHUARD C, 1991, J INFECT DIS, V163, P1369
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DWORKIN R, 1990, ANTIMICROB AGENTS CH, V34, P1014, DOI 10.1128/AAC.34.6.1014
   EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177
   EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V25, P585, DOI 10.1093/jac/25.4.585
   EVANS RC, 1987, ANTIMICROB AGENTS CH, V31, P889, DOI 10.1128/AAC.31.6.889
   GANDER S, 1992, 92ND GEN M AM SOC MI
   GILBERT P, 1989, APPL ENVIRON MICROB, V55, P1308
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   GILBERT P, 1987, J ANTIMICROB CHEMOTH, V20, P147, DOI 10.1093/jac/20.2.147
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   HENRY NK, 1987, AM J MED, V82, P73
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P129
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   MILLER MH, 1978, ANTIMICROB AGENTS CH, V14, P336, DOI 10.1128/AAC.14.3.336
   MILLER MH, 1980, ANTIMICROB AGENTS CH, V18, P722, DOI 10.1128/AAC.18.5.722
   MUSHER DM, 1977, J INFECT DIS, V136, P360, DOI 10.1093/infdis/136.3.360
   NICHOLS WW, 1989, J GEN MICROBIOL, V135, P1291
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   PELLETIER LL, 1979, J LAB CLIN MED, V94, P324
   PROSSER BL, 1987, ANTIMICROB AGENTS CH, V31, P1502, DOI 10.1128/AAC.31.10.1502
   SHETH NK, 1985, LANCET, V2, P1266
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   VERGERES P, 1992, J INFECT DIS, V165, P281, DOI 10.1093/infdis/165.2.281
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   WIDMER AF, 1991, ANTIMICROB AGENTS CH, V35, P741, DOI 10.1128/AAC.35.4.741
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIMMERLI W, 1986, EXPT MODELS ANTIMICR, P295
   1987, METHODS DETERMINING
NR 42
TC 57
Z9 60
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD APR
PY 1993
VL 37
IS 4
BP 625
EP 632
DI 10.1128/AAC.37.4.625
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA KV991
UT WOS:A1993KV99100002
PM 8494358
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU COURTNEY, JM
   SUNDARAM, S
   LAMBA, NMK
   FORBES, CD
AF COURTNEY, JM
   SUNDARAM, S
   LAMBA, NMK
   FORBES, CD
TI MONITORING OF THE BLOOD RESPONSE IN BLOOD PURIFICATION
SO ARTIFICIAL ORGANS
LA English
DT Article
DE BIOMATERIALS; BLOOD RESPONSE; BLOOD PURIFICATION
AB A principal objective of monitoring the blood response in procedures such as hemodialysis and cardiopulmonary bypass is to achieve an enhanced understanding of the relationship between blood component alterations and the biomaterials employed. The aim in a study of blood-biomaterial interactions of deriving a correlation between a characteristic of the biomaterial and a representative parameter of the blood response can be influenced in a clinical situation by antithrombotic agents, multimaterial contact, device utilization, blood condition, drug therapy, and the nature of the application. The selection of parameters representative of the blood response may require a compromise between the advantages of multiparameter assessment and the benefit of measuring a single parameter by a consistent methodology. Representative parameters are protein adsorption, platelet reactions, intrinsic coagulation and the contact activation phase, fibrinolysis, leukocyte alterations, and complement activation. Assessment during clinical application can be approached by consideration of blood response patterns.
C1 UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT MED,DUNDEE DD1 9SY,SCOTLAND.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,106 ROTTEROW,GLASGOW G4 0NW,SCOTLAND.
CR BLASS CR, 1992, INT J ARTIF ORGANS, V15, P200
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHENOWETH DE, 1986, T AM SOC ART INT ORG, V32, P226
   Courtney JM, 1992, CARDIOVASCULAR BIOMA, P37
   COURTNEY JM, 1992, MANAGEMENT BLEEDING, P236
   COURTNEY JM, 1991, INFLUENCE NEW TECHNO, P154
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   FEIJEN J, 1987, ARTIF ORGANS, P235
   FORBES CD, 1987, HAEMOSTASIS THROMBOS, P902
   HERZLINGER GA, 1983, BIOCOMPATIBLE POLYM, P89
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Klinkmann H., 1987, UREMIA THERAPY, P125
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   Ogston D., 1983, PHYSL HEMOSTASIS
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   SZYCHER M, 1983, BIOCOMPATIBLE POLYM, P1
   VROMAN L, 1980, BLOOD, V55, P156
NR 18
TC 7
Z9 7
U1 0
U2 1
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD APR
PY 1993
VL 17
IS 4
BP 260
EP 266
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA KW369
UT WOS:A1993KW36900011
PM 8498906
DA 2018-10-20
ER

PT J
AU CIAPETTI, G
   CENNI, E
   PRATELLI, L
   PIZZOFERRATO, A
AF CIAPETTI, G
   CENNI, E
   PRATELLI, L
   PIZZOFERRATO, A
TI INVITRO EVALUATION OF CELL BIOMATERIAL INTERACTION BY MTT ASSAY
SO BIOMATERIALS
LA English
DT Article
DE CELL-BIOMATERIAL INTERACTIONS; CYTOTOXICITY; MTT ASSAY
ID RAPID COLORIMETRIC ASSAY; GROWTH; PROLIFERATION; CYTOTOXICITY;
   BIOCOMPATIBILITY; FIBROBLASTS; COMPOSITES; SILICONE; SURVIVAL; STATE
AB The tetrazolium-based colorimetric assay (MTT test) measures only in vitro living cells and the results are directly related to the number of viable cultured cells. It has been adopted in immunological investigations, cancer research and, recently, biocompatibility evaluation. We used the MTT method with minor modifications to fit it to an in vitro study of biomaterial-cell interactions. The MTT assay was confirmed to be feasible, rapid and reproducible. Moreover, it showed a good correlation with other in vitro proliferation assays, such as the H-3-thymidine uptake assay. By using the MTT method and the ASTM procedure for extracting biomaterials, we quantified the in vitro cell compatibility of different metals and polymers.
RP CIAPETTI, G (reprint author), 1ST ORTOPED RIZZOLI,BIOCOMPATIBIL RES IMPLANT MAT LAB,VIA BARBIANO 1-10,I-40136 BOLOGNA,ITALY.
OI Ciapetti, Gabriela/0000-0001-6740-0357
CR BRANTLEY SK, 1990, PLAST RECONSTR SURG, V86, P1131, DOI 10.1097/00006534-199012000-00015
   CAUGHMAN WF, 1991, BIOMATERIALS, V12, P737, DOI 10.1016/0142-9612(91)90022-3
   CIAPETTI G, 1989, BIOMATERIALI, V3, P5
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   FALEZZA A, 1992, 1 C NAZ ASS IT TOSS
   FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z
   GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   GIVENS KT, 1990, INVEST OPHTH VIS SCI, V31, P1856
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   HANAWA T, 1992, BIOMATERIALS, V13, P20, DOI 10.1016/0142-9612(92)90089-7
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   HANSON JA, 1991, LEUKEMIA RES, V15, P565, DOI 10.1016/0145-2126(91)90024-N
   HARMAND M-F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P67, DOI 10.1163/156856291X00070
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MOSMANN TR, 1989, J IMMUNOL METHODS, V116, P151, DOI 10.1016/0022-1759(89)90198-1
   NAJI A, 1990, J BIOMED MATER RES, V24, P861, DOI 10.1002/jbm.820240706
   OEZ S, 1990, BLUT, V60, P97, DOI 10.1007/BF01720515
   Patterson M K Jr, 1979, Methods Enzymol, V58, P141
   ROSDY M, 1991, BIOMATERIALS, V12, P511, DOI 10.1016/0142-9612(91)90151-Y
   SCHAUER U, 1989, J IMMUNOL METHODS, V116, P221, DOI 10.1016/0022-1759(89)90207-X
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
   VANDELOOSDRECHT AA, 1991, J IMMUNOL METHODS, V141, P15, DOI 10.1016/0022-1759(91)90205-T
   WATAHA JC, 1991, J BIOMED MATER RES, V25, P1133, DOI 10.1002/jbm.820250907
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   WILSON JK, 1990, BRIT J CANCER, V62, P189, DOI 10.1038/bjc.1990.258
   1991, BIOL EVALUATION MED
   1985, ASTM STANDARDS, P176
NR 30
TC 242
Z9 268
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 1993
VL 14
IS 5
BP 359
EP 364
DI 10.1016/0142-9612(93)90055-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KY998
UT WOS:A1993KY99800007
PM 8507779
DA 2018-10-20
ER

PT J
AU SIEGEL, JF
   SMITH, AD
AF SIEGEL, JF
   SMITH, AD
TI THE IDEAL URETERAL STENT FOR ANTEGRADE AND RETROGRADE ENDOPYELOTOMY -
   WHAT WOULD IT BE LIKE
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
AB Current endopyelotomy stents are composed of polyurethane, which is an adequate biomaterial for 6 to 8 weeks of dwell time. It is easy to insert, has good internal now, and resists encrustation. Several designs are available. External designs have the advantage of providing easy access, while the internal designs appeal to patients because no external dressing is required. On the basis of our experience, we continue to advocate the tapering external endopyelotomy stent (14F to 8F) for 6 weeks of postoperative intubation. Although urologic catheters have progressed, the perfect endopyelotomy stent has yet to be produced.
C1 LONG ISL JEWISH MED CTR,DEPT UROL,278-05 76TH AVE,NEW HYDE PK,NY 11042.
CR ABDELHAKIM AM, 1987, J ENDOUROL, V1, P265
   BADLANI GH, 1988, J UROLOGY, V15, P439
   Bitschay J., 1956, HIST UROLOGY EGYPT, P76
   CLAYMAN RV, 1988, UROL CLIN N AM, V15, P433
   KARLIN GS, 1988, UROL CLIN N AM, V15, P445
   KUENKEL M, 1990, Journal of Endourology, V4, P109, DOI 10.1089/end.1990.4.109
   MACALUSO JN, 1990, J ENDOUROL, V4, P114
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   MARDIS HK, 1987, SEMIN INTERVENT RAD, V4, P34
   MOTOLA J, IN PRESS J UROL
   OPPENHEIMER R, 1955, J Urol, V74, P476
   SALTZMAN B, 1988, UROL CLIN N AM, V15, P481
   SMITH AD, 1984, UROLOGY, V23, P37, DOI 10.1016/0090-4295(84)90240-1
   VANCANGH PJ, 1989, J UROLOGY, V141, P1317, DOI 10.1016/S0022-5347(17)41293-6
NR 14
TC 20
Z9 20
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD APR
PY 1993
VL 7
IS 2
BP 151
EP 154
DI 10.1089/end.1993.7.151
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA LB019
UT WOS:A1993LB01900010
PM 8518829
DA 2018-10-20
ER

PT J
AU PAZIRANDEH, M
   CAMPBELL, JR
AF PAZIRANDEH, M
   CAMPBELL, JR
TI PROTEIN-COMPOSITION OF RHAPIDOSOMES ISOLATED FROM
   AQUASPIRILLUM-ITERSONII
SO JOURNAL OF GENERAL MICROBIOLOGY
LA English
DT Article
AB Rhapidosomes are tubular microstructures composed of proteins that are found in a variety of bacteria and algae. These structures, which are resistant to disruption by many denaturing agents, have potential application as a biomaterial and may serve as a new model for the study of self assembly. When rhapidosomes were purified and analysed by SDS-PAGE the presence of three proteins with molecular masses of 53, 29 and 18 kDa was revealed. However, lysozyme treatment of the rhapidosome preparations containing the three proteins resulted in the selective release of the 18 kDa protein from the rhapidosome complex. N-Terminal sequence analysis and amino acid composition analysis were performed on all three proteins. The amino acid composition of the 18 kDa protein closely matched the amino acid composition of protein H (a peptidoglycan-associated protein from Pseudomonas aeruginosa). These results suggest that the 18 kDa protein may be a contaminating peptidoglycan-associated protein and not part of the rhapidosome structure. Western blot analysis using antisera raised against rhapidosomes revealed that the 53 kDa component protein does not react with the antisera. We speculate that the 53 kDa protein may form the inner core of the rhapidosomes, whilst the 29 kDa protein forms the outer sheath of these structures.
RP PAZIRANDEH, M (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,WASHINGTON,DC 20375, USA.
CR CHANG HY, 1974, J GEN MICROBIOL, V18, P121
   CORRELL DL, 1964, CAN J MICROBIOL, V10, P63, DOI 10.1139/m64-010
   DELK AS, 1972, J MOL BIOL, V64, P287, DOI 10.1016/0022-2836(72)90336-1
   EVERS MCJM, 1980, CAN J MICROBIOL, V26, P1312, DOI 10.1139/m80-218
   FARALDO MLM, 1991, J BACTERIOL, V173, P5346, DOI 10.1128/jb.173.17.5346-5351.1991
   HYLEMON PB, 1973, INT J SYST BACTERIOL, V23, P340, DOI 10.1099/00207713-23-4-340
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035
   MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P979, DOI 10.1093/oxfordjournals.jbchem.a132630
   MIZUNO T, 1987, J BIOCH, V86, P991
   PARGE HE, 1990, J BIOL CHEM, V265, P2278
   Pazirandeh M, 1992, BIOMIMETICS, V1, P39
   ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 14
TC 3
Z9 3
U1 0
U2 0
PU SOC GENERAL MICROBIOLOGY
PI READING
PA HARVEST HOUSE 62 LONDON ROAD, READING, BERKS, ENGLAND RG1 5AS
SN 0022-1287
J9 J GEN MICROBIOL
JI J. Gen. Microbiol.
PD APR
PY 1993
VL 139
BP 859
EP 864
DI 10.1099/00221287-139-4-859
PN 4
PG 6
WC Microbiology
SC Microbiology
GA KY980
UT WOS:A1993KY98000026
PM 8515241
OA Bronze
DA 2018-10-20
ER

PT J
AU TANINGHER, M
   PELLERANO, P
   TERRANOVA, MP
   MALACARNE, D
   BONATTI, S
AF TANINGHER, M
   PELLERANO, P
   TERRANOVA, MP
   MALACARNE, D
   BONATTI, S
TI A GENOTOXICITY STUDY ON N-ACRYLOYL-N'-PHENYLPIPERAZINE - IMPLICATIONS OF
   ANEUGENIC EFFECTS IN RISK EVALUATIONS
SO MUTATION RESEARCH
LA English
DT Article
DE BIOMATERIALS; AROMATIC TERTIARY AMINES; DNA DAMAGE REPAIR; ANEUPLOIDY
ID DNA DAMAGE; REPAIR
AB Further to a previous genotoxicity study, we analyzed sister-chromatid exchange (SCE) and DNA-repair induction (V79 and EUE cells in vitro) and DNA damage (rat liver in vivo) with regard to N-acryloyl-N'-phenylpiperazine (AcrNPP), a chemical proposed for biomaterial polymerization which contains an aromatic tertiary amine function in a piperazine cycle. This chemical induced SCEs in a dose-dependent fashion (up to approximately 3.7 times the control value), while it was negative for DNA-repair induction and weakly yet significantly positive for in vivo DNA damage (maximum increase approximately 1.4 times the control value). Taken together with our previous genotoxicity data on AcrNPP and structurally related compounds, the present results confirm that aneuploidy is a possible major effect of aromatic tertiary amines. As regards exposure to aneugenic agents, considerations on cancer risk evaluation are presented.
C1 UNIV GENOA,CIRC,INST ONCOL,I-16132 GENOA,ITALY.
   CNR,IST MUTAGENESI & DIFFERENZIAMENTO,I-56100 PISA,ITALY.
RP TANINGHER, M (reprint author), UNIV GENOA,NATL INST CANC RES,IST,VIALE BENEDETTO XV NO 10,I-16132 GENOA,ITALY.
CR ASHBY J, 1991, MUTAT RES, V257, P229, DOI 10.1016/0165-1110(91)90003-E
   BIANCHI V, 1982, MUTAT RES, V93, P447, DOI 10.1016/0027-5107(82)90157-9
   BONATTI S, 1992, MUTAGENESIS, V7, P111, DOI 10.1093/mutage/7.2.111
   COX R, 1973, CANCER RES, V33, P2114
   DANESINO C, 1975, B SOC MED CHIR PA, V85, P275
   DANUSSO F, 1990, POLYMER, V31, P1577, DOI 10.1016/0032-3861(90)90168-X
   Evans H. J., 1985, ANEUPLOIDY ETIOLOGY, P165
   KOHN KW, 1986, MECHANISMS DNA DAMAG, P101
   PARODI S, 1978, MUTAT RES, V54, P39, DOI 10.1016/0165-1161(78)90133-4
   TANINGHER M, 1992, MUTAT RES, V282, P99, DOI 10.1016/0165-7992(92)90081-R
   TANINGHER M, 1992, UNPUB GENOTOXICITY A
   TANZI MC, 1990, POLYMER, V31, P1735, DOI 10.1016/0032-3861(90)90194-4
   1987, MONOGRAPHS EVALUA S7
   1987, MONOGRAPHS EVALUA S6
   1990, MUTAT RES, V241, P325
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD APR
PY 1993
VL 301
IS 4
BP 275
EP 279
DI 10.1016/0165-7992(93)90069-8
PG 5
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA KU561
UT WOS:A1993KU56100011
PM 7680763
DA 2018-10-20
ER

PT J
AU BERLINER, SD
AF BERLINER, SD
TI CLINICAL-EXPERIENCE WITH AN INLAY EXPANDED POLYTETRAFLUOROETHYLENE
   SOFT-TISSUE PATCH AS AN ADJUNCT IN INGUINAL-HERNIA REPAIR
SO SURGERY GYNECOLOGY & OBSTETRICS
LA English
DT Article
AB Fifteen percent of 2,331 inguinal hernias required a biomaterial to effect a tension-free repair- Using the anterior approach, a graft placed deep to the posterior wall fulfills all the requirements of a sound operation. The procedure is normally performed using local anesthesia in an ambulatory facility. Three hundred fifty inguinal hernias were repaired using an expanded polytetrafluoroethylene soft tissue inlay patch. Ninety-one percent of the patients had personal follow-up examination with a mean follow-up period of 41.8 months. There were four recurrences.
C1 YESHIVA UNIV ALBERT EINSTEIN COLL MED,SURG SERV,BRONX,NY 10461.
RP BERLINER, SD (reprint author), LONG ISL JEWISH MED CTR,SURG SERV,NEW HYDE PK,NY 11042, USA.
CR BALL L, 1958, BRIT J SURG, V45, P562, DOI 10.1002/bjs.18004519326
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   BERLINER SD, 1984, SURG CLIN N AM, V64, P197
   Berliner SD, 1989, HERNIA, P541
   Downes WA, 1920, ARCH SURG-CHICAGO, V1, P53, DOI 10.1001/archsurg.1920.01110010066005
   GLASSOW F, 1984, ANN ROY COLL SURG, V66, P382
   Harrison PW, 1922, ARCH SURG-CHICAGO, V4, P680, DOI 10.1001/archsurg.1922.01110120197008
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   READ RC, 1987, AM J SURG, V153, P324, DOI 10.1016/0002-9610(87)90620-9
   SHEARBURN EW, 1969, SURGERY, V66, P450
   Stoppa RE, 1989, HERNIA, P199
   WANTZ GE, 1989, SURG GYNECOL OBSTET, V168, P67
   WANTZ GE, 1989, SURG GYNECOL OBSTET, V169, P408
NR 13
TC 19
Z9 20
U1 0
U2 0
PU FRANKLIN H MARTIN FOUNDATION
PI CHICAGO
PA 55 E ERIE ST, CHICAGO, IL 60611
SN 0039-6087
J9 SURG GYNECOL OBSTET
JI Surg. Gynecol. Obstet.
PD APR
PY 1993
VL 176
IS 4
BP 323
EP 326
PG 4
WC Obstetrics & Gynecology; Surgery
SC Obstetrics & Gynecology; Surgery
GA KV571
UT WOS:A1993KV57100005
PM 8460406
DA 2018-10-20
ER

PT J
AU OHLIN, A
   LINDER, L
AF OHLIN, A
   LINDER, L
TI BIOCOMPATIBILITY OF POLYOXYMETHYLENE (DELRIN(R)) IN BONE
SO BIOMATERIALS
LA English
DT Article
DE DELRIN(R); PROSTHESES; HIPS; BIOCOMPATIBILITY
ID HIP; PROSTHESES; INTERFACE; IMPLANTS
AB The bone tissue reaction to bulk polyoxymethylene (Delrin(R)) was studied in eight adult albino rabbits followed for up to 5 months after insertion of implants into the tibial metaphyses. Each animal received two implants, one of pure Delrin, the other a 'mosaic' plug with alternating areas of commercially pure titanium and Delrin. At the passage through the cortex, a direct bone-Delrin contact was seen in more than half of the cases, but the contact was usually limited in extent. At the same time, in virtually all sections, a foreign-body reaction with macrophages and giant cells was prominent. It was concluded that bulk Delrin has inferior biocompatibility to titanium, and the advisability of using Delrin as a biomaterial for bone anchorage is questionable.
RP OHLIN, A (reprint author), MALMO GEN HOSP,DEPT ORTHOPAED SURG,S-21401 MALMO,SWEDEN.
CR AHNFELT L, 1990, ACTA ORTHOP SCAND, V61, P1
   ANDREW TA, 1986, CLIN ORTHOP RELAT R, V206, P127
   BOSS JH, 1990, INT ORTHOP, V14, P399
   FISTER JS, 1985, J BIOMED MATER RES, V19, P519, DOI 10.1002/jbm.820190505
   Jakim I, 1988, J Arthroplasty, V3, P191
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P129
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   LINDER L, 1986, BIOMATERIALS, V7, P17, DOI 10.1016/0142-9612(86)90082-7
   MAISTRELLI GL, 1991, J BONE JOINT SURG BR, V73, P43
   MATHYS R, 1984, CEMENTLESS FIXATION, P71
   OHLIN A, 1990, ACTA ORTHOP SCAND, V61, P7, DOI 10.3109/17453679008993055
   SUNDAL B, 1974, ACTA CHIR SCAND, V140, P189
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
NR 13
TC 6
Z9 7
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1993
VL 14
IS 4
BP 285
EP 289
DI 10.1016/0142-9612(93)90120-Q
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KU449
UT WOS:A1993KU44900006
PM 8476998
DA 2018-10-20
ER

PT J
AU COURTNEY, JM
   IRVINE, L
   JONES, C
   MOSA, SM
   ROBERTSON, LM
   SRIVASTAVA, S
AF COURTNEY, JM
   IRVINE, L
   JONES, C
   MOSA, SM
   ROBERTSON, LM
   SRIVASTAVA, S
TI BIOMATERIALS IN MEDICINE - A BIOENGINEERING PERSPECTIVE
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE BIOMATERIALS; ARTIFICIAL ORGANS; BLOOD-BIOMATERIAL INTERACTIONS;
   CELL-BIOMATERIAL INTERACTIONS
ID HEMODIALYSIS; ADHESION
AB Biomaterials are considered with an emphasis on those use in artificial organs. Attention is drawn to the importance of the polymeric biomaterials and factors which affect their properties. Functions of membranes, sorbents, blood tubing, ventricular diaphragms and cell culture substrates are examined in order to obtain a summary of fundamental properties. Observations are made on the importance of blood compatibility assessment and its association with a biomaterial structure-property relationship. Blood-biomaterial interactions are discussed in terms of an overall relationship between the three components - blood, biomaterial and antithrombotic agent, with examples given of factors influencing each component. Cell-biomaterial interactions are examined in the areas of toxicity evaluation and the promotion of cell attachment and growth, where an overall relationship is described for the cell, growth medium and growth factors, and the biomaterial acting as a substrate.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,106 ROTTENROW,GLASGOW G4 0NW,SCOTLAND.
CR ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   BEHM E, 1988, INFLUENCE NEW TECHNO, P75
   BIGGS MS, 1984, POLYM MED, P375
   BLASS CR, 1991, PLAST RUB COMPOS PRO, V15, P221
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHANG TMS, 1987, BIOMATER ARTIF CELL, V15, P1
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   Courtney J. M., 1980, A textbook of biomedical engineering, P77
   COURTNEY JM, 1989, BLOOD FLOW ARTIFICIA, P104
   FORBES CD, 1987, HAEMOSTASIS THROMBOS, P902
   GAYLOR JDS, 1988, J BIOMED ENG, V10, P541, DOI 10.1016/0141-5425(88)90113-6
   GURLAND HJ, 1987, UREMIA THERAPY, P64
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   HENDERSON LW, 1987, UREMIA THERAPY, P74
   IRVINE L, 1989, INT J ARTIF ORGANS, V12, P502
   IRVINE L, 1991, T AM SOC ART INT ORG, V37, P569
   JONES C, 1989, INT J ARTIF ORGANS, V12, P466
   Klinkmann H., 1987, UREMIA THERAPY, P125
   KLINKMANN H, 1989, PROGR BIOENGINEERING, P7
   MOSA SM, 1989, THESIS U STRATHCLYDE
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   PAUL JP, 1984, BIOMATERIALS ARTIFIC
   Piskin E, 1986, Life Support Syst, V4 Suppl 1, P2
   ROBERTSON LM, 1988, THESIS U STRATHCLYDE
   RUOSLAHTI E, 1985, ARTERIOSCLEROSIS, V5, P581, DOI 10.1161/01.ATV.5.6.581
   SCHAEFER RM, 1986, PROGR ARTIFICIAL ORG, P966
   SEVASTIANOV VI, 1987, ARTIF ORGANS, V11, P20, DOI 10.1111/j.1525-1594.1987.tb02621.x
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P133, DOI 10.1016/0142-9612(90)90129-E
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P162, DOI 10.1016/0142-9612(90)90149-K
   SRIVASTAVA S, 1988, THESIS U STRATHCLYDE
   Szycher M., 1983, BIOCOMPATIBLE POLYM
   VONSENGBUSCH G, 1987, UREMIA THERAPY, P64
   Williams D. F., 1987, DEFINITIONS BIOMATER
NR 33
TC 11
Z9 12
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 1993
VL 16
IS 3
BP 164
EP 171
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA LC859
UT WOS:A1993LC85900011
PM 8314641
DA 2018-10-20
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI THE BLOOD COMPATIBILITY CATASTROPHE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Editorial Material
ID BIOMATERIAL SURFACES; PLATELET CONSUMPTION; ARTERIAL; THROMBOEMBOLISM;
   THROMBOSIS; INHIBITION; POLYMERS
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
RP RATNER, BD (reprint author), UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195, USA.
CR ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1985, J CLIN INVEST, V75, P1591, DOI 10.1172/JCI111865
   HARKER LA, 1974, THROMB DIATH HAEMOST, V31, P188, DOI 10.1055/s-0038-1649157
   HARKER LA, 1980, BLOOD, V56, P824
   HARKER LA, 1977, ANN SURG, V186, P594, DOI 10.1097/00000658-197711000-00009
   HAYCOX CL, 1992, 4TH P INT C BIOM BER
   HAYCOX CL, IN PRESS J BIOMED MA
   HOFFMAN AS, 1982, ACS ADV CHEM SERIES, V199, P59
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   JOZEFOWICZ M, 1984, PURE APPL CHEM, V56, P1335, DOI 10.1351/pac198456101335
   KUSSEROW BK, 1972, B NEW YORK ACAD MED, V48, P468
   MALPASS TW, 1981, BLOOD, V57, P736
   MCINTIRE LV, 1985, NIH852185 NAT HEART
   Ratner B. D., 1984, CONT BIOMATERIALS MA, P193
   RATNER BD, 1987, TREATISECLEAN SURFAC, V1, P247
   RATNER BD, IN PRESS CLIN MATER
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   SOLEN KA, 1989, T AM SOC ART INT ORG, V35, P370
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
NR 26
TC 150
Z9 151
U1 1
U2 20
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1993
VL 27
IS 3
BP 283
EP 287
DI 10.1002/jbm.820270302
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KL907
UT WOS:A1993KL90700001
PM 8360198
DA 2018-10-20
ER

PT J
AU VANDERTWEEL, I
   VANNOORD, PAH
   KAAKS, R
AF VANDERTWEEL, I
   VANNOORD, PAH
   KAAKS, R
TI APPLICATION OF A SEQUENTIAL T-TEST IN A COHORT NESTED CASE-CONTROL STUDY
   WITH MULTIPLE CONTROLS PER CASE
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Article
DE SEQUENTIAL T-TEST; MULTIPLE CONTROLS; SIMULATIONS; EFFICIENCY;
   BIOBANKING; COHORT NESTED STUDIES
ID CLINICAL-TRIALS; SAMPLE; DESIGN
AB Application of sequential analysis may avoid unnecessary experimentation and achieve economical use of available biomaterial stored in biological banks. When, as often happens in cohort case-control studies, cases are scarce, it may be possible to use multiple control observations per case to increase the power of a test for detecting differences between cases and controls. Samples from a biological data bank were analysed. We compared results of a non-sequential analysis with results of sequential t-tests for 1 to 5 controls matched per case in a cohort nested case-control study. Simulations are performed to get an idea of the unreliability and the power of the sequential test. In general the sequential t-tests are too conservative with respect to the achieved power. Average sample numbers are lower for the sequential tests and decrease with multiple controls. More than 3 or 4 controls per case does not give a meaningful increase in efficiency.
C1 UNIV UTRECHT,DEPT EPIDEMIOL,3511 CK UTRECHT,NETHERLANDS.
   WHO,IARC,ANALYT EPIDEMIOL UNIT,F-69372 LYON 08,FRANCE.
RP VANDERTWEEL, I (reprint author), UNIV UTRECHT,CTR BIOSTAT,CENTRUMGEBOUW NOORD C122,PADUALAAN 14,3584 CH UTRECHT,NETHERLANDS.
CR ABRAMOWITZ M, 1968, HDB MATH FUNCTIONS
   GAIL M, 1976, J CHRON DIS, V29, P723, DOI 10.1016/0021-9681(76)90073-4
   LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5
   NOORD PA, 1987, INT J EPIDEMOL, V16, P318
   ONEILL RT, 1978, AM J EPIDEMIOL, V108, P415, DOI 10.1093/oxfordjournals.aje.a112639
   PASTERNACK BS, 1982, AM J EPIDEMIOL, V115, P778, DOI 10.1093/oxfordjournals.aje.a113359
   PASTERNACK BS, 1981, AM J EPIDEMIOL, V113, P182, DOI 10.1093/oxfordjournals.aje.a113082
   PASTERNAK BS, 1980, J CHRON DIS, V33, P365, DOI 10.1016/0021-9681(80)90046-6
   POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191
   RUSHTON S, 1952, BIOMETRIKA, V39, P302, DOI 10.1093/biomet/39.3-4.302
   SKOVLUND E, 1991, J CLIN EPIDEMIOL, V44, P265, DOI 10.1016/0895-4356(91)90038-B
   SKOVLUND E, 1987, SCAND J STAT, V14, P347
   Sokal RR, 1981, BIOMETRY
   URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548
   VANNOORD PAH, 1992, THESIS U UTRECHT
   Wald A., 1947, SEQUENTIAL ANAL
   WALD NJ, 1985, MATURITAS, V7, P59, DOI 10.1016/0378-5122(85)90035-0
   WETHERILL GB, 1908, SEQUENTIAL METHODS S
NR 18
TC 5
Z9 5
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0895-4356
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD MAR
PY 1993
VL 46
IS 3
BP 253
EP 259
PG 7
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA KV165
UT WOS:A1993KV16500006
PM 8455050
DA 2018-10-20
ER

PT J
AU CLARKE, KI
   GRAVES, SE
   WONG, ATC
   TRIFFITT, JT
   FRANCIS, MJO
   CZERNUSZKA, JT
AF CLARKE, KI
   GRAVES, SE
   WONG, ATC
   TRIFFITT, JT
   FRANCIS, MJO
   CZERNUSZKA, JT
TI INVESTIGATION INTO THE FORMATION AND MECHANICAL-PROPERTIES OF A
   BIOACTIVE MATERIAL BASED ON COLLAGEN AND CALCIUM-PHOSPHATE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE; HYDROXYAPATITE; OSTEONECTIN; APATITE
AB A biomaterial composite was formed by the room-temperature precipitation of calcium phosphate (in the form of brushite) on to collagen. It was found that the addition of 1 mm 0-phosphoserine (Ser P) causes the morphology of the brushite crystals to change from large plates to small needles. An increase in the surface coverage and weight fraction of brushite incorporated into the collagen was observed. The mechanical properties of this composite were tested in the wet state. The ultimate tensile strength (UTS) was 45 MPa compared with 34 MPa for the wet collagen. Osteoblastic differentiation was promoted on the surface of the material and new bone formed.
C1 NUFFIELD ORTHOPAED CTR,NUFFIELD DEPT ORTHOPAED SURG,OXFORD OX3 7LD,ENGLAND.
   NUFFIELD ORTHOPAED CTR,MRC,BONE RES LAB,OXFORD OX3 7LD,ENGLAND.
RP CLARKE, KI (reprint author), UNIV OXFORD,DEPT MAT,PK RD,OXFORD OX1 3PH,ENGLAND.
OI Graves, Stephen/0000-0002-1629-319X
CR BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X
   Billmeyer FW, 1984, TXB POLYM SCI
   BIOSTELLE R, 1990, J CRYST GROWTH, V102, P609
   CLARKE KI, 1991, BIOCERAMICS, V4, P107
   CLARKE KIJ, 1991, THESIS U OXFORD
   CURREY JD, 1990, J MATER SCI-MATER M, V1, P14, DOI 10.1007/BF00705348
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   DOI Y, 1989, CALCIFIED TISSUE INT, V44, P200, DOI 10.1007/BF02556565
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GLIMCHER MJ, 1989, CONNECT TISSUE RES, V21, P179
   HARRIS B, 1986, ENG COMPOSITE MAT, pCH2
   MATHERS NJ, 1991, J MATER SCI LETT, V10, P992, DOI 10.1007/BF00721823
   MATHERS NJ, 1990, THESIS U OXFORD
   Nancollas G H, 1989, Connect Tissue Res, V21, P239, DOI 10.3109/03008208909050013
   NANCOLLAS GH, 1989, BIOMINERALIZATION CH, pCH6
   SASAKI N, 1989, BIOMATERIALS, V10, P129, DOI 10.1016/0142-9612(89)90046-X
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
NR 18
TC 76
Z9 80
U1 1
U2 6
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1993
VL 4
IS 2
BP 107
EP 110
DI 10.1007/BF00120378
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LB029
UT WOS:A1993LB02900003
DA 2018-10-20
ER

PT J
AU ERIKSSON, AS
   THOMSEN, P
AF ERIKSSON, AS
   THOMSEN, P
TI IMPLANT EXUDATE LEUKOCYTE RESPONSE TO ANTIINFLAMMATORY DRUG-TREATMENT
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NEUTROPHIL FUNCTION; PROSTAGLANDIN
   BIOSYNTHESIS; RHEUMATOID-ARTHRITIS; CHEMI-LUMINESCENCE;
   IMMUNE-COMPLEXES; GLUCOCORTICOIDS; CHEMOTAXIS; INVITRO; INVIVO
AB Implantation of artificial materials elicits a local inflammatory response. In this study a chamber model technique, allowing sampling of the inflammatory exudate for further analysis in vitro, was used. Male Sprague Dawley rats were injected daily with two different anti-inflammatory drugs, betamethasone and indomethacin, and the local cellular response was compared with a control group. The retrieved exudate was evaluated with respect to the number of leucocytes, cell viability, differential counts and serum-opsonized zymosan stimulated chemiluminescence (CL). In all groups the majority of cells were polymorphonuclear granulocytes (PMNGs). Betamethasone and high-dose indomethacin (1.92 mg kg-1 body weight day-1) treatment caused a marked reduction in the number of accumulated leucocytes 6 days after implantation. A substantial inhibition of the CL response was observed 6 days after treatment with betamethasone (4.23 mg kg-1 body weight day-1). An increased CL responsiveness was observed after 24 h with low-dose indomethacin (0.03 mg kg-1 body weight day-1) and after 6 days with high-dose indomethacin (1.92 mg kg 1 body weight day-1) treatment. In summary, depending on the anti-inflammatory drug treatment, dose and time after implant surgery, either an inhibition or stimulation of leucocyte accumulation and activation was observed. This study shows the possibilities of sampling the inflammatory exudate adjacent to a biomaterial implanted in vivo. This chamber model may be useful for the analysis of the inflammatory reaction around an implanted biomaterial during pharmacological treatment.
RP ERIKSSON, AS (reprint author), UNIV GOTEBORG, DEPT ANAT, MEDICINAREGATAN 3, S-41390 GOTHENBURG, SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ABRAMSON S, 1989, CLIN EXP RHEUMATOL, V7, pS163
   ABRAMSON S, 1985, P NATL ACAD SCI USA, V82, P7227, DOI 10.1073/pnas.82.21.7227
   ABRAMSON SB, 1990, INFLAMMATION, V14, P11, DOI 10.1007/BF00914026
   ALLRED CD, 1978, INFECT IMMUN, V19, P833
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BELCH JJF, 1989, SCAND J RHEUMATOL, V18, P213, DOI 10.3109/03009748909099931
   BJURSTEN LM, 1988, ADV BIOMATER, V8, P37
   BRIHEIM G, 1988, INFLAMMATION, V12, P141, DOI 10.1007/BF00916397
   BURKER K, 1913, HDB PHYSL METHODIK, P1
   CHANG DM, 1990, J RHEUMATOL, V17, P1148
   CHESON BD, 1976, J CLIN INVEST, V58, P789, DOI 10.1172/JCI108530
   CHEUNG K, 1984, AUST J EXP BIOL MED, V62, P403, DOI 10.1038/icb.1984.39
   CLARK RAF, 1979, BLOOD, V53, P633
   CROWELL RE, 1990, INFLAMMATION, V14, P163, DOI 10.1007/BF00917455
   DANON A, 1978, NATURE, V273, P552, DOI 10.1038/273552a0
   DAYNES RA, 1989, EUR J IMMUNOL, V19, P2319, DOI 10.1002/eji.1830191221
   DIROSA M, 1979, BRIT J PHARMACOL, V66, P161
   DIROSA M, 1972, J PATHOL, V105, P239
   ERIKSSON AS, 1992, ANESTHESIOLOGY, V77, P74, DOI 10.1097/00000542-199207000-00011
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   FLOMAN Y, 1976, PROSTAGLANDINS, V12, P403, DOI 10.1016/0090-6980(76)90021-6
   FLOWER R, 1972, NATURE-NEW BIOL, V238, P104
   FRANK DE, 1986, J LEUKOCYTE BIOL, V40, P693
   GRETZER C, IN PRESS
   HIGGS GA, 1980, EUR J PHARMACOL, V66, P81, DOI 10.1016/0014-2999(80)90297-6
   HIGGS GA, 1984, ADV INFLAMMAT RES, P223
   HIRSCHELMANN R, 1988, BIOMED BIOCHIM ACTA, V47, pS316
   HORAN TD, 1983, IMMUNOPHARMACOLOGY, V6, P97, DOI 10.1016/0162-3109(83)90003-6
   HUNT JA, 1992, J MATER SCI-MATER M, V3, P160, DOI 10.1007/BF00713443
   IP M, 1990, BRIT J RHEUMATOL, V29, P363
   KANTROWITZ F, 1975, NATURE, V258, P737, DOI 10.1038/258737a0
   KAPLAN HB, 1984, BIOCHEM PHARMACOL, V33, P371, DOI 10.1016/0006-2952(84)90228-4
   KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129
   KURIHARA A, 1984, J PHARMACOBIO-DYNAM, V7, P747
   LACKIE JM, 1988, J CELL SCI, V89, P449
   MACGREGOR RR, 1977, ANN INTERN MED, V86, P35, DOI 10.7326/0003-4819-86-1-35
   MAJESKI JA, 1976, J SURG RES, V21, P265, DOI 10.1016/0022-4804(76)90036-6
   MCGILLEN J, 1980, J INFECT DIS, V141, P382, DOI 10.1093/infdis/141.3.382
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   PARENTE L, 1978, POL J PHARMACOL PHAR, V30, P141
   RINGROSE PS, 1975, BIOCHEM PHARMACOL, V24, P607, DOI 10.1016/0006-2952(75)90181-1
   ROBINSON DR, 1989, CLIN EXP RHEUMATOL, V7, pS155
   ROLAPLESZCZYNSKI M, 1985, IMMUNOL TODAY, V6, P302, DOI 10.1016/0167-5699(85)90181-1
   SAEED SA, 1988, BIOCHEM MED METAB B, V40, P143, DOI 10.1016/0885-4505(88)90115-6
   SAMUELSSON B, 1979, PATHWAYS ARACHIDONIC, P405
   SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598
   SCREIBER H, 1990, J EXP CHIR TRANSPLAN, V23, P23
   SEKIZUKA E, 1989, AM J PHYSIOL, V256, pH594
   SHEA C, 1978, ANN CLIN LAB SCI, V8, P30
   THOMPSON EB, 1974, METABOLISM, V23, P159, DOI 10.1016/0026-0495(74)90113-9
   THOMSEN P, 1986, INFLAMMATION, V10, P243, DOI 10.1007/BF00916120
   THOMSEN P, 1987, BIOMATERIALS CLIN AP, P615
   VANDYKE K, 1977, MICROCHEM J, V22, P463, DOI 10.1016/0026-265X(77)90114-X
   VANEPPS DE, 1987, INFLAMMATION, V11, P59, DOI 10.1007/BF00917772
   VANEPPS DE, 1980, J CLIN INVEST, V66, P167, DOI 10.1172/JCI109841
   WEBB DSA, 1987, J LEUKOCYTE BIOL, V41, P156
   WILDFEUR A, 1983, Z RHEUMATOL, V42, P356
NR 59
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1993
VL 4
IS 2
BP 186
EP 191
DI 10.1007/BF00120390
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LB029
UT WOS:A1993LB02900015
DA 2018-10-20
ER

PT J
AU LAQUERRIERE, A
   YUN, J
   TIOLLIER, J
   HEMET, J
   TADIE, M
AF LAQUERRIERE, A
   YUN, J
   TIOLLIER, J
   HEMET, J
   TADIE, M
TI EXPERIMENTAL EVALUATION OF BILAYERED HUMAN COLLAGEN AS A DURAL
   SUBSTITUTE
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE DURAL DEFECT REPAIR; DURAL SUBSTITUTE; COLLAGEN; BIOMATERIAL
ID GRAFT; FILM
AB Many substances have been tried as possible dural substitutes, and different tissues and materials have been evaluated for use in dural repair; however, an entirely satisfactory solution still remains to be found. The authors report an experimental study involving the closure of dural defects in dogs with a new biomaterial, resorbable bilayered human placental collagen, using two types of collagen material. These include a collagen bilayered dural substitute made of oxidized type III + I collagen layer covered by a type IV oxidized collagen film (collagen dural substitute I) and a collagen bilayered dural substitute made of oxidized type III + I collagen layer covered by a type III + I collagen film (collagen dural substitute II). Macroscopic and histological examination, performed over a period of between 15 and 180 days after implantation, showed the resorption of collagen graft and formation of a neomembrane that looked like a neodura within 3 months. No infection and no cerebrospinal fluid fistulae were noticed. Nevertheless, one slight cerebromembranous adhesion was found with collagen dural substitute II. The authors suggest that human resorbable collagen biomaterial could be used as a very satisfactory dural substitute.
C1 VER MED, NEUROCHIRURG EXPTL LAB, BLVD UNIV, F-76800 ST ETIENNE, FRANCE.
   LAB ANAT & CYTOL PATHOL, ROUEN, FRANCE.
   IMEDEX CORP, CHAPONOST, FRANCE.
CR ADEGBITE AB, 1983, J NEUROSURG, V58, P295, DOI 10.3171/jns.1983.58.2.0295
   CAMPBELL JB, 1958, J NEUROSURG, V15, P207, DOI 10.3171/jns.1958.15.2.0207
   Chao YC, 1940, BMJ-BRIT MED J, V1940, P517, DOI 10.1136/bmj.1.4134.517
   COHEN AR, 1989, J NEUROSURG, V70, P633, DOI 10.3171/jns.1989.70.4.0633
   Delarue NC, 1944, J NEUROSURG, V1, P239, DOI 10.3171/jns.1944.1.4.0239
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   DUPONT D, 1989, CORNEA, V8, P251
   INGRAHAM FD, 1945, JAMA-J AM MED ASSOC, V128, P1088, DOI 10.1001/jama.1945.02860320030008
   KEENER EB, 1959, J NEUROSURG, V16, P415, DOI 10.3171/jns.1959.16.4.0415
   KLINE DG, 1965, ARCH SURG-CHICAGO, V91, P924
   LEHMAN RAW, 1967, J NEUROSURG, V26, P92, DOI 10.3171/jns.1967.26.1part1.0092
   MASON MS, 1961, ANN SURG, V153, P423, DOI 10.1097/00000658-196103000-00014
   MAURER PK, 1985, J NEUROSURG, V63, P448, DOI 10.3171/jns.1985.63.3.0448
   MORGON A, 1989, ACTA OTO-LARYNGOL, V107, P450, DOI 10.3109/00016488909127539
   NUSSBAUM CE, 1989, J NEUROSURG, V71, P124, DOI 10.3171/jns.1989.71.1.0124
   ONEILL P, 1984, J NEUROSURG, V61, P351, DOI 10.3171/jns.1984.61.2.0351
   ONGKIKO CM, 1984, J NEUROSURG, V60, P1076, DOI 10.3171/jns.1984.60.5.1076
   PENFIELD WG, 1924, SURG GYNECOL OBSTET, V39, P903
   Pudenz RH, 1942, SURGERY, V12, P318
   ROBERTSON RCL, 1945, J NEUROSURG, V2, P281, DOI 10.3171/jns.1945.2.4.0281
   ROSOMOFF HL, 1959, J NEUROSURG, V16, P197, DOI 10.3171/jns.1959.16.2.0197
   SARMAH BD, 1984, BRIT J SURG, V71, P524, DOI 10.1002/bjs.1800710717
   SHARKEY PC, 1958, J NEUROSURG, V15, P192, DOI 10.3171/jns.1958.15.2.0192
   SIMPSON D, 1984, J NEUROSURG, V60, P408, DOI 10.3171/jns.1984.60.2.0408
   TENG P, 1955, J NEUROSURG, V12, P591, DOI 10.3171/jns.1955.12.6.0591
   THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766
   TINOIS E, 1991, EXP CELL RES, V193, P310, DOI 10.1016/0014-4827(91)90102-Z
   TIOLLIER J, 1990, EXP CELL RES, V191, P95, DOI 10.1016/0014-4827(90)90041-8
NR 28
TC 64
Z9 66
U1 0
U2 1
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 0022-3085
EI 1933-0693
J9 J NEUROSURG
JI J. Neurosurg.
PD MAR
PY 1993
VL 78
IS 3
BP 487
EP 491
DI 10.3171/jns.1993.78.3.0487
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA KN936
UT WOS:A1993KN93600018
PM 8433154
DA 2018-10-20
ER

PT J
AU IRIGARAY, JL
   OUDADESSE, H
   BLONDIAUX, G
   COLLANGETTES, D
AF IRIGARAY, JL
   OUDADESSE, H
   BLONDIAUX, G
   COLLANGETTES, D
TI KINETICS OF THE DIFFUSION OF SOME ELEMENTS EVALUATED BY
   NEUTRON-ACTIVATION IN A CORAL IMPLANTED INVIVO
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article; Proceedings Paper
CT 8TH INTERNATIONAL CONF ON MODERN TRENDS IN ACTIVATION ANALYSIS ( MTAA 8
   )
CY SEP 16-20, 1991
CL AUSTRIA
SP AUSTRIAN SOC ENVIRONM & RADIOCHEM, INT ATOM ENERGY AGCY
AB Some studies show that a coral implanted on bone tissue is gradually transformed to become a neoformed bone. In our work, we have, for the first time, determined quantitatively by NAA the transformation of a coral used as a biomaterial implanted ''in vivo'' in some ovine jaw-bones. Each month and during 9 months, biopsies were extracted. For neutron production, the nuclear reaction Be-9(d, n)B-10 was used with 17.5 MeV energy deuterons- The neutrons had a mean energy of 7 McV and a flux of 10(12) n CM-2 S-1. The radioactivation generated permitted concentration measurements of Ca, P, Mg, Sr and F in each part of the biopsies and a study of mineral transformations versus time in the coral implanted. Three months after implantation, Ca belonging to CaCO3 represented 11 % and Ca provided by the apatite formed represented 20% of the total mass. These quantitative evaluations clearly showed that five months after implantation, the coral had become a neo-formed bone.
C1 CERI,CNRS,F-45071 ORLEANS 2,FRANCE.
   CTR JEAN PERRIN,F-63000 CLERMONT FERRAND,FRANCE.
   UNIV CLERMONT FERRAND,F-63177 CLERMONT FERRAND,FRANCE.
RP IRIGARAY, JL (reprint author), LAB PHYS CORPUSCULAIRE CLERMONT FERRAND,IN2P3,NCRS,F-63177 CLERMONT FERRAND,FRANCE.
CR BREBERI N, 1983, MED MED, V57, P4
   GUILLEMIN G, 1987, BIOMAT 87
   HEUGUEBAERT JC, 1977, THESIS I NATIONAL PO
   IRIGARAY JL, 1989, APR C INT GAITH MAR
   IRIGARAY JL, 1987, DEC C INT BIOMAT
   MELKI S, 1986, THESIS CERI ORLEANS
   SIMONNET G, 1980, MESURES RADIOACTIVIT
NR 7
TC 10
Z9 11
U1 0
U2 1
PU AKADEMIAI KIADO
PI BUDAPEST
PA PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD MAR
PY 1993
VL 169
IS 2
BP 339
EP 346
DI 10.1007/BF02042992
PG 8
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA KX898
UT WOS:A1993KX89800010
DA 2018-10-20
ER

PT J
AU ASHOUR, I
   HAMMAM, H
AF ASHOUR, I
   HAMMAM, H
TI EQUILIBRIUM SOLUBILITY OF PURE MONOLAURIN, DILAURIN, AND TRILAURIN IN
   SUPERCRITICAL CARBON-DIOXIDE - EXPERIMENTAL MEASUREMENTS AND MODEL
   PREDICTION
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE EQUILIBRIUM SOLUBILITY; BIOMATERIAL; EQUATION-OF-STATE; SUPERCRITICAL
   CARBON DIOXIDE; SOLUTE SOLUTE INTERACTION
ID VAPOR LIQUID EQUILIBRIA; FATTY-ACIDS; BINARY-MIXTURES; ESTERS; OILS
AB By use of an experimental dynamic apparatus, the solubility of lipids in supercritical carbon dioxide has been established at 308, 313, 323, and 333 K for trilaurin and at 313 and 338 K for mono- and dilaurin, at a pressure ranging from 150 to 400 bar. The solubility data obtained at 308 and 313 K was correlated with a cubic equation-of-state. The effect of solute-solute interaction parameter has been studied. The equation with three binary interaction parameters gave accurate predictions.
C1 LUND UNIV,DEPT FOOD TECHNOL,S-22100 LUND,SWEDEN.
RP ASHOUR, I (reprint author), LUND UNIV,DEPT CHEM ENGN 1,POB 124,S-22100 LUND,SWEDEN.
CR ADAMS WR, 1988, AICHE J, V34, P1387, DOI 10.1002/aic.690340820
   ASHOUR I, 1989, THESIS LUND U
   ASHOUR I, 1990, PHASE EQUILIBRIA NON
   ASHOUR I, 1990, AUG CHISA 90 PRAH
   BAMBERGER T, 1988, J CHEM ENG DATA, V33, P327, DOI 10.1021/je00053a029
   BHARATH R, 1989, FLUID PHASE EQUILIBR, V50, P315, DOI 10.1016/0378-3812(89)80298-5
   BRENNECKE JF, 1989, ACS S SERIES, V406
   BRUNETTI L, 1989, J AM OIL CHEM SOC, V66, P209, DOI 10.1007/BF02546062
   BRUNNER G, 1978, THESIS U ERLANGEN
   CHRASTIL J, 1982, J PHYS CHEM-US, V86, P3016, DOI 10.1021/j100212a041
   HAMMAM H, IN PRESS FAT SCI
   HIROHAMA S, 1986, THESIS TOKOKU U
   INOMATA H, 1989, FLUID PHASE EQUILIBR, V46, P41, DOI 10.1016/0378-3812(89)80273-0
   KING MB, 1983, CHEM ENG SUPERCRITIC, pCH2
   KRAMER A, 1988, J CHEM ENG DATA, V33, P230, DOI 10.1021/je00053a002
   LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905
   MCHUGH MA, 1986, SUPERCRITICAL FLUID
   OHGAKI K, 1989, INT CHEM ENG, V29, P302
   PETER S, 1980, EFCE PUBLICATION SER, P355
   Prausnitz J. M., 1986, MOL THERMODYNAMICS F
   QUIRIN KW, 1982, FETT WISS TECHNOL, V84, P460, DOI 10.1002/lipi.19820841203
   Reid R. C., 1987, PROPERTIES GASES LIQ
   SAITO K, 1989, Patent No. 1117845
   SANDERS TAB, 1981, BRIT J NUTR, V45, P613, DOI 10.1079/BJN19810139
   SCHMITT WJ, 1988, CHEM ENG COMMUN, V64, P155, DOI 10.1080/00986448808940234
   Stahl E., 1987, DENSE GASES EXTRACTI
   Swern D., 1979, BAILEYS IND OIL FAT
   von Lossonczy T O, 1978, Am J Clin Nutr, V31, P1340
   WU AH, 1987, LBL24201 U CAL
   Zou M., 1990, J SUPERCRIT FLUID, V3, P85
   Zou M., 1990, J SUPERCRIT FLUID, V3, P23
NR 31
TC 20
Z9 20
U1 0
U2 4
PU PRA PRESS
PI CINCINNATI
PA POLYMER RES ASSOC INC 9200 MONTGOMERY RD, SUITE 23B, CINCINNATI, OH
   45242
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD MAR
PY 1993
VL 6
IS 1
BP 3
EP 8
DI 10.1016/0896-8446(93)90003-G
PG 6
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA LU706
UT WOS:A1993LU70600001
DA 2018-10-20
ER

PT J
AU WALTON, RL
   BROWN, RE
AF WALTON, RL
   BROWN, RE
TI TISSUE ENGINEERING OF BIOMATERIALS FOR COMPOSITE RECONSTRUCTION - AN
   EXPERIMENTAL-MODEL
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID REGENERATION; GAP
AB The fibrovascular integration of a biomaterial scaffold was examined in a rabbit model. Eight disks of expanded polytetrafluoroethylene measuring 2 x 2 x 0.2 cm were placed adjacent to dissected vascular pedicles in the ears of four rabbits and sealed between leaves of silicone sheeting. Fibrovascular outgrowth from the vascular pedicles completely integrated the biomaterial scaffolds by 6 weeks and was sufficient to sustain split-thickness skin grafts. Division of the distal vascular pedicle allowed isolation of the blood flow circuit to the construct. Successful microsurgical transfer was achieved in one construct. This model has proved useful in the study of tissue engineering of biomaterials for reconstruction and may well have use in the study of neovascularization as an isolated event.
C1 SO ILLINOIS UNIV,DIV PLAST SURG,SPRINGFIELD,IL 62708.
RP WALTON, RL (reprint author), UNIV MASSACHUSETTS,MED CTR,DIV PLAST & RECONSTRUCT SURG,55 LAKE AVE N,S4-751,WORCESTER,MA 01655, USA.
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ARNOLD J, 1872, VIRCHOWS ARCH PATH A, V54, P1
   BRENT B, 1980, PLAST RECONSTR SURG, V66, P1
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   CRONIN TD, 1966, PLAST RECONSTR SURG, V37, P399, DOI 10.1097/00006534-196605000-00003
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   FISHER J, 1988, PLAST RECONSTR SURG, V82, P857, DOI 10.1097/00006534-198811000-00021
   FOLKMAN J, 1974, CANCER RES, V34, P2109
   GREENBLATT M, 1971, TRANSPLANTATION, V2, P50
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   HUDLICKA O, 1986, GROWTH VESSELS INVIT, P27
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   KHOURI RK, 1991, 36TH ANN M CHARL
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   LANGHAM M, 1953, BRIT J OPHTHALMOL, V37, P210, DOI 10.1136/bjo.37.4.210
   LUNDBORG G, 1982, J NEUROPATH EXP NEUR, V41, P412, DOI 10.1097/00005072-198207000-00004
   PADGETT EC, 1938, GYNECOL OBSTET, V67, P761
   Sandison JC, 1928, AM J ANAT, V41, P447, DOI 10.1002/aja.1000410303
   SEVASTJANOVA NA, 1987, BIOMATERIALS, V8, P242, DOI 10.1016/0142-9612(87)90110-4
   TANZER R C, 1959, Plast Reconstr Surg Transplant Bull, V23, P1
   ZETTER BR, 1981, DIABETES, V30, P24, DOI 10.2337/diab.30.2.S24
NR 23
TC 24
Z9 25
U1 1
U2 7
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD FEB
PY 1993
VL 30
IS 2
BP 105
EP 110
DI 10.1097/00000637-199302000-00002
PG 6
WC Surgery
SC Surgery
GA KL870
UT WOS:A1993KL87000002
PM 7683854
DA 2018-10-20
ER

PT J
AU KINOSHITA, Y
   KUZUHARA, T
   KIRIGAKUBO, M
   KOBAYASHI, M
   SHIMURA, K
   IKADA, Y
AF KINOSHITA, Y
   KUZUHARA, T
   KIRIGAKUBO, M
   KOBAYASHI, M
   SHIMURA, K
   IKADA, Y
TI SOFT-TISSUE REACTION TO COLLAGEN-IMMOBILIZED POROUS POLYETHYLENE -
   SUBCUTANEOUS IMPLANTATION IN RATS FOR 20 WK
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN IMMOBILIZATION; POLYETHYLENE; BIOCOMPATIBILITY; TISSUE ADHESION
AB Collagen-immobilized porous polyethylene, in which the immobilization was through covalent bonding, and virgin porous polyethylene were implanted subcutaneously in rats from 1 to 20 wk. The results were the ingrowth of the connective tissue into collagen-immobilized porous polyethylene was rich and contained a low level of inflammatory cellular infiltration compared with that of virgin porous polyethylene. The material-tissue interface showed that the living body-originated collagen fibres were firmly anchored into the immobilized collagen layer. These results suggested that covalent immobilization of collagen on to the biomaterial surface is useful in promoting the ingrowth of soft tissue and the tissue adhesion.
C1 KYOTO UNIV,BIOMED ENGN RES CTR,DEPT BIOMAT,REG MOLEC DESIGN BIOMAT,KYOTO 606,JAPAN.
RP KINOSHITA, Y (reprint author), KANAGAWA DENT COLL,DEPT ORAL & MAXILLOFACIAL SURG,YOKOSUKA,JAPAN.
CR BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   BOLTONMAGGS PHB, 1979, THORAX, V34, P561, DOI 10.1136/thx.34.4.561
   EDGERTON M T, 1958, Plast Reconstr Surg Transplant Bull, V21, P279, DOI 10.1097/00006534-195804000-00005
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   HINO T, 1983, BIOMATERIALS, V1, P5
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LEWIN-EPSTEIN J, 1960, J Oral Surg Anesth Hosp Dent Serv, V18, P453
   OKADA T, 1987, BIOMATERIALS CLIN AP, P465
   Osborn J. F., 1980, DENT IMPLANTS MAT SY, P111
   PANGMAN WJ, 1960, W J SURG OBSTET  AUG, P503
   PETERS WJ, 1981, PLAST RECONSTR SURG, V67, P514, DOI 10.1097/00006534-198104000-00017
   ROB CG, 1956, BRIT J SURG, V43, P449, DOI 10.1002/bjs.18004318102
   SHABER EP, 1987, INT J ORAL MAX SURG, V16, P678, DOI 10.1016/S0901-5027(87)80052-8
   SHIMIZU Y, 1977, BIOMATER ARTIF CELL, V5, P49, DOI 10.3109/10731197709118665
   SHIMIZU Y, 1978, BIOMATER ARTIF CELL, V6, P375, DOI 10.3109/10731197809119795
NR 15
TC 30
Z9 30
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1993
VL 14
IS 3
BP 209
EP 215
DI 10.1016/0142-9612(93)90025-W
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KR055
UT WOS:A1993KR05500008
PM 8476994
DA 2018-10-20
ER

PT J
AU FRADIN, D
   CAUSS, T
   RABAUD, M
   DEMASCAREL, A
   FONTAN, F
AF FRADIN, D
   CAUSS, T
   RABAUD, M
   DEMASCAREL, A
   FONTAN, F
TI PRELIMINARY EXPERIMENTAL RESULTS OF A NEW RESORBABLE BIOMATERIAL AS
   PERICARDIAL SUBSTITUTE
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Letter
RP FRADIN, D (reprint author), HOP CARDIOL HAUT LEVEQUE,F-33604 PESSAC,FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
NR 2
TC 3
Z9 3
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 1993
VL 105
IS 2
BP 364
EP 365
PG 2
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA KL967
UT WOS:A1993KL96700024
PM 8429665
DA 2018-10-20
ER

PT J
AU GUO, WD
   ANDERSSON, R
   SHEN, W
   LJUNGH, A
   BENGMARK, S
   WADSTROM, T
AF GUO, WD
   ANDERSSON, R
   SHEN, W
   LJUNGH, A
   BENGMARK, S
   WADSTROM, T
TI BINDING OF ESCHERICHIA-COLI TO PENROSE RUBBER DRAINS - AN INVITRO STUDY
SO ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL
   MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; SURFACE HYDROPHOBICITY; AGGREGATION;
   ADHERENCE; ADHESION; BACTERIA; COAGGREGATION; BIOMATERIAL; TRANSLOCATE;
   CATHETERS
AB Ten different isolates of Escherichia coli were used to compare bacterial attachment to Penrose rubber drains at different temperatures and to investigate a possible relation with cell surface hydrophobicity and charges, as well as the capacity of autoaggregation. Penrose rubber drain pieces of 1 cm2 were incubated with 4.8 X 10(6)  E. coli cells for 1 h at 22, 37 and 42-degrees-C, respectively. After rinsing with phosphate buffered saline (PBS), the number of adhering bacteria on the drain pieces was calculated by measuring cellular ATP (adenosine triphosphate) bioluminescence. Bacterial cell surface properties at different temperatures were determined by two-phase partitioning and autoaggregation was determined by arbitrary scoring under the dissecting microscope. For most strains of E. coli, the number of adherence to Penrose rubber drain was higher at 22-degrees-C than at 37-degrees-C and 42-degrees-C. Bacterial cell-surface properties and autoaggregation capacity were influenced by the growth temperature, but without correlation to bacterial ability to attach to rubber drains. Thus, the present study demonstrates that attachment of E. coli to Penrose rubber drains was significantly influenced by temperature, but bacterial cell-surface hydrophobicity and charge as well as autoaggregation capacity had no influence on bacterial attachment ability.
C1 UNIV LUND,DEPT SURG,S-22185 LUND,SWEDEN.
   UNIV LUND,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR ASCENCIO F, 1990, APPL ENVIRON MICROB, V56, P1926
   BLAKE M, 1989, J MED MICROBIOL, V28, P9, DOI 10.1099/00222615-28-1-9
   BRUCE AW, 1984, J UROLOGY, V132, P184, DOI 10.1016/S0022-5347(17)49516-4
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARTY D W S, 1991, Microbial Ecology in Health and Disease, V4, P19
   HOGT AH, 1985, A VAN LEEUW J MICROB, V51, P510, DOI 10.1007/BF00404506
   KLUGER MJ, 1991, FEVER BASIC MECHANIS, P105
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   LJUNGH A, 1985, INFECT IMMUN, V47, P522
   Loosdrecht MCV, 1987, APPL ENVIRON MICROB, V53, P1893
   LUDWICKA A, 1985, J MICROBIOL METH, V4, P164
   LUNDIN A, 1986, METHOD ENZYMOL, V133, P27
   Mackowiak P.A., 1991, FEVER BASIC MECH MAN, P167
   MORA EM, 1989, MICROECOL T, V19, P185
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   REID G, 1990, CURR MICROBIOL, V20, P185, DOI 10.1007/BF02091995
   REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063
   REID G, 1990, CURR MICROBIOL, V20, P47, DOI 10.1007/BF02094024
   REIFSTECK F, 1987, J MED MICROBIOL, V24, P65, DOI 10.1099/00222615-24-1-65
   RIDRIGUEZ JL, 1986, CURR SURG, P423
   Roberts NJ., 1991, FEVER BASIC MECHANIS, P125
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   VANHAECKE E, 1990, APPL ENVIRON MICROB, V56, P788
   WELLS CL, 1986, ARCH SURG-CHICAGO, V121, P102
NR 27
TC 1
Z9 1
U1 0
U2 0
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8840
J9 ZBL BAKT-INT J MED M
JI Zent.bl. Bakteriol.-Int. J. Med. Microbiol. Virol. Parasitol. Infect.
   Dis.
PD FEB
PY 1993
VL 278
IS 1
BP 73
EP 82
DI 10.1016/S0934-8840(11)80281-1
PG 10
WC Microbiology; Virology
SC Microbiology; Virology
GA KY780
UT WOS:A1993KY78000007
PM 8518515
DA 2018-10-20
ER

PT J
AU VAQUERO, J
   ARIAS, A
   OYA, S
   MARTINEZ, R
   ZURITA, M
AF VAQUERO, J
   ARIAS, A
   OYA, S
   MARTINEZ, R
   ZURITA, M
TI EFFECT OF FIBRIN GLUE ON POSTLAMINECTOMY SCAR FORMATION
SO ACTA NEUROCHIRURGICA
LA English
DT Article
DE FIBRIN GLUE; EPIDURAL SCAR; LAMINECTOMY
ID LUMBAR SPINE; LAMINECTOMY; SURGERY; GRAFTS
AB An experimental study in rats has been carried out with the aim of studying the scar formation over the spinal dura in the presence of fibrin glue. Although the main action of fibrin glue is the enhancement of wound healing by increasing the fibrous tissue, our present data suggest that this re-absorbable biomaterial diminishes the epidural scar formation, at least the first two weeks after laminectomy. This finding leads us to consider the use of fibrin glue over spinal duramater when it is likely that reoperation may become necessary in a short period of time after a laminectomy .
C1 UNIV COMPLUTENSE MADRID, DEPT CELLULAR BIOL, MADRID 3, SPAIN.
RP VAQUERO, J (reprint author), AUTONOMOUS UNIV MADRID, PUERTA HIERRO CLIN, DEPT NEUROSURG, SAN MARTIN DE PORRES 4, E-28035 MADRID, SPAIN.
CR BARBERA J, 1978, J NEUROSURG, V49, P419, DOI 10.3171/jns.1978.49.3.0419
   BENOIST M, 1980, SPINE, V5, P432, DOI 10.1097/00007632-198009000-00007
   BRODSKY AE, 1976, CLIN ORTHOP RELAT R, P130
   BRYANT MS, 1983, NEUROSURGERY, V13, P367, DOI 10.1227/00006123-198310000-00003
   CABEZUDO JM, 1985, J NEUROSURG, V63, P633, DOI 10.3171/jns.1985.63.4.0633
   DEVILLIERS PD, 1976, CLIN ORTHOP RELAT R, P140
   Gill G G, 1979, Spine (Phila Pa 1976), V4, P176, DOI 10.1097/00007632-197903000-00016
   JACOBS RR, 1980, SPINE, V5, P223, DOI 10.1097/00007632-198005000-00004
   KELLER JT, 1978, J NEUROSURG, V49, P412, DOI 10.3171/jns.1978.49.3.0412
   KIVILUOTO O, 1988, ACTA ORTHOP SCAND S, V164, P3
   LANGENSKIOLD A, 1976, CLIN ORTHOP RELAT R, V115, P92
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   LEE CK, 1984, SPINE, V9, P305, DOI 10.1097/00007632-198404000-00016
   MARTINFERRER S, 1989, NEUROSURGERY, V24, P718, DOI 10.1227/00006123-198905000-00010
   NUSSBAUM CE, 1990, NEUROSURGERY, V26, P649, DOI 10.1227/00006123-199004000-00014
   ROSSITCH E, 1990, NEUROSURGERY UPDATE, V1, P195
NR 16
TC 29
Z9 29
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
EI 0942-0940
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PY 1993
VL 120
IS 3-4
BP 159
EP 163
DI 10.1007/BF02112036
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA KQ283
UT WOS:A1993KQ28300011
PM 8460569
DA 2018-10-20
ER

PT J
AU KE, HYD
   RAYSON, GD
AF KE, HYD
   RAYSON, GD
TI LUMINESCENCE STUDY OF UO-2(2+) BINDING TO IMMOBILIZED DATURA-INNOXIA
   BIOMATERIAL
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE LASER-INDUCED FLOURESCENCE SPECTROSCOPY; URANYL LUMINESCENCE;
   FLUORESCENCE LIFETIME; LUMINESCENCE SPECTRAL ANALYSIS; FLUORESCENCE
   EMISSION SPECTRA; BIOMASS MATERIAL
ID METAL
AB The spectrally and temporally resolved UO2(2+) fluorescence signals have been measured for solid samples of UO2(2+)-Datura, UO2(2+)-immobilized Datura), and UO2(2+)-(silicate polymer) at liquid nitrogen temperature. The binding capacity of UO2(2+) to Datura innoxia cell material has been enhanced significantly at pH 5 and 6 when immobilized in a polysilicate matrix. New binding sites having a greater binding strength with a lower availability have been observed for the binding of UO2(2+) after immobilization of the cultured biomaterial. However, chemical alteration of the cell material resulting from this immobilization process has not been observed. The chemical environment of the binding sites responsible for the binding of UO2(2+) in immobilized and free D. innoxia cell material has been demonstrated to be different. This difference results from the immobilization of the cell material within a polysilicate matrix.
C1 NEW MEXICO STATE UNIV,DEPT CHEM,LAS CRUCES,NM 88003.
CR BELL JT, 1968, J MOL SPECTROSC, V25, P312, DOI 10.1016/S0022-2852(68)80045-1
   DARNALL DW, 1991, Patent No. 4992207
   DIEKE GH, 1949, SPECTROSCOPIC PROPER, P36
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   Good N E, 1972, Methods Enzymol, V24, P53
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   Iler RK, 1979, CHEM SILICA, P172
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KUBIAK WW, 1989, ANAL CHEM, V61, P468, DOI 10.1021/ac00180a018
   LARA AS, 1990, ORGANIC AMINE TAILOR, P10
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   RAYSON GD, 1992, APPL SPECTROSC, V46, P1245, DOI 10.1366/0003702924123999
   Weigel F, 1986, CHEM ACTINIDE ELEMEN, P169
NR 19
TC 9
Z9 9
U1 0
U2 0
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA PO BOX 1438, FREDERICK, MD 21701
SN 0003-7028
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD JAN
PY 1993
VL 47
IS 1
BP 44
EP 51
DI 10.1366/0003702934048569
PG 8
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA KK259
UT WOS:A1993KK25900010
DA 2018-10-20
ER

PT B
AU ECKERT, KL
   ROSLER, U
   MATHEY, M
   MAYER, J
   WINTERMANTEL, E
   HOFMANN, H
AF ECKERT, KL
   ROSLER, U
   MATHEY, M
   MAYER, J
   WINTERMANTEL, E
   HOFMANN, H
BE Ducheyne, P
   Christiansen, D
TI OPEN POROUS CERAMICS FOR CELL TRANSPLANTATION DEVICES - A NEW
   BIOMATERIAL 1ST RESULTS
SO BIOCERAMICS, VOL 6
LA English
DT Proceedings Paper
CT 6th International Symposium on Ceramics in Medicine
CY NOV, 1993
CL PHILADELPHIA, PA
C1 ETH ZURICH,CHAIR BIOCOMPATIBLE MAT SCI & ENGN,CH-8952 SCHLIEREN,SWITZERLAND.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BUTTERWORTH-HEINEMANN
PI OXFORD
PA LINACRE HOUSE, JORDAN HILL, OXFORD, OXON, ENGLAND OX2 8DP
BN 0-7506-1884-1
PY 1993
BP 251
EP 255
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BA02R
UT WOS:A1993BA02R00039
DA 2018-10-20
ER

PT J
AU SERRE, CM
   PAPILLARD, M
   CHAVASSIEUX, P
   BOIVIN, G
AF SERRE, CM
   PAPILLARD, M
   CHAVASSIEUX, P
   BOIVIN, G
TI INVITRO INDUCTION OF A CALCIFYING MATRIX BY BIOMATERIALS CONSTITUTED OF
   COLLAGEN AND OR HYDROXYAPATITE - AN ULTRASTRUCTURAL COMPARISON OF 3
   TYPES OF BIOMATERIALS
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN SPONGE; HYDROXYAPATITE; CALCIFICATION; OSTEOBLASTS
ID PERIODONTAL DEFECTS; BONE-CELLS; OSTEOBLASTS; MINERALIZATION; RESPONSES;
   SUBSTRATA; IMPLANTS; CULTURES; CERAMICS; BEHAVIOR
AB The induction of a calcifying matrix was studied in vitro and compared for three biomaterials (collagen sponge, hydroxyapatite material and a mixture of both (Biostite(R))) cultured with human osteoblast-like cells. The influence of biomaterials on organic matrix synthesis and the calcification process was analysed at the ultrastructural level (transmission electron microscopy and X-ray microanalysis). Biomaterials were well tolerated by bone cells. Whichever biomaterial was used, osteoblasts proliferated and synthesized a new matrix constituted of fibrillar and non-fibrillar elements. This activity appeared earlier and was more intense with Biostite than with collagen sponge alone. A deposition of a mineral substance in this newly formed matrix was observed with the collagen sponge and Biostite, but never with hydroxyapatite alone. The mineral deposits were identified as hydroxyapatite crystals, similar to those observed and analysed in bone tissue. These in vitro observations clearly demonstrated the property of Biostite to produce a calcified collagenous matrix similar to bone tissue. However, in vivo confirmation is required before extending the use of this biomaterial to periodontology.
C1 FAC ODONTOL LYON,LYON,FRANCE.
RP SERRE, CM (reprint author), FAC A CARREL,INSERM,U234,LYON,FRANCE.
RI Chavassieux, Pascale/L-9071-2018
CR BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BARNEY VC, 1986, J PERIODONTOL, V57, P764, DOI 10.1902/jop.1986.57.12.764
   BLUMENTHAL N, 1986, J PERIODONTOL, V57, P84, DOI 10.1902/jop.1986.57.2.84
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BYE FL, 1987, J PERIODONTOL, V58, P110, DOI 10.1902/jop.1987.58.2.110
   CHAVASSIEUX PM, 1990, J BONE MINER RES, V5, P337, DOI 10.1002/jbmr.5650050406
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V262, P298
   LUBEN RA, 1976, ENDOCRINOLOGY, V99, P526, DOI 10.1210/endo-99-2-526
   MAOR G, 1987, COLLAGEN REL RES, V7, P351
   MINABE M, 1988, J PERIODONTOL, V59, P671, DOI 10.1902/jop.1988.59.10.671
   MOSKOW BS, 1983, J PERIODONTOL, V54, P455, DOI 10.1902/jop.1983.54.8.455
   PAPILLARD M, 1986, REACTIONS TISSULAIRE
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RODAN GA, 1975, SCIENCE, V189, P467, DOI 10.1126/science.168639
   ROSEN HM, 1990, PLAST RECONSTR SURG, V85, P718, DOI 10.1097/00006534-199005000-00011
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   YAFFE A, 1984, J PERIODONTOL, V55, P623, DOI 10.1902/jop.1984.55.11.623
   YAMADA S, 1986, Shikwa Gakuho, V86, P687
   YUKNA RA, 1989, J CLIN PERIODONTOL, V16, P398, DOI 10.1111/j.1600-051X.1989.tb01667.x
NR 24
TC 69
Z9 69
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 97
EP 106
DI 10.1016/0142-9612(93)90217-P
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500003
PM 8382091
DA 2018-10-20
ER

PT J
AU PULEO, DA
   PRESTON, KE
   SHAFFER, JB
   BIZIOS, R
AF PULEO, DA
   PRESTON, KE
   SHAFFER, JB
   BIZIOS, R
TI EXAMINATION OF OSTEOBLAST ORTHOPEDIC BIOMATERIAL INTERACTIONS USING
   MOLECULAR TECHNIQUES
SO BIOMATERIALS
LA English
DT Article
DE OSTEOBLASTS; OSTEONECTIN; OSTEOPONTIN; MESSENGER RNA; GENE EXPRESSION
ID BONE; OSTEOPONTIN; EXPRESSION; DIFFERENTIATION; OSTEONECTIN; PROTEIN;
   CLONING; INVITRO; GENE; RNA
AB Molecular techniques can be used to elucidate the effects of extended periods of cell-biomaterial interactions on the time-course and level of expression of particular genes which determine cellular phenotype. We used the polymerase chain reaction to demonstrate the expression of genes for the bone-related proteins osteocalcin, osteonectin and osteopontin by neonatal rat calvarial osteoblasts. In addition, Northern blotting was subsequently used to show that messenger RNAs encoding osteonectin and osteopontin were consistently expressed during a 5 wk period of interaction of osteoblasts with Ti-6Al-4V, a commercial brand of hydroxyapatite, and tissue culture polystyrene.
C1 RENSSELAER POLYTECH INST,DEPT BIOMED ENGN,TROY,NY 12180.
   NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201.
CR ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   BUTLER WT, 1985, CHEM BIOL MINERALIZE, P107
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   FRANZEN A, 1985, CHEM BIOL MINERALIZE, P279
   JINGUSHI S, 1990, BONE BIOMATERIAL INT
   KLEINSMITH LJ, 1988, PRINCIPLES CELL BIOL, P385
   MALIK MA, 1990, THESIS RENSSELAER PO
   MARK MP, 1987, J BONE MINER RES, V2, P337, DOI 10.1002/jbmr.5650020411
   MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Price PA., 1983, BONE MINERAL RES ANN, V1, P157
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   SHAFFER JB, 1990, BIOCHEM BIOPH RES CO, V173, P1043, DOI 10.1016/S0006-291X(05)80891-5
   SHAFFER JB, 1990, FREE RADICAL BIO MED, V8, P497, DOI 10.1016/0891-5849(90)90064-P
   STEIN GS, 1990, FASEB J, V4, P3111
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   TERMINE JD, 1985, CHEM BIOL MINERALIZE, P94
   WEINREB M, 1990, J BONE MINER RES, V5, P831
   YOON K, 1987, BIOCHEM BIOPH RES CO, V148, P1129, DOI 10.1016/S0006-291X(87)80250-4
   YOON K, 1988, BIOCHEMISTRY-US, V27, P8521, DOI 10.1021/bi00423a003
   YOUNG MF, 1986, NUCLEIC ACIDS RES, V14, P4483, DOI 10.1093/nar/14.11.4483
NR 26
TC 34
Z9 34
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 111
EP 114
DI 10.1016/0142-9612(93)90220-V
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500005
PM 8382089
DA 2018-10-20
ER

PT J
AU DION, I
   BAQUEY, C
   MONTIES, JR
   HAVLIK, P
AF DION, I
   BAQUEY, C
   MONTIES, JR
   HAVLIK, P
TI HEMOCOMPATIBILITY OF TI6AL4V-ALLOY
SO BIOMATERIALS
LA English
DT Article
DE TI ALLOY; HEMOCOMPATIBILITY
ID PROTEIN ADSORPTION; SURFACES
AB Ti6Al4V alloy has been mainly used as a biomaterial in the orthopaedic field. The present study describes the surface state of the Ti6Al4V material and evaluates its in vitro haemocompatibility in terms of protein adsorption, platelet retention and haemolysis. The behaviour of the Ti6Al4V alloy towards albumin and fibrinogen was compared to that of a reference medical-grade elastomer. The platelet retention test gave better results than those achieved with the elastomer. The haemolysis percentage of the alloy was almost zero. These results indicate that the Ti6Al4V alloy is well tolerated by blood.
C1 UNIV AIX MARSEILLE 2,LRC,F-13385 MARSEILLE,FRANCE.
   TERACOR,ZI TOULON EST,F-83089 TOULON,FRANCE.
RP DION, I (reprint author), UNIV BORDEAUX 2,INSERM,PHYS & INORGAN CHEM RES LABS,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAQUEY C, 1989, BIOMATERIALS, V10, P435, DOI 10.1016/0142-9612(89)90082-3
   BORDENAVE L, 1987, RBM, V6, P283
   CAZENAVE JP, 1983, ANN BIOL CLIN-PARIS, V41, P167
   DION I, 1992, INT J ARTIF ORGANS, V15, P457
   DUCASSOU D, 1976, BRIT J RADIOL, V49, P344, DOI 10.1259/0007-1285-49-580-344
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   ELWING H, 1991, J BIOMAT SCI-POLYM E, V3, P7
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   GRAHAM TR, 1990, EUR J CARDIO-THORAC, V4, P182, DOI 10.1016/1010-7940(90)90002-H
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   KIM SW, 1977, J BIOMED MATER RES, V8, P23
   MERRITT K, 1988, J BIOMED MATER RES, V22, P99, DOI 10.1002/jbm.820220203
   MONTIES JR, 1990, T AM SOC ART INT ORG, V36, P258
   MUTLU M, 1990, Artificial Organs, V14, P81
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   THAKUR ML, 1976, THROMB RES, V9, P345, DOI 10.1016/0049-3848(76)90135-3
   THERIN M, 1991, INNOV TECH BIOL MED, V12, P29
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
NR 21
TC 25
Z9 26
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 122
EP 126
DI 10.1016/0142-9612(93)90222-N
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500007
PM 8435455
DA 2018-10-20
ER

PT J
AU MAROM, G
   REUVENI, A
   COHN, D
AF MAROM, G
   REUVENI, A
   COHN, D
TI STIFFNESS VARIABILITY AND STRESS-DEPENDENT ELASTIC RESPONSE OF SYNTHETIC
   FIBER-REINFORCED COMPOSITES FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Article
DE MECHANICAL PROPERTIES; COMPOSITE MATERIALS; SYNTHETIC FIBER; YOUNG
   MODULUS
AB A major design requirement of biomaterial prostheses is to match their elastic properties with those of the natural host tissue. Composite materials address this requirement because their elastic properties can be altered accurately through composition and directionality parameters, and they can be designed to match closely the elastic properties of the biological tissues, in isocompliance, modulus gradient and anisotropy. This adds to a range of advantages of synthetic composite materials with respect to potential biomedical applications, which draw on their heterogeneity and anisotropy. This paper focuses on the elastic properties of synthetic fibre-reinforced composite materials that pertain to biomedical applications, and demonstrates the range of stiffnesses obtainable through selection of constituents and by choice of angle of reinforcement.
RP MAROM, G (reprint author), HEBREW UNIV JERUSALEM,GRAD SCH APPL SCI & TECHNOL,CASALI INST APPL CHEM,IL-91904 JERUSALEM,ISRAEL.
CR AGARWLA BD, 1990, ANAL PEFORMANCE COMP
   Chou TW, 1992, MICROSTRUCTURAL DESI
   COHN D, 1992, J BIOMED MATER RES, V26, P1185, DOI 10.1002/jbm.820260909
   GERSHON B, 1990, Clinical Materials, V5, P13, DOI 10.1016/0267-6605(90)90068-7
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   GERSHON B, 1982, BIOMATERIALS, V13, P38
   SCHEER W, 1981, PROCESSING USES CARB, P251
NR 7
TC 10
Z9 10
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 127
EP 131
DI 10.1016/0142-9612(93)90224-P
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500008
PM 8435456
DA 2018-10-20
ER

PT S
AU LIM, JO
   KAMATH, M
   MARX, KA
   TRIPATHY, SK
   KAPLAN, DL
   SAMUELSON, LA
AF LIM, JO
   KAMATH, M
   MARX, KA
   TRIPATHY, SK
   KAPLAN, DL
   SAMUELSON, LA
BE Viney, C
   Case, ST
   Waite, JH
TI BIOTINYLATED POLYTHIOPHENE COPOLYMER - A NOVEL ELECTROACTIVE BIOMATERIAL
   UTILIZING THE BIOTIN-STREPTAVIDIN INTERACTION
SO BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT SYMP ON BIOMOLECULAR MATERIALS
CY DEC 01-03, 1992
CL BOSTON, MA
SP MAT RES SOC, USN, OFF NAVAL RES, JOHNSON & JOHNSON, DUPONT CO
NR 0
TC 2
Z9 2
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA PITTSBURGH
SN 0272-9172
BN 1-55899-187-5
J9 MATER RES SOC SYMP P
PY 1993
VL 292
BP 141
EP 146
PG 6
WC Biochemistry & Molecular Biology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Materials Science
GA BY40A
UT WOS:A1993BY40A00016
DA 2018-10-20
ER

PT S
AU ZENG, SX
   YANG, ZX
   LING, P
   XU, GG
   CAO, WP
AF ZENG, SX
   YANG, ZX
   LING, P
   XU, GG
   CAO, WP
BE Viney, C
   Case, ST
   Waite, JH
TI HYDROXYAPATITE/AL2O3 COMPOSITE BIOMATERIAL IMPLANT
SO BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT SYMP ON BIOMOLECULAR MATERIALS
CY DEC 01-03, 1992
CL BOSTON, MA
SP MAT RES SOC, USN, OFF NAVAL RES, JOHNSON & JOHNSON, DUPONT CO
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA PITTSBURGH
SN 0272-9172
BN 1-55899-187-5
J9 MATER RES SOC SYMP P
PY 1993
VL 292
BP 271
EP 275
PG 5
WC Biochemistry & Molecular Biology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Materials Science
GA BY40A
UT WOS:A1993BY40A00033
DA 2018-10-20
ER

PT J
AU SZULCZEWSKI, DH
   MEYER, U
   MOLLER, K
   STRATMANN, U
   DOTY, SB
   JONES, DB
AF SZULCZEWSKI, DH
   MEYER, U
   MOLLER, K
   STRATMANN, U
   DOTY, SB
   JONES, DB
TI CHARACTERIZATION OF BOVINE OSTEOCLASTS ON AN IONOMERIC CEMENT INVITRO
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIAL TESTING; OSTEOCLASTS; CELL CULTURE METHODS
ID RESISTANT ACID-PHOSPHATASE; BONE-MARROW CULTURES; MONOCLONAL-ANTIBODIES;
   PARATHYROID-HORMONE; CHICK OSTEOCLASTS; GLASS-CERAMICS; CELL-FORMATION;
   MOUSE BONE; OSTEOBLASTS; RESORPTION
AB Primary bovine osteoclasts were obtained by an outgrowth method from bovine periosteum and cultured for 7 days on an ionomeric cement for biomaterial testing. Osteoclasts cultured on slices of bovine bone and on glass microscope cover-slides served as a control. The cells were characterised as osteoclasts by a number of tests. Osteoclasts showed positive staining for tartrate resistant acid phosphatase and reactivity with the antibodies 13C2 and 23C6, which react with the alpha-chain of the vitronectin receptor. Addition of salmon calcitonin to the culture medium led to sudden cessation of lamellipodial activity. The cells resorbed bone by making pits. In mixed cultures with osteoblasts, the morphology of the osteoclasts on the smooth ionomeric cement surface was comparable to the one on glass cover-slides, revealing broad cytoplasmatic extensions on the material. Acridine orange staining demonstrated viability of cells until the end of the culture period and increased acidification after parathyroid hormone (PTH) stimulation. Scanning electron microscopy did not reveal erosion of the material by osteoclasts. No signs of aluminium toxicity on osteoclasts could be detected during the 7 day culture period, although an increased uptake of aluminium into the cell was demonstrated.
C1 UNIV MUNSTER,INST ANAT,DENT SECT,CELL BIOL EXPTL ORTHOPAED LAB,DOMAGKSTR 3,W-4400 MUNSTER,GERMANY.
   HOSP SPECIAL SURG,NEW YORK,NY 10021.
CR ALI NN, 1984, ANAT EMBRYOL, V170, P51, DOI 10.1007/BF00319457
   ANDERSON RE, 1985, CALCIFIED TISSUE INT, V37, P646, DOI 10.1007/BF02554924
   ATHANASOU NA, 1990, BONE MINER, V8, P7, DOI 10.1016/0169-6009(91)90136-N
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BARON R, 1986, AM J PATHOL, V122, P363
   BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BIANCO P, 1988, CALCIFIED TISSUE INT, V43, P167, DOI 10.1007/BF02571315
   CHAMBERS TJ, 1984, CALCIFIED TISSUE INT, V36, P556, DOI 10.1007/BF02405365
   CHAMBERS TJ, 1983, CALCIFIED TISSUE INT, V35, P566, DOI 10.1007/BF02405095
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104
   CHAMBERS TJ, 1985, J PATHOL, V145, P297, DOI 10.1002/path.1711450403
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203, DOI 10.1177/35.2.3540104
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1986, INTERACTION PRIMAR 1, P72
   GOMI K, 1992, 4 WORLD BIOM C EUR S, P531
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   HEFLEY TJ, 1984, CALCIFIED TISSUE INT, V34, P480
   HORTON MA, 1986, J BONE MINER RES, V1, P5
   HORTON MA, 1985, CANCER RES, V45, P5663
   HORTON MA, 1986, BRIT J EXP PATHOL, V67, P95
   HUNTER SJ, 1988, J BONE MINER RES, V3, P297
   ITTEL TH, 1992, AKTUELLE ASPEKTE OST, P139
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   JONCK LM, 1989, CLIN MATER, V4, P85
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   JONES DB, 1990, 01VG86603 GERM MIN R
   JONES DB, 1988, Z ZAHNARZTL IMPLANTO, V4, P290
   JONES SJ, 1986, ANAT EMBRYOL, V174, P265, DOI 10.1007/BF00824342
   JONES SJ, 1986, SCANNING ELECTRON MI, V4, P1555
   LAMBRECHT JT, 1990, DEUT ZAHNAERZTL Z, V45, P82
   MACDONALD BR, 1986, J BONE MINER RES, V1, P227
   MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696
   MASON DY, 1978, J CLIN PATHOL, V31, P454, DOI 10.1136/jcp.31.5.454
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   OHTSUKI Y, 1989, STAIN TECHNOL, V64, P55, DOI 10.3109/10520298909108046
   OURSLER MJ, 1985, J CELL BIOL, V100, P1592, DOI 10.1083/jcb.100.5.1592
   PHAROAH MJ, 1985, CALCIFIED TISSUE INT, V37, P276, DOI 10.1007/BF02554874
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373
   VANDEWIJNGAERT FP, 1986, J HISTOCHEM CYTOCHEM, V34, P1317, DOI 10.1177/34.10.3745910
   Zambonin Zallone A, 1982, Anat Embryol (Berl), V165, P405
NR 47
TC 6
Z9 6
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 1
BP 83
EP 92
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA LA850
UT WOS:A1993LA85000008
DA 2018-10-20
ER

PT J
AU MEYER, U
   SZULCZEWSKI, DH
   MOLLER, K
   HEIDE, H
   JONES, DB
   GROSS, U
   VANWACHEM, PB
   BAGAMDISA, FB
   DEKKER, A
   DAVIES, JE
AF MEYER, U
   SZULCZEWSKI, DH
   MOLLER, K
   HEIDE, H
   JONES, DB
   GROSS, U
   VANWACHEM, PB
   BAGAMDISA, FB
   DEKKER, A
   DAVIES, JE
TI ATTACHMENT KINETICS AND DIFFERENTIATION OF OSTEOBLASTS ON DIFFERENT
   BIOMATERIALS
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOCOMPATIBILITY; OSTEOBLASTS; PLATING EFFICIENCY; KINETICS
ID HUMAN-ENDOTHELIAL-CELLS; POLYMER SURFACES; GLASS-CERAMICS; ADHESION;
   FIBRONECTIN; GROWTH; ADSORPTION; BINDING; CALCIUM; CULTURE
AB Primary bovine osteoblast cell cultures were used to study the response of osteoblasts ton three different biomaterials, ionomeric cement (IC), tri-calcium phosphate poly-L-lactic acid composite foil (TCP) and poly-L-lactate-polycitric acid composite foil (PLA). The cells which grew on the materials produced all typical bone matrix proteins and were osteoblast-like as shown by immuno-staining. Analysis of the cell attachment kinetics revealed significant differences within the first 7 hours between the various materials. The best rate of cell attachment was found on the IC surface, followed by the TCP and then the PLA surface. The kinetics of attachment appeared to be due to different surface wettabilities and could be expressed by a linear equation. Further investigations showed an ion mediated attachment of osteoblasts on the surfaces. Quantitative analysis of non-collagenous protein matrix production and DNA content per cell was carried out, showing the best results for PLA, followed by IC and TCP, indicating that the material with the best primary attachment characteristics is not necessarily that on which the cells differentiate the best. Scanning electron microscopy observations of primary outgrowth cultures showed close contact of osteoblasts on all surfaces. It was concluded that such techniques may be developed as a means of batch testing bioactive biomaterials and investigating bone cell/biomaterial interactions.
C1 WESTFAL WILHEMS UNIV,CELL BIOL LAB,DOMAGKSTR 3,D-48129 MUNSTER,GERMANY.
   GESELL GESUNDHEIT & UMWELTFORSCH MBH,FRANKFURT,GERMANY.
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P271, DOI 10.1002/jbm.820220403
   AMPHLETT GW, 1983, BIOCHEM BIOPH RES CO, V111, P1045, DOI 10.1016/0006-291X(83)91405-5
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355
   CURTIS ASG, 1973, PROGR BIOPHYS MOL BI, V27, P317
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1986, 6TH P EUR C BIOM BOL, P24
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GRINNELL F, 1976, EXP CELL RES, V97, P265, DOI 10.1016/0014-4827(76)90616-9
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   Hatton S., 1985, J COLLOID INTERF SCI, V104, P73
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   JOHNSONWINT B, 1982, ANAL BIOCHEM, V122, P338, DOI 10.1016/0003-2697(82)90292-5
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   JONES DB, 1988, Z ZAHNARZTL IMPLANTO, V4, P290
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   OLANDER JV, 1982, IN VITRO CELL DEV B, V18, P99, DOI 10.1007/BF02796401
   RABINOVITCH M, 1973, J CELL BIOL, V59, P165, DOI 10.1083/jcb.59.1.165
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P1
   SORGER T, 1983, ANAL BIOCHEM, V131, P245
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WESISS L, 1967, J CELL PHYSIOL, V70, P23
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
NR 36
TC 83
Z9 84
U1 1
U2 10
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 2
BP 129
EP 140
PG 12
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA MA395
UT WOS:A1993MA39500002
DA 2018-10-20
ER

PT J
AU CHRISTIANSEN, DL
   PINS, G
   SILVER, FH
AF CHRISTIANSEN, DL
   PINS, G
   SILVER, FH
TI A SIMPLE FREEZE-FRACTURE TECHNIQUE FOR SCANNING ELECTRON-MICROSCOPY OF
   COLLAGENOUS BIOMATERIALS
SO CELLS AND MATERIALS
LA English
DT Note
DE FREEZE FRACTURE; SCANNING ELECTRON MICROSCOPY; BIOMATERIALS; COLLAGEN;
   SAMPLE PREPARATION TECHNIQUE
AB A simple freeze fracture technique for the ultrastructural analysis of fragile collagenous biomaterials is presented. Following standard methods of preparation and dehydration, fragile biomaterials are fractured with a sharp blade attached to a modified slide hammer. The sliding mass imparts a sudden impact load on the frozen surface of the material, creating a distortion free cleavage plane across the material. More traditional methods including bending and cutting with scissors introduce artifacts indirectly associated with stress concentration produced by bending, and sample compression at the edges with cutting. The impact loading of the sample during fracture results in preservation of edge detail, showing clear structural features up to the surface of the collagenous biomaterial.
C1 UMDNJ,ROBERT WOOD JOHNSON MED SCH,CTR BIOMAT,ROOM V-14,675 HOES LANE,PISCATAWAY,NJ 08854.
   UNIV PENN,DEPT ORTHOPAED,PHILADELPHIA,PA 19104.
CR DUNN MG, 1993, 39TH P ANN M, P334
   ROBARDS AW, 1985, LOW TEMPERATURE METH, P336
   WASSERMAN AJ, 1991, CELL MATER, V1, P41
NR 3
TC 0
Z9 0
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 2
BP 189
EP 191
PG 3
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA MA395
UT WOS:A1993MA39500008
DA 2018-10-20
ER

PT J
AU KAWAGUCHI, H
   MCKEE, MD
   OKAMOTO, H
   NANCI, A
AF KAWAGUCHI, H
   MCKEE, MD
   OKAMOTO, H
   NANCI, A
TI IMMUNOCYTOCHEMICAL, AND LECTIN-GOLD CHARACTERIZATION OF THE INTERFACE
   BETWEEN ALVEOLAR BONE AND IMPLANTED HYDROXYAPATITE IN THE RAT
SO CELLS AND MATERIALS
LA English
DT Article
DE HYDROXYAPATITE; BIOMATERIAL; BONE; INTERFACE; ULTRASTRUCTURE; LECTIN
   CYTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; OSTEOPONTIN; OSTEOCALCIN; ALBUMIN;
   ALPHA-2HS-GLYCOPROTEIN
ID HUMAN CORTICAL BONE; SYNTHETIC HYDROXYAPATITE; ELECTRON-MICROSCOPY;
   OSTEOBLAST CULTURES; PHOSPHATE CERAMICS; PERIODONTAL TISSUE;
   PLASMA-PROTEINS; INVITRO; OSTEOCALCIN; GLYCOPROTEIN
AB The tissue response to implanted hydroxyapatite (HAP) in rat alveolar bone was investigated using morphological and cytochemical approaches. High-resolution immunogold labeling was used to examine the distribution of two non-collagenous bone proteins, osteopontin and osteocalcin, and two plasma proteins, alpha(2)HS-glycoprotein (fetuin) and albumin. Glycoconjugates were characterized by lectin-gold cytochemistry using Ricinus communis I agglutinin and Wheat germ agglutinin. Transmission electron microscopy demonstrated the presence of an electron-dense, lamina limitans-like layer at the HAP particle-bone interface and organic material within the micropores of the particles. Mineral was observed in relation to both these sites. The HAP particle-bone interface was strongly immunoreactive for osteopontin; moderately to weakly reactive for osteocalcin, alpha(2)HS-glycoprotein and albumin, and rich in glycoconjugates containing galactose and/or N-acetyl-glucosamine/sialic acid. Organic material within the micropores of the HAP particles was also labeled with the various antibodies and lectins. These results indicate that the lamina limitans at the HAP particle-bone interface is enriched in osteopontin as well as in sugars present in this and other molecules. Similarly, certain bone and plasma proteins infiltrate the micropores of HAP and distribute differentially throughout the particles.
C1 UNIV MONTREAL, FAC DENT, DEPT STOMATOL, MONTREAL H3C 3J7, PQ, CANADA.
   HIROSHIMA UNIV, SCH DENT, DEPT ENDODONTOL & PERIODONTOL, HIROSHIMA, JAPAN.
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   ASHTON BA, 1976, CALC TISS RES, V22, P27
   ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   BENDAYAN M, 1989, COLLOIDAL GOLD PRINC, V1, P33
   BENHAMOU N, 1989, COLLOIDAL GOLD PRINC, V1, P95
   BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   COLE DE, 1991, BONE BONE MATRIX BON, V3, P239
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DAVIES JE, 1991, CELL MATER, V1, P3
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DELANGE GL, 1990, CRC HDB BIOACTIVE CE, V2, P61
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FRAME JW, 1987, INT J ORAL MAX SURG, V16, P642, DOI 10.1016/S0901-5027(87)80048-6
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GROSS UM, 1990, CRC HDB BIOACTIVE CE, V1, P25
   HAUSCHKA PV, 1983, J BIOL CHEM, V258, P176
   HAUSCHKA PV, 1986, HAEMOSTASIS, V16, P258
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1978, 4TH T ANN M SOC BIOM, P112
   KAWAGUCHI H, 1992, J PERIODONTAL RES, V27, P48, DOI 10.1111/j.1600-0765.1992.tb02085.x
   Kenney E B, 1991, Dent Clin North Am, V35, P541
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   LINDE A, 1989, CONNECT TISSUE RES, V21, P527
   MATUKAS VJ, 1991, DENTAL IMPLANTS PRIN, P229
   MBUYI JM, 1982, CALCIFIED TISSUE INT, V34, P229, DOI 10.1007/BF02411242
   MCKEE MD, 1990, ANAT REC, V228, P77, DOI 10.1002/ar.1092280112
   MCKEE MD, 1993, J BONE MINER RES, V8, P485
   MCKEE MD, 1992, ANAT REC, V234, P479, DOI 10.1002/ar.1092340404
   MCKEE MD, 1991, J BONE MINER RES, V6, P937
   MCKEE MD, 1993, CELL MATER, V3, P219
   MIZUNO M, 1991, BONE MINER, V13, P1, DOI 10.1016/0169-6009(91)90046-3
   NANCI A, 1989, J HISTOCHEM CYTOCHEM, V37, P1619, DOI 10.1177/37.11.2809173
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NISHIYAMA K, 1990, CRC HDB BIOACTIVE CE, V2, P87
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   ORR RD, 1992, CELL MATER, V2, P241
   PRINCE CW, 1987, J BIOL CHEM, V262, P2900
   RAVAGLIOLI A, 1992, BIOMATERIALS, V13, P162, DOI 10.1016/0142-9612(92)90065-V
   RITTER NM, 1992, J BONE MINER RES, V7, P877
   ROTH J, 1983, J HISTOCHEM CYTOCHEM, V31, P987, DOI 10.1177/31.8.6190857
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   SLAVKIN HC, 1982, DIFFERENTIATION, V23, P73, DOI 10.1111/j.1432-0436.1982.tb01268.x
   SMITH AJ, 1985, CALCIFIED TISSUE INT, V37, P208, DOI 10.1007/BF02554843
   SODEK J, 1992, INT CONGR SER, V1002, P297
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   TRIFFITT JT, 1977, CALC TISS RES, V23, P303, DOI 10.1007/BF02012801
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998
   Young M F, 1992, Clin Orthop Relat Res, P275
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 63
TC 46
Z9 46
U1 0
U2 2
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 4
BP 337
EP 350
PG 14
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA NA053
UT WOS:A1993NA05300001
DA 2018-10-20
ER

PT J
AU RADDER, AM
   DAVIES, JE
   LEENDERS, H
   VANBLITTERSWIJK, CA
AF RADDER, AM
   DAVIES, JE
   LEENDERS, H
   VANBLITTERSWIJK, CA
TI THE PEO/PBT COPOLYMER-MINERALIZED MATRIX INTERFACE IN-VITRO
SO CELLS AND MATERIALS
LA English
DT Article
DE INTERFACE; BONE-BONDING; IN-VITRO; PEO/PBT COPOLYMER
ID HYDROXYAPATITE INTERFACE; BIOMATERIAL INTERFACE; ELECTRON-MICROSCOPY;
   OSTEOBLAST CULTURES; BONE INTERFACE; INVITRO; CELLS; TITANIUM; MARROW
AB Previous implantation experiments have investigated the interaction between a series of PEO/PBT copolymers (Polyactive(R)) and bone tissue, and shown the morphology of bone-bonding with several PEO/PBT ratios. However, the underlying mechanism of bone-bonding remains largely unknown. Therefore, an invitro approach was chosen to obtain more information on the events occurring at the PEO/PBT copolymer-bone interface. Rat marrow cells were cultured on two PEO/PBT copolymer proportions: a 60/40 ratio which is known to bond with bone tissue in-vivo and a 30/70 ratio which, within one year of implantation, does not bond with bone. Evaluation was performed with light microscopy, scanning, backscatter and transmission electron microscopy and X-ray microanalysis.
   Surface calcification of the 60/40 material was observed. Undecalcified specimens revealed a continuum between material calcification and biologically elaborated mineralized matrix. An electron-dense region was frequently observed at the interface of this material. No signs of calcification were seen within the surface of the stiffer 30/70 polymer. Mineralized matrix was found in contact with the surface of the 30/70 but the absence of a continuity was evident at all resolutions. These results indicate that reproduction of the in-vivo findings and a rapid differentiation between different PEO/PBT ratios can be accomplished in-vitro. The rat marrow system may therefore represent a controlled tool to achieve a better understanding of the events occurring at the bone-PEO/PBT copolymer interface.
C1 UNIV TORONTO, CTR BIOMAT, TORONTO M5S 1A1, ON, CANADA.
RP RADDER, AM (reprint author), LEIDEN UNIV HOSP, BIOMAT RES GRP, OTOBIOL & BIOCOMPATIBIL LAB, BLD 55, RIJNSBURGERWEG 10, 2333 AA LEIDEN, NETHERLANDS.
CR ALBREKTSSON T, 1990, International Journal of Prosthodontics, V3, P30
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BENAYAHU D, 1991, CALCIFIED TISSUE INT, V49, P202, DOI 10.1007/BF02556119
   BETTE MC, 1990, CALCIFIED TISSUE INT, V46, P46
   BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P214
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DAVIES JE, 1990, HDB BIOACTIVE CERAMI, V1, P1
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DEBRUIJN JD, 1992, BONE BONDING BIOMATE, P57
   DUCHEYNE P, 1991, BONE-BIOMATERIAL INTERFACE, P62
   ERICSON LE, 1991, BONE-BIOMATERIAL INTERFACE, P425
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   HANAWA T, 1990, J DENT RES S, V69, P1247
   HARMAND MF, 1986, BIOL BIOMECHANICAL P, P361
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KASSEM M, 1991, APMIS, V99, P269, DOI 10.1111/j.1699-0463.1991.tb05149.x
   LOWENBERG B, 1991, CELL MATER, V1, P177
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   OKUMURA M, 1992, BONE BONDING BIOMATE, P189
   ORR RD, 1992, CELL MATER, V2, P241
   OWEN M, 1980, ARTHRITIS RHEUM-US, V23, P1073, DOI 10.1002/art.1780231002
   PILLIAR RM, 1991, MRS BULL, V16, P55
   RADDER AM, 1993, IN PRESS J BIOMED MA
   RADDER AM, 1990, 11TH P ANN C CAN BIO, P17
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   SHEN X, 1993, CELL MATER, V3, P257
   TAKEUCHI Y, 1990, BIOCHEM J, V266, P15, DOI 10.1042/bj2660015
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P23
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEINER S, 1992, FASEB J, V6, P879
   WILLIAMS DF, 1991, ADV BIOMATERIALS BIO, P525
NR 37
TC 1
Z9 1
U1 0
U2 2
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 4
BP 367
EP 376
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA NA053
UT WOS:A1993NA05300004
DA 2018-10-20
ER

PT J
AU DERSOT, JM
   SEPTIER, D
   LLORENS, A
   SAFFAR, JL
AF DERSOT, JM
   SEPTIER, D
   LLORENS, A
   SAFFAR, JL
TI MULTINUCLEATED GIANT CELLS-HYDROXYAPATITE INTERACTIONS - A TIME-RELATED
   QUANTITATIVE STUDY IN A RAT SKULL DEFECT
SO CELLS AND MATERIALS
LA English
DT Article
DE MULTINUCLEATED GIANT CELLS; DEGRADATION; HYDROXYAPATITE; BIOMATERIAL;
   OSTEOCONDUCTION; CERAMIC; MORPHOMETRY
ID CALCIUM-PHOSPHATE CERAMICS; TRICALCIUM PHOSPHATE; BONE SUBSTITUTE;
   TISSUE; MACROPHAGES; CRYSTALS; INVITRO; IMPLANTATION; DISSOLUTION;
   OSTEOCLASTS
AB The implantation of calcium phosphate ceramics in the bone environment elicits the differentiation of multinucleated giant cells (MNGCs). MNGC interactions with both crushed and standard hydroxyapatite (HA, Bioapatite(R)) particles (cHA and sHA) were studied in rat skull defects. Light microscopy (LM) of undemineralized material after 21 and 42 days of implantation showed that the number of particles in the defect significantly decreased (about 50%) with the two HA forms. Concomitantly, average cHA particle size increased significantly due to the elimination of the smallest particles by the MNGCs. The number of MNGCs per mm(2) of defect decreased significantly between 21 and 42 days with the two HA forms as did the number of MNGCs per particle. MNGC-HA interactions were observed at the ultrastructural level with transmission electron microscopy (TEM) in 21 day demineralized samples. MNGCs appeared smaller than in the LM, since several MNGCs formed aggregates of interwoven cells. They were closely apposed to the particle surface but no typical ruffled border or clear zone were seen in any case. An organic material had penetrated the HA particles and scattered in centripetal direction. These results show that (a) the HA conditioning form had no effect on its degradation and integration behavior, (b) the HA was extensively degraded by MNGCs before the embedding of the remaining particles in bone, and (c) MNGCs did not exhibit the distinctive functional apparatus of osteoclasts.
C1 UNIV PARIS 05,FAC CHIRURG DENT,BIOL & BIOMAT MILIEU BUCCAL & OSSEUX LAB,F-92120 MONTROUGE,FRANCE.
CR BARON R, 1984, BONE MINERAL RES ANN, V2, P175
   BECK LS, 1991, J BONE MINER RES, V6, P1257
   BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, V275, P287
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DEPORTER DA, 1988, CALCIFIED TISSUE INT, V42, P321, DOI 10.1007/BF02556367
   DERSOT JM, 1992, THESIS U PARIS 5 FRA
   DONATH K, 1987, Journal of Oral Implantology, V13, P120
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, V232, P127
   FRAME JW, 1980, J ORAL SURG, V38, P176
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   HOLTROP ME, 1978, MECHANISMS LOCALIZED, P13
   HULTH A, 1989, CLIN ORTHOP RELAT R, V249, P265
   KAWAGUCHI H, 1992, J PERIODONTAL RES, V27, P48, DOI 10.1111/j.1600-0765.1992.tb02085.x
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KWONG CH, 1989, BIOMATERIALS, V10, P579, DOI 10.1016/0142-9612(89)90110-5
   MCMILLAN PJ, 1989, CALCIFIED TISSUE INT, V44, P399, DOI 10.1007/BF02555968
   MELLONIG JT, 1981, J PERIODONTOL, V52, P297, DOI 10.1902/jop.1981.52.6.297
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   NAKAMURA H, 1992, BONE, V13, P411, DOI 10.1016/8756-3282(92)90083-9
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   OWEN M, 1968, NATURE, V220, P1335, DOI 10.1038/2201335a0
   Owen M., 1985, BONE MINERAL RES ANN, V1, P1
   OWENS JL, 1986, CALCIFIED TISSUE INT, V38, P170, DOI 10.1007/BF02556877
   Parfitt A. M., 1988, BONE MINERAL MEASURE, P9
   REDDI AH, 1985, BONE MINERAL RES, V3, P27
   RENOOJI W, 1985, CLIN ORTHOP RELAT R, V197, P272
   ROBERTS WE, 1987, J PERIODONTAL RES, V22, P461, DOI 10.1111/j.1600-0765.1987.tb02056.x
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   Schenk R, 1984, METHODS CALCIFIED TI, P1
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   UCHIDA A, 1985, J ORTHOP RES, V3, P65, DOI 10.1002/jor.1100030108
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VIGNERY A, 1991, AM J PHYSIOL, V260, pF704
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   VILLANUEVA JE, 1990, J BONE MINER RES, V7, P733
   WADA T, 1989, J PERIODONTAL RES, V24, P391, DOI 10.1111/j.1600-0765.1989.tb00888.x
   YAMAMOTO T, 1992, J BONE MINER RES, V7, P1267
NR 48
TC 12
Z9 12
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 4
BP 395
EP 405
PG 11
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA NA053
UT WOS:A1993NA05300007
DA 2018-10-20
ER

PT J
AU WU, SG
   ELLERBY, LM
   COHAN, JS
   DUNN, B
   ELSAYED, MA
   VALENTINE, JS
   ZINK, JI
AF WU, SG
   ELLERBY, LM
   COHAN, JS
   DUNN, B
   ELSAYED, MA
   VALENTINE, JS
   ZINK, JI
TI BACTERIORHODOPSIN ENCAPSULATED IN TRANSPARENT SOL-GEL GLASS - A NEW
   BIOMATERIAL
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID PHOTOCYCLE; DEPROTONATION; MEMBRANE; MODEL
AB The Photosynthetic membrane protein of bacteriorhodopsin (bR) was encapsulated in an optically transparent and porous silica matrix using a modified sol-gel procedure. The absorption spectra and the kinetics of the photocycle characteristic of the proton pumping function of bR were studied systematically throughout the different stages of the glass formation process. This new biomaterial was characterized by means of its optical absorption, circular dichroism (CD), and Raman spectra; its photocycle kinetics; the characteristic activation parameters of its photocycle; and its deionization and cation regeneration properties. The global trimeric bR structure, the local structure of the retinal chromophore, and the proton pumping function of bR were not affected by the encapsulation process. It was also found that the bR glass formed allowed transport of small ions such as Ca2+ in to and out of the glass medium, and those ions were found to affect the properties of the protein just as they do in aqueous suspensions. The bR protein was found to bleach if delipidated prior to encapsulation. These observations as well as analysis of the CD spectrum suggest that the bR is encapsulated along with its membrane lipids. These results taken together suggest that this optically transparent system offers a potentially useful new bR-containing material for optical imaging and optically based ion-sensoring devices as developed and proposed for other bR-based systems.
C1 UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA.
RI Valentine, Joan/B-6665-2008
OI Valentine, Joan/0000-0002-7174-925X
CR BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343
   BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X
   BRAUCHLE C, 1991, ADV MATER, V3, P420, DOI 10.1002/adma.19910030903
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   CHANG CH, 1985, P NATL ACAD SCI USA, V82, P396, DOI 10.1073/pnas.82.2.396
   DUPUIS P, 1985, P NATL ACAD SCI USA, V82, P3662, DOI 10.1073/pnas.82.11.3662
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   ELSAYED MA, 1989, P NATL ACAD SCI USA, V86, P5376, DOI 10.1073/pnas.86.14.5376
   FISCHER U, 1979, BIOPHYS J, V28, P211, DOI 10.1016/S0006-3495(79)85172-3
   HAMPP N, 1990, BIOPHYS J, V58, P83, DOI 10.1016/S0006-3495(90)82355-9
   HAMPP N, 1989, SPIE, V1125, P2
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HUANG JY, 1989, J PHYS CHEM-US, V93, P3314, DOI 10.1021/j100345a086
   KHORANA HG, 1988, J BIOL CHEM, V263, P7439
   KORENSTEIN R, 1977, NATURE, V270, P184, DOI 10.1038/270184a0
   LIN GC, 1991, J PHYS CHEM-US, V95, P10442, DOI 10.1021/j100178a035
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   OESTERHELT D, 1991, Q REV BIOPHYS, V24, P425, DOI 10.1017/S0033583500003863
   SMITH SO, 1985, J MEMBRANE BIOL, V85, P95, DOI 10.1007/BF01871263
   STOECKENIUS W, 1982, ANNU REV BIOCHEM, V51, P587
   VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6
   WU SG, 1992, BIOPHYS J, V61, P1281, DOI 10.1016/S0006-3495(92)81936-7
   WU SG, 1991, BIOPHYS J, V60, P190, DOI 10.1016/S0006-3495(91)82042-2
   YAMANAKA SA, 1992, CHEM MATER, V4, P495, DOI 10.1021/cm00021a001
NR 24
TC 139
Z9 142
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD JAN
PY 1993
VL 5
IS 1
BP 115
EP 120
DI 10.1021/cm00025a022
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA KH609
UT WOS:A1993KH60900022
DA 2018-10-20
ER

PT J
AU STOL, M
   SMETANA, K
   KORBELAR, P
   ADAM, M
AF STOL, M
   SMETANA, K
   KORBELAR, P
   ADAM, M
TI POLY(HEMA) COLLAGEN COMPOSITE AS A BIOMATERIAL FOR HARD-TISSUE
   REPLACEMENT
SO CLINICAL MATERIALS
LA English
DT Proceedings Paper
CT CONF ON BIOMEDICAL POLYMERS
CY JUN 10-12, 1991
CL JERUSALEM, ISRAEL
SP UNESCO
ID HYDROXYETHYLMETHACRYLATE HYDROGELS; CELL; COPOLYMERS; GROWTH
RI Smetana, Karel/D-7039-2017
OI Smetana, Karel/0000-0002-7878-8403
CR BARVIC M., 1967, J BIOMED MAT RES, V1, P313, DOI 10.1002/jbm.820010303
   BILY B, 1977, ACTA FM U BRUNENSIS, V55, P53
   Chvapil M, 1969, J Biomed Mater Res, V3, P315, DOI 10.1002/jbm.820030211
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   FLEISHMAJER R, 1985, BIOL CHEM PATHOLOGY
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   KLIMENT K, 1971, Patent No. 3563925
   KOPECEK J, 1968, J POLYM SCI POL SYM, P3877
   KORBELAR P, 1988, J BIOMED MATER RES, V22, P751, DOI 10.1002/jbm.820220902
   KUHN K, 1986, CONNECTIVE TISSUE BI, P29
   KVASNICKA J, 1988, Zahn- Mund- und Kieferheilkunde, V76, P151
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   Ramachandran G. N., 1976, BIOCH COLLAGEN
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   SPRINCL L, 1971, J BIOMED MATER RES, V4, P447
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   STOL M, 1986, POLYM MED, V2, P139
   TOSELLI P, 1983, J ULTRA MOL STRUCT R, V83, P220, DOI 10.1016/S0022-5320(83)90079-5
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wichterle O., 1971, ENCYCLOPEDIA POLYMER, P273
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   1986, Patent No. 334886
NR 25
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCI PUBL LTD
PI OXFORD
PA OXFORD
SN 0267-6605
J9 CLIN MATER
JI Clin. Mat.
PY 1993
VL 13
IS 1-4
BP 19
EP 20
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LQ932
UT WOS:A1993LQ93200004
PM 10146239
DA 2018-10-20
ER

PT J
AU HLADY, V
   ANDRADE, JD
   HO, CH
   FENG, L
   TINGEY, K
AF HLADY, V
   ANDRADE, JD
   HO, CH
   FENG, L
   TINGEY, K
TI PLASMA-PROTEIN ADSORPTION ON MODEL BIOMATERIAL SURFACES
SO CLINICAL MATERIALS
LA English
DT Proceedings Paper
CT CONF ON BIOMEDICAL POLYMERS
CY JUN 10-12, 1991
CL JERUSALEM, ISRAEL
SP UNESCO
ID COMPETITIVE ADSORPTION; SOLID-SURFACES; FIBRINOGEN; ELECTROPHORESIS;
   HYDROXYAPATITE; GRADIENT; ALBUMIN
CR ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421
   ANDERSON NL, 1984, PLASMA PROTEINS, V4, P221
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BOCKOR JC, 1972, CHEM PHYS CARBON, V9, P103
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRASH JL, 1988, MAKROMOL CHEM-M SYMP, V17, P441, DOI 10.1002/masy.19880170133
   CHEN JH, 1990, J COLLOID INTERF SCI, V135, P496, DOI 10.1016/0021-9797(90)90020-O
   De Groot K, 1981, BIOCOMPATIBILITY CLI, V1, P199
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FENG L, IN PRESS J BIOMED MA
   GOLANDER CG, 1990, COLLOID SURFACE, V49, P289, DOI 10.1016/0166-6622(90)80111-G
   GOODMAN SL, 1988, SURFACE CHARACTERIZA
   HAUBOLD A, 1977, ANN NY ACAD SCI, V283, P383, DOI 10.1111/j.1749-6632.1977.tb41783.x
   HAUBOLD AD, 1981, CLIN IMPLANT MATERIA, V2, P4
   HLADY V, 1979, J COLLOID INTERF SCI, V69, P460, DOI 10.1016/0021-9797(79)90135-8
   HLADY V, 1991, APPL SPECTROSC, V45, P246, DOI 10.1366/0003702914337533
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   HO CH, 1990, THESIS U UTAH US
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   HORBETT TA, 1986, J COLLOID INTERFACE, V111
   HORBETT TA, 1987, ACS S SER
   LAMBERT JM, 1989, POLYM PREP-ACS, V30, P583
   LEA AS, 1992, LANGMUIR, V8, P68, DOI 10.1021/la00037a015
   Lelah M. D., 1986, POLYURETHANES MED
   LEONARD EF, 1987, ANN NEW YORK ACAD SC, V516
   LIN JN, 1990, LANGMUIR, V6, P509, DOI 10.1021/la00092a036
   MAKINO K, 1989, J CHROMATOGR SCI, V27, P659, DOI 10.1093/chromsci/27.11.659
   ORANG F, 1991, 7TH ICSCS COMP, V3, P365
   PACCAGNELLA A, 1986, INT J ARTIF ORGANS, V9, P127
   SCOTT SM, 1990, J SURG RES, V29, P395
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   STROUP EW, 1991, AUG INT C STM INT, P238
   SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1982, ADV CHEM SER, V199, P264
   WEI AP, 1990, THESIS U UTAH US
   TABLE HUMAN BLOOD PL
NR 40
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCI PUBL LTD
PI OXFORD
PA OXFORD
SN 0267-6605
J9 CLIN MATER
JI Clin. Mat.
PY 1993
VL 13
IS 1-4
BP 85
EP 93
DI 10.1016/0267-6605(93)90094-N
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LQ932
UT WOS:A1993LQ93200014
DA 2018-10-20
ER

PT J
AU THOMPSON, KP
   HANNA, KD
   GIPSON, IK
   GRAVAGNA, P
   WARING, GO
   JOHNSONWINT, B
AF THOMPSON, KP
   HANNA, KD
   GIPSON, IK
   GRAVAGNA, P
   WARING, GO
   JOHNSONWINT, B
TI SYNTHETIC EPIKERATOPLASTY IN RHESUS-MONKEYS WITH HUMAN TYPE-IV COLLAGEN
SO CORNEA
LA English
DT Article
DE SYNTHETIC EPIKERATOPLASTY; REFRACTIVE SURGERY; COLLAGEN; BIOMATERIALS
AB Human type IV collagen discs were found to support proliferation and adhesion of rabbit corneal epithelial cells in tissue culture. To assess the biocompatibility of this synthetic collagen for epikeratoplasty, seven eyes of seven rhesus monkeys underwent epikeratoplasty with lenticules made of human type IV collagen. Eye rubbing by the animals expulsed two of the lenticules and caused failure of two to epithelialize completely. The remaining three lenticules epithelialized, remained clear, and caused no adverse effects on the eye. Two of these lenticules developed focal areas of subepithelial thinning 3 months postoperatively and the third lenticule has remained stable for 30 months. The presence of epithelial attachment components at the epithelial-lenticule interface was demonstrated by immunolocalization. Histopathologic and ultrastructural examination revealed focal areas of epithelial invasion and degradation of the lenticule. Neutral proteases were detected in the thinning region of one specimen. Human type IV collagen supports epithelialization in vivo and may have potential as a biomaterial for epikeratoplasty, but the stability of the material must be improved.
RP THOMPSON, KP (reprint author), EMORY UNIV,YERKES REG PRIMATE RES CTR,954 GATEWOOD RD NE,ATLANTA,GA 30329, USA.
FU NEI NIH HHS [EY007388-02, P30 EY06360]; NCRR NIH HHS [RR-00165]
NR 0
TC 23
Z9 23
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0277-3740
J9 CORNEA
JI Cornea
PD JAN
PY 1993
VL 12
IS 1
BP 35
EP 45
DI 10.1097/00003226-199301000-00007
PG 11
WC Ophthalmology
SC Ophthalmology
GA KE951
UT WOS:A1993KE95100007
PM 8458230
DA 2018-10-20
ER

PT J
AU SHEU, MS
   HOFFMAN, AS
   RATNER, BD
   FEIJEN, J
   HARRIS, JM
AF SHEU, MS
   HOFFMAN, AS
   RATNER, BD
   FEIJEN, J
   HARRIS, JM
TI IMMOBILIZATION OF POLYETHYLENE OXIDE SURFACTANTS FOR NON-FOULING
   BIOMATERIAL SURFACES USING AN ARGON GLOW-DISCHARGE TREATMENT
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE SURFACE MODIFICATION; GLOW DISCHARGE TREATMENT; NON-FOULING SURFACES;
   WETTABLE POLYMER SURFACES; POLY(ETHYLENE OXIDE) SURFACTANTS
ID POLY(ETHYLENE OXIDE); POLYMERS; PLASMA; POLYMERIZATION; ADSORPTION;
   FIBRINOGEN; COPOLYMERS; INVITRO; EXVIVO
AB A non-fouling (protein-resistant) polymer surface is achieved by the covalent immobilization of polyethylene oxide (PEO) surfactants using an inert gas discharge treatment. Treated surfaces have been characterized using electron spectroscopy for chemical analysis (ESCA), static secondary ion mass spectrometry (SSIMS), water contact angle measurement, fibrinogen adsorption, and platelet adhesion. This paper is intended to review our recent work in using this simple surface modification process to obtain wettable polymer surfaces in general, and non-fouling biomaterial surfaces in particular.
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
   UNIV TWENTE,DEPT CHEM ENGN,7500 AE ENSCHEDE,NETHERLANDS.
   UNIV ALABAMA,DEPT CHEM,HUNTSVILLE,AL 35899.
CR ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   BRIDGETT MJ, 1989, BIOMATERIALS, V10, P411
   BROSSE JC, 1983, EUR POLYM J, V19, P743, DOI 10.1016/0014-3057(83)90142-8
   DENNISON KA, 1986, THESIS MIT CAMBRIDGE
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   EPAILLARD F, 1990, J APPL POLYM SCI, V38, P887
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   GREGONIS DE, 1984, 2ND T C BIOM WASH DC, P266
   HANSEN RH, 1966, J POLYM SCI POL LETT, V4, P203, DOI 10.1002/pol.1966.110040309
   HERMANS J, 1982, J CHEM PHYS, V77, P2193, DOI 10.1063/1.444026
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   KIAEI D, 1992, J BIOMED MATER RES, V26, P357, DOI 10.1002/jbm.820260307
   KIM SW, 1988, ANN NY ACAD SCI, V516, P116
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OMULLANE JE, 1988, BIOMATERIALS, V9, P203, DOI 10.1016/0142-9612(88)90124-X
   Randerson DH, 1983, PLASMAPHERESIS NEW T
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   Sharpe L.S., 1964, ADV CHEM SER, V43, P189
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SHEU MS, IN PRESS CLIN MATER
   SHEU MT, UNPUB
   SIMIONESCU CI, 1984, MAKROMOL CHEM S, V8, P17
   SUN YH, 1986, J BIOACT COMPAT POLY, V1, P3146
   TERLINGEN JGA, 1993, J COLLOID INTERF SCI, V155, P55, DOI 10.1006/jcis.1993.1009
   TERLINGEN JGA, UNPUB J BIOMATER SCI
   WANG SG, 1989, J MACROMOL SCI CHEM, VA26, P505, DOI 10.1080/00222338908051990
NR 32
TC 54
Z9 55
U1 0
U2 8
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 1993
VL 7
IS 10
BP 1065
EP 1076
DI 10.1163/156856193X00583
PG 12
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA MF059
UT WOS:A1993MF05900006
DA 2018-10-20
ER

PT J
AU FURUZONO, T
   YASHIMA, E
   KISHIDA, A
   MARUYAMA, I
   MATSUMOTO, T
   AKASHI, M
AF FURUZONO, T
   YASHIMA, E
   KISHIDA, A
   MARUYAMA, I
   MATSUMOTO, T
   AKASHI, M
TI A NOVEL BIOMATERIAL - POLY(DIMETHYLSILOXANE)-POLYAMIDE MULTIBLOCK
   COPOLYMER .1. SYNTHESIS AND EVALUATION OF BLOOD COMPATIBILITY
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE POLY(DIMETHYLSILOXANE); ARAMID; MULTIBLOCK COPOLYMER; BLOOD
   COMPATIBILITY; ELECTRON PROBE MICROANALYSIS; X-RAY PHOTOELECTRON
   SPECTROSCOPY; DYNAMIC CONTACT ANGLE
ID MEMBRANES
AB Aramid-silicone resins (PASs) consisting of aromatic polyamide (aramid) and poly(dimethylsiloxane) (PDMS) segments were synthesized by low temperature solution polycondensation. For the evaluation of blood compatibility in vitro, two kinds of experiments were carried out. One was the thromboxane B2(TXB2) release test from platelets attaching to PAS and Biomer(R). The other was the observation of the platelet adhesion on the surfaces of PAS by scanning electron microscopy (SEM). The results indicated that PAS was bio-inert in vitro. The surface chemical composition of PAS films was investigated by means of electron probe micro analysis (EPMA), X-ray photoelectron spectroscopy (XPS), and dynamic contact angle measurements. The relationship between blood compatibility and surface composition of PAS is discussed.
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,1-21-40 KORIMOTO,KAGOSHIMA 890,JAPAN.
   NOF CORP LTD,TSUKUBA RES LAB,TSUKUBA 30026,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT CLIN LAB MED,KAGOSHIMA 890,JAPAN.
RI Yashima, Eiji/H-5380-2011
OI Yashima, Eiji/0000-0001-6307-198X
CR Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   Asakawa S., 1983, National Technical Report, V29, P93
   FRISCH EE, 1984, ACS SYM SER, V256, P63
   GOLDBERG EP, 1961, Patent No. 2999845
   HARTMAN LC, 1988, J BIOMED MATER RES, V22, P475, DOI 10.1002/jbm.820220604
   IMAI Y, 1990, POLYM APPL, V39, P438
   IMAI Y, 1990, POLYM PREPR-JAPAN, V39, P1850
   KAJIYAMA M, 1989, MACROMOLECULES, V22, P4143, DOI 10.1021/ma00201a001
   KISHIDA A, 1992, BIOMATERIALS, V13, P113, DOI 10.1016/0142-9612(92)90006-A
   KOGA K, 1991, HYOMEN, V30, P288
   KOINUMA Y, 1992, POLYM PREP JAPAN, V41, P489
   Kurimoto F, 1990, Nihon Rinsho, V48 Suppl, P167
   LAURIN D, 1976, Patent No. 3994988
   LEGRAND DG, 1969, J POLYM SCI POL LETT, V7, P597
   LEGRAND DG, 1970, J ENG SCI, V10, P349
   Lynch W, 1978, HDB SILICONE RUBBER
   NYILAS E, 1971, Patent No. 3562352
   POWELL WS, 1980, PROSTAGLANDINS, V20, P947, DOI 10.1016/0090-6980(80)90144-6
   RUDOLPH R, 1978, PLAST RECONSTR SURG, V62, P185, DOI 10.1097/00006534-197808000-00006
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1988, HYOMEN, V26, P233
   TAKAHARA A, 1989, J BIOMAT SCI-POLYM E, V1, P29
   WARD WJ, 1976, J MEMBRANE SCI, V1, P99, DOI 10.1016/S0376-7388(00)82259-0
   1974, Patent No. 3821325
NR 24
TC 25
Z9 25
U1 3
U2 12
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 5
IS 1-2
BP 89
EP 98
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MG099
UT WOS:A1993MG09900007
PM 8297834
DA 2018-10-20
ER

PT J
AU STEELE, JG
   MCFARLAND, C
   DALTON, BA
   JOHNSON, G
   EVANS, MDM
   HOWLETT, CR
   UNDERWOOD, PA
AF STEELE, JG
   MCFARLAND, C
   DALTON, BA
   JOHNSON, G
   EVANS, MDM
   HOWLETT, CR
   UNDERWOOD, PA
TI ATTACHMENT OF HUMAN BONE-CELLS TO TISSUE-CULTURE POLYSTYRENE AND TO
   UNMODIFIED POLYSTYRENE - THE EFFECT OF SURFACE-CHEMISTRY UPON INITIAL
   CELL ATTACHMENT
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BONE-DERIVED CELLS; CELL ATTACHMENT; SERUM VITRONECTIN; FIBRONECTIN;
   TISSUE CULTURE POLYSTYRENE; UNMODIFIED POLYSTYRENE; HUMAN OSTEOBLASTS;
   BIOMATERIALS
ID HUMAN-ENDOTHELIAL-CELLS; VITRONECTIN RECEPTOR; ADHESION RECEPTORS;
   MONOCLONAL-ANTIBODIES; PROTEIN ADSORPTION; SERUM FIBRONECTIN; MATRIX
   PRODUCTION; POLYMER SURFACES; OSTEOBLASTS; GROWTH
AB Cell culture studies have often been used in the determination of the suitability of biomaterials as surfaces for the attachment and growth of cells. For such studies of surfaces for potential use in bone implants, cells derived from bone may be maintained in culture on tissue culture polystyrene (TCPS). We have determined the contribution that serum fibronectin (FN) or vitronectin (VN) make to the attachment and spreading of cells cultured from explanted human bone (bone-derived cells) during the first 90 min following seeding on culture surfaces.
   The attachment of bone-derived cells to TCPS was simulated two-fold by the addition of 10% (v/v) fetal bovine serum (FBS) to the seeding culture medium. The roles of FN and VN were determined by selective removal of the FN or VN from the FBS prior to addition to the culture medium. FBS from which the VN had been removed did not have this stimulatory activity. In contrast, the attachment of bone-derived cells onto TCPS from medium containing FN-depleted serum (which contained VN) was the same as when intact FBS was used. There was incomplete attachment of bone-derived cells (27% of cells) when seeded in medium containing FBS depleted of both VN and FN. Our results show that for human bone-derived cells, the attachment onto TCPS of cells planted in medium containing FBS during the first 90 min of culture is principally as a result of adsorption onto the surface of serum VN.
   As unmodified polystyrene (PS) has also been used previously as a model biomaterial surface, PS was compared to TCPS for attachment of the bone-derived cells. Attachment of bone-derived cells to TCPS was twice that onto PS, both when the medium was serum-free and when it contained FBS. Bone-derived cells attached to TCPS or PS onto which purified VN or FN had been precoated, with VN adsorbed onto PS being as effective as was VN adsorbed onto TCPS. With FN, there was an effect of the polystyrene surface chemistry which was evident in that suboptimal concentrations of FN had a slightly higher potency when adsorbed onto TCPS than did the same concentrations of FN coated onto PS. When preadsorbed onto TCPS, the potency of FN for attachment of bone-derived cells was at least equal to that of VN.
C1 UNIV NEW S WALES,SCH PATHOL,KENSINGTON,NSW 2033,AUSTRALIA.
RP STEELE, JG (reprint author), CSIRO,DIV BIOMOLEC ENGN,SYDNEY LABS,POB 184,N RYDE,NSW 2113,AUSTRALIA.
RI Evans, Margaret/B-3261-2011
OI Evans, Margaret/0000-0003-3078-1576
CR ANDERSON RC, 1983, CLIN ORTHOP RELAT R, V182, P242
   ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   Brash JL, 1987, ACS S SERIES, V343
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P285
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DAVIES JE, 1990, CRC HDB BIOACTIVE CE, V1, P195
   DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215
   DIDISHEIM P, 1984, T AM SOC ART INT ORG, V30, P370
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HORTON M, 1990, INT J EXP PATHOL, V71, P741
   HORTON MA, 1989, J BONE MINER RES, V4, P803
   IGNOTZ RA, 1989, J BIOL CHEM, V264, P389
   JANECZKO RA, 1992, 4TH WORLD BIOM C
   KABAT D, 1985, J CELL BIOL, V101, P2274, DOI 10.1083/jcb.101.6.2274
   LOWENBERG B, 1991, CELL MATER, V1, P177
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MAGLOIRE H, 1991, BONE-BIOMATERIAL INTERFACE, P229
   MOSKALEWSKI S, 1983, AM J ANAT, V167, P249, DOI 10.1002/aja.1001670210
   NORRIS WD, 1990, J CELL SCI, V95, P255
   OLIVER MH, 1989, J CELL SCI, V92, P513
   PEEL SAF, 1992, MATER RES SOC SYMP P, V252, P71
   PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1
   PITT WG, 1989, J COLLOID INTERF SCI, V129, P231, DOI 10.1016/0021-9797(89)90435-9
   PUELO DA, 1991, BONE, V12, P271
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269
   SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   STAHLI C, 1983, METHOD ENZYMOL, V92, P242
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   SUSUKI T, 1991, J FERMENT BIOENG, V72, P450
   TARRANT SF, 1986, 6TH EUR C BIOM ELS
   UNDERWOOD PA, 1991, J IMMUNOL METHODS, V142, P83, DOI 10.1016/0022-1759(91)90295-Q
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   UNDERWOOD PA, 1992, J CELL SCI, V102, P833
   VANDERSTEENHOVEN JJ, 1983, J BIOMED MATER RES, V17, P793, DOI 10.1002/jbm.820170507
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P79, DOI 10.1002/jcb.240280202
NR 53
TC 116
Z9 116
U1 2
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 5
IS 3
BP 245
EP 257
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MR116
UT WOS:A1993MR11600006
PM 7512377
DA 2018-10-20
ER

PT J
AU RATNER, BD
   HORBETT, TA
AF RATNER, BD
   HORBETT, TA
TI HOFFMAN,ALLAN,S. - OVERVIEW AND APPRECIATION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
ID RADIATION-GRAFTED HYDROGELS; THERMALLY REVERSIBLE HYDROGELS; BIOMATERIAL
   APPLICATIONS; POLY(ETHYLENE OXIDE); SURFACES; POLYMERS; IMMOBILIZATION;
   SEPARATION; COPOLYMER; INVIVO
C1 UNIV WASHINGTON, DEPT CHEM ENGN, SEATTLE, WA 98195 USA.
RP RATNER, BD (reprint author), UNIV WASHINGTON, CTR BIOENGN, BF-10, SEATTLE, WA 98195 USA.
CR ANTONSEN KP, IN PRESS BIOMAT ART
   AUDITOREHARGREAVES K, 1987, CLIN CHEM, V33, P1509
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   COLE CA, 1987, ACS SYM SER, V350, P245
   DONG LC, 1987, ACS SYM SER, V350, P236
   DONG LC, 1986, RADIAT PHYS CHEM, V28, P177
   DONG LC, 1989, P INT S CONTR REL BI, V16, P95
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GOMBOTZ W, 1985, RADIAT PHYS CHEM, V25, P549, DOI 10.1016/0146-5724(85)90134-7
   GOMBOTZ W R, 1985, Journal of Controlled Release, V2, P375, DOI 10.1016/0168-3659(85)90059-8
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOMBOTZ WR, 1987, ACS POLYM MATER SCI, V56, P720
   GOMBOTZ WR, 1988, J APPL POLYM SCI, V35, P1
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1979, ANN BIOMED ENG, V7, P357, DOI 10.1007/BF02364122
   HARKER LA, 1977, ANN NY ACAD SCI, V283, P317, DOI 10.1111/j.1749-6632.1977.tb41778.x
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   Hoffman A S, 1973, Biomater Med Devices Artif Organs, V1, P453, DOI 10.3109/10731197309118556
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   HOFFMAN AS, 1988, ARTIF ORGANS, V12, P504, DOI 10.1111/j.1525-1594.1988.tb02813.x
   HOFFMAN AS, 1984, PURE APPL CHEM, V56, P1329, DOI 10.1351/pac198456101329
   HOFFMAN AS, 1991, POLYMER GELS, P289
   HOFFMAN AS, 1977, BIOMATER ARTIF CELL, V5, P121
   HOFFMAN AS, 1969, J APPL POLYM SCI, V13, P2223, DOI 10.1002/app.1969.070131016
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1970, J APPL POLYM SCI, V14, P285, DOI 10.1002/app.1970.070140203
   HOFFMAN AS, 1980, BIORHEOLOGY, V17, P45
   HOFFMAN AS, 1959, J POLYM SCI, V34, P461, DOI 10.1002/pol.1959.1203412734
   HOFFMAN AS, 1986, CHEMTECH, V16, P426
   HOFFMAN AS, 1982, ACS ADV CHEM SERIES, V199, P59
   HOFFMAN AS, 1974, ACS COATINGS PLASTIC, V34, P568
   HOFFMAN AS, 1991, POLYM MED, V3, P161
   HOFFMAN AS, 1972, POLYM PREPR, V13, P740
   HOFFMAN AS, 1973, CURRENT TOPICS COAGU, P201
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HOFFMAN AS, 1975, PERMEABILITY PLASTIC
   HOFFMAN AS, 1975, POLYM MED SURG, P33
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HORBETT TA, 1975, ADV CHEM SER, P230
   JADWIN TA, 1970, J APPL POLYM SCI, V14, P1339, DOI 10.1002/app.1970.070140519
   KIAEI D, 1988, J APPL POLYM SCI APP, V42, P269
   KO YC, 1981, J COLLOID INTERF SCI, V82, P25, DOI 10.1016/0021-9797(81)90120-X
   KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0
   MATE TP, 1974, ENZYME ENG, V2, P137
   MEYERS AW, 1960, J APPL POLYM SCI, V4, P159
   MONJI N, 1987, APPL BIOCHEM BIOTECH, V14, P107, DOI 10.1007/BF02798429
   MUKHERJEE DP, 1974, BIOPOLYMERS, V13, P2447, DOI 10.1002/bip.1974.360131205
   MUKHERJEE DP, 1971, PHYSICAL PROPERTIE 1, P219
   PARK JB, 1978, ANN BIOMED ENG, V6, P167, DOI 10.1007/BF02584543
   PARK JB, 1976, FRONT MATRIX BIOL, V3, P218
   PARK TG, 1990, J BIOMED MATER RES, V24, P21, DOI 10.1002/jbm.820240104
   PARK TG, 1989, BIOTECHNOL LETT, V11, P17, DOI 10.1007/BF01026779
   PARKER L, 1988, LEARN MOTIV, V19, P1, DOI 10.1016/0023-9690(88)90022-7
   PETTIT DK, 1990, INVEST OPHTH VIS SCI, V31, P2269
   RAMAN SV, 1977, J MOL CATAL, V2, P275
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   RATNER BD, 1978, J BIOENG, V2, P313
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1975, BIOMATER ARTIF CELL, V3, P115, DOI 10.3109/10731197509118616
   RATNER BD, 1976, ACS SYM SER, P1
   RATNER BD, 1979, J POLYM SCI POL SYM, P363
   RATNER BD, 1973, A C S ORG COAT PLAST, V33, P386
   REYNOLDS LO, 1982, T SOC BIOMATER, V5, P37
   ROSSIN AD, 1955, NUCLEONICS, V13, P10
   SASAKI T, 1976, ACS SYM SER, P283
   SHEU MS, UNPUB J CLIN MAT
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   VENKATARAMAN S, 1977, J BIOMED MATER RES, V11, P111, DOI 10.1002/jbm.820110111
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   YANG HJ, 1990, J POLYM SCI POL CHEM, V28, P219, DOI 10.1002/pola.1990.080280116
   YANG HJ, 1989, PREPRINTS IUPAC INT
NR 76
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 3
BP 155
EP 164
DI 10.1163/156856293X00492
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA KV023
UT WOS:A1993KV02300002
PM 8476788
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   HENDERSON, SC
   LAM, TM
AF GREISLER, HP
   HENDERSON, SC
   LAM, TM
TI BASIC FIBROBLAST GROWTH-FACTOR PRODUCTION IN-VITRO BY MACROPHAGES
   EXPOSED TO DACRON AND POLYGLACTIN-910
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE MACROPHAGE; DACRON; POLYGLACTIN; VASCULAR GRAFTS; BASIC FIBROBLAST
   GROWTH FACTOR; SMOOTH MUSCLE CELLS
ID SMOOTH-MUSCLE CELLS
AB Macrophage activation by implanted bood-contacting biomaterials modulates smooth muscle cell and endothelial cell ingrowth. The present study evaluates the in vitro interactions between Dacron or polyglactin 910 with macrophages derived from rabbits fed either normal or atherogenic diets. Peritoneal macrophages were cultured in the presence or absence (negative controls) of either biomaterial for 7 weeks. Conditioned media was evaluated for mitogenic activity using a rabbit aortic smooth muscle cell bioassay with or without preincubation with neutralizing anti-basic-FGF antibody. Results demonstrated increased mitogen release from macrophages harvested from the atherosclerotic rabbits. Only macrophages harvested from normal diet fed rabbits increased their mitogen release following exposure to either polyglactin 910 (p < 0.05) or to Dacron (p < 0.005) over controls. The stimulation of mitogen release by polyglactin 910 did not significantly exceed that in response to Dacron. In rabbits fed normal diets neutralization with the anti-basic-FGF antibody inhibited 100% of the Dacron induced mitogen release as compared to 36% of the polyglactin 910 induced mitogen release (p < 0.01). These results demonstrate significant induced mitogen release from macrophages exposed to biomaterials in vitro, much of the smooth muscle cell mitogen represented by basic-FGF.
C1 HINES VA HOSP,HINES,IL.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BIANCO C, 1981, METHODS STUDYING MON, P273
   GONZALEZ AM, 1990, J CELL BIOL, V109, P203
   GOSPODAROWICZ D, 1991, FIBROBLAST GROWTH FA, V638, P1
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1991, J VASC SURG, V14, P10
   LAM TM, 1992, ANGIOGENESIS KEY PRI, P346
   LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217
   LINDNER V, 1991, CIRC RES, V68, P106, DOI 10.1161/01.RES.68.1.106
   LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739
   PETSIKAS D, 1991, Surgical Forum (Chicago), V42, P326
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
NR 13
TC 13
Z9 13
U1 0
U2 0
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 5
BP 415
EP 430
DI 10.1163/156856293X00672
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA LU040
UT WOS:A1993LU04000002
PM 8241060
DA 2018-10-20
ER

PT J
AU DAHIYAT, BI
   HOSTIN, E
   POSADAS, EM
   LEONG, KW
AF DAHIYAT, BI
   HOSTIN, E
   POSADAS, EM
   LEONG, KW
TI SYNTHESIS AND CHARACTERIZATION OF PUTRESCINE-BASED
   POLY(PHOSPHOESTER-URETHANES)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE DEGRADABLE POLYMERS; POLY(PHOSPHOESTERS); POLYURETHANES; DRUG DELIVERY
AB A novel set of putrescine-based segmented polyurethanes was synthesized using 1,4-butane-diisocyante and phosphoester diols, and was characterized for its potential as a degradable biomaterial. These poly(phosphoester-urethanes) (PPU) were flexible polymers with ultimate tensile strength (UTS) from 2 to 3 MPa, elongations up to 80% and tan delta near 0. 15. The incorporation of phosphoester bonds in the backbone of the polymer by using bis(2-hydroxyethyl)phosphite (BGP) and bis(6-hydroxyhexyl)-phosphite (BHP) as chain extenders resulted in hydrolytic degradation which was evaluated in vitro. By varying the content of the phosphoester diol BGP, degradation rate, as followed by mass loss and GPC, could be modulated. Polymers based on the more hydrophobic monomer, BHP, showed slower degradation than corresponding BGP based polymers. Tensile properties of PPU-B2 after 22 days in vitro degradation show more than a 50% drop in UTS and ultimate elongation, likely caused by void spaces left behind in the polymer after mass loss and swelling. The attachment of a drug, PAS, pendant to the phosphoester group of the PPU was demonstrated. PAS was linked via the spacer 4-hydroxybenzaldehyde, and free, intact drug was released in about 5 h from a thin film.
C1 JOHNS HOPKINS UNIV,DEPT BIOMED ENGN,CHARLES & 34TH STS,BALTIMORE,MD 21218.
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
CR BORISOV G, 1973, EUR POLYM J, V9, P1077, DOI 10.1016/0014-3057(73)90085-2
   DAHIYAT BI, 1992, P ACS DIV PMSE, V67, P87
   DAHIYAT BI, 1992, POLYM MAT SCI ENG, V66, P87
   ECKERT P, 1944, CHEM ABS, P1564
   GUISE GB, 1980, J APPL POLYM SCI, V25, P149, DOI 10.1002/app.1980.070250203
   Lelah M. D., 1986, POLYURETHANES MED
   PRETULA J, 1986, MACROMOLECULES, V19, P1797, DOI 10.1021/ma00161a003
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   Sander M., 1967, J MACROMOL SCI REV C, VC1, P91
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, pCH3
   VOGT W, 1973, MAKROMOL CHEM, V163, P111
NR 11
TC 26
Z9 26
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 5
BP 529
EP 543
DI 10.1163/156856293X00186
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA LU040
UT WOS:A1993LU04000011
PM 8241068
DA 2018-10-20
ER

PT J
AU VANKOOTEN, TG
   SCHAKENRAAD, JM
   VANDERMEI, HC
   BUSSCHER, HJ
AF VANKOOTEN, TG
   SCHAKENRAAD, JM
   VANDERMEI, HC
   BUSSCHER, HJ
TI INFLUENCE OF PULSATILE FLOW ON THE BEHAVIOR OF HUMAN FIBROBLASTS ADHERED
   TO GLASS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE CELLULAR ADHESION; CELLULAR SPREADING; CELLULAR DETACHMENT; HUMAN
   FIBROBLASTS; PULSATIONS; PULSATILE FLOW; PARALLEL PLATE FLOW CHAMBER
ID SHEAR-STRESS; ENDOTHELIAL-CELLS; ADHESION; SURFACES
AB In the human body, cells contacting biomaterials surfaces are frequently exposed to pulsatile shear stresses, e.g. blood vessel prostheses. Most studies involving shear, however, try to achieve a steady, pulse-free shear stress in studying cell-biomaterial interactions. In this study, human fibroblasts adhering to glass were exposed to an applied 0.5 Hz square-wave pulsatile shear, created in a parallel plate flow chamber by a computer-driven pump. Cells were also exposed to the single lower and higher shear stresses making up the square wave in the presence or absence of pressure variations due to the peristaltic roller pump. Results indicate that cells exposed to the applied square-wave regime showed a detachment rate in between that of the single shear stresses making up the square wave. Furthermore, the presence of the pulsations gave rise to elongated cell shapes in the direction of flow and the formation of a more extensive filopodial network than in the absence of pulsations. This was also true for cells exposed to the high shear component in the presence of pressure variations. Cells exposed to the high shear component without any pressure variations, however, adapted spherical shapes after the onset of flow.
C1 UNIV GRONINGEN,MAT TECHN LAB,ANTONIUS DEUSINGLAAN 1,9713 AV GRONINGEN,NETHERLANDS.
   UNIV GRONINGEN,CTR BIOMED TECHNOL,9713 EZ GRONINGEN,NETHERLANDS.
CR DAVIES PF, 1991, J VASC SURG, V13, P729
   DEWEY CF, 1979, ADV EXPT MED BIOL, V115, P61
   HERMAN IM, 1987, J CELL BIOL, V105, P291, DOI 10.1083/jcb.105.1.291
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   KIM DW, 1989, ARTERIOSCLEROSIS, V9, P439, DOI 10.1161/01.ATV.9.4.439
   LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   MIYATA T, 1991, J SURG RES, V50, P485, DOI 10.1016/0022-4804(91)90029-L
   NAKAJIMA T, 1990, AM J PHYSIOL, V259, pH1071
   NEREM RM, 1990, BLOOD FLOW LARGE ART, P117
   PADDOCK SW, 1989, J CELL SCI, V93, P142
   SCHAPERS A, 1990, TURBO PASCAL 5 5 CON, P223
   SUMPIO BE, 1991, J VASC SURG, V13, P744, DOI 10.1016/0741-5214(91)90372-2
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   VANDIJK LJ, 1991, J CLIN PERIODONTOL, V18, P196
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VIGGERS RF, 1986, J BIOMECH ENG-T ASME, V108, P332, DOI 10.1115/1.3138624
NR 17
TC 6
Z9 6
U1 0
U2 1
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 6
BP 601
EP 614
DI 10.1163/156856293X00249
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MA277
UT WOS:A1993MA27700004
PM 8280674
DA 2018-10-20
ER

PT J
AU GUERRA, GD
   BARBANI, N
   LAZZERI, L
   LELLI, L
   PALLA, M
   RIZZO, C
AF GUERRA, GD
   BARBANI, N
   LAZZERI, L
   LELLI, L
   PALLA, M
   RIZZO, C
TI THE ACTIVATION OF HUMAN PLASMA PREKALLIKREIN AS A HEMOCOMPATIBILITY TEST
   FOR BIOMATERIALS .2. CONTACT ACTIVATION BY EVAL AND EVAL SMA COPOLYMERS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE KALLIKREIN; CONTACT ACTIVATION IN PLASMA; HEMOCOMPATIBILITY;
   BIOMATERIALS; EVAL SMA COPOLYMERS
ID MEMBRANES; DIALYSIS
AB The activation of human plasma prekallikrein (PKK) to kallikrein (KK), induced by the contact of blood with foreign materials, is a useful in vitro hemocompatibility test. Kallikrein is easily detected by its reaction with the chromogenic substrate H-D-Pro-Phe-Arg-pNA, which releases p-nitroaniline, revealed by its absorption at 405 nm. This test, which was already carried out by evaluating PKK activation by the 'end-point' method, has been carried out in this work by the more accurate 'initial velocity' method, i.e. by evaluating the activation from the initial rates of the KK-substrate reaction. The tests were carried out on the following materials: borosilicate glass (as a high-activation reference material), silicone (as a low-activation reference material), the commercial biomaterial Cardiothane 51, three graft copolymers synthesized in our laboratory by reacting ethylene-vinyl alcohol copolymer (EVAL) with styrene-maleic anhydride copolymer (SMA), and EVAL itself. A mathematical treatment based on a simple kinetic model has been used for a first-approximation evaluation of the PKK-activating power of the materials tested. The quite low activating power of the EVAL-SMA copolymers, which are easily processable into water-permeable hollow fibers, suggests the possibility of their use in blood dialyzers.
C1 UNIV PISA,DIPARTIMENTO INGN CHIM,I-56100 PISA,ITALY.
RP GUERRA, GD (reprint author), CNR,CTR STUDI PROC ION POLIMERIZZAZ,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR BASILE C, 1989, NEPHRON, V52, P113, DOI 10.1159/000185612
   BERRETTINI M, 1989, J BIOL CHEM, V264, P11738
   BOTS JGF, 1986, DEV HEMATOL IMMUNOL, V14, P277
   CHEN LW, 1990, MAKROMOL CHEM-M SYMP, V33, P183, DOI 10.1002/masy.19900330116
   CHRISTENSEN U, 1980, THROMB HAEMOSTASIS, V43, P169
   FELICIANGELI G, 1991, BIOMATERIALI, V5, P70
   FRIBERGER P, 1982, SCAND J CLIN LA S162, V42, P3
   GALLIMORE MJ, 1982, THROMB RES, V25, P293
   GIUSTI P, 1970, MAKROMOLEKUL CHEM, V136, P97
   GIUSTI P, 1988, PROGR BIOMED ENG, V5, P51
   LAMMLE B, 1985, CLIN HAEMATOL, V14, P281
   RHODES NP, 1992, 4TH WORLD BIOM C BER, P239
   SAKURADA Y, 1987, POLYM J, V19, P501, DOI 10.1295/polymj.19.501
   SCHIFANO S, 1989, PRODUZIONE FIBRE CAV
   SCOTT CF, 1981, BLOOD, V57, P553
NR 15
TC 10
Z9 10
U1 0
U2 0
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 6
BP 643
EP 652
DI 10.1163/156856293X00852
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MA277
UT WOS:A1993MA27700007
PM 8280677
DA 2018-10-20
ER

PT J
AU TU, R
   LU, CL
   THYAGARAJAN, K
   WANG, E
   NGUYEN, H
   SHEN, S
   HATA, C
   QUIJANO, RC
AF TU, R
   LU, CL
   THYAGARAJAN, K
   WANG, E
   NGUYEN, H
   SHEN, S
   HATA, C
   QUIJANO, RC
TI KINETIC-STUDY OF COLLAGEN FIXATION WITH POLYEPOXY FIXATIVES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID GLUTARALDEHYDE
AB A new biomaterial has been developed by fixing native collagen with a polyepoxy compound (PC) fixative. In this study, bovine internal thoracic arteries were fixed with PC under various conditions to help understand the kinetics of the collagen-PC reactions and optimize the fixation process. At predetermined time intervals, small samples were cut from the arteries to determine the quantities of the remaining unreacted amino acids in the collagen. Temperature, concentration, and solution pH were among the key parameters studied. The overall fixation rate was found to be reaction-rate controlled, as the rate of fixation was relatively slow compared with the rate of diffusion of PC. As might be expected, the reaction rate was favored by a higher temperature, concentration, and solution pH. A kinetic model, with a 2.5th reaction order with respect to the reactive functional groups of collagen and a first order with respect to PC, was developed that gave a good fit to the experimental data. Based on this model, the degree of fixation, X, as a function of time, t, is given by (1 - X)-1.5 = 1 + Kt, where K is a constant related to the initial concentrations and the reaction rate constant.
RP TU, R (reprint author), BAXTER HEALTHCARE CORP,EDWARDS CVS DIV,IRVINE,CA, USA.
CR BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   HATA C, 1991, 8 WORLD C ISAO MONTR
   Heidemann E., 1988, COLLAGEN, VIII, P39
   HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   KORN AH, 1972, J MOL BIOL, V65, P525, DOI 10.1016/0022-2836(72)90206-9
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   LEVENSPIEL O, 1972, CHEM REACTION ENG, P35
   LOHRE J, 1991, 8 WORLD C ISAO MONTR
   MARCH J, 1985, ADV ORGANIC CHEM REA, P368
   MASUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   MONSAN P, 1975, BIOCHIMIE, V57, P1281
   MORRISON RT, 1986, ORGANIC CHEM, P548
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOIJIRI C, 1987, J THORAC CARDIOVASC, V93, P867
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   PAYNE JW, 1973, BIOCHEM J, V135, P867, DOI 10.1042/bj1350867
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   SAWYER PN, 1983, VASCULAR GRAFTING CL, P331
   SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   SUNG H, 1991, 8 WORLD C ISAO MONTR
   TOMIZAWA Y, 1990, T AM SOC ART INT ORG, V36, P734
   TOMIZAWA Y, 1989, T AM SOC ART INT ORG, V35, P199
   TU R, 1991, 1991 ASAIO M CHIC
   TU R, 1991, T AM SOC ART INT ORG, V37, P470
   TU R, 1991, 1991 SOC BIOM M SCOT
   Yamauchi M., 1988, COLLAGEN, P157
NR 34
TC 51
Z9 51
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 3
EP 9
DI 10.1002/jbm.820270103
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600002
PM 8420998
DA 2018-10-20
ER

PT J
AU KOIDE, M
   OSAKI, K
   KONISHI, J
   OYAMADA, K
   KATAKURA, T
   TAKAHASHI, A
   YOSHIZATO, K
AF KOIDE, M
   OSAKI, K
   KONISHI, J
   OYAMADA, K
   KATAKURA, T
   TAKAHASHI, A
   YOSHIZATO, K
TI A NEW TYPE OF BIOMATERIAL FOR ARTIFICIAL SKIN - DEHYDROTHERMALLY
   CROSS-LINKED COMPOSITES OF FIBRILLAR AND DENATURED COLLAGENS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID WOUND DRESSINGS; PORE STRUCTURE; FIBROBLASTS; GLUTARALDEHYDE;
   MORPHOLOGY; DESIGN; CELLS
AB A new type of biomaterial for artificial skin was developed as a form of sponge by combining fibrillar collagen (F-collagen) with gelatin. The sponge was physically and metabolically stabilized by introducing dehydrothermal cross links. To get the final product, various conditions in the preparation of sponges were evaluated by in vitro cellular responses and in vivo tissue reactions. Fibroblasts placed on a sponge of gelatin attached themselves to it, migrated well into the sponge, and remained inside it for at least 7 days. However, sponges of gelatin showed structural instability for hydrolytic degradation by the cells. Most fibroblasts appeared not to penetrate into the interior of a sponge of F-collagen but to remain on its surface when fibroblasts were placed on the sponge, suggesting poor attraction of F-collagen toward cells. Implantation experiments of sponges of F-collagen revealed an intense infiltration of neutrophils into the sponge, indicating F-collagen as an inducer of the inflammatory reaction. These aggravating characters of F-collagen sponges were greatly improved by blending gelatin with F-collagen. The new type of collagen-based biomaterials developed in the present study is expected to become a useful matrix substance for artificial skin.
C1 HIROSHIMA UNIV,FAC SCI,INST ZOOL,MOLEC CELL SCI LAB,1-3-1 HIGASHIHIROSHIMA SHI,HIROSHIMA 724,JAPAN.
   TERUMO CO,CTR R&D,KANAGAWA 25901,JAPAN.
CR BELL E, 1981, SCIENCE, V211, P1042
   BISWAS C, 1979, CELL, V18, P1035, DOI 10.1016/0092-8674(79)90216-2
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DOILLON CJ, 1984, SCANNING ELECTRON MI, V3, P1313
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   Linsenmayer TF, 1985, CELL BIOL EXTRACELLU, P5
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MCPHERSON JM, 1986, J BIOMED MATER RES, V20, P79, DOI 10.1002/jbm.820200108
   NIMINI ME, 1987, J BIOMEDICAL MAT RES, V21, P741
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   NORTON L, 1981, J TRAUMA, V21, P463
   OLIVER RF, 1981, CONNECT TISSUE RES, V9, P59, DOI 10.3109/03008208109160240
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   STRIVASTAVA S, 1990, BIOMATERIALS, V11, P162
   TAKEDA U, 1983, Journal of Dermatology (Tokyo), V10, P593
   WEADOCK K, 1984, BIOMAT MED EV ARTIF, V11, P293
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YOSHIZATO K, 1980, BIOCHIM BIOPHYS ACTA, V627, P23, DOI 10.1016/0304-4165(80)90119-1
   YOSHIZATO K, 1988, BIOMED RES-TOKYO, V9, P33, DOI 10.2220/biomedres.9.33
   YOSHIZATO K, 1985, BIOMED RES-TOKYO, V6, P61
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
NR 27
TC 144
Z9 147
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 79
EP 87
DI 10.1002/jbm.820270111
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600010
PM 8421002
DA 2018-10-20
ER

PT J
AU SMITH, BAH
   SEFTON, MV
AF SMITH, BAH
   SEFTON, MV
TI THROMBIN AND ALBUMIN ADSORPTION TO PVA AND HEPARIN PVA HYDROGELS .2.
   COMPETITION AND DISPLACEMENT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMATERIAL
AB Thrombin adsorption to polyvinyl alcohol (PVA) was different from its adsorption to polyethylene (PE)-not so much in amount, but in its affinity. Thrombin was more easily displaced from polyethylene and its adsorption was more readily prevented by prior or simultaneous exposure to albumin. From PVA (or heparin-PVA), only approximately 30% of the adsorbed protein could be removed by a series of eluents, including even harsh ones such as 2.5M NaOH and 6M guanidine; >85% could be removed from PE. Thrombin adsorption to PVA was not affected by the presence of BSA in solution or at the surface, but was virtually prevented on PE by preexposure to or adsorption with BSA. Heparin-PVA was not much different than PVA in most of these experiments, but did exhibit a ''Vroman effect''. In the absence of fibrinogen or antithrombin III, there was a maximum in thrombin adsorption from plasma at a plasma concentration of 1%. The behavior on this surface was dependent on both exposure time and protein concentration. These studies highlight the complexity of the interaction between plasma proteins and polymer surfaces (particularly hydrogel surfaces) and the difficulty of obtaining a clear picture of what happens when a single protein interacts with a polymer in the presence of other proteins.
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A4,ONTARIO,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO M5S 1A4,ONTARIO,CANADA.
FU NHLBI NIH HHS [HL24020]
CR BRASH JL, 1974, T AM SOC ART INT ORG, VA 20, P69
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HATTON MWC, 1983, THROMB HAEMOSTASIS, V50, P873
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   IP WF, 1985, J BIOMED MATER RES, V19, P161, DOI 10.1002/jbm.820190206
   ROLLASON G, 1989, Journal of Biomaterials Science Polymer Edition, V1, P31, DOI 10.1163/156856289X00046
   SMITH BAH, 1992, J BIOMED MATER RES, V26, P947, DOI 10.1002/jbm.820260709
NR 7
TC 8
Z9 8
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 89
EP 95
DI 10.1002/jbm.820270112
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600011
PM 8421003
DA 2018-10-20
ER

PT J
AU SANTERRE, JP
   LABOW, RS
   ADAMS, GA
AF SANTERRE, JP
   LABOW, RS
   ADAMS, GA
TI ENZYME BIOMATERIAL INTERACTIONS - EFFECT OF BIOSYSTEMS ON DEGRADATION OF
   POLYURETHANES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIODEGRADATION; POLYMERS; INVITRO; PROPERTY
AB Enzyme-induced liberation of hard-segment-containing components from polyurethanes was evaluated using two C-14-labeled polyurethanes. A polyester urea-urethane and polyether urea-urethane were synthesized from toluene-2,4-diisocyanate (TDI)/polycaprolactone diol (PCL) or TDI/polyethylene glycol (PEO) with C-14-labeled ethylene diamine. Both materials were characterized using electron spectroscopy for chemical analysis (ESCA), differential scanning calorimetry (DSC), size exclusion chromatography, and material chemistry by Fourier transform infrared (FTIR) spectroscopy. Biodegradation assays were carried out using cholesterol esterase (CE), collagenase (CO), cathepsin B (CB), and xanthine oxidase (XO) at the pH optimum conditions for each enzyme at 37-degrees-C. Biodegradation was analyzed by monitoring the release of radiolabel, by weight change, and by surface analysis using scanning electron microscopy. The polyester urea-urethane was shown to be susceptible to enzymatic degradation above the effect of the buffer control solution by the CE but not by the other enzyme systems as monitored by radiolabel released. In the initial period of incubation, the rate of degradation was increased for all systems, including buffer controls; however, the rates dropped off rapidly by day 28. The change in weight data for the polyester urea-urethane and polyether urea-urethane showed no enzyme-dependent biodegradation above the buffer controls. However, in sodium acetate buffer at pH = 5, the polymers showed a significant weight loss relative to other buffers. In conclusion, this study showed that the biological component responsible for the onset of the biodegradation process is more likely the result of a multitude of biologically mediated compounds acting synergistically, with the process being enhanced by physical parameters such as material dissolution. In addition characterization of surface and bulk chemistry as well as material structure evaluation have been shown to be essential to interpret degradation data.
C1 UNIV OTTAWA,OTTAWA K1H 8M5,ONTARIO,CANADA.
RP SANTERRE, JP (reprint author), UNIV OTTAWA,OTTAWA CIVIC HOSP,INST HEART,DIV CARDIOVASC DEVICES,OTTAWA K1Y 4E9,ONTARIO,CANADA.
CR BORETOS JW, 1981, BIOCOMPATIBILITY CLI, V2, P127
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1986, POLYURETHANES MED, pCH4
   Lemm W., 1983, BIOMATERIALS BIOMECH, P319
   LYNN KR, 1984, CAN J BIOCHEM CELL B, V62, P1301, DOI 10.1139/o84-166
   MIRKOVITCH V, 1969, J APPL PHYS, V16, P2
   PARINS DJ, 1981, REPORT CARDIAC PACEM
   PIERCE WS, 1975, POLYM MED SURGERY
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RODELL TC, 1987, J APPL PHYSIOL, V63, P2159
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES KB, 1985, ACS POLYM MAT SCI EN, V53, P1
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   SZYCHER M, 1984, T SOC BIOMATER, V7, P24
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 24
TC 68
Z9 69
U1 3
U2 21
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 97
EP 109
DI 10.1002/jbm.820270113
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600012
PM 8421004
DA 2018-10-20
ER

PT J
AU SUNG, JY
   LEUNG, JWC
   SHAFFER, EA
   LAM, K
   COSTERTON, JW
AF SUNG, JY
   LEUNG, JWC
   SHAFFER, EA
   LAM, K
   COSTERTON, JW
TI BACTERIAL BIOFILM, BROWN PIGMENT STONE AND BLOCKAGE OF BILIARY STENTS
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE BIOFILM; PIGMENT STONE; STENT
ID COMMON BILE-DUCT; ENDOSCOPIC PALLIATIVE TREATMENT; MALIGNANT
   OBSTRUCTIVE-JAUNDICE; ELECTRON-MICROSCOPY; PANCREATIC-CANCER; CALCIUM
   SECRETION; SOLID-SURFACES; SPHINCTER; TRACT; ODDI
AB Bacterial pathogens pin access into the biliary system by descending via the portal venous circulation or ascending through the sphincter of Oddi in duodenal-biliary reflux. Bacteria thrive as glycocalyx-enclosed microcolonies, coalescing to form an adherent biofilm. The establishment of biofilm is a key event in the formation of biliary sludge and pigment gallstones, and the blockage of biliary stents. The biofilm mode of growth is very effective because it provides bacteria with a measure of protection from antibacterial agents and phagocytic leucocytes. Calcification of the matrix confers further protection for the micro-organisms living inside the biofilm. To date, attempts to prevent blockage of biliary stent have employed physical methods by using large self-expandable stents and stents without side hole. Incorporation of antibiotics within stents has not been successful presumably because bacteria once living in their biofilm are quite resistant to antimicrobial agents. Even the most toxic bile salts have no effect on the biofilm bacteria. Yet, hydrophobic bile salts reduce bacterial adhesion on biomaterial, suggesting that incorporation of such bile salts might prevent the formation of bacterial biofilm.
C1 CHINESE UNIV HONG KONG,DEPT MED,SHA TIN,HONG KONG.
   UNIV CALGARY,DEPT MED,CALGARY T2N 1N4,ALBERTA,CANADA.
   UNIV CALGARY,DEPT BIOL SCI,CALGARY T2N 1N4,ALBERTA,CANADA.
   DUKE UNIV,MED CTR,DIV GASTROENTEROL,DURHAM,NC 27710.
RI Sung, Joseph J. Y./R-3203-2018; Hossain, Sarah/C-7332-2009
OI Sung, Joseph J. Y./0000-0003-3125-5199; Hossain,
   Sarah/0000-0003-1355-0979
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   BAKER MS, 1979, ARCH SURG-CHICAGO, V114, P748
   Charcot JM, 1877, LECONS MALADIES FOIE
   Christensen GD, 1989, INFECT ASS INDWELLIN, P4
   COENE PPLO, 1990, GUT, V31, P913, DOI 10.1136/gut.31.8.913
   COLEMAN R, 1980, BIOCHIM BIOPHYS ACTA, V242, P825
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COTTON PB, 1990, ANNU REV MED, V41, P211
   CSENDES A, 1975, AM J SURG, V129, P629, DOI 10.1016/0002-9610(75)90334-7
   DEMASI E, 1984, GUT, V25, P275, DOI 10.1136/gut.25.3.275
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P602, DOI 10.1128/AAC.33.5.602
   DINEEN P, 1964, SURG GYNECOL OBSTET, V119, P1001
   Dodds W. Y, 1989, HDB PHYSL, P1055
   DYE M, 1978, BRIT J SURG, V65, P285, DOI 10.1002/bjs.1800650419
   FERETIS CB, 1984, SURG GYNECOL OBSTET, V159, P363
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FRENCH GL, 1990, J ANTIMICROB CHEMO S, V25, P137
   GEENEN JE, 1980, GASTROENTEROLOGY, V78, P317
   Geoghegan J, 1991, GASTROINTEST ENDOSC, V37, P257
   GREGG JA, 1985, AM J SURG, V149, P668, DOI 10.1016/S0002-9610(85)80152-5
   GROEN AK, 1987, ENDOSCOPY, V19, P57, DOI 10.1055/s-2007-1018235
   HELM JF, 1985, AM J PHYSIOL, V249, pG572
   HOSMIN A, 1990, ANTIMICROB AGENTS CH, V34, P2043
   HOYLE BD, 1989, FEMS MICROBIOL LETT, V60, P339
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   HUIBREGTSE K, 1986, GASTROINTEST ENDOSC, V32, P334, DOI 10.1016/S0016-5107(86)71878-6
   HUIBREGTSE K, 1989, ENDOSCOPY, V21, P280, DOI 10.1055/s-2007-1012969
   HUMPHRIES M, 1987, FEMS MICROBIOL LETT, V42, P91, DOI 10.1111/j.1574-6968.1987.tb02305.x
   JACQUES M, 1987, MICROBIAL ECOL, V13, P173, DOI 10.1007/BF02024996
   KLOTZ SA, 1985, INFECT IMMUN, V50, P97
   Klotz SA, 1990, MICROBIAL CELL SURFA, P107
   LEE SP, 1990, HEPATOLOGY, V12, pS200
   LEUNG JWC, 1988, GASTROINTEST ENDOSC, V34, P19, DOI 10.1016/S0016-5107(88)71223-7
   LEUNG JWC, 1983, BRIT J SURG, V70, P584, DOI 10.1002/bjs.1800701006
   LEUNG JWC, 1989, J CLIN MICROBIOL, V27, P915
   Li A K, 1985, Trop Gastroenterol, V6, P119
   MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   MCSHERRY CK, 1970, SURG GYNECOL OBSTETR, V130, P829
   MOORE EW, 1985, HEPATOLOGY, V5, P994
   MOORE EW, 1990, HEPATOLOGY, V12, pS206
   NICKEL JC, 1985, ANTIMICROB AGENT CHE, V27, P19
   NICKEL JC, 1986, INVEST UROL, V6, P512
   ONG GB, 1962, ARCH SURG-CHICAGO, V84, P199
   REGE RV, 1990, J LAB CLIN MED, V115, P593
   SCHATTEN WE, 1955, ARCH SURG-CHICAGO, V71, P404, DOI 10.1001/archsurg.1955.01270150098011
   SEIGEL JH, 1988, ENDOSCOPY, V20, P137
   SMIT JM, 1989, GASTROINTEST ENDOSC, V35, P485, DOI 10.1016/S0016-5107(89)72895-9
   SPEER AG, 1987, LANCET, V2, P57
   SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546
   STEWART L, 1987, ANN SURG, V206, P242, DOI 10.1097/00000658-198709000-00002
   SUNG J Y, 1990, Microbial Ecology in Health and Disease, V3, P199
   SUNG JY, 1991, DIGEST DIS SCI, V36, P943, DOI 10.1007/BF01297145
   SUNG JY, 1992, J GASTROEN HEPATOL, V7, P240, DOI 10.1111/j.1440-1746.1992.tb00971.x
   SUNG JY, 1991, HEPATOLOGY, V14, P313, DOI 10.1002/hep.1840140218
   SUNG JY, 1991, HEPATOLOGY, V14, pA262
   SUNG JY, 1992, GASTROINTEST ENDOSC, V38, P263
   TOOULI J, 1982, GASTROENTEROLOGY, V82, P111
   TROTMAN BW, 1991, GASTROENTEROL CLIN N, V20, P111
   TURNER WW, 1983, SURGERY, V93, P397
   VELARDI ALM, 1991, GASTROENTEROLOGY, V101, P457, DOI 10.1016/0016-5085(91)90025-G
   WOSIEWITZ U, 1985, GASTROENTEROLOGY, V88, P1076
NR 62
TC 64
Z9 68
U1 0
U2 5
PU BLACKWELL SCIENCE
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA
SN 0815-9319
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD JAN-FEB
PY 1993
VL 8
IS 1
BP 28
EP 34
DI 10.1111/j.1440-1746.1993.tb01171.x
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA KP907
UT WOS:A1993KP90700005
PM 8439659
DA 2018-10-20
ER

PT J
AU FOX, WC
   AUFDEMORTE, TB
AF FOX, WC
   AUFDEMORTE, TB
TI EXPERIENCE WITH OSSEOUS IMPLANTS FOR BONE AND BIOMATERIALS RESEARCH
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Article
DE CANCELLOUS ACCESS PORT; ANALYTIC BONE IMPLANT; BIOCOMPATIBILITY;
   TITANIUM BONE IMPLANT; OSSEOUS INFUSION; BONE AND MARROW BIOPSY
ID GROWTH CHAMBER; IRRADIATION; TISSUE; REGENERATION; DEFECTS
AB A Cancellous Access Port (CAP) osseous implant for repeated sampling of cancellous tissue was developed and tested for experimental studies of bone, marrow, and materials biocompatibility. The CAP and associated methods were shown in a series of studies to allow the repeated biopsy of unstrained cancellous tissue with little morbidity and no mortality when used in baboons, rhesus, sheep, and horses. CAP infusion, material testing, and biopsy core assemblies were developed and tested for the administration and assessment of the effects of pharmaceuticals and biologics; the placement and retrieval of a biomaterial with the surrounding tissue; and studies of cancellous bone healing and remodeling.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT OTOLARYNGOL HEAD & NECK SURG,SAN ANTONIO,TX 78284.
   UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284.
RP FOX, WC (reprint author), BIOMED ENTERPRISES INC,TEXAS RES PK,14785 OMICRON DR,SAN ANTONIO,TX 78245, USA.
CR ALBREKTSSON T, 1982, ACTA ORTHOP SCAND, V53, P757, DOI 10.3109/17453678208992288
   ALBREKTSSON T, 1980, Scandinavian Journal of Plastic and Reconstructive Surgery, V14, P1
   ALBREKTSSON T, 1980, J BONE JOINT SURG BR, V62, P403
   ALBREKTSSON T, 1980, ACTA RADIOL ONCOL, V19, P235, DOI 10.3109/02841868009130158
   ALBREKTSSON T, 1979, THESIS U GOTEBORG SW
   ANDERSON C, 1982, HISTOMORPHOMETRY
   AUFDEMORTE TB, 1992, J BONE JT SURG, P1153
   BRANEMAR.PI, 1964, ACTA ANAT, V59, P1
   BUCH F, 1984, BIOMATERIALS, V5, P341, DOI 10.1016/0142-9612(84)90032-2
   BUCH F, 1986, J ORTHOPAED RES, V4, P194, DOI 10.1002/jor.1100040208
   BUCH F, 1986, J BIOELECTRICITY, V5, P105, DOI 10.3109/15368378609027721
   BUCH F, 1985, THESIS U GOTEBORG SW
   DEHOFF RT, 1983, J MICROSC-OXFORD, V131, P259, DOI 10.1111/j.1365-2818.1983.tb04254.x
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   GRIGIS FG, 1958, J BONE JT SURG B, V40, P274
   HALLEN O, 1976, ACTA OTO-LARYNGOL, V82, P394, DOI 10.3109/00016487609120924
   JACOBSSON M, 1985, INT J RADIAT ONCOL, V11, P1963, DOI 10.1016/0360-3016(85)90278-0
   JACOBSSON M, 1985, ACTA ONCOL, V24, P343, DOI 10.3109/02841868509136063
   JACOBSSON M, 1985, SCAND J PLAST RECONS, V19, P231, DOI 10.3109/02844318509074508
   JACOBSSON M, 1986, ACTA ONCOL, V25, P57, DOI 10.3109/02841868609136379
   JACOBSSON M, 1985, THESIS U GOTEBORG SW
   JACOBSSON MG, 1985, PLAST RECONSTR SURG, V76, P841, DOI 10.1097/00006534-198512000-00006
   KALEBO P, 1986, ARCH ORTHOP TRAUM SU, V105, P321, DOI 10.1007/BF00449935
   KETENJIAN AY, 1975, CLIN ORTHOP RELAT R, V107, P266
   LISTROM RD, 1984, THESIS U TORONTO CAN
   MATHOG RH, 1975, LARYNGOSCOPE, V83, P908
   NETO FLD, 1984, CLIN ORTHOP RELAT R, V187, P260
   PARFITT AM, 1987, J BONE MINER RES, V2, P545
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   SIROLA K, 1960, Ann Med Exp Biol Fenn, V38(Suppl 2), P1
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TJELLSTROM A, 1978, ACTA OTO-LARYNGOL, V85, P33, DOI 10.3109/00016487809121420
   TJELLSTROM A, 1978, ACTA OTO-LARYNGOL, V85, P232
   Urist MR, 1943, J BONE JOINT SURG, V25, P375
   WILLIAMS G, 1988, 4TH P ANN SCI SESS A
   1985, SAS STATISTICS USERS
   1987, ANN BOOK ASTM STANDA
NR 37
TC 4
Z9 4
U1 0
U2 2
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 1050-6934
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1993
VL 3
IS 1
BP 1
EP 27
PG 27
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA KZ655
UT WOS:A1993KZ65500001
PM 10171653
DA 2018-10-20
ER

PT J
AU NAGARAJAN, VS
   RAO, KJ
AF NAGARAJAN, VS
   RAO, KJ
TI STRUCTURAL, MECHANICAL AND BIOCOMPATIBILITY STUDIES OF
   HYDROXYAPATITE-DERIVED COMPOSITES TOUGHENED BY ZIRCONIA ADDITION
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
DE HYDROXYAPATITE; ZIRCONIA; COMPOSITE; BIOMATERIAL
ID FRACTURE-TOUGHNESS; TETRAGONAL ZRO2; GELS; CRYSTALLINE; EVOLUTION;
   MICROSTRUCTURE
AB Hydroxyapatite(OHAp)-based ceramic composites with added ZrO2 have been prepared both by sintering at 1400-degrees-C and by hot isostatic pressing (HIP) at 1450-degrees-C and 140 MPa pressure (argon atmosphere). The development of the crystalline phases and the microstructure of the composites have been examined using X-ray diffraction, electron microscopy, infrared and magic-angle spinning nuclear magnetic resonance (MASNMR) spectroscopic techniques. The fracture toughness and biocompatibility of the composites have also been studied. The effect of the addition of CeO2- and Y2O3-stabilized ZrO2 and of simple monoclinic ZrO2 to the initial physical mixture, on the structure and properties of the resulting composites has been investigated. In most of the sintered or HIP samples, the OHAp decomposes into tricalcium phosphate (beta-TCP). CaO, which forms as a product of decomposition, dissolves completely in ZrO2 and stabilizes the latter in its cubic/tetragonal phase. Presence of the beta-TCP phase in the product seems to be the result of a structural synergistic effect of hexagonal OHAp. Two structurally distinct orthophosphate groups have been identified in the composites by MASNMR of P-31 and attributed to decomposition products of OHAp at higher temperatures. The composites possess high K(IC) values (2-3 times higher than that of pure OHAp). Decomposition of hydroxyapatite gives rise to differences in microstructure between HIP and simply sintered composites although fracture toughness values are similar in magnitude indicating the presence of several toughening mechanisms. The in vitro SP2-O cell test suggests that these composites possess good biocompatibility. The combination of good biocompatibility, desirable microstructure and easy availability of initial reactants indicates that the simply sintered composite of OHAp and monoclinic ZrO2 (ZAP-30) appears to be the most suitable for prosthetic applications.
C1 INDIAN INST SCI,MAT RES CTR,BANGALORE 560012,KARNATAKA,INDIA.
CR CAMPBELL AM, LABORATORY TECHNIQUE, V13, P74
   CLAUSSEN N, 1976, J AM CERAM SOC, V59, P49, DOI 10.1111/j.1151-2916.1976.tb09386.x
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Evans A. G., 1984, ADV CERAM, P193
   Francis M D, 1968, Adv Oral Biol, V3, P83
   HEUER AH, 1982, J AM CERAM SOC, V65, P642, DOI 10.1111/j.1151-2916.1982.tb09946.x
   IOKU K, 1987, DEC P 87 FALL M MRS
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JORCHA M, 1977, J BIOENG, V1, P79
   KATZ JL, 1986, ENCY MAT SCI ENG, V1, P474
   KIJIMA T, 1979, J AM CERAM SOC, V62, P455, DOI 10.1111/j.1151-2916.1979.tb19104.x
   KUTTY TRN, 1973, INDIAN J CHEM, V11, P695
   LEE RR, 1987, J AM CERAM SOC, V70, P208, DOI 10.1111/j.1151-2916.1987.tb04969.x
   LIN FH, 1987, J MATER SCI LETT, V6, P501, DOI 10.1007/BF01739266
   NAGARAJAN VS, 1990, J SOLID STATE CHEM, V88, P419, DOI 10.1016/0022-4596(90)90237-R
   NAGARAJAN VS, 1991, J MATER RES, V6, P2688, DOI 10.1557/JMR.1991.2688
   NAGARAJAN VS, 1989, J MATER SCI, V24, P2140, DOI 10.1007/BF02385434
   NAGARAJAN VS, 1991, J SOLID STATE CHEM, V94, P149, DOI 10.1016/0022-4596(91)90228-A
   NAGARAJAN VS, 1991, PHILOS MAG A, V65, P771
   NAKAJIMA K, 1984, ADV CERAM, V12, P399
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M, P39
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   NOGAMI M, 1988, J NON-CRYST SOLIDS, V100, P298, DOI 10.1016/0022-3093(88)90036-1
   PRABAKAR S, 1991, J MATER RES, V6, P592, DOI 10.1557/JMR.1991.0592
   PRABHAKAR S, 1987, CHEM PHYS LETT, V139, P96, DOI 10.1016/0009-2614(87)80158-6
   RAO ECS, 1981, ADV CERAM, V3, P1
   REJDA BV, 1977, J BIOENG, V1, P93
   SANDERSON RT, 1979, POLAR COVALENCE, P39
   TSUKUMA K, 1985, J MATER SCI, V20, P1178, DOI 10.1007/BF01026311
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   YYOSHIMURA M, 1989, EUROCERAMICS, V3
NR 31
TC 28
Z9 28
U1 0
U2 2
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND
   CB4 4WF
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD JAN
PY 1993
VL 3
IS 1
BP 43
EP 51
DI 10.1039/jm9930300043
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA KH254
UT WOS:A1993KH25400008
DA 2018-10-20
ER

PT J
AU SOUZA, R
AF SOUZA, R
TI BEHAVIOR OF A 316L STAINLESS-STEEL IMPLANT PROCESSED BY SANDING OR
   ALUMINA-COATED IN THE METACARPUS BONE OF SHEEP
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOMATERIAL
AB The behaviour of bone was studied in the presence of two implant materials, a 316L stainless steel with its surface roughened by sanding (type I) and the same steel coated with alumina by plasma-spraying (type II). Twelve nails of types I and II were implanted in the medullary canal of previously fractured metacarpal bones of 12 sheep. Samples were taken from six sheep at 90 days (group A) and 180 days (group B) post-surgery. Clinical examination of the operated sheep as well as radiographic analysis did not show any difference between the two types of implants. Bone ingrowth was studied by optical microscopy and microradiography, by measuring the angle of bone growth around the implants and the minimum distance between the newly formed bone and the implants. Differences between the two types of implants were not statistically significant.
RP SOUZA, R (reprint author), ECOLE NATL VET LYON,SERV CHIRURG,1 AVE BOURGELAT,BP 83,F-69280 MARCY LETOILE,FRANCE.
CR BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   BOUTIN P, 1971, PRESSE MED, V79, P639
   BROW SD, 1984, INT C METALLURGICAL
   BUNNY F, 1975, ACTA ORTHOP BELG, V41, P6
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   DOREMUS RH, 1986, METAL CERAMIC BIOMAT, V1, P107
   GILL BJ, 1986, MATER SCI TECH SER, V2, P207, DOI 10.1179/mst.1986.2.3.207
   Kruger J., 1979, ASTM SPECIAL TECHNIC, P107
   MASSE Y, 1976, ANN ORTHOP OUEST, V8, P117
   NODA I, 1986, JPN SOC ORTHOP CERAM, V6, P1
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Schenk R, 1984, METHODS CALCIFIED TI, P1
   TULI SM, 1978, J BONE JOINT SURG, V3, P16
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 14
TC 0
Z9 0
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 1993
VL 4
IS 1
BP 55
EP 57
DI 10.1007/BF00122978
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK181
UT WOS:A1993KK18100010
DA 2018-10-20
ER

PT J
AU DEGEE, P
   DUBOIS, P
   JEROME, R
   TEYSSIE, P
AF DEGEE, P
   DUBOIS, P
   JEROME, R
   TEYSSIE, P
TI SYNTHESIS AND CHARACTERIZATION OF BIOCOMPATIBLE AND BIODEGRADABLE POLY
   (EPSILON-CAPROLACTONE-B-GAMMA-BENZYLGLUTAMATE) DIBLOCK COPOLYMERS
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Note
DE BIODEGRADABILITY; BIOCOMPATIBILITY; BIOMATERIAL
   POLY(EPSILON-CAPROLACTONE); POLYPEPTIDE; POLY-GAMMA-BENZYLGLUTAMATE;
   BLOCK COPOLYMER
ID BLOCK COPOLYMERS; POLYLACTONES
C1 STATE UNIV LIEGE,CTR ETUD & RECH MACROMOLEC,SART TILMAN B6,B-4000 LIEGE,BELGIUM.
RI DUBOIS, Philippe/B-9983-2008
CR CHO CS, 1988, MAKROMOL CHEM, V189, P1505
   DEGEE P, UNPUB MACROMOLECULES
   DUBOIS P, 1991, MACROMOLECULES, V24, P977, DOI 10.1021/ma00005a002
   DUBOIS P, 1989, POLYM BULL, V22, P475, DOI 10.1007/BF00718922
   DUBOIS P, UNPUB MACROMOLECULES
   FULLER WD, 1976, BIOPOLYMERS, V15, P1869, DOI 10.1002/bip.1976.360150922
   JANSSEN K, 1988, POLYMER, V29, P1513, DOI 10.1016/0032-3861(88)90318-7
   Kricheldorf H. R., 1987, ALPHA AMINO ACID N C, P59
   KUGO K, 1987, POLYM J, V19, P375, DOI 10.1295/polymj.19.375
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1991, MAKROMOL CHEM MACROM, V42, P103
   ORY SJ, 1983, AM J OBSTET GYNECOL, V145, P600, DOI 10.1016/0002-9378(83)91204-8
   OVSIANNIKOVA LA, 1986, MAKROMOL CHEM, V187, P2351
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   Pitt C G, 1980, CONTROLLED RELEASE B
NR 15
TC 21
Z9 21
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN
PY 1993
VL 31
IS 1
BP 275
EP 278
DI 10.1002/pola.1993.080310132
PG 4
WC Polymer Science
SC Polymer Science
GA KB969
UT WOS:A1993KB96900032
OA Bronze
DA 2018-10-20
ER

PT J
AU DENDUNNEN, WFA
   VANDERLEI, B
   SCHAKENRAAD, JM
   BLAAUW, EH
   STOKROOS, I
   PENNINGS, AJ
   ROBINSON, PH
AF DENDUNNEN, WFA
   VANDERLEI, B
   SCHAKENRAAD, JM
   BLAAUW, EH
   STOKROOS, I
   PENNINGS, AJ
   ROBINSON, PH
TI LONG-TERM EVALUATION OF NERVE REGENERATION IN A BIODEGRADABLE NERVE
   GUIDE
SO MICROSURGERY
LA English
DT Article
AB Nerve regeneration using artificial biodegradable conduits is of increasing interest. The aim of this study is to evaluate the regeneration and maturation of a nerve after long-term implantation (2 years) of a biodegradable poly-L-lactide/poly-E-caprolactone (PLLA/PCL) copolymeric nerve guide in the sciatic nerve of the rat. After harvesting, we evaluated both the regenerated nerves and the controls, using light microscopy, transmission electron microscopy, and morphometric techniques. Remnants of biomaterial were still present after 2 years of implantation, but the foreign body reaction was very mild at this stage, due to the rounded shapes of the polymer debris. Morphometric analysis showed significant differences between the regenerated nerve and the normal sciatic nerve: the number of myelinated fibers is higher, and the mean fiber diameter of the myelinated fibers in the regenerated nerve is smaller. In conclusion, the results demonstrate that the new PLLA/PCL nerve guide can provide optimal conditions for regeneration and maturation of damaged nerves. (C) 1993 Wiley-Liss, Inc.
C1 UNIV GRONINGEN,CTR BIOMED TECHNOL,DIV BIOMAT & BIOCOMPATIBIL,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS.
RI den Dunnen, Wilfred/A-4034-2009
NR 0
TC 102
Z9 103
U1 4
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0738-1085
J9 MICROSURG
JI Microsurgery
PY 1993
VL 14
IS 8
BP 508
EP 515
DI 10.1002/micr.1920140808
PG 8
WC Surgery
SC Surgery
GA ME285
UT WOS:A1993ME28500007
PM 8271930
DA 2018-10-20
ER

PT B
AU HANSON, SR
AF HANSON, SR
BE Missirlis, YF
   Wautier, JL
TI ROLE OF THROMBIN IN PLATELET-BIOMATERIAL INTERACTIONS
SO ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS
LA English
DT Proceedings Paper
CT Expert Meeting on the Role of Platelets in Blood, Biomaterials
   Interactions
CY MAY, 1992
CL PYTHAGORION, GREECE
SP EUROPEAN ECON COMMUNITIES
C1 EMORY UNIV,SCH MED,ATLANTA,GA 30322.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-2162-6
PY 1993
BP 81
EP 93
PG 13
WC Biochemistry & Molecular Biology; Engineering, Biomedical; Engineering,
   Chemical; Hematology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Engineering; Hematology; Materials
   Science
GA BZ40L
UT WOS:A1993BZ40L00007
DA 2018-10-20
ER

PT B
AU DAVIES, A
   HANSON, S
   ORDINAS, A
   MISSIRLIS, YF
   WAUTIER, JL
   MULVIHILL, J
   KIEFFER, N
   LEMM, W
AF DAVIES, A
   HANSON, S
   ORDINAS, A
   MISSIRLIS, YF
   WAUTIER, JL
   MULVIHILL, J
   KIEFFER, N
   LEMM, W
BE Missirlis, YF
   Wautier, JL
TI BIOLOGICAL TESTS FOR EVALUATING PLATELET BIOMATERIAL INTERACTION
SO ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS
LA English
DT Proceedings Paper
CT Expert Meeting on the Role of Platelets in Blood, Biomaterials
   Interactions
CY MAY, 1992
CL PYTHAGORION, GREECE
SP EUROPEAN ECON COMMUNITIES
C1 UNIV LEEDS,GEN INFIRM,ACAD UNIT MED,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-2162-6
PY 1993
BP 181
EP 198
PG 18
WC Biochemistry & Molecular Biology; Engineering, Biomedical; Engineering,
   Chemical; Hematology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Engineering; Hematology; Materials
   Science
GA BZ40L
UT WOS:A1993BZ40L00014
DA 2018-10-20
ER

PT B
AU SCHAMBERGER, PC
   GARDELLA, JA
   MCKEOWAN, PJ
   DAVIS, LE
AF SCHAMBERGER, PC
   GARDELLA, JA
   MCKEOWAN, PJ
   DAVIS, LE
GP SURFACES BIOMAT FDN
TI METHOD DEVELOPMENT FOR IMAGING CELL CONDITIONING FILM BIOMATERIAL
   INTERFACES - IMAGING A CRATER EDGE DEPTH PROFILE OF MODEL BIOFILM
   INTERFACES BY AUGER-ELECTRON SPECTROSCOPY AND TIME-OF-FLIGHT SIMS
SO SURFACES IN BIOMATERIALS SYMPOSIUM
LA English
DT Proceedings Paper
CT Surfaces in Biomaterials Symposium
CY SEP 13-15, 1993
CL CAMBRIDGE, MA
SP SURFACES BIOMAT FDN INC
C1 SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
NR 0
TC 0
Z9 0
U1 1
U2 4
PU SURFACES BIOMATERIALS FDN
PI MINNEAPOLIS
PA PO BOX 26111, MINNEAPOLIS, MN 55426-0111
PY 1993
BP 82
EP 87
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA BA72K
UT WOS:A1993BA72K00016
DA 2018-10-20
ER

PT B
AU PASCHALIS, EP
   TUCKER, BE
   SPECTOR, M
   NANCOLLAS, GH
AF PASCHALIS, EP
   TUCKER, BE
   SPECTOR, M
   NANCOLLAS, GH
GP SURFACES BIOMAT FDN
TI MODIFICATION AND CHARACTERIZATION OF BIOMATERIAL SURFACES BY KINETICALLY
   CONTROLLED MINERALIZATION AND DEMINERALIZATION
SO SURFACES IN BIOMATERIALS SYMPOSIUM
LA English
DT Proceedings Paper
CT Surfaces in Biomaterials Symposium
CY SEP 13-15, 1993
CL CAMBRIDGE, MA
SP SURFACES BIOMAT FDN INC
C1 SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SURFACES BIOMATERIALS FDN
PI MINNEAPOLIS
PA PO BOX 26111, MINNEAPOLIS, MN 55426-0111
PY 1993
BP 124
EP 128
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA BA72K
UT WOS:A1993BA72K00024
DA 2018-10-20
ER

PT B
AU MARCHANT, RE
AF MARCHANT, RE
GP SURFACES BIOMAT FDN
TI CELL AND MOLECULAR ADHESION TO BIOMATERIAL SURFACES
SO SURFACES IN BIOMATERIALS SYMPOSIUM
LA English
DT Proceedings Paper
CT Surfaces in Biomaterials Symposium
CY SEP 13-15, 1993
CL CAMBRIDGE, MA
SP SURFACES BIOMAT FDN INC
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SURFACES BIOMATERIALS FDN
PI MINNEAPOLIS
PA PO BOX 26111, MINNEAPOLIS, MN 55426-0111
PY 1993
BP 177
EP 184
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BA72K
UT WOS:A1993BA72K00033
DA 2018-10-20
ER

PT B
AU BADYLAK, SF
AF BADYLAK, SF
BE Bell, E
TI SMALL-INTESTINAL SUBMUCOSA (SIS) - A BIOMATERIAL CONDUCIVE TO SMART
   TISSUE REMODELING
SO TISSUE ENGINEERING: CURRENT PERSPECTIVES
LA English
DT Proceedings Paper
CT Tissue Engineering Meeting
CY 1992
CL KEYSTONE, CO
SP KEYSTONE ORG, GENETECH INC, KEYSTONE SYMP MOLEC & CELLULAR BIOL
C1 PURDUE UNIV,HILLENBRAND BIOMED ENGN CTR,W LAFAYETTE,IN 47907.
NR 0
TC 81
Z9 82
U1 0
U2 8
PU BIRKHAUSER BOSTON
PI CAMBRIDGE
PA 675 MASSACHUSETTS AVE, CAMBRIDGE, MA 02139-2333
BN 0-8176-3687-0
PY 1993
BP 179
EP 189
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BZ63F
UT WOS:A1993BZ63F00017
DA 2018-10-20
ER

PT J
AU CARROLL, JC
   SCHWAITZBERG, SD
   UCCI, AA
   SCHLESINGER, RM
   LAURITZEN, D
   SANT, GR
AF CARROLL, JC
   SCHWAITZBERG, SD
   UCCI, AA
   SCHLESINGER, RM
   LAURITZEN, D
   SANT, GR
TI NEW MATRIX MATERIAL FOR POTENTIAL USE IN REVERSIBLE VASECTOMY -
   PRELIMINARY ANIMAL BIOCOMPATIBILITY STUDIES
SO UROLOGY
LA English
DT Article
AB The biocompatibility of a new elastomeric-hydrogel matrix biomaterial for use as an intravasal occlusive device was assessed by inserting it into the vas deferens of dogs. The vas was removed and examined histologically after varying periods of time. The biomaterial resulted in total occlusion of the vas. Epithelial changes were limited to squamous metaplasia in areas adjacent to the implant. Changes in the subepithelium were minimal. This new material is biocompatible with the dog vas, and it has potential as an occlusive device for ''reversible'' vasectomy in men. Semen analysis studies are needed to assess the completeness and reversibility of the vasal occlusion achieved with this implant.
C1 NEW ENGLAND MED CTR,DEPT UROL,BOSTON,MA.
   NEW ENGLAND MED CTR,DEPT SURG,BOSTON,MA.
   NEW ENGLAND MED CTR,DEPT PATHOL,BOSTON,MA.
   LEMUEL SHATTUCK HOSP,BOSTON,MA 02130.
   TUFTS UNIV,SCH MED,BOSTON,MA 02111.
CR BREUSCHKE EE, 1975, FERTIL STERIL, V26, P29
   BRUESCHKE EE, 1975, FERTIL STERIL, V26, P40
   BRUESCHKE EE, 1974, FERTIL STERIL, V25, P659
   COOKE J E, 1987, Anesthesiology (Hagerstown), V67, pA208, DOI 10.1097/00000542-198709001-00208
   COS LR, 1983, UROLOGY, V22, P567, DOI 10.1016/0090-4295(83)90297-2
   DERRICK FC, 1974, J UROLOGY, V111, P523, DOI 10.1016/S0022-5347(17)60005-3
   FALLON B, 1981, J UROLOGY, V126, P361, DOI 10.1016/S0022-5347(17)54527-9
   HICKEY RF, 1987, ANESTH ANALG, V68, pS121
   HRDLICKA JG, 1967, FERTIL STERIL, V18, P289
   HULKA JF, 1972, FERTIL STERIL, V23, P683
   JHAVER PS, 1971, FERTIL STERIL, V22, P263
   JONES BR, 1989, ANESTHESIOLOGY, V71, P430
   LEE HY, 1969, FERTIL STERIL, V20, P735
NR 13
TC 4
Z9 4
U1 0
U2 1
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD JAN
PY 1993
VL 41
IS 1
BP 34
EP 37
DI 10.1016/0090-4295(93)90240-B
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA KW024
UT WOS:A1993KW02400008
PM 8420076
DA 2018-10-20
ER

PT J
AU ARIZONO, T
   OGA, M
   SUGIOKA, Y
AF ARIZONO, T
   OGA, M
   SUGIOKA, Y
TI INCREASED RESISTANCE OF BACTERIA AFTER ADHERENCE TO POLYMETHYL
   METHACRYLATE - AN INVITRO STUDY
SO ACTA ORTHOPAEDICA SCANDINAVICA
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; COLONIZATION;
   BIOMATERIALS; SLIME
AB The pathobiology of total joint prosthesis infection was investigated in vitro. Discs of polymethylmethacrylate (PMMA) were exposed to a suspension containing cells of 10(8) per mL Staphylococcus epidermidis E-46. After 12 hours, exposed discs were rinsed with phosphate-buffered saline and placed in brain heart infusion broth containing antibiotics (2.5 mg per mL of Cephaloridine). After gentle shaking for 24 hours at 37-degrees-C, the bacteria on the PMMA surface were detached and washed with phosphate-buffered saline to remove the antibiotics. Compared with the free bacteria which were detached from the PMMA by sonication immediately after exposure to the antibiotic solution, those allowed to remain adhered to the PMMA surface were more resistant to antibiotics. Scanning electron microscopy showed accumulation of bacteria surrounded by slime on PMMA discs exposed for 12 hours.
   Our results indicate that resistance of bacteria to antibiotics is increased after adherence to the biomaterial and formation of a slime layer.
RP ARIZONO, T (reprint author), KYUSHU UNIV,FAC MED,DEPT ORTHOPED,3-1-1 MAEDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.
CR BALTIMORE RS, 1980, J INFECT DIS, V141, P238, DOI 10.1093/infdis/141.2.238
   Dougherty S H, 1982, Curr Probl Surg, V19, P217
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   Poika I. A., 1990, ACTA ORTHOP SCAND, V61, P163
   SCHWARZMANN S, 1971, INFECT IMMUN, V3, P762
   UMEDA A, 1987, J BACTERIOL, V169, P2482, DOI 10.1128/jb.169.6.2482-2487.1987
   YAMAMOTO M, 1986, MICROBIOL IMMUNOL, V30, P969, DOI 10.1111/j.1348-0421.1986.tb03027.x
NR 11
TC 29
Z9 29
U1 2
U2 3
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0001-6470
J9 ACTA ORTHOP SCAND
JI Acta Orthop. Scand.
PD DEC
PY 1992
VL 63
IS 6
BP 661
EP 664
PG 4
WC Orthopedics
SC Orthopedics
GA KD134
UT WOS:A1992KD13400019
PM 1471518
DA 2018-10-20
ER

PT J
AU ARNOCZKY, SP
   DICARLO, EF
   OBRIEN, SJ
   WARREN, RF
AF ARNOCZKY, SP
   DICARLO, EF
   OBRIEN, SJ
   WARREN, RF
TI CELLULAR REPOPULATION OF DEEP-FROZEN MENISCAL AUTOGRAFTS - AN
   EXPERIMENTAL-STUDY IN THE DOG
SO ARTHROSCOPY
LA English
DT Article
DE MENISCUS; CELL REPOPULATION; AUTOGRAFT, DEEP-FROZEN
AB This study evaluated the cellular repopulation of deep-frozen meniscal autografts. Medial menisci of adult dogs were excised, deep-frozen in liquid nitrogen (- 196-degrees-C) for 10 min, and orthotopically reimplanted into the joint. Deep-freezing was found to effectively kill all the cells within the meniscus as determined by the absence of (Na2SO4)-S-35 incorporation. Following orthotopic replacement within the knee joint, menisci were repopulated with cells that seemed to originate from the adjacent synovium. These cells migrated over the surface of the meniscus and began to invade the deeper layers of the tissue. However, even after 6 months, the central core of the meniscus remained acellular. While the new cells appeared to modulate into cells that are similar in appearance to meniscal fibrochondrocytes, the exact phenotypic expression of these newly differentiated cells has yet to be determined. Histological alterations, as manifested by a loss of normal orientation of the collagen architecture of the superficial layers of the meniscus, was evident at 6 months and suggests that a remodeling phenomenon may be associated with the cellular repopulation. While biomaterial studies have not been carried out on these specimens, the morphologic alterations observed in the collagen orientation would suggest a possible alteration in the material properties of the repopulated meniscus. The clinical implication of this study is that the structural remodeling associated with the cellular repopulation of deep-frozen meniscal allografts may make the transplanted meniscus more susceptible to injury.
RP ARNOCZKY, SP (reprint author), MICHIGAN STATE UNIV,COLL VET MED,COMPARAT ORTHOPAED RES LAB,E LANSING,MI 48824, USA.
NR 0
TC 82
Z9 85
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0749-8063
J9 ARTHROSCOPY
JI Arthroscopy
PD DEC
PY 1992
VL 8
IS 4
BP 428
EP 436
DI 10.1016/0749-8063(92)90003-T
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA JZ034
UT WOS:A1992JZ03400003
PM 1466700
DA 2018-10-20
ER

PT J
AU OTSUKA, M
   MATSUDA, Y
   KOKUBO, T
   YOSHIHARA, S
   NAKAMURA, T
   YAMAMURO, T
AF OTSUKA, M
   MATSUDA, Y
   KOKUBO, T
   YOSHIHARA, S
   NAKAMURA, T
   YAMAMURO, T
TI NEW SKELETAL DRUG DELIVERY SYSTEM CONTAINING ANTIBIOTICS USING
   SELF-SETTING BIOACTIVE GLASS CEMENT
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Note
DE DRUG DELIVERY SYSTEM; BIOMATERIAL; CEPHALEXIN; CALCIUM PHOSPHATE GLASS;
   CRYSTALLINE TRANSFORMATION; HYDROXYAPATITE; SELF-SETTING CEMENT;
   CONTROLLED RELEASE
ID BONE-CEMENT
AB A novel device containing cephalexin as a model drug using a self-setting bioactive cement basing on CaO-SiO2-P2O5 glass was investigated. Glass powders contained 5% cephalexin powder hardened within 5 min after being mixed with a phosphate buffer. After hardening, in vitro drug release from homogeneous or heterogeneous drug-loaded cement pellets in a simulated body fluid at pH 7.25 and 37-degrees-C continued for more than 2 weeks.
C1 NIPPON ELECT GLASS CO, OTSU 520, JAPAN.
   KYOTO UNIV, FAC ENGN, KYOTO 606, JAPAN.
   KYOTO UNIV, BIOMED ENGN RES CTR, KYOTO 606, JAPAN.
   KYOTO UNIV, FAC MED, KYOTO 606, JAPAN.
RP OTSUKA, M (reprint author), KOBE WOMENS COLL PHARM, KOBE 658, JAPAN.
CR Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   KOKUBO T, 1991, J AM CERAM SOC, V74, P1739, DOI 10.1111/j.1151-2916.1991.tb07176.x
   MATSUDA T, 1990, SEITAI KOROIDO, P777
   NISHIMURA N, 1991, J APPL BIOMATER, V2, P219, DOI 10.1002/jab.770020402
   OTSUKA M, 1990, CHEM PHARM BULL, V38, P3500, DOI 10.1248/cpb.38.3500
   SALVATI EA, 1986, CLIN ORTHOP RELAT R, P83
   YOSHIHARA S, 1992, BIOCERAMICS, V3, P231
NR 7
TC 2
Z9 2
U1 0
U2 3
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD DEC
PY 1992
VL 40
IS 12
BP 3346
EP 3348
DI 10.1248/cpb.40.3346
PG 3
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA KH957
UT WOS:A1992KH95700046
OA Bronze
DA 2018-10-20
ER

PT J
AU GUIDOIN, R
   KING, MW
AF GUIDOIN, R
   KING, MW
TI THE POLYURETHANE FOAM COVERING THE MEME BREAST PROSTHESIS - A BIOMEDICAL
   BREAKTHROUGH OR A BIOMATERIAL TAR BABY - REPLY
SO ANNALS OF PLASTIC SURGERY
LA English
DT Letter
RP GUIDOIN, R (reprint author), UNIV LAVAL,CHIRURG EXPTL LAB,LOCAL 1701,PAVILLON SERV,QUEBEC CITY G1K 7P4,QUEBEC,CANADA.
CR ADAMS G, 1990, DEV TECHNIQUES MONIT
   BROWN DL, 1988, CUSTOM MADE ALIPHATI
   DUGUAY DG, 1992, 13TH P ANN C CAN BIO, P7
   ERFLE D, 1992, 13TH P ANN C CAN BIO, P46
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
NR 5
TC 1
Z9 1
U1 0
U2 0
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD NOV
PY 1992
VL 29
IS 5
BP 477
EP 478
DI 10.1097/00000637-199211000-00025
PG 2
WC Surgery
SC Surgery
GA JX808
UT WOS:A1992JX80800025
DA 2018-10-20
ER

PT J
AU SANTERRE, JP
   LABOW, RS
   ADAMS, GA
AF SANTERRE, JP
   LABOW, RS
   ADAMS, GA
TI THE POLYURETHANE FOAM COVERING THE MEME BREAST PROSTHESIS - A BIOMEDICAL
   BREAKTHROUGH OR A BIOMATERIAL TAR BABY
SO ANNALS OF PLASTIC SURGERY
LA English
DT Letter
C1 UNIV OTTAWA,DEPT SURG,OTTAWA K1H 8M5,ONTARIO,CANADA.
RP SANTERRE, JP (reprint author), UNIV OTTAWA,INST HEART,DIV CARDIOVASC DEVICES,1053 CARLING AVE,OTTAWA K1Y 4E9,ONTARIO,CANADA.
CR ADAMS G, 1990, DEV TECHNIQUES MONIT
NR 1
TC 1
Z9 1
U1 0
U2 1
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD NOV
PY 1992
VL 29
IS 5
BP 477
EP 477
DI 10.1097/00000637-199211000-00024
PG 1
WC Surgery
SC Surgery
GA JX808
UT WOS:A1992JX80800024
PM 1444145
DA 2018-10-20
ER

PT J
AU SILVE, C
   LOPEZ, E
   VIDAL, B
   SMITH, DC
   CAMPRASSE, S
   CAMPRASSE, G
   COULY, G
AF SILVE, C
   LOPEZ, E
   VIDAL, B
   SMITH, DC
   CAMPRASSE, S
   CAMPRASSE, G
   COULY, G
TI NACRE INITIATES BIOMINERALIZATION BY HUMAN OSTEOBLASTS MAINTAINED
   INVITRO
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
ID BONE-MARROW; CELLS-INVITRO; MINERALIZATION; MATRIX; CALCIUM;
   DIFFERENTIATION; PHENOTYPE; PHOSPHATE; CALVARIA; CULTURES
AB When nacreous shell produced by the marine oyster Pinctada maxima, used as a biomaterial in oral surgery, is implanted in human bone, new bone formation occurs, resulting in a tight welding of the bone to the nacre [16]. These findings are consistent with the possibility that nacre adjacent to bone can locally stimulate osteogenic activity. To test this hypothesis, we have evaluated the effect of the simultaneous presence of bone and nacre on human osteoblasts in vitro. Nacre chips (1 mm3) were placed at almost-equal-to 1 mm distance from a similarly sized bone chip on a layer of first passage human osteoblasts. None of the chemical inducers generally required to obtain bone mineralization in vitro (in particular, beta-glycerophosphate) was added to the cultures. Mineralized sections of the cultures were evaluated by light and electron microscopy, contact microradiography, and Laser Raman Spectroscopy. The results demonstrated that nacre has strong osteogenic effects on human osteoblasts when placed in proximity to bone in vitro. New bone formation occurred by both appositional growth on the existing bone and by the formation of mineralized nodules within the matrix adjacent to the bone explant. Electron microscopic evaluation of these sites demonstrated findings typical of those described in the course of bone formation in vivo, and no evidence of toxicity was observed. In addition, under the conditions of culture used, nacre can also promote the formation by osteoblasts of a structure with characteristics similar to nacre (e.g., lamellar organic matrix mineralized with aragonite, as demonstrated by Laser Raman Spectroscopy). Given the unusual capacity of nacre in the presence of human osteoblasts in vitro to induce different types of mineralization, this model should provide insights into the specific interactions between matrix proteins and minerals that control the type of mineral produced in the course of biomineralization.
C1 HOP NECKER ENFANTS MALAD,SERV STOMATOL,F-75730 PARIS 15,FRANCE.
   MUSEUM NATL HIST NAT,PHYSIOL GEN & COMPAREE LAB,CNRS,URA 90,F-75231 PARIS 05,FRANCE.
   CABINET DENTAIRE,CHELLES,FRANCE.
   MUSEUM NATL HIST NAT,MINERAL LAB,F-75231 PARIS 05,FRANCE.
RP SILVE, C (reprint author), HOP NECKER ENFANTS MALAD,CNRS,URA 583,149 RUE SEVRES,F-75730 PARIS 15,FRANCE.
CR ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   BENAYAHU D, 1989, J CELL PHYSIOL, V140, P1, DOI 10.1002/jcp.1041400102
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   DELHAYE M, 1975, J RAMAN SPECTROSC, V3, P33, DOI 10.1002/jrs.1250030105
   ECAROTCHARRIER B, 1988, BONE, V9, P147, DOI 10.1016/8756-3282(88)90004-X
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GOTOH Y, 1990, BONE MINER, V8, P39
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115
   KHOUJA HI, 1990, BONE, V11, P385, DOI 10.1016/8756-3282(90)90131-H
   Landis WJ, 1985, CHEM BIOL MINERALIZE, P360
   LOPEZ E, 1976, CALC TISS RES, V20, P173, DOI 10.1007/BF02546406
   LOPEZ E, 1978, ANN BIOL ANIM BIOCH, V18, P105, DOI 10.1051/rnd:19780113
   LURIA EA, 1987, CELL TISSUE RES, V248, P449
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   MARKS SC, 1988, AM J ANAT, V183, P1, DOI 10.1002/aja.1001830102
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   PINET M, IN PRESS B ASS FRANC
   RAISZ LG, 1983, NEW ENGL J MED, V309, P83, DOI 10.1056/NEJM198307143090206
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   SILVE C, 1986, J CLIN ENDOCR METAB, V62, P583, DOI 10.1210/jcem-62-3-583
   Simkiss K., 1989, BIOMINERALIZATION CE, P337
   SMITH DC, 1987, TERRA COGNITA, V7, P20
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3
   TENENBAUM HC, 1982, CALCIFIED TISSUE INT, V34, P76, DOI 10.1007/BF02411212
   VENECPEYRE MT, 1978, CR ACAD SCI D NAT, V287, P607
   WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G
   WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397
   Woodard H Q, 1964, Clin Orthop Relat Res, V37, P187
NR 32
TC 96
Z9 99
U1 0
U2 21
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PD NOV
PY 1992
VL 51
IS 5
BP 363
EP 369
DI 10.1007/BF00316881
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA JU767
UT WOS:A1992JU76700007
PM 1458341
DA 2018-10-20
ER

PT J
AU LEGEAIS, JM
   ROSSI, C
   RENARD, G
   SALVOLDELLI, M
   DHERMIES, F
   POULIQUEN, YJ
AF LEGEAIS, JM
   ROSSI, C
   RENARD, G
   SALVOLDELLI, M
   DHERMIES, F
   POULIQUEN, YJ
TI A NEW FLUOROCARBON FOR KERATOPROSTHESIS
SO CORNEA
LA English
DT Article
DE KERATOPROSTHESIS; BIOMATERIAL; POLYMER; FLUOROCARBON;
   POLYTETRAFLUOROETHYLENE; PROPLAST; GORE-TEX; IMPRA
AB Previous studies have demonstrated the potential use of microporous, biocompatible materials to improve the long-term stability of keratoprosthesis. To determine the factors that will influence corneal tissue ingrowth into biocompatible, microporous materials, we have compared three types of fluorocarbon polymers-Impra, Gore-Tex, and Proplast-after intrastromal implantation in rabbit corneas. Despite similar physicochemical structures, a great difference was observed in histologic and ultrastructural cross sections after 4- and 8-month follow-ups. For Gore-Tex, we observed extrusion of the implant and infiltration of necrotic and inflammatory cells. All implants of Proplast also led to significant corneal damage resulting in extrusion of the material. Through the use of electron and light microscopy and image analysis, this study demonstrates the presence of cell differentiation and collagen synthesis in the pores of the Impra implant. Apart from biocompatibility, this experiment demonstrates the influence of pore size, porous microorganization, and biomechanical factors on prosthetic corneal material. Only Impra offers satisfactory interface, allowing fibroblastic cells and neocollagen synthesis into its pores, and it can become transparent.
RP LEGEAIS, JM (reprint author), HOP HOTEL DIEU,INSERM,DEPT OPHTHALMOL,U86,1 PL PARVIS NOTRE DAME,F-75181 PARIS 04,FRANCE.
NR 0
TC 39
Z9 45
U1 0
U2 2
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0277-3740
J9 CORNEA
JI Cornea
PD NOV
PY 1992
VL 11
IS 6
BP 538
EP 545
DI 10.1097/00003226-199211000-00010
PG 8
WC Ophthalmology
SC Ophthalmology
GA JU431
UT WOS:A1992JU43100010
PM 1468216
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   JOYCE, KA
   KIM, DU
   PHAM, SM
   BERCELI, SA
   BOROVETZ, HS
AF GREISLER, HP
   JOYCE, KA
   KIM, DU
   PHAM, SM
   BERCELI, SA
   BOROVETZ, HS
TI SPATIAL AND TEMPORAL CHANGES IN COMPLIANCE FOLLOWING IMPLANTATION OF
   BIORESORBABLE VASCULAR GRAFTS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID MACROPHAGE BIOMATERIAL INTERACTIONS; GROWTH-FACTOR; CHARACTERIZATION
   INVITRO; BIOMECHANICAL PROPERTIES; ATHEROGENIC DIET; PROLIFERATION;
   COMBINATIONS; PROSTHESES; KINETICS
AB Compliance matching between the host vessel and vascular grafts used for small-diameter arterial replacements is thought to be important for long-term patency. However, currently available grafts elicit fibroplastic reactions, resulting in decreasing compliance with time after implantation. Bioresorbable prostheses elicit ingrowth of myofibroblasts containing abundant contractile elements. This led us to investigate whether compliance of implanted bioresorbable prostheses decreased as a function of time and if the kinetics of change correlated with the progession of tissue ingrowth. Woven polyglactin 910 prostheses (10 mm x 4 mm i.d.) were implanted into adult NZW rabbit infrarenal aortas and replicates were harvested serially through 8 months. Control grafts were implanted, and immediately resected. Dynamic compliance was measured at 1-mm axial increments along each explant using a pulse duplicator apparatus which exposed the harvested samples to realistic pulsatile hemodynamics. Compliance was calculated for proximal, mid, and distal segments of each graft and averaged at each time point by grouping into control (zero time, n = 3), early (1-4 weeks, n = 13), and late (6-36 weeks, n = 9) explant periods. At late explant periods both proximal and distal compliance were significantly greater than mid graft compliance (p < .02 and p < .03, respectively). There was a significant increase in proximal compliance between early and late explant times (p < .01). Measured increases in mid and distal segment compliance over time did not reach statistical significance. Myofibroblast laden tissue ingrowth into the inner capsule followed macrophage phagocytosis and was nearly complete prior to the time that an increase in compliance was demonstrated. Thus since the major histologic episodes precede the change in compliance, these are not likely initiated by this biomechanical change. We hypothesize the graft resorption coupled with the ingrowth of more compliant tissue likely leads to the increased compliance of the graft material.
C1 ST BARNABAS HOSP,DEPT PATHOL,LIVINGSTON,NJ 07039.
   UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA 15260.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,MAYWOOD,IL 60153, USA.
OI Berceli, Scott/0000-0003-2257-0111
FU NHLBI NIH HHS [R01 HL41272, R01 HL34739]
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BAIRD RN, 1976, LANCET, V30, P948
   BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686
   BRANT AM, 1986, ARTIF ORGANS, V10, P419, DOI 10.1111/j.1525-1594.1986.tb02591.x
   BRANT AM, 1987, J APPL PHYSIOL, V62, P679
   BUNTIN CM, 1990, ANN BIOMED ENG, V18, P549, DOI 10.1007/BF02364617
   CLOWES AW, 1983, LAB INVEST, V49, P327
   ENDEAN ED, 1987, SURG FORUM, V38, P323
   FRY DL, 1969, CIRC RES, V24, P93, DOI 10.1161/01.RES.24.1.93
   GOW BS, 1968, CIRC RES, V23, P111, DOI 10.1161/01.RES.23.1.111
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H. P., 1991, VASCULAR ENDOTHELIUM, P253
   GREISLER HP, 1987, J VASC SURG, V5, P572, DOI 10.1067/mva.1987.avs0050572
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1991, J VASC SURG, V14, P10
   GREISLER HP, 1990, CARDIOVASCULAR SCI T, P55
   Hasson J E, 1985, J Vasc Surg, V2, P419
   KIDSON IG, 1978, CIRCULATION S, V1, P1
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   MELLISINOS AC, 1966, EXPT MODERN PHYSICS, P469
   O'ROURKE MICHAEL F., 1967, CARDIOVASC RES, V1, P313, DOI 10.1093/cvr/1.4.313
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   RODGERS VGJ, 1986, J VASC SURG, V4, P396, DOI 10.1067/mva.1986.avs0040396
   RODGERS VGJ, 1987, J BIOMECH, V8, P795
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354
   WALDEN R, 1980, ARCH SURG-CHICAGO, V115, P1166
   ZWOLAK RM, 1987, J VASC SURG, V5, P126, DOI 10.1067/mva.1987.avs0050126
NR 34
TC 22
Z9 22
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1992
VL 26
IS 11
BP 1449
EP 1461
DI 10.1002/jbm.820261105
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JU766
UT WOS:A1992JU76600004
PM 1447229
DA 2018-10-20
ER

PT J
AU DRIESSENS, FCM
   RAMSELAAR, MMA
   SCHAEKEN, HG
   STOLS, ALH
   VANMULLEM, PJ
   DEWIJN, JR
AF DRIESSENS, FCM
   RAMSELAAR, MMA
   SCHAEKEN, HG
   STOLS, ALH
   VANMULLEM, PJ
   DEWIJN, JR
TI CHEMICAL-REACTIONS OF CALCIUM-PHOSPHATE IMPLANTS AFTER IMPLANTATION
   INVIVO
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CERAMICS; BETA-CA3(PO4)2; BEHAVIOR; DYNAMICS
AB Sintered microporous cylinders of hydroxyapatite (OHA), tertiary calcium phosphate (beta-TCP and rhenanite (CaNaPO4) were implanted in the bone of the forehead of the domestic pig (Sus scrofa). Implants together with the surrounding bone were retrieved after 6 and 12 weeks. X-ray diffraction showed that OHA and beta-TCP maintain their crystal structure upon implantation. However, rhenanite is transformed completely into an apatite within 6 weeks. This apatite later incorporates sodium and carbonate. Both beta-TCP and rhenanite implants showed some resorption but were otherwise covered with new bone. Electron microprobe analysis showed that the mineral at the interface had a Ca/P ratio characteristic of new bone. At a certain distance from the interface lower Ca/P ratios were found, characteristic of precursor phases of bone mineral. This suggests that the deposition of new bone starts, at least partially, from the surface of the implant. Therefore, beta-TCP as well as rhenanite may be called an osteoconductive biomaterial.
C1 CATHOLIC UNIV NIJMEGEN,SCH MED,SCH ORAL HISTOL DENT,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS.
   LEIDEN UNIV,DEPT BIOMAT,2300 RA LEIDEN,NETHERLANDS.
RP DRIESSENS, FCM (reprint author), CATHOLIC UNIV NIJMEGEN,SCH MED,SCH ORAL HISTOL DENT,DEPT ORAL FUNCT & PROSTHET DENT,NIJMEGEN,NETHERLANDS.
CR CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   de Groot K, 1985, Zahnarztl Mitt, V75, P1938
   Driessens F C, 1988, Ann N Y Acad Sci, V523, P131, DOI 10.1111/j.1749-6632.1988.tb38507.x
   Driessens F. C. M., 1988, IMPLANT MAT BIOFUNCT, P105
   DRIESSENS FCM, 1987, B SOC CHIM BELG, V96, P173
   DRIESSENS FCM, 1987, Z NATURFORSCH C, V42, P916
   DRIESSENS FCM, 1986, Z NATURFORSCH C, V41, P468
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   DRIESSENS FCM, 1989, 1ST EUR CER SOC C B, V1, P15
   DRIESSENS FCM, 1989, BIOMINERALS
   Driessens FCM, 1990, BIOMINERALS
   DRISKELL TD, 1973, IADR ABSTR, P259
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P634, DOI 10.1097/00006534-197905000-00005
   FISCHERBRANDIES E, 1989, DEUT ZAHNAERZTL Z, V44, P436
   GREGORY TM, 1974, J RES NBS A PHYS CH, VA 78, P667, DOI 10.6028/jres.078A.042
   GUILLEMIN G, 1989, 8TH EUR C BIOM HEID
   JACOBS HG, 1984, STSCH Z MUND KIEFER, V85, P38
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   KRAUSE A, 1986, STSCH Z MUND KIEFER, V10, P108
   Newesely H, 1984, Zahn Mund Kieferheilkd Zentralbl, V72, P230
   OONISHI H, 1989, 2ND INT S CER MED BI
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   RABALAIS ML, 1981, J PERIODONTOL, V52, P680, DOI 10.1902/jop.1981.52.11.680
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   RENOOJI W, 1985, CLIN ORTHOP RELAT R, V197, P272
   SCHAEKEN HG, 1983, Z ANORG ALLG CHEM, V505, P48, DOI 10.1002/zaac.19835051006
   VERBEECK RMH, 1986, B SOC CHIM BELG, V95, P455
   VERBEECK RMH, 1980, Z ANORG ALLG CHEM, V466, P76, DOI 10.1002/zaac.19804660109
   VERBEECK RMH, 1980, Z PHYS CHEM NEUE FOL, V119, P79, DOI 10.1524/zpch.1980.119.1.079
   WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0
NR 32
TC 25
Z9 25
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 1992
VL 3
IS 6
BP 413
EP 417
DI 10.1007/BF00701237
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JY820
UT WOS:A1992JY82000005
DA 2018-10-20
ER

PT J
AU REID, G
   DENSTEDT, JD
   KANG, YS
   LAM, D
   NAUSE, C
AF REID, G
   DENSTEDT, JD
   KANG, YS
   LAM, D
   NAUSE, C
TI MICROBIAL ADHESION AND BIOFILM FORMATION ON URETERAL STENTS INVITRO AND
   INVIVO
SO JOURNAL OF UROLOGY
LA English
DT Article
DE BACTERIA; STENTS; URETER
ID URINARY-TRACT INFECTION; CATHETERS; SURFACES; THERAPY; FLORA
AB Thirty ureteral stents, inserted for 5 to 128 days following extracorporeal shock wave lithotripsy, were examined for the presence of bacterial biofilms. Of these, 90% had adherent pathogens (44% mixed organisms) on the stents, 45% of which were present in low numbers (10(1)-10(2) per 1 cm3 section) and 55% were in small and large microcolony biofilms (>2 x 10(2)-10(7)). The organisms were recovered from the stents even though urine culture was only positive in 27% of patients. Of the organisms isolated, 77% were Gram positive cocci, 15% Gram negative rods and 8% Candida. No blockage of the stents occurred. All of the patients had received antimicrobial therapy post-insertion, and in 15 cases biofilms were found while on treatment. None of the patients received therapy for urinary tract infections while the stent remained in place. In vitro experiments demonstrated the ability of Escherichia coli, Proteus mirabilis, Staphylococcus epidermidis and Enterococcus faecalis uropathogens to adhere and form biofilms on ureteral stents within 24 hours. Clearly, bacterial biofilms do occur on ureteral stents and urinary culture may not detect their presence. The high recovery rate of Gram positive organisms may indicate a preferential adhesion to the biomaterial surface. The findings also indicate that unlike biofilm formation on many other prosthetic implants, colonization with Gram positive organisms on ureteral stents does not necessarily coincide with the development symptomatic infection.
C1 UNIV TORONTO,DEPT SURG,DIV UROL,TORONTO M5S 1A1,ONTARIO,CANADA.
   UNIV WESTERN ONTARIO,ST JOSEPHS HLTH CTR,DIV UROL,LONDON,ONTARIO,CANADA.
RP REID, G (reprint author), UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON N6A 5B8,ONTARIO,CANADA.
CR ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   ANWAR H, 1992, IN PRESS INT BIODETE
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DASGUPTA MK, 1989, BLOOD PURIFICAT, V7, P144, DOI 10.1159/000169586
   FRANCO G, 1990, BRIT J UROL, V65, P10, DOI 10.1111/j.1464-410X.1990.tb14650.x
   HAWTHORN L, 1990, J BIOMED MATER RES, V24, P1325, DOI 10.1002/jbm.820241005
   KUNIN CM, 1985, J CLIN MICROBIOL, V21, P902
   MARX M, 1988, J UROLOGY, V139, P180, DOI 10.1016/S0022-5347(17)42349-4
   NICKEL JC, 1985, CAN J SURG, V28, P50
   RAMSAY JWA, 1987, BRIT J UROL, V60, P504, DOI 10.1111/j.1464-410X.1987.tb05029.x
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1990, SCAND J INFECT DIS, V22, P43, DOI 10.3109/00365549009023118
   REID G, 1987, REV INFECT DIS, V9, P470
   REID G, 1992, AM UROLOGICAL ASS UP, V11, P138
   REID G, 1991, BIOFOULING, V4, P171, DOI DOI 10.1080/08927019109378207
   SPIRNAK JP, 1985, J UROLOGY, V134, P349, DOI 10.1016/S0022-5347(17)47163-1
NR 16
TC 120
Z9 122
U1 0
U2 15
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD NOV
PY 1992
VL 148
IS 5
BP 1592
EP 1594
DI 10.1016/S0022-5347(17)36976-8
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA JW460
UT WOS:A1992JW46000068
PM 1433574
DA 2018-10-20
ER

PT J
AU LEWANDOWSKA, K
   PERGAMENT, E
   SUKENIK, CN
   CULP, LA
AF LEWANDOWSKA, K
   PERGAMENT, E
   SUKENIK, CN
   CULP, LA
TI CELL-TYPE-SPECIFIC ADHESION MECHANISMS MEDIATED BY FIBRONECTIN ADSORBED
   TO CHEMICALLY DERIVATIZED SUBSTRATA
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FLUORESCENCE ENERGY-TRANSFER; SITE-DIRECTED MUTAGENESIS; NEURO-BLASTOMA
   CELLS; PLASMA FIBRONECTIN; BINDING DOMAIN; FRAGMENTS; ADSORPTION;
   FIBROBLASTS; MODULATION; SEQUENCE
AB Plasma fibronectin (pFN) adhesion mechanisms on inert substrata were evaluated for murine fibroblasts (3T3) and human neuroblastoma (Platt) cells using glass coverslips chemically derivatized with a self-assembled monolayer of aliphatic chains terminated with a specific end-group to interact with adsorbed pFN: [CH3], [SH], [SCOCH3], [NH2], [SO3H], or underivatized glass [SiOH]. All surfaces bound similar amounts of pFN and facilitated attachment of both cell types within narrow ranges. However, spreading/differentiation responses of cells differed considerably among the surfaces. While 3T3 cells spread and developed microfilament stress fibers comparably on all surfaces, inclusion of an RGDS-containing synthetic peptide in the medium revealed variation in resistance to stress fiber formation mediated by an RGDS-recognizing integrin: [NH2] > [CH3] >> [SiOH],[SH],[SCOCH3]. Different patterns of neurite formation were observed for neuroblastoma cells: [SiOH], [SO3H] > [SCOCH3],[SH] >> [CH3] > [NH2]. Similarity in cell responses to both [CH3] and [NH2] surfaces argues against a pattern dependent upon the hydrophobicity of substrata. When pFN was diluted to a subsaturable concentration with albumin for adsorption, neuroblastoma responses changed significantly from those observed on pFN-saturated surfaces, for both spreading and neurite generation: [NH2],[SO3H] >> [SH], [SCOCH3] > [SiOH],[CH3]. Responses to the pFN:albumin mixture were markedly improved from responses after sequential adsorptions, demonstrating "optimization" of pFN conformation (not merely binding) by coadsorption of albumin molecules. In most cases, the [NH2] surface yielded responses distinctively different from the other surfaces. Overall, these data suggest many variations in the conformation of pFN molecules adsorbed to specific inert surfaces, as well as variations in the responses of cell surface receptors to conformationally specific pFNs. They also reveal cell-type-specific changes in differentiated cell responses on derivatized substrata, mediated by different classes of cell surface receptors for the two cell types, and provide optimism for regulating FN-dependent adhesion mechanisms in either positive or negative contexts on biomaterial surfaces derivatized with one or more of these chemical end-groups.
C1 CASE WESTERN RESERVE UNIV, SCH MED, DEPT MOLEC BIOL & MICROBIOL, CLEVELAND, OH 44106 USA.
   CASE WESTERN RESERVE UNIV, DEPT CHEM, CLEVELAND, OH 44106 USA.
FU NINDS NIH HHS [NS17139]; NCI NIH HHS [CA27755]
CR AOTA S, 1991, J BIOL CHEM, V266, P15938
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   BALACHANDER N, 1988, TETRAHEDRON LETT, V29, P5593, DOI 10.1016/S0040-4039(00)80820-5
   BENECKY MJ, 1990, BIOCHEMISTRY-US, V29, P3082, DOI 10.1021/bi00464a027
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   CULP LA, 1986, CIBA F SYMP, V124, P158
   CULP LA, 1991, BIOCH MOL ASPECTS SE, V1, P99
   CULP LA, 1990, SEMINARS DEV BIOL DE, V1, P437
   DAVIES JS, 1990, BIOCHEM SOC T, V18, P1326, DOI 10.1042/bst0181326
   GIROUX TA, 1990, J COLLOID INTERF SCI, V139, P351, DOI 10.1016/0021-9797(90)90109-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   GRINNELL F, 1989, EXP CELL RES, V182, P668, DOI 10.1016/0014-4827(89)90270-X
   HAAS R, 1982, J CELL PHYSIOL, V113, P289, DOI 10.1002/jcp.1041130217
   HALL MD, 1988, EXP CELL RES, V179, P115, DOI 10.1016/0014-4827(88)90353-9
   HUGHES RC, 1979, EXP CELL RES, V121, P307, DOI 10.1016/0014-4827(79)90009-0
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cellbio.1.1.67
   KHAN MY, 1988, J BIOL CHEM, V263, P11314
   LEWANDOWSKA K, 1990, J CELL SCI, V95, P75
   LEWANDOWSKA K, 1988, FEBS LETT, V237, P35, DOI 10.1016/0014-5793(88)80166-2
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MCABEE DD, 1983, J CELL BIOL, V97, P1515, DOI 10.1083/jcb.97.5.1515
   MCCARTHY JB, 1988, J NATL CANCER I, V80, P108, DOI 10.1093/jnci/80.2.108
   MIYAMOTO Y, 1988, BIOCHIM BIOPHYS ACTA, V953, P306, DOI 10.1016/0167-4838(88)90039-8
   MUGNAI G, 1988, EXP CELL RES, V175, P229, DOI 10.1016/0014-4827(88)90189-9
   MUGNAI G, 1988, J CELL BIOL, V106, P931, DOI 10.1083/jcb.106.3.931
   NAGATA K, 1985, J CELL BIOL, V101, P386, DOI 10.1083/jcb.101.2.386
   NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RADINSKY R, 1990, CANCER RES, V50, P4388
   ROGERS SL, 1985, J NEUROSCI, V5, P369
   SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   WOLFF C, 1989, ARCH BIOCHEM BIOPHYS, V268, P536, DOI 10.1016/0003-9861(89)90320-2
   WOLFF CE, 1990, BIOCHEMISTRY-US, V29, P3354, DOI 10.1021/bi00465a030
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
   YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 42
TC 115
Z9 115
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1992
VL 26
IS 10
BP 1343
EP 1363
DI 10.1002/jbm.820261007
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JM852
UT WOS:A1992JM85200006
PM 1429751
DA 2018-10-20
ER

PT J
AU DEBRUIJN, JD
   KLEIN, CPAT
   DEGROOT, K
   VANBLITTERSWIJK, CA
AF DEBRUIJN, JD
   KLEIN, CPAT
   DEGROOT, K
   VANBLITTERSWIJK, CA
TI THE ULTRASTRUCTURE OF THE BONE HYDROXYAPATITE INTERFACE INVITRO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ELECTRON-MICROSCOPY; HYDROXYLAPATITE INTERFACE; MATRIX PRODUCTION;
   OSTEOBLASTS; TISSUE; APATITE; BIOMATERIALS; SUBSTRATA; IMPLANTS;
   CERAMICS
AB Rat bone marrow cells were cultured on plasma-sprayed hydroxyapatite (HA). The cells formed a mineralized extracellular matrix (ECM) that exhibited several characteristics of bone tissue. The interface between this mineralized ECM and the HA was studied at the ultrastructural level with scanning and transmission electron microscopy and x-ray microanalysis. Initially, the deposition of a globular, afibrillar matrix was observed on HA. This was followed by the integration of collagen fibers in this matrix and their subsequent mineralization. At the bone-HA interface two distinctly different interfacial structures were observed. An electron-dense layer with a thickness of 20-60 nm was regularly present, which contained both organic and inorganic material and was rich in glycosaminoglycans. The interfaces differed however, in the presence or absence of an amorphous zone which was free of collagen fibers and had an average thickness of 0.7-0.8-mu-m. It was frequently seen interposed between the electron-dense layer and the hydroxyapatite. Similar interfacial structures have also been described in the in vivo environment, where they were referred to as lamina limitans-like or cement linelike. From the results of this study, it can be concluded that the described in vitro system is a suitable model to study bone-biomaterial interactions.
RP DEBRUIJN, JD (reprint author), LEIDEN UNIV, DEPT EAR NOSE & THROAT, BIOMAT RES GRP, OTOBIOL & BIOCOMPATIBIL LAB, BLDG 25, 2333 AA LEIDEN, NETHERLANDS.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BANCROFT JD, 1982, THEORY PRACTICE HIST, P383
   BIANCO P, 1988, CALCIFIED TISSUE INT, V43, P167, DOI 10.1007/BF02571315
   BOIVIN G, 1990, ACTA ORTHOP SCAND, V61, P170, DOI 10.3109/17453679009006514
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1990, HDB BIOACTIVE CERAMI, V1, P1
   DEBRUIJN JD, 1991, INTERFACES MED MECHA, V2, P420
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FRASCA P, 1981, ACTA ANAT, V109, P115
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   GROOT CG, 1982, THESIS U LEIDEN NETH
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   HARMAND MF, 1987, BIOL BIOMECHANICAL P, P361
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   KLEIN CPAT, 1983, BIOMATERIALS, V4, P181, DOI 10.1016/0142-9612(83)90007-8
   LOWENBERG B, 1991, CELL MATER, V1, P177
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   OSBORN JF, 1980, BIOMATERIALS, P51
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SCHAFFLER MB, 1987, ANAT REC, V217, P223, DOI 10.1002/ar.1092170302
   SCHERFT JP, 1968, J ULTRA MOL STRUCT R, V23, P333, DOI 10.1016/S0022-5320(68)80010-3
   SCHERFT JP, 1978, J ULTRA MOL STRUCT R, V64, P173, DOI 10.1016/S0022-5320(78)80035-5
   SCOTT BL, 1971, J ULTRA MOL STRUCT R, V36, P565, DOI 10.1016/S0022-5320(71)90015-3
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   UCHIDA A, 1987, J BIOMED MATER RES, V21, P1, DOI 10.1002/jbm.820210106
   VAN PT, 1982, CELL TISSUE RES, V225, P283
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VEERMAN ECI, 1988, IMPLANT MATERIALS BI, V8, P331
   VEERMAN ECI, 1988, IMPLANT MATERIALS BI, V8, P337
NR 43
TC 115
Z9 115
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1992
VL 26
IS 10
BP 1365
EP 1382
DI 10.1002/jbm.820261008
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JM852
UT WOS:A1992JM85200007
PM 1331114
DA 2018-10-20
ER

PT J
AU WU, H
   ZHU, TB
   DU, JY
   HONG, GX
   SUN, SZ
   XU, XH
AF WU, H
   ZHU, TB
   DU, JY
   HONG, GX
   SUN, SZ
   XU, XH
TI NEW BONE-FORMATION IN THE INVIVO IMPLANTATION OF BIOCERAMICS - A
   QUANTITATIVE-ANALYSIS
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
ID ELECTROMAGNETIC-FIELDS
AB Two kinds of synthetic biomaterial, porous tricalcium phosphate (PTCP) and magnetic porous tricalcium phosphate (MPTCP) ceramic granules were implanted in rat femur. In the period of 4 months, the assessment of serial histological sections, scanning electron microphotographs and quantitative analysis of bone formation in the sections showed that both ceramics are biocompatible and degradable in vivo. More new bone formation occurred in the MPTCP group. Endochondral ossification was seen in both groups. The quantitative analysis in this study is reliable, and may be suitable to the similar experimental models.
C1 WUHAN TECHNOL UNIV,WUHAN 430070,PEOPLES R CHINA.
RP WU, H (reprint author), TONGJI MED UNIV,UNION HOSP,DEPT ORTHOPED,WUHAN 430022,PEOPLES R CHINA.
CR BASSETT CAL, 1984, ORTHOP CLIN N AM, V15, P61
   BRUCE GK, 1987, CLIN ORTHOP RELAT R, V222, P300
   BUCHOLZ RW, 1989, CLIN ORTHOPAEDICS, V248, P169
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, V232, P127
   ELLIES LG, 1988, J BIOMED MATER RES, V22, P137, DOI 10.1002/jbm.820220206
   HOLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   LAVINE LS, 1987, J BONE JOINT SURG AM, V69A, P626, DOI 10.2106/00004623-198769040-00024
   PASSUTI N, 1989, CLIN ORTHOPAEDICS, V240, P53
   RENOOIJ W, 1985, CLIN ORTHOPAEDICS, V197, P292
   SHARRARD WJW, 1984, ORTHOP CLIN N AM, V15, P143
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
NR 11
TC 3
Z9 6
U1 0
U2 3
PU CHINESE MEDICAL ASSOCIATION
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD SEP
PY 1992
VL 105
IS 9
BP 753
EP 757
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA JU435
UT WOS:A1992JU43500011
PM 1288979
DA 2018-10-20
ER

PT J
AU DACQUET, V
   VARLET, A
   TANDOGAN, RN
   TAHON, MM
   FOURNIER, L
   JEHL, F
   MONTEIL, H
   BASCOULERGUE, G
AF DACQUET, V
   VARLET, A
   TANDOGAN, RN
   TAHON, MM
   FOURNIER, L
   JEHL, F
   MONTEIL, H
   BASCOULERGUE, G
TI ANTIBIOTIC-IMPREGNATED PLASTER OF PARIS BEADS - TRIALS WITH TEICOPLANIN
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS; LOADED PLASTER; OSTEOMYELITIS; PELLETS
AB Teicoplanin-impregnated plaster of paris beads were made and in vitro release properties were studied. Teicoplanin was released in an initial massive dose, with a rapid decline during the first three days, followed by a slowly declining prolonged release up to 30 days. The release tested by diffusion in gelose and high-performance liquid chromatography was found to be 21.4% and 28.2%, respectively, of the amount theoretically present in the beads. Plaster of paris is a resorbable, nontoxic biomaterial that has already been used to fill dead spaces in bone and deliver antibiotics in the treatment of chronic osteomyelitis. The addition of teicoplanin, a new antistaphylococcal agent with low known bacterial resistance, is a promising alternative. Follow-up tests in vivo, simulating local conditions of the osteomyelitic bone, are necessary to prove efficacy.
RP DACQUET, V (reprint author), UNITE SEPT,INST CALOT,F-62608 BERCK,FRANCE.
CR BABUL N, 1988, DRUG INTEL CLIN PHAR, V22, P218, DOI 10.1177/106002808802200309
   BASCOULERGUE G, 1983, 2ND ANN M EUR GROUP
   BERNAREGGI A, 1986, ANTIMICROB AGENTS CH, V30, P733, DOI 10.1128/AAC.30.5.733
   BOIFFARD O, 1989, SEM HOP PARIS, V45, P2752
   Bouillet R, 1989, Acta Orthop Belg, V55, P1
   CARBON C, 1988, LETT INFECTIOLOG S20, V3, P13
   CARPER HT, 1987, J ANTIMICROB CHEMOTH, V19, P659, DOI 10.1093/jac/19.5.659
   DACQUET V, 1989, OCT JOURN I CAL BERC
   DAOUD A, 1979, REV CHIR ORTHOP, V65, P441
   Debeaumont D., 1982, CLIN ORTHOPAEDICS, V167, P263
   DINGELDEIN E, 1976, Z UNFALLCHIRUGI 1112
   DRESSMANN H, 1892, BEITR KLIN CHIR, V9, P804
   EVRARD J, 1971, SPECIAL MAI, V57, P439
   GREENWOOD D, 1988, J ANTIMIC CHEMOTH SA, V2
   GRIEBEN A, 1981, S AFR MED J, V60, P395
   GRISTINA AG, 1983, J BONE JOINT SURG AM, V65, P128, DOI 10.2106/00004623-198365010-00021
   GROVE DC, 1955, ASSAY METHODS ANTIBI
   JEHL F, 1988, J ANTIMICROB CHEMOTH, V21, P53, DOI 10.1093/jac/21.suppl_A.53
   Jenny G, 1988, Reconstr Surg Traumatol, V20, P36
   Jenny J Y, 1986, Acta Orthop Belg, V52, P113
   KORACEVIC B, 1953, DTSCH ZENTRALBLATT C, V276, P432
   KORENDIASEV M A, 1959, Ortop Travmatol Protez, V20, P18
   LEMAN G, 1986, ACTA CHIR BELG, V86, P41
   LEWIS P, 1988, J ANTIMICROB CHEMOTH, V21, P61, DOI 10.1093/jac/21.suppl_A.61
   LOPITAUX R, 1978, REV RHUM, V45, P193
   Martini M, 1981, Acta Orthop Belg, V47, P79
   NIKULIN A, 1956, ACTA MED IUGOSL, V10, P1
   NORDEN CW, 1988, REV INFECT DIS, V10, P103
   NORDEN CW, 1986, INFECTION, V14, P136, DOI 10.1007/BF01643479
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   PALLANZA R, 1989, EFFECT ANAEROBIOSIS
   PATTON KR, 1987, DRUG EXP CLIN RES, V13, P547
   PAULUZZI S, 1987, J ANTIMICROB CHEMOTH, V20, P431, DOI 10.1093/jac/20.3.431
   PELTIER L F, 1961, Clin Orthop, V21, P1
   PELTIER LF, 1978, J BONE JOINT SURG AM, V60, P820, DOI 10.2106/00004623-197860060-00017
   PETROVA A, 1927, TRAUMATOL I LENINGRA, V2, P1071
   PIGANIOL G, 1982, CHIRURGIE, V108, P484
   PINON P, 1981, REV CHIR ORTHOP, V67, P35
   SIX B, 1987, THESIS U LILLE I FRA
   TSUKAYAMA DT, 1988, ORTHOPEDICS, V11, P1285
   VARLET A, 1985, REV CHIR ORTHOP, V71, P73
   VARLET A, 1983, REV CHIR ORTHOP, V69, P239
   VARLET A, 1984, TECNICIEN BIOL, V6, P297
   VINCENEUX P, 1984, ACTUALITE RHUMATOLOG, P284
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
   WALEMKAMP GH, 1983, GENTAMYCIN PMMA BEAD
   WALENKAMP GHI, 1986, CLIN ORTHOP RELAT R, V205, P171
NR 47
TC 54
Z9 55
U1 0
U2 3
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD SEP
PY 1992
IS 282
BP 241
EP 249
PG 9
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA JM402
UT WOS:A1992JM40200032
PM 1387599
DA 2018-10-20
ER

PT J
AU BANDYK, DF
AF BANDYK, DF
TI DIAGNOSIS AND TREATMENT OF BIOMATERIAL-ASSOCIATED VASCULAR INFECTIONS
SO INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
LA English
DT Article
ID AORTIC GRAFT INFECTION; STAPHYLOCOCCUS-EPIDERMIDIS; PROSTHESES; CULTURES
C1 UNIV S FLORIDA, COLL MED, DEPT SURG, TAMPA, FL 33612 USA.
CR BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BANDYK DF, 1991, J VASC SURG, V13, P575
   BERGAMINI TM, 1989, J VASC SURG, V9, P665, DOI 10.1067/mva.1989.vs0090665
   DURHAM JR, 1987, J VASC SURG, V5, P160, DOI 10.1067/mva.1987.avs0050160
   ERNST CB, 1977, ANN SURG, V185, P626, DOI 10.1097/00000658-197706000-00003
   GEARY KJ, 1990, J VASC SURG, V11, P339, DOI 10.1067/mva.1990.17626
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   KAEBNICK HW, 1987, SURGERY, V102, P756
   KINNEY EV, 1991, J SURG RES, V50, P430, DOI 10.1016/0022-4804(91)90020-M
   LEVY MF, 1990, J CLIN MICROBIOL, V28, P664
   LIEKWEG WG, 1977, SURGERY, V81, P335
   MACBETH GA, 1984, J VASC SURG, V1, P750, DOI 10.1067/mva.1984.avs0010750
   OLOFSSON PA, 1988, J VASC SURG, V8, P99, DOI 10.1067/mva.1988.avs0080099
   REILLY LM, 1987, J VASC SURG, V5, P421, DOI 10.1067/mva.1987.avs0050421
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   SEDWITZ MM, 1987, J VASC SURG, V6, P476, DOI 10.1067/mva.1987.avs0060476
   SHAH PM, 1987, J SURG RES, V42, P298, DOI 10.1016/0022-4804(87)90147-8
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
NR 19
TC 12
Z9 12
U1 1
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0891-5520
EI 1557-9824
J9 INFECT DIS CLIN N AM
JI Infect. Dis. Clin. North Am.
PD SEP
PY 1992
VL 6
IS 3
BP 719
EP 729
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA JT668
UT WOS:A1992JT66800014
PM 1431048
DA 2018-10-20
ER

PT J
AU XI, TF
   MA, JZ
   TIAN, WH
   LEI, XH
   LONG, SH
   XI, BS
AF XI, TF
   MA, JZ
   TIAN, WH
   LEI, XH
   LONG, SH
   XI, BS
TI PREVENTION OF TISSUE CALCIFICATION ON BIOPROSTHETIC HEART-VALVE BY USING
   EPOXY COMPOUNDS - A STUDY OF CALCIFICATION TESTS INVITRO AND INVIVO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BOVINE PERICARDIUM; MINERALIZATION; BIOMATERIAL; MECHANISMS
AB Calcification is the principal cause of the clinical failures of the bioprosthetic heart valves fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. In this paper, we compared the calcification on various types of bovine pericardiums pretreated with two hydrophilic epoxy compounds adding GA post-treatment (EP 1 and EP 2), glutaraldehyde (GA)- and nontreated pericardium (Fresh), respectively, by in vitro and in vivo tests. Significant decrease of calcification was found by pretreatment with both epoxy compounds rather than with glutaraldehyde: 0.250 +/- 0.001 (Fresh), 0.276 +/- 0.058 (EP 1), 0.302 +/- 0.071 (EP 2), and 0.478 +/- 0.172 (G )mu-g (Ca)/mg (dried tissue), respectively, after 20 days dipping in a simulating serum solution in vitro; 115.13 +/- 60.11 (Fresh), 129.84 +/- 51.08 (EP 1), 167.39 +/- 20.81 (EP 2), and 205.19 +/- 16.86 (GA) mu-g/mg, respectively, after 3 months subcutaneous implantation in rabbits. The in vitro method for evaluating calcification designed by us gave the similar order among four samples with that obtained by in vivo test. Because the bovine pericardium pretreated with the epoxy compounds adding GA post-treatment possesses the greater tenacity than that pretreated only with epoxy compounds or GA, meanwhile the calcification is also significantly decreased with this pretreatment, it may be expected that the bovine pericardium with this pretreatment will have the greater anticalcification and durability in dynamic stress.
C1 NATL INST CONTROL PHARMACEUT & BIOL PROD,CTR MED DEVICES,BEIJING 100050,PEOPLES R CHINA.
   TSING HUA UNIV,BIOMECH LAB,BEIJING 100084,PEOPLES R CHINA.
CR COSGROVE DM, 1985, J THORAC CARDIOV SUR, V89, P358
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   IONESCU MI, 1979, TISSUE HEART VALVES, P201
   Levy R J, 1985, Trans Am Soc Artif Intern Organs, V31, P459
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   REUL GJ, 1985, J VASC SURG, V2, P192
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   WEBB CL, 1990, T AM SOC ART INT ORG, V36, P56
   WEBB CL, 1988, T AM SOC ART INT ORG, V34, P855
   WOODWARD SC, 1981, T AM SOC ART INT ORG, V27, P697
   XI TF, IN PRESS EFFECT PORE
NR 21
TC 32
Z9 32
U1 3
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1992
VL 26
IS 9
BP 1241
EP 1251
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JJ464
UT WOS:A1992JJ46400012
PM 1429769
DA 2018-10-20
ER

PT J
AU COLLET, D
   RABAUD, M
   LEFEBVRE, F
   COUDERC, B
   QUENTIN, C
   PERISSAT, J
AF COLLET, D
   RABAUD, M
   LEFEBVRE, F
   COUDERC, B
   QUENTIN, C
   PERISSAT, J
TI EVALUATION OF ELASTIN FIBRIN BIOMATERIAL IN EXPERIMENTAL PANCREATIC
   SURGERY
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Artificial connective soft tissue, so-called "Elastin-Fibrin" biomaterial, was investigated to reinforce a pancreato-jejunum anastomosis in the dog. The ambiguous results invite us, however, to improve the quality of the material, especially against proteolytic degradation: elastinolysis and fibrinolysis. Antibiotic was also added. The improved material was tested, first in rabbit then in dog, to repair a large loss of substance in the duodenum, just in front of the Wirsung duct. In view of the successful results, we are now attempting an evaluation in humans, for all indications throughout the digestive system.
C1 UNIV BORDEAUX 2, HISTOL EMBRYOL LAB, F-33076 BORDEAUX, FRANCE.
   UNIV BORDEAUX 2, DETERCA, F-33076 BORDEAUX, FRANCE.
   HOSP PELLEGRIN, SERV MICROBIOL, F-33000 BORDEAUX, FRANCE.
RP COLLET, D (reprint author), UNIV BORDEAUX 2, INSERM, U306, 146 RUE LEO SAIGNAT, F-33076 BORDEAUX, FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   BARBIE C, 1989, BIOMATERIALS, V10, P445, DOI 10.1016/0142-9612(89)90084-7
   CHAPUIS Y, 1987, CHIRURGIE, V113, P262
   COLLET D, 1991, BIOMATERIALS, V12, P763, DOI 10.1016/0142-9612(91)90027-8
   COLLET D, 1991, OCT POST SESS ASS FR
   DUBOIS F, 1988, ANN CHIR, V42, P319
   GRIPON S, 1988, J CHIR-PARIS, V125, P161
   LEFEBVRE F, 1989, J BIOMED MATER RES, V23, P1423, DOI 10.1002/jbm.820231205
   MARTIN MT, 1988, BIOMATERIALS, V9, P519, DOI 10.1016/0142-9612(88)90048-8
   MINABE M, 1989, J CLIN PERIODONTOL, V16, P291, DOI 10.1111/j.1600-051X.1989.tb01657.x
   RABAUD M, 1986, THROMB RES, V43, P205, DOI 10.1016/0049-3848(86)90061-7
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
   RIQUET M, 1990, BIOMATERIALS, V11, P518, DOI 10.1016/0142-9612(90)90069-3
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
NR 14
TC 1
Z9 1
U1 1
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1992
VL 3
IS 5
BP 382
EP 386
DI 10.1007/BF00705372
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JP861
UT WOS:A1992JP86100012
DA 2018-10-20
ER

PT J
AU NERY, EB
   LEGEROS, RZ
   LYNCH, KL
   LEE, K
AF NERY, EB
   LEGEROS, RZ
   LYNCH, KL
   LEE, K
TI TISSUE-RESPONSE TO BIPHASIC CALCIUM-PHOSPHATE CERAMIC WITH DIFFERENT
   RATIOS OF HA/BETA-TCP IN PERIODONTAL OSSEOUS DEFECTS
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE PERIODONTAL DISEASES THERAPY; BONE LOSS THERAPY; BETA-TRICALCIUM
   PHOSPHATE THERAPEUTIC USE
ID POROUS HYDROXYAPATITE; BIOMATERIAL ASPECTS; IMPLANT; BONE
AB THE PURPOSE OF THIS STUDY was to determine the optimal ratio of calcium hydroxyapatite (HA) to beta tricalcium phosphate (betaTCP) in a biphasic porous calcium phosphate (BCP) ceramic for effective repair of periodontal osseous defects. Defects were surgically produced in beagle dogs and made chronic for 4 months to simulate periodontal disease. Mucoperiosteal periodontal flaps were reflected, followed by osseous defect debridement and root planing. Specially prepared ceramic with different HA/betaTCP ratios were implanted into the prepared defects. The sites were allowed to heal for 6 months, animals were euthanized, and site-blocks were removed for histological study. During the follow-up phase, scaling and polishing were done once a month, and standardized probing attachment levels were recorded pre- and 6-months postoperatively. The Duncan's multiple range test showed that all the treatments produced statistically significant higher gain in probing attachment levels than the control group (OHA/ObetaTCP) (P <0.05). Among the 7 "active" treatment groups, 2 (65/35 and 85/15) had significantly higher gain in probing attachment levels than those in 3 groups (50/50, 100/0, and 0/100) (P < 0.05). Histologically, higher HA ratio (but not 100% HA) showed accelerated new bone formation and new attachment levels. Based on histological results, the 85HA/15betaTCP ratio appears to demonstrate greater gain in attachment level and bone regeneration in the treatment of periodontal osseous defects.
C1 NYU,CTR DENT,OFF RES PROGRAM,NEW YORK,NY 10003.
   VET ADM MED CTR,COOPERAT STUDIES PROGRAM,CTR COORDINAT,PALO ALTO,CA 94304.
   MED COLL WISCONSIN,DEPT ORTHOPAED SURG,MILWAUKEE,WI 53226.
RP NERY, EB (reprint author), CLEMENT J ZABLOCKI VET ADM MED CTR,DENT RES SECT,MILWAUKEE,WI 53295, USA.
FU NIDCR NIH HHS [DE04123]
CR Biederman W, 1968, DENT CLIN N AM, V12, P409
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DEGROOT K, 1983, BIOCERAMIC CALCIUM P, P91
   DUNCAN DB, 1975, BIOMETRICS, V31, P339, DOI 10.2307/2529425
   ELLINGER RF, 1986, INT J PERIDONTICS RE, V6, P223
   FROUM SJ, 1982, J PERIODONTOL, V53, P719, DOI 10.1902/jop.1982.53.12.719
   Hubbard W, 1974, THESIS MARQUETTE U M
   ITATANI C, 1984, T ORTHOPED RES SOC, V9, P123
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LEGEROS RZ, 1990, CRC HDB BIOACTIVE CE, V2, P17
   LEGEROS RZ, 1983, 9TH P ANN M SOC BIOM, P86
   Levin M P, 1974, J Clin Periodontol, V1, P197
   LEVIN MP, 1974, ORAL SURG ORAL MED O, V38, P344, DOI 10.1016/0030-4220(74)90359-4
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   LYNCH KL, 1992, BIOCERAMICS, V3, P295
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MOSKOW BS, 1983, J PERIODONTOL, V54, P455, DOI 10.1902/jop.1983.54.8.455
   NERY EB, 1990, J PERIODONTOL, V61, P166, DOI 10.1902/jop.1990.61.3.166
   OSBORN JF, 1985, IMPLANTATWERKSTOFF H
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   ROBALAIS ML, 1981, J PERIODONTOL, V52, P680
   SHAFER WB, 1983, ORAL PATHOL, P540
   VITEK RM, 1979, J PERIODONTAL RES, V14, P93, DOI 10.1111/j.1600-0765.1979.tb00222.x
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Yukna R A, 1986, Int J Periodontics Restorative Dent, V6, P34
   YUKNA RA, 1985, J PERIODONTOL, V56, P540, DOI 10.1902/jop.1985.56.9.540
NR 30
TC 223
Z9 226
U1 1
U2 14
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD SEP
PY 1992
VL 63
IS 9
BP 729
EP 735
DI 10.1902/jop.1992.63.9.729
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JP674
UT WOS:A1992JP67400002
PM 1335498
DA 2018-10-20
ER

PT J
AU ITO, Y
   IMANISHI, Y
AF ITO, Y
   IMANISHI, Y
TI A BIOMATERIAL AS A STRONG BIOSIGNAL
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 KYOTO UNIV,DEPT POLYMER CHEM,KYOTO 606,JAPAN.
RI Ito, Yoshihiro/F-4370-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 23
PY 1992
VL 204
BP 303
EP POLY
PN 2
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA JJ313
UT WOS:A1992JJ31301499
DA 2018-10-20
ER

PT J
AU DACULSI, G
   DARC, MB
   CORLIEU, P
   GERSDORFF, M
AF DACULSI, G
   DARC, MB
   CORLIEU, P
   GERSDORFF, M
TI MACROPOROUS BIPHASIC CALCIUM-PHOSPHATE EFFICIENCY IN MASTOID CAVITY
   OBLITERATION - EXPERIMENTAL AND CLINICAL FINDINGS
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE BIOMATERIAL; CALCIUM PHOSPHATE; CERAMIC; MASTOID CAVITY OBLITERATION;
   OTOLOGIC SURGERY; TYMPANOPLASTY
ID HYDROXYLAPATITE INTERFACE; ELECTRON-MICROSCOPY; BONE; DOGS
AB Following our previous experimental studies on the performance of macroporous biphasic calcium phosphate (MBCP) in canine mastoid cavities, we used this material in patients requiring surgical intervention. Twenty-two cases were selected, and in eight specific cases a biopsy specimen was taken. Histologic, ultrastructural, and microanalysis studies were performed. This study demonstrates the effectiveness of MBCP implants as bone graft substitutes for mastoid cavity obliteration. Clinical evaluation of the series and histologic and ultrastructural results demonstrated the bioactivity and osteoconduction of this material, with partial transformation of MBCP granules into lamellar bone after several months.
C1 HOP COCHIN, DEPT OTOLARYNGOL, F-75674 PARIS 14, FRANCE.
   CATHOLIC UNIV LOUVAIN, DEPT OTOLARYNGOL, B-1200 BRUSSELS, BELGIUM.
RP DACULSI, G (reprint author), FAC CHIRURG DENT, CALCIFIED TISSUES & BIOMAT RES LAB, PL A RICORDEAU, F-44042 NANTES, FRANCE.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR Bebear J P, 1985, Rev Laryngol Otol Rhinol (Bord), V106, P325
   CORLIEU P, 1989, CHOLESTEATOMA MASTOI, P935
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1989, REV CHIR ORTHOP, V75, P65
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P115
   GERSDORFF MCH, 1987, AM J OTOL, V8, P133
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   NERY E B, 1988, Journal of Dental Research, V67, P178
   NERY EB, 1978, J PERIODONTOL, V49, P523, DOI 10.1902/jop.1978.49.10.523
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   WULLSTEIN SR, 1984, BIOMATERIALS OTOLOGY, P250, DOI DOI 10.1007/978-94-009-6756-4_30
NR 17
TC 61
Z9 61
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD AUG
PY 1992
VL 101
IS 8
BP 669
EP 674
DI 10.1177/000348949210100808
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA JH737
UT WOS:A1992JH73700008
PM 1497273
DA 2018-10-20
ER

PT J
AU JOOS, UE
   FEHRENBACH, E
   HOGHJANOVSKY, K
   WIMMER, FM
   SCHNEIDER, EM
   SCHMIDT, KH
AF JOOS, UE
   FEHRENBACH, E
   HOGHJANOVSKY, K
   WIMMER, FM
   SCHNEIDER, EM
   SCHMIDT, KH
TI EFFECTS OF A NEW BONE-INDUCING BIOMATERIAL ON MESENCHYMAL CELLS-INVITRO
SO ARTIFICIAL ORGANS
LA English
DT Article
DE OSTEOBLASTS; TRANSFORMING GROWTH FACTOR BETA; EPIDERMAL GROWTH FACTOR;
   NEUTRALIZING ANTIBODY; RAT
ID GROWTH FACTOR-BETA; PHENOTYPES INVITRO; INDUCTION; MATRIX;
   DIFFERENTIATION; EXPRESSION; PURIFICATION; STIMULATION; OSTEOBLAST;
   PLATELETS
AB A purified bone-inducing protein complex (BIC), isolated from bovine bone and causing de novo bone formation in vivo, induces defined effects on rat mesenchymal cells in vitro. Spindle-like mesenchymal cells growing in monolayers change to polygonal cells, forming a multilayered growth pattern. The mesenchymal cells acquire alkaline phosphatase activity. Upon culture with BIC, the typical collagen Type III deposition of these mesenchymal cells is remarkably reduced whereas the collagen Type I expression remains unaffected. All these in vitro effects are consistent with the strong bone-forming capacity of BIC in vivo. A combination of two cytokines, transforming growth factor beta-1 (TGF-beta-1) and epidermal growth factor (EGF), shows a similar activity to BIC. Neutralizing anti-TGF-beta antibodies interfere with all in vitro effects of BIC. The neutralization of BIC and the inductive capacity of the combination of TGF-beta-1 plus EGF point to the substantial role of TGF-beta or TGF-beta-like molecules in BIC; whether the active polypeptides are identical to TGF-beta or somewhat structurally homologous to TGF-beta remains to be elucidated.
C1 UNIV TUBINGEN, CHIRURG KLIN, PULVERMUHLSTR 3, W-7400 TUBINGEN 1, GERMANY.
   UNIV DUSSELDORF, INST BLUTGERINNUNG & TRANSFUS MED, W-4000 DUSSELDORF, GERMANY.
CR ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   CANALIS E, 1989, J ENDOCRINOL INVEST, V12, P577, DOI 10.1007/BF03350764
   CANALIS E, 1985, CLIN ORTHOP RELAT R, P246
   CENTRELLA M, 1986, ENDOCRINOLOGY, V119, P2306, DOI 10.1210/endo-119-5-2306
   CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
   ELLINGSWORTH LR, 1986, J BIOL CHEM, V261, P2362
   FIRSCHEIN HE, 1971, CALC TISS RES, V7, P108, DOI 10.1007/BF02062599
   HALL BK, 1987, CLIN ORTHOP RELAT R, P255
   KOSHIHARA Y, 1987, BIOCHEM BIOPH RES CO, V145, P651, DOI 10.1016/0006-291X(87)91014-X
   MASSAGUE J, 1987, J CELL PHYSIOL, P43
   NIJWEIDE PJ, 1986, PHYSIOL REV, V66, P855
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   ROBERTS AB, 1980, P NATL ACAD SCI-BIOL, V77, P3494, DOI 10.1073/pnas.77.6.3494
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   ROSEN DM, 1988, J CELL PHYSIOL, V134, P337, DOI 10.1002/jcp.1041340304
   ROSEN DM, 1986, EXP CELL RES, V165, P127, DOI 10.1016/0014-4827(86)90538-0
   SCHONFELD HJ, 1991, BONE MINER, V13, P171, DOI 10.1016/0169-6009(91)90067-A
   SWOBODA HF, 1990, BIOMATER ARTIF CELL, V18, P383, DOI 10.3109/10731199009117316
   THIELEMANN FW, 1982, ARCH ORTHOP TRAUM SU, V99, P217, DOI 10.1007/BF00381396
   URIST MR, 1987, METHOD ENZYMOL, V146, P294
   VUKICEVIC S, 1989, P NATL ACAD SCI USA, V86, P8793, DOI 10.1073/pnas.86.22.8793
   WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484
   WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167
   WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915
NR 24
TC 1
Z9 1
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 1992
VL 16
IS 4
BP 354
EP 360
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA JH743
UT WOS:A1992JH74300006
PM 10078274
DA 2018-10-20
ER

PT J
AU KAPLAN, SS
   BASFORD, RE
   MORA, E
   JEONG, MH
   SIMMONS, RL
AF KAPLAN, SS
   BASFORD, RE
   MORA, E
   JEONG, MH
   SIMMONS, RL
TI BIOMATERIAL-INDUCED ALTERATIONS OF NEUTROPHIL SUPEROXIDE PRODUCTION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FOREIGN-BODY INFECTION; MICROBIAL ADHESION; TISSUE INTEGRATION;
   PATHOGENESIS; GRAFTS; DEFECT
AB Because periprosthetic infection remains a vexing problem for patients receiving implanted devices, we evaluated the effect of several materials on neutrophil free radical production.  Human peripheral blood neutrophils were incubated with several sterile, lipopolysaccharide (LPS)-free biomaterials used in surgically implantable prosthetic devices:  polyurethane, woven dacron, and velcro.  Free radical formation as the superoxide (O2-) anion was evaluated by cytochrome c reduction in neutrophils that were exposed to the materials and then removed and in neutrophils allowed to remain in association with the materials.  Neutrophils exposed to polyurethane or woven dacron for 30 or 60 min and then removed consistently exhibited an enhanced release of O2- after simulation via receptor engagement with formyl methionyl-leucyl-phenylalanine.  Enhanced reactivity to stimulation via protein kinase C with phorbol myristate acetate, however, was not consistently observed.  The cells evaluated for O2- release during continous association with the biomaterials showed enhanced metabolic activity during short periods of association (especially with polyurethane and woven dacron).  Although O2- release by neutrophils in association with these materials decreased with longer periods of incubation, it was not obliterated.  These studies, therefore, show that several commonly used biomaterials activate neutrophils soon after exposure and that this activated state diminishes with prolonged exposure but nevertheless remains measurable.  The diminishing level of activity with prolonged exposure, however, suggests that ultimately a depletion of reactivity may occur and may result in increased susceptibility to periprosthetic infection.
C1 UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15213.
   UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA 15213.
RP KAPLAN, SS (reprint author), UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15213, USA.
FU NIGMS NIH HHS [R01-GM41734-01]
CR Almgren B, 1985, Acta Chir Scand Suppl, V529, P91
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   BERNHARD VM, 1975, SURG CLIN N AM, V55, P1412
   BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1
   Charnley J, 1972, Clin Orthop Relat Res, V87, P167, DOI 10.1097/00003086-197209000-00020
   DISABATO G, 1986, METHOD ENZYMOL, V132, P407
   Dougherty S H, 1989, Infect Dis Clin North Am, V3, P199
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408
   HURST NP, 1987, ANN RHEUM DIS, V46, P265, DOI 10.1136/ard.46.4.265
   KAPLAN SS, 1987, ANN ALLERGY, V59, P213
   KLOCK JC, 1976, BLOOD, V48, P149
   KLOCK JC, 1983, J CLIN INVEST, V60, P1183
   LEVINE M, 1988, CLIN ORTHOPAEDICS, V226, P235
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   MARASCUILO LA, 1983, MULTIVARIATE STATIST
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   PARTHASARATHY T, 1986, INDIAN J MED RES, V84, P440
   ROSENMAN JE, 1985, J SURG RES, V38, P648, DOI 10.1016/0022-4804(85)90088-5
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SZILAGYI DE, 1972, ANN SURG, V176, P321, DOI 10.1097/00000658-197209000-00008
   WADE BH, 1983, AM J MED, V74, P686, DOI 10.1016/0002-9343(83)91028-8
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIPSER RD, 1986, AM J MED A S, V1, P78
NR 28
TC 49
Z9 49
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1992
VL 26
IS 8
BP 1039
EP 1051
DI 10.1002/jbm.820260806
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD962
UT WOS:A1992JD96200005
PM 1331115
DA 2018-10-20
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
AF VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
TI RELATIONS BETWEEN INVITRO CYTOTOXICITY AND CROSS-LINKED DERMAL SHEEP
   COLLAGENS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FIXED PERICARDIUM; GLUTARALDEHYDE; BIOMATERIALS; TOXICITY; DEGRADATION;
   CELLS; RAT
AB Collagen-based biomaterials have found various applications in the biomedical field.  However, collagen-based biomaterials may induce cytotoxic effects.  This study evaluated possible cytotoxic effects of (crosslinked) dermal sheep collagen (DSC) using a 7-d-methylcellulose cell culture with human skin fibroblasts.  Noncrosslinked DSC (NDSC), hexamethylene-diisocyanate-crosslinked DSC (HDSC), and glutaraldehyde-crosslinked DSC (GDSC), their extracts (1 x 10 d to 4 x 10 d extracts), or the corresponding extracted DSC samples were tested.  Cell growth was evaluated by cell counting, while cell morphology was assessed by light microscopy and transmission-electron microscopy.  Both GDSC and, to a lesser extent, HDSC, induced cytotoxicity, observed as inhibited cell growth and deviant cell morphology.  The deviant morphology consisted of extensive accumulations of lipid, reduction in the amount and dilatation of rough endoplasmatic reticulum, increased inclusions of cell remnants, and relatively rounded cell membranes.  With HDSC, both primary cytotoxicity, due to extractable products from the material, and secondary cytotoxicity, possibly due to a release of cytotoxic products resulting from enzymatic cell-biomaterial interactions, could be discriminated.  With GDSC, however, no clear distinction between primary and secondary cytotoxicity could be made.  With NDSC, only primary cytotoxicity, measured as low inhibition of cell proliferation, but without deviant morphology, was observed.  These remarkable differences in cytotoxicity are discussed in relation to residual agents and specific crosslinks present in DSCs as a consequence of processing and the crosslinking agents used.  The residual agents and the specific crosslinks give rise to differences in direct release of products and in sensitivity to hydrolysis and enzymatic breakdown.
C1 TWENTE UNIV,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,BIOMAT RES SECT,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
RI Dijkstra, Pieter/N-9328-2013
CR BAJPAI PK, 1980, IRCS MED SCI-BIOCHEM, V8, P642
   BERODE M, 1988, BIOCH INT, V17, P1
   BROWN WE, 1982, TOXICOL APPL PHARM, V63, P45, DOI 10.1016/0041-008X(82)90025-4
   CHANG KC, 1984, CLIN ALLERGY, V14, P329, DOI 10.1111/j.1365-2222.1984.tb02213.x
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   EVERTS V, 1987, THESIS U AMSTERDAM N
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   HULSTAERT CE, 1983, HISTOCHEMISTRY, V78, P71, DOI 10.1007/BF00491113
   ISCOVE NN, 1979, IMMUNOLOGICAL METHOD, P379
   JOHANNSEN FR, 1987, J APPL TOXICOL, V7, P259, DOI 10.1002/jat.2550070407
   KENNEDY GL, 1986, J APPL TOXICOL, V6, P145, DOI 10.1002/jat.2550060302
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LAZARUS SL, 1969, J INVEST DERMATOL, V52, P6
   MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, COLLAGEN, V1, P1
   PHARRISS BB, 1980, J AM LEATHER CHEM AS, V75, P474
   SHUBIK VM, 1978, J HYG EPID MICROB IM, V22, P408
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPEER DP, 1981, J BIOMED MATER RES, V15, P913
   TRAUBEL H, 1977, LEDER, P150
   TRAUBEL H, 1977, LEDER, P181
   ULREICH JB, 1981, J BIOMED MATER RES, V15, P913, DOI 10.1002/jbm.820150615
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANGULIK TM, 1981, THESIS U AMSTERDAM
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, IN PRESS CELLS MATER
   WOODROOF EA, 1978, J BIOENG, V2, P1
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   YAJIMA T, 1986, CELL TISSUE RES, V245, P253
   YANO E, 1981, Japanese Journal of Industrial Health, V23, P537
NR 38
TC 112
Z9 112
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1992
VL 26
IS 8
BP 1091
EP 1110
DI 10.1002/jbm.820260810
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD962
UT WOS:A1992JD96200009
PM 1429758
DA 2018-10-20
ER

PT J
AU CHRISTOFFERSEN, MR
   CHRISTOFFERSEN, J
AF CHRISTOFFERSEN, MR
   CHRISTOFFERSEN, J
TI POSSIBLE MECHANISMS FOR THE GROWTH OF THE BIOMATERIAL, CALCIUM
   HYDROXYAPATITE MICROCRYSTALS
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
ID AQUEOUS-SOLUTION; SURFACE-TENSION; CRYSTAL-GROWTH; CONSTANT PH;
   DISSOLUTION; KINETICS; NUCLEATION; SOLUBILITY; PHOSPHATE; WATER
AB Experimental data for the growth of calcium hydroxyapatite crystals, HA, are reported. The rate is shown to be controlled by a surface process. Two models, the spiral growth model and the polynuclear model, may explain the results. From the polynuclear theory, the surface tension is found to be 80 mJ/m2. The deviation of this value from the value expected from theory, 240 mJ/m2. is suggested to be due to imperfections in the surface of HA. If all rates are dependent on activities and not concentrations, the frequency of ion integration is found to be 9 X 10(4) s-1 for the polynuclear model, close to the value 1.6 X 10(5) s-1, expected if the rate-determining step is partial dehydration of calcium ions. If the rate of lateral growth of nuclei is concentration-dependent, the value of the frequency of ion integration depends on assumptions made for the value of the activity coefficient of a monomer in the adsorbed layer, or the adsorption constant. For the spiral mechanism, the frequency of ion integration is also dependent on the value assumed for the surface tension. If similar assumptions to those used for the application of the polynuclear theory are applied to the spiral theory, similar values of the ion integration frequency are obtained, thus making it difficult to distinguish the rate-controlling mechanism.
RP CHRISTOFFERSEN, MR (reprint author), UNIV COPENHAGEN,PANUM INST,DEPT BIOCHEM A,BLEGDAMSVEJ 3,DK-2200 COPENHAGEN,DENMARK.
CR ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   BELL RP, 1959, PROTON CHEM, P120
   BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006
   CHRISTOFFERSEN J, 1992, J CRYST GROWTH, V121, P608, DOI 10.1016/0022-0248(92)90568-4
   CHRISTOFFERSEN J, 1979, J CRYST GROWTH, V47, P671, DOI 10.1016/0022-0248(79)90011-3
   CHRISTOFFERSEN J, 1980, J CRYST GROWTH, V49, P29, DOI 10.1016/0022-0248(80)90057-3
   CHRISTOFFERSEN J, 1976, J CRYST GROWTH, V35, P79, DOI 10.1016/0022-0248(76)90247-5
   CHRISTOFFERSEN J, 1978, J CRYST GROWTH, V43, P501, DOI 10.1016/0022-0248(78)90350-0
   CHRISTOFFERSEN J, 1988, J CRYST GROWTH, V87, P41, DOI 10.1016/0022-0248(88)90342-9
   CHRISTOFFERSEN J, 1991, J CRYST GROWTH, V113, P599, DOI 10.1016/0022-0248(91)90096-N
   CHRISTOFFERSEN J, 1982, J CRYST GROWTH, V57, P21, DOI 10.1016/0022-0248(82)90244-5
   CHRISTOFFERSEN J, 1990, J CRYST GROWTH, V10, P203
   CHRISTOFFERSEN MR, 1988, J CRYST GROWTH, V87, P51, DOI 10.1016/0022-0248(88)90343-0
   CHUGHTAI A, 1968, J PHYS CHEM-US, V72, P208, DOI 10.1021/j100847a039
   FLODGAARD H, 1974, J BIOL CHEM, V249, P3465
   GREGORY TM, 1970, J RES NBS A PHYS CH, VA 74, P461, DOI 10.6028/jres.074A.036
   INSKEEP WP, 1988, GEOCHIM COSMOCHIM AC, V52, P1883, DOI 10.1016/0016-7037(88)90012-9
   Kielland J, 1937, J AM CHEM SOC, V59, P1675, DOI 10.1021/ja01288a032
   KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   MORENO EC, 1977, CALC TISS RES, V24, P47, DOI 10.1007/BF02223296
   MORENO EC, 1981, J CRYST GROWTH, V53, P20, DOI 10.1016/0022-0248(81)90052-X
   NANCOLLAS GH, 1974, J PHYS CHEM-US, V78, P2218, DOI 10.1021/j100615a007
   NANCOLLAS GH, 1980, PROG CRYST GROWTH CH, V3, P77, DOI 10.1016/0146-3535(80)90013-1
   NIELSEN AE, 1984, J CRYST GROWTH, V67, P289, DOI 10.1016/0022-0248(84)90189-1
   NIELSEN AE, 1971, J CRYST GROWTH, V11, P233, DOI 10.1016/0022-0248(71)90090-X
   ZHANG JW, 1990, J CRYST GROWTH, V106, P181, DOI 10.1016/0022-0248(90)90062-P
NR 27
TC 27
Z9 27
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD AUG
PY 1992
VL 121
IS 4
BP 617
EP 630
DI 10.1016/0022-0248(92)90569-5
PG 14
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA JK560
UT WOS:A1992JK56000009
DA 2018-10-20
ER

PT J
AU PINHOLT, EM
   RUYTER, IE
   HAANAES, HR
   BANG, G
AF PINHOLT, EM
   RUYTER, IE
   HAANAES, HR
   BANG, G
TI CHEMICAL, PHYSICAL, AND HISTOLOGIC-STUDIES ON 4 COMMERCIAL APATITES USED
   FOR ALVEOLAR RIDGE AUGMENTATION
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID BONE-GRAFT SUBSTITUTE; POROUS HYDROXYLAPATITE; BIOMATERIAL ASPECTS;
   AUTOGENOUS BONE; HYDROXYAPATITE; CARBONATE; PARTICLES; TISSUE
C1 SCANDINAVIAN INST DENT MAT, NIOM, DIV PHYS CHEM, HASLUM, NORWAY.
   UNIV BERGEN, HAUKELAND HOSP, DEPT ORAL PATHOL & FORENS ODONTOL, N-5016 BERGEN, NORWAY.
   UNIV OSLO, DEPT ORAL & MAXILLOFACIAL SURG, OSLO 3, NORWAY.
   NATL HOSP NORWAY, INST SURG RES, NORWEGIAN RES COUNCIL SCI & HUMANITIES, OSLO 1, NORWAY.
CR BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BLOCK MS, 1985, J ORAL MAXIL SURG, V43, P3, DOI 10.1016/S0278-2391(85)80005-7
   BONEL G, 1964, CR HEBD ACAD SCI, V258, P923
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   CHANG CS, 1983, J ORAL MAXIL SURG, V41, P729, DOI 10.1016/0278-2391(83)90190-8
   CHIROFF RT, 1975, J BIOMED MATER RES, V9, P29, DOI 10.1002/jbm.820090407
   CRANIN AN, 1988, J BIOMED MATER RES, V22, P1165, DOI 10.1002/jbm.820221208
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Donath K, 1985, Dtsch Z Mund Kiefer Gesichtschir, V9, P438
   DONATH K, 1987, ORAL SURG ORAL MED O, V63, P651, DOI 10.1016/0030-4220(87)90362-8
   DONATH K, 1987, J ORAL IMPLANTS, V13, P11
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   FRAME JW, 1987, J ORAL MAXIL SURG, V45, P771, DOI 10.1016/0278-2391(87)90200-X
   GREGOIRE M, 1988, ADV BIOMATER, V8, P215
   HJOERTINGHANSEN E, 1970, STUDIES IMPLANTATION, P1
   HOLMES RE, 1987, INT J ORAL MAX SURG, V16, P718, DOI 10.1016/S0901-5027(87)80059-0
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   JANICKE S, 1988, Z ZAHNARZTL IMPLANTO, V4, P101
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KASPERK C, 1988, INT J ORAL MAX SURG, V17, P319
   Kasperk C, 1986, Z ZAHNARZTL IMPLANTO, V2, P242
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   KAWAMURA M, 1987, CLIN ORTHOP RELAT R, V217, P281
   KENNEY EB, 1988, J BIOMED MATER RES, V22, P1233, DOI 10.1002/jbm.820221211
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   KLEIN CPAT, 1986, BIOMATERIALS, V7, P144
   MARIE PJ, 1987, MAGNESIUM, V6, P100
   ORLY I, 1988, ADV BIOMATER, V8, P211
   OSBORN JF, 1983, HYDROXYLAPATITKERAMI, P37
   PINHOLT EM, 1992, J ORAL MAXIL SURG, V50, P250, DOI 10.1016/0278-2391(92)90321-P
   PINHOLT EM, 1990, SCAND J DENT RES, V98, P434
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   ROTHSTEIN SS, 1984, J AM DENT ASSOC, V109, P571, DOI 10.14219/jada.archive.1984.0127
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SCHOLL FK, 1973, INFRARED ANAL POLYM, V2, P76
   SOEVIK T, 1979, J FISH RES BOARD CAN, V36, P1414, DOI 10.1139/f79-204
   STUTMAN JM, 1965, T NEW YORK ACAD SCI, V27, P669, DOI 10.1111/j.2164-0947.1965.tb02224.x
   TROMBE JC, 1973, CR ACAD SCI C CHIM, V276, P1271
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WORSAAE N, 1988, ODONTOLOGI 88, P159
NR 46
TC 25
Z9 25
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD AUG
PY 1992
VL 50
IS 8
BP 859
EP 867
DI 10.1016/0278-2391(92)90280-D
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JH473
UT WOS:A1992JH47300016
PM 1321896
DA 2018-10-20
ER

PT J
AU WALKER, RD
   WILSON, J
   CLARK, AE
AF WALKER, RD
   WILSON, J
   CLARK, AE
TI INJECTABLE BIOGLASS AS A POTENTIAL SUBSTITUTE FOR INJECTABLE
   POLYTETRAFLUOROETHYLENE
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT 1991 ANNUAL MEETING OF THE SECTION OF UROLOGY OF THE AMERICAN ACADEMY OF
   PEDIATRICS
CY OCT 26-31, 1991
CL NEW ORLEANS, LA
SP AMER ACAD PEDIAT
DE URINARY INCONTINENCE; VESICOURETERAL REFLUX; POLYTETRAFLUOROETHYLENE;
   COLLAGEN; ANIMALS, LABORATORY
ID PERIURETHRAL TEFLON INJECTION; URINARY-INCONTINENCE; MIGRATION;
   COLLAGEN; IMPLANTS; REFLUX
AB Injectable polytetrafluoroethylene (Teflon) and collagen have inherent problems that may prevent their long-term success. In search of a different injectable biomaterial we confirmed in rabbits the safety of injected Bioglass* particles suspended in sodium hyaluronate. A second study was performed testing the ability of the Bioglass suspension to increase urethral resistance in pigs. Bioglass particles in suspension have the potential to substitute for polytetrafluoroethylene or collagen in the treatment of urinary incontinence or vesicoureteral reflux.
RP WALKER, RD (reprint author), UNIV FLORIDA,DEPT SURG,DIV UROL,GAINESVILLE,FL 32611, USA.
CR APPELL R A, 1991, Journal of Urology, V145, p225A
   BALASZ EA, 1988, BIOL HYALURONAN, P265
   BURKE KE, 1985, ANN PLAS SURG, V14, P515, DOI 10.1097/00000637-198506000-00004
   CANNING CA, 1991, DIAL PED UROL, V14, P6
   CARLISLE EM, 1974, FED PROC, V33, P1758
   FERRO MA, 1988, UROLOGY, V31, P422, DOI 10.1016/0090-4295(88)90740-6
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   MERGUERIAN PA, 1990, J UROLOGY, V144, P531, DOI 10.1016/S0022-5347(17)39514-9
   MITTLEMAN RE, 1983, ARCH PATHOL LAB MED, V107, P611
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   POLITANO VA, 1974, J UROLOGY, V111, P180, DOI 10.1016/S0022-5347(17)59921-8
   RAMER M, 1990, 16TH T ANN M SOC BIO
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   STEGMAN SJ, 1987, ARCH DERMATOL, V123, P1644, DOI 10.1001/archderm.123.12.1644
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1, P283
   WILSON J, IN PRESS J APPL BIOM
NR 18
TC 39
Z9 39
U1 0
U2 3
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD AUG
PY 1992
VL 148
IS 2
BP 645
EP 647
DI 10.1016/S0022-5347(17)36680-6
PN 2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA JF961
UT WOS:A1992JF96100044
PM 1640537
DA 2018-10-20
ER

PT J
AU ANSELME, K
   PETITE, H
   HERBAGE, D
AF ANSELME, K
   PETITE, H
   HERBAGE, D
TI INHIBITION OF CALCIFICATION INVIVO BY ACYL AZIDE CROSS-LINKING OF A
   COLLAGEN-GLYCOSAMINOGLYCAN SPONGE
SO MATRIX
LA English
DT Article
DE ACYL AZIDE; COLLAGEN-BASED BIOMATERIALS; CROSS-LINKING; DYSTROPHIC
   CALCIFICATION; GLUTARALDEHYDE; GLYCOSAMINOGLYCAN
ID BOVINE PERICARDIUM; CONTROLLED RELEASE; HYALURONIC-ACID; ARTIFICIAL
   SKIN; CELLS; MINERALIZATION; SULFATE; FIBRONECTIN; BIOMATERIAL;
   PREVENTION
AB A collagen-glycosaminoglycan sponge composed of collagen (80%), chondroitin-4-sulfate (13.3%) and heparan sulfate (6.6%) was cross-linked using the acyl azide methode or glutaraldehyde (0.0075%). Under optimal conditions, the denaturation temperature (T(d)) was raised to 69-degrees-C (+ 23-degrees-C) for the sponge treated by the acyl azide method and to 68-degrees-C (+ 22-degrees-C) for that treated with glutaraldehyde. The biocompatibility of the treated and control sponges was studied up to 3 months after subcutaneous implantation in rats by analysing cellular responses and calcification by histological and ultrastructural methods. A control collagen-glycosaminoglycan sponge was rapidly invaded by mononuclear cells (8 days), with the formation of granulation tissue. Calcification was observed at the periphery of the implant after 8 days, and the implant was entirely calcified after 15 days; it was degraded progressively after 30 days. Acyl azide treatment increased the persistence of the sponge in vivo up to 90 days and inhibited its calcification. A glutaraldehyde-treated sponge was completely calcified after 15 days, and calcified nodules persisted after 90 days. Thus, acyl azide method efficiently cross-linked a collagen-glycosaminoglycan sponge and inhibited calcification after subcutaneous implantation in rats (at least up to 90 days after implantation).
RP ANSELME, K (reprint author), UNIV LYON 1,INST BIOL & CHIM PROT,CNRS,URA 412,CYTOL MOLEC LAB,F-69622 VILLEURBANNE,FRANCE.
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Anselme, Karine/0000-0002-6669-205X
CR ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605
   ANSELME K, 1990, TISSUE CELL, V22, P881
   BERTOLOTTO A, 1984, ELECTROPHORESIS, V5, P97, DOI 10.1002/elps.1150050207
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DOILLON CJ, 1988, BIOMATERIALS, V9, P91, DOI 10.1016/0142-9612(88)90077-4
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GLIMCHER MJ, 1968, TREATISE COLLAGEN  B, V2, P68
   JOHNSTON TP, 1990, INT J PHARM, V59, P95, DOI 10.1016/0378-5173(90)90083-G
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   LEVY RJ, 1986, AM J PATHOL, V122, P741
   MARTIN G, 1990, ACTUALITES BIOMATERI, P20
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MCPHERSON JM, 1986, J BIOMED MATER RES, V20, P79, DOI 10.1002/jbm.820200108
   MCPHERSON JM, 1988, COLLAGEN REL RES, V1, P83
   MURATA K, 1976, CONNECT TISSUE RES, V4, P131, DOI 10.3109/03008207609152208
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   OLIVER RF, 1980, BRIT J EXP PATHOL, V64, P544
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PRIVALOV PL, 1970, BIOPOLYMERS, V9, P127, DOI 10.1002/bip.1970.360090202
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   ROE SC, 1990, ARTIF ORGANS, V14, P443, DOI 10.1111/j.1525-1594.1990.tb03001.x
   ROUSSILLE G, 1991, J MATER SCI-MATER M, V2, P208, DOI 10.1007/BF00703372
   SABELMAN EE, 1985, BIOCOMPATIBILITY TIS, V1, P27
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SHAHABEDDIN L, 1990, Skin Pharmacology, V3, P107
   SILVER FH, 1978, THROMB RES, V13, P267, DOI 10.1016/0049-3848(78)90014-2
   UMEMURA Y, 1988, BIOMATERIALS, V9, P133, DOI 10.1016/0142-9612(88)90111-1
   URIST MR, 1966, ARCH PATHOL, V81, P325
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 39
TC 26
Z9 26
U1 1
U2 3
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8832
J9 MATRIX
JI Matrix
PD AUG
PY 1992
VL 12
IS 4
BP 264
EP 273
DI 10.1016/S0934-8832(11)80078-8
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JK670
UT WOS:A1992JK67000003
PM 1435510
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   CZIPERLE, DJ
   KIM, DU
   GARFIELD, JD
   PETSIKAS, D
   MURCHAN, PM
   APPLEGREN, EO
   DROHAN, W
   BURGESS, WH
AF GREISLER, HP
   CZIPERLE, DJ
   KIM, DU
   GARFIELD, JD
   PETSIKAS, D
   MURCHAN, PM
   APPLEGREN, EO
   DROHAN, W
   BURGESS, WH
TI ENHANCED ENDOTHELIALIZATION OF EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS
   BY FIBROBLAST GROWTH-FACTOR TYPE-1 PRETREATMENT
SO SURGERY
LA English
DT Article; Proceedings Paper
CT 53RD ANNUAL MEETING OF THE SOC OF UNIV SURGEONS
CY FEB 13-15, 1992
CL CINCINNATI, OH
SP SOC UNIV SURGEONS
ID SMOOTH-MUSCLE; PROSTHESES; MECHANISMS; EXPRESSION; RECEPTOR
AB Background. Biomaterial pretreatment with endothelial cell mitogens may enhance endothelialization.
   Methods. Modified fibrin glue (FG) containing 1 ng/cm2 recombinant I-125-labeled fibroblast growth factor type 1 (I-125-FGF-1), 20-mu-g/cm2 heparin, 2.86 mg/cm2 fibrinogen, and 2.86 X 10(-2) units/cm2 thrombin was pressure perfused into expanded polytetrafluoroethylene (ePTFE) grafts. Grafts were interposed into infrarenal aortas of 24 New Zealand white rabbits and explanted after 0, 5, 30, and 60 minutes and 1, 7, 14, and 30 days. Residual radioactivity was determined by gamma-counting. Remaining I-125-FGF-1 is expressed as percent of value at time 0. To determine the effect of the FG/FGF-1 on graft healing, three groups of 50 X 4 mm 60-mu-m internodal-distance nonreinforced ePTFE grafts were implanted in the aortoiliac position of 12 dogs. Group I (n = 12) contained the complete modified FG, group II (n = 6) contained FG with heparin but no FGF-1, and group III (n = 6) contained untreated identical ePTFE. Tritiated thymidine (0.5-mu-Ci/kg) was injected intramuscularly 10 hours before explantation after 7 and 28 days for light and electron microscopy and en face autoradiography.
   Results. Retention of I-125-FGF-1 showed rapid initial loss (DELTA-%/DELTA-min = -24.1) followed by slow loss after 1 hour (DELTA-%/DELTA-min = -0.03), with 13.4% +/- 6.9% remaining at 1 week and 3.8% +/- 1.1% at 30 days. Every FG/FGF-1 graft at 28 days showed extensive capillary ingrowth and confluent endothelialized luminal surfaces, not seen in any specimen of the other two groups. Autoradiography revealed a significant increase (p < 0.05) in H-3-thymidine incorporation in the FG/FGF-1 grafts at 28 days versus all groups as a function of time and graft treatment.
   Conclusions. Pressure perfusion of an FGF-1/FG suspension into 60-mu-m internodal-distance ePTFE grafts promotes endothelialization through capillary ingrowth and increased endothelial cell proliferation.
C1 VET ADM MED CTR,HINES,IL 60141.
   ST BARNABAS HOSP,LIVINGSTON,NJ 07039.
   AMER RED CROSS,ROCKVILLE,MD.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,ROOM 2675,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR BJORNSSON TD, 1991, P NATL ACAD SCI USA, V88, P8651, DOI 10.1073/pnas.88.19.8651
   BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129
   CLOWES AW, 1991, J VASC SURG, V13, P734
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   FRIESEL R, 1986, J BIOL CHEM, V261, P7581
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H P, 1986, ASAIO Trans, V32, P346
   Greisler H. P., 1991, NEW BIOL SYNTHETIC V
   GREISLER HP, 1991, SURGERY, V110, P645
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1990, J CARDIOVASC SURG, V31, P712
   GREISLER HP, 1987, J VASC SURG, V2, P393
   TAN EML, 1991, BIOCHEM J, V278, P863, DOI 10.1042/bj2780863
   WINKLES JA, 1991, BIOCHEM BIOPH RES CO, V180, P519, DOI 10.1016/S0006-291X(05)81095-2
NR 16
TC 110
Z9 110
U1 0
U2 2
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0039-6060
J9 SURGERY
JI Surgery
PD AUG
PY 1992
VL 112
IS 2
BP 244
EP 255
PG 12
WC Surgery
SC Surgery
GA JG451
UT WOS:A1992JG45100016
PM 1641764
DA 2018-10-20
ER

PT J
AU GROTH, T
   DERDAU, K
   STRIETZEL, F
   FOERSTER, F
   WOLF, H
AF GROTH, T
   DERDAU, K
   STRIETZEL, F
   FOERSTER, F
   WOLF, H
TI THE HEMOCOMPATIBILITY OF BIOMATERIALS INVITRO - INVESTIGATIONS ON THE
   MECHANISM OF THE WHOLE-BLOOD CLOT FORMATION TEST
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE BIOMATERIALS INVITRO HEMOCOMPATIBILITY; CLOT FORMATION TEST; PLATELETS;
   CONTACT ACTIVATION
ID ARTIFICIAL SURFACES; PLATELET; INHIBITORS
AB Twenty years ago Imai & Nose introduced a whole-blood clotting test for the estimation of haemocompatibility of biomaterials in vitro. In our paper, a modification of this assay is discribed and the mechanism of clot formation further elucidated. It was found that neither the inhibition of platelet function nor the removal of platelets from blood significantly changed the clot formation rate on glass and polyvinyl chloride in comparison to the rate for whole blood. Scanning electron microscopy demonstrated that platelets were not involved in clot formation near the blood/biomaterial interface. Thus, it was concluded that the system of contact activation of the coagulation cascade dominates during clot formation under static conditions. The latter conclusion was supported by the fact that preadsorption of human serum albumin or human fibrinogen onto the glass plates used, decreased the clot formation rate in the same manner.
RP GROTH, T (reprint author), HUMBOLDT UNIV,FACHBEREICH MED CHARITE,BIOMAT FORSCH & MED WERKSTOFFKUNDE ABT,O-1040 BERLIN,GERMANY.
OI Groth, Thomas/0000-0001-6647-9657
CR GROTH T, 1991, BIOMED TECH, V36, P322
   HARKER LA, 1986, J AM COLL CARDIOL, V8, pB21, DOI 10.1016/S0735-1097(86)80004-3
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   KARWATH R, 1989, STUD BIOPHYS, V131, P117
   KARWATH R, 1987, ADV BIOMATER, V7, P557
   KOMAI T, 1975, ARTIF ORGANS JPN, V4, P114
   PACKHAM MA, 1983, THROMB HAEMOSTASIS, V50, P610
   SCOTT CF, 1991, J BIOMAT SCI-POLYM E, V3, P173
   SILVERBERG M, 1987, ANN NY ACAD SCI, V516, P268
   STRIETZEL F, 1990, THESIS HUMBOLDT U BE
   WACHTFOGEL YT, 1987, ANN NY ACAD SCI, V516, P253
   WOLF H, 1987, ARTIF ORGANS, V11, P325
NR 12
TC 5
Z9 5
U1 0
U2 2
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM, NOTTS,
   ENGLAND NG1 4EE
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUL
PY 1992
VL 20
IS 3
BP 390
EP 395
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA JG146
UT WOS:A1992JG14600004
DA 2018-10-20
ER

PT J
AU CARDONA, MA
   SIMMONS, RL
   KAPLAN, SS
AF CARDONA, MA
   SIMMONS, RL
   KAPLAN, SS
TI TNF AND IL-1 GENERATION BY HUMAN MONOCYTES IN RESPONSE TO BIOMATERIALS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TUMOR NECROSIS FACTOR; INTERLEUKIN-1; MACROPHAGE; INVIVO; CELLS;
   IMMUNOFLUORESCENCE; BIOCOMPATIBILITY; INHIBITOR; INVITRO
AB The biocompatibility of surgically implanted materials may be compromised as a consequence of inflammatory reactions associated with phagocyte activation.  Two important mediators of the inflammatory response are Interleukin-1 (IL-1) and tumor necrosis factor (TNF), both of which exert a wide range of biologic effects on many cells.  This study was designed to evaluate the release of these cytokines by human monocytes (HM) brought into contact with four biomaterials utilized in clinical practice:  polyurethane, expanded polytetrafluorethylene (ePTFE), Dacron velour, and woven Dacron.  In vitro cultures for the generation of IL-1 and TNF by HM in the presence of the above biomaterials were established by exposing cells to each biomaterial in the presence and absence of lipopolysaccharide (LPS) with harvest of supernatants after 6 or 18 h.  These studies showed that in the absence of LPS, IL-1 was released only by Dacron velour and woven Dacron associated monocytes while TNF was secreted in response to all of the materials.  When LPS was present, however, monocytes associated with all of the materials released IL-1; and TNF release was greatly augmented.  Further, the quantity of released cytokine was directly related to the duration of the association time.  This study demonstrated that HM in association with various biomaterials were activated to produce both TNF and IL-1 and that the addition of nanogram quantities of LPS, such as would be produced if infection were present, greatly increased the amount of cytokines released.
C1 UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA 15261.
   UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261.
FU NIGMS NIH HHS [R01-GM-41734]
CR AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
   ANDERSON JE, 1991, POLITICAL EC INT TRA, P49
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BARKLEY D, 1989, J IMMUNOL METHODS, V120, P277, DOI 10.1016/0022-1759(89)90253-6
   BENTLEY C, 1981, LYMPHOKINES, V4, P197
   BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706
   CARTY TJ, 1989, AGENTS ACTIONS, V26, P391, DOI 10.1007/BF01967307
   CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3
   DECKER T, 1987, J IMMUNOL, V138, P957
   DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433
   HALME J, 1989, AM J OBSTET GYNECOL, V161, P1718, DOI 10.1016/0002-9378(89)90957-5
   HAMISH R, 1988, NEW ENGL J MED, V318, P1481
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HOFSLI E, 1989, CELL IMMUNOL, V122, P405, DOI 10.1016/0008-8749(89)90087-7
   IWAMOTO G, 1989, AM J PHYSIOL, V132, pC1012
   KAPLAN SS, IN PRESS J BIOMED MA
   KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   LARSON C, 1990, INFLAMMATION DIFFERE, P419
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   OFLAHERTY JT, 1991, J IMMUNOL, V147, P3842
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   RIBEIRO RA, 1991, IMMUNOLOGY, V73, P472
   Rosen J J, 1988, ASAIO Trans, V34, P163
   SCHUR PH, 1990, CLIN IMMUNOL IMMUNOP, V57, P45, DOI 10.1016/0090-1229(90)90021-H
   SHALDON S, 1987, LIFE SUPPORT SYST, V5, P341
   YUO A, 1991, BLOOD, V78, P2708
   ZIFF M, 1988, ADV INFLAMMAT RES, V12, P1
NR 34
TC 74
Z9 74
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 851
EP 859
DI 10.1002/jbm.820260703
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200002
PM 1535076
DA 2018-10-20
ER

PT J
AU STEELE, JG
   JOHNSON, G
   UNDERWOOD, PA
AF STEELE, JG
   JOHNSON, G
   UNDERWOOD, PA
TI ROLE OF SERUM VITRONECTIN AND FIBRONECTIN IN ADHESION OF FIBROBLASTS
   FOLLOWING SEEDING ONTO TISSUE-CULTURE POLYSTYRENE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID HUMAN-ENDOTHELIAL CELLS; RADIOFREQUENCY PLASMA DEPOSITION; SPREADING
   FACTOR; ADSORPTION; ATTACHMENT; SURFACES; PROTEINS; COLLAGEN;
   ENHANCEMENT; COPOLYMERS
AB The suitability of polymeric biomaterials as surfaces for the attachment and growth of cells has often been investigated in tissue culture.  In this study the contribution that adsorption of serum fibronectin (Fn) or vitronectin (Vn) make to the attachment and spreading of fibroblast cells during the first 90 min following seeding was determined for two modified tissue culture polystyrenes, as model biomaterial surfaces.  The amount of serum Vn and Fn which adsorbed onto tissue culture grade polystyrene (TCP) from different serum concentrations over the range of 0.1-30% (v/v) were determined and compared to attachment of cells of the BHK-21 and HT1080 fibroblast lines.  There was no simple correlation between the amount of Fn or the amount of Vn adsorbed and cell attachment and spreading.  The requirement for Fn or Vn for attachment and spreading of BHK-21 or HT1080 cells onto modified polystyrene (either TCP or to Primaria) during the first 90 min of cell culture was directly tested by selective removal of Fn or Vn from the serum prior to addition to the culture medium.  Attachment and spreading of BHK-21 or HT1080 cells onto TCP or Primaria surfaces were reduced in a concentration-dependent manner when the cells were seeded in medium containing 2% (v/v) or higher concentrations of Vn-depleted serum.  BHK-21 cells or HT1080 cells seeded in medium containing Fn-depleted serum (which contained Vn) attached and spread onto TCP or Primaria.  Both BHK-21 cells and HT1080 cells failed to attach to TCP or Primaria when seeded in medium containing serum depleted of both Vn and Fn.  The requirement for serum Vn or Fn for fibroblast attachment to TCP was also tested using cells of a human dermal fibroblast strain.  The attachment of the dermal fibroblasts to TCP during the first 90 min of culture was not decreased by depletion of Vn from the 15% (v/v) serum, but there was a reduction in the proportion of the attached cells which had spread.  Selective depletion of serum Fn did not have any effect on either cell attachment or spreading.  Our results show that for fibroblast cells, particularly with cell lines such as BHK-21 or HT1080 but also with cell strains, the first binding of cells onto tissue culture polystyrene when plated in medium containing serum is a result of adsorption onto the surface of serum Vn.  The adsorption of serum Vn onto the surface overcomes the effect of serum components which tend to decrease cell attachment.
RP STEELE, JG (reprint author), CSIRO,DIV BIOMOLEC ENGN,MOLEC BIOL LAB,POB 184,N RYDE,NSW 2113,AUSTRALIA.
CR BALE MD, 1989, BLOOD, V74, P2698
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   CINATL J, 1990, IN VITRO CELL DEV B, V26, P841
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1983, J CELL PHYSIOL, V116, P289, DOI 10.1002/jcp.1041160305
   GRINNELL F, 1981, J CELL SCI, V48, P19
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   KNOX P, 1980, J CELL SCI, V46, P97
   KNOX P, 1984, J CELL SCI, V71, P51
   LAUG WE, 1985, THROMB HAEMOSTASIS, V54, P498
   LYDON MJ, 1988, BIOMATERIALS, V9, P525, DOI 10.1016/0142-9612(88)90049-X
   MATSUDA T, 1974, J POLYM SCI POL CHEM, V12, P489, DOI 10.1002/pol.1974.170120301
   NORRIS WD, 1990, J CELL SCI, V95, P255
   PITT WG, 1989, J COLLOID INTERF SCI, V129, P231, DOI 10.1016/0021-9797(89)90435-9
   PREISSNER KT, 1988, BLOOD, V71, P1581
   SHAFFER MC, 1984, J LAB CLIN MED, V103, P783
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   STENN KS, 1987, J INVEST DERMATOL, V89, P59, DOI 10.1111/1523-1747.ep12580392
   UNDERWOOD PA, 1991, J IMMUNOL METHODS, V142, P83, DOI 10.1016/0022-1759(91)90295-Q
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P79, DOI 10.1002/jcb.240280202
NR 32
TC 135
Z9 135
U1 1
U2 18
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 861
EP 884
DI 10.1002/jbm.820260704
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200003
PM 1376730
DA 2018-10-20
ER

PT J
AU SMITH, BAH
   SEFTON, MV
AF SMITH, BAH
   SEFTON, MV
TI THROMBIN AND ALBUMIN ADSORPTION TO PVA AND HEPARIN-PVA HYDROGELS .1.
   SINGLE PROTEIN ISOTHERMS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ANTITHROMBIN-III; BIOMATERIAL
AB More radiolabeled thrombin was adsorbed to heparin-polyvinyl alcohol (PVA) than to PVA, consistent with a specific interaction with the immobilized heparin.  The maximum surface concentration on heparin-PVA was estimated to be approximately 450 nmol/m2 with an apparent affinity constant (K(a)) of 2.5-mu-M-1; on PVA, the plateau concentration was 10 nmol/m2 with a K(a) < 1 nM-1.  There was little difference in bovine serum albumin (BSA) adsorption between PVA and heparin-PVA.  Interestingly, thrombin adsorption to polyethylene was indistinguishable from that to PVA despite the large difference in surface chemistry.  BSA adsorbed to polyethylene with higher affinity than to the hydrogels, although the plateau concentrations were comparable.  The adsorbed thrombin was biologically inactive at least towards chromogenic substrate, with the residual activity on PVA unaffected by subsequent incubations with antithrombin III.  PVA and heparin-PVA presented a heterogeneous and complex substrate for interaction with proteins.  The adsorbed protein was likely present in multiple states depending on the groups with which it interacted.
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A4,ONTARIO,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO M5S 1A4,ONTARIO,CANADA.
FU NHLBI NIH HHS [HL24020]
CR BASMADJIAN D, 1983, J BIOMED MATER RES, V17, P509, DOI 10.1002/jbm.820170310
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   BRASH JL, 1974, T AM SOC ART INT ORG, VA 20, P69
   CHUANG HYK, 1979, THROMB RES, V14, P273, DOI 10.1016/0049-3848(79)90237-8
   FOUGNOT C, POLYM MED BIOMEDICAL, P261
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HATTON MWC, 1983, THROMB HAEMOSTASIS, V50, P873
   IP WF, 1985, J BIOMED MATER RES, V19, P161, DOI 10.1002/jbm.820190206
   ROLLASON G, 1989, Journal of Biomaterials Science Polymer Edition, V1, P31, DOI 10.1163/156856289X00046
   SMITH BA, UNPUB THROMBIN ALBUM, V2
   SMITH BAH, 1988, J BIOMED MATER RES, V22, P673, DOI 10.1002/jbm.820220802
   WAIEWSKI WG, 1976, THRMB RES, V8, P881
   WAUGH DF, 1975, J BIOMED MATER RES, V9, P511, DOI 10.1002/jbm.820090513
NR 13
TC 9
Z9 9
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 947
EP 958
DI 10.1002/jbm.820260709
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200008
PM 1607375
DA 2018-10-20
ER

PT J
AU GOLOMB, G
AF GOLOMB, G
TI CALCIFICATION OF POLYURETHANE-BASED BIOMATERIALS IMPLANTED
   SUBCUTANEOUSLY IN RATS - ROLE OF POROSITY AND FLUID ABSORPTION IN THE
   MECHANISM OF MINERALIZATION
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HEART-VALVE CALCIFICATION; BIOPROSTHESES; PREVENTION
AB The object of this study was to investigate the mineralization of polyurethane in the rat subcutaneous environment, in comparison to collageneous biomaterials, which would facilitate investigation of the calcification mechanism in implantable biomaterials. This model was compared to an in vitro model of non-spontaneous formation of calcium phosphate precipitate. To study the role of porosity/fluid absorption capacity, various biomaterials such as polyurethane, hydrophilic polyurethane foam, Type I collagen sponges, and bioprosthetic heart valve tissue were examined in in vitro and in vivo models. In view of the exceedingly low levels of polyurethane calcification, it seems that the rat subcutaneous model is not suitable for routine studies of the mechanism of polyurethane calcification. The calcification extent of both collageneous and hydrophilic polyurethane, was found to be in good correlation with the water absorption capacity of these biomaterials. It is suggested that the water capacity of the biomaterial determines the bulk level of calcification, which in turn is generated and propagates via the inherent affinity sites of the biomaterial to Ca2+.
RP GOLOMB, G (reprint author), HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,POB 12065,IL-91120 JERUSALEM,ISRAEL.
OI Golomb, Gershon/0000-0002-7369-9831
CR ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341
   BOSKEY AL, 1977, CALC TISS RES, V23, P251, DOI 10.1007/BF02012794
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COLEMAN DL, 1985, CALCIUM BIOL SYSTEMS, P661
   CUMMING RD, 1985, DEVICES TECHNOLOGY B, P104
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FISHBEIN MC, 1982, J THORAC CARDIOV SUR, V83, P602
   GLIMCHER MJ, 1976, HDB PHYSIOLOGY     7, V7, P25
   GOFFIN YA, 1986, BIOL BIOPROSTHETIC V, P405
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   Harasaki H, 1985, Trans Am Soc Artif Intern Organs, V31, P489
   HARASAKI H, 1980, J THORAC CARDIOV SUR, V79, P125
   HARASAKI H, 1987, T AM SOC ART INT ORG, V33, P643
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   ISHIHARA T, 1982, J THORAC CARDIOV SUR, V83, P399
   KRONMAN JH, 1979, BIOMATER ARTIF CELL, V7, P299, DOI 10.3109/10731197909117585
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   LIAN JB, 1981, T AM SOC ART INT ORG, V27, P683
   MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4
   POLLOCK E, 1981, T AM SOC ART INT ORG, V27, P405
   Ratner B. D., 1983, PHYSICOCHEMICAL ASPE, P969
   Schoen F J, 1987, J Card Surg, V2, P65, DOI 10.1111/j.1540-8191.1987.tb00174.x
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SCHOEN FJ, 1989, INTERVENTIONAL SURGI, P41
   SCHOEN FJ, 1986, AM J PATHOL, V123, P143
   SINGH PI, 1984, CONTRACTORS M NHLBI, P78
   STRATES BS, 1957, J PHYS CHEM-US, V61, P279, DOI 10.1021/j150549a005
   Thoma R J, 1987, J Biomater Appl, V1, P449
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   THOMA RJ, 1987, J BIOMED MATER RES, V21, P525, DOI 10.1002/jbm.820210411
   THOMA RJ, 1987, T SOC BIOMATER, V10, P245
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TSAO JW, 1987, T SOC BIOMATER, V10, P180
   URRY DW, 1976, BIOCHEMISTRY-US, V15, P4089, DOI 10.1021/bi00663a027
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WESOLOWSKI SA, 1963, SURGERY, V53, P19
   WHALEM RL, 1980, T AM SOC ART INT ORG, V24, P487
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
NR 49
TC 16
Z9 16
U1 1
U2 7
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 1992
VL 3
IS 4
BP 272
EP 277
DI 10.1007/BF00705292
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD706
UT WOS:A1992JD70600007
DA 2018-10-20
ER

PT J
AU BERNACCA, GM
   FISHER, AC
   MACKAY, TG
   WHEATLEY, DJ
AF BERNACCA, GM
   FISHER, AC
   MACKAY, TG
   WHEATLEY, DJ
TI A DYNAMIC INVITRO METHOD FOR STUDYING BIOPROSTHETIC HEART-VALVE
   CALCIFICATION
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FAILURE; CUSPS
AB The most predictable cause of failure of a biological prosthetic heart valve is calcification. The deposition process appears to be related both to the biomaterial composition and to the presence of dynamic stresses in the leaflets. A dynamic in vitro test has been developed to investigate the calcification process. The test apparatus consists of a modified Rowan Ash fatigue tester with the test fluid maintained at 37-degrees-C. Six valves can be tested simultaneously under similar physical conditions, but with individual incubation media. The valves tested were glutaraldehyde-fixed bovine pericardial valves (the Glasgow Heart Valve). These have been tested in a range of different simple salt solutions containing approximately physiological concentrations of calcium and phosphate. Calcification has been analysed by assay of the incubation media for depletion of calcium and phosphate and direct measurement of uptake of calcium by the valves. There is a wide variability among pericardial valves treated similarly. This may be related to the variability in calcification rate seen in patients with valve implants.
C1 GLASGOW ROYAL INFIRM,DEPT CARDIAC SURG,GLASGOW G4 0SF,SCOTLAND.
RP BERNACCA, GM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,GLASGOW G1 1XW,SCOTLAND.
CR ADAMIC R J, 1988, Journal of Colloid and Interface Science, V124, P111, DOI 10.1016/0021-9797(88)90331-1
   ANDERSON HC, 1981, T AM SOC ART INT ORG, V27, P702
   CASTANEDA AR, 1982, CARDIAC BIOPROSTHESE, P205
   DECK JD, 1982, CARDIAC BIOPROSTHESE, P293
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   Fisher J, 1987, Eur J Cardiothorac Surg, V1, P71, DOI 10.1016/1010-7940(87)90015-7
   GABBAY S, 1986, T AM SOC ART INT ORG, V32, P282
   GLASMACHER B, 1987, POLYURETHANES BIOMED, V2, P151
   HARASAKI H, 1987, T AM SOC ART INT ORG, V32, P643
   Jones M, 1989, J Card Surg, V4, P69, DOI 10.1111/j.1540-8191.1989.tb00258.x
   LEVY RJ, 1983, AM J CARDIOL, V52, P629, DOI 10.1016/0002-9149(83)90040-1
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LONG MM, 1981, T AM SOC ART INT ORG, V27, P690
   NISTAL F, 1990, J THORAC CARDIOV SUR, V99, P1074
   NISTAL F, 1986, AM J CARDIOL, V57, P161, DOI 10.1016/0002-9149(86)90972-0
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   REUL GJ, 1985, J VASC SURG, V2, P192
   RUSSELL RGG, 1984, METABOLIC BONE STONE, P344
   SABBAH HN, 1985, AM J CARDIOL, V55, P1091, DOI 10.1016/0002-9149(85)90752-0
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   VARLEY H, 1980, PRACTICAL CLIN BIOCH, V1, P850
   VILLANI M, 1982, CARDIAC BIOPROSTHESI, P248
   WADKINS CL, 1978, CALC TISS RES, V26, P51, DOI 10.1007/BF02013234
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
   WOUTERS LHG, 1987, POLYURETHANES BIOMED, V2, P169
NR 27
TC 18
Z9 18
U1 1
U2 6
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 1992
VL 3
IS 4
BP 293
EP 298
DI 10.1007/BF00705296
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD706
UT WOS:A1992JD70600011
DA 2018-10-20
ER

PT J
AU WOLF, RFE
   LAM, KH
   MOOYAART, EL
   BLEICHRODT, RP
   NIEUWENHUIS, P
   SCHAKENRAAD, JM
AF WOLF, RFE
   LAM, KH
   MOOYAART, EL
   BLEICHRODT, RP
   NIEUWENHUIS, P
   SCHAKENRAAD, JM
TI MAGNETIC-RESONANCE-IMAGING USING A CLINICAL WHOLE-BODY SYSTEM - AN
   INTRODUCTION TO A USEFUL TECHNIQUE IN SMALL ANIMAL-EXPERIMENTS
SO LABORATORY ANIMALS
LA English
DT Article
DE MAGNETIC RESONANCE IMAGING; ANIMAL; RAT; INVIVO; ANIMAL SAVING
AB A clinical whole body magnetic resonance imaging (MRI) system with high resolution coils was used to obtain non-invasive images of the living rat. The results demonstrate the feasibility of the set-up and the advantages of this new imaging technique: detailed information, no extra costs, longitudinal studies without killing animals and simple anaesthesia. It is concluded that in small animal experimentation, this use of high resolution coils in whole body magnetic resonance systems may be particularly helpful in establishing effects of experimental procedures. Whenever non-invasive visualization is required, especially in longitudinal animal studies, e.g. biomaterial research or tumour investigation, this use of MRI will offer challenging possibilities.
C1 UNIV GRONINGEN, FAC MED, DEPT HISTOL & CELL BIOL, OOSTERSINGEL 69-1, 9713 EZ GRONINGEN, NETHERLANDS.
   UNIV GRONINGEN HOSP, DEPT MAGNET RESONANCE, 9700 RB GRONINGEN, NETHERLANDS.
   UNIV GRONINGEN, FAC MED, DEPT SURG, 9700 RB GRONINGEN, NETHERLANDS.
   UNIV GRONINGEN, FAC MED, CTR BIOMED TECHNOL, 9700 RB GRONINGEN, NETHERLANDS.
CR ALLEGRINI PR, 1990, LAB INVEST, V63, P568
   Brady T.J., 1991, 10 ANN M SOC MAGN RE, P2
   BULTE JWM, 1992, MAGNET RESON MED, V23, P215, DOI 10.1002/mrm.1910230203
   Bushong S. C., 1988, MAGNETIC RESONANCE I
   Hebel R., 1976, ANATOMY LABORATORY R
   LEE R, 1989, SMALL ANIMAL PRACTIC
   MOONEN CTW, 1990, SCIENCE, V250, P53, DOI 10.1126/science.2218514
   RUDIN M, 1988, MAGNET RESON MED, V7, P285, DOI 10.1002/mrm.1910070305
   RUSSEL WMS, 1959, PRINCIPLES HUMAN EXP
   SECRIST RD, 1989, MAGN RESON IMAGING, V7, P149, DOI 10.1016/0730-725X(89)90698-X
NR 10
TC 13
Z9 13
U1 0
U2 0
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD JUL
PY 1992
VL 26
IS 3
BP 222
EP 227
DI 10.1258/002367792780740495
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC833
UT WOS:A1992JC83300012
PM 1501439
DA 2018-10-20
ER

PT J
AU EMCH, R
   ZENHAUSERN, F
   JOBIN, M
   TABORELLI, M
   DESCOUTS, P
AF EMCH, R
   ZENHAUSERN, F
   JOBIN, M
   TABORELLI, M
   DESCOUTS, P
TI MORPHOLOGICAL DIFFERENCE BETWEEN FIBRONECTIN SPRAYED ON MICA AND ON PMMA
SO ULTRAMICROSCOPY
LA English
DT Article
ID ADSORPTION; SURFACES
AB We have imaged with scanning force microscopy in air fibronectin (Fn) molecules sprayed on mica and on polymethylmetacrylate (PMMA), the latter being extensively used as biomaterial for implants. On mica we can observe small aggregates as well as individual molecules whose shape is influenced by the tip interaction during the scanning process, most of the isolated molecules showing a V-shape oriented in the scan direction. This indicates that the arms of the molecules are relatively free to move and the binding to the mica substrate is located near the disulfide bridge between the two subunits of the molecule. On the other side, when Fn molecules are sprayed on PMMA under the same conditions as for mica, we observe a thin network which we interpret as Fn molecules bound to each other. We relate our observation to the fact that mica is known to be strongly hydrophilic, which could reduce the Fn binding properties by interacting relatively strongly with molecules. On the other side, PMMA being hydrophobic, would interact less with molecules, leaving more binding sites for inter-molecular attachment.
RP EMCH, R (reprint author), UNIV GENEVA,PHYS APPL GRP,20 RUE ECOLE MED,CH-1211 GENEVA 4,SWITZERLAND.
CR EMCH R, 1990, J VAC SCI TECHNOL A, V8, P655, DOI 10.1116/1.576366
   GOELANDER CG, 1990, COLLOID SURF, V50, P113
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   IWAMOTO GK, 1985, J COLLOID INTERF SCI, V106, P459, DOI 10.1016/S0021-9797(85)80020-5
   MURTHY KD, 1987, SCANNING MICROSCOPY, V1, P765
   PROCTOR RA, 1987, REV INFECT DIS S4, V9, P317
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1990, ADV BIOMAT, V9, P31
   WATKINS RW, 1977, J BIOMED MATER RES, V11, P915, DOI 10.1002/jbm.820110611
   ZENHAUSERN F, 1992, ULTRAMICROSCOPY, V42, P1167
NR 12
TC 28
Z9 28
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD JUL
PY 1992
VL 42
BP 1155
EP 1160
DI 10.1016/0304-3991(92)90417-I
PN B
PG 6
WC Microscopy
SC Microscopy
GA JM423
UT WOS:A1992JM42300032
PM 1413252
DA 2018-10-20
ER

PT J
AU CHEN, G
   VANDERDOES, L
   BANTJES, A
AF CHEN, G
   VANDERDOES, L
   BANTJES, A
TI INVESTIGATIONS ON VINYLENE CARBONATE .4. RADIATION-INDUCED
   GRAFT-COPOLYMERIZATION OF VINYLENE CARBONATE AND
   N-VINYL-N-METHYLACETAMIDE ONTO POLYETHYLENE FILMS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID METHYL-METHACRYLATE; BIOMATERIAL APPLICATIONS; CELLULOSE-ACETATE;
   POLYMERS; STYRENE; ACRYLAMIDE; MONOMERS; MIXTURES; SOLVENTS; SURFACE
AB Graft copolymerization of binary mixtures of vinylene carbonate (VCA) and N-vinyl N-methylacetamide (VIMA) onto low density polyethylene (LDPE) films was studied by the mutual gamma-irradiation technique. Sufficient amounts of functionally active VCA groups could be grafted onto the surface and the hydrophilicity of the surface was also improved. The grafting of VCA onto polyethylene films in the binary solutions was found to be promoted by the presence of VIMA, thus showing a positive synergism. The VCA content in the graft copolymers was always higher than in the copolymers obtained by homogeneous copolymerization using the same monomer feed composition. The monomer reactivity ratios, as well as a preferential partitioning of the monomers surrounding the polymeric substrate, were considered to explain the grafting reactions in the binary systems.
RP CHEN, G (reprint author), TWENTE UNIV TECHNOL,DEPT CHEM TECHNOL,BIOMAT SECT,POB 217,7500 AE ENSCHEDE,NETHERLANDS.
CR ALLMER K, 1990, J POLYM SCI POL CHEM, V28, P173, DOI 10.1002/pola.1990.080280112
   ANBAR M, 1967, INT J APPL RADIAT IS, V18, P493, DOI 10.1016/0020-708X(67)90115-9
   Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BHATTACHARYYA SN, 1982, J POLYM SCI POL CHEM, V20, P939, DOI 10.1002/pol.1982.170200404
   BHATTACHARYYA SN, 1986, J POLYM SCI POL CHEM, V24, P2507, DOI 10.1002/pola.1986.080241011
   CHEN G, 1991, J APPL POLYM SCI APP, V48, P545
   CHEN G, UNPUB
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   DAVIS TP, 1990, POLYM COMMUN, V31, P442
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   FENG XD, 1985, POLYM J, V17, P189, DOI 10.1295/polymj.17.189
   FISCHER JP, 1979, J POLYM SCI POLYM S, V66, P443
   GERMAN AL, COMMUNICATION
   HARRIS JA, 1970, J APPL POLYM SCI, V14, P3113, DOI 10.1002/app.1970.070141214
   HARWOOD HJ, 1987, MAKROMOL CHEM-M SYMP, V10, P331, DOI 10.1002/masy.19870100117
   HEBEISH A, 1982, J APPL POLYM SCI, V27, P197, DOI 10.1002/app.1982.070270121
   HEGAZY ESA, 1990, J APPL POLYM SCI, V39, P1029, DOI 10.1002/app.1990.070390502
   HOFFMAN AS, 1981, RADIAT PHYS CHEM, V18, P323, DOI 10.1016/0146-5724(81)90085-6
   HSIUE GH, 1990, ANGEW MAKROMOL CHEM, V179, P149, DOI 10.1002/apmc.1990.051790111
   HUEMER H, 1977, Patent No. 2552510
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   JANSEN B, 1986, MAKROMOL CHEM-M SYMP, V5, P237, DOI 10.1002/masy.19860050122
   JANSEN B, 1979, J POLYM SCI PS, V66, P465
   KAELBLE D, 1976, 1ST P CLEV S MACR PR
   KELEN T, 1975, J MACROMOL SCI CHEM, VA  9, P1, DOI 10.1080/00222337508068644
   KING RN, 1985, J COLLOID INTERF SCI, V103, P62, DOI 10.1016/0021-9797(85)90077-3
   KOVACS G, 1982, IUPAC MACROMOL S, V28, P396
   LAWRENCE KDN, 1973, J APPL POLYM SCI, V17, P2658
   LEE HB, 1972, POLYM PREPR, V13, P729
   LOKHANDE HT, 1984, J APPL POLYM SCI, V29, P1843, DOI 10.1002/app.1984.070290535
   MAUZ O, 1984, ANN NY ACAD SCI, V434, P251, DOI 10.1111/j.1749-6632.1984.tb29836.x
   MAUZ O, 1982, Patent No. 3243591
   MULLERSCHULTE D, 1982, POLYM BULL, V7, P77
   ODIAN G, 1971, J POLYM SCI A1, V9, P91, DOI 10.1002/pol.1971.150090108
   ODIAN G, 1961, J POLYM SCI, V54, P159
   PARK KY, 1989, EUR POLYM J, V25, P651, DOI 10.1016/0014-3057(89)90024-4
   PLOCHOCKA K, 1978, AM CHEM SOC DIV POLY, V19, P240
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   SANKHOLKAR S, 1990, J APPL POLYM SCI, V39, P1681, DOI 10.1002/app.1990.070390806
   Sasaki T., 1976, ACS SYM SER, V31, P283
   黄家贤, 1990, Chinese Journal of Polymer Science, V8, P197
   TIJSMA EJ, 1990, MAKROMOL CHEM-RAPID, V11, P501
   WILSON JE, 1981, POLYM-PLAST TECHNOL, V16, P119, DOI 10.1080/03602558108067692
NR 46
TC 9
Z9 9
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 1992
VL 45
IS 5
BP 853
EP 864
DI 10.1002/app.1992.070450512
PG 12
WC Polymer Science
SC Polymer Science
GA HV698
UT WOS:A1992HV69800012
DA 2018-10-20
ER

PT J
AU IYENGAR, V
AF IYENGAR, V
TI EMERGING CONCEPTS IN BIOANALYTICAL CHEMISTRY OF TRACE-ELEMENTS
SO ANALYTICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT JOINT AND SATELLITE KITAMI CONF OF THE 1991 INTERNATIONAL CONGRESS ON
   ANALYTICAL SCIENCES ( ICAS 91 )
CY SEP 02-04, 1991
CL KITAMI, JAPAN
SP INT UNION PURE & APPL CHEM
DE BIOLOGICAL TRACE ELEMENT RESEARCH; BIOLOGICAL STANDARDIZATION;
   ANALYTICAL STANDARDIZATION; MULTIDISCIPLINAL APPROACH; PRESERVATION;
   STORAGE; PRESAMPLING FACTOR; POSTMORTEM CHANGE; INTERNAL CONTAMINATION
ID BOTANICAL REFERENCE MATERIALS
AB The emerging discipline of Biological Trace Element Research (BTER) demands that adequate considerations be given to both biological and analytical standardization while planning an investigation. Unfortunately, the "bio" dimension of the analytical problem in the BTER area, has been rather slow in unfolding. This lack of appreciation has been a major setback since the early days of BTER, delaying the onset of multidisciplinary approaches that are vital for conceiving meaningful investigations. The presampling factors e.g., biological variations, environmental influences, post-mortem changes and intrinsic (e.g. differences in residence times of various elements in the blood stream) and inadvertent situations (e.g. medico-legal restrictions), are potential sources of serious errors, and require careful evaluation and data interpretation,   Yet, these are poorly identified and currently, very little effort is expended to evaluate them. Concerning analytical standardization, progress in technical aspects of sampling are preparation, instrumentation, calibration procedures, increased awareness of matrix interferences and preparation of primary standards have collectively contributed to several improvements. However, information on long-term storage (several years) and its impact on the validity of the stored biomaterial, and experimental findings on the quantitative recovery of biominerals during acid decomposition of different types of sample matrices are still scarce.
RP IYENGAR, V (reprint author), NATL INST STAND & TECHNOL,INT HUMAN NUTR PROJECT,BLDG 235,RM B125,GAITHERSBURG,MD 20899, USA.
CR BRAODHEAD GD, 1965, BRIT MED J, V1, P343
   DAHL K, 1990, FRESEN J ANAL CHEM, V338, P526, DOI 10.1007/BF00322530
   GHELBERG NW, 1979, P MANAGEMENT HEAVY M, P163
   GREENBERG RR, 1990, FRESEN J ANAL CHEM, V338, P394, DOI 10.1007/BF00322502
   IYENGAR GV, 1981, J PATHOL, V134, P173, DOI 10.1002/path.1711340302
   IYENGAR GV, 1986, TRACE ELEM MED, V3, P25
   IYENGAR GV, 1980, SCI TOTAL ENVIRON, V15, P217, DOI 10.1016/0048-9697(80)90051-0
   IYENGAR GV, 1991, SCI TOTAL ENVIRON, V100, P1, DOI 10.1016/0048-9697(91)90370-T
   IYENGAR GV, 1989, ELEMENTAL ANAL BIOL, V1
   IYENGAR GV, 1982, ANAL CHEM, V54, pA554
   IYENGAR V, 1988, CLIN CHEM, V34, P474
   KARTHA KK, 1985, CRYOPRESERVATION PLA
   KASPEREK K, 1981, SCI TOTAL ENVIRON, V17, P133, DOI 10.1016/0048-9697(81)90179-0
   KASPEREK K, 1977, EUR J PEDIATR, V126, P199, DOI 10.1007/BF00477045
   KASPEREK K, 1972, P IAEA S NUCLEAR ACT, P517
   LINDSTROM RM, 1990, FRESEN J ANAL CHEM, V338, P569, DOI 10.1007/BF00322541
   MERTZ W, 1975, CLIN CHEM, V21, P468
   Muramatsu Y, 1983, HOKEN BUTSURI, V18, P113
   PARR RM, 1991, BIOL TRACE ELE RES, V29, P52
   PERSIGEHL M, 1976, BEITR PATHOL, V157, P260, DOI 10.1016/S0005-8165(76)80086-8
   STOEPPLER M, 1982, TALANTA, V29, P963, DOI 10.1016/0039-9140(82)80237-3
   Stoeppler M., 1985, P281
   SUBRAMANIAN KS, 1990, ACS S, V445
   TURLE R, 1988, NBS SPEC PUBL, V740, P171
   VANEIJK HG, 1974, CLIN CHIM ACTA, V50, P278
   WISE SA, 1989, INT J ENVIRON AN CH, V37, P91, DOI 10.1080/03067318908026889
   ZEISLER R, 1988, FRESEN Z ANAL CHEM, V332, P612, DOI 10.1007/BF00472652
   1991, MONITORING HUMAN TIS
NR 28
TC 4
Z9 4
U1 0
U2 0
PU JAPAN SOC ANALYTICAL CHEM
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PD JUN
PY 1992
VL 8
IS 3
BP 399
EP 404
DI 10.2116/analsci.8.399
PG 6
WC Chemistry, Analytical
SC Chemistry
GA HY446
UT WOS:A1992HY44600025
OA Bronze
DA 2018-10-20
ER

PT J
AU JOHNSON, PC
   GARRETT, KO
   BRASH, JL
   CORNELIUS, RM
   KAPLAN, SS
   WARTY, V
AF JOHNSON, PC
   GARRETT, KO
   BRASH, JL
   CORNELIUS, RM
   KAPLAN, SS
   WARTY, V
TI DELIVERY OF PASSIVATING PROTEINS TO SUTURES DURING PASSAGE THROUGH THE
   VESSEL WALL REDUCES SUBSEQUENT PLATELET DEPOSITION BY BLOCKING
   FIBRINOGEN ADSORPTION
SO ARTERIOSCLEROSIS AND THROMBOSIS
LA English
DT Article
DE BIOMATERIALS; PLATELETS; MICROSURGERY; VASCULAR ANASTOMOSIS;
   SUBENDOTHELIUM
ID MICROVASCULAR SURGERY; THROMBUS FORMATION; FOREIGN SURFACES; PLASMA;
   POLYETHYLENE; ANASTOMOSES; STRATEGIES; HEMOGLOBIN; TRAUMA
AB Intraluminal vascular suture material, which attracts fewer than the expected number of platelets compared with the same biomaterial exposed to blood in vitro, differs from the untreated biomaterial in that it has been passed once through the vessel wall. The mechanism by which this apparently trivial maneuver reduces platelet deposition was investigated. Polypropylene suture (7-0 Prolene) was passed through human arteries (fetal and adult), and platelet deposition to the suture was measured in a standardized perfusion chamber. Single vessel passage of the sutures reduced platelet deposition by 68+/-23%, which contrasts sharply with the power of prostaglandin E1 (1-mu-M PGE1 is sufficient to abolish platelet shape change and aggregation), which inhibited only 11% of platelet deposition to the sutures. Aspirin treatment of the vessel (to prevent PGI2 formation) or endothelial stripping (to remove the ability to produce nitric oxide) had no effect on the degree of inhibition. Passage of the suture through a vessel analogue (expanded polytetrafluoroethylene) did not inhibit platelet deposition. I-125-fibrinogen adsorption to the suture after vessel passage was reduced to a degree similar to that of platelet deposition. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins eluted from vessel-passed sutures revealed bands at 66, 47, and 16 kd. Western blotting indicated the presence of large amounts of albumin and hemoglobin, a moderate amount of haptoglobin, and only trace amounts of fibrinogen. When sutures were exposed to each of these proteins in vitro before perfusion, albumin and hemoglobin were found to reproduce the effect of vessel passage alone on platelet deposition. We conclude that albumin and hemoglobin adsorb to sutures during their passage through the vessel subendothelium. This reduces the subsequent adsorption of fibrinogen from blood, thereby reducing the ability of platelets to attach to the suture.
C1 UNIV PITTSBURGH, SCH MED, DEPT SURG, PITTSBURGH, PA 15261 USA.
   UNIV PITTSBURGH, SCH MED, DEPT PATHOL, PITTSBURGH, PA 15261 USA.
   MCMASTER UNIV, DEPT CHEM ENGN, HAMILTON L8S 4L8, ONTARIO, CANADA.
RP JOHNSON, PC (reprint author), UNIV PITTSBURGH, DIV PLAST & RECONSTRUCT SURG, 676 SCAIFE HALL, PITTSBURGH, PA 15261 USA.
FU NHLBI NIH HHS [R29 HL-45891]
CR ACLAND R, 1973, SURGERY, V73, P766
   ACLAND RD, 1980, PLAST RECONSTR SURG, V65, P460, DOI 10.1097/00006534-198004000-00010
   ACLAND RD, 1977, PLAST RECONSTR SURG, V60, P868, DOI 10.1097/00006534-197712000-00004
   ACLAND RD, 1989, PLAST RECONSTR SURG, V84, P280, DOI 10.1097/00006534-198908000-00015
   ADAMS PC, 1987, AM J CARDIOL, V60, pG9, DOI 10.1016/0002-9149(87)90586-8
   BENTZ ML, 1991, PLAST RECONSTR SURG, V88, P851, DOI 10.1097/00006534-199111000-00018
   BIRD RB, 1960, TRANSPORT PHENOMENA, P51
   BRASH JL, 1988, BLOOD, V71, P932
   BRUNELLI G, 1982, INT SURG, V67, P163
   CASNOCHA SA, 1989, J APPL PHYSIOL, V67, P1997
   DAHLKE H, 1980, J BIOMED MATER RES, V14, P251, DOI 10.1002/jbm.820140307
   DRYJSKI M, 1985, THROMB HAEMOSTASIS, V54, P773
   EBERHART RC, 1989, IEEE ENG MED BIOL, V8, P26
   GOLDSMITH MF, 1990, JAMA-J AM MED ASSOC, V263, P789, DOI 10.1001/jama.263.6.789
   GREENBERG BM, 1988, PLAST RECONSTR SURG, V82, P463, DOI 10.1097/00006534-198809000-00016
   GREGORIUS F K, 1975, Surgical Neurology, V4, P258
   HARASHINA T, 1976, PLAST RECONSTR SURG, V58, P608, DOI 10.1097/00006534-197611000-00012
   HAWKER RJ, 1980, CLIN SCI, V58, P243, DOI 10.1042/cs0580243
   HORBETT TA, 1977, J BIOENG, V1, P61
   HORBETT TA, 1978, THROMB RES, V12, P319, DOI 10.1016/0049-3848(78)90302-X
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   IGNARRO LJ, 1989, FASEB J, V3, P31
   ISOGAI N, 1988, Microsurgery, V9, P87, DOI 10.1002/micr.1920090206
   JAMES MJ, 1985, THROMB RES, V39, P587, DOI 10.1016/0049-3848(85)90238-5
   JOHNSON PC, 1990, PLAST RECONSTR SURG, V86, P359, DOI 10.1097/00006534-199008000-00032
   JOHNSON PC, 1991, ARTERIOSCLER THROMB, V11, P552, DOI 10.1161/01.ATV.11.3.552
   JOHNSON PC, 1992, J APPL BIOMATER, V3, P1, DOI 10.1002/jab.770030102
   JOHNSON PC, IN PRESS PLAST RECON
   KHOURI RK, 1990, PLAST RECONSTR SURG, V86, P110, DOI 10.1097/00006534-199007000-00017
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LELAH MD, 1986, POLYURETHANES MED, P125
   LINDON JN, 1986, BLOOD, V68, P355
   MALIK AB, 1989, J INVEST DERMATOL, V93, pS62, DOI 10.1111/1523-1747.ep12581072
   MATTOX D E, 1980, Otolaryngology - Head and Neck Surgery, V88, P252
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   NEMERSON Y, 1988, BLOOD, V71, P1
   NIEVELSTEIN PFEM, 1988, HAEMOSTASIS, V18, P342
   OSGOOD CP, 1976, ANGIOLOGY, V27, P96, DOI 10.1177/000331977602700203
   PACKHAM MA, 1988, P SOC EXP BIOL MED, V189, P261
   PAGNANELLI DM, 1980, J NEUROSURG, V53, P32, DOI 10.3171/jns.1980.53.1.0032
   RICHLING B, 1979, J NEUROSURG, V51, P654, DOI 10.3171/jns.1979.51.5.0654
   ROSENBAUM TJ, 1977, J NEUROSURG, V47, P430, DOI 10.3171/jns.1977.47.3.0430
   SHAW WW, 1987, PLAST SURG FORUM, V4, P93
   SHEPPECK RA, 1991, BLOOD, V78, P673
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   SMITH EB, 1990, ARTERIOSCLEROSIS, V10, P263, DOI 10.1161/01.ATV.10.2.263
   TOMASELLO F, 1981, J NEUROSURG, V54, P525, DOI 10.3171/jns.1981.54.4.0525
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   YAREMCHUK MJ, 1987, PLAST RECONSTR SURG, V80, P1
   YUDONG G, 1989, J RECONSTR MICROSURG, V5, P327
NR 51
TC 3
Z9 3
U1 0
U2 2
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596 USA
SN 1049-8834
J9 ARTERIOSCLER THROMB
JI Arterioscler. Thromb.
PD JUN
PY 1992
VL 12
IS 6
BP 727
EP 735
DI 10.1161/01.ATV.12.6.727
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA HX939
UT WOS:A1992HX93900011
PM 1591232
OA Bronze
DA 2018-10-20
ER

PT J
AU OGA, M
   ARIZONO, T
   SUGIOKA, Y
   NAYLOR, PT
   MYRVIK, QN
   GRISTINA, AG
AF OGA, M
   ARIZONO, T
   SUGIOKA, Y
   NAYLOR, PT
   MYRVIK, QN
   GRISTINA, AG
TI INVITRO ANALYSIS OF THE EFFECTS OF BIOMATERIAL ADHERENCE ON A
   STAPHYLOCOCCUS-EPIDERMIDIS STRAIN SENSITIVITY TO CEPHALORIDINE
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
AB This study examined the effects biomaterial adherence had on Staphylococcus epidermidis-46 morphology and sensitivity to the antibiotic cephaloridine. Polymethylmethacrylate (PMMA) discs served as the biomaterial substratum in this study. Suspension cultures of SE-46 at 10(8) CFU/mL were allowed to adhere to PMMA discs for 2, 6, or 12 h prior to exposure to cephaloridine at 250-mu-g/mL, which is 500 times greater than the MIC of 0.5-mu-g/mL. After a 24-h exposure to the antibiotic viable bacteria adherent to the disc were removed and counted. Those data revealed that at shorter adherence times a larger percentage of the adherent organism were erradicated by antibiotic exposure, 83.6% versus 15.6% for 2-h and 12-h adherence times, respectively. Although a significant percent of the organisms were killed with short adherence times, the organism still persisted in the face of high concentrations of cephaloridine. Scanning electron micrographs of organism adherent for 2 and 12 h revealed distinct morphological changes in the extracellular matrix indicating increased matrix production with longer adherence. Thus, these data reveal that adherence to biomaterials provides a protected environment for the bacteria and the time an organism is adherent to a biomaterial surface prior to antibiotic exposure can also increase the organism's resistance to antibiotics.
C1 KYUSHU UNIV,FAC MED,DEPT ORTHOPED SURG,FUKUOKA 812,JAPAN.
   MED SCI RES INST,SCI ADVISORY BOARD,KNOXVILLE,TN.
   MED SCI RES INST,HERNDON,VA.
CR ATKINSON RM, 1966, C TOXICAL APPL PHARM, V8, P389
   BROWN MRW, 1985, ANNU REV MICROBIOL, V39, P525
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COSTERTON JW, 1977, MICROBIOLOGY 1977, P151
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P269
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P517
   Naylor P T, 1990, Clin Orthop Relat Res, P126
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   YAMAMOTO M, 1986, MICROBIOL IMMUNOL, V30, P969, DOI 10.1111/j.1348-0421.1986.tb03027.x
NR 15
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SUM
PY 1992
VL 3
IS 2
BP 95
EP 98
DI 10.1002/jab.770030205
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HT988
UT WOS:A1992HT98800004
DA 2018-10-20
ER

PT J
AU MENCONI, MJ
   OWEN, T
   DASSE, KA
   STEIN, G
   LIAN, JB
AF MENCONI, MJ
   OWEN, T
   DASSE, KA
   STEIN, G
   LIAN, JB
TI MOLECULAR APPROACHES TO THE CHARACTERIZATION OF CELL AND BLOOD
   BIOMATERIAL INTERACTIONS
SO JOURNAL OF CARDIAC SURGERY
LA English
DT Article
DE GENE EXPRESSION; BIOMATERIALS; ENDOTHELIAL CELLS; LEFT VENTRICULAR
   ASSIST DEVICE; BIOMER; RIBONUCLEIC ACID
AB In order to address questions related to cell/biomaterial interactions with respect to cell function and production of extracellular matrix proteins that support or maintain cell/tissue specific properties, we have developed molecular approaches for analysis of in vivo implanted materials and in vitro studies. In an explant of a human left ventricular assist device (LVAD), intact total cellular RNA could be isolated in sufficient quantities for hybridization analyses with gene-specific probes to evaluate cell growth, cytoskeletal organization, and production of extracellular matrix proteins. Cells harvested from a 132-day implanted LVAD exhibited proliferative activity and expressed genes for fibronectin and collagen types I, III, and IV. In vitro studies revealed that endothelial cells cultured on two different segmented polyurethane biomaterials (Biomer and Tecoflex 60D) exhibited different patterns of gene expression that reflected differences in cell growth rates, morphology, and composition of the extracellular matrix. These methodologies provide a valuable approach for a detailed evaluation of: (1) the biocompatibility of cells colonizing implanted cardiac assist devices; and (2) the functionality of cells seeded onto biomaterials.
C1 UNIV MASSACHUSETTS,SCH MED,DEPT CELL BIOL,55 LAKE AVE N,WORCESTER,MA 01655.
NR 0
TC 14
Z9 14
U1 0
U2 2
PU FUTURA PUBL CO
PI ARMONK
PA 135 BEDFORD RD, PO BOX 418, ARMONK, NY 10504-0418
SN 0886-0440
J9 J CARDIAC SURG
JI J. Card. Surg.
PD JUN
PY 1992
VL 7
IS 2
BP 177
EP 187
DI 10.1111/j.1540-8191.1992.tb00794.x
PG 11
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA HY504
UT WOS:A1992HY50400009
PM 1606370
DA 2018-10-20
ER

PT J
AU TANINGHER, M
   PASQUINI, R
   TANZI, MC
   BONATTI, S
AF TANINGHER, M
   PASQUINI, R
   TANZI, MC
   BONATTI, S
TI GENOTOXICITY OF N-ACRYLOYL-N'-PHENYLPIPERAZINE, A REDOX ACTIVATOR FOR
   ACRYLIC RESIN POLYMERIZATION
SO MUTATION RESEARCH
LA English
DT Article
DE BIOMATERIALS; DNA DAMAGE; GENE MUTATIONS; GENOMIC MUTATIONS
ID DNA DAMAGE
AB N-Acryloyl-N'-phenylpiperazine is a promoter of redox reactions synthesized recently, and proposed as an activator for the polymerization of acrylic resins for biomedical use. The chemical was analyzed for different genotoxicity endpoints, to obtain both information on its possible mutagenic/carcinogenic potential and a model analysis of a tertiary arylamine, which belongs to a class of chemicals commonly used as polymerization accelerators in the biomaterial field. The genotoxicity endpoints considered were: gene mutation in the Salmonella test; structural and numerical chromosome alterations in Chinese hamster V79 cells, evaluated by the micronucleus test together with an immunofluorescent staining specific for kinetochore proteins; in vitro and in vivo DNA damage, evaluated in V79 cells and in mouse liver by the alkaline DNA elution technique. On the whole, the results indicate that N-acryloyl-N'-phenylpiperazine is to be regarded not so much as a DNA-damaging agent, but as a genomic mutagen. Indeed, it was not mutagenic in Salmonella (though its toxicity did not allow testing concentrations over 70-mu-g/plate), and it was weakly positive in inducing chromosomal fragmentation in vitro (one positive, not dose-related, result out of five different doses tested) and in vivo DNA damage (increases in DNA elution rate never doubling control values). The chemical was, however, clearly positive (with dose-dependent effects up to about 25 times the control value) in causing numerical chromosome alterations, at the maximal non-toxic doses.
C1 UNIV GENOA,CIRC,INST ONCOL,I-16132 GENOA,ITALY.
   UNIV PERUGIA,DEPT HYG,I-06100 PERUGIA,ITALY.
   UNIV MILAN,DEPT BIOENGN,I-20133 MILAN,ITALY.
   CNR,IST MUTAGENESI & DIFFERENZIAMENTO,I-56100 PISA,ITALY.
RP TANINGHER, M (reprint author), NATL INST CANC RES,VIALE BENEDETTO XV NO 10,I-16132 GENOA,ITALY.
RI Tanzi, Maria Cristina/I-4620-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633
CR COX R, 1973, CANCER RES, V33, P2114
   Lawley P. D., 1976, IARC SCI PUBL, V12, P181
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   NUSSE M, 1989, MUTAGENESIS, V4, P174, DOI 10.1093/mutage/4.3.174
   PARODI S, 1978, MUTAT RES, V54, P39, DOI 10.1016/0165-1161(78)90133-4
   SINA JF, 1983, MUTAT RES, V113, P357, DOI 10.1016/0165-1161(83)90228-5
   TANZI MC, 1990, POLYMER, V31, P1735, DOI 10.1016/0032-3861(90)90194-4
   WARREN W, 1979, BIOCHIM BIOPHYS ACTA, V563, P82, DOI 10.1016/0005-2787(79)90009-1
   WILLIAMS JR, 1974, NATURE, V252, P754, DOI 10.1038/252754a0
NR 9
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD JUN
PY 1992
VL 282
IS 2
BP 99
EP 105
DI 10.1016/0165-7992(92)90081-R
PG 7
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA HY734
UT WOS:A1992HY73400007
PM 1377358
DA 2018-10-20
ER

PT J
AU SIGHOLM, G
   GENDLER, E
   MCKELLOP, H
   MARSHALL, GJ
   MOORE, TM
   SARMIENTO, A
AF SIGHOLM, G
   GENDLER, E
   MCKELLOP, H
   MARSHALL, GJ
   MOORE, TM
   SARMIENTO, A
TI GRAFT PERFORATIONS FAVOR OSTEOINDUCTION - STUDIES OF RABBIT CORTICAL
   GRAFTS STERILIZED WITH ETHYLENE-OXIDE
SO ACTA ORTHOPAEDICA SCANDINAVICA
LA English
DT Article
ID BONE-MATRIX; DECALCIFIED BONE; DEMINERALIZED BONE; BIOMATERIAL;
   INDUCTION
AB The healing of freeze-dried, ethylene oxide sterilized, segmental, allogenic cortical bone grafts was investigated in 15 rabbits using a 2-cm ulnar diaphyseal defect. Five different groups of bone grafts were evaluated: 1) unperforated undemineralized, 2) perforated undemineralized, 3) unperforated demineralized, 4) perforated demineralized, and 5) perforated demineralized grafts enclosed by silicone rubber (Silastic) sheets. There were 3 animals in each group. At 18 days, the study was terminated, and the implants were examined using radiographs and qualitative histologic preparations.
   We observed that healing of perforated demineralized bone was superior to unperforated demineralized bone, that undemineralized bone was partially sequestered in reactive lacunae, and that perforations in demineralized bone became centers of osteoinduction. Demineralized bone sterilized with ethylene oxide by this method vigorously formed new bone.
C1 EAST HOSP, DEPT ORTHOPED, GOTHENBURG, SWEDEN.
   PACIFIC COAST TISSUE BANK, LOS ANGELES, CA USA.
   UNIV SO CALIF, DEPT ORTHOPED, LOS ANGELES, CA 90089 USA.
   ORTHOPED HOSP, LOS ANGELES, CA 90007 USA.
CR ASPENBERG P, 1990, J BONE JOINT SURG BR, V72, P1036
   BERNICK S, 1989, J ORTHOPAED RES, V7, P1, DOI 10.1002/jor.1100070102
   BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018
   DELLOYE C, 1985, ACTA ORTHOP SCAND, V56, P318, DOI 10.3109/17453678508993024
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   GENDLER E, 1986, J BIOMED MATER RES, V20, P687, DOI 10.1002/jbm.820200603
   GEPSTEIN R, 1987, J BONE JOINT SURG AM, V69A, P984, DOI 10.2106/00004623-198769070-00005
   HOLLINGER JO, 1991, CLIN ORTHOP RELAT R, P255
   IWATA H, 1981, CLIN ORTHOP RELAT R, V154, P150
   KOHLER P, 1987, CLIN ORTHOP RELAT R, V218, P247
   MOORE TM, 1990, CLIN ORTHOP RELAT R, V259, P239
   MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340
   NADE S, 1977, J BONE JOINT SURG BR, V59, P189
   OIKARINEN J, 1979, ACTA ORTHOP SCAND, V50, P21
   REDDI AH, 1985, J BIOMED MATER RES, V19, P233, DOI 10.1002/jbm.820190306
   SAVELIEV VI, 1986, ORTOPED TRAVMAT PROT, V8, P22
   TULI SM, 1978, J BONE JOINT SURG BR, V60, P116
   URIST MR, 1968, CLIN ORTHOP RELAT R, P37
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1975, ARCH SURG-CHICAGO, V110, P416
   URIST MR, 1987, METHOD ENZYMOL, V146, P294
   VANDERSTEENHOVEN JJ, 1983, J BIOMED MATER RES, V17, P1003, DOI 10.1002/jbm.820170610
   Zislis T, 1989, J Oral Implantol, V15, P41
NR 23
TC 25
Z9 25
U1 0
U2 0
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0001-6470
J9 ACTA ORTHOP SCAND
JI Acta Orthop. Scand.
PD APR
PY 1992
VL 63
IS 2
BP 177
EP 182
DI 10.3109/17453679209154818
PG 6
WC Orthopedics
SC Orthopedics
GA HU268
UT WOS:A1992HU26800014
PM 1590053
OA Bronze
DA 2018-10-20
ER

PT J
AU GUIDOIN, R
   THERRIEN, M
   ROLLAND, C
   KING, M
   GRANDMAISON, JL
   KALIAGUINE, S
   BLAIS, P
   PAKDEL, H
   ROY, C
AF GUIDOIN, R
   THERRIEN, M
   ROLLAND, C
   KING, M
   GRANDMAISON, JL
   KALIAGUINE, S
   BLAIS, P
   PAKDEL, H
   ROY, C
TI THE POLYURETHANE FOAM COVERING THE MEME BREAST PROSTHESIS - A BIOMEDICAL
   BREAKTHROUGH OR A BIOMATERIAL TAR BABY
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID IMPLANTS; RECONSTRUCTION
AB Because controversy continues to surround the implantation of the polyurethane foam-covered Meme breast prosthesis, in vitro experiments were conducted to determine: (1) whether the polyurethane foam contains extractable toluene diamine isomers (TDAs), and (2) whether the polyurethane foam releases TDAs on exposure to mild hydrolytic conditions. Results confirmed the presence of extractable TDAs and other impurities in the foam covering the unused Meme prosthesis, and that the concentrations of these impurities could be significantly reduced by washing the foam in a regular detergent. This washing step was omitted from the manufacturer's production process. Furthermore, on exposure to mild alkalis, the foam exhibited significant degradation, rapid fragmentation, loss of mechanical strength and physical integrity, as well as the release of additional TDAs. Because of the potential long-term risks associated with the release of TDAs in vivo, continued clinical use of the Meme prosthesis containing this particular type of foam appears questionable.
C1 UNIV LAVAL,DEPT CHEM ENGN,QUEBEC CITY G1K 7P4,QUEBEC,CANADA.
   ST FRANCIS ASSISI HOSP,INST BIOMAT,QUEBEC CITY,QUEBEC,CANADA.
   UNIV MANITOBA,WINNIPEG R3T 2N2,MANITOBA,CANADA.
RP GUIDOIN, R (reprint author), UNIV LAVAL,DEPT SURG,CHIRURG EXPTL LAB,PAVILLON SERV,LOCAL 1701,QUEBEC CITY G1K 7P4,QUEBEC,CANADA.
CR ADAMS G, 1990, DEV TECHNIQUES MONIT
   AMES BN, 1975, P NATL ACAD SCI USA, V72, P2423, DOI 10.1073/pnas.72.6.2423
   ASHLEY FL, 1972, PLAST RECONSTR SURG, V49, P414, DOI 10.1097/00006534-197204000-00009
   ASHLEY FL, 1970, PLAST RECONSTR SURG, V45, P421, DOI 10.1097/00006534-197005000-00001
   BATICH C, 1989, J BIOMED MATER RES-A, V23, P311, DOI 10.1002/jbm.820231406
   BAUDELOT S, 1989, ANN CHIR PLAST ESTH, V34, P279
   BLAIR EA, 1967, CELL STRUCTURE PHYSI, P143
   BLAIS P, 1988, TRANSPLANTATION IMPL, V5, P28
   Blais P., 1990, J APPL BIOMATER, V1, P197
   CAFFEE HH, 1990, PLAST RECONSTR SURG, V86, P708, DOI 10.1097/00006534-199010000-00015
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHAWLA AS, 1989, MEME PROSTHESIS 5
   COPPINGER WJ, 1984, MUTAT RES, V135, P115, DOI 10.1016/0165-1218(84)90164-2
   DAKA J, 1991, RELEASE CHEM POLYURE
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   GERSTENBERG GJ, 1989, COMMUNICATION   0306
   GOGOLEWSKI S, 1987, LIFE SUPPORT SYST, V5, P41
   GUIDOIN R, 1991, HIGH PERFORMANCE BIO, P191
   HERMAN S, 1984, PLAST RECONSTR SURG, V73, P411, DOI 10.1097/00006534-198403000-00012
   HESTER TR, 1988, CLIN PLAST SURG, V15, P569
   HUM LL, 1990, J APPL BIOMATER, V1, P193
   ITO N, 1969, CANCER RES, V29, P1137
   JABALEY ME, 1986, PLAST RECONSTR SURG, V78, P390, DOI 10.1097/00006534-198609000-00020
   JOHNSON DL, 1989, COMMUNICATION   0629
   KERRIGAN CL, 1989, JUN REP MEM BREAST F
   LELAH DM, 1986, POLYURETHANES MED
   LOWE A, 1970, P ROY SOC MED, V63, P367
   MELMED EP, 1988, PLAST RECONSTR SURG, V82, P285, DOI 10.1097/00006534-198808000-00013
   OKUNSKI WJ, 1987, AESTHET PLAST SURG, V11, P49, DOI 10.1007/BF01575483
   Pangman W.J., 1958, US Patent, Patent No. 2842775
   PANGMAN WJ, 1836, Patent No. 189921
   PANGMAN WJ, 1971, Patent No. 3559214
   PENNISI VR, 1985, AESTHET PLAST SURG, V9, P73, DOI 10.1007/BF01570332
   SLADE CL, 1982, PLAST RECONSTR SURG, V70, P379, DOI 10.1097/00006534-198209000-00018
   SMAHEL J, 1978, PLAST RECONSTR SURG, V61, P80
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   UMANSKY C, 1985, PLAST RECONSTR SURG, V75, P925
   WARD CJP, 1985, J LIQ CHROMATOGR, V8, P677, DOI 10.1080/01483918508067112
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   1986, IARC MONOGRAPHS EVAL, V39, P287
   1990, FED REG 20568, V55
   1978, IARC MONOGRAPHS EVAL, V16, P83
   1989, W6 MED DEV DIAGN IND, P15
NR 43
TC 7
Z9 7
U1 0
U2 2
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 1992
VL 28
IS 4
BP 342
EP 353
DI 10.1097/00000637-199204000-00009
PG 12
WC Surgery
SC Surgery
GA HN467
UT WOS:A1992HN46700009
PM 1596068
DA 2018-10-20
ER

PT J
AU LOPEZ, GP
   RATNER, BD
   TIDWELL, CD
   HAYCOX, CL
   RAPOZA, RJ
   HORBETT, TA
AF LOPEZ, GP
   RATNER, BD
   TIDWELL, CD
   HAYCOX, CL
   RAPOZA, RJ
   HORBETT, TA
TI GLOW-DISCHARGE PLASMA DEPOSITION OF TETRAETHYLENE GLYCOL DIMETHYL ETHER
   FOR FOULING-RESISTANT BIOMATERIAL SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID HEPARIN-IMMOBILIZED POLYURETHANES; OXIDE)-HEPARIN BLOCK COPOLYMERS;
   POLY(ETHYLENE OXIDE); FIBRINOGEN ADSORPTION; POLYSILOXANE NETWORKS;
   PROTEIN ADSORPTION; PLATELET-ADHESION; ETHYLENE-OXIDE; ACRYLIC-ACID;
   CELL-GROWTH
AB The glow discharge plasma deposition (GDPD) of tetraethylene glycol dimethyl ether is introduced as a novel method for obtaining surfaces that are resistant to protein adsorption and cellular attachment. Analysis of films by x-ray photoelectron spectroscopy and several biological assays indicate the formation of a fouling-resistant, PEO-like surface on several substrata (e.g., glass, polytetrafluoroethylene, polyethylene). Adsorption of I-125-radiolabelled proteins (fibrinogen, albumin and IgG) from buf fer and plasma was very low (typically < 20 ng/cm2) when compared to the untreated substrata, which exhibited much higher levels of protein adsorption. Not all coated substrata adsorbed equal amounts of protein (e.g., coated glass samples typically adsorbed more protein than coated polyethylene or coated polytetrafluoroethylene samples), suggesting that the substratum used may affect the amount of protein adsorbed. Measurement of dynamic platelet adhesion, using epifluorescent video microscopy, and endothelial cell attachment further demonstrates the short-term nonadhesiveness of these surfaces.
C1 UNIV WASHINGTON,DEPT CHEM ENGN,BF-10,SEATTLE,WA 98195.
   UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
FU NCRR NIH HHS [RR01296]
CR ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   BENSON RS, 1985, J POLYM SCI POL CHEM, V23, P399, DOI 10.1002/pol.1985.170230215
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BOTS JGF, 1986, BIOMATERIALS, V7, P393, DOI 10.1016/0142-9612(86)90011-6
   BRACE LD, 1985, SEMIN THROMB HEMOST, V11, P190, DOI 10.1055/s-2007-1004374
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   BRINKMAN E, 1989, INT J ARTIF ORGANS, V12, P390
   CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8
   CHAIKOF EL, 1989, J SURG RES, V47, P193, DOI 10.1016/0022-4804(89)90106-6
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   CHINN JA, 1986, THESIS U WASHINGTON
   CHINN JA, 1989, 2ND TOP C EM TECHN M, P1
   CHINN JA, 1989, THROMB HAEMOSTASIS, V65, P608
   CORRETGE E, 1988, POLYM MED, V3, P61
   DESAI NP, 1990, ACS POLYM MATER SCI, V62, P731
   DILKS A, 1981, ELECTRON SPECTROSCOP, V4, P277
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, IN PRESS J BIOMATER
   GNANOU Y, 1984, MACROMOLECULES, V17, P945, DOI 10.1021/ma00134a069
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GOMBOTZ WR, 1988, J APPL POLYM SCI, V35, P1
   GOMBOTZ WR, 1988, THESIS U WASHINGTON
   GRAINGER D, 1985, ACS POLYM MATER SCI, V53, P21
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P403, DOI 10.1002/jbm.820240402
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   GRAMAIN P, 1987, MAKROMOL CHEM, V188, P593
   GREGONIS DE, 1984, T SOC BIOMATER, V10, P266
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Harris J. M., 1989, AM CHEM SOC POLYM PR, V30, P356
   HAYCOX CL, 1991, T SOC BIOMAT, V14, P40
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   KISS E, 1986, 9TH P SCAND S SURF C
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JH, 1988, ACS POLYM MAT SCI EN, V59, P234
   LEE JH, 1987, POLYM MATER SCI ENG, V57, P613
   LIU S Q, 1989, Journal of Biomaterials Science Polymer Edition, V1, P111
   LOPEZ GP, 1991, SURF INTERFACE ANAL, V17, P267, DOI 10.1002/sia.740170508
   LOPEZ GP, 1991, LANGMUIR, V7, P766, DOI 10.1021/la00052a027
   LOPEZ GP, 1990, J APPL POLYM SCI APP, V46, P493
   LOPEZ GP, UNPUB FOULING RESIST
   MACFARLANE AS, 1958, NATURE, V182, P53
   MAECHLINGSTRASSER C, 1989, J BIOMED MATER RES, V23, P1395, DOI 10.1002/jbm.820231203
   MAECHLINGSTRASSER C, 1989, J BIOMED MATER RES, V23, P1385, DOI 10.1002/jbm.820231202
   MAHMUD NA, 1986, ACS POLYM MATER SCI, V55, P751
   MARCHANT RE, 1990, J BIOMED MATER RES, V24, P1521, DOI 10.1002/jbm.820241108
   Merril EW, 1987, HYDROGELS MED PHARM, V3, P1
   MERRILL EW, 1982, T AM SOC ART INT ORG, V28, P482
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   MERRILL EW, 1985, P INT SOC ARTIFICIAL
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   NAGAOKA S, 1983, POLYM PREPR-ACS, V24, P67
   NAKAO A, 1986, T AM SOC ART INT ORG, V32, P319
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PEKALA RW, 1986, BIOMATERIALS, V7, P372, DOI 10.1016/0142-9612(86)90008-6
   PEKALA RW, 1986, BIOMATERIALS, V7, P379, DOI 10.1016/0142-9612(86)90009-8
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   SAKARIASSEN KS, 1983, J LAB CLIN MED, V102, P522
   SUN Y, 1987, ACS POLYM PREPR, V28, P292
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   TAKAHARA A, 1988, ACS POLYM MATER SCI, V59, P264
   VULIC I, 1988, J POLYM SCI POL CHEM, V26, P381, DOI 10.1002/pola.1988.080260204
   WANG SG, 1989, J MACROMOL SCI CHEM, VA26, P505, DOI 10.1080/00222338908051990
   WASIEWSKI W, 1976, THROMB RES, V8, P881, DOI 10.1016/0049-3848(76)90017-7
NR 74
TC 214
Z9 217
U1 1
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1992
VL 26
IS 4
BP 415
EP 439
DI 10.1002/jbm.820260402
PG 25
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HJ628
UT WOS:A1992HJ62800001
PM 1601898
DA 2018-10-20
ER

PT J
AU MARUNO, S
   BAN, S
   WANG, YF
   IWATA, H
   ITOH, H
AF MARUNO, S
   BAN, S
   WANG, YF
   IWATA, H
   ITOH, H
TI PROPERTIES OF FUNCTIONALLY GRADIENT COMPOSITE CONSISTING OF
   HYDROXYAPATITE CONTAINING GLASS COATED TITANIUM AND CHARACTERS FOR
   BIOACTIVE IMPLANT
SO NIPPON SERAMIKKUSU KYOKAI GAKUJUTSU RONBUNSHI-JOURNAL OF THE CERAMIC
   SOCIETY OF JAPAN
LA English
DT Article
DE HYDROXYAPATITE; GLASS; TITANIUM; COATING; COMPOSITE; BIOMATERIAL;
   IMPLANT; FUNCTIONALLY GRADIENT MATERIAL
ID PHOSPHATE
AB Composites comprising hydroxyapatite (HA) containing glass layer and pure titanium or Ti-6Al-4V alloy, so called HA-G-Ti functionally gradient materials, have been shown to be useful for bioactive artificial joints and dental implants.  In the present study, the mechanical and thermal properties of the HA containing glasses were examined.  The compressive strength of HA containing glasses less than 70 wt% HA content was sufficiently larger than that of bone.  The hardness of about 70 wt% HA containing glass corresponded to that of natural teeth.  It has been found from DSC analysis that the glass little reacts with HA at firing temperature (950-degrees-C).  Thermal expansion coefficients of HA containing glasses with relatively low HA content were suitable values for the coating on Ti and Ti-6Al-4V.  The bonding strength of the glass to Ti substrate reached the maximum value of 28 MPa under the condition of 2.3-mu-m in surface roughness (center line average).  The HA-G-Ti composites with bioactive surface, etched in a mixture of HF and HNO3, showed a good apposition to the bone in vivo.
C1 AICHI GAKUIN UNIV,SCH DENT,CHIKUSA KU,NAGOYA 464,JAPAN.
   TOKYO KOUSEINENKIN HOSP,SHINJUKU KU,TOKYO 162,JAPAN.
   NAGOYA UNIV,DEPT ORTHOPED SURG,SHOWA KU,NAGOYA,AICHI 466,JAPAN.
RP MARUNO, S (reprint author), NAGOYA INST TECHNOL,SHOWA KU,NAGOYA,AICHI 466,JAPAN.
CR BAN S, 1991, JPN J APPL PHYS, V29, pL1333
   BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   CURREY JD, 1970, CLIN ORTHOP RELAT R, V73, P210
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   De Groot K, 1981, BIOCOMPATIBILITY CLI, V1, P199
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, V225, P147
   HASTINGS GW, 1989, BIOCERAMICS, V1, P355
   IWATA H, 1989, BIOCERAMICS, V1, P411
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   MARUNO S, 1991, BIOMATERIALS, V12, P225, DOI 10.1016/0142-9612(91)90204-N
   MARUNO S, 1990, BIOCERAMICS, V2, P321
   MARUNO S, 1990, HDB BIOACTIVE CERAMI, V2, P187
   MARUNO S, 1987, ANN M CERAM SOC JAPA, P959
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   Togaya T, 1983, Dent Mater J, V2, P210
   VICKERY RC, 1968, J DENT RES, V47, P683, DOI 10.1177/00220345680470050301
NR 18
TC 39
Z9 40
U1 0
U2 6
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17 HYAKUNIN-CHO SHINJUKU-KU, TOKYO 169, JAPAN
SN 0914-5400
J9 NIPPON SERAM KYO GAK
PD APR
PY 1992
VL 100
IS 4
BP 362
EP 367
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA HP368
UT WOS:A1992HP36800002
DA 2018-10-20
ER

PT J
AU SPECTOR, M
AF SPECTOR, M
TI BIOMATERIAL FAILURE
SO ORTHOPEDIC CLINICS OF NORTH AMERICA
LA English
DT Article
ID PLASMA-SPRAYED COATINGS; UHMW POLYETHYLENE; ION-IMPLANTATION; COATED
   IMPLANTS; HIP PROSTHESES; BONE; WEAR; HYDROXYLAPATITE; TITANIUM;
   INTERFACE
C1 HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT ORTHOPED SURG,BOSTON,MA 02115.
   VET ADM MED CTR W ROXBURY,REHABIL ENGN R & D LAB,BOSTON,MA 02132.
OI Spector, Myron/0000-0003-3328-4858
CR ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   ALBREKTSSON T, 1983, J PROSTHET DENT, V50, P255, DOI 10.1016/0022-3913(83)90027-6
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   ALBREKTSSON T, 1984, CRIT REV BIOCOMPAT, V1, P53
   BARTEL DL, 1985, J BIOMECH ENG-T ASME, V107, P193, DOI 10.1115/1.3138543
   BARTEL DL, 1989, T JOINT M AM SOC MEC
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   BURKE DW, 1984, J BONE JOINT SURG AM, V66A, P1265, DOI 10.2106/00004623-198466080-00016
   CHIN HC, 1990, J BONE JOINT SURG AM, V72A, P363, DOI 10.2106/00004623-199072030-00007
   COLLIER JP, 1991, T ANN M SOC BIOM CON, V14, P292
   Cook S D, 1987, Int J Oral Maxillofac Implants, V2, P15
   Cook S D, 1988, J Arthroplasty, V3, P249
   COOK SD, 1991, J BONE JOINT SURG BR, V73, P20
   COOK SD, 1991, T SOC BIOMATERIALS, V14, P210
   COOK SD, 1991, CLIN ORTHOP RELAT R, V265, P280
   COOK SD, 1991, OCT T COMB M ORTH RE, P229
   COOKE TDV, 1990, CLIN ORTHOP RELAT R, V258, P204
   DAVEY JR, 1988, CLIN ORTHOPAEDICS, V231, P97
   DAVIES JP, 1988, CLIN ORTHOP RELAT R, V229, P156
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Drucker D A, 1991, Orthop Rev, V20, P179
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GAINES RK, 1991, POROUS POLYSULFONE C
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Geesink RGT, 1990, CLIN ORTHOP RELAT R, V261, P39
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, V225, P147
   GORSKI JM, 1988, CLIN ORTHOP RELAT R, V228, P110
   HARRIS WH, 1991, INSTRUCTIONAL COURSE, P141
   HOWLE DW, 1988, J BONE JOINT SURG AM, V70, P257
   ITOH Y, 1991, J MATER RES, V6, P871, DOI 10.1557/JMR.1991.0871
   KRAUSE W, 1988, J BIOMED MATER RES-A, V22, P37
   Landy M M, 1988, J Arthroplasty, V3 Suppl, pS73, DOI 10.1016/S0883-5403(88)80013-5
   LI S, 1990, T SOC BIOMATER, V13, P190
   MANN KA, 1991, OCT T COMB M ORTH RE
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   NAGY EV, 1990, T SOC BIOMATERIALS, V13, P274
   NASSER S, 1989, 15TH SOC BIOM ANN M, P32
   OCONNOR DO, 1989, 15TH SOC BIOM ANN M, P50
   PILLIAR R M, 1986, Critical Reviews in Biocompatibility, V1, P371
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   RIMNAC CM, 1986, J BONE JOINT SURG AM, V68A, P281, DOI 10.2106/00004623-198668020-00014
   Ritter M A, 1990, J Arthroplasty, V5, P83, DOI 10.1016/S0883-5403(06)80014-8
   ROSENQVIST R, 1986, J BONE JOINT SURG AM, V68A, P538, DOI 10.2106/00004623-198668040-00009
   ROSTLUND T, 1989, BIOMATERIALS, V10, P176, DOI 10.1016/0142-9612(89)90020-3
   SPECTOR M, 1987, Journal of Orthopaedic Surgical Techniques, V3, P21
   SPECTOR M, 1988, CLIN ORTHOP RELAT R, V235, P207
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   TULLOS HS, 1984, J BONE JOINT SURG AM, V66A, P888, DOI 10.2106/00004623-198466060-00009
   WEIGHTMAN B, 1991, J BONE JOINT SURG BR, V73, P806
   WEIGHTMAN B, 1987, J BONE JOINT SURG BR, V69, P558
   WRIGHT TM, 1982, J MATER SCI, V17, P2463, DOI 10.1007/BF00543876
   WRIGHT TM, 1985, CORROSION DEGRADATIO, P415
   WRIGHT TM, 1989, T I MECHANICAL ENG, P187
   WRIGHT TM, 1986, CLIN ORTHOP RELAT R, V205, P67
   WROBLEWSKI BM, 1987, J BONE JOINT SURG BR, V69, P61
NR 60
TC 36
Z9 37
U1 0
U2 3
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0030-5898
J9 ORTHOP CLIN N AM
JI Orthop. Clin. North Am.
PD APR
PY 1992
VL 23
IS 2
BP 211
EP 217
PG 7
WC Orthopedics
SC Orthopedics
GA LA283
UT WOS:A1992LA28300003
PM 1570135
DA 2018-10-20
ER

PT J
AU HARWOOD, IR
   GREENE, LM
   KOZAKOWSKIKOCH, JA
   RASOR, JS
AF HARWOOD, IR
   GREENE, LM
   KOZAKOWSKIKOCH, JA
   RASOR, JS
TI NEW PERIPHERALLY INSERTED MIDLINE CATHETER - A BETTER ALTERNATIVE FOR
   INTRAVENOUS ANTIBIOTIC-THERAPY IN PATIENTS WITH CYSTIC-FIBROSIS
SO PEDIATRIC PULMONOLOGY
LA English
DT Article
DE CATHETER PERFORMANCE; PATIENT COMFORT; COST COMPARISON
AB A study was performed on outpatients with cystic fibrosis (CF) to evaluate the performance of an over-the-needle peripherally inserted midline catheter for the delivery of 2-week courses of antibiotic therapy. The midline is a 7-inch catheter inserted in the antecubital region with the tip located in the axillary region. It is made of a newly developed biomaterial that softens and expands upon contact with body fluids. The hypotheses for the study were that the midline catheter: 1) is useful for intermediate-length therapies; 2) can prevent multiple 3-day conventional peripheral catheter restarts; 3) can prevent or delay the use of more invasive central devices; 4) is comfortable for patients; and 5) is economical. A total of 41 midlines were inserted in 27 patients with an average age and weight of 22 years and 109 pounds, respectively. Prior to this study implanted ports and primarily conventional short peripheral catheters were used to administer I.V. therapy to these patients; fifty percent of these short peripheral catheters failed within 2.6 days. At 2 weeks of dwell, 80% of the midline catheters placed in these patients were still indwelling. Also, 80% of all midline catheter removals were for non-catheter-related reasons. There were no cases of midline catheter phlebitis. In contrast, the phlebitis rates published for peripherally inserted central catheters (PICCs) and conventional short peripheral catheters at 7 days of dwell are 20% and > 51% respectively. The midline catheters were comfortable and well liked by most patients and became more economical than conventional peripheral catheters for therapies lasting approximately 6 days through 1 to 2 months. These data indicate that the low complication rate and the cost savings of the midline catheter make it a better alternative than conventional peripheral catheters or central devices for most I.V. antibiotic therapies lasting for 1 week or longer in patients with CF.
C1 UNIV CALIF SAN DIEGO,MED CTR,PHARM HOME CARE PROGRAM,LA JOLLA,CA 92093.
   MENLO CARE INC,MENLO PK,CA.
   UNIV CALIF SAN DIEGO,MED CTR,CTR CYST FIBROSIS,LA JOLLA,CA 92093.
RP HARWOOD, IR (reprint author), UNIV CALIF SAN DIEGO,MED CTR,DIV PEDIAT PULM DIS,4130 FRONT ST,LA JOLLA,CA 92093, USA.
CR ANDREWS P, 1991, JVAN, V1, P14
   BOTTINO J, 1979, CANCER, V43, P1937, DOI 10.1002/1097-0142(197905)43:5<1937::AID-CNCR2820430554>3.0.CO;2-T
   COLLIN J, 1975, LANCET, V1, P150
   CROCKER KS, 1990, MAY INTR NURS SOC AN, V13, P55
   EARLE FL, 1991, MAY INTR NURS SOC AN, V14, P80
   Fontaine P J, 1991, J Intraven Nurs, V14, P91
   GAHART BL, 1990, HDB INTRAVENOUS MED, P108
   GUTHRIE J, 1991, MAY INTR NURS SOC AN, V14, P86
   HEILVEIL L, 1991, MAY ONC NURS SOC ANN, V18, P377
   HICKEY RF, 1989, ANESTHES ANALG, V68, pS121
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   LAWSON M, 1979, AM J NURS, V79, P1100, DOI 10.2307/3462269
   McKee J M, 1989, J Intraven Nurs, V12, P288
   OLIN BR, 1990, DRUG FACTS COMP, P1468
   RASOR JS, 1991, JVAN, V1, P8
   Rutherford C, 1988, J Intraven Nurs, V11, P169
   SMEED C, 1990, AIDS PATIENT CARE, V4, P34
   STRUMPFER AL, 1992, IN PRESS JIN
   THOMAS ET, 1970, ANESTH ANAL CURR RES, V49, P150
   WEHRBERGER M, 1991, HNS HOME INFUSION RE, V2, P4
   Williams D N, 1982, NITA, V5, P379
NR 21
TC 29
Z9 29
U1 1
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 8755-6863
J9 PEDIATR PULM
JI Pediatr. Pulmonol.
PD APR
PY 1992
VL 12
IS 4
BP 233
EP 239
DI 10.1002/ppul.1950120407
PG 7
WC Pediatrics; Respiratory System
SC Pediatrics; Respiratory System
GA HQ376
UT WOS:A1992HQ37600006
PM 1614749
DA 2018-10-20
ER

PT J
AU SMITH, MD
   BARBENEL, JC
   COURTNEY, JM
   GRANT, MH
AF SMITH, MD
   BARBENEL, JC
   COURTNEY, JM
   GRANT, MH
TI NOVEL QUANTITATIVE METHODS FOR THE DETERMINATION OF BIOMATERIAL
   CYTOTOXICITY
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Note
DE BIOMATERIAL; CYTOTOXICITY; CELL CULTURE
ID CYTO-TOXICITY; COLORIMETRIC ASSAY; CELL-CULTURE
AB Two novel methods for the determination of biomaterial cytotoxicity using cell culture are presented. The methods combine a standardized protocol for producing extracts from medical devices with either the established MTT assay or a new fluorimetric assay. The suitability of both methods for evaluating the toxicity of candidate materials was demonstrated by resolution of the differences in the toxic effects of serial dilutions of a PVC extract on BHK21 and HT1080 cells. The tests yield highly reproducible, quantitative results and can be applied to materials in the usual physical forms applicable to artificial organs.
C1 UNIV STRATHCLYDE,WOLFSON CTR,BIOENGN UNIT,106 ROTTENROW,GLASGOW G4 0WN,SCOTLAND.
CR CARMICHAEL J, 1987, CANCER RES, V47, P936
   DOILLON CJ, 1990, INT J ARTIF ORGANS, V13, P517
   KOLBER MA, 1988, J IMMUNOL METHODS, V108, P255, DOI 10.1016/0022-1759(88)90427-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134
   SCHMALZ G, 1985, J BIOMED MATER RES, V19, P653, DOI 10.1002/jbm.820190605
   SCHMALZ G, 1990, J MATER SCI-MATER M, V1, P228, DOI 10.1007/BF00701081
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   WIERDA WG, 1989, J IMMUNOL METHODS, V122, P15, DOI 10.1016/0022-1759(89)90329-3
   1988, BS5736 BRIT STAND 10
NR 10
TC 28
Z9 29
U1 1
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 1992
VL 15
IS 3
BP 191
EP 194
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA HN587
UT WOS:A1992HN58700012
PM 1521905
DA 2018-10-20
ER

PT J
AU GOLOMB, G
   LEVI, M
   VANGELDER, JM
AF GOLOMB, G
   LEVI, M
   VANGELDER, JM
TI CONTROLLED RELEASE OF BISPHOSPHONATE FROM A BIODEGRADABLE IMPLANT -
   EVALUATION OF RELEASE KINETICS AND ANTICALCIFICATION EFFECT
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID SUSTAINED-RELEASE; CHITOSAN GRANULES; CALCIFICATION; DIPHOSPHONATE;
   BIOPROSTHESES; INDOMETHACIN; BIOMATERIAL
AB The present investigation describes the formulation and the in vivo efficacy of prolonged controlled-release chitosan matrices, containing the novel anticalcification agents adipoyl- and suberoylbisphosphonate (AdBP and SuBP).  Chitosan matrices were prepared by the solvent-cast method and the role of several factors such as polymer molecular weight (MW), crosslinking, and drug load concentration, on the release rate profile have been examined.  Crosslinking of chitosan films retarded degradation rate of the polymer but not the release rate of the embedded drug.  Chitosan's MW and drug load concentration did not affect drug release rate.  The release kinetics of the bisacylphosphonates were characterized by initial burst-effect and pseudo zero-order kinetics in the following release phase.  AdBP/chitosan matrices (co-implanted subdermally in rats with the calcifiable bioprosthetic heart valve tissue) significantly inhibited tissue calcification after 15 and 30 days implantation (66.4 and 108.6-mu-g/mg Ca++ in comparison to 2.7 and 3.6-mu-g/mg Ca++, untreated and treated groups, respectively).  No side effects were noted.
RP GOLOMB, G (reprint author), HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,POB 12065,IL-91120 JERUSALEM,ISRAEL.
CR BREUER E, 1836, Patent No. 191362
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   Francis M.D., 1983, P55
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   Golomb G, 1987, J Biomater Appl, V2, P266, DOI 10.1177/088532828700200205
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   GOLOMB G, 1986, T AM SOC ART INT ORG, V32, P587
   GOLOMB G, 1991, IN PRESS CLIN MATER
   GOLOMB G, IN PRESS PHARM RES
   HOU WM, 1985, CHEM PHARM BULL, V33, P3986
   JOHNSTON TP, 1989, INT J PHARM, V52, P139, DOI 10.1016/0378-5173(89)90288-3
   JOHNSTON TP, 1990, INT J PHARM, V59, P95, DOI 10.1016/0378-5173(90)90083-G
   JOHNSTON TP, 1988, T AM SOC ART INT ORG, V34, P835
   Levy R J, 1985, Trans Am Soc Artif Intern Organs, V31, P459
   LEVY RJ, 1985, CIRCULATION, V71, P349, DOI 10.1161/01.CIR.71.2.349
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   MIYAZAKI S, 1988, J PHARM PHARMACOL, V40, P642, DOI 10.1111/j.2042-7158.1988.tb05325.x
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI RAA, 1986, CHITIN
   NISHIOKA Y, 1989, CHEM PHARM BULL, V37, P3074
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
NR 25
TC 18
Z9 18
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SPR
PY 1992
VL 3
IS 1
BP 23
EP 28
DI 10.1002/jab.770030105
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HD761
UT WOS:A1992HD76100004
DA 2018-10-20
ER

PT J
AU KUMMER, FJ
   RICCI, JL
   BLUMENTHAL, NC
AF KUMMER, FJ
   RICCI, JL
   BLUMENTHAL, NC
TI RF PLASMA TREATMENT OF METALLIC IMPLANT SURFACES
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID TITANIUM; CONTAMINATION; BIOMATERIAL; INTERFACE; TISSUE
AB Radio-frequency air plasma treatments of Ti-6-4 and Co-Cr implants increased surface wettability but concurrently increased ionic release.  In vitro tissue culture experiments demonstrated no enhancement of cell growth and enrichment.  Short-term rabbit tibial implants also showed no difference between treated and untreated implants.
RP KUMMER, FJ (reprint author), HOSP JOINT DIS & MED CTR,INST ORTHOPAED,DEPT BIOENGN,301 & 17TH ST,NEW YORK,NY 10003, USA.
CR BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   BLUMENTHAL NC, 1989, CLIN ORTHOP RELAT R, V247, P279
   CARTER JM, 1981, J BIOMED MATER RES, V15, P843
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   FLYNN HE, 1982, J PROSTHET DENT, V48, P241
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   GROBE GL, 1989, 15TH T ANN M SOC BIO, P42
   JANSEN JA, 1989, BIOMATERIALS, V10, P604, DOI 10.1016/0142-9612(89)90114-2
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
NR 10
TC 6
Z9 6
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SPR
PY 1992
VL 3
IS 1
BP 39
EP 44
DI 10.1002/jab.770030107
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HD761
UT WOS:A1992HD76100006
DA 2018-10-20
ER

PT J
AU FORNASIER, VL
   SANDERS, G
   GOODMAN, SB
AF FORNASIER, VL
   SANDERS, G
   GOODMAN, SB
TI HISTOLOGICAL TECHNIQUES FOR THE STUDY OF THE BIOMATERIAL-TISSUE
   INTERFACE OF TOTAL JOINT REPLACEMENTS - A MODIFICATION FOR THE
   PRESERVATION OF BONE-CEMENT
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID IMPLANTS
AB The methods usually employed for the histological processing of orthopaedic specimens of cemented joint arthroplasties involve treatment with methacrylate monomer and organic solvents which dissolve the polymethylmethacrylate cement. This may distort the intimate relationship of the cell layers along the surface of the interface between the bone and the cemented implant. The authors report on a technique for the processing and embedding of cemented orthopaedic implants which permits preservation of the polymethylmethacrylate cement. The method utilizes a modification of Spurr's low viscosity epoxy resin and avoids the use of solvents such as acetone. Undecalcified sections of cemented joint replacements from animal studies and human specimens have been prepared using this method. It is possible to use these sections for detailed histomorphologic and histomorphometric analysis of bone tissue and of the soft tissue membrane adjacent to the polymethylmethacrylate cement.
C1 PRINCESS MARGARET HOSP, BONE & JOINT PATHOL LAB, TORONTO M4X 1K9, ONTARIO, CANADA.
   WELLESLEY COLL HOSP, DEPT PATHOL, TORONTO M4Y 1J3, ONTARIO, CANADA.
   STANFORD UNIV, MED CTR, DIV ORTHOPAED SURG, R171, 300 PASTEUR DR, STANFORD, CA 94305 USA.
CR ANDERSON C, 1982, MANUAL EXAMINATION B
   BLOEBAUM RD, 1990, J HISTOTECHNOL, V13, P55, DOI 10.1179/his.1990.13.1.55
   BUTANY J, 1990, ASAIO T, V36
   COCSHUTT JR, 1988, VET COMP ORTHOPAED, V3, P141
   Drury R.A., 1967, CARLETONS HISTOLOGIC, P214
   EMMANUAL J, 1987, STAIN TECHNOL, V62, P401, DOI 10.3109/10520298709108030
   FORNASIER VL, 1975, HUM PATHOL, V6, P623, DOI 10.1016/S0046-8177(75)80046-3
   FORNASIER VL, 1976, CLIN ORTHOP RELAT R, P248
   FROST HM, 1959, STAIN TECHNOL, V34, P135, DOI 10.3109/10520295909114665
   FROST HM, 1958, STAIN TECHNOL, V33, P273, DOI 10.3109/10520295809111862
   GOODMAN SB, 1988, CLIN ORTHOP RELAT R, P255
   JOHNSTONE JC, 1973, MED LAB TECHNOL, V30, P355
   MURICELAMBERT E, 1989, STAIN TECHNOL, V64, P19, DOI 10.3109/10520298909108039
   OKEEFE P, 1976, MICROSTRUCT SCI, V4, P169
   RHINELANDER FW, 1979, COMBINED M ORTHOPAED
   SCHATZKER J, 1989, ARCH ORTHOP TRAUM SU, V108, P132, DOI 10.1007/BF00934255
   Schenk R. K., 1984, PREPARATION CALCIFIE
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   XIPELL J, 1974, STAIN TECHNOL, V49, P69, DOI 10.3109/10520297409116944
NR 19
TC 7
Z9 7
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SPR
PY 1992
VL 3
IS 1
BP 59
EP 62
DI 10.1002/jab.770030110
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HD761
UT WOS:A1992HD76100009
DA 2018-10-20
ER

PT J
AU BLOEBAUM, RD
   RUBMAN, MH
   MERRELL, M
   THACKER, K
   HOFMANN, AA
AF BLOEBAUM, RD
   RUBMAN, MH
   MERRELL, M
   THACKER, K
   HOFMANN, AA
TI HYALURONAN SOLUTION AS A CARTILAGE ANTIDESICCANT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INTRA-ARTICULAR INJECTIONS; SODIUM HYALURONATE; ARTHRITIS; GONARTHROSIS
AB During arthrotomy, desiccation of the articular cartilage of synovial joints by the ambient environment of the operating room causes chondrocyte death and may promote degenerative changes within the joint.  This study documents the efficacy of a biomaterial, hyaluronan (HY) solution, to maintain chondrocyte viability during desiccation.  Rabbit patellar articular cartilage was air-dried for 2 h with and without application of the HY solution.  As assessed by (SO4)-S-35 uptake and autoradiography, the HY solution helped maintain chondrocyte viability, when compared to air dried specimens (p less-than-or-equal-to 0.02).  HY solution applied to the articular surfaces of joints undergoing arthrotomy may offset the detrimental effects of desication, such as chondrocyte death and degenerative joint changes.
C1 UNIV UTAH,SCH MED,DIV ORTHOPED SURG,SALT LAKE CITY,UT 84112.
RP BLOEBAUM, RD (reprint author), DEPT VET AFFAIRS MED CTR,BONE & JOINT RES LABS,SALT LAKE CITY,UT, USA.
CR AKESON W, 1988, DIAGNOSIS BONE JOINT, P764
   ASHEIM A, 1976, ACTA VET SCAND, V17, P379
   BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407
   BAUMGARTEN M, 1985, J BONE JOINT SURG AM, V67A, P1336, DOI 10.2106/00004623-198567090-00005
   BLOEBAUM RD, 1981, THESIS U W AUSTR
   COLLINS DH, 1960, ANN RHEUM DIS, V19, P318, DOI 10.1136/ard.19.4.318
   GINGERICH D A, 1979, Journal of Veterinary Pharmacology and Therapeutics, V2, P291, DOI 10.1111/j.1365-2885.1979.tb00403.x
   GRECOMORO G, 1987, PHARMATHERAPEUTICA, V5, P137
   HAM A, 1974, JOINTS
   HORNBECK C, 1986, Journal of Histotechnology, V9, P227
   KOPP S, 1987, J ORAL MAXIL SURG, V45, P929, DOI 10.1016/0278-2391(87)90443-5
   KOPP S, 1985, J ORAL MAXIL SURG, V43, P429, DOI 10.1016/S0278-2391(85)80050-1
   LEARDINI G, 1987, CLIN TRIALS J, V24, P341
   MITCHELL N, 1989, J BONE JOINT SURG AM, V71A, P89, DOI 10.2106/00004623-198971010-00014
   NAMIKI O, 1982, INT J CLIN PHARM TH, V20, P501
   PEYRON JG, 1974, PATHOL BIOL, V22, P731
   REAGAN BF, 1983, J BONE JOINT SURG AM, V65, P629, DOI 10.2106/00004623-198365050-00007
   RYDELL N, 1971, CLIN ORTHOPAEDICS, V80, P25
   SHANFIELD S, 1988, CLIN ORTHOPAEDICS, V235, P289
   SIMON WH, 1976, J BONE JOINT SURG AM, V58, P517, DOI 10.2106/00004623-197658040-00015
   SIMON WH, 1981, CLIN ORTHOPAEDICS, V155, P259
   SPEER K, 1990, T ORTHOP RES SOC, V15, P349
   STONGE R, 1980, CLIN ORTHOP RELAT R, P269
   Straehely D, 1985, T ORTHOP RES SOC, V10, P260
   SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318
   WEISS C, 1981, SEMIN ARTHRITIS RHEU, V11, P143, DOI 10.1016/0049-0172(81)90081-0
NR 26
TC 7
Z9 7
U1 1
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1992
VL 26
IS 3
BP 303
EP 317
DI 10.1002/jbm.820260304
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HE263
UT WOS:A1992HE26300003
PM 1613023
DA 2018-10-20
ER

PT J
AU VERONSKI, A
   SUROVSKA, BM
AF VERONSKI, A
   SUROVSKA, BM
TI EFFECT OF HEAT-TREATMENT ON THE STRUCTURE OF COBALT ALLOYS USED AS
   MEDICAL IMPLANT MATERIAL
SO METAL SCIENCE AND HEAT TREATMENT
LA English
DT Article
AB Engineering and materials science have courageously entered the field of medicine. The replacement of live tissue by inorganic materials solves many functional problems which would be impossible with the implant of tissue. This requires that designers, technologists, and physicians become acquainted with the nature of the phenomena accompanying the implantation of biomaterial.
RP VERONSKI, A (reprint author), LUBLIN POLYTECH INST,LUBLIN,POLAND.
CR BARDOS DJ, 1979, BIOMAT MED DIV, P73
   Bylica A., 1985, TYTAN JEGO STOPY
   Dobbs H S, 1982, Eng Med, V11, P175
   IMMARIGEON JP, 1984, METALL TRANS A, V15, P339, DOI 10.1007/BF02645120
   JONES RL, 1979, CORROSION, V37, P226
   NIELSEN K, 1986, B KORROSIONSINST, V101, P413
   PERRY J, 1975, J BONE JOINT SURG AM, V57, P961, DOI 10.2106/00004623-197557070-00014
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   WERONSKI A, 1986, WIADOMOSCI HUTNICZE, P191
NR 9
TC 2
Z9 2
U1 0
U2 0
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 0026-0673
J9 MET SCI HEAT TREAT+
JI Met. Sci. Heat Treat.
PD MAR-APR
PY 1992
VL 34
IS 3-4
BP 210
EP 214
DI 10.1007/BF00703640
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA JP397
UT WOS:A1992JP39700014
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   ELLINGER, J
   LAM, TM
   ZENNI, GC
AF GREISLER, HP
   ELLINGER, J
   LAM, TM
   ZENNI, GC
TI BIOMATERIAL INDUCED MACROPHAGE ACTIVATION AND MONOKINE RELEASE
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 LOYOLA UNIV, MED CTR, MAYWOOD, IL 60153 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD FEB 28
PY 1992
VL 6
IS 5
BP A1603
EP A1603
PN 2
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA HH271
UT WOS:A1992HH27100018
DA 2018-10-20
ER

PT J
AU TSAI, CL
   LIU, TK
   HUNG, MH
AF TSAI, CL
   LIU, TK
   HUNG, MH
TI GLYCOCALYX PRODUCTION AND ADHERENCE OF STAPHYLOCOCCUS TO BIOMATERIALS
SO ACTA MEDICA OKAYAMA
LA English
DT Article
DE GLYCOCALYX; BACTERIAL ADHERENCE; STAPHYLOCOCCUS-EPIDERMIDIS BIOMATERIAL
   INFECTION; COLONY FORMING UNITS
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CEREBROSPINAL-FLUID SHUNTS; BACTERIAL
   ADHERENCE; SLIME PRODUCTION; INFECTION; STRAINS; EPIDERMIDIS; SURFACES;
   DEVICES; AUREUS
AB Glycocalyx is suggested to play an important role in the pathogenesis of biomaterial-centered infection. Using an accurate and sensitive method to quantify glycocalyx and bacterial adherence, we have demonstrated that the producer of the most glycocalyx also exhibited the highest adherence index, whereas low producers exhibited the least (p < 0.01). Additionally, at various concentrations the high producer had the greater tendency to adhere and grow on stainless steel wires and tubes (p < 0.001). The adherence index, referred as the ratio of tritiated thymidine uptake on wires to colony forming units (CFU), was also the highest in high producers. The adherence index increased as the glycocalyx index increased. It was suggested that glycocalyx production enhanced the adherence of Staphylococcus epidermidis to biomaterials and caused persistent and intractable infections. In short, the glycocalyx index and the adherence index can be reliable indices of biomaterial-centerted infection.
C1 NATL TAIWAN UNIV, COLL MED, DEPT BACTERIOL, TAIPEI, TAIWAN.
RP TSAI, CL (reprint author), NATL TAIWAN UNIV, COLL MED, DEPT ORTHOPAED SURG, TAIPEI, TAIWAN.
CR CALLAGHAN R, 1961, BRIT MED J, V1, P860, DOI 10.1136/bmj.1.5229.860
   CAPUTY GG, 1982, INFECT IMMUN, V36, P759
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   DIMITRACOPOULOS G, 1980, INFECT IMMUN, V30, P402
   DISMUKES WE, 1973, CIRCULATION, V48, P365, DOI 10.1161/01.CIR.48.2.365
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P517
   Hammond GW, 1975, CAN MED ASSOC J, V118, P524
   JONES HC, 1969, J BACTERIOL, V99, P316
   MARRIE TJ, 1983, AM J OBSTET GYNECOL, V146, P384, DOI 10.1016/0002-9378(83)90818-9
   MAYBERRYCARSON KJ, 1984, INFECT IMMUN, V43, P825
   MOORE WS, 1980, ARCH SURG-CHICAGO, V115, P1379
   PATTERSON FP, 1972, J BONE JOINT SURG AM, V54, P527
   SCHIMKE RT, 1961, NEW ENGL J MED, V264, P264, DOI 10.1056/NEJM196102092640602
   SCHOENBAUM SC, 1975, J INFECT DIS, V131, P543, DOI 10.1093/infdis/131.5.543
   TSAI CL, 1988, J ORTHOPAED RES, V6, P666, DOI 10.1002/jor.1100060507
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 22
TC 2
Z9 2
U1 0
U2 0
PU OKAYAMA UNIV MED SCHOOL
PI OKAYAMA
PA EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL
   2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN
SN 0386-300X
J9 ACTA MED OKAYAMA
JI Acta Med. Okayama
PD FEB
PY 1992
VL 46
IS 1
BP 11
EP 16
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HH017
UT WOS:A1992HH01700003
PM 1561900
DA 2018-10-20
ER

PT J
AU RIES, P
AF RIES, P
TI COLLAGENFLEECE AS A BIOIMPLANT FOR ORTHOPEDIC-SURGERY
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
ID BONE REGENERATION
AB Man-made bone implant materials as substitutes for autogenic spongiosa transplantation are reviewed, specifically materials made from collagen.  The intra- and extracellular biosynthesis of collagen is described.  Manufacture, properties and indications of sterile Collagen-fleece(TM), a well proven surgical biomaterial prepared from porcine collagen, is presented.  Further research led to the development of a new bone-replacement material called Collapat.
RP RIES, P (reprint author), PENTAPHARM LTD,DEPT RES & DEV,ENGELGASSE 109,CH-4002 BASEL,SWITZERLAND.
CR BEDACHT R, 1969, TIEREXPERIMENTELLE K
   BENFER J, 1972, DEUT MED WOCHENSCHR, V97, P523
   Buser D, 1986, Dtsch Z Mund Kiefer Gesichtschir, V10, P191
   BUSER D, 1984, THESIS U BERNE
   COBB CM, 1976, ORAL SURG ORAL MED O, V41, P24, DOI 10.1016/0030-4220(76)90248-6
   Gay S., 1978, COLLAGEN PHYSL PATHO
   Haussmann P, 1974, Fortschr Med, V92, P579
   JOOS U, 1980, BIOMATERIALS, V1, P23, DOI 10.1016/0142-9612(80)90053-8
   JOOS U, 1986, DEUT ZAHNAERZTL Z, V41, P426
   Joos U, 1978, ZWR, V87, P810
   JOOS U, 1978, HAMOSTYPTISCHE WIRKU
   Krekeler G, 1980, Dtsch Zahnarztl Z, V35, P18
   MERGARD U, 1971, THESIS U FREIBURG FR
   MITTELMEIER H, 1983, Z ORTHOP GRENZGEB, V121, P115, DOI 10.1055/s-2008-1051325
   Mittelmeier H., 1982, OSTEOGENESE KNOCHENW, P194
   RIEGE W, 1978, CHIRURG, V49, P246
   SPRINGORUM HW, 1977, Z ORTHOP GRENZGEB, V115, P686
   SPRINGORUM HW, 1980, TIEREXPERIMENTELLE U
   SPRINGORUM HW, 1982, OSTEOGENESE KNOCHEND, P211
NR 19
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0936-8051
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD FEB
PY 1992
VL 111
IS 2
BP 66
EP 69
DI 10.1007/BF00443469
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA HE669
UT WOS:A1992HE66900002
PM 1562426
DA 2018-10-20
ER

PT J
AU SHANBHAG, A
   YANG, J
   LILIEN, J
   BLACK, J
AF SHANBHAG, A
   YANG, J
   LILIEN, J
   BLACK, J
TI DECREASED NEUTROPHIL RESPIRATORY BURST ON EXPOSURE TO COBALT-CHROME
   ALLOY AND POLYSTYRENE INVITRO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID HUMAN POLYMORPHONUCLEAR LEUKOCYTES; FOREIGN-BODY INFECTION;
   CYTOCHALASIN-B; PHAGOCYTOSIS; METHYLMETHACRYLATE; PATHOGENESIS;
   EXOCYTOSIS; ADHERENCE; ADHESION
AB The effect of biomaterials on the superoxide-producing ability of neutrophils was studied. Human peripheral blood neutrophils were incubated with cobalt-base alloy (F-75) or polystyrene beads of a nonphagocytosable size. Respiratory burst activity was studied by measuring superoxide dismutase inhibitable reduction of cytochrome C. Neutrophils were found to release no more superoxide anion on incubation for up to 3 h with either material in a protein-free medium than controls without foreign material. However, the ability of neutrophils incubated with either biomaterial to subsequently respond to phorbol myristate acetate challenge was decreased (p < 0.05). Chemical analysis of supernatants for the F-75 samples showed a high concentration of cobalt in the medium within 1 h of incubation. Minimal chromium and nickel was detected. No correlation could be demonstrated between metal in solution and the respiratory burst defect in neutrophils. Instead it appears that interaction of cells with either surface was the critical event in altering the response to phorbol myristate acetate. This observed functional defect may play an important role in rendering tissue around implanted biomaterials susceptible to infections.
C1 CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634.
   CLEMSON UNIV,DEPT BIOL SCI,CLEMSON,SC 29634.
FU NIAMS NIH HHS [5R01 AR39334]
CR Absolom D R, 1986, Methods Enzymol, V132, P95
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   DAVIES P, 1973, LAB INVEST, V28, P16
   Dougherty SH, 1986, HDB BIOMATERIALS EVA, P276
   ELLIOTT TSJ, 1988, J MED MICROBIOL, V27, P161, DOI 10.1099/00222615-27-3-161
   Fleer A, 1989, J Invest Surg, V2, P391, DOI 10.3109/08941938909018264
   GOLDSTEIN IM, 1977, J CLIN INVEST, V59, P249, DOI 10.1172/JCI108635
   GRISHAM MB, 1985, J IMMUNOL METHODS, V82, P315, DOI 10.1016/0022-1759(85)90363-1
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HUNT JE, 1990, AUG BIOINT 90 OXF
   Jansen B, 1989, J Invest Surg, V2, P361, DOI 10.3109/08941938909018262
   KELLY DE, 1984, BAILEYS TXB MICROSCO, P232
   KLOCK JC, 1976, BLOOD, V48, P149
   MALAWISTA SE, 1971, YALE J BIOL MED, V44, P286
   MARKERT M, 1984, METHOD ENZYMOL, V105, P358
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   MCNAMARA A, 1981, BIOMATERIALS, V2, P33, DOI 10.1016/0142-9612(81)90085-5
   MORA EM, 1990, T SOC BIOMATERIALS, V13, P163
   MURPHY P, 1976, NEUTROPHIL, P179
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   PETTY W, 1978, J BONE JOINT SURG AM, V60, P752, DOI 10.2106/00004623-197860060-00004
   PETTY W, 1978, J BONE JOINT SURG AM, V60, P492, DOI 10.2106/00004623-197860040-00011
   Pick E, 1986, Methods Enzymol, V132, P407
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   RAE T, 1983, BIOMATERIALS, V4, P175, DOI 10.1016/0142-9612(83)90006-6
   REMES A, 1990, J MATER SCI-MATER M, V1, P26, DOI 10.1007/BF00705350
   Roos D, 1986, Methods Enzymol, V132, P225
   Smolen JE, 1989, NEUTROPHIL CELLULAR, P23
   TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901
   WRIGHT DG, 1979, J IMMUNOL, V123, P285
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 33
TC 48
Z9 49
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1992
VL 26
IS 2
BP 185
EP 195
DI 10.1002/jbm.820260205
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GZ869
UT WOS:A1992GZ86900004
PM 1314837
DA 2018-10-20
ER

PT J
AU BLAYNEY, AW
   WILLIAMS, KR
   ERRE, JP
   LESSER, THJ
   PORTMANN, M
AF BLAYNEY, AW
   WILLIAMS, KR
   ERRE, JP
   LESSER, THJ
   PORTMANN, M
TI PROBLEMS IN ALLOPLASTIC MIDDLE-EAR RECONSTRUCTION
SO ACTA OTO-LARYNGOLOGICA
LA English
DT Article
DE MIDDLE EAR; RECONSTRUCTION; BIOMATERIALS; CERAMICS
ID PROSTHESIS
AB Alloplastic materials have been used in middle ear reconstruction since 1952. Biologically, biomaterials and specifically ceramics can be defined as being bioinert, bioactive or biodegradable; these terms being descriptive of the biochemical response provoked by the material in the host tissue. Various ceramics, carbons and polymers and their reactions have been studied by the author and his colleagues over the past 5 years utilising animal implantation and fibroblast culture studies aligned with experience from clinical usage. The qualities of the ideal alloplastic implant namely: biocompatibility, stabilisation and incorporation, the consistency of the implant and bioactive bonding and the biofunctionality or mechanics, are applied to the materials currently available. No single alloplastic material fulfills all criteria, the problems encountered in relation to the biomaterials are reported. A better understanding of the microstresses, fatigue and microfractures is necessary, before the ideal alloplastic biomaterial becomes available.
C1 UNIV WALES COLL MED,DEPT BASIC MED SCI,CARDIFF CF4 4XN,S GLAM,WALES.
   INSERM,SERV OTORHINOLARYNGOL,AUDIOL EXPTL LAB,F-33077 BORDEAUX,FRANCE.
   UNIV WALES COLL MED,DEPT OTOLARYNGOL,CARDIFF CF4 4XN,S GLAM,WALES.
RP BLAYNEY, AW (reprint author), MATER PRIVATE HOSP,DEPT OTOLARYNGOL,SUITE 2,DUBLIN 7,IRELAND.
CR AUSTIN DF, 1965, ARCHIV OTOLARYNGOL, V81, P20
   BLAYNEY AW, 1986, CLIN OTOLARYNGOL, V11, P189, DOI 10.1111/j.1365-2273.1986.tb00127.x
   BLAYNEY AW, 1985, THESIS NATIONAL U IR
   BRUCKMANN H, 1980, BIOMATERIALS, V1, P73, DOI 10.1016/0142-9612(80)90003-4
   FROOTKO NJ, 1983, 1ST P INT S BIOM OT, P169
   GROTE JJ, 1990, ANN OTO RHINOL LARYN, V144, P12
   HOBKIRK JA, 1977, J ORAL REHABIL, V4, P355, DOI 10.1111/j.1365-2842.1977.tb01001.x
   HOUSE HP, 1960, ARCHIV OTOLARYNGOL, V71, P926
   Jahnke K, 1988, Adv Otorhinolaryngol, V39, P65
   JANEKE JB, 1976, S AFR MED J, V50, P781
   JENKINS GM, 1980, CLIN PHYS PHYSL MEAS, V1, P171
   KERR AG, 1983, 1ST P INT S BIOM OT, P161
   KLEY W, 1955, LARYN RHINOL OTOL, V34, P719
   LESSER THJ, 1991, CLIN OTOLARYNGOL, V16, P29, DOI 10.1111/j.1365-2273.1991.tb01938.x
   PALVA T, 1987, CLIN OTOLARYNGOL, V12, P33, DOI 10.1111/j.1365-2273.1987.tb00160.x
   Reck R, 1988, Ann N Y Acad Sci, V523, P100, DOI 10.1111/j.1749-6632.1988.tb38504.x
   SHEA JJ, 1974, LARYNGOSCOPE, V84, P1835, DOI 10.1288/00005537-197410000-00014
   SHEA JJ, 1962, ARCHIV OTOLARYNGOL, V76, P516
   SHEA JJ, 1976, LARY NGOSCOPE, V876, P239
   Wullstein HL, 1952, ARCH OHR NAS KEHLKOP, V161, P422, DOI [DOI 10.1007/BF02129204, 10.1007/BF02129204]
   YAMAMOTO E, 1987, J LARYNGOL OTOL, V101, P897, DOI 10.1017/S0022215100102944
NR 21
TC 17
Z9 17
U1 0
U2 0
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0001-6489
J9 ACTA OTO-LARYNGOL
JI Acta Oto-Laryngol.
PY 1992
VL 112
IS 2
BP 322
EP 327
DI 10.1080/00016489.1992.11665426
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA HR482
UT WOS:A1992HR48200030
PM 1605000
DA 2018-10-20
ER

PT B
AU BERTOLUZZA, A
   MORELLI, MA
   TINTI, A
AF BERTOLUZZA, A
   MORELLI, MA
   TINTI, A
BE RAVAGLIOLI, A
   KRAJEWSKI, A
TI RELATIONSHIPS BETWEEN BULK AND SURFACE-STRUCTURE AND BIOMATERIAL
   BIOCOMPATIBILITY
SO BIOCERAMICS AND THE HUMAN BODY
LA English
DT Proceedings Paper
CT INTERNATIONAL CONGRESS ON BIOCERAMICS AND THE HUMAN BODY
CY APR 02-05, 1991
CL FAENZA, ITALY
SP CNR
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER APPL SCI PUBL LTD
PI BARKING ESSEX
PA BARKING ESSEX
BN 1-85166-748-2
PY 1992
BP 189
EP 194
PG 6
WC Engineering, Biomedical; Materials Science, Ceramics
SC Engineering; Materials Science
GA BW91A
UT WOS:A1992BW91A00023
DA 2018-10-20
ER

PT B
AU USHIDA, T
   NAKAYAMA, M
   TATEISHI, T
AF USHIDA, T
   NAKAYAMA, M
   TATEISHI, T
BE Doherty, PJ
   Williams, RL
   Williams, DF
   Lee, AJC
TI CELL-ADHESION STRENGTH TO BIOMATERIALS AND INFLUENCE OF FIBRONECTIN
SO BIOMATERIAL-TISSUE INTERFACES
SE ADVANCES IN BIOMATERIALS-UK
LA English
DT Proceedings Paper
CT 9TH EUROPEAN CONF ON BIOMATERIALS
CY SEP 09-11, 1991
CL CHESTER, ENGLAND
DE BIOMATERIAL; CELL ADHESION; ADHESION STRENGTH; CELL MORPHOLOGY
NR 0
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA AMSTERDAM
BN 0-444-89065-3
J9 ADV BIOMAT
PY 1992
VL 10
BP 99
EP 103
PG 5
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BX47G
UT WOS:A1992BX47G00014
DA 2018-10-20
ER

PT B
AU GROTH, T
   MIHANETZIS, G
   MISSIRLIS, Y
   WOLF, H
AF GROTH, T
   MIHANETZIS, G
   MISSIRLIS, Y
   WOLF, H
BE Doherty, PJ
   Williams, RL
   Williams, DF
   Lee, AJC
TI THE INTERRELATIONSHIP BETWEEN PLATELET-ADHESIVENESS AND RELEASED
   PLATELET FACTORS DURING STANDARDIZED INVITRO BLOOD BIOMATERIAL CONTACT
SO BIOMATERIAL-TISSUE INTERFACES
SE ADVANCES IN BIOMATERIALS-UK
LA English
DT Proceedings Paper
CT 9TH EUROPEAN CONF ON BIOMATERIALS
CY SEP 09-11, 1991
CL CHESTER, ENGLAND
DE HEMOCOMPATIBILITY; PLATELET ADHESION; PLATELET RELEASE REACTION
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA AMSTERDAM
BN 0-444-89065-3
J9 ADV BIOMAT
PY 1992
VL 10
BP 247
EP 251
PG 5
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BX47G
UT WOS:A1992BX47G00035
DA 2018-10-20
ER

PT B
AU FLAUTRE, B
   ANSELME, K
   DEVYVER, B
   CHOPIN, D
   HARDOUIN, P
AF FLAUTRE, B
   ANSELME, K
   DEVYVER, B
   CHOPIN, D
   HARDOUIN, P
BE Doherty, PJ
   Williams, RL
   Williams, DF
   Lee, AJC
TI RADIOLOGICAL AND HISTOLOGICAL STUDY OF SPINAL ARTHRODESIS AFTER PORITES
   CORAL IMPLANTATION IN SHEEP
SO BIOMATERIAL-TISSUE INTERFACES
SE ADVANCES IN BIOMATERIALS-UK
LA English
DT Proceedings Paper
CT 9TH EUROPEAN CONF ON BIOMATERIALS
CY SEP 09-11, 1991
CL CHESTER, ENGLAND
DE BIOMATERIAL; AUTOLOGOUS BONE GRAFT, EXPERIMENTAL SPINAL ARTHRODESIS
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA AMSTERDAM
BN 0-444-89065-3
J9 ADV BIOMAT
PY 1992
VL 10
BP 311
EP 317
PG 7
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BX47G
UT WOS:A1992BX47G00043
DA 2018-10-20
ER

PT B
AU SZMUKLERMONCLER, S
   DACULSI, G
   DELECRIN, J
   PASSUTI, N
   DEUDON, C
AF SZMUKLERMONCLER, S
   DACULSI, G
   DELECRIN, J
   PASSUTI, N
   DEUDON, C
BE Doherty, PJ
   Williams, RL
   Williams, DF
   Lee, AJC
TI CALCIUM-METALLIC-PHOSPHATES - A NEW COATING BIOMATERIAL
SO BIOMATERIAL-TISSUE INTERFACES
SE ADVANCES IN BIOMATERIALS-UK
LA English
DT Proceedings Paper
CT 9TH EUROPEAN CONF ON BIOMATERIALS
CY SEP 09-11, 1991
CL CHESTER, ENGLAND
DE CZP; BIOCOMPATIBILITY; IR SPECTROSCOPY
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
NR 0
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA AMSTERDAM
BN 0-444-89065-3
J9 ADV BIOMAT
PY 1992
VL 10
BP 377
EP 383
PG 7
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BX47G
UT WOS:A1992BX47G00052
DA 2018-10-20
ER

PT B
AU RUIJGROK, JM
   DEWIJN, JR
   BOON, ME
   DEGROOT, K
AF RUIJGROK, JM
   DEWIJN, JR
   BOON, ME
   DEGROOT, K
BE Doherty, PJ
   Williams, RL
   Williams, DF
   Lee, AJC
TI SHRINKAGE TEMPERATURE PROFILES OF GLUTARALDEHYDE TANNED COLLAGEN IN A
   MULTILAYER DIFFUSION-MODEL
SO BIOMATERIAL-TISSUE INTERFACES
SE ADVANCES IN BIOMATERIALS-UK
LA English
DT Proceedings Paper
CT 9TH EUROPEAN CONF ON BIOMATERIALS
CY SEP 09-11, 1991
CL CHESTER, ENGLAND
DE GLUTARALDEHYDE; COLLAGEN; BIOMATERIAL
NR 0
TC 2
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA AMSTERDAM
BN 0-444-89065-3
J9 ADV BIOMAT
PY 1992
VL 10
BP 453
EP 457
PG 5
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BX47G
UT WOS:A1992BX47G00062
DA 2018-10-20
ER

PT J
AU ELAGLI, K
   NEUT, C
   ROMOND, C
   HILDEBRAND, HF
AF ELAGLI, K
   NEUT, C
   ROMOND, C
   HILDEBRAND, HF
TI INVITRO EFFECTS OF TITANIUM POWDER ON ORAL BACTERIA
SO BIOMATERIALS
LA English
DT Article
DE TITANIUM; BACTERIA; DENTAL MATERIALS
ID IMPLANTS
AB Biomaterial research has been mostly concerned with biocompatibility, i.e. tissue response, of materials for dental or orthopaedic implantation. In this study, the effects of titanium powder on seven bacterial species commonly found in dental plaque or gingival sulcus, were determined by agar incorporation and by liquid medium culture. In neither culture system could any inhibitory or stimulatory activity be detected.
C1 FAC MED LILLE,INST MED TRAVAIL,1 PL VERDUM,F-59045 LILLE,FRANCE.
   FAC PHARM LILLE,MICROBIOL LAB,F-59045 LILLE,FRANCE.
RI Neut, Christel/S-2521-2018
OI Neut, Christel/0000-0002-2036-6152
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALEXANDER M, 1971, MICROBIAL ECOLOGY
   Breme J, 1989, Int J Oral Maxillofac Implants, V4, P113
   Breme J., 1989, MEMOIRES ETUDES SCI, P625
   BUNDY KJ, 1980, J BIOMED MATER RES, V14, P653, DOI 10.1002/jbm.820140511
   DEVEAUX E, 1990, ORAL MICROBIOL IMMUN, V5, P320, DOI 10.1111/j.1399-302X.1990.tb00433.x
   ELAGLI K, 1989, CHIR DENT FRANCE, V457, P35
   ELAGLI K, 1991, INNOV TECH BIOL MED, V12, P191
   ERICSSON I, 1986, J CLIN PERIODONTOL, V13, P307, DOI 10.1111/j.1600-051X.1986.tb02227.x
   Frazier M. E, 1979, TRACE METALS HLTH DI, P71
   Hildebrand H F, 1984, Rev Odontostomatol (Paris), V13, P41
   JOSHI RI, 1988, J MED MICROBIOL, V27, P105, DOI 10.1099/00222615-27-2-105
   NEUT C, 1987, ZBL BAKT-INT J MED M, V266, P330
   Simpson JH, 1986, BAROCLINIC PROCESSES, P63
   SOCRANSKY SS, 1971, J PERIODONTOL, V42, P485, DOI 10.1902/jop.1971.42.8.485
   WEST SEH, 1980, ANTIMICROB AGENTS CH, V17, P288, DOI 10.1128/AAC.17.2.288
NR 16
TC 20
Z9 22
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 1
BP 25
EP 27
DI 10.1016/0142-9612(92)90090-B
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HA923
UT WOS:A1992HA92300005
PM 1543803
DA 2018-10-20
ER

PT J
AU LETOURNEUR, D
   JOZEFOWICZ, M
AF LETOURNEUR, D
   JOZEFOWICZ, M
TI INSOLUBLE DNA-LIKE PHOSPHORYLATED POLYSTYRENE - SPECIFIC INTERACTIONS
   WITH ANTI-DNA ANTIBODIES FROM SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
SO BIOMATERIALS
LA English
DT Article
DE PHOSPHORYLATED POLYSTYRENES; ANTIBODIES; DNA
ID CELL-SURFACE PROTEIN(S); NATIVE DNA; AUTOANTIBODIES; BINDING; AFFINITY;
   THROMBIN; RESINS; SERA
AB Systemic lupus erythematosus (SLE) is an autoimmune disease. Antibodies directed mainly against DNA and/or phospholipids are present in the serum of SLE patients. Therefore phosphorylated polystyrene derivatives acting as DNA-like polymers should be able to interact with the SLE anti-DNA antibodies. Such functional polymers were synthesized and subsequently their interactions with the anti-DNA antibodies studied. Adsorption experiments performed with both anti-DNA antibodies and normal immunoglobulins showed high affinity constants of the phosphorylated polymer for anti-DNA antibodies (4 X 10(9) M-1) whereas for normal IgG the affinity was low (2 X 10(5) M-1). Moreover, the interaction was specific involving the idiotypic moiety of the anti-DNA antibodies and an array of phosphoester groups at the surface of this biomaterial.
RP LETOURNEUR, D (reprint author), CSP UNIV PARIS NORD,RECH MACROMOLEC LAB,AVE JB CLEMENT,F-93430 VILLETANEUSE,FRANCE.
RI Didier, letourneur/H-5268-2012
OI Didier, letourneur/0000-0003-2197-9468
CR AARDEN LA, 1976, J IMMUNOL METHODS, V11, P153, DOI 10.1016/0022-1759(76)90143-5
   Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   ANDRZEJEWSKI C, 1981, J IMMUNOL, V126, P226
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   CARROLL P, 1985, J IMMUNOL, V135, P1086
   EMLEN W, 1986, ARTHRITIS RHEUM, V29, P1417, DOI 10.1002/art.1780291201
   FOUGNOT C, 1983, BIOMATERIALS, V4, P294, DOI 10.1016/0142-9612(83)90031-5
   FRECHET JMJ, 1979, J ORG CHEM, V44, P1774, DOI 10.1021/jo01325a006
   FRECHET JMJ, 1977, CHEM PROPERTIES CROS, P59
   JACOB L, 1984, P NATL ACAD SCI-BIOL, V81, P3843, DOI 10.1073/pnas.81.12.3843
   JACOB L, 1986, P NATL ACAD SCI USA, V83, P6970, DOI 10.1073/pnas.83.18.6970
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   JOZEFOWICZ M, 1988, ACTA POLYM, V39, P331, DOI 10.1002/actp.1988.010390701
   JOZEFOWICZ M, 1988, ACTA POLYM, V39, P321
   LAFER EM, 1981, J EXP MED, V153, P897, DOI 10.1084/jem.153.4.897
   LETOURNEUR D, 1990, CLIN EXP RHEUMATOL, V8, P208
   LETOURNEUR D, 1988, Patent No. 7235113
   Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
   MANTHORPE R, 1978, ALLERGY, V33, P42, DOI 10.1111/j.1398-9995.1978.tb01505.x
   MINITER MF, 1979, ARTHRITIS RHEUM, V22, P959, DOI 10.1002/art.1780220903
   PISETSKY DS, 1908, MED CLIN N AM, V70, P337
   RAUCH J, 1985, J IMMUNOL, V134, P180
   REICHLIN M, 1981, CLIN EXP IMMUNOL, V44, P1
   SCHWARTZ RS, 1985, J CLIN INVEST, V75, P321, DOI 10.1172/JCI111704
   SHOENFELD Y, 1983, NEW ENGL J MED, V308, P414, DOI 10.1056/NEJM198302243080802
   STOLLAR BD, 1981, CLIN IMMUNOL ALLERGY, V1, P243
   TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
   TRON F, 1977, CLIN EXP IMMUNOL, V28, P426
   VALESINI G, 1987, CLIN EXP IMMUNOL, V70, P18
   YOUNT WJ, 1988, MONOGR ALLERGY, V23, P41
   YU XJ, 1986, J CHROMATOGR, V376, P429, DOI 10.1016/S0378-4347(00)80860-9
NR 31
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 1
BP 59
EP 63
DI 10.1016/0142-9612(92)90096-7
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HA923
UT WOS:A1992HA92300011
PM 1543810
DA 2018-10-20
ER

PT J
AU VALENTINI, RF
   VARGO, TG
   GARDELLA, JA
   AEBISCHER, P
AF VALENTINI, RF
   VARGO, TG
   GARDELLA, JA
   AEBISCHER, P
TI ELECTRICALLY CHARGED POLYMERIC SUBSTRATES ENHANCE NERVE-FIBER OUTGROWTH
   INVITRO
SO BIOMATERIALS
LA English
DT Article
DE NERVE REGENERATION; SYNTHETIC NERVE GUIDES; SURFACE CHARACTERIZATION;
   PIEZOELECTRIC POLYMERS
ID MORPHOLOGICAL-DIFFERENTIATION; NEUROBLASTOMA-CELLS; NEURITE OUTGROWTH;
   GROWTH; CULTURE; REGENERATION; FIELDS
AB The physical, chemical and electrical properties of synthetic guidance devices are known to influence nerve regeneration in vivo. In the present study, neurons were cultured directly on electrically charged polymer growth substrates to determine if local electrical charges enhance nerve fibre outgrowth in vitro. Piezoelectric polymers such as polyvinylidene fluoride (PVDF) generate transient surface charges under minute mechanical strain. Mouse neuroblastoma (Nb2a) cells were cultured directly on electrically poled (i.e. piezoelectric) and unpoled (i.e. non-piezoelectric) PVDF substrates in serum-free and serum-containing media. Nerve fibre outgrowth was analysed 24, 48, 72 and 96 h after plating. Piezoelectric PVDF substrates generated 2-3 mV at 1200 Hz when placed on standard incubator shelves and unpoled PVDF substrates showed no output. Nb2a cells grown on piezoelectric substrates exhibited significantly greater levels of process outgrowth and neurite lengths at all time periods for both media conditions. Detailed surface characterization of PVDF substrates using electron spectroscopy for chemical analysis (ESCA) and a comprehensive wettability profile revealed that poled and unpoled PVDF was chemically indistinguishable and showed similar surface wettabilities and adhesive properties. Therefore, we conclude that enhanced process outgrowth was induced by the film's piezoelectric output, making poled PVDF a unique biomaterial for which cell/polymer interactions are mediated predominantly through bulk electrical properties rather than surface properties.
C1 BROWN UNIV,ARTIFICIAL ORGANS BIOMAT & CELLULAR TECHNOL SECT,PROVIDENCE,RI 02912.
   SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
   SUNY BUFFALO,CTR BIOSURFACES,BUFFALO,NY 14214.
RI Aebischer, Patrick/E-1387-2013
FU NINDS NIH HHS [NS 26159]
CR AEBISCHER P, 1988, TISSUE ENG, P257
   AEBISCHER P, 1987, BRAIN RES, V2436, P165
   BORGENS RB, ELECTRIC FIELDS VERT, P117
   BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514
   BRIGHTON CT, 1979, ELECTRICAL PROPERTIE
   BROADHURST MG, 1987, TOP APPL PHYS, V33, P285
   DAVIS GT, 1984, FERROELECTRICS, V57, P73, DOI 10.1080/00150198408012753
   EDELMAN GM, 1985, MOL BASES NEURONAL D
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   FRANK EH, 1987, J BIOMECH, V20, P615, DOI 10.1016/0021-9290(87)90282-X
   Fukada E., 1981, MECHANISMS GROWTH CO, P192
   GOLDBERG DJ, 1989, TRENDS NEUROSCI, V12, P503, DOI 10.1016/0166-2236(89)90110-0
   GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440
   HOOK DJ, 1991, LANGMUIR, V7, P142, DOI 10.1021/la00049a026
   JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114
   KLIGMAN D, 1987, DEV BRAIN RES, V33, P296, DOI 10.1016/0165-3806(87)90163-5
   LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6
   LETOURNEAU PC, 1985, MOL BASES NEURAL DEV, P269
   LIPINSKI R, 1982, ELECTRONIC CONDUCTIO
   LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115
   MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882
   MARINO AA, 1970, NATURE, V228, P473, DOI 10.1038/228473a0
   MASCARENHAS S, 1987, TOP APPL PHYS, V33, P321
   MCLEOD KJ, 1987, SCIENCE, V236, P1465, DOI 10.1126/science.3589667
   NELSON PG, 1975, PHYSIOL REV, V55, P1
   PATEL N, 1982, J NEUROSCI, V2, P483
   PATEL NB, 1984, J NEUROSCI, V4, P2939
   PRASAD KN, 1972, NATURE-NEW BIOL, V236, P49
   PRASAD KN, 1975, BIOL REV, V50, P129, DOI 10.1111/j.1469-185X.1975.tb01055.x
   SCHUBERT D, 1971, DEV BIOL, V25, P514, DOI 10.1016/0012-1606(71)90004-2
   SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   WEAVER JC, 1990, SCIENCE, V247, P459, DOI 10.1126/science.2300806
NR 34
TC 116
Z9 116
U1 5
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 3
BP 183
EP 190
DI 10.1016/0142-9612(92)90069-Z
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HF571
UT WOS:A1992HF57100010
PM 1567943
DA 2018-10-20
ER

PT J
AU GUIDOIN, R
   SIGOT, M
   KING, M
   SIGOTLUIZARD, MF
AF GUIDOIN, R
   SIGOT, M
   KING, M
   SIGOTLUIZARD, MF
TI BIOCOMPATIBILITY OF THE VASCUGRAFT (R) - EVALUATION OF A NOVEL POLYESTER
   URETHANE VASCULAR SUBSTITUTE BY AN ORGANOTYPIC CULTURE TECHNIQUE
SO BIOMATERIALS
LA English
DT Article
DE VASCULAR PROSTHESES; POLYURETHANES; BLOOD-MATERIAL INTERACTIONS; CELL
   CULTURE
ID POLYURETHANE MICROVASCULAR PROSTHESIS; HYDROPHILIC MICROPOROUS
   POLYURETHANE; EXPANDED POLYTETRAFLUOROETHYLENE; ABDOMINAL-AORTA; VEIN
   GRAFTS; DOGS; POLYETHERURETHANE; ARTERIES; FILMS; UREA
AB To evaluate the biocompatibility of chemically and structurally modified polyurethane elastomers for use as blood vessel replacements, small squares of vascular prostheses were cultured in direct contact with endothelium from chick embryo aorta using an organotypic culture assay. The polyurethane materials tested were: Vascugraft(R) (fibrous, open pore structure); commercial Hydrophilic Mitrathane(R) prosthesis (high porosity, smooth surface, non-permeable, closed pore structure); experimental hydrophobic Mitrathane (less porosity but a fibrous, open pore structure, similar to Vascugraft). The commercial expanded polytetrafluoroethylene prostheses Impra(R) and reinforced GORETEX(R) were included as controls on account of their extensive clinical application in the femoropopliteal position. After 5 d incubation at 37-degrees-C biocompatibility was assessed in terms of average area of migrating cells on the biomaterial, total number of cells surrounding the explant and level of adhesion between the cells and the biomaterial. The Vascugraft prosthesis promoted the growth of a continuous monolayer of cells on its surface. This behaviour was equivalent to Impra and reinforced GORETEX materials in terms of cell density and area of cell migration but appeared to be superior for cell adhesion. From a second series of cell culture tests, in which the extractables leached from the biomaterials were added to the nutrient medium, it was concluded that none of the biomaterials tested released cytotoxic contaminants.
C1 HOP ST FRANCOIS ASSISE,INST BIOMAT,QUEBEC CITY,QUEBEC,CANADA.
   UNIV TECHNOL COMPIEGNE,DEPT GENIE BIOL,F-60206 COMPIEGNE,FRANCE.
   UNIV MANITOBA,FAC HUMAN ECOL,WINNIPEG R3T 2N2,MANITOBA,CANADA.
RP GUIDOIN, R (reprint author), UNIV LAVAL,DEPT CHIRURG,QUEBEC CITY G1K 7P4,QUEBEC,CANADA.
CR ANNIS D, 1978, T AM SOC ART INT ORG, V24, P209
   BRAUN B, 1988, VASA J VASC DIS S, V22, P5
   BURKEL WE, 1976, ANN NY ACAD SCI, V283, P419
   BUSH HL, 1984, J VASC SURG, V1, P149
   CAMILLERI JP, 1985, ARCH PATHOL LAB MED, V109, P833
   CHARARA J, 1991, HIGH PERFORMANCE BIO, P287
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   ESQUIVEL CO, 1984, SURGERY, V95, P102
   Fisher A C, 1985, Trans Am Soc Artif Intern Organs, V31, P324
   GILDING DK, 1984, T AM SOC ART INT ORG, V30, P571
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P213
   HESS F, 1983, J CARDIOVASC SURG, V24, P516
   HESS F, 1983, J CARDIOVASC SURG, V24, P509
   HOW TV, 1984, J BIOMECH, V17, P597, DOI 10.1016/0021-9290(84)90091-5
   JANSEN B, 1985, J BIOMED MATER RES, V19, P1085, DOI 10.1002/jbm.820190918
   KOWLIGI RR, 1986, 5TH SO BIOM ENG C, P125
   LANNERSTAD O, 1986, ACTA CHIR SCAND, V152, P187
   LEI B, 1985, T AM SOC ART INT ORG, V37, P107
   LEIDNER J, 1983, J BIOMED MATER RES, V17, P229, DOI 10.1002/jbm.820170203
   Lelah M. D., 1986, POLYURETHANES MED
   MAROIS Y, 1989, BIOMATERIALS, V10, P521, DOI 10.1016/0142-9612(89)90057-4
   MARTZ H, 1988, J BIOMED MATER RES, V22, P63, DOI 10.1002/jbm.820220107
   MARTZ H, 1987, BIOMATERIALS, V8, P3, DOI 10.1016/0142-9612(87)90020-2
   MARTZ H, 1987, J BIOMED MATER RES, V21, P399, DOI 10.1002/jbm.820210311
   MERHI Y, 1988, CLIN INVEST MED, V11, P403
   SHIBUTA R, 1986, J BIOMED MATER RES, V20, P971, DOI 10.1002/jbm.820200712
   SIGOTLUIZARD MF, 1986, IN VITRO CELL DEV B, V22, P234
   SIGOTLUIZARD MF, 1988, MAR C METH IN VITR P
   SOSA K, 1985, BIOMATERIALS, V6, P312, DOI 10.1016/0142-9612(85)90087-0
   STANLEY JC, 1986, ASTM STP, V898, P33
   TEIJEIRA FJ, 1989, BIOMATERIALS, V10, P80, DOI 10.1016/0142-9612(89)90035-5
   VEITH FJ, 1978, SURG GYNECOL OBSTET, V147, P749
   WILKES GL, 1973, J BIOMED MATER RES, V7, P541, DOI 10.1002/jbm.820070606
NR 33
TC 23
Z9 23
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 5
BP 281
EP 288
DI 10.1016/0142-9612(92)90051-O
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HQ144
UT WOS:A1992HQ14400003
PM 1600030
DA 2018-10-20
ER

PT J
AU SAUTIER, JM
   NEFUSSI, JR
   FOREST, N
AF SAUTIER, JM
   NEFUSSI, JR
   FOREST, N
TI SURFACE-REACTIVE BIOMATERIALS IN OSTEOBLAST CULTURES - AN
   ULTRASTRUCTURAL-STUDY
SO BIOMATERIALS
LA English
DT Article
DE CELL-MATERIAL INTERFACE; OSTEOBLASTS; ULTRASTRUCTURE
ID INTERFACE
AB The tissue/biomaterial interface reactions of three biomaterials selected as candidates for hard tissue replacement were studied at the electron microscopical level after incubation with enzymatically isolated rat bone cells. An electron-dense layer was routinely observed between hydroxyapatite, coral, cytodex polymer and the neighbouring cells. This layer was visible before bone formation occurred, and was collagen free. The ultrastructural features revealed a needle-shaped filamentous layer continuous with coral material, whereas hydroxyapatite or cytodex/tissue interface was granular in appearance. These different structures may indicate reactive surfaces, depending on the composition of the substrate.
RP SAUTIER, JM (reprint author), UNIV PARIS 07, BIOL ODONTOL LAB, F-75221 PARIS 05, FRANCE.
CR DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   Hench L L, 1973, Med Instrum, V7, P136
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   LINDE A, 1989, CONNECT TISSUE RES, V21, P527
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   SAUTIER JM, IN PRESS CALCIF TISS
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
NR 10
TC 38
Z9 38
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 6
BP 400
EP 402
DI 10.1016/0142-9612(92)90046-Q
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HU926
UT WOS:A1992HU92600010
PM 1377034
DA 2018-10-20
ER

PT J
AU SCHMIDT, JA
   VONRECUM, AF
AF SCHMIDT, JA
   VONRECUM, AF
TI SURFACE CHARACTERIZATION OF MICROTEXTURED SILICONE
SO BIOMATERIALS
LA English
DT Article
DE MICROTEXTURED SILICONE; PROFILOMETRY
ID BIOMATERIAL SURFACES; ROUGHNESS
AB A set of microtextured silicone surfaces was manufactured using the technique of photolithography. The textures consist of a uniform array that imparts anisotropy to the surfaces. Processing the material required multiple steps which may have altered the surface characteristics. This project aimed to determine if a surface texture on implant grade silicone would affect the material characteristics. ESCA and contact angle studies revealed no measurable alteration of the surface chemistry or surface energy due to the texturing procedure or the presence of the texture. Both analytical techniques confirmed the material was silicone. The actual dimensions of the surface textures, size, spacing, depth and orientation of the textures were found to be close to the design values, using SEM and quantitative two- and three-dimensional profilometry. Standard 2D profilometry was not sufficient to characterize the surfaces, as a direct result of the uniformity of the arrays. A method of characterizing regular surface periodic structures is presented.
C1 CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634.
CR BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   BAIER RE, 1986, HDB BIOMATERIALS EVA, P101
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   GUENARD V, 1991, BIOMATERIALS, V12, P259, DOI 10.1016/0142-9612(91)90210-2
   HECKER JF, 1981, J BIOMED MATER RES, V15, P1, DOI 10.1002/jbm.820150104
   LANGE S, 1986, WYKO86002 APPL NOT
   MEYER AE, 1986, HDB BIOMATERIALS EVA, P131
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   OWEN MJ, 1990, ADV CHEM SER, V244, P705
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   RATNER BD, 1986, SPECTROSC-BIOMED APP, P107
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RICH A, 1981, J CELL SCI, V50, P1
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P483, DOI 10.1016/0142-9612(92)90171-J
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   WHITEHOUSE DJ, 1976, CHARACTERIZATION SOL, P49
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 18
TC 23
Z9 23
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 10
BP 675
EP 681
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JK985
UT WOS:A1992JK98500005
PM 1420712
DA 2018-10-20
ER

PT J
AU MCCLUNG, WG
   FEUERSTEIN, IA
AF MCCLUNG, WG
   FEUERSTEIN, IA
TI EPIFLUORESCENT VIDEO MICROSCOPY (EVM) FOR PLATELET-BIOMATERIAL
   INTERACTIONS - ELIMINATION OF PHOTOACTIVATION AND DYE EFFECTS
SO BIOMATERIALS
LA English
DT Article
DE MICROSCOPY; CELL-SURFACE INTERACTIONS; FLUORESCENCE
ID BLOOD; FIBRINOGEN; SURFACES; FLUORESCENT; AGGREGATION; DETACHMENT;
   ADHERENCE; MEPACRINE; ADHESION; FLOW
AB The use of two intracellular dyes for epifluorescent video microscoy (EVM) in observations of cell-surface interactions is evaluated and discussed. This methodology permits determinations of cell adhesion, detachment and movement at the surfaces of biomaterials in the presence of flow and physiological haematocrit. Two tests, one which examines for the effect of incident light on platelet adhesion and one which checks for sufficient light for accurate observation of cells, have been designed. Evaluations were made of the adhesion of platelets labelled with the fluorescent dyes mepacrine and acridine orange, used singly and in combination. The use of a number of light level-dye level combinations with glass and several polymers and the addition of a plasma level of fibrinogen did not show any photoactivation effects. This methodology paves the way for longer than previous exposures to light with our system, from 1 min up to 30 min now. Washed platelet suspensions are preferred; these allow for the selective labelling of specific cells and the removal of dye from the surface of the cell.
C1 MCMASTER UNIV,DEPT CHEM ENGN,HAMILTON L8S 4L7,ONTARIO,CANADA.
   MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L7,ONTARIO,CANADA.
CR ADAMS GA, 1980, T AM SOC ART INT ORG, V26, P17
   ALLEN RD, 1985, ANNU REV BIOPHYS BIO, V14, P265, DOI 10.1146/annurev.biophys.14.1.265
   BOX GEP, 1978, STATISTICS EXPERIMEN, P204
   CAPSON DW, 1989, IEEE T BIO-MED ENG, V36, P860, DOI 10.1109/10.30814
   COSTA JL, 1984, RES COMMUN CHEM PATH, V43, P25
   DAPRADA M, 1975, EUR J PHARMACOL, V32, P179
   ELLIS CG, 1990, AM J PHYSIOL, V258, pH1216
   FEUERSTEIN IA, 1986, THROMB HAEMOSTASIS, V55, P184
   FEUERSTEIN IA, 1991, J BIOMED MATER RES, V25, P185, DOI 10.1002/jbm.820250206
   FEUERSTEIN IA, 1986, J BIOMECH ENG-T ASME, V108, P49, DOI 10.1115/1.3138579
   GODO MN, 1992, THESIS U TORONTO CAN
   GRABOWSKI EF, 1990, BLOOD, V75, P390
   HAYCOX CL, 1991, J BIOMED MATER RES, V25, P1317, DOI 10.1002/jbm.820251011
   HERMAN B, 1990, OPTICAL MICROSCOPY B
   HUBBELL JA, 1986, BIOMATERIALS, V7, P354, DOI 10.1016/0142-9612(86)90006-2
   INOUE S, 1986, VIDEO MICROSCOPY
   INTAGLIETTA M, 1989, INT J MICROCIRC, V8, P313
   KWALSKI P, 1972, APPLIED PHOTOGRAPHIC, P21
   Lawrie JS, 1979, BIOCHEM SOC T, V7, P693, DOI 10.1042/bst0070693
   LOREZ HP, 1977, J LAB CLIN MED, V89, P200
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   RICHARDSON PD, 1979, T AM SOC ART INT ORG, V25, P147
   TSAY TT, 1990, OPTICAL MICROSCOPY FOR BIOLOGY, P219
   WINOCOUR PD, 1981, THROMB HAEMOSTASIS, V45, P257
NR 24
TC 3
Z9 4
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 12
BP 871
EP 877
DI 10.1016/0142-9612(92)90181-M
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JV211
UT WOS:A1992JV21100009
PM 1457681
DA 2018-10-20
ER

PT J
AU LIN, HB
   GARCIAECHEVERRIA, C
   ASAKURA, S
   SUN, W
   MOSHER, DF
   COOPER, SL
AF LIN, HB
   GARCIAECHEVERRIA, C
   ASAKURA, S
   SUN, W
   MOSHER, DF
   COOPER, SL
TI ENDOTHELIAL-CELL ADHESION ON POLYURETHANES CONTAINING COVALENTLY
   ATTACHED RGD-PEPTIDES
SO BIOMATERIALS
LA English
DT Article
DE POLYURETHANES; GRAFT COPOLYMER; ENDOTHELIAL CELLS; CELL ADHESION
ID SPECIFICITY; INTEGRINS; SURFACES
AB Peptides based on cell-adhesive regions of fibronectin, Arg-Gly-Asp-Ser (RGDS), and vitronectin, Arg-Gly-Asp-Val (RGDV), were covalently bound to a polyurethane backbone via amide bonds. Nuclear magnetic resonance (NMR) and Fourier-transform infrared (FTIR) spectroscopies were used to monitor the reactions. The amount of grafted peptide was determined by amino acid analysis. X-ray photoelectron spectroscopy (XPS) suggested the presence of the grafted peptide at the polymer-air interface in vacuo. Dynamic contact angle analysis showed that, in water, the peptide-grafted polyurethane surfaces were more polar than the underivatized polyurethane indicating enrichment of peptide groups at the surface. The attachment and spreading of human umbilical vein endothelial cells (HUVECs) on the underivatized and peptide-grafted polyurethanes was investigated. The GRGDSY- and GRGDVY-grafted substrates supported cell adhesion and spreading even without serum in the culture medium. The GRGDVY-grafted substrate supported a larger number of adherent cells and a higher extent of cell spreading than the GRGDSY-grafted substrate. These RGD-containing peptide-grafted polyurethane copolymers may be useful in providing an easily prepared cell-adhesive substrate for various biomaterial applications.
C1 UNIV WISCONSIN,DEPT CHEM,MADISON,WI 53706.
   UNIV WISCONSIN,DEPT MED & PHYSIOL CHEM,MADISON,WI 53706.
   UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706.
FU NHLBI NIH HHS [HL-24046, HL-29684, HL-47179]
CR ANDERHEIDEN D, 1990, POLYM IMMOBILIZED CE, P80
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Barany G, 1979, PEPTIDES           A, V2, P1
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215
   DILLEY RS, 1984, BIOL ENDOTHELIAL CEL, P401
   FATH KR, 1989, J CELL SCI, V92, P67
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GRINNELL F, 1976, EXP CELL RES, V102, P51, DOI 10.1016/0014-4827(76)90298-6
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   HERRING M, 1978, SURGERY, V84, P498
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   KING DS, 1990, INT J PEPT PROT RES, V36, P255
   KNUTSON K, 1982, ACS ADV CHEM SER, V199, P109
   LANGUINO LR, 1989, BLOOD, V73, P734
   Lelah M. D., 1986, POLYURETHANES MED
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MATSUDA T, 1989, T AM SOC ART INT ORG, V35, P677
   NICHOLS WK, 1981, T AM SOC ART INT ORG, V27, P208
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   OKKEMA AZ, 1990, THESIS U WISCONSIN M
   Ozeki E, 1990, ASAIO Trans, V36, pM294
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   RAMAGE R, 1987, TETRAHEDRON LETT, V28, P2287, DOI 10.1016/S0040-4039(00)96103-3
   RATNER BD, 1988, MAKROMOL CHEM-M SYMP, V19, P163, DOI 10.1002/masy.19880190113
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAUNDERS JH, 1965, POLYURETHANES CHEM 1
   SZYCHER M, 1983, BIOCOMPATIBLE POLYM, P1
   VOYTA JC, 1984, J CELL BIOL, V99, pA81
NR 32
TC 89
Z9 92
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 13
BP 905
EP 914
DI 10.1016/0142-9612(92)90113-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JX073
UT WOS:A1992JX07300003
PM 1477259
DA 2018-10-20
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LHHO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
AF VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LHHO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
TI SECONDARY CYTOTOXICITY OF CROSS-LINKED DERMAL SHEEP COLLAGENS DURING
   REPEATED EXPOSURE TO HUMAN FIBROBLASTS
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN; CROSS-LINKING; FIBROBLASTS; CYTOTOXICITY
ID AORTIC ENDOTHELIAL-CELLS; FIXED PERICARDIUM; GLUTARALDEHYDE;
   DEGRADATION; BIOMATERIALS
AB We investigated commercially available dermal sheep collagen either cross-linked with hexamethylenedlisocyanate, or cross-linked with glutaraldehyde. In previous in vitro studies we could discriminate primary, i.e. extractable, and secondary cytotoxicity, due to cell-biomaterial interactions, i.e. enzymatic actions. To develop dermal sheep collagen for clinical applications, we focused in this study on the release, e.g. elimination, of secondary cytotoxicity over time. We used the universal 7 d methylcellulose cell culture with human skin fibroblasts as a test system. Hexamethylenediisocyanate-cross-linked dermal sheep collagen and glutaraldehyde-cross-linked dermal sheep collagen were tested, with intervals of 6 d, over a culture period of 42 d. With hexamethylenediisocyanate-cross-linked dermal sheep collagen, cytotoxicity, i.e. cell growth inhibition and deviant cell morphology, was eliminated after 18 d of exposure. When testing glutaraldehyde-cross-linked dermal sheep collagen, the bulk of cytotoxic products was released after 6 d, but a continuous low secondary cytotoxicity was measured up to 42 d. As a control, non-cross-linked dermal-sheep collagen was tested over a period of 36 d, but no secondary cytotoxic effects were observed. The differences in release of secondary cytotoxicity between hexamethylenediisocyanate-cross-linked dermal sheep collagen, glutaraldehyde-cross-linked dermal sheep collagen and non-cross-linked dermal sheep collagen are explained from differences in cross-linking agents and cross-links obtained. We hypothesize that secondary cytotoxicity results from enzymatic release of pendant molecules from hexamethylenediisocyanate-cross-linked dermal sheep collagen, e.g. formed after reaction of hydrolysis products of hexamethylenediisocyanate with dermal sheep collagen. Glutaraldehyde-cross-linked dermal sheep collagen contains residual cross-linking agents, which induce the bulk cytotoxicity. Apart from being sensitive to enzymatic degradation, glutaraldehyde-cross-linked dermal sheep collagen was also found to be sensitive to aqueous hydrolysis. Hydrolysis of cross-links may release cytotoxic products and introduce new pendant molecules within glutaraldehyde-cross-linked dermal sheep collagen, which in turn induce cytotoxicity after enzymatic attack.
C1 TWENTE UNIV TECHNOL,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,BIOMAT RES SECT,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
RI Dijkstra, Pieter/N-9328-2013
CR BAJPAI PK, 1980, IRCS MED SCI-BIOCHEM, V8, P642
   CHVAPIL M, 1903, J SURG RES, V35, P402
   DAMINK LHH, 1992, 4TH T WORLD C BIOM, P45
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   HARRIS ED, 1974, NEW ENGL J MED, V291, P557, DOI 10.1056/NEJM197409122911105
   HEY KB, 1990, BIOTECHNOL APPL BIOC, V12, P85
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   ISCOVE NN, 1979, CLONAL GROWTH CELLS
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204
   NIMNI ME, 1988, COLLAGEN BIOCH, V1, P3
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPEER DP, 1981, J BIOMED MATER RES, V15, P913
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P267, DOI 10.1016/0142-9612(92)90049-T
   VANLUYN MJA, 1992, MATERIALS RES SOC, V252, P117
   VANWACHEM PB, 1992, MATER RES SOC SYMP P, V252, P117
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, 1991, CELL MATER, V1, P251
   WOODROOF EA, 1978, J BIOENG, V2, P1
   YAJIMA T, 1986, CELL TISSUE RES, V245, P253
NR 25
TC 63
Z9 63
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 14
BP 1017
EP 1024
DI 10.1016/0142-9612(92)90153-F
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JY793
UT WOS:A1992JY79300007
PM 1472588
DA 2018-10-20
ER

PT B
AU MARIOLANI, JRL
   BELANGERO, WD
   DEARRUDA, ACF
AF MARIOLANI, JRL
   BELANGERO, WD
   DEARRUDA, ACF
GP CANADIAN MED & BIOL ENGN SOC
TI PROPOSITION OF A METHODOLOGY FOR THE EVALUATION OF THE INTERFACE
   BIOMATERIAL OSSEOUS TISSUE
SO CANADIAN MEDICAL AND BIOLOGICAL ENGINEERING SOCIETY CONFERENCE:
   PROCEEDINGS
LA English
DT Proceedings Paper
CT 18th Canadian Medical and Biological Engineering Conference (CMBEC 18)
CY JUN 08-11, 1992
CL TORONTO, CANADA
SP CANADIAN MED & BIOL ENGN SOC, INT FEDERAT MED & BIOL ENGN, INT UNION PHYS & ENGN SCI MED
C1 STATE UNIV CAMPINAS,CTR TECHNOL,CAMPINAS,BRAZIL.
RI Mariolani, Jose/I-6969-2013
OI Mariolani, Jose/0000-0002-2862-2042
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CANADIAN MEDICAL & BIOLOGICAL ENGINEERING SOC
PI GLOUCESTER
PA 837 EASTVALE DRIVE#134, GLOUCESTER ON KIJ 7T5, CANADA
BN 0-919529-32-1
PY 1992
BP 128
EP 129
PG 2
WC Engineering, Biomedical
SC Engineering
GA BA33V
UT WOS:A1992BA33V00064
DA 2018-10-20
ER

PT J
AU SLUTSKII, LI
   SEVASTJANOVA, NA
   OZOLANTA, IL
   KUZMINA, IV
   DOMBROVSKA, LE
AF SLUTSKII, LI
   SEVASTJANOVA, NA
   OZOLANTA, IL
   KUZMINA, IV
   DOMBROVSKA, LE
TI REACTOGENICITY OF BIOMATERIALS AS STUDIED BY BIOCHEMICAL, MORPHOLOGICAL
   AND ULTRASTRUCTURAL TECHNIQUES
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIALS; IMPLANTS; REACTOGENICITY; CONNECTIVE TISSUE REACTION;
   INFLAMMATION; GRANULOFIBROUS TISSUE; SURGICAL THREADS; METHODS OF STUDY
ID WOUND REPAIR; POLYMER SURFACES; TISSUE REACTION; CARRAGEENIN GRANULOMA;
   BIOMEDICAL POLYMERS; COLLAGEN PRODUCTION; IMPLANT INTERFACE;
   GUINEA-PIGS; FIBRONECTIN; INVITRO
AB Reactogenicity is a characteristic of biocompatible materials that provokes the reparative and proliferative reaction of connective tissues, a compulsory stage of which is inflammation. Thus, reactogenicity studies should include experiments in vivo. A quantitative assessment of reactogenicity can be obtained by subcutaneous implantation of standard olive-shaped specimens covered by the biomaterial under study followed by biochemical, histological and scanning electron microscopical studies of the capsule developing around the implant. Reactogenicity of surgical threads is evaluated by semiquantitative histological analysis of the wound healing process after suture application. Biomaterial reactogenicity can be modified by changing the structure of the surface and its chemical characteristics, and in particular, by applying different biologically active substances including atrane-containing compounds. The reactogenicity indices suggested present the results of the interaction between the biomaterials and the cells.
RP SLUTSKII, LI (reprint author), LATVIAN TRAUMATOL & ORTHOPAED RES INST, 226005 RIGA, LATVIA, USSR.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   AGELLI M, 1986, CLIN EXP RHEUMATOL, V4, P379
   AMUDESWARI S, 1986, J BIOMED MATER RES, V20, P1103, DOI 10.1002/jbm.820200804
   ANDREASSEN TT, 1985, EUR SURG RES, V17, P264, DOI 10.1159/000128477
   ASMAN B, 1988, ARCH ORAL BIOL, V33, P65, DOI 10.1016/0003-9969(88)90097-0
   BAGNALL RD, 1980, BIOMATERIALS, V1, P97, DOI 10.1016/0142-9612(80)90006-X
   BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   BARBUL A, 1989, SURGERY, V105, P764
   BARNES D, 1988, METHOD ENZYMOL, V163, P707
   BATEMAN JF, 1986, J BIOL CHEM, V261, P4198
   BEAHAN P, 1982, J BIOMED MATER RES, V16, P827, DOI 10.1002/jbm.820160608
   BELL PB, 1980, BIOMEDICAL RES APPLI, V2, P1
   BERNHARD WF, 1980, J THORAC CARDIOV SUR, V79, P552
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BOYLE E, 1980, BRIT J EXP PATHOL, V61, P351
   BRETCHER MS, 1988, J CELL BIOL, V106, P235, DOI 10.1083/jcb.106.2.235
   BROWDER W, 1988, SURGERY, V104, P224
   BRUIN P, 1990, J BIOMED MATER RES, V24, P217, DOI 10.1002/jbm.820240208
   CAFFEE HH, 1990, ANN PLAS SURG, V24, P197, DOI 10.1097/00000637-199003000-00001
   CHEGINI N, 1988, J BIOMED MATER RES, V22, P71, DOI 10.1002/jbm.820220108
   CHENG CY, 1988, ARCH DERMATOL, V124, P221, DOI 10.1001/archderm.124.2.221
   CHIU TC, 1981, J BIOMED MATER RES, V15, P781, DOI 10.1002/jbm.820150513
   CHRINTZ H, 1989, BRIT J SURG, V76, P204, DOI 10.1002/bjs.1800760232
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CLARK RAF, 1988, ARCH DERMATOL, V124, P201, DOI 10.1001/archderm.124.2.201
   CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7
   CLERC C, 1990, CLIN CHIM ACTA, V189, P181, DOI 10.1016/0009-8981(90)90090-F
   DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018
   DATUBOBROWN DD, 1990, BRIT J PLAST SURG, V43, P70, DOI 10.1016/0007-1226(90)90047-4
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DIEGELMANN RF, 1985, FUND APPL TOXICOL, V5, P219, DOI 10.1016/0272-0590(85)90070-3
   DIEGELMANN RF, 1986, J SURG RES, V40, P229, DOI 10.1016/0022-4804(86)90156-3
   DIEGELMANN RF, 1986, CLIN IMMUNOL IMMUNOP, V41, P331, DOI 10.1016/0090-1229(86)90004-8
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481
   ECKERSLEY JRT, 1988, BRIT MED BULL, V44, P423, DOI 10.1093/oxfordjournals.bmb.a072259
   EXBRAYAT P, 1987, BIOMATERIALS, V8, P385, DOI 10.1016/0142-9612(87)90010-X
   FAGA A, 1985, PLAST RECONSTR SURG, V76, P570, DOI 10.1097/00006534-198510000-00016
   FALANGA V, 1988, J AM ACAD DERMATOL, V19, P559, DOI 10.1016/S0190-9622(88)80317-7
   FIGUERAS T, 1986, COLLAGEN REL RES, V6, P379
   FUKASAWA M, 1988, J SURG RES, V45, P460, DOI 10.1016/0022-4804(88)90196-5
   GAY S, 1978, ACTA CHIR SCAND, V144, P205
   GILBERT DL, 1987, J BIOMED MATER RES, V21, P643, DOI 10.1002/jbm.820210509
   GOSLEN JB, 1988, J DERMATOL SURG ONC, V14, P959, DOI 10.1111/j.1524-4725.1988.tb03734.x
   HAYASHI T, 1979, J BIOCHEM-TOKYO, V86, P453, DOI 10.1093/oxfordjournals.jbchem.a132544
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HORSLEVPETERSEN K, 1988, EUR J CLIN INVEST, V18, P352, DOI 10.1111/j.1365-2362.1988.tb01023.x
   HOUCK JC, 1976, J INVEST DERMATOL, V67, P124, DOI 10.1111/1523-1747.ep12512997
   IGISU K, 1986, THROMB RES, V44, P455, DOI 10.1016/0049-3848(86)90324-5
   ITO G, 1987, J BIOMED MATER RES, V21, P485, DOI 10.1002/jbm.820210408
   JALKANEN M, 1983, CELL BIOL INT REP, V7, P745, DOI 10.1016/0309-1651(83)90202-3
   JAYAKUMARI N, 1989, J BIOMED MATER RES, V23, P1261, DOI 10.1002/jbm.820231104
   KALNBERZS VK, 1983, ADV BIOMATER, V3, P649
   KANZLER MH, 1986, J DERMATOL SURG ONC, V12, P1156, DOI 10.1111/j.1524-4725.1986.tb02099.x
   KAUFMAN T, 1985, ANN PLAS SURG, V14, P420, DOI 10.1097/00000637-198505000-00004
   KELLER F, 1985, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V18, P9
   KELLER JC, 1984, J BIOMED MATER RES, V18, P829, DOI 10.1002/jbm.820180713
   KENYON AJ, 1986, AM J VET RES, V47, P96
   Knofler W, 1984, Z Exp Chir Transplant Kunstliche Organe, V17, P316
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   KOPECEK J, 1983, PROG POLYM SCI, V9, P1
   KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950
   KRAJEWSKI A, 1988, J BIOMED MATER RES, V22, P445, DOI 10.1002/jbm.820220602
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   KSANDER GA, 1988, ANN PLAS SURG, V20, P215, DOI 10.1097/00000637-198803000-00004
   KSANDER GA, 1981, J SURG RES, V31, P433, DOI 10.1016/0022-4804(81)90083-4
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   LEAPER DJ, 1986, J ANTIMICROB CHEMOTH, V17, P135, DOI 10.1093/jac/17.2.135
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LENTZ AJ, 1985, J BIOMED MATER RES, V19, P1101, DOI 10.1002/jbm.820190919
   LINDNER J, 1983, HAMOSTASEOLOGIE, V1, P8
   LIPATOVA TE, 1979, J POLYM SCI PS, V66, P239
   LIPSKY MH, 1989, J BIOMED MATER RES, V23, P1441, DOI 10.1002/jbm.820231207
   LUNDBERG C, 1983, INFLAMMATORY REACTIO
   LUSTSKII LI, 1982, POLYTRAUMA, P213
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   LYNCH SE, 1989, J CLIN INVEST, V84, P640, DOI 10.1172/JCI114210
   MAKISALO SE, 1989, BIOMATERIALS, V10, P105, DOI 10.1016/0142-9612(89)90041-0
   MARCHANT RE, 1984, POLYM BIOMATERIALS, P209
   MARSHALL WR, 1989, ANN PLAS SURG, V23, P401, DOI 10.1097/00000637-198911000-00004
   MARTINEZ IR, 1987, CLIN DERMATOL, V5, P37, DOI 10.1016/0738-081X(87)90026-5
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MATSUDA T, 1987, J BIOMED MATER RES, V21, P499, DOI 10.1002/jbm.820210409
   MCCAULEY RL, 1990, J SURG RES, V49, P103, DOI 10.1016/0022-4804(90)90118-L
   MCCOY BJ, 1984, PLAST RECONSTR SURG, V73, P924, DOI 10.1097/00006534-198406000-00012
   MENDES DG, 1985, J BONE JOINT SURG BR, V67, P645
   MERKER PC, 1984, FED PROC, V43, P2791
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   MUIR IFK, 1990, BRIT J PLAST SURG, V43, P61, DOI 10.1016/0007-1226(90)90046-3
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   NAGELSCHMIDT M, 1987, J TRAUMA, V27, P1267
   NEUPERT G, 1987, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V20, P139
   NIEDNER R, 1986, BRIT J DERMATOL, V115, P41, DOI 10.1111/j.1365-2133.1986.tb02106.x
   PARDO A, 1983, J HISTOCHEM CYTOCHEM, V31, P641, DOI 10.1177/31.5.6302163
   Park JB, 1979, BIOMATERIALS INTRO
   PARRY DAD, 1982, FEBS LETT, V149, P1, DOI 10.1016/0014-5793(82)81060-0
   PASYK KA, 1984, J SURG RES, V36, P125, DOI 10.1016/0022-4804(84)90077-5
   PESSA ME, 1987, J SURG RES, V42, P207, DOI 10.1016/0022-4804(87)90120-X
   PETERSON JM, 1987, SURGERY, V102, P300
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PIZZOFERRATO A, 1985, BIOMATERIALS, V6, P346
   POSTLETHWAIT RW, 1979, ANN SURG, V190, P54, DOI 10.1097/00000658-197907000-00012
   PREISSNER KT, 1988, BLOOD, V71, P1581
   PRICOLO VE, 1990, J SURG RES, V48, P534, DOI 10.1016/0022-4804(90)90226-R
   QUEEN D, 1987, BURNS, V13, P218, DOI 10.1016/0305-4179(87)90170-7
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REICHELT H, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P71
   REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269
   RIGG BM, 1982, PLAST RECONSTR SURG, V69, P566, DOI 10.1097/00006534-198203000-00043
   SALAMON A, 1980, ACTA CHIR HUNG, V21, P32
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SALTHOUSE TN, 1983, BIOMATERIALS RECONST, P131
   SANZ LE, 1988, OBSTET GYNECOL, V71, P418
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   SCHAKENRAAD JM, 1987, BIOMATERIALS, V8, P207, DOI 10.1016/0142-9612(87)90065-2
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAKENRAAD JM, 1987, THESIS U GRONINGEN N
   SCHECHTER AB, 1984, ARCH PATHOL, V46, P20
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHREIBER H, 1990, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V23, P23
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   SCHUBERT R, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P20
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   SEVASTJANOVA NA, 1987, BIOMATERIALS, V8, P242, DOI 10.1016/0142-9612(87)90110-4
   SEWELL WR, 1955, SURG GYNECOL OBSTET, V100, P483
   Slutskii L.I., 1969, BIOCH NORMAL PATHOLO
   SLUTSKII LI, 1984, BIOMATERIALS BIOMECH, P367
   SLUTSKII LI, 1981, P LATVIAN ACAD SCI, P94
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   TAYLOR D E M, 1986, Journal of the Royal College of Surgeons of Edinburgh, V31, P13
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   THOMAS IT, 1986, BIOMATERIALS, V7, P301, DOI 10.1016/0142-9612(86)90055-4
   VANMULLEM PJ, 1988, J CRANIO MAXILL SURG, V16, P99, DOI 10.1016/S1010-5182(88)80029-5
   VANMULLEM PJ, 1988, ANN PLAS SURG, V21, P576, DOI 10.1097/00000637-198812000-00015
   VANRIJSSEL EJC, 1988, EUR J OBSTET GYN R B, V27, P165, DOI 10.1016/0028-2243(88)90011-1
   VERBURG AD, 1988, ARCH ORTHOP TRAUM SU, V107, P293, DOI 10.1007/BF00451510
   VITALE T D, 1988, Journal of Foot Surgery, V27, P533
   VONBECKER R, 1985, Z EXP CHIR TRANSPLAN, V18, P318
   Voronkov M G, 1979, Top Curr Chem, V84, P77
   WARD PA, 1980, CLIN BIOCHEM, V13, P187, DOI 10.1016/S0009-9120(80)80021-X
   Whalen R L, 1988, ASAIO Trans, V34, P887
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   YAN JYJ, 1989, J BIOMED MATER RES, V23, P171, DOI 10.1002/jbm.820230204
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 150
TC 2
Z9 2
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 2
BP 119
EP 134
PG 16
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA JU596
UT WOS:A1992JU59600004
DA 2018-10-20
ER

PT J
AU KIRKPATRICK, CJ
   OTTERBACH, T
   ANDERHEIDEN, D
   SCHIEFER, J
   RICHTER, H
   HOCKER, H
   MITTERMAYER, C
   DEKKER, A
AF KIRKPATRICK, CJ
   OTTERBACH, T
   ANDERHEIDEN, D
   SCHIEFER, J
   RICHTER, H
   HOCKER, H
   MITTERMAYER, C
   DEKKER, A
TI QUANTITATIVE SCANNING ELECTRON-MICROSCOPY (SEM) TO STUDY THE ADHESION
   AND SPREADING OF HUMAN ENDOTHELIAL-CELLS TO SURFACE-MODIFIED
   POLY(CARBONATE URETHANE)S
SO CELLS AND MATERIALS
LA English
DT Article
DE ENDOTHELIAL CELL SEEDING; VASCULAR GRAFT; POLY(CARBONATE URETHANE);
   SURFACE MODIFICATION; CELL ADHESION; CELL SPREADING
ID SHEAR-STRESS; POLYTETRAFLUOROETHYLENE; POLYURETHANE; RETENTION; GRAFTS;
   VEIN
AB The polymers currently in use as vascular prostheses are, in the native state, poor substrates for endothelial cell (EC) adhesion and growth. This has a negative effect on the success of pre-seeding regimes. One attempt to improve the polymer substrate is to covalently couple reactive molecules to the surface, which can be used as anchorage points for EC or serve as spacer molecule to couple biological signal molecules such as oligopeptides. We have used a digitized image analysis system coupled to a scanning electron microscope to study the adhesion and spreading of human venous EC to unmodified poly(carbonate urethane) (uPCU), hydroxyl-functionalized PCU (mPCU) and to mPCU surfaces with succinyl or adipoyl dichloride coupled to it. Although the uPCU did not promote EC growth over a 5 day period, the early (30 minutes) adhesion and spreading behaviour on this surface was comparable to that of some modified surfaces which gave good promotion of EC growth in the longer term studies. Adhesion, but not spreading data at 4 hours gave a good correlation with the longer term studies of EC growth on the polymer surfaces. This study not only presents new directions in polymer development for vascular grafts, but also indicates the dangers associated with using early cell adhesion behaviour as a parameter of bifunctionality of biomaterial surfaces.
C1 RHEIN WESTFAL TH AACHEN,INST PATHOL,W-5100 AACHEN,GERMANY.
   RHEIN WESTFAL TH AACHEN,INST MACROMOLEC & TEXT CHEM,W-5100 AACHEN,GERMANY.
CR ANDERHEIDEN D, 1992, J MATER SCI-MATER M, V3, P1, DOI 10.1007/BF00702936
   ANDERHEIDEN D, 1991, ANGEW MAKROMOL CHEM, V185, P109, DOI 10.1002/apmc.1991.051850111
   BREUERS W, 1988, ADV BIOMATER, V8, P297
   BROTHERS TE, 1990, J BIOMED MATER RES, V24, P761, DOI 10.1002/jbm.820240610
   Curti T, 1989, Ann Vasc Surg, V3, P351, DOI 10.1016/S0890-5096(06)60159-3
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   GREISLER HP, 1990, ARCH SURG-CHICAGO, V125, P1622
   KESLER KA, 1986, J VASC SURG, V3, P58
   KIRKPATRICK CJ, 1991, CELL MATER, V1, P93
   KIRKPATRICK CJ, 1984, THESIS U ULM GERMANY
   MIYATA T, 1991, J SURG RES, V50, P485, DOI 10.1016/0022-4804(91)90029-L
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   TEIJEIRA FJ, 1989, BIOMATERIALS, V10, P80, DOI 10.1016/0142-9612(89)90035-5
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
   Vohra R K, 1990, Eur J Vasc Surg, V4, P33, DOI 10.1016/S0950-821X(05)80036-2
   WILLIAMS SK, 1985, J SURG RES, V38, P618, DOI 10.1016/0022-4804(85)90084-8
NR 16
TC 12
Z9 12
U1 0
U2 2
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 2
BP 169
EP 177
PG 9
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA JU596
UT WOS:A1992JU59600009
DA 2018-10-20
ER

PT J
AU MULLERMAI, CM
   VOIGT, C
   BAIER, RE
   GROSS, UM
AF MULLERMAI, CM
   VOIGT, C
   BAIER, RE
   GROSS, UM
TI THE INCORPORATION OF GLASS-CERAMIC IMPLANTS IN BONE AFTER SURFACE
   CONDITIONING GLOW-DISCHARGE TREATMENT
SO CELLS AND MATERIALS
LA English
DT Article
DE BONE; IMPLANT; GLASS-CERAMIC; GLOW-DISCHARGE; HISTOLOGY; ULTRASTRUCTURE;
   MORPHOMETRY
ID CALCIUM-PHOSPHATE FORMATION; MATRIX VESICLES; INTERFACE; INVITRO;
   INVIVO; BIOMATERIAL; REPLACEMENT; TISSUES; TEETH
AB Glow discharge (GD)-treated and autoclaved glass-ceramics of bone-bonding and non-bonding type were implanted into the femoral diaphysis of rats for 3, 7, 14 and 28 days and were investigated by applying light microscopy and histomorphometry, and scanning and transmission electron microscopy. More bone and chondroid, and faster osteoid development were observed at glow-discharge treated implants even in non-bonding implants when compared to autoclaved controls. Ultrastructural investigations showed a higher leaching-rate of GD-treated bone-bonding implants during the early days after implantation leading to a higher rugosity, whereas no morphological changes were observed on non-bonding implant surfaces. More extracellular matrix (ECM) forming productive cells and less macrophages were observed on GD-sterilized implant surfaces. Osteoclast-like cells were detected exclusively at 3 and 7 days post-operatively on GD-sterilized bone-bonding implants. The higher amount of bone at GD-treated surfaces was thought to be due to a higher leaching rate leading to higher surface-rugosity and interface alkalinity. Thus, GD-treatment seems to be suitable for sterilization of surface-reactive implants to yield earlier functionality and to reduce possible degradative processes.
C1 FREE UNIV BERLIN,KLINIKUM STEGLITZ,DEPT TRAUMATOL & RECONSTRUCT SURG,W-1000 BERLIN 45,GERMANY.
   SUNY BUFFALO,DEPT BIOMAT,BUFFALO,NY 14214.
RP MULLERMAI, CM (reprint author), FREE UNIV BERLIN,KLINIKUM STEGLITZ,INST PATHOL,HINDENBURGDAMM 30,W-1000 BERLIN 45,GERMANY.
CR ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   BAIER RE, 1975, J BIOMED MATER RES, V9, P547, DOI 10.1002/jbm.820090603
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   BAIER RE, 1986, MAT SCI IMPLANT ORTH, P153
   BONUCCI E, 1976, FED PROC, V35, P163
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   CARLSSON L V, 1989, International Journal of Oral and Maxillofacial Implants, V4, P199
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DAVIES JE, 1990, CELLS MATERIALS, V1, P3
   GOMI K, 1992, 4 WORLD BIOM C EUR S, P531
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   GROSS UM, 1977, STAIN TECHNOL, V52, P217, DOI 10.3109/10520297709116778
   HENCH LL, 1977, J BIOMED MATER RES, V11, P267, DOI 10.1002/jbm.820110211
   HENCH LL, 1992, BIOCERAMICS, V5, P67
   HEYWOOD BR, 1987, CALCIFIED TISSUE INT, V41, P192, DOI 10.1007/BF02555238
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KIM KM, 1976, FED PROC, V35, P156
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1109, DOI 10.1002/jbm.820210905
   MEENAGHAN MA, 1979, J BIOMED MATER RES, V13, P631, DOI 10.1002/jbm.820130409
   MULLERMAI C, 1991, BIOMATERIALS, V12, P865, DOI 10.1016/0142-9612(91)90076-M
   MULLERMAI C, 1989, J BIOMED MATER RES, V23, P1149, DOI 10.1002/jbm.820231005
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   MULLERMAI CM, 1992, 4TH T WORLD BIOM C B, P237
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   PERNOT F, 1985, J BIOMED MATER RES, V19, P293, DOI 10.1002/jbm.820190310
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RICH A, 1981, J CELL SCI, V50, P1
   RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754
   SENDAX V I, 1992, Dental Clinics of North America, V36, P221
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   VANKOOTEN TG, 1991, CELL MATER, V1, P307
   WENNERBERG A, 1991, SWED DENT J, V15, P95
NR 45
TC 7
Z9 7
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 4
BP 309
EP 327
PG 19
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA KP120
UT WOS:A1992KP12000005
DA 2018-10-20
ER

PT J
AU DUMAS, H
   TARDY, M
   ROCHAT, MH
   TAYOT, JL
AF DUMAS, H
   TARDY, M
   ROCHAT, MH
   TAYOT, JL
TI PRILLING PROCESS APPLIED TO COLLAGEN SOLUTIONS
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE HUMAN PLACENTA COLLAGEN; BIOMATERIALS PRILLING; MICROBEADS
AB The present work concerns the preparation Of microbeads of collagen by a prilling process.
   Collagen is one of the main components of vertebrate proteins, especially in such tissues as skin, tendons, placenta, ... Furthermore, it has some properties which makes it interesting to use as a biomaterial : biocompatibility, biodegradability, high   tensile strength,  hemostatic power, participation to thc wound heating.
   The patented process which is developped in this paper combines two techniques : .breaking of a capillary flow by prilling and .reticulation of collagen after oxydation with periodic acid.
   It uses neither organic solvents, nor variation of temperature and allows the production of microbeads which can be utilized for many different medical  applications.
C1 FAC PHARM DIJON,PHARM GALEN LAB,F-21000 DIJON,FRANCE.
RP DUMAS, H (reprint author), IMEDEX,BP 38,ZI TROQUES,F-69630 CHAPONOST,FRANCE.
CR CHARLEUX J, 1986, 25 INT C OPHTH ROM
   CHVAPIL M, 1979, SCI IND MED ASPECTS
   Kuhn K., 1987, STRUCTURE FUNCTION C, P1
   MOUILLON MD, 1986, 25 INT C OPHTH ROM
   TIOLLIER J, 1988, NOUVEAUX BIOMATERIAU
   WEISS JB, 1982, COLLAGEN HLTH DISEAS, P1
   1986, Patent No. 8605591
   1986, Patent No. 8610160
   1988, Patent No. 8809544
NR 9
TC 6
Z9 6
U1 0
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0363-9045
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PY 1992
VL 18
IS 13
BP 1395
EP 1409
DI 10.3109/03639049209040847
PG 15
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JC641
UT WOS:A1992JC64100002
DA 2018-10-20
ER

PT J
AU SUNG, JY
   LEUNG, JWC
   COSTERTON, JW
AF SUNG, JY
   LEUNG, JWC
   COSTERTON, JW
TI A NEW BIOFILM STORY IN BILIARY-TRACT INFECTION
SO INTERNATIONAL BIODETERIORATION & BIODEGRADATION
LA English
DT Article
AB Acute cholangitis is commonly caused by biliary obstruction due to gallstones blocking the bile ducts and to malignancies of the biliary and pancreatic system. The pathogenesis of brown pigment gallstones, blockage of biliary stents, and biliary parasitic infestation are related to the formation of bacterial biofilms. Biliary pathogens, such as Escherichia coli and other enteric organisms, attach themselves to the surface of an ulcerated biliary mucosa or implanted biomaterial to form a bacterial biofilm. Some of these bacteria produce enzymes (beta-glucuronidase and phospholipid A1) and glycocalyx material that aid colonization and infestation. Crystals of calcium bilirubinate and other biliary sediments accumulate around the bacterial microcolonies and glycoproteins, forming adherent bacterial biofilms. The thick and often calcified biofilms obstruct the normal bile flow and lead to cholangitis.
RP SUNG, JY (reprint author), CHINESE UNIV HONG KONG,DEPT MED,SHA TIN,HONG KONG.
RI Hossain, Sarah/C-7332-2009; Sung, Joseph J. Y./R-3203-2018
OI Hossain, Sarah/0000-0003-1355-0979; Sung, Joseph J.
   Y./0000-0003-3125-5199
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0964-8305
J9 INT BIODETER BIODEGR
JI Int. Biodeterior. Biodegrad.
PY 1992
VL 30
IS 2-3
BP 155
EP 165
DI 10.1016/0964-8305(92)90060-2
PG 11
WC Biotechnology & Applied Microbiology; Environmental Sciences
SC Biotechnology & Applied Microbiology; Environmental Sciences & Ecology
GA JV959
UT WOS:A1992JV95900008
DA 2018-10-20
ER

PT J
AU GRAZIANI, EI
   MCKEOWN, NB
   KALMAN, PG
   THOMPSON, M
AF GRAZIANI, EI
   MCKEOWN, NB
   KALMAN, PG
   THOMPSON, M
TI SURFACE SELECTIVE MODIFICATION OF FLUOROPOLYMER BIOMATERIAL
SO INTERNATIONAL BIODETERIORATION & BIODEGRADATION
LA English
DT Article
AB A brief review of techniques employed for the chemical modification of the surface of various fluoropolymers is presented. Such modification of poly(tetrafluoroethylene) (PTFE) in its expanded form (ePTFE) is an important consideration with respect to the use of this material in the fabrication of vascular grafts. The present paper describes the chemical treatment of planar and expanded PTFE, and poly(tetrafluoroethylene-co-hexa fluoropropylene) (FEP) with previously reported benzoin and sodium naphthalide reagents. Angular dependent-X-ray photoelectron spectroscopy, scanning electron microscopy and water contact angle measurements show that a degree of surface selectivity is obtained in the reduction of FEP with benzoin. In contrast, both treatments cause very corrosive action of PTFE. The reduction of ePTFE by sodium naphthalide, even under relatively mild conditions, causes the material to lose much of its structural integrity. Accordingly, the use of these reagents to generate new chemical functionalities on ePTFE is not recommended.
C1 TORONTO GEN HOSP, MAX BELL RES CTR, 200 ELIZABETH ST, TORONTO M4C 1G6, ONTARIO, CANADA.
RI McKeown, Neil/A-2451-2011
OI McKeown, Neil/0000-0002-6027-261X
NR 0
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-8305
EI 1879-0208
J9 INT BIODETER BIODEGR
JI Int. Biodeterior. Biodegrad.
PY 1992
VL 30
IS 2-3
BP 217
EP 231
DI 10.1016/0964-8305(92)90065-V
PG 15
WC Biotechnology & Applied Microbiology; Environmental Sciences
SC Biotechnology & Applied Microbiology; Environmental Sciences & Ecology
GA JV959
UT WOS:A1992JV95900013
DA 2018-10-20
ER

PT J
AU SHEU, MS
   HOFFMAN, AS
   FEIJEN, J
AF SHEU, MS
   HOFFMAN, AS
   FEIJEN, J
TI A GLOW-DISCHARGE TREATMENT TO IMMOBILIZE POLY(ETHYLENE OXIDE)
   POLY(PROPYLENE OXIDE) SURFACTANTS FOR WETTABLE AND NONFOULING
   BIOMATERIALS
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE SURFACE MODIFICATION; GLOW DISCHARGE; WETTABLE POLYMER SURFACES;
   NONFOULING SURFACES; POLY(ETHYLENE OXIDE) SURFACTANTS; POLY(ETHYLENE
   OXIDE) POLY(PROPYLENE OXIDE) COPOLYMERS
ID BLOCK COPOLYMERS; ADSORPTION; FIBRINOGEN; SURFACES; PLASMA
AB A non-fouling (protein resistant) polymer surface was achieved using an argon glow discharge treatment of a polyethylene surface which had been precoated with various poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) (PEO-PPO-PEO) tri-block copolymer surfactants. The surfactant is first deposited on the polymer surface via a solvent swelling and evaporation method. Then the coated surfactant is immobilized on the substrate surface by an inert gas discharge treatment. ESCA and water contact angle (theta) measurements on treated and solvent washed surfaces show significant increases in both surface O/C ratios and surface water wettability (theta < 30-degrees) compared to LDPE control surfaces, revealing the presence of PEO on the treated surfaces. A great reduction of fibrinogen adsorption on the modified surfaces is also observed for the highest PEO content surfactants. This simple surface modification process may have wide applicability to obtain wettable polymer surfaces in general, and non-fouling biomaterial surfaces in specific.
C1 UNIV WASHINGTON,CTR BIOENGN,FL-20,SEATTLE,WA 98195.
   TWENTE UNIV TECHNOL,DEPT CHEM ENGN,7500 AE ENSCHEDE,NETHERLANDS.
CR ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   BAILEY NFE, 1991, ALKYLENE OXIDES THEI, P130
   COHENSTUART MA, 1984, MACROMOLECULES, V17, P1825
   DENNISON KA, 1986, THESIS MIT CAMBRIDGE
   DESAI NP, 1991, BIOMATERIALS, V12, P145
   FRIEDRICH C, 1980, MACROMOLECULES, V13, P1625, DOI 10.1021/ma60078a049
   GILDING DK, 1979, POLYMER, V20, P1454, DOI 10.1016/0032-3861(79)90008-9
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GOMBOTZ WR, 1988, THESIS U WASHINGTON
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   GREGONIS DE, 1984, 2ND T C BIOM WASH DC, P266
   HANSEN RH, 1966, J POLYM SCI POL LETT, V4, P203, DOI 10.1002/pol.1966.110040309
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   KIM SW, 1988, ANN NY ACAD SCI, V516, P116
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MACFARLANE A, 1959, NATURE, V182, P53
   MAROUDAS NG, 1974, NATURE, V254, P695
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   OKANO T, 1986, J BIOMED MATER RES, V20, P1035, DOI 10.1002/jbm.820200716
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OMULLANE JE, 1988, BIOMATERIALS, V9, P203, DOI 10.1016/0142-9612(88)90124-X
   RANDERSON DH, 1983, NEW TRENDS THERAPEUT
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   Sharpe L.S., 1964, ADV CHEM SER, V43, P189
   SHEU MS, 1991, 18TH CRS INT S CONTR, P148
   SHEU MS, 1991, UNPUB CLIN MATERIALS
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   TERLINGEN JGA, 1991, UNPUB J COLLOID INTE
   TERLINGEN JGA, 1992, 4TH WORLD BIOM C BER
NR 31
TC 58
Z9 58
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 1992
VL 6
IS 9
BP 995
EP 1009
DI 10.1163/156856192X00890
PG 15
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA JU533
UT WOS:A1992JU53300005
DA 2018-10-20
ER

PT J
AU KIAEI, D
   HOFFMAN, AS
   HORBETT, TA
AF KIAEI, D
   HOFFMAN, AS
   HORBETT, TA
TI TIGHT-BINDING OF ALBUMIN TO GLOW-DISCHARGE TREATED POLYMERS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE RADIO FREQUENCY GLOW DISCHARGE; POLYMERIC BIOMATERIAL; PROTEIN
   ADSORPTION
ID PROTEIN ADSORPTION; SURFACE; ENZYMES; LATEX
AB Tetrafluoroethylene (TFE) glow discharge-treated Dacron vascular grafts resist thrombus deposition, embolization and thrombotic occlusion. In addition, albumin adsorbed on TFE-treated surfaces resists elution by sodium dodecyl sulfate (SDS). Since the tight binding of albumin to TFE-treated surfaces may contribute to their thromboresistant character, we decided to examine the mechanism responsible for this tenacious adsorption. We have investigated albumin adsorption and retention (after SDS elution) on a number of untreated and glow discharge-treated surfaces. Fluorocarbon glow discharge-treated polymers retain a larger fraction of the adsorbed albumin than ethylene and hexamethyldisiloxane glow discharge-treated surfaces. Albumin retention by surfaces appears to be closely related to their surface free energy (in air). Low energy surfaces (in air), whether untreated or glow discharge-treated, retain a larger fraction of the albumin adsorbed than higher energy surfaces. The lowest energy surfaces should have the highest interfacial energies in water, with correspondingly high driving forces for adsorption of proteins. This can lead to the formation of multiple binding sites upon adsorption, permitting strong hydrophobic interactions, which leads to the observed strong binding.
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
RP KIAEI, D (reprint author), UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195, USA.
FU NHLBI NIH HHS [HL 33229-04, HL 19419, HL 33229-03]
CR BALE MD, 1989, J COLLOID INTERF SCI, V132, P176, DOI 10.1016/0021-9797(89)90227-0
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   CLARK DT, 1980, J POLYM SCI POL CHEM, V18, P407, DOI 10.1002/pol.1980.170180202
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   HOFFMAN AS, 1987, Patent No. 4656083
   HOFFMAN AS, 1986, BIOMEDICAL MATERIALS, V55, P3
   HOFFMAN AS, 1986, ASTM SPECIAL TECHNIC, V898, P137
   HOFFMAN AS, 1986, POLYM MED, P157
   HOFFMAN AS, 1991, Patent No. 5055316
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KIAEI D, 1992, J BIOMED MATER RES, V26, P357, DOI 10.1002/jbm.820260307
   KIAEI D, 1988, J APPL POLYM SCI APP, V42, P269
   LEWIS D, 1988, BIOMATERIALS, V9, P71, DOI 10.1016/0142-9612(88)90073-7
   MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1021/j100842a055
   MORRISSEY BW, 1974, J COLLOID INTERF SCI, V46, P152, DOI 10.1016/0021-9797(74)90036-8
   OKANE DF, 1976, J MACROMOL SCI CHEM, VA 10, P567, DOI 10.1080/00222337608061200
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   SAFRANJ A, 1991, BIOTECHNOL PROGR, V7, P173, DOI 10.1021/bp00008a012
   SANDWICK RK, 1988, J COLLOID INTERF SCI, V121, P1, DOI 10.1016/0021-9797(88)90402-X
   SANDWICK RK, 1987, J COLLOID INTERF SCI, V115, P130, DOI 10.1016/0021-9797(87)90017-8
   STROBEL M, 1985, J POLYM SCI POL CHEM, V23, P1125, DOI 10.1002/pol.1985.170230417
NR 28
TC 65
Z9 65
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 4
IS 1
BP 35
EP 44
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JX501
UT WOS:A1992JX50100005
PM 1463700
DA 2018-10-20
ER

PT J
AU COTE, MF
   SIROIS, E
   DOILLON, CJ
AF COTE, MF
   SIROIS, E
   DOILLON, CJ
TI INVITRO CONTRACTION RATE OF COLLAGEN IN SPONGE-SHAPE MATRICES
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE COLLAGEN; CROSS-LINKING; SPONGE; CONTRACTION
ID HYALURONIC-ACID; FIBROBLASTS; CROSSLINKING; GLUTARALDEHYDE;
   HETEROGRAFTS; FIBRONECTIN; MECHANISM; GROWTH; SKIN
AB Connective tissue substitute can be made of collagen sponge-shape matrice which is reconstituted by freeze-drying a collagen dispersion. This procedure is then followed by a crosslinking treatment to decrease the in vivo biodegradation rate. In the present study, collagen dispersions made of collagen fibrils with a D-staggered pattern were submitted to the following treatments: (1) cyanamide or glutaraldehyde was introduced during the dispersion step followed by the manufacture of sponges; (2) uncrosslinked sponges were exposed to formaldehyde vapor; or (3) uncrosslinked and crosslinked sponges were severely dehydrated. To characterize the in vitro contraction rate, the surface areas of sponges were sequentially recorded in relation to soaking time. Contraction did not significantly occur when sponges were chemically treated. However, collagen in sponges treated by either severe dehydration or by both cyanamide treatment and severe dehydration contracted. On the other hand, the different treatments of the collagen modified the distribution of the D-staggered pattern within fibrils. After glutaraldehyde treatment, the periodicity of collagen fibrils disappeared and large fibres were observed. These experiments show that the different treatments of the collagen can be useful for designing a contractile as well as a non-contractile biomaterial.
C1 HOP ST FRANCOIS ASSISE, CTR RECH D00-744, 10 RUE ESPINAY, QUEBEC CITY G1L 3L5, QUEBEC, CANADA.
   UNIV LAVAL, QUEBEC CITY G1K 7P4, QUEBEC, CANADA.
CR ALLEN TD, 1983, J ULTRA MOL STRUCT R, V83, P205, DOI 10.1016/S0022-5320(83)90078-3
   BARKER H, 1980, BIOCHIM BIOPHYS ACTA, V632, P589, DOI 10.1016/0304-4165(80)90335-9
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BOYCE ST, 1988, SURGERY, V103, P421
   CARPENTIER A, 1974, J THORAC CARDIOV SUR, V68, P771
   CHAPVIL M, 1977, J BIOMED MATER RES, V11, P721
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   COTE MF, UNPUB BIOMATERIALS
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   ESDALE T, 1972, J CELL BIOL, V54, P626
   GUIDRY C, 1985, J CELL SCI, V79, P67
   GUIDRY C, 1986, COLLAGEN REL RES, V6, P515
   KETHARNATHAN V, 1980, ARCH SURG-CHICAGO, V115, P967
   KLEINMAN HK, 1987, ANAL BIOCH, V166
   KRONICK P, 1988, CONNECT TISSUE RES, V18, P123, DOI 10.3109/03008208809008064
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   Piez K. A., 1984, EXTRACELLULAR MATRIX
   SHEEHAN JC, 1956, J ORG CHEM, V21, P439, DOI 10.1021/jo01110a017
   TZAPHIDOU M, 1985, MICRON MICROSCOPIA A, V17, P201
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   YANNAS AV, 1967, NATURE, V215, P509
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 25
TC 16
Z9 16
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 4
BP 301
EP 313
DI 10.1163/156856292X00394
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA HM117
UT WOS:A1992HM11700003
PM 1596476
DA 2018-10-20
ER

PT J
AU BRAATZ, JA
   HEIFETZ, AH
   KEHR, CL
AF BRAATZ, JA
   HEIFETZ, AH
   KEHR, CL
TI A NEW HYDROPHILIC POLYMER FOR BIOMATERIAL COATINGS WITH LOW PROTEIN
   ADSORPTION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOPOL(R) POLYURETHANE POLYMERS; HYPOL(R)POLYMERS; PROTEIN ADSORPTION;
   POLYMER COATED SURFACES; BIOMEDICAL COATINGS
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SURFACE INTERACTIONS; POLYETHYLENE
   OXIDE; SILICA; PHASE
AB BIOPOL(R) polyurethane polymers, an extension of the HYPOL(R) Polymer series of foamable hydrophilic polymers, have been developed which exhibit improved performance for selected biomedical applications. Members of the BIOPOL polyurethane polymer series, with molecular weights in the range of 7000 to 30000, are larger molecules than HYPOL polymers (MW < 3000) and produce hydrogels, rather than foams, when mixed with water. The prototype material in this series, BIOPOL XP-5, is a liquid prepolymer which chain extends in water and forms a hydrogel which can contain > 85% water. The time required for polymerization with water was dependent on the prepolymer: water ratio. This prepolymer was coated onto silica and medical grade tubing and then cured in place with water to form a stable coating which was resistant to non-specific protein binding. In addition, soluble, isocyanate-free forms of the prepolymer were tested for toxicity and shown to produce no adverse effects when injected intravenously into mice or when applied to a chicken chorioallantoic membrane. BIOPOL polymers can be useful in applications where protein adsorption is an undesirable event.
C1 WR GRACE & CO CONN RES DIV,DEPT DESIGNED POLYMERS RES,COLUMBIA,MD 21044.
RP BRAATZ, JA (reprint author), WR GRACE & CO CONN RES DIV,DEPT MAMMALIAN CELL RES,7379 ROUTE 32,COLUMBIA,MD 21044, USA.
CR Agostoni A, 1989, J Biomater Appl, V4, P102, DOI 10.1177/088532828900400202
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   BRAATZ JA, 1984, J NATL CANCER I, V72, P841
   BRAATZ JA, 1991, AM SOC ART INT ORG A, V20, P23
   BRAATZ JA, 1989, Patent No. 4886866
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   CHANG JP, 1988, CHROMATOGRAPHIA, V25, P350, DOI 10.1007/BF02324714
   CHANG JP, 1985, J CHROMATOGR, V319, P396, DOI 10.1016/S0021-9673(01)90578-3
   CLAESSON PM, 1986, J CHEM SOC FARAD T 1, V82, P2735, DOI 10.1039/f19868202735
   ENGELHARDT H, 1981, CHROMATOGRAPHIA, V14, P325, DOI 10.1007/BF02259229
   FOLKMAN J, 1986, CANCER RES, V46, P467
   HARDEGEN FJ, 1980, Patent No. 4237229
   HORBETT TA, 1977, J BIOENG, V1, P61
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KILLMANN E, 1975, ANGEW MAKROMOL CHEM, V43, P53, DOI 10.1002/apmc.1975.050430105
   Lelah M. D., 1986, POLYURETHANES MED
   MARCINKA K, 1972, ACTA VIROL, V16, P52
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   NAGAOKA S, 1987, J AM SOC ART INT ORG, V10, P76
   PARHAM ME, 1989, Patent No. 4787976
   PARHAM ME, 1989, Patent No. 4794090
   RUBIO J, 1976, J COLLOID INTERF SCI, V57, P132, DOI 10.1016/0021-9797(76)90182-X
   SAUNDERS JH, 1962, POLYURETHANES CHEM T, V1, P11
   SAUNDERS JH, 1964, POLYURETHANES CHEM T, V2, P8
   SIGGIA S, 1963, QUANTITATIVE ORGANIC, P559
   Wood L. L., 1976, J CELL PLAST, V12, P285
NR 29
TC 12
Z9 12
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 6
BP 451
EP 462
DI 10.1163/156856292X00439
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JH313
UT WOS:A1992JH31300003
PM 1419974
DA 2018-10-20
ER

PT J
AU ULUBAYRAM, K
   HASIRCI, N
AF ULUBAYRAM, K
   HASIRCI, N
TI POLYURETHANES - EFFECT OF CHEMICAL-COMPOSITION ON MECHANICAL-PROPERTIES
   AND OXYGEN PERMEABILITY
SO POLYMER
LA English
DT Article
DE POLYETHER POLYURETHANE; MECHANICAL PROPERTIES; OXYGEN PERMEABILITY;
   BIOMATERIAL
AB A series of polyether urethane films with varying hard/soft segment ratio were synthesized using toluene-2,4-diisocyanate (TDI) and polypropylene glycol (PPG) in order to evaluate them as biomaterials. In order to obtain medical purity the polymerization reactions were carried out in bulk without using any other ingredients such as solvent, catalyst, u.v. absorber, etc. The effects of chemical composition and the presence of the chain extender on some properties were examined. For the samples with higher TDI to PPG ratio, a decrease in ultimate elongation and an increase in tensile strength were observed. Addition of chain extender caused an increase in both. On the other hand, the ultimate elongation increased and tensile strength decreased with an increase in molecular weight of the PPG used. As the chemical compositions are changed by increasing the polyol content, an increase in oxygen permeability is also observed.
C1 MIDDLE E TECH UNIV,DEPT CHEM,ANKARA 06531,TURKEY.
OI HASIRCI, Nesrin/0000-0002-4497-0194
CR AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BENSON RS, 1988, J POLYM SCI POL CHEM, V26, P1393, DOI 10.1002/pola.1988.080260512
   BORETOS JW, 1973, CONCISE GUIDE BIOMED, P4
   BURKE A, 1988, J BIOACT COMPAT POLY, V3, P232
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Hasirci N., 1987, J BIOACT COMPAT POL, V2, P131
   HEPBRUN C, 1982, POLYURETHANE ELASTOM, P55
   KUTAY S, 1990, BRIT POLYM J, V23, P267, DOI 10.1002/pi.4980230316
   SCHAEFER H, 1982, SKIN PERMEABILITY, P756
   SZYCHER M, 1985, PLASTIC TECHNOL, P45
   TAKAHARA A, 1985, J BIOMED MATER RES, V19, P13, DOI 10.1002/jbm.820190104
   TRAPPE G, 1968, POLYURETHANE TEHCNOL, P89
   WILKES GL, 1979, J BIOMED MATER RES, V13, P189, DOI 10.1002/jbm.820130204
   WRIGHT P, 1969, SOLID POLYURETHANE E, P27
   WRIGHT P, 1969, SOLID POLYURETHANE E, P51
NR 15
TC 22
Z9 22
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1992
VL 33
IS 10
BP 2084
EP 2088
DI 10.1016/0032-3861(92)90874-V
PG 5
WC Polymer Science
SC Polymer Science
GA HW559
UT WOS:A1992HW55900009
DA 2018-10-20
ER

PT B
AU KELLY, TC
AF KELLY, TC
BE Kurusz, M
TI WHAT IS A BIOMATERIAL
SO PROCEEDINGS OF THE AMERICAN ACADEMY OF CARDIOVASCULAR PERFUSION, VOL 13
SE PROCEEDINGS OF THE AMERICAN ACADEMY OF CARDIOVASCULAR PERFUSION
LA English
DT Proceedings Paper
CT 13TH ANNUAL SEMINAR OF THE AMERICAN ACADEMY OF CARDIOVASCULAR PERFUSION
   : CARDIOVASCULAR PERFUSION
CY JAN 31-FEB 03, 1992
CL ORLANDO, FL
SP AMER ACAD CARDIOVASC PERFUS
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ACAD CARDIOVASCULAR PERFUSION
PI BIRMINGHAM
PA BIRMINGHAM
J9 P AM AC CAR
PY 1992
VL 13
BP 166
EP 169
PG 4
WC Cardiac & Cardiovascular Systems; Hematology; Surgery
SC Cardiovascular System & Cardiology; Hematology; Surgery
GA BX99J
UT WOS:A1992BX99J00035
DA 2018-10-20
ER

PT B
AU BONZON, N
   RABAUD, M
   LEFEBVRE, F
   ROUAIS, F
   PICARD, P
AF BONZON, N
   RABAUD, M
   LEFEBVRE, F
   ROUAIS, F
   PICARD, P
BE Morucci, JP
   Plonsey, R
   Coatrieux, JL
   Laxminarayan, S
TI A NEW COMPOSITE BIOMATERIAL - AN ARTIFICIAL CONNECTIVE MATRIX LINKED TO
   A POLYGLACTINE LATTICE - USED FOR VASCULAR PROSTHESIS
SO PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 14, PTS 1-7
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 14TH ANNUAL INTERNATIONAL CONF OF THE IEEE ENGINEERING IN MEDICINE AND
   BIOLOGY SOCIETY
CY OCT 29-NOV 01, 1992
CL PARIS, FRANCE
SP IEEE, ENGN MED & BIOL SOC
NR 0
TC 0
Z9 0
U1 0
U2 1
PU I E E E
PI NEW YORK
PA NEW YORK
BN 0-7803-0785-2
J9 P IEEE EMBS
PY 1992
VL 14
BP 10
EP 11
PG 2
WC Engineering, Biomedical
SC Engineering
GA BY25Z
UT WOS:A1992BY25Z00005
DA 2018-10-20
ER

PT B
AU SALMONS, S
   JARVIS, JC
AF SALMONS, S
   JARVIS, JC
BE Morucci, JP
   Plonsey, R
   Coatrieux, JL
   Laxminarayan, S
TI SKELETAL-MUSCLE AS AN ADAPTIVE CONTRACTILE BIOMATERIAL FOR CARDIAC
   ASSISTANCE - FUNDAMENTAL CONSIDERATIONS
SO PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 14, PTS 1-7
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 14TH ANNUAL INTERNATIONAL CONF OF THE IEEE ENGINEERING IN MEDICINE AND
   BIOLOGY SOCIETY
CY OCT 29-NOV 01, 1992
CL PARIS, FRANCE
SP IEEE, ENGN MED & BIOL SOC
NR 0
TC 1
Z9 1
U1 0
U2 0
PU I E E E
PI NEW YORK
PA NEW YORK
BN 0-7803-0785-2
J9 P IEEE EMBS
PY 1992
VL 14
BP 2798
EP 2799
PG 2
WC Engineering, Biomedical
SC Engineering
GA BY25Z
UT WOS:A1992BY25Z01350
DA 2018-10-20
ER

PT B
AU SCHMIDT, MB
   BRUNSKI, JB
AF SCHMIDT, MB
   BRUNSKI, JB
BE CIMA, LG
   RON, ES
TI INVITRO-CELL ADHESION AND DETACHMENT BEHAVIOR FOR VARIOUS BIOMATERIAL
   SUBSTRATES
SO TISSUE-INDUCING BIOMATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT SYMP ON TISSUE INDUCING BIOMATERIALS, AT THE 1991 FALL MEETING OF THE
   MATERIALS RESEARCH SOC
CY DEC 04-06, 1991
CL BOSTON, MA
SP MAT RES SOC
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA PITTSBURGH
BN 1-55899-146-8
J9 MATER RES SOC SYMP P
PY 1992
VL 252
BP 193
EP 198
PG 6
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BW25W
UT WOS:A1992BW25W00027
DA 2018-10-20
ER

PT J
AU SEYFERT, UT
   BOHNERTH, S
   HEINRICH, W
   WENZEL, E
AF SEYFERT, UT
   BOHNERTH, S
   HEINRICH, W
   WENZEL, E
TI CLINICAL RELEVANCE OF BIOLOGICAL INCOMPATIBILITY AND ROLE OF A CENTRAL
   REGISTER
SO ARTIFICIAL ORGANS
LA English
DT Note
DE BIOINCOMPATIBILITY; CENTRAL REGISTER; ALGORITHM; QUESTIONNAIRE
ID INFLAMMATORY REACTION; BIOMATERIALS; BIOCOMPATIBILITY; HEMODIALYSIS;
   INTERLEUKIN-1; PLASMA; CELLS; CALCIFICATION; FIBROBLASTS; ACTIVATION
AB Different aspects relevant for the assessment and characterization of biomaterials are presented. Quite a number of basic concepts that play an important role when detecting unwanted adverse effects of drugs have to be taken into consideration when registering and evaluating unwanted effects of biomaterials. The institutionalization of the Central Bioregister at the University of Saarland is described. This Bioregister is a so-called "spontaneous" ad hoc recording system whose efficiency depends largely on the collaboration of physicians. Thus, the efficiency and rationality of the use of biomaterials can certainly be improved. The possibility of registering even rarely occurring unwanted effects as well as new indications will result in and allow a more general and/or a more specific therapy, depending on the biomaterial.
RP SEYFERT, UT (reprint author), UNIV SAARLAND,KLIN HAMOSTASEOL & TRANSFUS MED ABT,UNIKLINIKEN,W-6650 HOMBURG,GERMANY.
CR AMUDESWARE S, 1969, J BIOMED MATER RES, V20, P1103
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   AVERY CW, 1967, AM J PSYCHIAT, V123, P875, DOI 10.1176/ajp.123.7.875
   BALDAMUS CA, 1983, CONTRIBUTIONS NEPHRO, V36, P1
   BERGESIO F, 1988, BLOOD PURIFICAT, V6, P16, DOI 10.1159/000169480
   BINGEL M, 1986, NEPHRON, V43, P161, DOI 10.1159/000183822
   BRUCK SD, 1988, MED PROG TECHNOL, V13, P149
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   CHANG HYK, 1980, THROMB RES, V19, P1
   CHESTERMANN CN, 1986, CLIN HAEMATOL, V15, P575
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   DAMLE NK, 1987, J IMMUNOL, V138, P1779
   DINARELLO CA, 1986, J CLIN INVEST, V77, P1734, DOI 10.1172/JCI112495
   DOILLON CJ, 1988, BIOMATERIALS, V9, P91, DOI 10.1016/0142-9612(88)90077-4
   DOLLE W, 1986, GRUNDLAGEN ARZNEIMIT
   ELY JL, 1984, POLYURETHANES BIOMED
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   FARRELL PC, 1984, BIOMATERIALS ARTIFIC, P342
   FISCHER JP, 1982, ANGEWANDTE MAKROMOLE, P131
   FORBES CD, 1981, CLIN HAEMATOL, V10, P653
   Forth W, 1987, ALLGEMEINE SPEZIELLE
   HAKIM RM, 1982, NEPHRON, V32, P32, DOI 10.1159/000182728
   HAKIM RM, 1984, KIDNEY INT, V26, P194, DOI 10.1038/ki.1984.155
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   HEINRICH D, 1986, HAMOSTASEOLOGIE, V6, P57
   HENDERSON L W, 1987, Blood Purification, V5, P100, DOI 10.1159/000169459
   JUNGI TW, 1986, BLOOD, V67, P629
   KAMBIC HE, 1983, BIOCOMPATIBLE POLYM, P179
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   Kimbel K, 1986, GRUNDLAGEN ARZNEIMIT, P292
   KLEINSORGE H, 1987, ARZNEIMITTELPRUFUNG
   Klinkmann H, 1987, Contrib Nephrol, V55, P231
   KNUDSEN PJ, 1989, NEPHRON, V53, P188, DOI 10.1159/000185743
   KUEMMERLE HP, 1984, KLIN PHARMAKOLOGIE G
   LEMONS J, 1986, DENT CLIN N AM, V30, P3
   LEONARD EF, 1983, CONTRIB NEPHROL, V36, P34
   LODI M, 1988, INT ANGIOL, V4, P344
   MANNHALTER C, 1984, THROMB RES, V35, P713, DOI 10.1016/0049-3848(84)90274-3
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MORITZ A, 1988, WIEN KLIN WOCHENSCHR, V100, P161
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154
   NEISS A, 1982, MUNCHEN MED WOCHEN, V124, P444
   NOSE Y, 1971, T AM SOC ART INT ORG, V17, P482
   NOSE Y, 1982, T AM SOC ART INT ORG, V28, P631
   NOSE Y, 1984, ARTIF ORGANS, V8, P135, DOI 10.1111/j.1525-1594.1984.tb04259.x
   OATES JA, 1985, CLIN PHYSL SERIES
   OKKEMA AZ, 1989, BIOMATERIALS, V10, P23, DOI 10.1016/0142-9612(89)90005-7
   OZAWA K, 1980, T AM SOC ART INT ORG, V26, P461
   PELZER H, 1984, POLYURETHANES BIOMED, P69
   PLANCK H, 1984, PROGR BIOMEDICAL ENG
   RINGOIR S, 1986, ARTIF ORGANS, V10, P20, DOI 10.1111/j.1525-1594.1986.tb02511.x
   SCHMIDSCHONBEIN H, 1979, 1978 WORKSH S STOLB
   SCHOEN FJ, 1986, J BIOMED MATER RES, V20, P709, DOI 10.1002/jbm.820200605
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SEELOS HJ, 1987, KRANKENHAUS ARZT, V60, P831
   SEELOS HJ, 1989, DTSCH ARZTEBL, V86, P1932
   SEYFERT UT, 1990, HAEMOSTASEOLOGIE, V10, P97
   SEYFERT UT, IN PRESS MED TEXTILE
   SHALDON S, 1988, BLOOD PURIFICAT, V6, P162, DOI 10.1159/000169541
   Shaldon S, 1988, Adv Nephrol Necker Hosp, V17, P423
   Shaldon S, 1985, P EUR DIAL TRANSPLAN, V22, P229
   SMITH JW, 1982, T AM SOC ART INT ORG, V28, P391
   SUNDSMO JS, 1983, CLIN PHYSIOL BIOCH, V1, P225
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   Vanholder R C, 1988, ASAIO Trans, V34, P543
   VROMAN L, 1980, BLOOD, V55, P156
   Waitzova D, 1986, Polim Med, V16, P93
   WENZEL E, 1984, POLYURETHANES BIOMED, P17
   WENZEL E, 1979, BASIC ASPECTS BLOOD, P159
   WENZEL E, 1986, RATIONELLE THERAPIE, V7, P1
   WENZEL E, 1981, TAGUNG GTH DAB, P165
   WETZELS E, 1986, HAMODIALYSE PERITONE, V3
   WILLIAMS DF, 1982, BIOCOMPATIBILITY CLI
   WILLIAMS KR, 1986, BIOMATERIALS, V7, P287, DOI 10.1016/0142-9612(86)90052-9
   WUMOLE TA, 1986, J ORTHOPAED RES, V4, P346
   Young BR, 1982, ADV CHEM SER, V199, P317
   ZEPPEZAUER M, 1986, RATIONELLE THERAPIE, V7, P10
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 82
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD DEC
PY 1991
VL 15
IS 6
BP 507
EP 513
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA GU527
UT WOS:A1991GU52700012
PM 1763974
DA 2018-10-20
ER

PT J
AU TIMMERMAN, CP
   FLEER, A
   BESNIER, JM
   DEGRAAF, L
   CREMERS, F
   VERHOEF, J
AF TIMMERMAN, CP
   FLEER, A
   BESNIER, JM
   DEGRAAF, L
   CREMERS, F
   VERHOEF, J
TI CHARACTERIZATION OF A PROTEINACEOUS ADHESIN OF
   STAPHYLOCOCCUS-EPIDERMIDIS WHICH MEDIATES ATTACHMENT TO POLYSTYRENE
SO INFECTION AND IMMUNITY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; STREPTOCOCCUS-SANGUIS; CELL-SURFACE;
   MONOCLONAL-ANTIBODIES; ADHERENCE; CATHETERS; SLIME; FIBRONECTIN;
   INFECTION; STRAINS
AB Coagulase-negative staphylococci (CoNS) have evolved into important agents of foreign body-related infections.  Adhesion of causative bacteria to biomaterials is considered to be an essential step in these infections.  We and others have shown that adhesion of CoNS to biomaterials may be mediated by protease-sensitive surface constituents.  In the present study we expanded on these investigations by characterizing a biomaterial adhesin of Staphylococcus epidermidis 354 by using a strain-specific monoclonal antibody (MAb 36.4).  MAb 36.4 was strongly and exclusively reactive with strain 354 in an enzyme-linked immunosorbent assay in which whole bacteria were used as antigens.  Immunoblotting of cell wall polypeptides of strain 354 revealed strong reactivity with a 200- to 220-kDa band and a weaker reaction in the 100- to 110-kDa range.  Preincubation of strain 354 with MAb 36.4 resulted in a 54 to 91% (mean +/- standard deviation, 74% +/- 14%; n = 10) inhibition of adhesion to polystyrene spheres.  Fab fragments prepared from MAb 36.4 also inhibited adhesion effectively, indicating specific blocking of an adhesion antigen rather than aspecific inhibition.  Immunogold electron microscopy with MAb 36.4 revealed deposition of gold particles on the cell surface and possibly also on fimbrialike surface projections.  It is concluded that a surface-located protein antigen of S. epidermidis 354 recognized by MAb 36.4 acts as an adhesin mediating attachment to uncoated foreign material.  It is speculated that this type of adhesion to biomaterials may play an important role in the pathogenesis of foreign body-related infections caused by CoNS.
C1 STATE UNIV UTRECHT,EIJKMAN WINKLER LAB MED MICROBIOL,HEIDELBERGLAAN 100,3584 CH UTRECHT,NETHERLANDS.
   STATE UNIV UTRECHT,DEPT MOLEC CELL BIOL,UTRECHT,NETHERLANDS.
   UNIV CHILDRENS HOSP HET WILHELMINA KINDERZIEKENHUIS,3512 LK UTRECHT,NETHERLANDS.
   BRETONNEAU HOSP,DEPT INFECT DIS,F-37044 TOURS,FRANCE.
CR CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   CHRISTENSEN GD, 1985, PRINCIPLES PRACTICE, P6
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5
   DUGUID JP, 1955, J PATHOL BACTERIOL, V70, P335, DOI 10.1002/path.1700700210
   ELDER BL, 1986, INFECT IMMUN, V54, P421
   HANDLEY PS, 1984, J BACTERIOL, V157, P64
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   KLEMM P, 1985, REV INFECT DIS, V7, P321
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAMONT RJ, 1988, INFECT IMMUN, V56, P2417
   LILJEMARK WF, 1981, INFECT IMMUN, V34, P428
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V258, P256, DOI 10.1016/S0176-6724(84)80043-7
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   MORRIS EJ, 1985, J BACTERIOL, V164, P255
   MORRIS EJ, 1987, J BACTERIOL, V169, P164, DOI 10.1128/jb.169.1.164-171.1987
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   SCHMIDT H, 1988, ZBL BAKT-INT J MED M, V268, P228
   SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0
   SNYDMAN DR, 1982, LANCET, V2, P1385
   STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VERHOEF J, 1977, J IMMUNOL METHODS, V14, P303, DOI 10.1016/0022-1759(77)90141-7
   VOORHOUT WF, 1986, J MICROSC-OXFORD, V141, P303, DOI 10.1111/j.1365-2818.1986.tb02724.x
   WEERKAMP AH, 1986, J BACTERIOL, V165, P746, DOI 10.1128/jb.165.3.746-755.1986
NR 33
TC 84
Z9 84
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD NOV
PY 1991
VL 59
IS 11
BP 4187
EP 4192
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GM530
UT WOS:A1991GM53000049
PM 1682256
DA 2018-10-20
ER

PT J
AU THOMANECK, U
   VIENKEN, J
   WALDSCHLAGER, U
   DIAMANTOGLOU, M
   SCHUTT, W
   FALKENHAGEN, D
   KLINKMANN, H
AF THOMANECK, U
   VIENKEN, J
   WALDSCHLAGER, U
   DIAMANTOGLOU, M
   SCHUTT, W
   FALKENHAGEN, D
   KLINKMANN, H
TI DETECTION OF CHARGES AND THEIR DISTRIBUTION ON DIALYSIS MEMBRANES WITH
   CATIONIC ANIONIC DYES USING CONFOCAL LASER SCANNING MICROSCOPY
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE STAINING; DIALYSIS MEMBRANES; CHARGES; PHOTOMETRY; LASER SCANNING
   MICROSCOPY
ID FLUORESCENCE
AB Methods for the detection of positive or negative charges on the surface of biomaterials/membranes and inside a membrane are important for the characterisation of such materials. We tested different dyes and optimized staining procedures. Under standardized conditions negatively charged membranes were stained with cationic triarylmethane compounds such as crystal violet and positively charged membranes with the anionic anthraquinone dye anthralan blue B. There was no staining of uncharged cellulose membranes. The applicability of these methods was demonstrated on membranes coated to varying degrees with charged compounds such as heparin, these changes in charge being detectible quantitatively by photometry. The distribution of charges inside a membrane was detected by optical sectioning across the stained (F/TC labelled poly-L-lysine) membrane using confocal laser scanning microscopy (LSM). LSM offers a completely new application possibility in biomaterial and biocompatibility research.
C1 AKZO ENICA AG, WUPPERTAL, GERMANY.
RP THOMANECK, U (reprint author), UNIV ROSTOCK, CTR BIOENGN, DEPT INTERNAL MED, ERNST HEYDEMANN STR 6, O-2500 ROSTOCK, GERMANY.
CR ARNDTJOVIN DJ, 1985, SCIENCE, V230, P247, DOI 10.1126/science.4048934
   BRAKENHOFF GJ, 1986, ANN NY ACAD SCI, V483, P405, DOI 10.1111/j.1749-6632.1986.tb34549.x
   CARRENO MP, BIOMATERIALS 88 T, V11, P145
   GRASEL TG, 1988 BIOM T, V11, P424
   IWATA H, 1988 BIOM T, V11, P291
   Matsuda T., 1989, NEPHROL DIAL TRANS S, V4, P60
   NICOUD R, 1989, EUR J CELL BIOL S25, V48, P49
   PAUL D, 1990, ARTIF ORGANS, V14, P122
   PAWLEY J, 1989, HDB BIOL CONFOCAL MI
   REINHOLZ F, 1989, OPTIK, V82, P165
   SASAKI M, 1988 BIOM T, V11, P154
   WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41
   WILSON T, 1985, THEORY PRACTICE SCAN
NR 13
TC 6
Z9 6
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 1991
VL 14
IS 11
BP 686
EP 690
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA GT769
UT WOS:A1991GT76900002
PM 1721897
DA 2018-10-20
ER

PT J
AU SUNDARAM, S
   IRVINE, L
   COURTNEY, JM
   LOWE, GDO
AF SUNDARAM, S
   IRVINE, L
   COURTNEY, JM
   LOWE, GDO
TI MODIFICATION OF THE INFLUENCE OF BIOMATERIALS ON CONTACT ACTIVATION
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 1990 ANNUAL MEETING OF THE EUROPEAN SOC FOR ARTIFICIAL ORGANS
CY SEP, 1990
CL BOLOGNA, ITALY
SP EUROPEAN SOC ARTIFICIAL ORGANS
DE CONTACT ACTIVATION; FXIIA; BIOMATERIAL; ANTICOAGULANT
AB Knowledge of the influence of biomaterials on the contact phase activation of blood is important. Consequently, it is important to examine if the biomaterial influence is modified by the action of anticoagulants. Contact activation was determined by measuring FXII activity (FXIIA) by a chromogenic substrate assay. Cuprophan in the absence of anticoagulants and in the presence of heparin, low molecular weight heparin (LMWH) and hirudin was compared with controls. The controls were a polystyrene incubation test cell (PS) and two polyamide membranes, NR (zeta potential -28.6 mv and NRZ (zeta potential -18.0 mv). The investigation has confirmed that measurement of FXIIA is material dependent and demonstrated that contact activation can be mediated by antithrombotic agent.
C1 UNIV GLASGOW,GLASGOW ROYAL INFIRM,DEPT MED,GLASGOW,SCOTLAND.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,WOLFSON CTR,BIOENGN UNIT,106 ROTTENROW,GLASGOW G4 ONW,SCOTLAND.
CR ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   COCHRANE CG, 1982, ADV IMMUNOL, V33, P241, DOI 10.1016/S0065-2776(08)60837-8
   FORBES CD, 1987, HAEMOSTASIS THROMBOS, P902
   GALLIMORE M J, 1987, Fibrinolysis, V1, P123, DOI 10.1016/0268-9499(87)90020-8
   HOLMER E, 1981, BIOCHEM J, V193, P395, DOI 10.1042/bj1930395
   IRVINE L, 1989, THESIS U STRATHCLYDE
   MARKWARDT F, 1984, THROMB HAEMOSTASIS, V52, P226
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   PALL FILTRATION GUID
NR 9
TC 4
Z9 4
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 1991
VL 14
IS 11
BP 729
EP 731
PG 3
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA GT769
UT WOS:A1991GT76900009
PM 1661710
DA 2018-10-20
ER

PT J
AU RADU, GL
   TANASE, A
   CALOIANUIORDACHEL, M
   TODOR, I
AF RADU, GL
   TANASE, A
   CALOIANUIORDACHEL, M
   TODOR, I
TI STRUCTURAL DIFFERENCES OF SOME BIOMATERIALS BASED ON COLLAGEN
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article
ID I COLLAGEN
AB Collagen became the basic material to obtain biomaterials used in various medical fields. The physico-chemical and biological properties of biomaterials are dependent, among other factors, on the structure. The paper characterises certain spongy biomaterials, by thermal analysis. The thermograms obtained on the temperature range 20 - 500-degrees are specific for each biomaterial and may become their "fingerprint". "Structural water" was detected in an approximate amount of 1 %, its elimination being done within the temperature range of 180-210-degrees. The denaturation of the collagen contained in samples, revealed by DTA curves, is preceded and accompanied by mass loss evidenced by TG and DTG curves. It is considered that this mass loss (probably water) is determining the denaturation.
C1 RES & PRODUCT ENTREPRISE ELECTR MAT,BUCHAREST,ROMANIA.
RP RADU, GL (reprint author), INST BIOL SCI BUCHAREST,SPL INDEPENDENTEI 296,R-77748 BUCHAREST 17,ROMANIA.
RI Radu, GL/F-7766-2011; RADU, Gabriel-Lucian/E-8560-2011
OI Radu, GL/0000-0002-4385-1177; RADU, Gabriel-Lucian/0000-0002-4385-1177
CR ANGEL G, 1980, REV ROUM BIOCHIM, V17, P3
   BOURGOIN D, 1977, J BIOPHYS BIOMEC, V1, P53
   BROKAW JL, 1985, INT J BIOL MACROMOL, V7, P135, DOI 10.1016/0141-8130(85)90015-7
   JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X
   KUHN K, 1986, RHEUMATOLO, V10, P26
   MILLIONOVA MI, 1985, BIOFIZIKA+, V30, P578
   MITCHEL J, 1975, ANAL CHEM REV, V47, P289
   MOULD AP, 1985, J ULTRA MOL STRUCT R, V91, P66, DOI 10.1016/0889-1605(85)90077-1
   PIEZ KA, 1985, ENCY POLYM SCI ENG, V3, P669
   RADU GL, 1987, ST CERC BIOCH, V30, P198
   TRAUB W, 1986, FEBS LETT, V198, P213, DOI 10.1016/0014-5793(86)80407-0
   YANNAS IV, 1972, J MACROMOL SCI R M C, VC  7, P49, DOI 10.1080/15321797208068160
NR 12
TC 0
Z9 0
U1 0
U2 1
PU EDITURA ACADEMIEI ROMANE
PI BUCHAREST
PA CALEA VICTORIEI 125, BUCHAREST 79717, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD NOV-DEC
PY 1991
VL 36
IS 11-12
BP 1363
EP 1369
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA HU672
UT WOS:A1991HU67200020
DA 2018-10-20
ER

PT J
AU RUDOLPHY, VJ
   TUKKIE, R
   KLOPPER, PJ
AF RUDOLPHY, VJ
   TUKKIE, R
   KLOPPER, PJ
TI CHEST-WALL RECONSTRUCTION WITH DEGRADABLE PROCESSED SHEEP DERMAL
   COLLAGEN IN DOGS
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID DEFECTS; REPAIR; MESH
AB Chest wall defects resulting from oncological operations often require prosthetic repair. The objectives of prosthetic repair are to provide a cosmetically acceptable substitute, prevent paradoxical chest wall movement, and protect vital organs. Of the many materials that have been used in these repairs, none have proved to be ideal. The aim of our study was to investigate the application of a biodegradable material-processed sheep dermal collagen-as a chest wall prosthesis. A full-thickness chest wall defect of 10 x 10 cm was created in 12 dogs; 10 had repair with a processed sheep dermal collagen prosthesis and 2, the controls, with polypropylene mesh. In this study, the biomaterial fulfilled its function as a chest wall prosthesis at 24 weeks' follow-up. No respiratory problems were seen, the chest wall remained stable with minimal and decreasing respiratory paradoxical movement, and the processed sheep dermal collagen slowly degraded and was replaced by the host collagen. Processed sheep dermal collagen offers long-term advantages because it is degradable. Late complications from a nonabsorbable prosthesis, ie, infection or disintegration of the material possibly causing extrusion or fistula formation, are avoided.
RP RUDOLPHY, VJ (reprint author), UNIV AMSTERDAM,ACAD MED CTR,DEPT SURG RES,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS.
CR ARNOLD PG, 1984, ANN SURG, V199, P725, DOI 10.1097/00000658-198406000-00011
   BOYD AD, 1981, ANN THORAC SURG, V32, P337, DOI 10.1016/S0003-4975(10)61754-7
   BURNARD RJ, 1974, J THORAC CARDIOV SUR, V68, P530
   DINGMAN RO, 1981, ANN THORAC SURG, V32, P202, DOI 10.1016/S0003-4975(10)61032-6
   ELLIOTT MP, 1979, AM J SURG, V137, P342, DOI 10.1016/0002-9610(79)90063-1
   ERHARD J, 1987, THORAC CARDIOV SURG, V35, P119, DOI 10.1055/s-2007-1020210
   GRAHAM J, 1960, ANN SURG, V151, P469, DOI 10.1097/00000658-196004000-00005
   GROSS E, 1984, ZBL CHIR, V109, P1238
   HUBBARD SG, 1979, ANN THORAC SURG, V27, P440, DOI 10.1016/S0003-4975(10)63343-7
   LAMB JP, 1983, SURGERY, V93, P643
   le Roux B T, 1983, Curr Probl Surg, V20, P345, DOI 10.1016/S0011-3840(83)80007-0
   LEROUX B T, 1964, Thorax, V19, P397, DOI 10.1136/thx.19.5.397
   MCCORMACK PM, 1989, SURG CLIN N AM, V69, P965
   SALMON RJ, 1985, PRESSE MED, V14, P27
   STARZYNS.TE, 1969, PLAST RECONSTR SURG, V44, P525, DOI 10.1097/00006534-196912000-00001
   USHER FC, 1959, AM J SURG, V97, P629, DOI 10.1016/0002-9610(59)90256-9
   VANBULIK TM, 1981, THESIS U AMSTERDAM A
   VANDERWAL AC, 1988, ADV BIOMATER, V8, P61
   VANGEEL AN, 1989, BRIT J SURG, V76, P870, DOI 10.1002/bjs.1800760835
   VANGULIK TM, 1987, NETH J SURG, V39, P90
NR 20
TC 11
Z9 15
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD OCT
PY 1991
VL 52
IS 4
BP 821
EP 825
DI 10.1016/0003-4975(91)91218-K
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA GM201
UT WOS:A1991GM20100017
PM 1929636
DA 2018-10-20
ER

PT J
AU LEVY, RJ
   SCHOEN, FJ
   ANDERSON, HC
   HARASAKI, H
   KOCH, TH
   BROWN, W
   LIAN, JB
   CUMMING, R
   GAVIN, JB
AF LEVY, RJ
   SCHOEN, FJ
   ANDERSON, HC
   HARASAKI, H
   KOCH, TH
   BROWN, W
   LIAN, JB
   CUMMING, R
   GAVIN, JB
TI CARDIOVASCULAR IMPLANT CALCIFICATION - A SURVEY AND UPDATE
SO BIOMATERIALS
LA English
DT Article
DE PROSTHESES; CALCIFICATION; POLYMERS
ID PORCINE BIOPROSTHETIC VALVES; GAMMA-CARBOXYGLUTAMIC ACID; DYSTROPHIC
   CALCIFICATION; HEART-VALVES; ATHEROSCLEROTIC PLAQUE; MECHANICAL
   STRESSES; CARDIAC VALVES; CLOSED CUSPS; VALVULOPLASTY; PROSTHESES
AB Calcification of cardiovascular prosthetic implants is a common and important problem. This review provides an update based upon the Conference on Cardiovascular Implant Calcification held as part of the 13th World Congress of the International Society for Heart Research, 1989. A variety of cardiovascular prostheses are affected clinically by calcification, including bioprosthetic heart valves, aortic homografts and trileaflet polymeric valve prostheses. In addition, experimental studies have demonstrated calcification of artificial heart devices in ventricular assist systems in long-term calf studies. The pathophysiology of this disease process is incompletely understood. A common element between the various types of cardiovascular implant calcification is the localization of calcific deposits to devitalized cells and membranous debris. Prevention of cardiovascular implant calcification by either biomaterial modifications or regional drug therapy (controlled release) is being investigated.
C1 BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115.
   HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115.
   UNIV KANSAS,MED CTR,DEPT PATHOL,KANSAS CITY,KS 66103.
   CLEVELAND CLIN,DEPT ARTIFICIAL ORGANS,CLEVELAND,OH 44106.
   UNIV COLORADO,DEPT CHEM,BOULDER,CO 80309.
   AMER DENT ASSOC,ROCKVILLE,MD.
   UNIV MASSACHUSETTS,DEPT ANAT & CELL BIOL,WORCESTER,MA 01605.
   ABIOMED,DANVERS,MA.
   UNIV AUCKLAND,DEPT EXPTL PATHOL,AUCKLAND,NEW ZEALAND.
RP LEVY, RJ (reprint author), UNIV MICHIGAN,DEPT PEDIAT,KRESGE 2,ROOM 5014,ANN ARBOR,MI 48109, USA.
FU NHLBI NIH HHS [1R13 HL41941]
CR ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341
   ANDERSON HC, 1984, SCANNING ELECTRON MI, V2, P953
   ARBUSTINI E, 1983, AM J CARDIOL, V52, P632, DOI 10.1016/0002-9149(83)90041-3
   BARNHART GR, 1982, CIRCULATION, V66, P167
   BARNHART GR, 1982, J THORAC CARDIOV SUR, V83, P618
   BERNHARD WF, 1984, J THORAC CARDIOV SUR, V88, P11
   BOSKEY AL, 1988, AM J PATHOL, V133, P22
   BOSKEY AL, 1977, CALC TISS RES, V22, P197
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   BROCK L, 1968, THORAX, V23, P249
   CHRISTOFFERSEN MR, 1985, CALCIFIED TISSUE INT, V37, P673, DOI 10.1007/BF02554929
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   CUMMING RD, 1985, DEC DEV TECHN BRANCH
   FISHBEIN MC, 1975, AM HEART J, V89, P443, DOI 10.1016/0002-8703(75)90149-0
   FISHBEIN MC, 1982, J THORAC CARDIOV SUR, V83, P602
   FLEISCH H, 1989, RECENT RES CANCER, V16, P1
   GALLOP PM, 1980, NEW ENGL J MED, V302, P1406
   GARDNER MB, 1968, ARCH PATHOL, V85, P397
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   GONZALEZLAVIN L, 1988, TRANSPLANT P, V10, P815
   HARASAKI H, 1980, T AM SOC ART INT ORG, V26, P470
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   JONAS RA, 1988, J THORAC CARDIOV SUR, V96, P746
   JONES M, 1988, T AM SOC ART INT ORG, V34, P1027
   KHAN MAA, 1986, AM HEART J, V112, P158
   Khatib H., 1990, TRANSPLANTATION, V49, P765
   KIM KM, 1983, SURV SYN PATHOL RES, V2, P215
   KOCH TH, 1984, METHOD ENZYMOL, V107, P563
   LEVY RJ, 1983, ATHEROSCLEROSIS, V46, P49, DOI 10.1016/0021-9150(83)90163-6
   LEVY RJ, 1983, ANN THORAC SURG, V36, P187, DOI 10.1016/S0003-4975(10)60454-7
   LEVY RJ, 1983, AM J CARDIOL, V52, P629, DOI 10.1016/0002-9149(83)90040-1
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   LEVY RJ, 1987, J THORAC CARDIOV SUR, V94, P551
   Lian J B, 1988, Clin Orthop Relat Res, P267
   LIAN JB, 1976, BIOCHEM BIOPH RES CO, V73, P349, DOI 10.1016/0006-291X(76)90714-2
   LIAN JB, 1981, LVAD MINERALIZATION, V26, P683
   LLOYD TR, 1987, AM HEART J, V114, P268, DOI 10.1016/0002-8703(87)90489-3
   LOCK JE, 1985, NEW ENGL J MED, V313, P1515, DOI 10.1056/NEJM198512123132405
   MARANTO AR, 1988, CIRC RES, V63, P844, DOI 10.1161/01.RES.63.4.844
   MAXWELL L, 1989, PATHOLOGY, V21, P5, DOI 10.3109/00313028909059521
   MCKAY CR, 1988, AM HEART J, V115, P463, DOI 10.1016/0002-8703(88)90496-6
   Miller D C, 1987, J Card Surg, V2, P185
   PERRY SB, 1988, AM J CARDIOL, V61, pG109, DOI 10.1016/S0002-9149(88)80042-0
   PHELPS KR, 1988, AM J MED, V84, P774
   REUL GJ, 1985, J VASC SURG, V2, P192
   SABBAH HN, 1986, ANN THORAC SURG, V42, P93, DOI 10.1016/S0003-4975(10)61845-0
   SABBAH HN, 1985, AM J CARDIOL, V55, P1091, DOI 10.1016/0002-9149(85)90752-0
   SAFIAN RD, 1988, NEW ENGL J MED, V319, P125, DOI 10.1056/NEJM198807213190301
   SARAVALLI OA, 1980, J THORAC CARDIOV SUR, V80, P909
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, J BIOMED MATER RES-A, V21, P91
   SCHOEN FJ, 1989, INTERVENTIONAL SURGI, P124
   SCHOEN FJ, 1988, CONT ISSUES CARDIOVA, P289
   THIENE G, 1986, J THORAC CARDIOV SUR, V91, P215
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TOMAZIC BB, 1988, ATHEROSCLEROSIS, V69, P5, DOI 10.1016/0021-9150(88)90284-5
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   TSAO JW, 1988, BIOMATERIALS, V9, P393, DOI 10.1016/0142-9612(88)90002-6
   VALENTE M, 1985, AM J PATHOL, V119, P12
   VANBUSKIRK JJ, 1984, P NATL ACAD SCI-BIOL, V81, P722
   WALDMAN JD, 1987, CIRCULATION, V76, P109, DOI 10.1161/01.CIR.76.1.109
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
   WEBB CL, 1989, EXP MOL PATHOL, V50, P291, DOI 10.1016/0014-4800(89)90039-7
   WEBB CL, 1991, AM J PATHOL, V138, P971
   WEBB CL, 1990, T AM SOC ART INT ORG, V36, P56
   WEBB CL, 1988, T AM SOC ART INT ORG, V34, P851
   WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666
   WISEMAN CB, 1982, T AM SOC ART INT ORG, V128, P164
NR 73
TC 52
Z9 55
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1991
VL 12
IS 8
BP 707
EP 714
DI 10.1016/0142-9612(91)90017-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GN190
UT WOS:A1991GN19000001
PM 1799646
DA 2018-10-20
ER

PT J
AU CORTIVO, R
   BRUN, P
   RASTRELLI, A
   ABATANGELO, G
AF CORTIVO, R
   BRUN, P
   RASTRELLI, A
   ABATANGELO, G
TI INVITRO STUDIES ON BIOCOMPATIBILITY OF HYALURONIC-ACID ESTERS
SO BIOMATERIALS
LA English
DT Article
DE HYALURONIC ACID ESTERS; BIOCOMPATIBILITY; CELL ADHESION; CELL
   CULTIVATION
ID ADHESION; VIRUS
AB The biocompatibility of semisynthetic polymers formed from hyaluronic acid esters has been studied using fibroblast cultures. The polymers, added to the culture medium, used either in powdered form or as thin membranes, behave as inert materials. The cells used in the experiments grow normally in the culture dishes. With regard to adhesiveness the cells were not able to spread on the biomembranes and tended to form isolated clusters of round cells. Human fibronectin, placental collagen (type I-IV) and fibrin could be stratified on biomembranes. When these molecules reacted with the biomaterial the film became suitable for fibroblasts spreading and growth.
C1 UNIV PADUA,INST HISTOL,75 VIA TRIESTE,I-35131 PADUA,ITALY.
   FIDIA RES LABS,DIV BIOSKIN,ABANO TERME,ITALY.
CR ABATANGELO G, 1982, EXP CELL RES, V137, P73, DOI 10.1016/0014-4827(82)90009-X
   ABATANGELO G, 1983, J SURG RES, V35, P410, DOI 10.1016/0022-4804(83)90030-6
   ABATANGELO G, 1989, CLIN ORTHOP RELAT R, V241, P278
   ASHEIM A, 1976, ACTA VET SCAND, V17, P379
   BRAGANTINI A, 1987, CLIN TRIALS J, V24, P333
   CORTIVO R, 1990, CELL BIOL INT REP, V14, P111
   Della V.F., 1987, European Patent, Patent No. 216453
   DOIILON CJ, 1986, BIOMATERIALS, V7, P3
   FORRESTER JV, 1981, J CELL SCI, V50, P329
   HAKANSSON L, 1980, J CLIN INVEST, V66, P298, DOI 10.1172/JCI109857
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   LAURENT TC, 1986, FUNCTIONS PROTEOGLYC, P9
   RAFANELLI A, 1986, Chronica Dermatologica, V17, P251
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   ROLLINS BJ, 1979, BIOCHEMISTRY-US, V18, P141, DOI 10.1021/bi00568a022
   Toole B.P., 1983, P203
   TOOLE BP, 1981, CELL BIOL EXTRACELLU, P259
   UNDERHILL CB, 1978, EXP CELL RES, V17, P155
   WEIGEL PH, 1986, J THEOR BIOL, V119, P229
   WRIGHT TC, 1981, CANCER RES, V41, P5107
NR 20
TC 59
Z9 59
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1991
VL 12
IS 8
BP 727
EP 730
DI 10.1016/0142-9612(91)90020-B
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GN190
UT WOS:A1991GN19000004
PM 1799648
DA 2018-10-20
ER

PT J
AU COLLET, D
   LEFEBVRE, F
   QUENTIN, C
   RABAUD, M
AF COLLET, D
   LEFEBVRE, F
   QUENTIN, C
   RABAUD, M
TI INVITRO STUDIES OF ELASTIN FIBRIN BIOMATERIAL DEGRADATION - PRESERVATIVE
   EFFECTS OF PROTEASE INHIBITORS AND ANTIBIOTICS
SO BIOMATERIALS
LA English
DT Article
DE ELASTIN; FIBRIN; PROTEASE INHIBITORS; ANTIBIOTICS
AB The degradability of a new elastin-fibrin material was tested in vitro versus human pancreatic elastase (HPE) and plasmin (PL) activities. It is shown that aprotinine Iniprol(R), a well-known protease inhibitor and Eglin C(R), a new potent inhibitor of HPE, especially when used in synergy, efficiently protected the material. A small amount of specific antibiotics was incorporated into the material. The two products will allow the material to be used in digestive surgery with improved safety.
C1 UNIV BORDEAUX 2, CEEMASI, INSERM, U306, 146 RUE LEO SAIGNAT, F-33076 BORDEAUX, FRANCE.
   HOP PELLEGRIN, SERV BACTERIOL, F-33000 BORDEAUX, FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   BARBIE C, 1989, BIOMATERIALS, V10, P445, DOI 10.1016/0142-9612(89)90084-7
   BIETH J, 1978, FRONTIERS MATRIX BIO, V6, P1
   FALLER B, IN PRESS BIOCH J
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   LARGMAN C, 1976, BIOCHEMISTRY-US, V15, P2491, DOI 10.1021/bi00656a036
   LEFEBVRE F, 1989, J BIOMED MATER RES, V23, P1423, DOI 10.1002/jbm.820231205
   MARDER VJ, 1982, HEMOSTASIS THROMBOSI, P145
   MARESCAUX J, 1988, 3RD WORLD BIOM C KYO
   MARTIN MT, 1988, BIOMATERIALS, V9, P519, DOI 10.1016/0142-9612(88)90048-8
   MINABE M, 1989, J CLIN PERIODONTOL, V16, P291, DOI 10.1111/j.1600-051X.1989.tb01657.x
   RABAUD M, 1986, THROMB RES, V43, P205, DOI 10.1016/0049-3848(86)90061-7
   RABAUD M, 1975, CLIN CHIM ACTA, V61, P257, DOI 10.1016/0009-8981(75)90415-5
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
   RIQUET M, IN PRES BIOMATERIALS
   SEEMULLER U, 1977, H-S Z PHYSIOL CHEM, V358, P1105, DOI 10.1515/bchm2.1977.358.2.1105
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   STROUD RM, 1975, PROTEASES BIOL CONTR, P13
NR 18
TC 8
Z9 8
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1991
VL 12
IS 8
BP 763
EP 766
DI 10.1016/0142-9612(91)90027-8
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GN190
UT WOS:A1991GN19000011
PM 1724734
DA 2018-10-20
ER

PT J
AU HANAWA, T
   OTA, M
AF HANAWA, T
   OTA, M
TI CALCIUM-PHOSPHATE NATURALLY FORMED ON TITANIUM IN ELECTROLYTE SOLUTION
SO BIOMATERIALS
LA English
DT Article
DE TITANIUM; CALCIUM PHOSPHATE; SURFACE FILM; BIOCOMPATIBILITY
ID RAY PHOTOELECTRON-SPECTROSCOPY; XPS SPECTRA; IMPLANTS; INTERFACE;
   ANCHORAGE; SURFACES; TISSUE; ENERGY; OXIDES; METAL
AB Surface films formed on titanium specimens immersed in electrolyte solutions (pH 4.5, 5.2, 7.4) at 37-degrees-C for 1 h, 1 d, 30 d, and/or 60 d, were characterized using X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared reflection absorption spectroscopy (FTIR-RAS) to understand the reaction between titanium and inorganic ions. For comparison, the surfaces of Ti-6AI-4V and Ti-50Ni were also characterized. XPS data revealed that calcium phosphates were naturally formed on these specimens. In particular, compared with the calcium phosphates formed on the titanium alloys, the calcium phosphate formed on titanium immersed for 30 d in the solution with pH 7.4 was more like hydroxyapatite. The compositions of the calcium phosphates formed on the specimens changed with the immersion time and the pH value of the solution. The spectrum obtained using FTIR-RAS from titanium immersed in the solution with pH 7.4 for 60 d was similar to that obtained from carbonate-containing hydroxyapatite. The results indicate that a calcium phosphate similar to apatite is naturally formed on titanium in a neutral electrolyte solution in 30 d. In regard to titanium being a biomaterial, we found this to be an intriguing property. It is possible that this calcium phosphate is responsible for the resulting biocompatibility of titanium.
RP HANAWA, T (reprint author), HOKKAIDO UNIV, SCH DENT, DEPT DENT MAT & ENGN, KITA 13 NISHI 7, KITA KU, SAPPORO, HOKKAIDO 060, JAPAN.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1983, J PROSTHET DENT, V50, P255, DOI 10.1016/0022-3913(83)90027-6
   ALBREKTSSON T, 1982, CLIN APPL BIOMATERIA, P167
   Asami K., 1976, Journal of the Japan Institute of Metals, V40, P438
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   ASK M, 1985, GIPR264 GOTH I PHYS
   BRUNDLE CR, 1974, J VAC SCI TECHNOL, V11, P212, DOI 10.1116/1.1318572
   CHENG PT, 1985, CALCIFIED TISSUE INT, V37, P91, DOI 10.1007/BF02557685
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   DOI Y, 1982, CALCIFIED TISSUE INT, V34, P178, DOI 10.1007/BF02411230
   ECHIZENYA T, 1989, J JPN SOC DENT MATER, V8, P161
   FRANZEN HF, 1976, J SOLID STATE CHEM, V18, P363, DOI 10.1016/0022-4596(76)90119-5
   FUGGLE JC, 1980, J ELECTRON SPECTROSC, V21, P275, DOI 10.1016/0368-2048(80)85056-0
   GREENLER RG, 1969, J CHEM PHYS, V50, P1963, DOI 10.1063/1.1671315
   HANAWA T, 1989, J JPN SOC DENT MATER, V8, P832
   HANSSON HA, 1983, J PROSTHET DENT, V50, P108, DOI 10.1016/0022-3913(83)90175-0
   HASHIMOTO K, 1977, CORROS ENG, V26, P375
   HENCH LL, 1982, BIOMATERIALS INTERFA, P87
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   KASEMO B, 1988, SURFACE CHARACTERIZA, P1
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   Lausmaa J, 1986, MATER RES SOC S P, V55, P351
   LAUSMAA J, 1985, T ANN M SOC BIOMATER, V8, P12
   LIEDBERG B, 1984, J BIOCHEM BIOPH METH, V9, P233, DOI 10.1016/0165-022X(84)90028-9
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   LUMSDEN JB, 1986, METALS HDB, V10, P568
   MATTSSON L, 1985, GIPR268 GOTH I PHYS
   MCINTYRE NS, 1982, APPLIED ELECTRON SPE, P89
   McQueen D, 1982, CLIN APPLICATIONS BI, P179
   MITAMURA Y, 1983, J JPN SOC BIOMATER, V1, P45
   Pelavin M., 1970, Journal of Physical Chemistry, V74, P1116, DOI 10.1021/j100700a027
   RAMQVIST L, 1969, J PHYS CHEM SOLIDS, V30, P1835, DOI 10.1016/0022-3697(69)90252-2
   SATO N, 1985, B JPN I MET, V24, P724
   SCHARLI M, 1981, Z PHYS B CON MAT, V42, P285, DOI 10.1007/BF01293192
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   STEC WJ, 1972, INORG CHEM, V11, P219, DOI 10.1021/ic50108a001
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TAKAHASHI H, 1984, J ELECTROCHEM SOC, V131, P1856, DOI 10.1149/1.2115978
   Takahashi H., 1985, J MET FINISH SOC JPN, V36, P96
   UHLIC HH, 1985, CORROSION CORROSION, P192
   VANDOVEREN H, 1980, J ELECTRON SPECTROSC, V21, P265, DOI 10.1016/0368-2048(80)85055-9
   VULLI M, 1977, J PHYS E SCI INSTRUM, V10, P158, DOI 10.1088/0022-3735/10/2/013
   WAGNER CD, 1978, J VAC SCI TECHNOL, V15, P518, DOI 10.1116/1.569459
   WAGNER CD, 1980, J ELECTRON SPECTROSC, V20, P83, DOI 10.1016/0368-2048(80)85008-0
   WAGNER CD, 1979, ANAL CHEM, V51, P466, DOI 10.1021/ac50040a005
   Wagner CD, 1983, PRACTICAL SURFACE AN, P477
   WEAST RC, 1988, CRC HDB CHEM PHYSICS
NR 47
TC 288
Z9 290
U1 0
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1991
VL 12
IS 8
BP 767
EP 774
DI 10.1016/0142-9612(91)90028-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GN190
UT WOS:A1991GN19000012
PM 1799652
DA 2018-10-20
ER

PT J
AU OTSUKA, M
   MATSUDA, Y
   SUWA, Y
   FOX, JL
   POWELL, GL
   HIGUCHI, WI
AF OTSUKA, M
   MATSUDA, Y
   SUWA, Y
   FOX, JL
   POWELL, GL
   HIGUCHI, WI
TI EFFECT OF CO2-LASER IRRADIATION ON THE SURFACE HARDNESS OF SELF-SETTING
   HYDROXYAPATITE CEMENT
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Note
DE LASER IRRADIATION; ARTIFICIAL HARD TISSUE; VICKERS HARDNESS;
   HYDROXYAPATITE; SELF-SETTING CEMENT; BIOMATERIAL
ID CARIES; PREVENTION; ENAMEL
AB A novel approach to the use of self-setting hydroxyapatite cement in a dental cement system using CO2 laser irradiation is proposed to increase the hardness of the cement. After setting, the cement was transformed to apatite which has a high affinity for hard tissues. The Vicker's hardness of the cement matrix was significantly increased by CO2 laser irradiation.
C1 KYORITSU CERAM MAT CO, MINATO KU, NAGOYA 455, JAPAN.
   UNIV UTAH, DEPT PHARMACEUT, SALT LAKE CITY, UT 84112 USA.
   UNIV UTAH, DEPT DENT EDUC, SALT LAKE CITY, UT 84112 USA.
RP OTSUKA, M (reprint author), KOBE WOMENS COLL PHARM, MOTOYAMA KITAMACHI, HIGASHI NADA, KOBE 658, JAPAN.
CR APFELBERG DB, 1984, ANN PLAST SURG, V12, P355
   ARENDS J, 1975, CALC TISS RES, V18, P65, DOI 10.1007/BF02546227
   Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   DOI Y, 1987, J JPN SOC DENTAL MAT, V6, P53
   LEGEROS RZ, 1968, B SOC CHIM FR, P1712
   MAGEE F, 1986, 12TH ANN M SOC BIOM, P135
   MUNEMIYA M, 1981, CENTRAL JPN J ORTHOP, V24, P1267
   NELSON DGA, 1986, CARIES RES, V20, P289, DOI 10.1159/000260948
   SHIMIZU T, 1984, DENTAL MATERIALS DEV, V3, P95
   STERN RH, 1966, J AM DENT ASSOC, V73, P838, DOI 10.14219/jada.archive.1966.0319
   STERN RH, 1972, J DENT RES, V51, P455, DOI 10.1177/00220345720510023501
   TABATA T, 1983, J DENT, V18, P337
   WONG J, 1990, J PHARM SCI, V79, P510, DOI 10.1002/jps.2600790611
   YAMAMOTO H, 1974, J ORAL PATHOL MED, V3, P7, DOI 10.1111/j.1600-0714.1974.tb01693.x
   YAMAMOTO H, 1980, J DENT RES, V59, P2171
NR 15
TC 1
Z9 1
U1 0
U2 1
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD OCT
PY 1991
VL 39
IS 10
BP 2753
EP 2755
PG 3
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA GP555
UT WOS:A1991GP55500062
DA 2018-10-20
ER

PT J
AU VANDERLAAN, JS
   LOPEZ, GP
   VANWACHEM, PB
   NIEUWENHUIS, P
   RATNER, BD
   BLEICHRODT, RP
   SCHAKENRAAD, JM
AF VANDERLAAN, JS
   LOPEZ, GP
   VANWACHEM, PB
   NIEUWENHUIS, P
   RATNER, BD
   BLEICHRODT, RP
   SCHAKENRAAD, JM
TI TFE-PLASMA POLYMERIZED DERMAL SHEEP COLLAGEN FOR THE REPAIR OF
   ABDOMINAL-WALL DEFECTS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 1990 ANNUAL MEETING OF THE EUROPEAN SOC FOR ARTIFICIAL ORGANS
CY 1990
CL BOLOGNA, ITALY
SP EUROPEAN SOC ARTIFICIAL ORGANS
DE ABDOMINAL WALL RECONSTRUCTION; COLLAGEN; PLASMA POLYMERIZATION;
   TETRAFLUOROETHYLENE
ID MESH
AB The aim of this study was to design and evaluate a degradable biomaterial for the repair of abdominal wall defects.  Hexamethylenediisocyanate-tanned dermal sheep collagen (HDSC) was plasma-polymerized with tetrafluoroethylene (TFE) which resulted in a hydrophobic surface on the visceral side (TFE-HDSC).  Full-thickness abdominal wall defects were made in rats and repaired with HDSC or TFE-HDSC implants.
   Unmodified HDSC implants showed excellent fixation to the adjacent muscle tissue but intestinal adhesions were observed.  These implants showed insufficient strength after four weeks, illustrated by bulging of the peritoneal contents (herniation).  Plasma-polymerized implants after four weeks of implantation showed firm incorporation into the surrounding muscle tissue.  With one exception there were no bowel adhesions.  Fewer herniations were observed, indicating a prolonged degradation period.  Further studies on the optimalization of degradation time are in progress.
C1 UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,OOSTERSINGEL 69-1,9713 EZ GRONINGEN,NETHERLANDS.
   UNIV HOSP GRONINGEN,DEPT SURG,GRONINGEN,NETHERLANDS.
   UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
   UNIV GRONINGEN,CTR BIOCHEM TECHNOL,9700 AB GRONINGEN,NETHERLANDS.
FU NCRR NIH HHS [RRO 1296]
CR CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   CUMBERLAND V H, 1952, Med J Aust, V1, P143
   JENKINS SD, 1983, SURGERY, V94, P392
   KLOPPER PJ, 1986, EUR SURG RES, V18, P218, DOI 10.1159/000128529
   LAMB JP, 1983, SURGERY, V93, P643
   LOPEZ GP, IN PRESS LANGMUIR
   ROBBINS SL, 1989, PATHOLOGIC BASIS DIS, P1
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   SMITH S, 1989, J PEDIATR SURG, V24, P519, DOI 10.1016/S0022-3468(89)80496-8
   STONE HH, 1981, ANN SURG, V193, P612, DOI 10.1097/00000658-198105000-00011
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   VANDERLAAN JS, 1990, NETH J SURG, V42, P26
   VANGULIK TM, 1989, NETH J SURG, V41, P65
   VANWACHEM PB, IN PRESS BIOMATERIAL
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
NR 15
TC 21
Z9 21
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 1991
VL 14
IS 10
BP 661
EP 666
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA GP296
UT WOS:A1991GP29600010
PM 1836203
DA 2018-10-20
ER

PT J
AU BARBUCCI, R
   ALBANESE, A
   MAGNANI, A
   TEMPESTI, F
AF BARBUCCI, R
   ALBANESE, A
   MAGNANI, A
   TEMPESTI, F
TI COATING OF COMMERCIALLY AVAILABLE MATERIALS WITH A NEW HEPARINIZABLE
   MATERIAL
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYURETHANE
AB Different commercial materials, such as polyurethane (PU), plasticized PVC (PVC), glass, Gore-tex, and Dacron, were coated with a well-characterized biomaterial (PUPA) based on polyurethane and poly(amido-amine) components. Two different classes of coating were obtained due to the different characteristics of the substrates. In the case of PVC and polyurethane which are soluble in the solvent of the PUPA-coating solution, there was penetration and blending of the coating and underlying materials. In the case of glass, Gore-tex, and Dacron, which are insoluble in the solvent of the coating solution, only a superficial layer of PUPA could be obtained. The coating stability was investigated and the interaction between coating and underlying material studied by FT-IR. All the stable coatings showed the ability to bind as much heparin as PUPA material by itself.
C1 DIPARTIMENTO CHIM,I-53100 SIENA,ITALY.
RP BARBUCCI, R (reprint author), UNIV SIENA,NUOVO POLICLIN,CTR DIDATT,CRISMA,PIAN MANTELLINI 44,I-53100 SIENA,ITALY.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR BARBUCCI R, 1991, POLYMER, V32, P897, DOI 10.1016/0032-3861(91)90517-M
   BARBUCCI R, 1989, BIOMATERIALS, V10, P299, DOI 10.1016/0142-9612(89)90069-0
   BARBUCCI R, 1989, BIOMATERIALS, V10, P429, DOI 10.1016/0142-9612(89)90136-1
   BARBUCCI R, 1990, Patent No. 4944767
   BARBUCCI R, 1987, POLYM MED, V2, P67
   BELLAMY LJ, 1975, INFRARED SPECTRA COM, V1, P369
   BELLAMY LJ, 1975, INFRARED SPECTRA COM, V2
   BENVENUTI M, 1989, POLYM THEIR PROPERTI, V23, P259
   BIGGS R, 1976, HUMAN BLOOD COAGULAT, P143
   Clarke E. F, 1950, ANAL CHEM, V22, P553
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   Harrick NJ, 1979, INTERNAL REFLECTION, P30
   ITO Y, 1987, BIOMATERIALS APPL, V2, P235
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   Mirabella Jr FM, 1985, INTERNAL REFLECTION, P6
   TABB DL, 1975, MACROMOLECULES, V8, P929, DOI 10.1021/ma60048a043
NR 16
TC 15
Z9 15
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1991
VL 25
IS 10
BP 1259
EP 1274
DI 10.1002/jbm.820251007
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GF652
UT WOS:A1991GF65200006
PM 1839834
DA 2018-10-20
ER

PT J
AU HAYCOX, CL
   RATNER, BD
   HORBETT, TA
AF HAYCOX, CL
   RATNER, BD
   HORBETT, TA
TI PHOTOENHANCEMENT OF PLATELET-ADHESION TO BIOMATERIAL SURFACES OBSERVED
   WITH EPIFLUORESCENT VIDEO MICROSCOPY (EVM)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195.
FU NCRR NIH HHS [RR-01296]
CR SAKARIASSEN KS, 1983, J LAB CLIN MED, V102, P522
   SATO M, 1984, THROMB RES, V35, P319, DOI 10.1016/0049-3848(84)90363-3
NR 2
TC 8
Z9 8
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1991
VL 25
IS 10
BP 1317
EP 1320
DI 10.1002/jbm.820251011
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GF652
UT WOS:A1991GF65200010
PM 1812122
DA 2018-10-20
ER

PT J
AU CHOW, LC
AF CHOW, LC
TI DEVELOPMENT OF SELF-SETTING CALCIUM-PHOSPHATE CEMENTS
SO NIPPON SERAMIKKUSU KYOKAI GAKUJUTSU RONBUNSHI-JOURNAL OF THE CERAMIC
   SOCIETY OF JAPAN
LA English
DT Article
DE CALCIUM PHOSPHATE CEMENT; DICALCIUM PHOSPHATE; HYDROXYAPATITE;
   TETRACALCIUM PHOSPHATE; BONE IMPLANT MATERIAL; SELF-SETTING CEMENT
AB This paper reviews recent studies on self-setting calcium phosphate cements (CPC). Discussions are focused on the cement setting reactions, the products formed, the effects of the products on properties of the cement, and in vivo characteristics of CPC. Although cementation can occur in systems based on several different mixtures, data in the literature at present indicate that mixtures of tetracalcium phosphate and dicalcium phosphate (or dicalcium phosphate dihydrate) may be most desirable because they produce cements that have greater strengths and contain nearly pure hydroxyapatite. The strengths of CPC are considerably lower than ceramic calcium phosphate biomaterial and are also lower than some of the dental cements. On the other hand, the combination of self-setting capability and high biocompatibility makes CPC a unique biomaterial. Near perfect adaptation of the cement to the tissue surfaces in a defect, and an optimum resorption rate followed by new bone formation are some of the distinctive advantages of CPC. In its present state CPC appears to be suitable for a number of applications. Much remains to be done to further improve its properties to meet the requirements for different applications.
RP CHOW, LC (reprint author), NATL INST STAND & TECHNOL,AMER DENT ASSOC HLTH FDN,PAFFENBARGER RES CTR,DIV POLYMERS,GAITHERSBURG,MD 20899, USA.
NR 0
TC 164
Z9 165
U1 0
U2 21
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17 HYAKUNIN-CHO SHINJUKU-KU, TOKYO 169, JAPAN
SN 0914-5400
J9 NIPPON SERAM KYO GAK
PD OCT
PY 1991
VL 99
IS 10
BP 954
EP 964
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA GK934
UT WOS:A1991GK93400013
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   TATTERSALL, CW
   KLOSAK, JJ
   CABUSAO, EA
   GARFIELD, JD
   KIM, DU
AF GREISLER, HP
   TATTERSALL, CW
   KLOSAK, JJ
   CABUSAO, EA
   GARFIELD, JD
   KIM, DU
TI PARTIALLY BIORESORBABLE VASCULAR GRAFTS IN DOGS
SO SURGERY
LA English
DT Article
ID MACROPHAGE BIOMATERIAL INTERACTIONS; PROSTHESES; ENDOTHELIALIZATION;
   STIMULATION
AB Previous studies have shown the effectiveness of partially resorbable arterial prostheses in the rabbit. This study compares these same compound prostheses with commercial graft materials in the dog. Conduits 4 mm inner diameter x 50 mm in length were woven from composite yarns containing 69% polyglactin 910 (PG910)/31% polypropylene or containing 70% polydioxanone/30% polypropylene. Nonresorbable controls were woven Dacron and expanded polytetrafluoroethylene (ePTFE). Baseline platlet aggregometry to 10(-5) mol/L adenosine diphosphate was performed. Seventy prostheses were implanted into the aorto-ilac positions, and the prosthesis/tissue complexes were harvested serially from 2 weeks to 1 year. Explanted specimens were photographed and fixed for light microscopy and for scanning and transmission electron microscopy. Results showed no aneurysms or perigraft hematomas. Overall patency for the PG910/polypropylene grafts was 18 of 20 (90%) and for polydioxanone/polypropylene was 19 of 22 (86%). For Dacron and ePTFE, 13 of 19 (68%) and 6 of 11 (54%) remained patient at time of explantation. The partially resorbable grafts, as a group, had significantly greater patency than the control grafts (p < 0.03). Platelet aggregometry was not predictive of graft patency. Histologic analysis of the partially bioresorbable groups showed inner capsules (IC) composed of myofibrobasts and collagen beneath confluent endothelialized surfaces by 1 month. Kinetics of IC formation paralleled the rates of resorption of the resorbable components. IC cellularity and thickness were greater than those within Dacron or ePTFE. This study suggests an enhanced transinterstitial endothelial cell and myofibroblast ingrowth into the ICs of partially resorbable grafts and shows the effectiveness of these prostheses in the dog.
C1 HINES VET AFFAIRS HOSP, HINES, IL USA.
   ST BARNABAS HOSP, DEPT PATHOL, LIVINGSTON, NJ 07039 USA.
RP GREISLER, HP (reprint author), LOYOLA UNIV, MED CTR, DEPT SURG, 2160 S 1ST AVE, MAYWOOD, IL 60153 USA.
FU NHLBI NIH HHS [R01 HL41272]
CR ENDEAN ED, 1987, SURG FORUM, V38, P323
   Greisler H, 1988, ASAIO Trans, V34, P1051
   Greisler H P, 1986, ASAIO Trans, V32, P346
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   GREISLER HP, 1987, J VASC SURG, V5, P393, DOI 10.1067/mva.1987.avs0050393
   GREISLER HP, 1987, J VASC SURG, V5, P572, DOI 10.1067/mva.1987.avs0050572
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1990, J CARDIOVASC SURG, V31, P712
   GREISLER HP, 1991, J VASC SURG, V13, P748, DOI 10.1016/0741-5214(91)90374-4
   GREISLER HP, 1991, J VASC SURG, V14, P10
   GREISLER HP, 1991, CARDIOVASCULAR SCI T, V2, P55
   GREISLER HP, IN PRESS J INVEST SU
   GRIESLER HP, 1987, ARCH SURG-CHICAGO, V122, P715
   SUMPIO BE, 1988, J SURG RES, V44, P696, DOI 10.1016/0022-4804(88)90103-5
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
NR 19
TC 31
Z9 31
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD OCT
PY 1991
VL 110
IS 4
BP 645
EP 655
PG 11
WC Surgery
SC Surgery
GA GH642
UT WOS:A1991GH64200011
PM 1833846
DA 2018-10-20
ER

PT J
AU JENNINGS, DA
   MORYKWAS, MJ
   BURNS, WW
   CROOK, ME
   HUDSON, WP
   ARGENTA, LC
AF JENNINGS, DA
   MORYKWAS, MJ
   BURNS, WW
   CROOK, ME
   HUDSON, WP
   ARGENTA, LC
TI INVITRO ADHESION OF ENDOGENOUS SKIN MICROORGANISMS TO BREAST PROSTHESES
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR CONTRACTURE; INTRALUMINAL
   ANTIBIOTICS; SYNTHETIC-POLYMERS; EPIDERMIDIS; IMPLANTS; SLIME;
   COLONIZATION; INFECTION; ADHERENCE
AB Bacterial proliferation on polymeric biomaterials varies with the material and microorganism.  Subclinical infection is implicated frequently as the initiative factor in capsular contracture around breast prostheses.  The ability of endogenous skin microorganisms to produce an exopolysaccharide "slime" is emerging as an important factor in biomaterial colonization.  This study was designed to demonstrate the ability of microoganisms of varying slime productivity to colonize, in vitro, different kinds of breast prostheses.  Six-millimeter disks from seven kinds of silicone prostheses and polyurethane foam were exposed to three radioactively labeled strains of bacteria, one slime producer, and two nonslime producers, for 1 hour.  Data were expressed as colony-forming units bound per disk.  There was no significant difference in adherence between the bacterial strains used, suggesting that initial adherence was nonspecific.  The adherence did not appear to be related to surface type, whether smooth or textured, nor to the polymeric composition of the implant material, whether silicone or polyurethane, nor to the presence or absence of slime.  Also, adherence was consistent with expected nonspecific bacterial adherence to biomaterials.
RP JENNINGS, DA (reprint author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PLAST & RECONSTRUCT SURG,300 S HAWTHORNE RD,WINSTON SALEM,NC 27103, USA.
CR AGARWAL DS, 1967, BRIT J EXP PATHOL, V48, P436
   ASPLUND O, 1984, PLAST RECONSTR SURG, V73, P270, DOI 10.1097/00006534-198402000-00022
   BOYCE ST, 1986, IN VITRO MODELS CANC, V3, P245
   BRAND KG, 1988, CLIN PLAST SURG, V15, P533
   BURKHARDT BR, 1981, PLAST RECONSTR SURG, V68, P43, DOI 10.1097/00006534-198107000-00010
   BURKHARDT BR, 1988, CLIN PLAST SURG, V15, P521
   BURKHARDT BR, 1986, PLAST RECONSTR SURG, V77, P919, DOI 10.1097/00006534-198606000-00008
   CAFFEE HH, 1984, ANN PLAS SURG, V12, P348, DOI 10.1097/00000637-198404000-00007
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   COURTISS EH, 1979, PLAST RECONSTR SURG, V63, P812, DOI 10.1097/00006534-197963060-00006
   Dougherty S H, 1989, Infect Dis Clin North Am, V3, P199
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   GRAY ED, 1984, LANCET, V1, P365
   Gristina A. G., 1987, ZENTRALBL BAKTERIO S, V16, P143
   GRISTINA AG, 1985, SURGERY, V98, P12
   GYLBERT L, 1990, PLAST RECONSTR SURG, V86, P260, DOI 10.1097/00006534-199008000-00009
   ICHIMAN Y, 1981, J APPL BACTERIOL, V51, P229, DOI 10.1111/j.1365-2672.1981.tb01237.x
   LUDWICKA A, 1983, ZBL BAKT MIK HYG B, V177, P527
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V256, P479, DOI 10.1016/S0174-3031(84)80024-4
   MCKINNEY P, 1983, PLAST RECONSTR SURG, V72, P27, DOI 10.1097/00006534-198307000-00006
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   SANGER JR, 1989, ANN PLAS SURG, V22, P337, DOI 10.1097/00000637-198904000-00009
   SHAH Z, 1982, PLAST RECONSTR SURG, V69, P809, DOI 10.1097/00006534-198205000-00016
   SHAH Z, 1981, PLAST RECONSTR SURG, V68, P34, DOI 10.1097/00006534-198107000-00007
   SHAPIRO MA, 1989, PLAST RECONSTR SURG, V84, P449, DOI 10.1097/00006534-198909000-00011
   THORNTON JW, 1988, ANN PLAS SURG, V20, P39, DOI 10.1097/00000637-198801000-00008
NR 29
TC 17
Z9 18
U1 0
U2 0
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD SEP
PY 1991
VL 27
IS 3
BP 216
EP 220
DI 10.1097/00000637-199109000-00005
PG 5
WC Surgery
SC Surgery
GA GD868
UT WOS:A1991GD86800003
PM 1952748
DA 2018-10-20
ER

PT J
AU HANSON, VA
   NADIJCKA, MD
   CAMAC, JW
AF HANSON, VA
   NADIJCKA, MD
   CAMAC, JW
TI THE EFFECT OF BIOMATERIAL CHOICES ON POSTIMPLANT INFECTION
SO COMPLICATIONS IN SURGERY
LA English
DT Article
DE ADHESIONS; GRAFT, SYNTHETIC; INFECTION, PROSTHETIC; PERITONITIS
AB Marlex mesh is regarded by many surgeons as the prosthesis of choice in abdominal wall reconstruction when fecal contamination is present.  This study compared abdominal wall implants of Marlex mesh with a polydimethylsiloxane-Dacron laminate in rats in which feces were placed in the peritoneal cavity.  There was an 88% incidence of infection (22 out of 25) in Marlex, compared with 17% (3 out of 18) in polydimethylsiloxane-Dacron (P < 0.01).  The Marlex interface was characterized by tissue ingrowth, whereas encapsulation typified the polydimethylsiloxane-Dacron laminate.  The biomaterial-tissue interface may play a more significant role in postimplant infection than previously recognized.
RP HANSON, VA (reprint author), NORTHSIDE HOSP DOCTORS CTR,980 JOHNSON FERRY RD,SUITE 860,ATLANTA,GA 30342, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SCP COMMUNICATIONS INC
PI NEW YORK
PA 134 W 29TH ST, NEW YORK, NY 10001-5304
SN 1053-749X
J9 COMPLICATION SURG
JI Complicat. Surg.
PD SEP
PY 1991
VL 10
IS 9
BP 44
EP 47
PG 4
WC Surgery
SC Surgery
GA GD984
UT WOS:A1991GD98400007
DA 2018-10-20
ER

PT J
AU SMITH, DC
   PILLIAR, RM
   CHERNECKY, R
AF SMITH, DC
   PILLIAR, RM
   CHERNECKY, R
TI DENTAL IMPLANT MATERIALS .1. SOME EFFECTS OF PREPARATIVE PROCEDURES ON
   SURFACE-TOPOGRAPHY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMATERIAL SURFACES; WHOLE-BLOOD; TITANIUM; STERILIZATION; CR; CO
AB The effect of different treatments for preparing implant materials was examined by scanning electron microscopy and by contact angle measurements. The materials examined were Ti6Al4V alloy, Co-Cr-Mo alloy, Al2O3, and synthetic hydroxyapatite. Samples were prepared with solid or porous surfaces of these materials. These were detergent-cleaned and then either autoclaved (steam sterilization), radiation-sterilized, nitric acid-etched, or plasma-cleaned. The results of wettability studies indicated marked changes in surface energy corresponding to the different preparation methods, and differences in surface morphology were also observed. These differences could have significant consequences on in vivo implant behaviour as mediated by tissue-implant interactions.
RP SMITH, DC (reprint author), UNIV TORONTO, CTR BIOMAT, 170 COLL ST, TORONTO M5S 1A1, ONTARIO, CANADA.
CR ALBREKTSSON T, 1988, J PROSTHET DENT, V60, P75, DOI 10.1016/0022-3913(88)90355-1
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   BAIER RE, 1988, J DENT EDUC, V52, P770
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Carlsson L, 1988, Int J Oral Maxillofac Implants, V3, P21
   Carlsson L. V., 1988, INT J ORAL MAXILLOF, V4, P199
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHESMEL K, 1989, 15TH P ANN M SOC BIO, V1
   COX JF, 1985, J DENT RES, V64
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   English C E, 1988, CDA J, V16, P17
   FINNEGAN M, 1989, CRIT REV BIOCOMPAT, V5, P1
   Geis-Gerstorfer J, 1988, Int J Oral Maxillofac Implants, V3, P135
   Gross U M, 1988, J Dent Educ, V52, P798
   Hartman L C, 1989, Int J Oral Maxillofac Implants, V4, P11
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KILNER T, 1982, J BIOMED MATER RES, V16, P63, DOI 10.1002/jbm.820160109
   LUGOWSKI S, 1987, J BIOMED MATER RES, V21, P657, DOI 10.1002/jbm.820210510
   LUGOWSKI S, 1987, TRACE ELEM MED, V4, P28
   Meffert RM, 1987, INT J PERIODONT REST, V4, P9
   MICHEL R, 1987, CRIT REV BIOCOMPAT, V3, P235
   Mito R S, 1989, J Calif Dent Assoc, V17, P12
   PILLIAR R M, 1986, Critical Reviews in Biocompatibility, V1, P371
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   RATNER BD, 1986, SPECTROSC-BIOMED APP, P107
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rizzo A, 1988, J DENT EDUC, V52, P678
   SALTHOUSE TM, 1985, BIOMATERIALS RECONST, P40
   Smith D C, 1988, J Dent Educ, V52, P815
   SMITH DC, 1987, J ADHESION, V22, P291, DOI 10.1080/00218468708071248
   STEINEMANN SG, 1986, BIOL BIOMECHANICAL P, V6, P404
   WILLIAMS D, 1981, FUNDAMENTAL ASPECTS, V1
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V2
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1
   Williams DF., 1981, FUNDAMENTAL ASPECTS, V2
   Worthington P, 1988, J Dent Educ, V52, P692
   Young F A, 1988, J Dent Educ, V52, P770
NR 42
TC 50
Z9 50
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1991
VL 25
IS 9
BP 1045
EP 1068
DI 10.1002/jbm.820250902
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GB216
UT WOS:A1991GB21600001
PM 1663951
DA 2018-10-20
ER

PT J
AU WERKMEISTER, JA
   RAMSHAW, JAM
AF WERKMEISTER, JA
   RAMSHAW, JAM
TI MONOCLONAL-ANTIBODIES TO TYPE-V COLLAGEN FOR IMMUNOHISTOLOGICAL
   EXAMINATION OF NEW TISSUE DEPOSITION ASSOCIATED WITH BIOMATERIAL
   IMPLANTS
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE COLLAGEN TYPE-V; MONOCLONAL ANTIBODIES; IMMUNOHISTOLOGY; VASCULAR
   PROSTHESIS; BIOMATERIAL
ID HUMAN-SKIN; LOCALIZATION; CORNEA; ORGANIZATION; PROTEINS
AB We developed a panel of highly specific monoclonal antibodies (MAb) against dog Type V collagen. Each antibody showed differential reactivities towards Type V collagen from other species. All the antibodies were highly reactive in conventional ELISA, as well as with electroblots of collagen after polyacrylamide gel electrophoresis using non-denaturing conditions. The MAb were shown to be suitable for the immunohistological detection of Type V collagen in tissue sections, although this normally required pre-treatment of sections with 50 mM acetic acid. In particular, the antibodies were shown to be useful for examining samples of a collagen-based biomaterial, a vascular prosthesis, after explant from evaluation in an animal model. This showed that Type V collagen was most prominent in regions of new tissue formation within the neointima, dose to the inner surface of the prosthesis. The broad spectrum of differential reactivities allows the antibodies to be used for a wide range of experimental models. These MAb therefore provide a novel approach for the evaluation of biomaterial performance, particularly for collagen-based implants.
C1 CSIRO,DIV BIOMOLEC ENGN,343 ROYAL PARADE,PARKVILLE,VIC 3052,AUSTRALIA.
RI Ramshaw, John/A-9411-2011
CR AYAD S, 1984, COLLAGEN REL RES, V4, P165
   BIRK DE, 1986, INVEST OPHTH VIS SCI, V27, P1470
   BRONCKERS ALJJ, 1986, COLLAGEN REL RES, V6, P1
   CHANOKI M, 1988, ARCH DERMATOL RES, V280, P145, DOI 10.1007/BF00456844
   DANIELS AU, 1988, J BIOMED MATER RES A, P113
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Ferrans V. J., 1988, COLLAGEN, V3, P145
   FRIGUET B, 1983, J IMMUNOL METHODS, V60, P351, DOI 10.1016/0022-1759(83)90292-2
   HESSLE H, 1984, J BIOL CHEM, V259, P3955
   HONG BS, 1979, BIOCHEMISTRY-US, V18, P4278, DOI 10.1021/bi00587a003
   KETHARNATHAN V, 1980, ARCH SURG-CHICAGO, V115, P967
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LINSENMAYER TF, 1986, EXP CELL RES, V165, P518, DOI 10.1016/0014-4827(86)90604-X
   LINSENMAYER TF, 1983, J CELL BIOL, V96, P124, DOI 10.1083/jcb.96.1.124
   Mayne R., 1987, STRUCTURE FUNCTION C
   MECHAM RP, 1982, METHOD ENZYMOL, V82, P744
   MORTON LF, 1989, BIOCHEM J, V258, P157, DOI 10.1042/bj2580157
   RAMSHAW JAM, 1988, ANAL BIOCHEM, V168, P82, DOI 10.1016/0003-2697(88)90013-9
   RAMSHAW JAM, 1989, J BIOMED MATER RES, V23, P649, DOI 10.1002/jbm.820230608
   RAMSHAW JAM, 1990, CURRENT PERSPECTIVES, V2, P151
   RENNARD SI, 1980, ANAL BIOCHEM, V104, P205, DOI 10.1016/0003-2697(80)90300-0
   STEFFEN C, 1967, Z IMMUNITATSFORSCH, V134, P205
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Trelstad R.L., 1982, IMMUNOCHEMISTRY EXTR, P31
   VONDERMARK K, 1982, COLLAGEN REL RES, V2, P541
   VONDERMARK K, 1982, COLLAGEN REL RES, V3, P117
   Wallace D. G., 1988, COLLAGEN, V3, P117
   WERKMEISTER J A, 1990, Clinical Materials, V6, P13, DOI 10.1016/0267-6605(90)90040-3
   WERKMEISTER JA, 1984, J IMMUNOL, V133, P1385
   WERKMEISTER JA, 1989, ACTA DERM-VENEREOL, V69, P399
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   WERKMEISTER JA, 1989, J BIOMED MATER R, P273
   YANNAS IV, 1988, COLLAGEN, V3, P87
NR 33
TC 16
Z9 16
U1 0
U2 1
PU HISTOCHEMICAL SOC INC
PI NEW YORK
PA MT SINAI MEDICAL CENTER 19 EAST 98TH ST SUTIE 9G, NEW YORK, NY 10029
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD SEP
PY 1991
VL 39
IS 9
BP 1215
EP 1220
DI 10.1177/39.9.1918939
PG 6
WC Cell Biology
SC Cell Biology
GA GB792
UT WOS:A1991GB79200007
PM 1918939
OA Bronze
DA 2018-10-20
ER

PT J
AU PILLIAR, RM
   DAVIES, JE
   SMITH, DC
AF PILLIAR, RM
   DAVIES, JE
   SMITH, DC
TI THE BONE-BIOMATERIAL INTERFACE FOR LOAD-BEARING IMPLANTS
SO MRS BULLETIN
LA English
DT Article
RP PILLIAR, RM (reprint author), UNIV TORONTO,BIOMAT,TORONTO M5S 1A1,ONTARIO,CANADA.
NR 0
TC 36
Z9 36
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI PITTSBURGH
PA 9800 MC KNIGHT ROAD SUITE 327, PITTSBURGH, PA 15237
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD SEP
PY 1991
VL 16
IS 9
BP 55
EP 61
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA GF320
UT WOS:A1991GF32000010
DA 2018-10-20
ER

PT J
AU UNDERWOOD, PA
   STEELE, JG
AF UNDERWOOD, PA
   STEELE, JG
TI PRACTICAL LIMITATIONS OF ESTIMATION OF PROTEIN ADSORPTION TO POLYMER
   SURFACES
SO JOURNAL OF IMMUNOLOGICAL METHODS
LA English
DT Article
DE ADSORPTION; ELISA; COATING; POLYMERIC; BIOMATERIAL
ID SOLID-PHASE IMMUNOASSAYS; MONOCLONAL-ANTIBODIES; POLYSTYRENE; ELISA;
   FIBRONECTIN; MIGRATION; COLLAGEN; LAMININ; PLASMA
AB The estimation of protein adsorption to polymeric surfaces is a prerequisite for analysing the biological activity of a coated protein both in the evaluation of polymeric biomaterials and in the standardisation of ELISA assays.  Direct quantitative methods utilise either measurements of the physical characteristics of the coated surface (equipment necessary for this is not always available), or measurements of radiolabelled protein.  We demonstrate that proteins labelled with I-125 using chloramine-T contain a significant proportion of I-125 label which is unable to adsorb to polyvinyl microtitre wells.  This non-bindable label is not separable from protein by fractionation on Sephadex G-25 but does dissociate upon SDS gel electrophoresis.  The proportion of non-adsorbable label increases with storage time at -70-degrees-C, the effect being accelerated at higher temperatures.  A method is described for estimating protein adsorption which is both independent of the non adsorbable fraction but can also be used to estimate it.  The use of biotin as a protein label does not apparently result in deterioration of adsorption with short storage times.  The problem of subsequent desorption in ELISA buffers, tissue culture media, or body fluids is discussed.
RP UNDERWOOD, PA (reprint author), CSIRO,DIV BIOMOLEC ENGN,MOLEC BIOL LAB,POB 184,N RYDE,NSW 2113,AUSTRALIA.
CR BAIER RE, 1971, FED PROC, V30, P1523
   BAIER RE, 1983, ANN NY ACAD SCI, V416, P34, DOI 10.1111/j.1749-6632.1983.tb35177.x
   BOLTON BA, 1977, RADIOIODINATION TECH
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   CANTARERO LA, 1980, ANAL BIOCHEM, V105, P375, DOI 10.1016/0003-2697(80)90473-X
   DEYME M, 1986, J BIOMED MATER RES, V20, P951, DOI 10.1002/jbm.820200710
   DIERKS SE, 1986, MOL IMMUNOL, V23, P403, DOI 10.1016/0161-5890(86)90138-0
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HERBST TJ, 1988, J CELL BIOL, V106, P1365, DOI 10.1083/jcb.106.4.1365
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   LEHTONEN OP, 1980, J IMMUNOL METHODS, V34, P61, DOI 10.1016/0022-1759(80)90225-2
   MCCARTHY JB, 1984, J CELL BIOL, V98, P1474, DOI 10.1083/jcb.98.4.1474
   MCGINLAY PB, 1989, BIOCHEM J, V261, P715, DOI 10.1042/bj2610715
   NIETO A, 1986, ANN INST PASTEUR IMM, VC137, P161, DOI 10.1016/S0771-050X(86)80022-5
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PESCE AJ, 1977, BIOCHIM BIOPHYS ACTA, V492, P399, DOI 10.1016/0005-2795(77)90091-5
   Pitt W.G., 1987, PROTEINS INTERFACES, P324
   PITT WG, 1989, J COLLOID INTERF SCI, V129, P231, DOI 10.1016/0021-9797(89)90435-9
   SALONEN EM, 1979, J IMMUNOL METHODS, V30, P209, DOI 10.1016/0022-1759(79)90095-4
   SCHMITT A, 1983, J COLLOID INTERF SCI, V92, P25, DOI 10.1016/0021-9797(83)90113-3
   SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446
   SORENSEN K, 1986, J IMMUNOL METHODS, V95, P291, DOI 10.1016/0022-1759(86)90419-9
   STAHLI C, 1983, METHOD ENZYMOL, V92, P242
   UNDERWOOD PA, 1990, J IMMUNOL METHODS, V127, P91, DOI 10.1016/0022-1759(90)90344-U
   VANDERSCHEER AT, 1978, J COLLOID INTERF SCI, V66, P136, DOI 10.1016/0021-9797(78)90194-7
   WALSH J, 1986, ANAL BIOCHEM, V158, P413, DOI 10.1016/0003-2697(86)90569-5
NR 26
TC 26
Z9 26
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-1759
J9 J IMMUNOL METHODS
JI J. Immunol. Methods
PD AUG 28
PY 1991
VL 142
IS 1
BP 83
EP 94
DI 10.1016/0022-1759(91)90295-Q
PG 12
WC Biochemical Research Methods; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA GD761
UT WOS:A1991GD76100010
PM 1717596
DA 2018-10-20
ER

PT J
AU GAEBEL, K
   FEUERSTEIN, IA
AF GAEBEL, K
   FEUERSTEIN, IA
TI PLATELETS PROCESS ADSORBED PROTEIN - A MORPHOLOGICAL-STUDY
SO BIOMATERIALS
LA English
DT Article
DE FIBRINOGEN; FIBRONECTIN; PLATELET ADHESION
ID VIII-VONWILLEBRAND-FACTOR; ELECTRON-MICROSCOPY; FIBRINOGEN RECEPTOR;
   SURFACE; FIBRONECTIN; EXPRESSION; ADHESION; BINDING; ACTIVATION;
   LEUKOCYTES
AB The nature of the adsorbed protein on a non-biological biomaterial surface is known to influence cell adhesion.  This work deals with the contribution of adherent platelets towards the redistribution of preadsorbed proteins.  A redistribution was only observed with spread platelets on adsorbed fibrinogen and fibronectin, but not with adsorbed beta-lactoglobulin.  The labelled protein images showed a dark outer ring with an inner region having fluorescent areas, with greater intensity than regions not covered by platelets.  The fluorescent patterns observed may be a result of the binding of adsorbed fluorescent protein to the glycoprotein IIb/IIIa receptors of platelets, followed by their redistribution within the plasma membrane.
C1 MCMASTER UNIV,DEPT CHEM ENGN,JHE 136,1280 MAIN ST W,HAMILTON L8S 4L7,ONTARIO,CANADA.
   MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L7,ONTARIO,CANADA.
CR AVNER Z, 1981, CELL, V25, P121
   BRANDTZAEG P, 1973, SCAND J IMMUNOL, V2, P273, DOI 10.1111/j.1365-3083.1973.tb02037.x
   CHEN WT, 1984, J CELL BIOL, V98, P1546, DOI 10.1083/jcb.98.4.1546
   CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205
   Doolittle R. F., 1981, Scientific American, V245, P92
   FURBY FH, 1984, THROMB RES, V35, P501, DOI 10.1016/0049-3848(84)90282-2
   GAMLIEL H, 1983, J MICROSC-OXFORD, V131, P87, DOI 10.1111/j.1365-2818.1983.tb04234.x
   GEORGE JN, 1982, BLOOD, V59, P194
   GINSBERG MH, 1980, P NATL ACAD SCI-BIOL, V77, P1049, DOI 10.1073/pnas.77.2.1049
   GOODMAN SL, 1987, SCANNING MICROSCOPY, V1, P727
   GREEN DW, 1979, J MOL BIOL, V131, P375, DOI 10.1016/0022-2836(79)90082-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1985, THROMB RES, V39, P165, DOI 10.1016/0049-3848(85)90104-5
   HOURDILLE P, 1985, BLOOD, V65, P912
   LAMBRECHT LK, 1986, THROMB RES, V41, P99, DOI 10.1016/0049-3848(86)90283-5
   LOFTUS JC, 1984, J CELL BIOL, V99, P822, DOI 10.1083/jcb.99.3.822
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006
   SCHAKENRAAD JM, 1989, BIOMATERIALS, V10, P43, DOI 10.1016/0142-9612(89)90008-2
   THE TH, 1970, IMMUNOLOGY, V18, P875
   WICK G, 1978, IMMUNOFLUORESCENCE
NR 23
TC 18
Z9 18
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1991
VL 12
IS 6
BP 597
EP 602
DI 10.1016/0142-9612(91)90058-I
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GA674
UT WOS:A1991GA67400013
PM 1772958
DA 2018-10-20
ER

PT J
AU GOLOMB, G
   SHPIGELMAN, A
AF GOLOMB, G
   SHPIGELMAN, A
TI PREVENTION OF BACTERIAL-COLONIZATION ON POLYURETHANE INVITRO BY
   INCORPORATED ANTIBACTERIAL AGENT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID SUSTAINED-RELEASE; MASS-TRANSPORT; BIOMATERIALS; RESISTANCE
AB The presence of implanted biomaterials increases host susceptibility to infections. Once established, biomaterial-mediated infections are resistant to treatment and persist until the device is removed. The objective of this work was to study the prevention of bacterial-biofilm formation on polymeric implant (polyurethane) by controlled release of incorporated antibacterial agents (parabens). By embedding parabens in PU by the solvent-cast method, matrices with amorphous dispersions (or solid solutions) were obtained. Release rate modulation was achieved by using different MW parabens and by a rate-limiting membrane. Preliminary in vitro antibacterial studies of both methyl and propyl paraben matrices exhibited significant inhibition of Staphylococcus epidermidis biofilm formation. Propyl paraben matrices (15 and 20% w/w drug load) decreased the number of colony-forming units on PU surface to 2 x 10(4)/mL, in comparison to 6 x 10(5) on control polymers. This significant reduction was obtained without any effect on the number of viable bacteria in the suspension culture. This type of delivery system provides regional prophylactic activity by creating a high local concentration of antibacterial agent.
RP GOLOMB, G (reprint author), HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,POB 12065,IL-91120 JERUSALEM,ISRAEL.
OI Golomb, Gershon/0000-0002-7369-9831
CR BAKER RW, 1973, ADV EXPT MED BIOL, V47, P15
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P269
   FLYNN GL, 1974, J PHARM SCI-US, V63, P479, DOI 10.1002/jps.2600630403
   FLYNN GL, 1972, J PHARM SCI-US, V61, P838, DOI 10.1002/jps.2600610603
   FRIEDMAN M, 1982, J PERIODONTAL RES, V17, P323, DOI 10.1111/j.1600-0765.1982.tb01160.x
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   GRISTINA AG, 1987, SCIENCE, V33, P8
   HAAG TE, 1984, COSMETIC DRUG PRESER, V1, P64
   Lelah M. D., 1986, POLYURETHANES MED
   MORAIN WD, 1977, PLAST RECONSTR SURG, V59, P217
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   OLANOFF LS, 1979, T AM SOC ART INT ORG, V25, P334
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   SANTOSHAM M, 1977, J PEDIATR-US, V91, P719, DOI 10.1016/S0022-3476(77)81022-6
   Schoen F J, 1987, ASAIO Trans, V33, P8
   SOLOMON D D, 1987, Journal of Controlled Release, V6, P343, DOI 10.1016/0168-3659(87)90087-3
   YALKOWSKY SH, 1972, J PHARM SCI-US, V61, P852, DOI 10.1002/jps.2600610604
NR 22
TC 30
Z9 30
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1991
VL 25
IS 8
BP 937
EP 952
DI 10.1002/jbm.820250803
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FY245
UT WOS:A1991FY24500002
PM 1918109
DA 2018-10-20
ER

PT J
AU PEPPAS, NA
   STAUFFER, SR
AF PEPPAS, NA
   STAUFFER, SR
TI REINFORCED UNCROSSLINKED POLY (VINYL ALCOHOL) GELS PRODUCED BY CYCLIC
   FREEZING-THAWING PROCESSES - A SHORT REVIEW
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE POLY (VINYL ALCOHOL); HYDROGEL; BIOMATERIAL; FREEZING OF SOLUTION;
   SUPERMOLECULAR STRUCTURE
AB Novel methods of preparation of strong poly(vinyl alcohol) hydrogels without utilization of chemical crosslinking or reinforcing agents are reviewed.  Aqueous poly (vinyl alcohol) solutions exposed to several freezing-thawing cycles lead to such materials.  The process of reinforcement of these hydrogels is a densification of the macromolecular structure.  This is probably due to the microparticle-microgel formation within the hydrogel or to microcrystalline structural formations or to partial phase separation.  The densification process is more prominent for gels that are exposed to up to five freezing-thawing cycles.  Important biomedical and pharmaceutical applications of these gels are reviewed.
RP PEPPAS, NA (reprint author), PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907, USA.
NR 0
TC 164
Z9 167
U1 4
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG
PY 1991
VL 16
IS 3
BP 305
EP 310
DI 10.1016/0168-3659(91)90007-Z
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA GB151
UT WOS:A1991GB15100007
DA 2018-10-20
ER

PT J
AU URRY, DW
   PARKER, TM
   REID, MC
   GOWDA, DC
AF URRY, DW
   PARKER, TM
   REID, MC
   GOWDA, DC
TI BIOCOMPATIBILITY OF THE BIOELASTIC MATERIALS, POLY(GVGVP) AND ITS
   GAMMA-IRRADIATION CROSS-LINKED MATRIX - SUMMARY OF GENERIC BIOLOGICAL
   TEST-RESULTS
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
AB The complete series of the recommended generic biological tests for materials and devices in contact with tissues and tissue fluids and blood have been carried out by an independent testing laboratory on the elastic protein-based (bioelastic) polymer, poly(L-Val1-L-Pro2-Gly3-L-Val4-Gly5) with a degree of polymerization greater than 120, and its 20 Mrad gamma-irradiation cross-linked elastic matrix, X20-poly(VPGVG).  The specific tests and the summarized results given in parentheses are:  (1) the Ames mutagenicity test (non-mutagenic), (2) cytotoxicity-agarose overlay (non-toxic), (3) acute systemic toxicity (non-toxic), (4) intracutaneous toxicity (non-toxic), (5) muscle implantation (favorable), (6) acute intraperitoneal toxicity (non-toxic), (7) systemic antigenicity (non-antigenic), (8) dermal sensitization-the Magnusson and Kligman maximization method (non-sensitizing), (9) pyrogenicity (non-pyrogenic), (10) Lee White clotting study (normal clotting time), and (11) in vitro hemolysis test (non-hemolytic).  Thus, this new elastomeric polypeptide biomaterial which is based on the most striking repeating sequence in the mammalian elastic fiber exhibits an extraordinary biocompatibility.  This parent bioelastic material and a wide range of component peptide variations are under development for an equally wide range of potential medical applications such as prevention of adhesions, drug delivery, and synthetic arteries.
RP URRY, DW (reprint author), UNIV ALABAMA,MOLEC BIOPHYS LAB,POB 300,UNIV STN,BIRMINGHAM,AL 35294, USA.
NR 0
TC 166
Z9 167
U1 1
U2 16
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 1991
VL 6
IS 3
BP 263
EP 282
DI 10.1177/088391159100600306
PG 20
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA GJ702
UT WOS:A1991GJ70200006
DA 2018-10-20
ER

PT J
AU BURET, A
   WARD, KH
   OLSON, ME
   COSTERTON, JW
AF BURET, A
   WARD, KH
   OLSON, ME
   COSTERTON, JW
TI AN INVIVO MODEL TO STUDY THE PATHOBIOLOGY OF INFECTIOUS BIOFILMS ON
   BIOMATERIAL SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BACTERIAL ADHERENCE; PERITONEAL-DIALYSIS; PROSTHETIC DEVICES;
   COLONIZATION; CATHETERS; FIBRIN
AB This study examines the morphology, ultrastructure, and microbiology of the intact biofilm developing on an implant surface.  Silastic subdermal implant material was colonized with P. aeruginosa and surgically inserted into the peritoneal cavity of adult rabbits.  After 4, 8, 28, and 42 days implants were recovered and the intact biofilms examined.  P. aeruginosa colonized the implant throughout the entire experimental time.  Microcolonies of glycocalyx-coated bacteria were observed within the biofilm.  However, the bulk of the biofilm was host-generated and typically contained phagocytes trapped within a thick mesh of fibrin.  Polymorphonuclear neutrophils were the predominant cell type.  Isolated erythrocytes, macrophages, and fibroblasts were also observed.  By day 28, the biofilm was enclosed in a fibrous capsule of vascularized connective tissue.  The low numbers of neutrophils seen in biofilms from sterile Silastic sheets implanted into control animals suggested that neutrophilia may represent a specific cellular response to the bacterial colonization.  The results indicate that the cell-mediated immune response provides for most of the biofilm mass on colonized implant surfaces.  Inactivated phagocytes trapped in fibrin may "wall-off" the embedded bacterial microcolonies and thus shield them from live phagocytic leucocytes.  Such a mechanism may play an important role in the pathogenesis of prosthetic device infections.
C1 UNIV CALGARY,DEPT MICROBIOL & INFECT DIS,CALGARY T2N 1N4,ALBERTA,CANADA.
RP BURET, A (reprint author), UNIV CALGARY,DEPT BIOL SCI,BIOSCI 025,2500 UNIV DR NW,CALGARY T2N 1N4,ALBERTA,CANADA.
OI Olson, Merle/0000-0003-3654-7692
CR ARCHER GL, 1977, INFECT PROSTHETIC HE, P43
   BROWN MRW, 1984, FEMS MICROBIOL LETT, V21, P113, DOI 10.1016/0378-1097(84)90188-5
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   COSTERTON JW, 1986, BACTERIA NATURE, V2, P49
   DASGUPTA MK, 1987, PERITON DIALYSIS INT, V7, P168
   DASGUPTA MK, 1986, ADV CONTINUOUS AMBUL, P102
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   HURLEY RM, 1977, CAN MED ASSOC J, V117, P1061
   JACQUES M, 1987, MICROBIAL ECOL, V13, P173, DOI 10.1007/BF02024996
   KATZ S, 1981, ANN SURG, V194, P35, DOI 10.1097/00000658-198107000-00007
   KHOURY TE, 1988, 3RD ECCM S FOR BOD R, P2
   LADD TI, 1985, J CLIN MICROBIOL, V21, P1004
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   OLSON ME, 1988, J BIOMED MATER RES, V22, P485, DOI 10.1002/jbm.820220605
   SCHELD WM, 1978, J CLIN INVEST, V61, P1394, DOI 10.1172/JCI109057
   STAMM WE, 1975, ANN INTERN MED, V82, P386, DOI 10.7326/0003-4819-82-3-386
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VAUDAUX PE, INFECTIONS ASS INDWE, P3
   VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407
   VERBRUGH HA, 1983, J INFECT DIS, V147, P1018, DOI 10.1093/infdis/147.6.1018
NR 22
TC 83
Z9 86
U1 2
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1991
VL 25
IS 7
BP 865
EP 874
DI 10.1002/jbm.820250706
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FR974
UT WOS:A1991FR97400005
PM 1918103
DA 2018-10-20
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   NIEUWENHUIS, P
   DAMINK, LO
   TENHOOPEN, H
   FEIJEN, J
AF VANLUYN, MJA
   VANWACHEM, PB
   NIEUWENHUIS, P
   DAMINK, LO
   TENHOOPEN, H
   FEIJEN, J
TI METHYLCELLULOSE CELL-CULTURE AS A NEW CYTOTOXICITY TEST SYSTEM FOR
   BIOMATERIALS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB The cytotoxicity of biomaterials can be tested in vitro using various culture systems.  Liquid culture systems may detect cytotoxicity of a material either by culture of cells with extracts or with the material itself.  In the latter instance, renewing the medium will remove possible released cytotoxic products.  The agar-overlay test is a short term semi-solid culture system in which the possible cytotoxicity of biomaterials is identified only by the presence of cell free zones.  The aim of this study was to develop a more sensitive cytotoxicity test system for biomaterials, using methylcellulose as a culture gel, mixed with human fibroblasts.  The main advantage of the test system is the possibility of evaluating cytotoxicity for a period of up to seven days without renewal of the culture gel.  Furthermore it is possible to both quantitatively evaluate by counting absolute cell numbers and to qualitatively evaluate by studying cell morphology with light- and/or electron microscopy.  Processed dermal sheep collagen was selected as test material, since contradictory results concerning the cytotoxicity of its extracts have been reported by others [2, 15, 18, 19].  Using our test system, both primary and secondary cytotoxic effects were found.  Primary cytotoxicity is due to direct leakage of products from the material, detected by testing, extracts of the collagen or the collagen itself.  Secondary cytotoxicity is due to release of cytotoxic products resulting from cell-biomaterial interactions.  We conclude that our test system is extremely useful to test materials which are suspected of primary and/or secondary cytotoxicity, either with slow release of cytotoxic products or release of products with late cytotoxic effects.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
NR 0
TC 25
Z9 25
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 1991
VL 2
IS 3
BP 142
EP 148
DI 10.1007/BF00692972
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FX073
UT WOS:A1991FX07300005
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   ELLINGER, J
   HENDERSON, SC
   SHAHEEN, AM
   BURGESS, WH
   KIM, DU
   LAM, TM
AF GREISLER, HP
   ELLINGER, J
   HENDERSON, SC
   SHAHEEN, AM
   BURGESS, WH
   KIM, DU
   LAM, TM
TI THE EFFECTS OF AN ATHEROGENIC DIET ON MACROPHAGE BIOMATERIAL
   INTERACTIONS
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID SMOOTH-MUSCLE CELLS; FACTOR-LIKE PROTEIN; GROWTH-FACTOR; BIOMEDICAL
   POLYMERS; HUMAN-MONOCYTES; INTERLEUKIN-1; INVITRO; PROLIFERATION;
   STIMULATION; CULTURE
AB We previously reported that biomaterials differentially induce macrophages to secrete growth factors that mediate reendothelialization.  The present study evaluates the effect of an atherogenic diet on macrophage/biomaterial interactions.  Female New Zealand white rabbits were fed an atherogenic diet.  Peritoneal macrophages were harvested from these as well as rabbits fed a normal diet and cultured in Minimum Essential Medium with platelet-poor serum.  Dacron or polyglactin 910 were added to two of three conditions of both cell groups in passage 2.  Conditioned media were collected weekly through week 15.  Mitogenicity assays were performed with quiescent mouse embryonal (BALB/c3T3) fibroblasts, atherosclerotic rabbit aortic smooth muscle cells, and murine capillary lung (LE-II) endothelial cells.  Mitogenic activity was assayed by scintillation counting of tritiated thymidine incorporation into deoxyribonucleic acid (DNA).  Results showed increased mitogenic activity released by macrophages from atherosclerotic rabbits, in the absence of prosthetic material, when assayed against every cell line.  In normal diet macrophages, polyglactin 910 stimulated mitogen release for every cell line, and Dacron yielded minimal mitogen release.  In lipid diet macrophages polyglactin 910 slightly increased mitogen release for all three cell lines, whereas Dacron resulted in stimulation of DNA synthesis in smooth muscle cells and BALB/c3T3 cells but less DNA synthesis in LE-II cells than in control, no graft material, media.  Western blotting demonstrated immunoreactivity to basic fibroblast growth factor in media from normal diet macrophages but only in the presence of polyglactin 910 or Dacron.  Radioimmunoassay for platelet-derived growth factor B chain was negative in all groups, and polymerase chain reaction techniques to amplify transforming growth factor-beta messenger ribonucleic was negative.  These data demonstrate the effect of in vivo dietary manipulation on macrophage activation as well as the effect of an atherogenic diet in modulating macrophage/biomaterial interactions.  Additionally, different biomaterials differentially induce macrophages to release factors that stimulate and inhibit growth.
C1 VET ADM MED CTR,HINES,IL 60141.
   ST BARNABAS HOSP,LIVINGSTON,NJ 07039.
   AMER RED CROSS,ROCKVILLE,MD.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BIANCO C, 1981, METHODS STUDYING MON, P273
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   COZZOLINO E, 1989, BLOOD S1, V74, pA144
   DICORLETO PE, 1983, P NATL ACAD SCI-BIOL, V80, P1919, DOI 10.1073/pnas.80.7.1919
   Greisler H P, 1987, J Vasc Surg, V5, P393
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H P, 1986, ASAIO Trans, V32, P346
   GREISLER H P, 1989, Journal of Vascular Surgery, V10, P566
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1988, CIRCULATION S1, V78, P112
   Hannan R L, 1988, Growth Factors, V1, P7, DOI 10.3109/08977198809000242
   LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NILSSON J, 1985, P NATL ACAD SCI USA, V82, P4418, DOI 10.1073/pnas.82.13.4418
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498
   ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   ZACHARIAS RK, 1988, J VASC SURG, V7, P606
NR 28
TC 14
Z9 15
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD JUL
PY 1991
VL 14
IS 1
BP 10
EP 23
PG 14
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA FW525
UT WOS:A1991FW52500002
PM 1829487
DA 2018-10-20
ER

PT J
AU GOYCOOLEA, MV
   MUCHOW, DC
   SCHOLZ, MT
   SIRVIO, LM
   STYPULKOWSKI, PH
AF GOYCOOLEA, MV
   MUCHOW, DC
   SCHOLZ, MT
   SIRVIO, LM
   STYPULKOWSKI, PH
TI IN SEARCH OF MISSING LINKS IN OTOLOGY .1. DEVELOPMENT OF A
   COLLAGEN-BASED BIOMATERIAL
SO LARYNGOSCOPE
LA English
DT Article
ID TYMPANIC MEMBRANE; CROSS-LINKING
AB Experiments leading to the development and use of a biomaterial based on reconstituted collagen for use in tympanoplasty are presented.  A stable, even membrane with optimal strength and an organized matrix of collagen protein strands has been obtained.  Biocompatibility was documented by subcutaneous implantation, cytotoxicity with agar overlay, cell contact, and cell-growth inhibition studies.  Experimental grafting in chinchillas with perforated tympanic membranes demonstrated that the collagen membrane performed well in all cases.  Histopathological studies in chinchillas showed that the collagen membrane compared favorably with fascia grafts.  Of significance is that:  1.  The membrane has a matrix of microperforations that enhance tissue ingrowth, allow stable anchoring, and permit aeration of the middle ear cavity.  2.  The membranes obtained are not exposed to aldehyde cross-linking; therefore, tissue reaction due to aldehydes is avoided.
C1 UNIV MINNESOTA,MINNESOTA EAR HEAD & NECK CLIN,DEPT OTOLARYNGOL,MINNEAPOLIS,MN 55455.
   THREE M CO,BIOSCI RES LAB,ST PAUL,MN 55144.
FU NIDCD NIH HHS [8-P50-DC-00133]
CR Doillon C J, 1988, J Biomater Appl, V2, P562
   Goycoolea M V, 1988, Laryngoscope, V98, P1, DOI 10.1288/00005537-198806001-00002
   GOYCOOLEA MM, 1980, ANN OTO RHINOL LARYN, V89, P121
   GOYCOOLEA MV, 1980, LARYNGOSCOPE, V90, P2037, DOI 10.1288/00005537-198012000-00015
   GOYCOOLEA MV, 1989, ATLAS OTOLOGIC SURG, P164
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   KUBO K, 1959, J KYOTO PREF MED U, V66, P464
   LIM DJ, 1970, ACTA OTO-LARYNGOL, V70, P176, DOI 10.3109/00016487009181875
   MCINTIRE C, 1970, ANN OTO RHINOL LARYN, V79, P1129, DOI 10.1177/000348947007900617
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   RICARDBLUM S, 1988, CELL MOL BIOL, V34, P581
NR 11
TC 4
Z9 4
U1 0
U2 0
PU LARYNGOSCOPE CO
PI ST LOUIS
PA 10 S BROADWAY 14TH FLOOR, ST LOUIS, MO 63102-1741
SN 0023-852X
J9 LARYNGOSCOPE
JI Laryngoscope
PD JUL
PY 1991
VL 101
IS 7
BP 717
EP 726
PN 1
PG 10
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA FW845
UT WOS:A1991FW84500005
PM 2062151
DA 2018-10-20
ER

PT J
AU BOUVIER, M
   CHAWLA, AS
   HINBERG, I
AF BOUVIER, M
   CHAWLA, AS
   HINBERG, I
TI INVITRO DEGRADATION OF A POLY(ETHER URETHANE) BY TRYPSIN
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYETHER POLYURETHANES; BLOCK COPOLYMERS; SURFACE; BIODEGRADATION;
   POLYMERS; ENZYME; BULK
AB In vitro enzymatic degradation of nonporous films of segmented poly(ether urethane) (Pellethane 2363-80AE) was investigated by incubating the biomaterial in concentrated trypsin solutions for 5 months at room temperature.  Chemical degradation of films was monitored by surface analysis techniques such as Fourier transform infrared spectroscopy-attenuated total reflectance and electron spectroscopy for chemical analysis.  This latter technique proved to be much superior in detecting chemical changes.  Extraction of films with methanol and characterization of the extracts by gel permeation chromatography revealed the presence of low-molecular-weight polymers.  Results have shown that trypsin has the ability to induce degradation in PEU, the soft segment being most affected, particularly the CH2 - O bond of the ether linkages.
C1 HLTH & WELF CANADA,BUR RADIAT & MED DEVICES,OTTAWA K1A 0L2,ONTARIO,CANADA.
CR BRAUMAN SK, 1981, ANN BIOMED ENG, V9, P45, DOI 10.1007/BF02584557
   CHAWLA AS, 1988, BIOMATER ARTIF CELL, V16, P785, DOI 10.3109/10731198809117569
   COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P465, DOI 10.1002/jbm.820150403
   GRASEL TG, 1988, BIOMATERIALS, V9, P383, DOI 10.1016/0142-9612(88)90001-4
   Harrick N. J, 1967, INTERNAL REFLECTION
   HENNIG E, 1988, INT J ARTIF ORGANS, V11, P416
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393
   HUNTER SK, 1982, T AM SOC ART INT ORG, V28, P473
   ISHIHARA H, 1974, J MACROMOL SCI PHYS, VB 10, P591, DOI 10.1080/00222347408219408
   KNUTSON K, 1982, ACS ADV CHEM SER, V199, P109
   Leininger R I, 1972, CRC Crit Rev Bioeng, V1, P333
   Lelah M. D., 1986, POLYURETHANES MED
   LEMM W, 1984, BIOMATERIALS BIOMECH, P319
   LEMM W, 1980, P EUR SOC ARTIF ORGA, V7, P86
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MATHUR G, 1978, ADV URETHANE SCI TEC, V6, P103
   OKKEMA AZ, 1989, BIOMATERIALS, V10, P23, DOI 10.1016/0142-9612(89)90005-7
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   RATNER BD, 1988, MAKROMOL CHEM-M SYMP, V19, P163, DOI 10.1002/masy.19880190113
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   RATNER BD, 1984, POLYURETHANES BIOMED, P41
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   SMITH R, 1985, J MATER SCI LETT, V4, P547, DOI 10.1007/BF00720029
   SRICHATRAPIMUK WV, 1978, J MACROMOL SCI PHY B, V15, P267
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   STOKES KB, 1984, 10TH P ANN M SOC BIO, P254
   Sung C.S.P, 1975, MACROMOLECULES, V8, P68, DOI DOI 10.1021/MA60043A015
   Szycher M., 1985, CORROSION DEGRADATIO, P308
   THOMA RJ, 1987, J BIOMED MATER RES, V21, P525, DOI 10.1002/jbm.820210411
   WILLIAMS DF, 1977, J BIOENG, V1, P279
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   WILLIAMS DF, 1980, PLAST RUBBER MAT APP, V5, P179
NR 41
TC 39
Z9 39
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1991
VL 25
IS 6
BP 773
EP 789
DI 10.1002/jbm.820250607
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FL241
UT WOS:A1991FL24100006
PM 1874760
DA 2018-10-20
ER

PT J
AU LOPEZLOPEZ, G
   PASCUAL, A
   PEREA, EJ
AF LOPEZLOPEZ, G
   PASCUAL, A
   PEREA, EJ
TI EFFECT OF PLASTIC CATHETER MATERIAL ON BACTERIAL ADHERENCE AND VIABILITY
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; INTRAVASCULAR CATHETERS; INTRAVENOUS
   CATHETERS; INVITRO
AB The kinetics of adherence of single isolates of Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa and Escherichia coli to catheters made of polyvinyl chloride (PVC), Teflon(R), siliconised latex, polyurethane and Vialon(R) was evaluated by a radiometric assay.  Radiolabelled bacteria (10(8) cfu/ml) were incubated in vials containing 1-cm lengths of catheter for up to 3 days.  The peak of maximal adherence to each biomaterial was reached after 24 h for P. aeruginosa and after 72 h for the other strains.  Bacterial adherence to PVC and siliconised latex was significantly higher (2-6 times; p < 0.05) than to the other biomaterials for all the strains.  The lowest values of adherence were observed with polyurethane and Vialon(R) for the staphylococci but with Teflon(R) for E. coli and P. aeruginosa.  Bacterial viability and growth was evaluated in eluates obtained from incubation of segments of each catheter in buffer for 24 h.  None of the eluates affected the viability of the staphylococci.  However, all of them, significantly increased the growth of E. coli and P. aeruginosa with the exception of the eluate from siliconised latex, in which the inoculum count was reduced to an undetectable level for E. coli.  We conclude that bacterial adherence to catheters may depend in part on the nature of the biomaterial and that certain substances eluted from the catheters may affect the viability and growth of different micro-organisms.
C1 UNIV SEVILLE,SCH MED,DEPT MICROBIOL,APDO 914,E-41080 SEVILLE,SPAIN.
OI Pascual Hernandez, Alvaro/0000-0002-8672-5891
CR ASHKENAZI S, 1984, PEDIATR RES, V18, P1361, DOI 10.1203/00006450-198412000-00029
   CLERI DJ, 1980, J INFECT DIS, V141, P781, DOI 10.1093/infdis/141.6.781
   FRANSON TR, 1986, J CLIN MICROBIOL, V24, P559
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   MAKI DG, 1981, AM J MED, V70, P719, DOI 10.1016/0002-9343(81)90603-3
   MAKI DG, 1973, ANN INTERN MED, V79, P867, DOI 10.7326/0003-4819-79-6-867
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   SHETH NK, 1983, J SURG RES, V34, P213, DOI 10.1016/0022-4804(83)90062-8
   VERHOEF J, 1977, J IMMUNOL METHODS, V14, P303, DOI 10.1016/0022-1759(77)90141-7
   WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1
   WELCH GW, 1974, SURG GYNECOL OBSTET, V138, P421
NR 13
TC 54
Z9 56
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2615
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD JUN
PY 1991
VL 34
IS 6
BP 349
EP 353
DI 10.1099/00222615-34-6-349
PG 5
WC Microbiology
SC Microbiology
GA FR413
UT WOS:A1991FR41300007
PM 1905357
OA Bronze
DA 2018-10-20
ER

PT J
AU GOLOMB, G
   WAGNER, D
AF GOLOMB, G
   WAGNER, D
TI DEVELOPMENT OF A NEW INVITRO MODEL FOR STUDYING IMPLANTABLE POLYURETHANE
   CALCIFICATION
SO BIOMATERIALS
LA English
DT Article
DE CALCIFICATION; POLYMERS; POLYURETHANE; PROSTHESES
ID HEART-VALVE CALCIFICATION; BIOPROSTHESES; DEPOSITS; FAILURE
AB The objective of this study was to reproduce mineralization of polymeric substrate in an extracirculatory environment which would facilitate investigation of the calcification mechanism in implantable biomaterials and methods of prevention.  Calcification was examined on polyurethane films incubated in metastable solutions of calcium phosphate and the role of strain, serum and polymer porosity was examined.  Validation of the model was evaluated by examining the calcification of both highly calcifiable biomaterial (bioprosthetic tissue) and a non-calcifiable biomaterial (charge-modified tissue and polyurethane containing anticalcification agent).  It is concluded that the development model is adequately sensitive to diagnose biomaterials' propensity to calcify and could serve as a pre-screening method to examine calcification mechanism and methods of prevention.
RP GOLOMB, G (reprint author), HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,JERUSALEM,ISRAEL.
OI Golomb, Gershon/0000-0002-7369-9831
CR ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341
   BARNHART GR, 1982, J THORAC CARDIOV SUR, V83, P618
   BOSKEY AL, 1977, CALC TISS RES, V23, P251, DOI 10.1007/BF02012794
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COLEMAN DL, 1985, CALCIUM BIOL SYSTEMS, P661
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FISHBEIN MC, 1982, J THORAC CARDIOV SUR, V83, P602
   GLASMACHER B, 1987, POLYURETHANES BIOMED, V2, P151
   GLASMACHERSEILE.B, 1989, 8TH P EUR C BIOM HEI
   GLIMCHER MJ, 1976, HDB PHYSL ENDOCRINOL, P25
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Golomb G, 1987, J Biomater Appl, V2, P266, DOI 10.1177/088532828700200205
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   GOLOMB G, 1986, T AM SOC ART INT ORG, V32, P587
   GOLOMB G, 1988, MAY INT C PHARM SCI
   GOLOMB G, 1987, T SOC BIOMATERIALS, V10, P178
   GOLOMB G, 1989, T SOC BIOMATERIALS, V14, P118
   GOLOMB G, 1990, P INT S CONTROL REL, V17, P449
   Harasaki H, 1985, Trans Am Soc Artif Intern Organs, V31, P489
   HARASAKI H, 1987, T AM SOC ART INT ORG, V33, P643
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   LEVY RJ, 1982, ANN THORAC SURG, V62, P313
   LIAN JB, 1981, T AM SOC ART INT ORG, V27, P683
   Lo H B, 1988, ASAIO Trans, V34, P839
   MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4
   POLLOCK E, 1981, T AM SOC ART INT ORG, V27, P405
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   RIDDELL MN, 1966, POLYM ENG SCI, V6, P363
   Schoen F J, 1987, J Card Surg, V2, P65, DOI 10.1111/j.1540-8191.1987.tb00174.x
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SCHOEN FJ, 1986, AM J PATHOL, V123, P143
   SINGH PI, 1984, CONTRACTORS M NHLBI, P78
   Thoma R J, 1987, J Biomater Appl, V1, P449
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   TSAO JW, 1987, T SOC BIOMATER, V10, P180
   URRY DW, 1971, P NATL ACAD SCI USA, V68, P810, DOI 10.1073/pnas.68.4.810
   URRY DW, 1976, BIOCHEMISTRY-US, V15, P4089, DOI 10.1021/bi00663a027
   WAGNER D, 1990, THESIS HEBREW U JERU
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WESOLOWSKI SA, 1963, SURGERY, V53, P19
   WHALEM RL, 1980, T AM SOC ART INT ORG, V24, P487
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
NR 53
TC 66
Z9 66
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1991
VL 12
IS 4
BP 397
EP 405
DI 10.1016/0142-9612(91)90008-X
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FM912
UT WOS:A1991FM91200007
PM 1888809
DA 2018-10-20
ER

PT J
AU GREISLER, HP
AF GREISLER, HP
TI BIORESORBABLE MATERIALS AND MACROPHAGE INTERACTIONS
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID BIOMATERIAL
RP GREISLER, HP (reprint author), LOYOLA UNIV,STRITCH SCH MED,MAYWOOD,IL 60153, USA.
CR Greisler H P, 1987, J Vasc Surg, V5, P393
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, IN PRESS J CARDIOVAS
   GREISLER HP, IN PRESS MACROPHAGE
   GREISLER HP, IN PRESS J VASC SURG
   GREISLER HP, UNPUB EFFECTS HYPERC
   PHAM S M, 1988, Surgical Forum (Chicago), V39, P330
   TATTERSALL CW, 1990, SURG FORUM, V40, P368
NR 12
TC 8
Z9 8
U1 0
U2 3
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD MAY
PY 1991
VL 13
IS 5
BP 748
EP 750
DI 10.1016/0741-5214(91)90374-4
PG 3
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA FL780
UT WOS:A1991FL78000037
PM 2027225
DA 2018-10-20
ER

PT J
AU DELMAS, RA
   MARENCO, A
   TATHY, JP
   CROS, B
   BAUDET, JGR
AF DELMAS, RA
   MARENCO, A
   TATHY, JP
   CROS, B
   BAUDET, JGR
TI SOURCES AND SINKS OF METHANE IN THE AFRICAN SAVANNA-CH4 EMISSIONS FROM
   BIOMASS BURNING
SO JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES
LA English
DT Article
ID BACKGROUND TROPOSPHERE 70-DEGREES-N-60-DEGREES-S; SCIENTIFIC AIRCRAFT
   MEASUREMENTS; EXPERIMENT JUNE 1984; 0-12KM ALTITUDE; CARBON; CO;
   ATMOSPHERE; BRAZIL
AB Sources and sinks of atmospheric methane are studied in savanna regions of west and central Africa. Flux measured over dry savanna soils, using static chambers, is always negative the average uptake rate being 2 x 10(10) molecules/cm2/s. In these regions, sources are linked to biomass burning. Methane and CO2 emission from combustion of savanna plants and wood is studied by both field experiments and laboratory experiments using a combustion chamber. For savanna plants most of the carbon (85%) contained in the biomaterial is volatilized as CO2 and 0.1 to 0.25% as methane. For graminaceous plants like loudetia simplex the ratio C-CH4/C-CO2 is 0.11%; it is 0.28% for hyparrhenia the other main type of savanna plants and it attains 1.4% for the combustion of wood. In natural fire plumes this ratio is around 0.26% for savanna fires and 0.56 to 2.22% for forest fires. These results show that methane release is highly dependent on the type of combustion. Methane to CO2 ratios are also studied in vertical profiles in the troposphere taken during the TROPOZ I campaign, an aerial research expedition carried out over west Africa during the bushfire period. Within polluted layers, the average ratio of CH4 to CO2 excess over ambient air concentration is 0.34%. These results show that biomass burning in tropical Africa constitutes an important source of atmospheric methane estimated to about 9.2 x 10(6) T(CH4)/yr.
C1 UNIV MARIEN NGOUABI, PHYS ATMOSPHERE LAB, Brazzaville, REP CONGO.
   FAC SCI ABIDJAN, PHYS ATMOSPHERE LAB, ABIDJAN, COTE IVOIRE.
RP DELMAS, RA (reprint author), UNIV TOULOUSE 3, AEROL LAB, 118 ROUTE NARBONNE, F-31062 TOULOUSE, FRANCE.
CR ANDREAE MO, 1988, J GEOPHYS RES-ATMOS, V93, P1509, DOI 10.1029/JD093iD02p01509
   BLAKE DR, 1986, J ATMOS CHEM, V4, P43, DOI 10.1007/BF00053772
   BOLLE HJ, 1986, SCOPE, V29, P157
   BORN M, 1990, Tellus Series B Chemical and Physical Meteorology, V42, P2, DOI 10.1034/j.1600-0889.1990.00002.x
   Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299
   COFER WR, 1990, MAR C GLOB BIOM BURN
   CRUTZEN PJ, 1985, J ATMOS CHEM, V2, P233, DOI 10.1007/BF00051075
   CRUTZEN PJ, 1979, NATURE, V282, P253, DOI 10.1038/282253a0
   DELMAS R, 1982, GEOPHYS RES LETT, V9, P761, DOI 10.1029/GL009i007p00761
   DELMAS R, 1991, IN PRESS BIOMASS BUR
   DELMAS RA, 1991, IN PRESS J GEOPHYS R
   EHHALT DH, 1983, J GEOPHYS RES-OCEANS, V88, P8442, DOI 10.1029/JC088iC13p08442
   EHHALT DH, 1978, PURE APPL GEOPHYS, V116, P452, DOI 10.1007/BF01636899
   EHHALT DH, 1988, CHANGING ATMOSPHERE
   EIMER P, 1987, CARBONISATION RATIO
   GREENBERG JP, 1984, J GEOPHYS RES-ATMOS, V89, P1350, DOI 10.1029/JD089iD01p01350
   HAO WM, 1990, MAR CHAPM C GLOB BIO
   Keller M, 1990, GLOBAL BIOGEOCHEM CY, V4, P21, DOI 10.1029/GB004i001p00021
   KHALIL MAK, 1985, ATMOS ENVIRON, V19, P397, DOI 10.1016/0004-6981(85)90161-1
   MARENCO A, 1989, ATMOS ENVIRON, V23, P185, DOI 10.1016/0004-6981(89)90111-X
   MARENCO A, 1980, J GEOPHYS RES-OCEANS, V85, P5599, DOI 10.1029/JC085iC10p05599
   MARENCO A, 1990, ATMOS ENVIRON A-GEN, V24, P2823, DOI 10.1016/0960-1686(90)90169-N
   MARENCO A, 1989, ATMOS ENVIRON, V23, P201, DOI 10.1016/0004-6981(89)90112-1
   MARENCO A, 1990, MAR CHAPM C GLOB BIO
   MENAUT JC, 1974, B LIAISON CHERCHEURS, V3
   PATT TE, 1974, J BACTERIOL, V120, P955
   RASMUSSEN RA, 1984, J GEOPHYS RES-ATMOS, V89, P1599, DOI 10.1029/JD089iD07p11599
   SEILER W, 1984, J ATMOS CHEM, V1, P171, DOI 10.1007/BF00053839
   TATHY JP, 1991, IN PRESS J GEOPHYS R
   VERNET P, 1988, NOV SEM EN DOM BAS B
NR 30
TC 40
Z9 41
U1 0
U2 11
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 2169-897X
EI 2169-8996
J9 J GEOPHYS RES-ATMOS
JI J. Geophys. Res.-Atmos.
PD APR 20
PY 1991
VL 96
IS D4
BP 7287
EP 7299
DI 10.1029/90JD02496
PG 13
WC Meteorology & Atmospheric Sciences
SC Meteorology & Atmospheric Sciences
GA FJ455
UT WOS:A1991FJ45500002
DA 2018-10-20
ER

PT J
AU RABAUD, M
   LEFEBVRE, F
   DUCASSOU, D
AF RABAUD, M
   LEFEBVRE, F
   DUCASSOU, D
TI INVITRO ASSOCIATION OF TYPE-III COLLAGEN WITH ELASTIN AND WITH ITS
   SOLUBILIZED PEPTIDES
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN; ELASTIN; PEPTIDES
ID SMOOTH-MUSCLE CELLS; BASEMENT-MEMBRANE; IV COLLAGEN; FIBRIN BIOMATERIAL;
   LAMININ; FIBRONECTIN
AB Elastin fibres or elastin solubilized peptides associated with type III collagen, under physiological conditions, to form a gel-like substance.  The gel cohesion could be markedly improved either by desiccation process (gently air-dried rather than lyophilized) or by addition of adhesive connective proteins such as fibronectin, laminin and type IV collagen.  They conferred to the material the composition and the structural appearance of typical basement membrane-like structure.  Their properties enable us to investigate the biomaterial in several domains.
RP RABAUD, M (reprint author), UNIV BORDEAUX 2,INSERM,U306,CEEMASI,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   ARMENDER C, 1989, J BIOMED MATER RES, V23, P285
   AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x
   BARBIE C, 1989, BIOMATERIALS, V10, P445, DOI 10.1016/0142-9612(89)90084-7
   GRANT DS, 1989, J CELL BIOL, V108, P1567, DOI 10.1083/jcb.108.4.1567
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   HEICKENDORFF L, 1988, INT J BIOCHEM, V20, P381, DOI 10.1016/0020-711X(88)90205-4
   HERBERT JM, 1989, J CELL PHYSIOL, V138, P424, DOI 10.1002/jcp.1041380226
   HERBST TJ, 1988, J CELL BIOL, V106, P1365, DOI 10.1083/jcb.106.4.1365
   JONAS RA, 1986, ANN THORAC SURG, V41, P657, DOI 10.1016/S0003-4975(10)63083-4
   LEFEBVRE F, 1989, J BIOMED MATER RES, V23, P1423, DOI 10.1002/jbm.820231205
   LEPPERT PC, 1983, ARCH BIOCHEM BIOPHYS, V222, P53, DOI 10.1016/0003-9861(83)90501-5
   LITTLE CD, 1989, ANAT REC, V224, P417, DOI 10.1002/ar.1092240310
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   MANNING JN, 1989, J CHROMATOGR-BIOMED, V487, P41, DOI 10.1016/S0378-4347(00)83005-4
   MERCKEL JR, 1988, P SOC EXP BIOL MED, V187, P493
   POLY H, 1988, J PERIODONTAL RES, V23, P252, DOI 10.1111/j.1600-0765.1988.tb01368.x
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
   Robert L, 1985, FRONTIERS MATRIX BIO, V10, P92
   TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x
NR 20
TC 19
Z9 19
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 1991
VL 12
IS 3
BP 313
EP 319
DI 10.1016/0142-9612(91)90040-H
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FH068
UT WOS:A1991FH06800008
PM 1854899
DA 2018-10-20
ER

PT J
AU MARESCAUX, JF
   APRAHAMIAN, M
   MUTTER, D
   LOZA, E
   WILHELM, M
   SONZINI, P
   DAMGE, C
AF MARESCAUX, JF
   APRAHAMIAN, M
   MUTTER, D
   LOZA, E
   WILHELM, M
   SONZINI, P
   DAMGE, C
TI PREVENTION OF ANASTOMOSIS LEAKAGE - AN ARTIFICIAL CONNECTIVE-TISSUE
SO BRITISH JOURNAL OF SURGERY
LA English
DT Article
ID COLORECTAL ANASTOMOSES; STAPLING DEVICE; ADHESIVE; SUTURES; TRIAL
AB Anastomosis leakage still causes considerable morbidity and mortality after digestive tract surgery.  We report here our experience of the use of reconstituted connective tissue created from elastin, fibronectin and collagen in preventing anastomosis leakage and closing intestinal fistulas.  In animal studies (56 rats), this connective tissue was used as a patch applied with fibrin sealant to the edges of a 1 cm diameter colonic defect.  In a clinical evaluation, eight patients had an intestinal fistula closed by a simple sewn suture reinforced by a sealed patch and seven patients had a high risk anastomosis reinforced by a sealed patch, in most cases as an alternative to staged surgery.   In animal studies, complete reconstitution of the three colonic layers was obtained without retraction and without inflammatory reaction within 40 days, while the patch was slowly resorbed.  In clinical trials all 15 defects and anastomoses healed without complication.  Three patients died from other causes and, at autopsy, the patch was found to have remained in place covering the suture line.  If these results are confirmed by a prospective clinical trial, such biomaterial offers the possibility of reducing the occurrence of anastomosis leakage, especially in high risk circumstances.
C1 UNIV STRASBOURG 1,SERV CHIRURG DIGEST,F-67070 STRASBOURG,FRANCE.
   INSERM,UNITE RECH,F-67200 STRASBOURG,FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED RES, V21, P865
   BALLANTYNE GH, 1985, ANN SURG, V201, P360, DOI 10.1097/00000658-198503000-00019
   BEART RW, 1981, AM J SURG, V141, P143, DOI 10.1016/0002-9610(81)90027-1
   BEHL PR, 1983, ANN SURG, V198, P134, DOI 10.1097/00000658-198308000-00003
   BOLTON RA, 1980, LANCET, V1, P850
   BRENNAN SS, 1982, BRIT J SURG, V69, P722, DOI 10.1002/bjs.1800691212
   CONTO J, 1987, SURGERY, V101, P352
   DRESDALE A, 1985, SURGERY, V97, P750
   EVERETT WG, 1986, BRIT J SURG, V73, P345, DOI 10.1002/bjs.1800730506
   HIROTA K, 1965, SURGERY, V58, P1013
   HJORTRUP A, 1986, BRIT J SURG, V73, P760, DOI 10.1002/bjs.1800730928
   MCGINN FP, 1985, BRIT J SURG, V72, P603, DOI 10.1002/bjs.1800720807
   OKA H, 1982, AM J SURG, V43, P561
   OVERY RD, 1980, BRIT J SURG, V67, P363
   PETRELLI NJ, 1982, J SURG ONCOL, V19, P59, DOI 10.1002/jso.2930190115
   RABAUD M, 1986, THROMB RES, V43, P205, DOI 10.1016/0049-3848(86)90061-7
   RUSCA JA, 1969, ANN SURG, V169, P727, DOI 10.1097/00000658-196905000-00010
   SIEDENTOP KH, 1986, LARYNGOSCOPE, V96, P1062
   TASHIRO S, 1987, BRIT J SURG, V74, P392, DOI 10.1002/bjs.1800740523
   THORSON GK, 1983, J SURG ONCOL, V24, P221, DOI 10.1002/jso.2930240317
NR 20
TC 15
Z9 15
U1 0
U2 3
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0007-1323
J9 BRIT J SURG
JI Br. J. Surg.
PD APR
PY 1991
VL 78
IS 4
BP 440
EP 444
DI 10.1002/bjs.1800780417
PG 5
WC Surgery
SC Surgery
GA FH499
UT WOS:A1991FH49900016
PM 2032102
DA 2018-10-20
ER

PT J
AU ENGBERS, GH
   FEIJEN, J
AF ENGBERS, GH
   FEIJEN, J
TI CURRENT TECHNIQUES TO IMPROVE THE BLOOD COMPATIBILITY OF BIOMATERIAL
   SURFACES
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Editorial Material
ID OXIDE)-HEPARIN BLOCK COPOLYMERS; HUMAN-ENDOTHELIAL CELLS; PROTEIN
   ADSORPTION; POLYMER SURFACES; HEPARINIZED POLYMER; ALBUMIN;
   POLYURETHANES; INVITRO; PLASMA; IMMOBILIZATION
C1 UNIV TWENTE,DEPT CHEM TECHNOL,BIOMED MAT TECHNOL SECT,POB 217,7500 AE ENSCHEDE,NETHERLANDS.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AOSHIMA R, 1982, J BIOMED MATER RES, V16, P289, DOI 10.1002/jbm.820160309
   ARNANDER C, 1986, J BIOMED MATER RES, V20, P235, DOI 10.1002/jbm.820200212
   BAMFORD CH, 1983, EUR POLYM J, V19, P1027, DOI 10.1016/0014-3057(83)90068-X
   BARBUCCI R, 1985, POLYMER, V26, P1349, DOI 10.1016/0032-3861(85)90310-6
   BARBUCCI R, 1987, J BIOMED MATER RES, V21, P443, DOI 10.1002/jbm.820210405
   BASSMODIJON D, 1983, J BIOMED MATER RES, V17, P509
   BRINKMAN E, 1989, INT J ARTIF ORGANS, V12, P390
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   DANISHEFSKY I, 1974, THROMB RES, V4, P237, DOI 10.1016/0049-3848(74)90089-9
   DANISHEFSKY I, 1976, THROMB RES, V8, P131, DOI 10.1016/0049-3848(76)90256-5
   DEKKER A, 1990, THESIS U TWENTE NETH
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   DURRANI AA, 1987, POLYM SURFACES INTER, P189
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   EBERT CD, 1982, ACS ADV CHEM SERIES, V199, P161
   ELOY R, 1987, THROMB RES, V45, P223, DOI 10.1016/0049-3848(87)90190-3
   ENGBERS GHM, 1987, J BIOMED MATER RES, V21, P613, DOI 10.1002/jbm.820210507
   ENGBERS GHM, 1990, THESIS U TWENTE NETH
   EVANGELISTA RA, 1986, BIOMATERIALS, V7, P206, DOI 10.1016/0142-9612(86)90104-3
   FALB RD, 1968, INTERAC LIQUID SOLID, V87, P181
   FEIJEN J, Patent No. 294905
   FEIJEN J, Patent No. 81853
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   GOOSEN MFA, 1979, J BIOMED MATER RES, V13, P347, DOI 10.1002/jbm.820130302
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GUIDOIN R, 1984, J BIOMED MATER RES, V18, P1059, DOI 10.1002/jbm.820180909
   GUIDOIN RG, 1976, BIOMATER ARTIF CELL, V4, P205, DOI 10.3109/10731197609118651
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HAYWARD JA, 1986, BIOMATERIALS, V7, P126, DOI 10.1016/0142-9612(86)90069-4
   HENNINK WE, 1983, T AM SOC ART INT ORG, V29, P200
   HENNINK WE, 1984, BIOMATERIALS, V5, P264, DOI 10.1016/0142-9612(84)90070-X
   HENNINK WE, 1983, THROMB RES, V29, P1, DOI 10.1016/0049-3848(83)90120-2
   HENNINK WE, 1984, J BIOMED MATER RES, V18, P911, DOI 10.1002/jbm.820180806
   HENNINK WE, 1983, 5TH P SEM BIOM ART O, P203
   HERRING M, 1984, SURGERY, V96, P745
   HEYMAN PW, 1985, J BIOMED MATER RES, V19, P419, DOI 10.1002/jbm.820190407
   IDEZUKI Y, 1975, T AM SOC ART INT ORG, V21, P436
   IPP WF, 1989, BIOMAT, V10, P313
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   JACOBS H, 1985, Journal of Controlled Release, V2, P313, DOI 10.1016/0168-3659(85)90053-7
   JANSEN B, 1985, RADIAT PHYS CHEM, V25, P529, DOI 10.1016/0146-5724(85)90132-3
   JANSEN B, 1979, J POLYM SCI PS, V66, P465
   KESLER KA, 1986, J VASC SURG, V3, P58
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LAGERGREN HR, 1971, T AM SOC ART INT ORG, V17, P10
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LARSSON N, 1982, J COLLOID INTERF SCI, V90, P127, DOI 10.1016/0021-9797(82)90405-2
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEININGER RI, 1966, T AM SOC ART INT ORG, V12, P151
   LEININGER RI, 1972, T AM SOC ART INT ORG, V18, P312
   LIU S Q, 1989, Journal of Biomaterials Science Polymer Edition, V1, P111
   MITTERMAYER C, Patent No. 290642
   MIYAMA H, 1977, J BIOMED MATER RES, V11, P251, DOI 10.1002/jbm.820110210
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NOISHIKI Y, 1981, T AM SOC ART INT ORG, V27, P213
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   OHSHIRO T, 1980, ARTIF ORGANS, V4, P58, DOI 10.1111/j.1525-1594.1980.tb03902.x
   OKANO T, 1988, 2ND P INT S ART HEAR, P45
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PIAO A Z, 1990, Journal of Biomaterials Science Polymer Edition, V1, P299
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   PUSINERI C, 1982, 9 P ANN M ESAO
   RAGHUNATH K, 1983, J BIOMED MATER RES, V17, P613, DOI 10.1002/jbm.820170406
   SANADA T, 1986, J BIOMED MATER RES, V20, P1179, DOI 10.1002/jbm.820200809
   SEFTON MV, 1976, J BIOMED MATER RES, V10, P33, DOI 10.1002/jbm.820100105
   SHANKAR H, 1990, BIOMATER ARTIF CELL, V18, P59, DOI 10.3109/10731199009117289
   SIPEHIA R, 1990, BIOMATER ARTIF CELL, V18, P437, DOI 10.3109/10731199009117319
   SIPEHIA R, 1982, BIOMATER ARTIF CELL, V10, P229, DOI 10.3109/10731198209118783
   TANZAWA H, 1973, T AM SOC ART INT ORG, V19, P188
   TANZI MC, 1989, J BIOMED MATER RES, V23, P863, DOI 10.1002/jbm.820230805
   Usdin V R, 1969, J Biomed Mater Res, V3, P107, DOI 10.1002/jbm.820030110
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   VULIC I, 1988, J POLYM SCI POL CHEM, V26, P381, DOI 10.1002/pola.1988.080260204
   VULIC I, 1989, THESIS U TWENTE NETH
   WATANABE S, 1981, J BIOMED MATER RES, V15, P553, DOI 10.1002/jbm.820150410
NR 86
TC 72
Z9 74
U1 1
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD APR
PY 1991
VL 14
IS 4
BP 199
EP 215
PG 17
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA FM933
UT WOS:A1991FM93300003
PM 2060987
DA 2018-10-20
ER

PT J
AU HAYASHI, K
   UENOYAMA, K
   MATSUGUCHI, N
   SUGIOKA, Y
AF HAYASHI, K
   UENOYAMA, K
   MATSUGUCHI, N
   SUGIOKA, Y
TI QUANTITATIVE-ANALYSIS OF INVIVO TISSUE RESPONSES TO
   TITANIUM-OXIDE-COATED AND HYDROXYAPATITE-COATED TITANIUM-ALLOY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TOTAL HIP REPLACEMENTS; METAL IMPLANTS; BONE; INTERFACE
AB We have previously studied a large number of histological specimens of biomaterials and found that regions with and without an intervening fibrous membrane coexisted in many specimens.  Therefore, it appears necessary to perform an evaluation of the entire specimen when histologically assessing the affinity of bone for a biomaterial.  Accordingly, we performed a quantitative histological evaluation of hydroxyapatite (HAP)- and titanium-oxide(TiO2)-coated Ti-6Al-4V and un-coated Ti-6Al-4V (control) by determining the affinity index.  This was defined as the length of bone directly opposed to the implant/the total length of the bone-implant interface X 100%.  The test materials were inserted into the distal epiphyseal region of the femurs of adult dogs, and follow-up quantitative histological comparisons were performed from 4 weeks to 96 weeks.  The HAP-coated implants had the highest affinity index 4 weeks after insertion, and this superiority was maintained up to 96 weeks.  There was a significant difference in affinity index between HAP-coated implants and control implants (P < 0.001), while TiO2-coated implants showed no significant difference in comparison to the control.
RP HAYASHI, K (reprint author), KYUSHU UNIV,FAC MED,DEPT ORTHOPAED SURG,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.
CR DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, V225, P147
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1111, DOI 10.1002/jbm.820240813
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   HULBERT SF, 1975, J BIOMED MATER RES, V6, P189
   RONNINGEN H, 1984, ACTA ORTHOP SCAND, V55, P352, DOI 10.3109/17453678408992373
   RONNINGEN H, 1985, ACTA ORTHOP SCAND, V56, P67, DOI 10.3109/17453678508992983
   SALVATI EA, 1981, J BONE JOINT SURG AM, V63, P753, DOI 10.2106/00004623-198163050-00010
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
NR 10
TC 69
Z9 69
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1991
VL 25
IS 4
BP 515
EP 523
DI 10.1002/jbm.820250408
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FB981
UT WOS:A1991FB98100007
PM 2050714
DA 2018-10-20
ER

PT J
AU VANBLITTERSWIJK, CA
   BAKKER, D
   HESSELING, SC
   KOERTEN, HK
AF VANBLITTERSWIJK, CA
   BAKKER, D
   HESSELING, SC
   KOERTEN, HK
TI REACTIONS OF CELLS AT IMPLANT SURFACES
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 1990 CONF ON BIOINTERACTIONS ( BIOINTERACTIONS 90 )
CY AUG 21-23, 1990
CL OXFORD, ENGLAND
DE CELL-BIOMATERIAL INTERACTIONS; SURFACE MODIFICATION; BIOACTIVE MATERIALS
ID RAT MIDDLE-EAR; BETA-WHITLOCKITE; BIOLOGICAL PERFORMANCE; TISSUE
   INTERFACE; BONE; PARTICLES; CERAMICS; INVITRO; NICKEL; COBALT
AB The surface of implants is an important parameter in host-implant integration.  Several strategies can be used to obtain integration, such as the application of grooves or pores at the implant surface.  Most of these surface alterations, however, will lead to an increase of total implant surface area which might influence the inflammatory response to an implant.  As far as integration with bone is concerned several biomaterials have been successful in mimicking this material, by having similar crystals at their surface (calcium phosphate ceramics) or by containing a certain amount of calcium and phosphorus.  Polyactive, a poly(ethylene oxide)-poly(butylene terephthalate) segmented copolymer, also possesses favourable integration properties with bone, but initially lacks calcium and phosphorus.  It is proposed that the application of hydrogels as biomaterial may add a new dimension to integration capacity.
RP VANBLITTERSWIJK, CA (reprint author), STATE UNIV LEIDEN HOSP,DEPT EAR NOSE & THROAT,OTOBIOL & BIOCOMPATIBIL LAB,BIOMAT RES GRP,2333 AA LEIDEN,NETHERLANDS.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   BAKKER D, 1990, CLIN IMPLANT MAT, P99
   BAKKER D, 1989, INTERFACES MED MECHA, P102
   BAKKER D, 1989, POLYM MED SURGERY, V6, P11
   BEUMER GJ, 1990, CLIN IMPLANT MATERIA, P169
   BLACK J, 1983, BIOMATERIALS, V4, P160, DOI 10.1016/0142-9612(83)90003-0
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   Bobyn JD, 1980, CLIN ORTHOPAEDICS, V150, P263
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Cheroudi B, 1988, J BIOMED MATER RES, V22, P459
   COTTON E, 1854, VOICE WATERLOO, P84
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DAVIES JE, IN PRESS CRC HDB BIO
   DEBOER DEH, 1981, HUTSPOT HARING WITTE
   DEBRUIJN JD, IN PRESS INTERFACES
   DEGROOT K, 1985, J HEAD NECK PATHOL, V4, P90
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   DEPUTTER C, 1984, PERMUCOSAL DENTAL IM, P119
   DRIESSEN AA, 1982, BIOMATERIALS, V3, P113
   Eaton Charlotte Ann, 1817, NARRATIVE RESIDENCE
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   HARMS J, 1907, J BIOMED MATER RES, V13, P67
   HEIMKE G, 1983, BIOCERAMICS CALCIUM, P79
   HEIMKE G, 1980, MECH PROPERTIES BIOM, P207
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1982, BIOMATERIALS INTERFA, P132
   HESSELING SC, UNPUB ACTA OTOLARYNG
   HOMSY CA, 1972, CLIN ORTHOPAEDICS, V83, P317
   Jansen J A, 1989, J Invest Surg, V2, P29, DOI 10.3109/08941938909016502
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KLAWITTER JJ, BIOMED MATER S, V2, P161
   KLEIN CPA, 1990, CLIN IMPLANT MATERIA, P277
   KLUMPERMAN J, UNPUB J CELL BIOL
   KOERTEN HK, 1990, AM J PATHOL, V136, P141
   KOERTEN HK, IN PRESS INTERFACES
   KOERTEN HK, 1990, CLIN IMPLANT MATERIA, P219
   KOERTEN HK, 1989, THESIS U LEIDEN NETH, pCH5
   LOER F, 1986, BIOL BIOMECHANICAL P, P501
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MCNAMARA A, 1982, BIOMATERIALS, V3, P165, DOI 10.1016/0142-9612(82)90007-2
   MERRITT K, 1980, EVALUATION BIOMATERI, P315
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Osborn J. F., 1980, DENT IMPLANTS MAT SY, P111
   PARKINSON IM, 1981, J CLIN PATHOL, V34, P1258
   PIZZOFERATO A, 1987, BIOMATERIALS BIOMECH, P301
   PONEC M, 1989, PHARM RETINOIDS SKIN, P45
   PREDECKI P, 1972, J BIOMED MATER RES, P401
   RADDER AM, 1990, T CAN SOC BIOMATER O
   RICHTER KH, 1980, EVALUATION BIOMATERI, P361
   SCHERFT JP, 1972, J ULTRA MOL STRUCT R, V38, P318, DOI 10.1016/S0022-5320(72)90008-1
   SEMMELINK JM, 1986, BIOMATERIALS, V7, P152, DOI 10.1016/0142-9612(86)90074-8
   SWART JGN, THESIS FREE U AMSTER
   THOMA RJ, 1987, ADV BIOMET POLYM, P131
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P1197, DOI 10.1002/jbm.820200810
   VANBLITTERSWIJK CA, 1989, CRIT REV BIOCOMPAT, V5, P13
   VANBLITTERSWIJK CA, 1986, ACTA OTO-LARYNGOL, V101, P453, DOI 10.3109/00016488609108632
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VANBLITTERSWIJK.CA, 1990, BIOCERAMICS, P41
   VANBLITTERSWIJK CA, 1989, INTERFACE MED MECHAN, P110
   VANBLITTERSWIJK.CA, 1989, EUROCERAMICS, V3, P11
   VANBLITTERSWIJK CA, 1989, 15TH T ANN SOC BIOM, P107
   VANDERLEI, 1986, THESIS U GRONINGEN, pCH6
   VANMUIJEN GNP, 1987, EXP CELL RES, V171, P331, DOI 10.1016/0014-4827(87)90166-2
   VANSLIEDREGT A, J BIOMED MATER RES
   VERHEYEN CCP, 1990, PROGRAMME ABSTRACT B, P53
   VONRECUM AF, 1990, CLIN IMPLANT MAT, P297
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
NR 72
TC 40
Z9 40
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1991
VL 12
IS 2
BP 187
EP 193
DI 10.1016/0142-9612(91)90198-J
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FE629
UT WOS:A1991FE62900015
PM 1878452
DA 2018-10-20
ER

PT J
AU OTSUKA, M
   MATSUDA, Y
   FOX, JL
   POWELL, GL
   HIGUCHI, WI
AF OTSUKA, M
   MATSUDA, Y
   FOX, JL
   POWELL, GL
   HIGUCHI, WI
TI EFFECT OF LASER IRRADIATION ON SURFACE HARDNESS OF SELF-SETTING
   HYDROXYAPATITE CEMENT
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Note
DE CO2 LASER; ARTIFICIAL HARD TISSUE; VICKERS HARDNESS; HYDROXYAPATITE;
   SELF-SETTING CEMENT; BIOMATERIAL
ID CARIES; PREVENTION
AB A novel approach to the use of self-setting hydroxyapatite cement in a dental cement system uses CO2 laser irradiation is proposed to solve the problem of the insufficient hardness of the cement. After setting, the cement is transformed to hydroxyapatite which has a high affinity for hard tooth and bone tissuess. The Vickers hardness of the cement system is significantly increased by CO2 laser irradiation.
C1 UNIV UTAH, DEPT PHARMACEUT, SALT LAKE CITY, UT 84112 USA.
   UNIV UTAH, DEPT DENT EDUC, SALT LAKE CITY, UT 84112 USA.
RP OTSUKA, M (reprint author), KOBE WOMENS COLL PHARM, MOTOYAMA KITAMACHI, KOBE 658, JAPAN.
CR APFELBERG DB, 1984, ANN PLAST SURG, V142, P355
   Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   DOI Y, 1987, J JPN SOC DENTAL MAT, V6, P53
   MAGEE F, 1986, 12TH ANN M SOC BIOM, P135
   MUNEMIYA M, 1981, CENTRAL JPN J ORTHOP, V24, P1267
   NELSON DGA, 1986, CARIES RES, V20, P289, DOI 10.1159/000260948
   SHIMIZU T, 1984, DENTAL MATERIALS DEV, V3, P95
   STERN RH, 1966, J AM DENT ASSOC, V73, P838, DOI 10.14219/jada.archive.1966.0319
   WONG J, 1990, J PHARM SCI, V79, P510, DOI 10.1002/jps.2600790611
   YAMAMOTO H, 1974, J ORAL PATHOL MED, V3, P7, DOI 10.1111/j.1600-0714.1974.tb01693.x
   YAMAMOTO H, 1980, J DENT RES, V59, P2171
NR 11
TC 0
Z9 0
U1 0
U2 0
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD MAR
PY 1991
VL 39
IS 3
BP 814
EP 816
PG 3
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA FF269
UT WOS:A1991FF26900059
DA 2018-10-20
ER

PT J
AU JANATOVA, J
   CHEUNG, AK
   PARKER, CJ
AF JANATOVA, J
   CHEUNG, AK
   PARKER, CJ
TI BIO-MEDICAL POLYMERS DIFFER IN THEIR CAPACITY TO ACTIVATE COMPLEMENT
SO COMPLEMENT AND INFLAMMATION
LA English
DT Review
DE BIOCOMPATIBILITY; BIO-MEDICAL POLYMERS; COMPLEMENT ACTIVATION; C3A; C5A;
   HEMODIALYSIS MEMBRANES
AB Conventionally, complement activation by biomedical polymers has been evaluated by determining the C3a concentration in the fluid phase only.  According to this criterion, biomaterials such as hemodialysis membranes made from cellulosic or various synthetic polymers were classified as activators or nonactivators of complement.  Since certain membranes bind large quantities of C3a from the fluid phase, classification based on fluid-phase C3a concentration has in some instances been inaccurate.  As follows from the comparison of complement activation by cuprophane and polyacrylonitrile membranes, the capacity of a biomedical polymer to activate complement is not determined by the number of potential covalent binding sites on its surface.  Biomaterial itself may lack hydroxyl and/or amino groups, and yet it may activate C3 in human serum very efficiently.  Some of the biomaterials may also bind unactivated/unfragmented C3 whether in the absence or presence of other serum proteins.  In addition, binding of factor B (a promotor of C3 activation) and binding of factor H (an inhibitor of C3 activation) to certain biomaterials have been found to be independent of complement activation and unaffected by the presence or absence of C3.  Thus, it is becoming apparent that the requirements for the formation and stability of the C3 convertase on artificial surfaces differ from those on biological membranes, and that the relative magnitude of binding of factor B and factor H to the surface per se cannot be used as a reliable indicator of the capacity of the biomaterial to activate complement.  Further studies are necessary to elucidate the molecular mechanisms of C3 and C5 activation on the surfaces of biomedical polymers.  Its understanding should lead to the development of new or modification of existing artificial membranes which would cause less adverse effects for patients during extracorporeal procedures.
RP JANATOVA, J (reprint author), UNIV UTAH,SCH MED,DEPT PATHOL,50 N MED DR,SALT LAKE CITY,UT 84132, USA.
FU NIAID NIH HHS [AI 19319]; NIDDK NIH HHS [DK 35830]
NR 0
TC 56
Z9 56
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1012-8204
J9 COMPLEMENT INFLAMMAT
PD MAR-APR
PY 1991
VL 8
IS 2
BP 61
EP 69
DI 10.1159/000463181
PG 9
WC Immunology
SC Immunology
GA FF582
UT WOS:A1991FF58200001
PM 2055009
DA 2018-10-20
ER

PT J
AU IOKU, K
   SOMIYA, S
   YOSHIMURA, M
AF IOKU, K
   SOMIYA, S
   YOSHIMURA, M
TI HYDROXYAPATITE CERAMICS WITH TETRAGONAL ZIRCONIA PARTICLES DISPERSION
   PREPARED BY HIP POSTSINTERING
SO NIPPON SERAMIKKUSU KYOKAI GAKUJUTSU RONBUNSHI-JOURNAL OF THE CERAMIC
   SOCIETY OF JAPAN
LA English
DT Article
DE BIOMATERIAL; APATITE; ZIRCONIA; HOT-PRESSING; POSTSINTERING; HIP; KIC
AB Hydroxyapatite (HAp) powders with dispersed tetragonal zirconia particles were synthesized hydrothermally at 200-degrees-C under 2 MPa for 10 h.  Transmission electron microscopy (TEM) demonstrated that the homogeneous mixture of ultra-fine HAp single crystals and zirconia particles could be obtained by the hydrothermal technique.  The mixture with the volume ratio of HAp:  zirconia = 90:  10 was hot-pressed at 1050-degrees-C under 30 MPa for 1 h in Ar, then post-sintered by HIP at the same temperature under 200 MPa of Ar for 1 h.  The product had almost pore free microstructures consisting of HAp matrix and tetragonal zirconia particles.  Its fracture toughness was 2.5 times as large as that of the transparent pure HAp ceramics.  This ceramic was toughened by the crack deflection toughening mechanism and probably by the transformation toughening mechanism due to tetragonal zirconia particles dispersed in the matrix.  Furthermore, the reactivity between HAp and zirconia was examined.  The decomposition of HAp to beta-tricalcium phosphate (beta-TCP) was accelerated by zirconia, and CaO was not detected in every temperature.  Thus the decomposition was taken place by dissolution of Ca components in zirconia in the first step, then HAp decomposed to beta-TCP subsequently.
RP IOKU, K (reprint author), KOCHI UNIV,KOCHI 780,JAPAN.
NR 0
TC 18
Z9 18
U1 0
U2 3
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17 HYAKUNIN-CHO SHINJUKU-KU, TOKYO 169, JAPAN
SN 0914-5400
J9 NIPPON SERAM KYO GAK
PD MAR
PY 1991
VL 99
IS 3
BP 196
EP 203
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA FD650
UT WOS:A1991FD65000003
DA 2018-10-20
ER

PT J
AU MORA, EM
   CARDONA, MA
   SIMMONS, RL
AF MORA, EM
   CARDONA, MA
   SIMMONS, RL
TI ENTERIC BACTERIA AND INGESTED INERT PARTICLES TRANSLOCATE TO
   INTRAPERITONEAL PROSTHETIC MATERIALS
SO ARCHIVES OF SURGERY
LA English
DT Article; Proceedings Paper
CT 10TH ANNIVERSARY MEETING OF THE SURGICAL INFECTION SOC
CY JUN   14, 1990
CL CINCINNATI, OH
SP SURG INFECT SOC
ID GASTROINTESTINAL-TRACT; INTESTINAL BACTERIA; THERMAL-INJURY; ENDOTOXIN;
   MICE; GUT; PROMOTES; MALNUTRITION; FLORA; MECHANISMS
AB Sterile and endotoxin-free biomaterials commonly used in prosthetic devices (Dacron velour, woven Dacron, and Blomer polyurethane) and cotton (control material) were implanted intraperitoneally in mice with normal enteric flora.  Intraperitioneal Biomer and woven Dacron became contaminated with 100 to 10 000 enteric bacteria, including Escherichia coli, Pseudomonas aeruginosa, enterococci, and staphylococci species, within 3 days; intraperitoneal cotton and Dacron velour were contaminated within 24 hours.  Mesenteric lymph nodes showed parallel incidences of translocation.  The peritoneal cavity became contaminated only if the biomaterial itself became contaminated.  No bacterial overgrowth, perforation, or histologic changes in the bowel were found.  Subcutaneous biomaterials remained sterile.  Ingested fluorescent beads appeared in enterocytes, in lamina propria within macrophages, and in intraperitoneal biomaterials.  The data suggest that intraperitoneal sterile reactive stimuli can induce bacterial translocation to the dense prosthesis directly through the intact normal bowel wall.  One of the mechanisms seems to involve phagocytosis of particles and bacteria within the bowel wall that are then chemotactically attracted to nearby sites of inflammation.
RP MORA, EM (reprint author), UNIV PITTSBURGH,DEPT SURG,497 SCAIFE HALL,PITTSBURGH,PA 15261, USA.
FU NIAID NIH HHS [AI 14032-11]
CR ALVERDY JC, 1988, SURGERY, V104, P185
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BAKER J W, 1987, Surgical Forum (Chicago), V38, P73
   BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002
   BERG RD, 1988, ARCH SURG-CHICAGO, V123, P1359
   BURKE DJ, 1989, ARCH SURG-CHICAGO, V124, P1396
   DEITCH EA, 1989, SURGERY, V106, P292
   DEITCH EA, 1987, J TRAUMA, V27, P161, DOI 10.1097/00005373-198702000-00012
   DEITCH EA, 1989, ARCH SURG-CHICAGO, V124, P699
   DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185
   DEITCH EA, 1989, J CLIN INVEST, V84, P36, DOI 10.1172/JCI114164
   DEITCH EA, 1987, ANN SURG, V205, P681, DOI 10.1097/00000658-198706000-00010
   DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P1019
   DEITCH EA, 1988, SURGERY, V104, P191
   DEITCH EA, 1986, ARCH SURG-CHICAGO, V121, P97
   DEITCH EA, 1987, J SURG RES, V42, P536, DOI 10.1016/0022-4804(87)90029-1
   DEITCH EA, 1989, J TRAUMA, V29, P1679, DOI 10.1097/00005373-198912000-00017
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DOUGHERTY SH, 1988, CURR PROBL SURG, V19, P268
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   INOVE S, 1988, J SURG RES, V44, P479
   INOVE S, 1989, J PARENTER ENTERAL N, V13, P565
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P129
   LI M, 1989, JPEN-PARENTER ENTER, V13, P572, DOI 10.1177/0148607189013006572
   MA L, 1989, J TRAUMA, V29, P1480
   MADDAUS MA, 1988, ANN SURG, V207, P387, DOI 10.1097/00000658-198804000-00004
   MAEJIMA K, 1984, INFECT IMMUN, V43, P6
   MAEJIMA K, 1984, ARCH SURG-CHICAGO, V119, P166
   MORA EM, 1989, MICROECOL T, V19, P185
   ODWYER ST, 1988, ARCH SURG-CHICAGO, V123, P1459
   SCHWEINBURG FB, 1950, NEW ENGL J MED, V242, P747, DOI 10.1056/NEJM195005112421903
   STEFFEN EK, 1988, J INFECT DIS, V157, P1032, DOI 10.1093/infdis/157.5.1032
   VAS SI, 1989, INFECT DIS CLIN N AM, V3, P310
   VAS SI, 1989, INFECTIONS ASS INDWE, P215
   VINCENT P, 1988, J INFECT DIS, V158, P1395, DOI 10.1093/infdis/158.6.1395
   WELLS CL, 1989, MICROECOL T, V19, P191
   WELLS CL, 1988, INFECT IMMUN, V56, P278
   WELLS CL, 1988, REV INFECT DIS, V10, P958
   WELLS CL, 1987, INFECT IMMUN, V55, P2834
   WELLS CL, 1986, ARCH SURG-CHICAGO, V121, P102
   WELLS CL, 1987, ARCH SURG-CHICAGO, V122, P48
   WELLS CL, 1989, SPLANCHNIC ISCHEMIA, V17, P195
NR 43
TC 35
Z9 35
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610
SN 0004-0010
J9 ARCH SURG-CHICAGO
JI Arch. Surg.
PD FEB
PY 1991
VL 126
IS 2
BP 157
EP 163
PG 7
WC Surgery
SC Surgery
GA EX217
UT WOS:A1991EX21700005
PM 1825166
DA 2018-10-20
ER

PT J
AU KALMAN, PG
   WARD, CA
   MCKEOWN, NB
   MCCULLOUGH, D
   ROMASCHIN, AD
AF KALMAN, PG
   WARD, CA
   MCKEOWN, NB
   MCCULLOUGH, D
   ROMASCHIN, AD
TI IMPROVED BIOCOMPATIBILITY OF SILICONE-RUBBER BY REMOVAL OF SURFACE
   ENTRAPPED AIR NUCLEI
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COMPLEMENT ACTIVATION; DECOMPRESSION-SICKNESS; BLOOD COMPATIBILITY;
   LEUKOCYTE COUNTS; IMPLANTS; ADHESION; C3A
AB Biomaterials activate the complement system which is important since C3a promotes platelet aggregation and release, and C5a activates neutrophils that may augment coagulation.  Tiny air nuclei (microbubbles) are found in the surface roughness of biomaterials on exposure to a liquid, therefore two interfaces exist:  (a) a blood/biomaterial, and (b) a blood/air interface.  Experiments were carried out that documented that air bubbles activate complement and augment in vitro platelet aggregation in human plasma.  The air nuclei were removed from the surface of silicone rubber by a technique termed denucleation to determine if complement activation and platelet aggregation could be reduced.  We observed a significant reduction in C3a and C5a in the plasma samples incubated with denucleated silicone rubber as compared to the control samples (p < 0.001, ANOVA).  The plasma incubated with the denucleated silicone caused reduced platelet aggregation as compared to the plasma incubated with the control silicone when added to a platelet suspension (p < 0.001, ANOVA).  Surface chemical analysis by x-ray photoelectron spectroscopy (XPS) showed no change in the silicone rubber surface after the denucleation procedure.
C1 UNIV TORONTO,DEPT SURG,TORONTO M5S 1A1,ONTARIO,CANADA.
   UNIV TORONTO,DEPT MECH ENGN,TORONTO M5S 1A1,ONTARIO,CANADA.
RP KALMAN, PG (reprint author), TORONTO GEN HOSP,DIV VASC SURG,9 EATON N ROOM 215,200 ELIZABETH ST,TORONTO M5G 1L7,ONTARIO,CANADA.
RI McKeown, Neil/A-2451-2011
OI McKeown, Neil/0000-0002-6027-261X
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P105
   ARKLES B, 1983, BIOCOMPATIBLE POLYM, P749
   ASHTON F, 1969, BRIT MED J, V3, P409, DOI 10.1136/bmj.3.5667.409
   BECKENBAUGH RD, 1976, J BONE JOINT SURG AM, V58, P483, DOI 10.2106/00004623-197658040-00009
   BOHLER J, 1983, CONTRIB NEPHROL, V36, P15
   CHENOWETH DE, 1986, T AM SOC ART INT ORG, V32, P226
   CHENOWETH DE, 1980, FUTURE PERSPECTIVES
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DAHLGREN C, 1984, INFLAMMATION, V8, P201, DOI 10.1007/BF00916095
   GORSKI JP, 1981, J IMMUNOL METHODS, V47, P61, DOI 10.1016/0022-1759(81)90257-X
   HALL B, 1989, BIOMATERIALS, V10, P219, DOI 10.1016/0142-9612(89)90096-3
   HAMMERSCHMIDT DE, 1981, J THORAC CARDIOV SUR, V81, P370
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   JANSEN B, 1988, ANGEW MAKROMOL CHEM, V164, P115, DOI 10.1002/apmc.1988.051640109
   KOLOBOW T, 1976, T AM SOC ART INT ORG, V2, P110
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   LOOS M, 1985, COMPLEMENT SYSTEM AC, P9
   MCCAUGHAN JS, 1969, SURGERY, V66, P375
   MEUER S, 1981, J IMMUNOL, V126, P1506
   NIEMETZ J, 1984, ANN NY ACAD SCI, V95, P331
   OSADA H, 1978, AM J PHYSIOL, V234, pH646
   PHILP RB, 1972, AEROSPACE MED, V43, P946
   POLLEY MJ, 1983, J EXP MED, V158, P603, DOI 10.1084/jem.158.2.603
   RATNER BD, 1987, POLYM SURFACES INTER, P231
   RYHANEN P, 1979, J THORAC CARDIOV SUR, V77, P259
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   van Noort R., 1977, Plastics and Rubber Materials and Applications, V2, P7
   VANNOORT R, 1979, J BIOMED MATER RES, V13, P623, DOI 10.1002/jbm.820130408
   WARD CA, 1987, J APPL PHYSIOL, V62, P1160
   WARD CA, 1984, J BIOMED MATER RES, V18, P255, DOI 10.1002/jbm.820180303
   WARD CA, 1986, J APPL PHYSIOL, V60, P1651
   WARD CA, 1975, T AM SOC ART INT ORG, V9, P77
   WILLIAMS JE, 1972, PLAST RECONSTR SURG, V49, P253, DOI 10.1097/00006534-197203000-00002
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
NR 34
TC 11
Z9 12
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1991
VL 25
IS 2
BP 199
EP 211
DI 10.1002/jbm.820250207
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV472
UT WOS:A1991EV47200006
PM 2055917
DA 2018-10-20
ER

PT J
AU ROSANOVA, IB
   MISCHENKO, BP
   ZAITSEV, VV
   VASIN, SL
   SEVASTIANOV, VI
AF ROSANOVA, IB
   MISCHENKO, BP
   ZAITSEV, VV
   VASIN, SL
   SEVASTIANOV, VI
TI THE EFFECT OF CELLS ON BIOMATERIAL CALCIFICATION - EXPERIMENTS WITH
   INVIVO DIFFUSION-CHAMBERS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Note
C1 MOSCOW TRANSPLANTOL & ARTIFICAL ORGANS,SHUKINSKAYA 1,MOSCOW 123436,USSR.
   BAKULEV HEART VASC SURG INST,MOSCOW,USSR.
RI Sevastianov, Victor/B-6674-2017
OI Sevastianov, Victor/0000-0003-1995-3373
CR ANDERSON HC, 1981, T AM SOC ART INT ORG, V27, P702
   BOSKEY A L, 1982, Calcified Tissue International, V34, pS24
   CARPENTIER A, 1984, CIRCULATION, V70, P1
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   NOSE Y, 1981, T AM SOC ART INT ORG, V27, P714
   SPRINCL L, 1973, CALC TISS RES, V13, P63, DOI 10.1007/BF02015397
NR 7
TC 10
Z9 11
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1991
VL 25
IS 2
BP 277
EP 280
DI 10.1002/jbm.820250213
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV472
UT WOS:A1991EV47200012
PM 1829083
DA 2018-10-20
ER

PT J
AU PINHOLT, EM
   BANG, G
   HAANAES, HR
AF PINHOLT, EM
   BANG, G
   HAANAES, HR
TI ALVEOLAR RIDGE AUGMENTATION IN RATS BY COMBINED HYDROXYLAPATITE AND
   OSTEOINDUCTIVE MATERIAL
SO SCANDINAVIAN JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE ALVEOLAR RIDGE AUGMENTATION; HYDROXYLAPATITE; JAWS; OSTEOINDUCTIVE
   MATERIAL
ID HETEROTOPIC BONE FORMATION; SOFT-TISSUE RESPONSES; COLLAGEN-APATITE;
   MANDIBULAR AUGMENTATION; POROUS HYDROXYLAPATITE; DEMINERALIZED DENTIN;
   BIOMATERIAL ASPECTS; GUINEA-PIGS; CERAMICS; IMPLANTS
AB The purpose of this study was to examine if increased bony ingrowth developed when hydroxylapatite was implanted together with an osteoinductive substrate.  Dense hydroxylapatite granules (HA) (Calcitite, Calcitek, San Diego, CA, USA) were mixed with equal volumes of allogenic, demineralized, lyophilized dentin or bone and implanted subperiosteally for alveolar ridge augmentation purposes and heterotopically in the abdominal muscles in rats.  Light microscopic evaluation revealed that HA was surrounded by fibrous connective tissue containing foreign body giant cells and it had neither an osteoinductive nor an osteoconductive effect.  The newly formed bone induced from the implanted allogenic, demineralized, lyophilized dentin or bone was never found in close contact with the HA and did not incorporate the implant.
C1 UNIV BERGEN,DEPT ORAL PATHOL & FORENS DENT,N-5014 BERGEN,NORWAY.
   UNIV OSLO,FAC DENT,DEPT ORAL SURG & ORAL MED,OSLO 3,NORWAY.
RP PINHOLT, EM (reprint author), UNIV OSLO,RIKSHOSP,INST SURG RES,N-0027 OSLO 1,NORWAY.
CR ASPENBERG P, 1988, J BONE JOINT SURG BR, V70, P625
   BANG G, 1967, ARCH SURG-CHICAGO, V94, P781
   BANG G, 1973, SCAND J DENT RES, V81, P240
   BANG G, 1973, SCAND J DENT RES, V81, P230
   BLOCK MS, 1985, J ORAL MAXIL SURG, V43, P3, DOI 10.1016/S0278-2391(85)80005-7
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P414, DOI 10.1016/0278-2391(87)90009-7
   BLOCK MS, 1984, J ORAL MAXIL SURG, V42, P793, DOI 10.1016/0278-2391(84)90347-1
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   CHANG CS, 1983, J ORAL MAXIL SURG, V41, P729, DOI 10.1016/0278-2391(83)90190-8
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   DONATH K, 1988, ZAHNLOSE UNTERKIEFER, P177
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   ELDEEB M, 1989, J ORAL MAXIL SURG, V47, P50
   HATCHER JE, 1986, J DENT RES, V65, P347
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HJORTINGHANSEN E, 1970, THESIS U COPENHAGEN, P1
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   JASTY V, 1978, 9TH INT C EL MICR ST
   Kallenberger A, 1978, SSO Schweiz Monatsschr Zahnheilkd, V88, P90
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   KATTHAGEN BD, 1984, ARCH ORTHOP TRAUM SU, V103, P291, DOI 10.1007/BF00432417
   KAWAMURA M, 1987, CLIN ORTHOP RELAT R, V217, P281
   KENT JN, 1983, J ORAL MAXIL SURG, V41, P629, DOI 10.1016/0278-2391(83)90016-2
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLEIN CPAT, 1985, BIOMATERIALS, V6, P189, DOI 10.1016/0142-9612(85)90008-0
   KOEHLER P, 1987, CLIN ORTHOPAEDICS, V218, P247
   KOESTER K, 1976, Langenbecks Archiv fuer Chirurgie, V341, P77
   MEHLISCH DR, 1987, J ORAL MAXIL SURG, V45, P408, DOI 10.1016/0278-2391(87)90008-5
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   MITTELMEIER H, 1983, Z ORTHOP GRENZGEB, V121, P115, DOI 10.1055/s-2008-1051325
   MITTELMEIER H, 1984, ORTHOPAD PRAX, V5, P389
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PINHOLT EM, IN PRESS SCAND J DEN
   PINHOLT EM, 1988, THESIS U MINNESOTA M, P1
   REDDI AH, 1973, P SOC EXP BIOL MED, V143, P634
   ROTHSTEIN SS, 1984, J AM DENT ASSOC, V109, P571, DOI 10.14219/jada.archive.1984.0127
   RUEGER JM, 1984, LANGENBECK ARCH CHIR, P223
   SCHWARZ N, 1987, ARCH ORTHOP TRAUM SU, V106, P113, DOI 10.1007/BF00435424
   URIST MR, 1985, ANN BIOL CLIN-PARIS, V43, P755
   URIST MR, 1971, J ORAL SURG, V29, P88
   URIST MR, 1987, CLIN ORTHOPAEDICS, V214, P295
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   Van de Putte K A, 1965, Clin Orthop Relat Res, V43, P257
   VANDERSTEENHOVEN JJ, 1983, J BIOMED MATER RES, V17, P793, DOI 10.1002/jbm.820170507
   VANJOOS U, 1982, DTSCH ZAHNAERZTL Z, V37, P22
   WEST TL, 1985, J PERIODONTOL, V56, P348, DOI 10.1902/jop.1985.56.6.348
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 52
TC 12
Z9 12
U1 1
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0029-845X
J9 SCAND J DENT RES
PD FEB
PY 1991
VL 99
IS 1
BP 64
EP 74
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EX935
UT WOS:A1991EX93500011
PM 1646480
DA 2018-10-20
ER

PT J
AU GOODMAN, SB
   FORNASIER, VL
   KEI, J
AF GOODMAN, SB
   FORNASIER, VL
   KEI, J
TI QUANTITATIVE COMPARISON OF THE HISTOLOGICAL EFFECTS OF PARTICULATE
   POLYMETHYLMETHACRYLATE VERSUS POLYETHYLENE IN THE RABBIT TIBIA
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
ID SYNOVIAL-LIKE MEMBRANE; BONE-CEMENT INTERFACE; TOTAL HIP-REPLACEMENT;
   WEAR PRODUCTS
AB Fourteen mature female New Zealand White rabbits underwent implantation of Simplex polymethyl-methacrylate (PMMA) powder or particulate (average 67-mu-m) ultrahigh-molecular-weight polyethylene (UHMWPE) through a drill hole in the proximal right tibia.  The left tibia functioned as a prepared but nonimplanted control.  Animals were killed after 16 weeks.  Histological examination of the bone-implant interface in the particulate PMMA group disclosed a florid foreign-body reaction with the presence of giant cells and histiocytes.  The particulate UHMWPE group demonstrated positively bire-fringent UHMWPE fragments, rimmed by foreign-body giant cells and histiocytes, embedded in a loose connective tissue stroma.  UHMWPE interfaces were thicker and contained more histiocytes and fibrocytes; PMMA interfaces contained more marrow cells and lymphocytes.  This study underscores the importance of biomaterial debris in the process of aseptic loosening of cemented joint arthroplasties.
C1 UNIV TORONTO,PRINCESS MARGARET HOSP,DEPT PATHOL,TORONTO M4X 1K9,ONTARIO,CANADA.
RP GOODMAN, SB (reprint author), STANFORD UNIV,CTR MED,DIV ORTHOPAED SURG,300 PASTEUR DR,SUITE R171,STANFORD,CA 94305, USA.
CR AMSTUTZ HC, 1982, CLIN ORTHOP RELAT R, V170, P21
   BELL RS, 1985, J BONE JOINT SURG AM, V67A, P1165, DOI 10.2106/00004623-198567080-00004
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   Goodman S B, 1988, J Arthroplasty, V3 Suppl, pS41, DOI 10.1016/S0883-5403(88)80007-X
   GOODMAN SB, 1988, CLIN ORTHOP RELAT R, V232, P255
   GROTH H E, 1983, Journal of Orthopaedic Research, V1, P129, DOI 10.1002/jor.1100010203
   HARRIS WH, 1982, J BONE JOINT SURG AM, V64, P745, DOI 10.2106/00004623-198264050-00013
   HOY ALS, 1981, CLIN ORTHOPAEDICS, V155, P231
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   KAVANAGH BF, 1985, J BONE JOINT SURG AM, V64, P518
   LINDER L, 1983, CLIN ORTHOP RELAT R, V175, P93
   MAGUIRE JK, 1987, CLIN ORTHOP RELAT R, V216, P213
   MIRRA JM, 1982, CLIN ORTHOP RELAT R, V170, P175
   NUSBAUM HJ, 1979, J APPL POLYM SCI, V23, P777, DOI 10.1002/app.1979.070230313
   PIZZOFERRATO A, 1979, BIOMATER ARTIF CELL, V7, P257, DOI 10.3109/10731197909117580
   REVELL PA, 1978, ARCH ORTHOP TRAUM SU, V91, P167, DOI 10.1007/BF00379748
   ROSE RM, 1979, CLIN ORTHOP RELAT R, V145, P277
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P317, DOI 10.1002/jbm.820120306
   SCHATZKER J, 1987, ARCH ORTHOP TRAUM SU, V106, P94, DOI 10.1007/BF00435421
   STINSON NE, 1964, BR J EXP PATHOL, V46, P135
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
NR 24
TC 13
Z9 13
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0936-8051
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PY 1991
VL 110
IS 3
BP 123
EP 126
DI 10.1007/BF00395792
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA FJ151
UT WOS:A1991FJ15100001
PM 2059533
DA 2018-10-20
ER

PT J
AU BOS, RRM
   ROZEMA, FR
   BOERING, G
   NIJENHUIS, AJ
   PENNINGS, AJ
   VERWEY, AB
   NIEUWENHUIS, P
   JANSEN, HWB
AF BOS, RRM
   ROZEMA, FR
   BOERING, G
   NIJENHUIS, AJ
   PENNINGS, AJ
   VERWEY, AB
   NIEUWENHUIS, P
   JANSEN, HWB
TI DEGRADATION OF AND TISSUE REACTION TO BIODEGRADABLE POLY(L-LACTIDE) FOR
   USE AS INTERNAL-FIXATION OF FRACTURES - A STUDY IN RATS
SO BIOMATERIALS
LA English
DT Article
DE IMPLANTS; BIODEGRADATION; FRACTURE FIXATION
ID POLYLACTIC ACID; RESORBABLE MATERIALS; STAINLESS-STEEL; PLATES; SCREWS;
   POLY(EPSILON-CAPROLACTONE); COPOLYMERS; POLYMERS; INVIVO
AB Samples of high-molecular-weight poly (L-lactide) (PLLA) (MBAR(v) = 9.0 x 10(5)), a biomaterial developed for plates and screws used in internal fixation of jaw fractures, were implanted subcutaneously in the backs of rats to study tissue reaction to PLLA and to follow the degradation process.  The PLLA seemed to follow the degradation pattern typical of biodegradable polyesters.  After pure hydrolysis up to about 104 wk, phagocytic activity of macrophages was found at about 143 wk.  Full resorption of PLLA was not demonstrated in this study.  Except for the early and final parts of the implant period, no acute or chronic inflammatory reaction was observed.  No implant was rejected.  It is estimated that more than 3 yr will be required for total resorption of PLLA.  For bone-healing this long period is of no practical importance.  There is no need for removal of PLLA after fracture healing as is the case with metal fixation devices.  Thus, PLLA has potential application in internal fixation of fractures and osteotomies in the maxillofacial region and other fractures that are not too heavily loaded in the human body.
C1 STATE UNIV GRONINGEN,DEPT POLYMER CHEM,9700 AB GRONINGEN,NETHERLANDS.
   STATE UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,9700 AB GRONINGEN,NETHERLANDS.
RP BOS, RRM (reprint author), UNIV GRONINGEN,DEPT ORAL & MAXILLOFACIAL SURG,POB 72,9700 RB GRONINGEN,NETHERLANDS.
CR AKESON WH, 1975, CALC TISS RES, V19, P27, DOI 10.1007/BF02563988
   ALTMAN NH, 1979, LABORATORY RAT, V1, P334
   ANVER MR, 1979, LABORATORY RAT, V1, P378
   BLACK J, 1988, ORTHOPEDIC BIOMATERI, P292
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOS RRM, 1989, BRIT J ORAL MAX SURG, V27, P467, DOI 10.1016/S0266-4356(89)80004-X
   BRADY JM, 1973, J BIOMED MATER RES, V7, P155, DOI 10.1002/jbm.820070204
   CASTILLO MH, 1988, 41ST T ANN CANC S NE, P114
   CHRISTEL P, 1981, BIOMATERIALS 1980, P271
   CUTRIGHT DE, 1971, J ORAL SURG, V29, P393
   CUTRIGHT DE, 1972, ORAL SURG ORAL MED O, V33, P28, DOI 10.1016/0030-4220(72)90204-6
   CUTRIGHT DE, 1974, ORAL SURG ORAL MED O, V37, P142, DOI 10.1016/0030-4220(74)90171-6
   CUTRIGHT DE, 1971, ORAL SURG ORAL MED O, V31, P134, DOI 10.1016/0030-4220(71)90044-2
   GETTER L, 1972, J ORAL SURG, V30, P344
   Katz JL, 1984, CALCIFIED TISSUE INT, V36, P31
   KOPECEK J, 1983, PROG POLYM SCI, V9, P1
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   PAAVOLAINEN P, 1978, CLIN ORTHOP RELAT R, V136, P287
   PITT CG, 1981, BIOMATERIALS, V2, P215
   SCHER N, 1988, LARYNGOSCOPE, V98, P561
   SIMON BR, 1978, J BIOENG, V2, P543
   TUNC DC, 1985, 31ST P ANN ORTH RES, P165
   Uhthoff H K, 1971, Clin Orthop Relat Res, V81, P165, DOI 10.1097/00003086-197111000-00026
   VERT M, 1981, MAKROMOL CHEM S, V5, P30, DOI DOI 10.1002/MACP.1981.020051981103
   VERT M, 1984, MACROMOLECULAR BIOMA, P119
   WOKALEK H, 1988, CRIT REV BIOCOMPAT, V4, P209
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
NR 31
TC 208
Z9 222
U1 3
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1991
VL 12
IS 1
BP 32
EP 36
DI 10.1016/0142-9612(91)90128-W
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ET716
UT WOS:A1991ET71600006
PM 2009343
DA 2018-10-20
ER

PT B
AU BENGHUZZI, HA
   ENGLAND, BG
   BAJPAI, PK
AF BENGHUZZI, HA
   ENGLAND, BG
   BAJPAI, PK
GP INSTRUMENT SOC AMER
TI TRICALCIUM PHOSPHATE AMINO-ACID CAPSULES AS A DRUG DELIVERY SYSTEM FOR
   STEROID-HORMONES
SO BIOMEDICAL SCIENCES INSTRUMENTATION, VOL 27
SE BIOMEDICAL SCIENCES INSTRUMENTATION
LA English
DT Proceedings Paper
CT 28TH ANNUAL ROCKY MOUNTAIN BIOENGINEERING SYMP / 28TH INTERNATIONAL SYMP
   OF THE INSTRUMENT SOC OF AMERICA : BIOMEDICAL SCIENCES INSTRUMENTATION
CY APR 12-13, 1991
CL MAYO CLIN, ROCHESTER, MN
SP ROCK MT BIOENGN SYMP, INSTRUMENT SOC AMER, DIV BIOMED SCI
HO MAYO CLIN
DE DELIVERY OF CONTRACEPTIVES; BIOMATERIAL; DRUG DELIVERY
NR 0
TC 10
Z9 12
U1 0
U2 1
PU INSTRUMENT SOC AMER
PI RESEARCH TRIANGLE PARK
PA RESEARCH TRIANGLE PARK
BN 1-55617-308-3
J9 BIOMED SCI INSTRUM
PY 1991
VL 27
BP 197
EP 203
PG 7
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT14M
UT WOS:A1991BT14M00026
PM 2065155
DA 2018-10-20
ER

PT J
AU BAQUEY, C
   DUPUY, B
   JANVIER, G
   BORDENAVE, L
   CAIX, J
   BASSECATHALINAT, B
AF BAQUEY, C
   DUPUY, B
   JANVIER, G
   BORDENAVE, L
   CAIX, J
   BASSECATHALINAT, B
TI RATIONALE FOR THE DESIGN OF BIOMATERIALS AND THE EVALUATION OF THEIR
   BIOCOMPATIBILITY
SO BIORHEOLOGY
LA English
DT Article
DE BIOMATERIALS; BIOCOMPATIBILITY; BIOARTIFICIAL PANCREAS; VASCULAR
   SUBSTITUTES
AB The biocompatibility of a material can be considered as the ideally expectable result of its interactions with living tissues with which it is interfaced. This property determines the ability of devices involving this material in their constitution, to correctly assume their ascribed function; reciprocally a bad fitting, between devices and their intended use, coming from a non-optimized design or from an inappropriate prescription, may alter the original biocompatibility of constitutive materials. Accordingly, the actual biocompatibility of a biomaterial depends upon both its intrinsic properties and the application in which it is involved. Such considerations must be taken into account by specialists who try to design more performant biomaterials, or new assist devices, should they be implantable or not; but they draw also methodological guidelines for the evaluation of the biocompatibility of these biomedical products.
RP BAQUEY, C (reprint author), UNIV BORDEAUX 2,INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR BAMFORD CH, 1985, BLOOD COMPATIBLE MAT, P159
   Baquey C., 1981, ITBM, V2, P378
   BORDENAVE L, 1989, BIOMATERIALS, V10, P235, DOI 10.1016/0142-9612(89)90099-9
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   GIN H, IN PRESS J MICROENCA
   JACOBS HA, 1989, J BIOMED MATER RES, V23, P611, DOI 10.1002/jbm.820230606
   KUSSEROW BK, 1973, T AM SOC ART INT ORG, V19, P8
   Lin J Y, 1985, Trans Am Soc Artif Intern Organs, V31, P468
   MCREA JC, 1981, T AM SOC ART INT ORG, V27, P511
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
NR 11
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 1991
VL 28
IS 5
BP 463
EP 472
PG 10
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA GM822
UT WOS:A1991GM82200006
PM 1782396
DA 2018-10-20
ER

PT B
AU KASEMO, B
   LAUSMAA, J
   SAUK, JJ
   NIZNICK, G
   MCVAY, G
   BRUNETTE, DM
AF KASEMO, B
   LAUSMAA, J
   SAUK, JJ
   NIZNICK, G
   MCVAY, G
   BRUNETTE, DM
BE DAVIES, JE
TI THE BIOMATERIAL-TISSUE INTERFACE AND ITS ANALOGS IN SURFACE SCIENCE AND
   TECHNOLOGY
SO BONE-BIOMATERIAL INTERFACE
LA English
DT Proceedings Paper
CT WORKSHOP ON BONE-BIOMATERIAL INTERFACE
CY DEC 03-04, 1990
CL TORONTO, CANADA
SP APATITE INT, BIO RES LABS, BIOMET, BOEHRINGER MANNHEIM, CALCITEK, UNIV TORONTO, CTR BIOMAT, CIBA GEIGY CANADA, CORE VENT, DEPUY, HOWMEDICA
NR 0
TC 61
Z9 62
U1 0
U2 0
PU UNIV TORONTO PRESS
PI TORONTO
PA TORONTO
BN 0-8020-5941-4
PY 1991
BP 19
EP 32
PG 14
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV08Y
UT WOS:A1991BV08Y00002
DA 2018-10-20
ER

PT B
AU GOLDRING, SR
   WANG, JT
   RICCI, JL
   WINDELER, AS
   HENCH, LL
   SODEK, J
   LEMONS, JE
   BOLANDER, M
   KASEMO, B
AF GOLDRING, SR
   WANG, JT
   RICCI, JL
   WINDELER, AS
   HENCH, LL
   SODEK, J
   LEMONS, JE
   BOLANDER, M
   KASEMO, B
BE DAVIES, JE
TI MOLECULAR BIOLOGICAL APPROACHES TO INVESTIGATE CELL BIOMATERIAL
   INTERACTIONS
SO BONE-BIOMATERIAL INTERFACE
LA English
DT Proceedings Paper
CT WORKSHOP ON BONE-BIOMATERIAL INTERFACE
CY DEC 03-04, 1990
CL TORONTO, CANADA
SP APATITE INT, BIO RES LABS, BIOMET, BOEHRINGER MANNHEIM, CALCITEK, UNIV TORONTO, CTR BIOMAT, CIBA GEIGY CANADA, CORE VENT, DEPUY, HOWMEDICA
NR 0
TC 3
Z9 3
U1 0
U2 1
PU UNIV TORONTO PRESS
PI TORONTO
PA TORONTO
BN 0-8020-5941-4
PY 1991
BP 241
EP 249
PG 9
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV08Y
UT WOS:A1991BV08Y00022
DA 2018-10-20
ER

PT B
AU JINGUSHI, S
   BOLANDER, ME
   SODEK, J
   GLOWACKI, J
   CARTER, R
   CAPLAN, A
   BENEDICT
AF JINGUSHI, S
   BOLANDER, ME
   SODEK, J
   GLOWACKI, J
   CARTER, R
   CAPLAN, A
   BENEDICT
BE DAVIES, JE
TI BIOLOGICAL CASCADES OF FRACTURE-HEALING AS MODELS FOR BONE-BIOMATERIAL
   INTERFACIAL REACTIONS
SO BONE-BIOMATERIAL INTERFACE
LA English
DT Proceedings Paper
CT WORKSHOP ON BONE-BIOMATERIAL INTERFACE
CY DEC 03-04, 1990
CL TORONTO, CANADA
SP APATITE INT, BIO RES LABS, BIOMET, BOEHRINGER MANNHEIM, CALCITEK, UNIV TORONTO, CTR BIOMAT, CIBA GEIGY CANADA, CORE VENT, DEPUY, HOWMEDICA
NR 0
TC 7
Z9 7
U1 0
U2 0
PU UNIV TORONTO PRESS
PI TORONTO
PA TORONTO
BN 0-8020-5941-4
PY 1991
BP 250
EP 262
PG 13
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV08Y
UT WOS:A1991BV08Y00023
DA 2018-10-20
ER

PT B
AU BRUNSKI, JB
   SUMNER, R
   HENCH, LL
   LEMONS, JE
   PILLIAR, RM
AF BRUNSKI, JB
   SUMNER, R
   HENCH, LL
   LEMONS, JE
   PILLIAR, RM
BE DAVIES, JE
TI INFLUENCE OF BIOMECHANICAL FACTORS AT THE BONE-BIOMATERIAL INTERFACE
SO BONE-BIOMATERIAL INTERFACE
LA English
DT Proceedings Paper
CT WORKSHOP ON BONE-BIOMATERIAL INTERFACE
CY DEC 03-04, 1990
CL TORONTO, CANADA
SP APATITE INT, BIO RES LABS, BIOMET, BOEHRINGER MANNHEIM, CALCITEK, UNIV TORONTO, CTR BIOMAT, CIBA GEIGY CANADA, CORE VENT, DEPUY, HOWMEDICA
NR 0
TC 60
Z9 60
U1 0
U2 2
PU UNIV TORONTO PRESS
PI TORONTO
PA TORONTO
BN 0-8020-5941-4
PY 1991
BP 391
EP 405
PG 15
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV08Y
UT WOS:A1991BV08Y00036
DA 2018-10-20
ER

PT B
AU LEMONS, JE
   SAUK, JJ
   DAVIES, JE
   KASEMO, B
   BJURSTEN, LM
   CAPLAN, A
   LEGEROS, RZ
AF LEMONS, JE
   SAUK, JJ
   DAVIES, JE
   KASEMO, B
   BJURSTEN, LM
   CAPLAN, A
   LEGEROS, RZ
BE DAVIES, JE
TI BONE-BIOMATERIAL INTERFACES OF RETRIEVED IMPLANTS
SO BONE-BIOMATERIAL INTERFACE
LA English
DT Proceedings Paper
CT WORKSHOP ON BONE-BIOMATERIAL INTERFACE
CY DEC 03-04, 1990
CL TORONTO, CANADA
SP APATITE INT, BIO RES LABS, BIOMET, BOEHRINGER MANNHEIM, CALCITEK, UNIV TORONTO, CTR BIOMAT, CIBA GEIGY CANADA, CORE VENT, DEPUY, HOWMEDICA
NR 0
TC 1
Z9 1
U1 0
U2 0
PU UNIV TORONTO PRESS
PI TORONTO
PA TORONTO
BN 0-8020-5941-4
PY 1991
BP 419
EP 424
PG 6
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV08Y
UT WOS:A1991BV08Y00038
DA 2018-10-20
ER

PT J
AU SCHAKENRAAD, JM
   OOSTERBAAN, JA
   BLAAUW, EH
AF SCHAKENRAAD, JM
   OOSTERBAAN, JA
   BLAAUW, EH
TI PRESERVATION OF THE CELL-BIOMATERIAL INTERFACE AT THE ULTRASTRUCTURAL
   LEVEL
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIALS; CELL-BIOMATERIAL INTERFACE; EMBEDDING; EPON RESIN;
   TRANSMISSION ELECTRON MICROSCOPY; BUTYL-2,3-EPOXYPROPYLETHER;
   IMPREGNATION; TERT-BUTYL GLYCIDYLETHER
ID POLYMER INTERACTIONS; GLYCOL METHACRYLATE; VASCULAR GRAFTS;
   ARTERIAL-WALL; REGENERATION; COMPLIANT; SECTIONS
AB Studying the tissue-biomaterial interface at the ultrastructural level is not without problems. Dissolution of the biomaterial in one of the dehydration or embedding media causes holes and shatter during sectioning or dislodgement of the biomaterial.
   The fine tuning of the hardness of both biomaterial and embedding medium, as well as the introduction of butyl-2,3-epoxypropylether as an intermediate between the dehydration series and the Epon resin, improving the impregnation, will solve many of the problems mentioned.
   With this improved technique good results were obtained with materials ranging from teflon, poly(Lactic acid) and polyurethanes to tissue culture polystyrene. No holes, shatter or dislodgement of the biomaterial was observed.
C1 UNIV GRONINGEN,CTR BIOMED TECHNOL,9713 EZ GRONINGEN,NETHERLANDS.
RP SCHAKENRAAD, JM (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,OOSTERSINGEL 69-1,9713 EZ GRONINGEN,NETHERLANDS.
CR BLAAUW EH, 1987, ACTA MORPHOL NEER SC, V25, P167
   BLAAUW EH, 1989, BIOMATERIALS, V10, P356, DOI 10.1016/0142-9612(89)90079-3
   DEBRUYN WC, 1968, ELECTRON MICROS, V2, P65
   FEDORS RF, 1974, POLYM ENG SCI, V14, P147, DOI 10.1002/pen.760140211
   GERRITS PO, 1983, J MICROSC-OXFORD, V132, P81, DOI 10.1111/j.1365-2818.1983.tb04711.x
   GERRITS PO, 1987, STAIN TECHNOL, V62, P181, DOI 10.3109/10520298709107990
   GERRITS PO, 1990, IN PRESS HISTOCHEM J
   GLAUERT AM, 1974, PRACTICAL METHODS EL, V3, P1
   HULSTAERT CE, 1983, HISTOCHEMISTRY, V78, P71, DOI 10.1007/BF00491113
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   SCHAKENRAAD JM, 1987, BIOMATERIALS, V8, P207, DOI 10.1016/0142-9612(87)90065-2
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAKENRAAD JM, 1989, COLLOID SURFACE, V42, P331
   SIMMERMACHER RKJ, 1990, IN PRESS BIOMATERIAL
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   VANDERLEI B, 1987, J THORAC CARDIOV SUR, V93, P695
   VANDERLEI B, 1985, CELL TISSUE RES, V242, P569, DOI 10.1007/BF00225423
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
NR 20
TC 5
Z9 5
U1 0
U2 2
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 1
BP 35
EP 40
PG 6
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK711
UT WOS:A1991GK71100004
DA 2018-10-20
ER

PT J
AU WASSERMAN, AJ
   KATO, YP
   SILVER, FH
AF WASSERMAN, AJ
   KATO, YP
   SILVER, FH
TI A SIMPLE METHOD FOR ULTRASTRUCTURAL EVALUATION OF FRAGILE COLLAGENOUS
   BIOMATERIALS
SO CELLS AND MATERIALS
LA English
DT Article
DE COLLAGENOUS MATERIALS; COLLAGEN FIBERS; COLLAGEN FIBRILS; BIOMATERIALS;
   FREEZE FRACTURE
ID SCANNING ELECTRON-MICROSCOPY; TENDON; FIBROBLAST; TISSUE; GROWTH;
   FIBERS; CELLS; RAT
AB The ultrastructural characteristics and quality of preservation of collagen fibers was evaluated by cutting dry fibers at room temperature and fracturing frozen dehydrated fibers. The preparations were examined by scanning or transmission electron microscopy.
   The surface of dry collagen fibers cut at room temperature appeared compressed. Observations of the internal substructure were distorted. The open face of the fibers were frequently covered with debris. Conversely, when fibers were frozen and then fractured, dehydrated fibers appeared to have undistorted features and were intact around their edges. No contamination across the face of the fiber was apparent and there was no difference in morphology between the nitrogen and Freon frozen dehydrated collagen fibers. Transmission electron microscopy showed that collagen fibers were composed of a subpopulation of transverse and longitudinal collagen fibrils and fibril bundles embedded in a disorganized amorphous collagen matrix.
   Freeze fracturing or snapping collagenous biomaterials was shown to be an effective method for retaining the substructure of these dry and very fragile materials. There may be other applications of this technique to the field of biomaterial morphology.
C1 UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PATHOL,CTR BIOMAT,PISCATAWAY,NJ 08854.
CR ABRAHAM JL, 1973, LANCET, V1, P1125
   ABRAHAM JL, 1974, SCANNING ELECTRON MI, V2, P251
   ATTENBURROW GE, 1972, I PHYSICS C SERIES, V14, P256
   BULLIVANT S, 1970, SOME BIOL TECHNIQUES, P101
   CHRISTENSEN AK, 1971, J CELL BIOL, V51, P772, DOI 10.1083/jcb.51.3.772
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DOILLON CJ, 1988, SCANNING MICROSCOPY, V2, P985
   DOILLON CJ, 1986, 44TH P ANN M EL MICR, P212
   DUNN GA, 1978, EXP CELL RES, V111, P475, DOI 10.1016/0014-4827(78)90196-9
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GRINNELL F, 1982, METHOD ENZYMOL, V82, P535
   HUMPHREYS WJ, 1974, SCANNING ELECTRON MI, V1, P275
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1988, 25TH P AN ROCK MOUNT, V24, P87
   KATO YP, 1990, 12TH P INT C EL MICR, P856
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   KONERDING MA, 1988, SCANNING MICROSCOPY, V2, P1021
   LAANE MM, 1974, MIKROSKOPIE, V30, P163
   LAANE MM, 1976, PRINCIPLES TECHNIQUE, V5, P36
   MOOR H, 1971, PHILOS T R SOC B, V261, P121
   OLSEN OA, 1974, HEREDITAS, V77, P287
   OSATAKE H, 1985, J ELECTRON MICR TECH, V2, P201, DOI 10.1002/jemt.1060020305
   RICCI JL, 1984, J BIOMED MATER RES, V18, P1073, DOI 10.1002/jbm.820180910
   SCOTT JE, 1980, BIOCHEM J, V187, P887, DOI 10.1042/bj1870887
   THOMASECK JT, 1982, DEV BIOL, V92, P107
   WASSERMAN AJ, 1988, SCANNING MICROSCOPY, V2, P1635
   WASSERMAN AJ, 1989, SCANNING MICROSCOPY, V3, P1183
   WASSERMAN AJ, 1989, 47TH ANN M EL MICR S, P888
   WASSERMAN AJ, 1989, 47TH P ANN M EL MICR, P880
   WEADOCK K, 1984, BIOMAT MED EV ARTIF, V11, P293
   WINBORN WB, 1974, CYTOBIOS, V10, P83
NR 31
TC 4
Z9 4
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 1
BP 41
EP 48
PG 8
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK711
UT WOS:A1991GK71100005
DA 2018-10-20
ER

PT J
AU VARON, S
   HAGG, T
   VAHLSING, HL
   MANTHORPE, M
AF VARON, S
   HAGG, T
   VAHLSING, HL
   MANTHORPE, M
TI PERIPHERAL-NERVE BRIDGES FOR CENTRAL-NERVOUS-SYSTEM REGENERATION
SO CELLS AND MATERIALS
LA English
DT Article
DE BASAL LAMINA; CHOLINERGIC NEURONS; HIPPOCAMPAL FORMATION; NERVE BRIDGE;
   NERVE GROWTH FACTOR; NEUROTROPHIC FACTORS; SCHWANN CELLS; SEPTUM
ID FOREBRAIN CHOLINERGIC NEURONS; NEURITE-PROMOTING FACTORS; GROWTH-FACTOR;
   SILICONE CHAMBER; NGF RECEPTOR; ADULT-RAT; PREVENTS; BRAIN; TRANSECTION;
   EXPRESSION
AB A neuronotrophic hypothesis for the adult central nervous system (CNS) has been increasingly supported by in vivo studies of Nerve Growth Factor (NGF) impacts on adult rat CNS cholinergic neurons. We have extended these investigations to NGF effects on cholinergic axonal regeneration in an adult rat septo-hippocampal model. A fimbria-fornix lesion deprives the dorsal hippocampal formation (HF) of its cholinergic afferents and provides a cavity into which sciatic nerve segments can be implanted to serve as regeneration bridges from septum to HF. Septal cholinergic fibers enter and course through fresh cell-containing nerve bridges to attain a maximal number by the end of one month, but enter and grow further into the HF much more slowly and to a limited depth. The importance of NGF for axonal regeneration in the nerve bridge was shown by the demonstration that an "acellular" nerve preparation deprived of its NGF-producing living cells fails to be invaded by the cholinergic fibers, but regains its competence if pre-incubated in NGF. The importance of NGF for intra-hippocampal regeneration was documented by the much greater cholinergic invasion of the HF induced by local (i.e., intra-hippocampal) NGF infusions. Advances in biomaterial science should provide further progress regarding: i) the continuous intracerebral delivery of NGF or other protein factors, and ii) the availability of surrogate materials as regeneration bridges.
RP VARON, S (reprint author), UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,DEPT BIOL,M-001,LA JOLLA,CA 92093, USA.
CR AEBISCHER P, 1989, J NEUROSCI RES, V23, P282, DOI 10.1002/jnr.490230306
   Aguayo AJ, 1985, SYNAPTIC PLASTICITY, P457
   CAVICCHIOLI L, 1989, EUR J NEUROSCI, V1, P258, DOI 10.1111/j.1460-9568.1989.tb00793.x
   DANIELSEN N, 1988, J NEUROSCI RES, V20, P320, DOI 10.1002/jnr.490200306
   FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0
   GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7
   GUNDERSEN RW, 1985, J NEUROSCI RES, V13, P199, DOI 10.1002/jnr.490130114
   HAGG T, 1990, J NEUROSCI, V10, P3087
   HAGG T, 1989, BRAIN RES, V505, P29, DOI 10.1016/0006-8993(89)90112-1
   HAGG T, 1989, NEUROSCIENCE, V30, P95, DOI 10.1016/0306-4522(89)90356-4
   HAGG T, 1990, EXP NEUROL, V109, P153, DOI 10.1016/0014-4886(90)90069-5
   HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1
   HAGG T, 1990, IN PRESS COMM DEV NE
   HAGG T, 1991, IN PRESS EXP NEUROL
   HEFTI F, 1986, J NEUROSCI, V6, P2155
   HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8
   HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623
   JAEGER CB, 1990, IN PRESS PROGR BRAIN
   KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   MANTHORPE M, 1989, Society for Neuroscience Abstracts, V15, P1258
   MANTHORPE M, 1990, DIFFERENTIATION FUNC, P135
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   MONTERO CN, 1988, J NEUROSCI, V8, P2986
   MUIR D, 1989, NEUROCHEM RES, V14, P1003, DOI 10.1007/BF00965935
   RIZVI A, 1990, IN PRESS 12TH ANN IN
   SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001
   SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664
   VAHLSING HL, 1989, EXP NEUROL, V105, P233, DOI 10.1016/0014-4886(89)90125-8
   VARON S, 1981, DEV BRAIN RES, V1, P73, DOI 10.1016/0165-3806(81)90095-X
   VARON S, 1984, DEV NEUROSCI-BASEL, V6, P73
   Varon S, 1986, PERIPHERAL NERVE REP, V1, P9
   WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7
   WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
NR 36
TC 2
Z9 2
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 1
BP 83
EP 91
PG 9
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK711
UT WOS:A1991GK71100010
DA 2018-10-20
ER

PT J
AU JOHN, T
AF JOHN, T
TI INTERACTIONS OF BACTERIA AND AMEBAS WITH OCULAR BIOMATERIALS
SO CELLS AND MATERIALS
LA English
DT Review
DE BIOMATERIAL; SOFT CONTACT LENS; SUTURE; INTRAOCULAR LENS; BACTERIA;
   ACANTHAMOEBA; ADHERENCE; PSEUDOMONAS-AERUGINOSA;
   STAPHYLOCOCCUS-EPIDERMIDIS; STAPHYLOCOCCUS-AUREUS
ID SOFT CONTACT-LENSES; EXTRACAPSULAR CATARACT-EXTRACTION; ACANTHAMOEBA
   KERATITIS; PROPIONIBACTERIUM-ACNES; ULCERATIVE KERATITIS; DAILY-WEAR;
   ENDOPHTHALMITIS; ADHERENCE; SURGERY; IMPLANTATION
AB The use of biomaterials in periocular and intraocular sites has resulted in some ocular inflammations and infections which can result in vision-threatening ocular disease.  This review addresses bacterial interactions with, and adherence to ocular biomaterials such as soft contact lenses, surgical suture materials, and intraocular lenses. In addition, adherence of Acanthamoeba to soft contact lenses is described, and the role of these lenses in the development of Acanthamoeba keratitis is discussed.
C1 UNIV CHICAGO,PRITZKER SCH MED,DEPT OPHTHALMOL & VISUAL SCI,CORNEA SERV,CHICAGO,IL 60637.
   UNIV CHICAGO,PRITZKER SCH MED,DEPT OPHTHALMOL & VISUAL SCI,RES UNIT,CHICAGO,IL 60637.
CR ASWAD MI, 1990, OPHTHALMOLOGY, V97, P296
   Auran J D, 1987, Cornea, V6, P2, DOI 10.1097/00003226-198706010-00002
   BOHIGIAN GM, 1986, AM J OPHTHALMOL, V101, P332, DOI 10.1016/0002-9394(86)90829-9
   COHEN EJ, 1987, AM J OPHTHALMOL, V103, P615, DOI 10.1016/S0002-9394(14)74320-X
   DESAI D, 1990, Investigative Ophthalmology and Visual Science, V31, P421
   DILLY PN, 1989, J CATARACT REFR SURG, V15, P317, DOI 10.1016/S0886-3350(89)80092-6
   DURAN JA, 1987, ARCH OPHTHALMOL-CHIC, V105, P105
   FONG LP, 1988, OPHTHALMOLOGY, V95, P1269
   GELENDER H, 1982, AM J OPHTHALMOL, V94, P528, DOI 10.1016/0002-9394(82)90249-5
   GRISTINA A G, 1980, Orthopaedic Transactions, V4, P355
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   HOLDEN BA, 1985, INVEST OPHTH VIS SCI, V26, P1489
   JAFFE GJ, 1986, OPHTHALMIC SURG LAS, V17, P791
   JOHN T, 1988, Investigative Ophthalmology and Visual Science, V29, P278
   JOHN T, 1991, REV INFECT DIS, V13, pS440
   JOHN T, 1991, REV INFECT DIS, V13, pS419
   JOHN T, 1989, AM J OPHTHALMOL, V108, P658, DOI 10.1016/0002-9394(89)90857-X
   JOHN T, 1991, CLAO Journal, V17, P109
   JOHN T, 1989, CORNEA, V8, P21
   JOHN T, 1990, Investigative Ophthalmology and Visual Science, V31, P559
   JOHN T, 1991, INVEST OPHTH VIS SCI, V32, P728
   JOHN T, 1988, YB OPHTHALMOLOGY, P49
   JOHNS KJ, 1988, OPHTHALMOLOGY, V95, P635
   JOHNSON ML, 1990, MIDWEST QUART, V31, P484
   KEATES RH, 1978, OPHTHALMOLOGY, V85, P408
   KOCH J M, 1989, Investigative Ophthalmology and Visual Science, V30, P42
   LIN J, 1990, Investigative Ophthalmology and Visual Science, V31, P419
   LINDQUIST TD, 1988, ARCH OPHTHALMOL-CHIC, V106, P73
   MATHERS W, 1987, AM J OPHTHALMOL, V103, P626, DOI 10.1016/S0002-9394(14)74321-1
   MATUURA H, 1971, JPN J OPHTHALMOL, V15, P116
   MEISLER DM, 1986, AM J OPHTHALMOL, V102, P733, DOI 10.1016/0002-9394(86)90401-0
   MELTZER DW, 1980, ARCH OPHTHALMOL-CHIC, V98, P100
   MOORE MB, 1985, AM J OPHTHALMOL, V100, P396, DOI 10.1016/0002-9394(85)90500-8
   PERKINS RE, 1975, J CLIN MICROBIOL, V1, P147
   POGGIO EC, 1989, NEW ENGL J MED, V321, P779, DOI 10.1056/NEJM198909213211202
   ROUSSEL TJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P1199
   SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201
   SEYMOUR RG, 1989, CAN J OPHTHALMOL, V24, P152
   SHANZLIN DJ, 1980, BR J OPHTHALMOL, V64, P684
   SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110
   STEHRGREEN JK, 1989, AM J OPHTHALMOL, V107, P331, DOI 10.1016/0002-9394(89)90654-5
   Stern GA, 1986, CORNEA, V5, P41
   TUBERVILLE AW, 1981, CURR EYE RES, V1, P479, DOI 10.3109/02713688109019989
   VAFIDIS GC, 1984, BRIT J OPHTHALMOL, V68, P520, DOI 10.1136/bjo.68.8.520
   WILHELMUS KR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1309
NR 45
TC 5
Z9 6
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 2
BP 129
EP 139
PG 11
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK712
UT WOS:A1991GK71200004
DA 2018-10-20
ER

PT J
AU SAUTIER, JM
   NEFUSSI, JR
   FOREST, N
AF SAUTIER, JM
   NEFUSSI, JR
   FOREST, N
TI ULTRASTRUCTURAL-STUDY OF BONE-FORMATION ON SYNTHETIC HYDROXYAPATITE IN
   OSTEOBLAST CULTURES
SO CELLS AND MATERIALS
LA English
DT Article
DE INVITRO; HYDROXYAPATITE; OSTEOBLAST; BONE TISSUE; INTERFACE;
   ULTRASTRUCTURE
ID ELECTRON-MICROSCOPY; HYDROXYLAPATITE INTERFACE; PERIODONTAL DEFECTS;
   ENAMEL CRYSTALS; TISSUE; INVITRO; INVIVO; MINERALIZATION; DISSOLUTION;
   IMPLANTS
AB Collagenase isolated rat calvaria cells forming a mineralized matrix in vitro were cultured in the presence of synthetic hydroxyapatite. Interactions between bone cells and hydroxyapatite biomaterial were followed by transmission electron microscopy. The appearance of a granular, collagen free, electron-dense layer at the periphery of the material was noted initially. Progressively, an amorphous, granular material formed and extended between the hydroxyapatite aggregates. Osteoblastic cells then synthesized an osteoid matrix which mineralized on the first formed granular collagen free layer, following a classical pattern of calcification. Demineralization of ultrathin sections confirmed the presence of this interface between the material and bone tissue formed in vitro.
C1 UNIV PARIS 07,BIOL ODONTOL LAB,F-75221 PARIS 05,FRANCE.
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   AOBA T, 1987, CALCIFIED TISSUE INT, V41, P281, DOI 10.1007/BF02555230
   BEERTSEN W, 1991, J DENT RES, V70, P176, DOI 10.1177/00220345910700030401
   BONUCCI E, 1987, SCANNING MICROSCOPY, V1, P1089
   BOSKEY AL, 1989, BONE MINER, V6, P111, DOI 10.1016/0169-6009(89)90044-5
   BOYAN BD, 1989, ANAT REC, V224, P211, DOI 10.1002/ar.1092240210
   CHARDIN H, 1990, J HISTOCHEM CYTOCHEM, V38, P885, DOI 10.1177/38.6.2110588
   COLLIN P, 1991, IN PRESS CALCIF TISS, V649
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DAVIES JE, 1991, CELL MATER, V1, P3
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P99
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   FRANK RM, 1987, J BIOL BUCCALE, V15, P125
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   HENCH L L, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P117
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1978, 4TH T ANN M SOC BIOM, P112
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   JONGEBLOED WL, 1975, CALC TISS RES, V19, P109, DOI 10.1007/BF02563996
   KENNEY EB, 1985, J PERIODONTOL, V56, P82, DOI 10.1902/jop.1985.56.2.82
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEVIN MP, 1974, ORAL SURG ORAL MED O, V38, P344, DOI 10.1016/0030-4220(74)90359-4
   LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763
   LOWENBERG B, 1991, CELL MATER, V1, P177
   MELCHER AH, 1986, J PERIODONTAL RES, V21, P592, DOI 10.1111/j.1600-0765.1986.tb01497.x
   MENANTEAU J, 1987, BONE MINER, V3, P137
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   NEFUSSI JR, 1989, CALCIFIED TISSUE INT, V44, P11, DOI 10.1007/BF02556235
   NEFUSSI JR, 1989, BONE, V10, P345, DOI 10.1016/8756-3282(89)90131-2
   NEFUSSI JR, 1991, JIN PRESS CALCIF TIS, V50
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PATKA P, 1989, 15TH T ANN M SOC BIO, P103
   SAUTIER JM, 1990, IN VITRO CELL DEV B, V26, P1079
   TOHDA H, 1987, J DENT RES, V66, P1647, DOI 10.1177/00220345870660110901
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   TROMBE JC, 1972, THESIS U TOULOUSE FR
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VOEGEL JC, 1974, J BIOL BUCCALE, V2, P39
   VOEGEL JC, 1977, CALC TISS RES, V24, P19, DOI 10.1007/BF02223292
NR 45
TC 49
Z9 49
U1 0
U2 3
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 3
BP 209
EP 217
PG 9
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK713
UT WOS:A1991GK71300003
DA 2018-10-20
ER

PT J
AU MARTINEZMARTINEZ, L
   PASCUAL, A
   PEREA, EJ
AF MARTINEZMARTINEZ, L
   PASCUAL, A
   PEREA, EJ
TI EFFECT OF PREINCUBATION OF PSEUDOMONAS-AERUGINOSA IN SUBINHIBITORY
   CONCENTRATIONS OF AMIKACIN, CEFTAZIDIME AND CIPROFLOXACIN ON ADHERENCE
   TO PLASTIC CATHETERS
SO CHEMOTHERAPY
LA English
DT Article
DE POLYVINYL CHLORIDE; POLYURETHANE; SILICONIZED LATEX;
   PSEUDOMONAS-AERUGINOSA; ANTIMICROBIALS
AB The effect of preincubation of Pseudomonas aeruginosa in subinhibitory concentrations (1/4x minimum inhibitory concentration) of amikacin, ceftazidime and ciprofloxacin on the expression of surface hydrophobicity and adherence to polyvinyl chloride, siliconized latex and polyurethane was evaluated.  None of the antimicrobials significantly altered the expression of surface hydrophobicity.  Subinhibitory concentrations of amikacin did not significantly reduce the adherence of P. aeruginosa to any of these 3 biomaterials.  A significant inhibition of the adherence to polyvinyl chloride and siliconized latex but not to polyurethane was induced by both ceftazidime (p < 0.05 to p < 0.01 in different times) and ciprofloxacin (p < 0.01).  The effect of ceftazidime was present only for the first 4 h of bacteria-biomaterial interaction, whereas that of ciprofloxacin persisted throughout the study period (72 h).
RP MARTINEZMARTINEZ, L (reprint author), UNIV SEVILLA,SCH MED,DEPT MICROBIOL,APDO 914,E-41080 SEVILLE,SPAIN.
RI Martinez Martinez, Luis/U-1801-2017
OI Martinez Martinez, Luis/0000-0002-6091-4045; Pascual Hernandez,
   Alvaro/0000-0002-8672-5891
CR ANASTASSIOU ED, 1987, J CLIN MICROBIOL, V25, P656
   COSTERTON JW, 1979, PSEUDOMONAS AERUGINO, P15
   DUNE WM, 1985, APPL ENVIRON MICROB, V50, P562
   GEERS TA, 1987, J ANTIMICROB CHEMOTH, V19, P569, DOI 10.1093/jac/19.5.569
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   SUAREZ AI, 1988, ENFERM INFECC MICROB, V6, P187
   VIRSHWANATH S, 1987, J ANTIMICROB CHEMOTH, V19, P579
   1985, NCCLS M7A NAT COMM C
NR 8
TC 3
Z9 3
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0009-3157
J9 CHEMOTHERAPY
JI Chemotherapy
PD JAN-FEB
PY 1991
VL 37
IS 1
BP 62
EP 65
DI 10.1159/000238834
PG 4
WC Oncology; Pharmacology & Pharmacy
SC Oncology; Pharmacology & Pharmacy
GA EZ271
UT WOS:A1991EZ27100010
PM 1901544
DA 2018-10-20
ER

PT B
AU STEMBERGER, A
   UNKAUF, M
   ARNOLD, DE
   BLUMEL, G
AF STEMBERGER, A
   UNKAUF, M
   ARNOLD, DE
   BLUMEL, G
BE GEBELEIN, CG
   CHENG, TC
   YANG, VC
TI DRUG CARRIER SYSTEMS BASED ON RESORBABLE POLYESTER COLLAGEN AND OR
   BIOMATERIAL COMBINATIONS
SO COSMETIC AND PHARMACEUTICAL APPLICATIONS OF POLYMERS
LA English
DT Proceedings Paper
CT SYMP ON POLYMERS FOR COSMETIC AND PHARMACEUTICAL APPLICATIONS
CY AUG 26-31, 1990
CL WASHINGTON, DC
SP AMER CHEM SOC, BIOMATRIX, DOW CHEM, FELTON WORLDWIDE, GOLDSCHMIDT CHEM, B F GOODRICH, JOHNSON & JOHNSON, PFIZER, UNION CARBIDE, VAN DYKE & CO
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA NEW YORK
BN 0-306-44088-1
PY 1991
BP 263
EP 268
PG 6
WC Pharmacology & Pharmacy; Polymer Science
SC Pharmacology & Pharmacy; Polymer Science
GA BV11K
UT WOS:A1991BV11K00027
DA 2018-10-20
ER

PT J
AU KALICHARAN, D
   JONGEBLOED, WL
   VANDERVEEN, G
   LOS, LI
   WORST, JGF
AF KALICHARAN, D
   JONGEBLOED, WL
   VANDERVEEN, G
   LOS, LI
   WORST, JGF
TI CELL-INGROWTH IN A SILICONE PLOMBE - INTERACTIONS BETWEEN BIOMATERIAL
   AND SCLERAL TISSUE AFTER 8 YEARS INSITU - A SEM AND TEM INVESTIGATION
SO DOCUMENTA OPHTHALMOLOGICA
LA English
DT Article; Proceedings Paper
CT 185TH MEETING OF THE NETHERLANDS OPHTHALMOLOGICAL SOC
CY MAR 20-22, 1991
CL MAASTRICHT, NETHERLANDS
SP NETHERLANDS OPHTHALMOL SOC
DE SEM-TEM; BIODEGRADATION; SILICONE PLOMBE; CELL INGROWTH; SCLERA
ID DEGRADATION; INTERFACE; SURFACE
AB A male patient (42 years) who had been treated for retinal detachment by the implantation of a silicone plombe into the sclera, returned to the clinic 8 years after implantation because of inflammation of the tissue and partial protrusion from the sclera. After removal of the plombe this was processed for TEM and SEM and examination of the plombe material after 8 years in situ could be carried out in order to get information about the cell-biomaterial interface. A large proportion of the silicone pores was filled with cellular material, including macrophages, giant cells and erythrocytes thus indicating a foreign body granuloma. The external surface of the pores showed a granular osmiophilic dense amorphous layer including extracellular debris. Engulfing of silicone particles by macrophages and the evidence of long-term tissue response suggest partial biodegradation of the silicone and certainly not complete inertness as was formerly claimed.
C1 ACAD HOSP GRONINGEN,HAREN EYE CLIN,GRONINGEN,NETHERLANDS.
RP KALICHARAN, D (reprint author), UNIV GRONINGEN,HISTOL & CELL BIOL LAB,OOSTERSINGEL 69-1,9713 EZ GRONINGEN,NETHERLANDS.
CR BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BOTTEMA JR, 1980, T AM SOC ART INT ORG, V26, P412
   CUPERUS PL, 1989, DOC OPHTHALMOL, V71, P29, DOI 10.1007/BF00155130
   Hall C W, 1968, Ann N Y Acad Sci, V146, P314, DOI 10.1111/j.1749-6632.1968.tb20290.x
   HIRSCH BC, 1984, INT J DERMATOL, V33, P90
   JONGEBLOED WL, 1986, DOC OPHTHALMOL, V64, P143, DOI 10.1007/BF00166695
   JONKMAN MF, 1988, SURGERY, V104, P532
   MALICK LE, 1975, SCANN ELECTR MICROSC, V3, P259
   MATLAGA BF, 1983, J BIOMED MATER RES, V17, P185, DOI 10.1002/jbm.820170115
   MURAKAMI T, 1974, Archivum Histologicum Japonicum, V36, P189
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROZEMA FR, 1991, THESIS U GRONINGEN
   SAUVAGE LR, 1971, SURGERY, V70, P940
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   STEWART GJ, 1977, ANN NY ACAD SCI, V283, P179, DOI 10.1111/j.1749-6632.1977.tb41765.x
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, P1
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
NR 17
TC 5
Z9 5
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0012-4486
J9 DOC OPHTHALMOL
JI Doc. Ophthalmol.
PY 1991
VL 78
IS 3-4
BP 307
EP 315
DI 10.1007/BF00165694
PG 9
WC Ophthalmology
SC Ophthalmology
GA GZ251
UT WOS:A1991GZ25100022
PM 1790754
DA 2018-10-20
ER

PT J
AU FABRIZIUSHOMAN, DJ
   COOPER, SL
AF FABRIZIUSHOMAN, DJ
   COOPER, SL
TI A COMPARISON OF THE ADSORPTION OF 3 ADHESIVE PROTEINS TO BIOMATERIAL
   SURFACES
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT 75TH BIRTHDAY SYMP OF LEO VROMAN
CY APR   27, 1990
CL GOUDA, NETHERLANDS
SP NEDERLANDSE HARTSTICHTING, HOSPAL C O T, GAMBO DIALYSATOREN, NATL MED CARE, BAXTER HEALTHCARE, SANTA ANA, ELI LILLY, D S M HEERLEN
DE PROTEIN ADSORPTION; ADHESIVE PROTEINS; VROMAN EFFECT; VITRONECTIN;
   FIBRINOGEN; FIBRONECTIN
ID SERUM FIBRONECTIN ADSORPTION; POLYMERIC BIOMATERIALS; COMPETITIVE
   ADSORPTION; FIBRINOGEN ADSORPTION; ARTIFICIAL SURFACES; CELL-ADHESION;
   NARROW SPACES; HUMAN-PLASMA; S-PROTEIN; BLOOD
AB The adsorption of three cell adhesive proteins with known thrombogenic activity [fibrinogen (FGN), fibronectin (FN), and vitronectin (VN)] was quantified from mono-component protein solutions, from a quaternary-component protein solution, and from plasma and diluted plasma in order to compare their potential for adsorption to polymeric substrates from solutions of varying complexity. The surfaces studied included polyethylene (PE), silicone rubber (SR), Teflon-FEP (FEP), and two polyetherurethanes: one with a poly(tetramethylene oxide) soft segment (PTMO-PU) and one with a poly(ethylene oxide) soft segment (PEO-PU). The adsorption of these proteins from single-component solutions followed the Freundlich isotherm and the adhesive proteins showed similar trends in Freundlich parameters for surfaces of similar surface wettability. Adsorption from a quaternary-component solution composed of physiological molar ratios of the three proteins and human serum albumin (HSA) revealed a significant enrichment of adsorbed vitronectin as determined from ratios of the adsorbed surface fraction of each protein to its respective bulk fraction. The other proteins' adsorption was enriched to a lesser extent in the decreasing order of FGN > FN > HSA for all surfaces. The relative enrichment of VN from plasma was also high as compared with its bulk concentration, whereas the enrichment of FGN, FN, and HSA was much lower and of approximately the same magnitude. Compared with the three other proteins, VN showed a resistance to displacement from the polymer substrates as either the plasma concentration was increased or the length of contact with plasma and diluted plasma was increased.
C1 UNIV WISCONSIN,DEPT CHEM ENGN,1415 W JOHNSON DR,MADISON,WI 53706.
FU NHLBI NIH HHS [HL-21001, HL-24046]
CR ADAMS AL, 1984, J BIOMED MATER RES, V18, P643, DOI 10.1002/jbm.820180606
   ADAMSON AW, 1976, PHYSICAL CHEM SURFAC
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158
   BALE MD, 1989, BLOOD, V74, P2698
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRASH JL, 1988, MAKROMOL CHEM-M SYMP, V17, P441, DOI 10.1002/masy.19880170133
   BRASH JL, 1985, T SOC BIOMATERIALS, V8, P105
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
   COLLINS WE, 1987, ANN NY ACAD SCI, V516, P292
   DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036
   DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2
   FABRIZIUSHOMAN DJ, 1990, THESIS U WISCONSIN M
   FABRIZIUSHOMAN DJ, UNPUB J BIOMED MATER
   FABRIZIUSHOMAN DJ, UNPUB
   GIMBRONE MA, 1987, ANN NY ACAD SCI, V516, P5
   GRAINGER DW, 1989, J COLLOID INTERF SCI, V132, P161, DOI 10.1016/0021-9797(89)90226-9
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   GRASEL TG, 1987, BIOMATERIALS, V8, P329, DOI 10.1016/0142-9612(87)90002-0
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1983, J CELL PHYSIOL, V116, P289, DOI 10.1002/jcp.1041160305
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   HORBETT TA, 1975, ADV CHEM SER, V145, P230
   HUGHES RC, 1979, EXP CELL RES, V121, P307, DOI 10.1016/0014-4827(79)90009-0
   IHLENFELD JV, 1978, T AM SOC ART INT ORG, V24, P727
   JAKOBSEN E, 1973, Thrombosis Research, V3, P145, DOI 10.1016/0049-3848(73)90065-0
   KEMKESMATTHES B, 1987, EUR J HAEMATOL, V39, P161
   LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6
   LEE RG, 1974, THROMB RES, V4, P485, DOI 10.1016/0049-3848(74)90083-8
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LINDON JN, 1986, BLOOD, V68, P355
   NAGOAKA S, 1983, POLYM PREPRINTS, V24, P67
   PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057
   PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006
   REGOECZI E, 1967, THROMB DIATH HAEMOST, V18, P276, DOI 10.1055/s-0038-1655036
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SANTERRE JP, 1989, T SOC BIOMAT, V12, P113
   Saunders J.H., 1962, POLYURETHANES CHEM T
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223
   TAKAHARA A, IN PRESS BIOMATERIAL
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Vroman L., 1982, ADV CHEM SER, V199, P265
   WEISS HJ, 1987, ANN NY ACAD SCI, V516, P380
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
   Young BR, 1982, ADV CHEM SER, V199, P317
NR 53
TC 68
Z9 68
U1 0
U2 26
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1991
VL 3
IS 1
BP 27
EP 47
DI 10.1163/156856292X00060
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA GL568
UT WOS:A1991GL56800005
PM 1723894
DA 2018-10-20
ER

PT J
AU LEONARD, EF
   VROMAN, L
AF LEONARD, EF
   VROMAN, L
TI IS THE VROMAN EFFECT OF IMPORTANCE IN THE INTERACTION OF BLOOD WITH
   ARTIFICIAL MATERIALS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT 75TH BIRTHDAY SYMP OF LEO VROMAN
CY APR   27, 1990
CL GOUDA, NETHERLANDS
SP NEDERLANDSE HARTSTICHTING, HOSPAL C O T, GAMBO DIALYSATOREN, NATL MED CARE, BAXTER HEALTHCARE, SANTA ANA, ELI LILLY, D S M HEERLEN
DE ADSORPTION; PROTEIN; TRANSPORT; FLOW; BLOOD; BIOMATERIAL
ID SOLID-SURFACES; MASS-TRANSFER; FIBRINOGEN; PLASMA; FLOW; ADSORPTION;
   GLASS; EXPLANATION
AB The successive displacement of plasma proteins adsorbed to artificial surfaces (biomaterials) is well documented, mostly by specially designed experiments that stretch out the effect in time and space. Analysis of displacement has been focused principally on molecular events on the adsorbing surface. In this paper attention is directed rather to the antecedent transport phenomena necessary to deliver successive proteins to a surface. The different limitations on protein arrival fixed by the total quantity present and by the rates of transport of super-sufficient quantities are distinguished. The transport perspective is then used to ask, and partly answer, the question:  Can protein displacement be responsible for patterns of thrombus formation and cellular adhesion that are seen on the blood-wetted surfaces of devices found in medical practice:  artificial organs and vascular prostheses? Calculations and a small amount of preliminary data suggest that such patterns may form when blood is introduced into these devices, particularly in the neighborhood of boundary shapes that cause separated flows.
RP LEONARD, EF (reprint author), COLUMBIA UNIV,ARTIFICIAL ORGANS RES LAB,NEW YORK,NY 10027, USA.
CR AUNG W, 1985, INT J HEAT MASS TRAN, V28, P1757
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   CHANG HN, 1987, INT J HEAT MASS TRAN, V30, P2137
   COLMAN RW, 1987, ANN NY ACAD SCI, V586, P253
   CUYPERS PA, 1987, ANN NY ACAD SCI, V516, P244
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   STANFORD MF, 1983, ANN NY ACAD SCI, V416, P504, DOI 10.1111/j.1749-6632.1983.tb35208.x
   THUM TF, 1986, CHEM ENG COMMUN, V47, P93, DOI 10.1080/00986448608911755
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   VROMAN L, 1964, THROMB DIATH HAEMOST, V10, P455, DOI 10.1055/s-0038-1654798
   VROMAN L, 1980, BLOOD, V55, P156
   VROMAN L, 1985, HAEMOSTASIS, V15, P300
   Vroman L., 1982, ADV CHEM SER, V199, P265
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
NR 15
TC 54
Z9 55
U1 0
U2 17
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1991
VL 3
IS 1
BP 95
EP 107
DI 10.1163/156856292X00105
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA GL568
UT WOS:A1991GL56800009
PM 1786247
DA 2018-10-20
ER

PT J
AU BERTOLUZZA, A
   SIMONI, R
   TINTI, A
   MOROCUTTI, M
   OTTANI, V
   RUGGERI, A
AF BERTOLUZZA, A
   SIMONI, R
   TINTI, A
   MOROCUTTI, M
   OTTANI, V
   RUGGERI, A
TI CALCIUM-PHOSPHATE MATERIALS CONTAINING ALUMINA - RAMAN SPECTROSCOPICAL,
   HISTOLOGICAL, AND ULTRASTRUCTURAL-STUDY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID GLASS-CERAMICS; IMPLANT MATERIALS; BONE TISSUE; INTERFACE; BEHAVIOR;
   HYDROXYAPATITE; APATITES; BIOGLASS; FEMUR
AB Variable alumina quantities were added to two types of calcium phosphate materials-hydroxyapatite ceramics with Ca/P = 1.67 and calcium metaphosphate glass with Ca/P = 1-in order to increase their mechanical properties.  Raman spectroscopy shows that alumina interacts with the phosphate group of these materials, while thermomechanical analysis shows that their elastic modulus has a value similar to that of bone.  Histological sections demonstrate that the surface in close contact with ceramic materials shows a good integration between bone and biomaterial.  All ceramic specimens are penetrated by well-stained, presumably glycoprotein, matrix, that consistently forms a thin network in close contact with the implant.  After 6 weeks bone growing on both ceramic and glass shows signs of maturation with a lamellar structure and an apparently normal mineralization.  In the case of the glass, inside this newly formed bone, were often observed two layers, the internal one showing a well defined lamellar structure.
C1 DIPARTIMENTO CHIM G CIAMICIAN,I-40126 BOLOGNA,ITALY.
RP BERTOLUZZA, A (reprint author), CTR STUDI INTERFAC SPETTROSCOPIA RAMAN,DIPARTIMENTO BIOCHIM,SEZ CHIM & PROPEDEUT BIOCHIM,I-40126 BOLOGNA,ITALY.
OI TINTI, ANNA/0000-0001-8452-815X
CR BERGER G, 1984, PHYS STATUS SOLIDI A, pK9
   BERTOLUZZA A, 1983, J RAMAN SPECTROSC, V14, P178, DOI 10.1002/jrs.1250140309
   BERTOLUZZA A, 1987, BIOMATERIALS CLIN AP, P511
   BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   BLENKE BA, 1973, LANGENBECHS ARCH SF, P107
   BLUMENTHAL NC, 1988, J BIOMED MATER RES, V22, P1033, DOI 10.1002/jbm.820221107
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DACULSI G, 1986, BIOL BIOMECHANICAL P, P337
   De Groot K, 1981, BIOCOMPATIBILITY CLI, V1, P199
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   DUCHEYNE P, 1985, J BIOMED MATER RES, V19, P273, DOI 10.1002/jbm.820190309
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   EGAN EP, 1956, J AM CHEM SOC, V78, P4245, DOI 10.1021/ja01598a015
   FUKUI H, 1977, J DENT RES, V56, P1260, DOI 10.1177/00220345770560102801
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   HAN F, 1984, J W SOC PERIODONT PE, V32, P88
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1982, BIOCOMPATIBILITY ORT, V2, P129
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KIHARA S, 1984, J AM CERAM SOC, V67, pC100
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KONDO K, 1984, J AM CERAM SOC, V67, pC222, DOI 10.1111/j.1151-2916.1984.tb19487.x
   KRAJEWSKI A, 1988, J BIOMED MATER RES, V22, P445, DOI 10.1002/jbm.820220602
   KRAJEWSKI A, 1984, BIOMATERIALS, V5, P105, DOI 10.1016/0142-9612(84)90010-3
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NELSON DGA, 1982, AUST J CHEM, V35, P715, DOI 10.1071/CH9820715
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   OSHEA DC, 1974, ARCH ORAL BIOL, V19, P995, DOI 10.1016/0003-9969(74)90086-7
   Peelen J. G. J., 1978, Ceramurgia International, V4, P71, DOI 10.1016/0390-5519(78)90122-9
   Pernot F., 1983, Ceramics International, V9, P127, DOI 10.1016/0272-8842(83)90013-5
   PERNOT F, 1985, B SOC CHIM FR, V4, P519
   PORTO SPS, 1967, J CHEM PHYS, V47, P1009, DOI 10.1063/1.1711980
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   YUAN TC, 1982, J NON-CRYST SOLIDS, V52, P487, DOI 10.1016/0022-3093(82)90324-6
   ZHU PN, 1982, J NON-CRYST SOLIDS, V52, P503, DOI 10.1016/0022-3093(82)90326-X
NR 41
TC 14
Z9 15
U1 1
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1991
VL 25
IS 1
BP 23
EP 38
DI 10.1002/jbm.820250103
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EP136
UT WOS:A1991EP13600002
PM 2019610
DA 2018-10-20
ER

PT J
AU GOLOMB, G
   EZRA, V
AF GOLOMB, G
   EZRA, V
TI PREVENTION OF BIOPROSTHETIC HEART-VALVE TISSUE CALCIFICATION BY CHARGE
   MODIFICATION - EFFECTS OF PROTAMINE BINDING BY FORMALDEHYDE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID GLUTARALDEHYDE; BIOMATERIAL; MECHANISMS; DEPOSITION
AB Calcification is the principal cause of the clinical failure of bioprosthetic heart valves (BHV).  Calcification occurs through an interaction of host and implant factors, mainly younger age and glutaraldehyde pretreatment, respectively.  The hypothesis of this work was that an impaired balance between positively and negatively charged amino acids, due to the reaction with Lys and Hyl tissue-collagen residues, expose affinity sites to Ca++.  We further hypothesized that regardless of the cause(s) of BHV calcification, positive charge modification of the tissues will prevent their propensity to calcify.  Modification of BHV tissue was obtained by covalently binding protamine sulfate, a polybasic peptide, via formaldehyde and subsequent glutaraldehyde tissue crosslinking.  Protamine-bound tissue exhibited stability properties (shrinkage temperature and resistance to collagenase digestion) similar to BHV tissue.  Protamine-treated tissue was less permeable to Ca++, and reduced staining was observed with positively charged dyes, indicating the presence of positively charged functional groups in the modified tissue.  Significant prevention of calcification was exhibited by the p-bound tissue in comparison to BHV tissue, 30.9 and 109 mu-g/mg calcium, respectively, after 30 days of subdermal implants in rats.  The modification procedure resulted in stable, covalent links of approximately 10% w/w protamine with undiminished anticalcification properties, even after 1 year storage.  The results support our hypotheses, and orthotopical heart valve replacements are required in order to completely evaluate the treatment efficacy and biocompatibility.
RP GOLOMB, G (reprint author), HEBREW UNIV JERUSALEM,SCH PHARM,POB 12065,IL-91120 JERUSALEM,ISRAEL.
OI Golomb, Gershon/0000-0002-7369-9831
CR ANDERSON J, 1967, BRIT J CANCER, V21, P48, DOI 10.1038/bjc.1967.7
   ANDO T, 1973, PROTAMINES ISOALTION, P12
   BARNHART GR, 1982, J THORAC CARDIOV SUR, V83, P618
   CLARK RE, 1988, T AM SOC ART INT ORG, V34, P1021
   DECK JD, 1982, CARDIAC BIOPROSTHESE, P293
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FRAENKELCONRAT H, 1948, J AM CHEM SOC, V70, P2673, DOI 10.1021/ja01188a018
   FRAENKELCONRAT H, 1948, J BIOL CHEM, V174, P827
   FRAENKELCONRAT H, 1946, J AM CHEM SOC, V68, P34, DOI 10.1021/ja01205a011
   GALVILANES JG, 1984, CONNECT TISSUE RES, V13, P34
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   GOLOMB G, 1989, T SOC BIOMAT, V12, P118
   GOLOMB G, 1987, T SOC BIOMAT, V10, P179
   HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005
   HOUGIE C, 1958, P SOC EXP BIOL MED, V98, P130
   LEVY RJ, 1983, ANN THORAC SURG, V36, P187, DOI 10.1016/S0003-4975(10)60454-7
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   MARTINDALE, 1989, EXTRA PHARMACOPOEIA, P29
   MIYATA T, 1986, ASAIO ABST, V15, P19
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PETERS K, 1977, ANNU REV BIOCHEM, V46, P523, DOI 10.1146/annurev.bi.46.070177.002515
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P1061, DOI 10.1161/01.CIR.76.5.1061
   SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6
   TSAO JW, 1987, T SOC BIOMATER, V10, P180
   WOODROOF EA, 1978, J BIOENG, V2, P1
NR 30
TC 47
Z9 49
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1991
VL 25
IS 1
BP 85
EP 98
DI 10.1002/jbm.820250107
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EP136
UT WOS:A1991EP13600006
PM 1902234
DA 2018-10-20
ER

PT J
AU CARBALLO, J
   FERREIROS, CM
   CRIADO, MT
AF CARBALLO, J
   FERREIROS, CM
   CRIADO, MT
TI IMPORTANCE OF EXPERIMENTAL-DESIGN IN THE EVALUATION OF THE INFLUENCE OF
   PROTEINS IN BACTERIAL ADHERENCE TO POLYMERS
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; TRANSIENT ADSORPTION; FIBRINOGEN;
   SURFACES; ATTACHMENT; PLASMA; HYDROPHOBICITY; EPIDERMIDIS; FIBRONECTIN;
   CATHETERS
AB The use of intravascular catheters is frequently associated with coagulase-negative staphylococcal infections.  Colonization of catheters depends on the ability of bacteria to attach to artificial surfaces, this process is affected by macromolecules present in the body fluids.  We determined the adherence of five coagulase-negative strains onto polyethylene, nylon and polyvinyl-chloride catheters, after treatment of bacteria, catheters or both with citrated human plasma, human serum albumin or fibrinogen. Plasma and serum albumin produced a marked inhibition of bacterial adherence (P < 0.05) by means of adsorption on biomaterial surface.  Fibrinogen enhanced (P < 0.05) the number of bound bacteria, specially through its interaction with the staphylococcal surface.  These observations suggest the possible role of plasma proteins in these infections.
C1 UNIV SANTIAGO DE COMPOSTELA,FAC FARM,DEPT MICROBIOL & PARASITOL,SANTIAGO,SPAIN.
RI Carballo, Julia/K-9953-2014
OI Carballo, Julia/0000-0003-4388-358X
CR ABSOLOM DR, 1988, CAN J MICROBIOL, V34, P287, DOI 10.1139/m88-054
   BAIER RE, 1983, ANN NY ACAD SCI, P34
   BAIRDPARKER AC, 1990, J APPL BACTERIOL S S, P15
   BRASH JL, 1989, J BIOMED MATER RES, V23, P157, DOI 10.1002/jbm.820230203
   BRASH JL, 1988, BLOOD, V71, P932
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P597, DOI 10.1128/AAC.33.5.597
   DUGUID JP, 1951, J PATHOL BACTERIOL, V63, P673, DOI 10.1002/path.1700630413
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   FLETCHER M, 1976, J GEN MICROBIOL, V94, P400, DOI 10.1099/00221287-94-2-400
   GIBBONS JD, 1976, NONPARAMETRIC METHOD, P157
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGH AH, 1985, J GEN MICROBIOL, V131, P2485
   HOGH AH, 1983, J GEN MICROBIOL, V129, P2959
   KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82
   LAMMLER C, 1988, CAN J MICROBIOL, V34, P1
   LUDWICKA A, 1983, ZBL BAKT MIK HYG B, V177, P527
   MOHAMMAD SF, 1988, T AM SOC ART INT ORG, V34, P573
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PEDERSEN K, 1981, FEMS MICROBIOL LETT, V12, P365
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   Rutter P. R., 1980, MICROBIAL ADHESION S, P79
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
NR 24
TC 13
Z9 13
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0300-8584
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PY 1991
VL 180
IS 3
BP 149
EP 155
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FY627
UT WOS:A1991FY62700005
PM 1921857
DA 2018-10-20
ER

PT J
AU ZHANG, C
   TANG, NX
   ZHENG, CF
   XU, YW
   WANG, TD
AF ZHANG, C
   TANG, NX
   ZHENG, CF
   XU, YW
   WANG, TD
TI EXPERIMENTAL-STUDY ON MICROVASCULAR ANASTOMOSIS USING A DISSOLVABLE
   STENT SUPPORT IN THE LUMEN
SO MICROSURGERY
LA English
DT Article
AB A new method for microvascular anastomosis was developed and compared with conventional techniques, using the rabbit femoral artery.  A dissolvable stent biomaterial was placed in the lumen to expose the vessel walls clearly, so that the quality of anastomosis could be improved.  The results showed no significant difference in immediate and late patency rates between the methods, but the use of the stent resulted in faster repair, less dilation at the anastomosis, and less narrowing of the distal segments, causing apparently minor hemodynamic disturbance, with increased blood flow distally.  Minor damage to the vessel walls and rapid healing of the wound were verified by histologic evaluation.
RP ZHANG, C (reprint author), AIR FORCE HOSP,DEPT ORTHOPAED SURG,1 GONGNONGYUAN ST,CHENGDU 610061,PEOPLES R CHINA.
NR 0
TC 11
Z9 11
U1 0
U2 2
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0738-1085
J9 MICROSURG
JI Microsurgery
PY 1991
VL 12
IS 2
BP 67
EP 71
PG 5
WC Surgery
SC Surgery
GA EY723
UT WOS:A1991EY72300001
PM 2011068
DA 2018-10-20
ER

PT J
AU NAJJAR, TA
   LERDRIT, W
   PARSONS, JR
AF NAJJAR, TA
   LERDRIT, W
   PARSONS, JR
TI ENHANCED OSSEOINTEGRATION OF HYDROXYLAPATITE IMPLANT MATERIAL
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID BIOMATERIAL ASPECTS; HYDROXYAPATITE; AUGMENTATION; CERAMICS
AB This study was undertaken to determine whether the addition of calcium sulfate to hydroxylapatite (HA) implant material would improve its working properties without adversely affecting its osseointegration. The clinical and histologic examinations of bone response of three implant materials, hard tissue replacement (HTR), HA, and HA composite (HA plus calcium sulfate), were performed after 2-, 4-, and 6-week implantation in tibia and mandible of rabbits. No sign of extensive chronic inflammatory response was detected. The highest rate of bone ingrowth occurred with the HA composite, followed by HA, with HTR showing the least ingrowth. Bone was deposited directly on the surface of HA and HA composite implant materials. In contrast, HTR particles had a thin layer of fibrous tissue encapsulation with the normal bony investment.
RP NAJJAR, TA (reprint author), UNIV MED & DENT NEW JERSEY, NEW JERSEY DENT SCH, DEPT ORAL PATHOL, 110 BERGEN ST, NEWARK, NJ 07103 USA.
CR ALEXANDER H, 1987, CRIT REV BIOCOMPAT, V4, P43
   Beirne O R, 1985, CDA J, V13, P45
   BLOCK MS, 1986, J ORAL MAXIL SURG, V44, P89, DOI 10.1016/0278-2391(86)90187-4
   BOYNE PJ, 1984, J AM DENT ASSOC, V108, P822
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   CHANG CS, 1983, J ORAL MAXIL SURG, V41, P729, DOI 10.1016/0278-2391(83)90190-8
   DESJARDINS RP, 1985, J PROSTHET DENT, V54, P374, DOI 10.1016/0022-3913(85)90556-6
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   PARSONS JR, 1988, BIOCERAMICS, P190
   PARSONS JR, 1986, ADV BIOMATER, V477, P82
   POSNER AS, 1985, CLIN ORTHOP RELAT R, V200, P87
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 16
TC 15
Z9 15
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
EI 1528-395X
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD JAN
PY 1991
VL 71
IS 1
BP 9
EP 15
DI 10.1016/0030-4220(91)90512-B
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EU075
UT WOS:A1991EU07500002
PM 1847237
DA 2018-10-20
ER

PT J
AU KEMPTER, F
   MOHRING, K
   BERSCH, W
AF KEMPTER, F
   MOHRING, K
   BERSCH, W
TI RESULTS OF ENDOSCOPIC SUBURETERAL COLLAGEN INJECTION FOR REFLUX
   CORRECTION IN PIGS AND DOGS
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE ENDOSCOPIC CORRECTION; VESICOURETERAL REFLUX; BOVINE COLLAGEN; ANIMAL
   EXPERIMENTS; HISTOLOGICAL EVALUATION
AB The efficacy of endoscopic correction of reflux with the use of Teflon has been proven, but there are safety concerns because of granuloma formation and particle migration.  Using glutaraldehyde cross-linked (GAX-) bovine collagen as an alternate biomaterial, animal experiments were performed with 6 female pigs and 20 beagle dogs.  Primary and experimentally-induced vesicoureteral reflux was treated by endoscopic injection of bovine GAX-collagen (Zyplast) submucosally at the ureteric orifice.  Radiographic controls after 6, 8, or 12 months revealed successful reflux correction in 14 of 19 treated ureters of dogs.  After the animals were killed, pathohistological evaluation demonstrated persistence of the collagen depot at the site of injection even after 12 months, although not in all cases, without inflammatory or foreign-body tissue reaction.  No evidence of particle migration was found.  Invasion of fibroblasts and fibrocytes into the collagen depot and capillary vessel formation appeared the same after the different time intervals, and there was no difference between the two animal species.  The biocompatibility of purified bovine GAX-collagen makes it an alternative to Teflon for reflux correction.
RP KEMPTER, F (reprint author), UNIV HEIDELBERG,DEPT UROL,W-6900 HEIDELBERG,GERMANY.
NR 0
TC 6
Z9 6
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0179-0358
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PY 1991
VL 6
IS 4-5
BP 261
EP 262
PG 2
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA FY606
UT WOS:A1991FY60600007
DA 2018-10-20
ER

PT J
AU BERNARD, SL
   PICHA, GJ
AF BERNARD, SL
   PICHA, GJ
TI THE USE OF CORALLINE HYDROXYAPATITE IN A BIOCOMPOSITE FREE FLAP
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID POROUS HYDROXYAPATITE; BONE; IMPLANTS
AB An animal model was developed to determine the feasibility of vascularizing a porous biomaterial and transferring it as part of a free flap to a recipient site with enhanced resistance to infection due to the maintenance of a blood supply.  To that end, the experiment was divided into three stages.  Stage 1 compared the soft-tissue response of Interpore-200 to Interpore-500, both continuously porous hydroxyapatite materials implanted beneath the panniculus carnosus of the male Sprague-Dawley rat.  Pore size was an important factor as it influenced vascular ingrowth, with Interpore-200 vascularizing earlier (complete at 1 week) and more intensely.  Interpore-200 was therefore used for the remainder of the experiment.  After 1 week of tissue ingrowth, the implants were moved from the abdomen to the skull on a vascular pedicle as a "biocomposite" free flap.  Stage 2 was the histologic evaluation of 15 "biocomposite" free flaps over various time intervals up to 8 months.  The free flaps formed a fibrous union to the skull, while a simple nonvascularized Interpore-200 onlay graft (stage 2 control) demonstrated a bony union in three of four implants placed up to 2 months.  Stage 3 confirmed the free flap's resistance to bacterial infection.  A highly significant difference (p < 0.005) in infection rates was demonstrated between the "biocomposite" and nonvascularized stage 3 controls with no Pseudomonas growth from 9 of 10 cultures of the free flaps 5 days after exposure to 10(4) Pseudomonas aeruginosa, while stage 3 controls demonstrated Pseudomonas growth in all cultures (heavy growth in 8 of 10).  The "biocomposite" free flap has excellent potential to provide form and structure to wounds requiring reconstruction where bacterial contamination is a significant risk factor.
C1 METROHLTH MED CTR,DEPT SURG,DIV PLAST SURG,3395 SCRANTON RD,CLEVELAND,OH 44109.
   CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106.
CR BUNCKE HJ, 1977, PLAST RECONSTR SURG, V59, P799, DOI 10.1097/00006534-197706000-00002
   BUNCKE HJ, 1965, PLAST RECONSTR SURG, V36, P61
   COBBETT JR, 1967, SURG CLIN N AM, V47, P521
   DANIEL RK, 1973, PLAST RECONSTR SURG, V52, P111, DOI 10.1097/00006534-197308000-00001
   FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4
   Flatley TJ, 1983, CLIN ORTHOP RELAT R, V179, P246
   GIBBONS DF, NASA CR135311 ANN RE
   HARPER MC, 1988, J ORTHOPAED RES, V6, P287, DOI 10.1002/jor.1100060217
   HOLMES R, 1984, CLIN ORTHOPAEDICS, V188, P252
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   ITATANI C, 1984, 30TH T ANN M ORTH RE, P9
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MITCHELL OG, 1976, J DENT RES, V55, pB243
   MURAKAMI T, 1971, Archivum Histologicum Japonicum, V32, P445
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   PIECUCH JF, 1983, J DENT RES, V62, P148, DOI 10.1177/00220345830620021301
   SALVATORE J, 1961, SURG GYNECOL OBSTET, V112, P463
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   TAYLOR GI, 1979, PLAST RECONSTR SURG, V64, P745, DOI 10.1097/00006534-197912000-00001
   TAYLOR GI, 1983, CLIN PLAST SURG, V10, P185
   TENCER AF, 1987, J ORTHOPAED RES, V5, P275, DOI 10.1002/jor.1100050214
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
NR 24
TC 28
Z9 31
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD JAN
PY 1991
VL 87
IS 1
BP 96
EP 105
DI 10.1097/00006534-199101000-00015
PG 10
WC Surgery
SC Surgery
GA EQ143
UT WOS:A1991EQ14300015
PM 1845783
DA 2018-10-20
ER

PT J
AU WENNERBERG, A
   BOLIND, P
   ALBREKTSSON, T
AF WENNERBERG, A
   BOLIND, P
   ALBREKTSSON, T
TI GLOW-DISCHARGE PRETREATED IMPLANTS COMBINED WITH TEMPORARY BONE TISSUE
   ISCHEMIA
SO SWEDISH DENTAL JOURNAL
LA English
DT Article
DE BIOMATERIAL; TITANIUM IMPLANTS; SURFACE TREATMENT; GLOW DISCHARGE
AB The aim of present experimental study, was to investigate whether glow-discharge pretreated screws improved the implant take if initial blood flow was prevented in the implant bed.  Glow discharge treatment has in previous studies in soft tissue showed to be advantageous for biological adhesion, presumably due to an increase in surface energy.  In bone tissue, so far, positive effects of glow discharge have not been reported.  One reason for this could be that circulating blood would immediately contaminate the implant surface and lower the high energy state.  To prevent circulating blood to reach the implant bed, we used an infant pneumatic cuff placed on the right leg of the rabbit.  The pressure was 300 mm Hg during 2.5 hours.  The left leg served as control.  After 5 minutes when there were no longer a noticeable pulse, 40 glow-discharged pretreated screws were inserted in the tibia.  After 7 weeks the animals were sacrificed.  There were no significant differences in torque measurements or histomorphometric analysis between control and test implants.
RP WENNERBERG, A (reprint author), UNIV GOTHENBURG,DEPT HANDICAP RES,BIOMAT GRP,BRUNNSGATAN 2,S-41312 GOTHENBURG,SWEDEN.
CR Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   CARLSSON L V, 1989, International Journal of Oral and Maxillofacial Implants, V4, P199
   CARLSSON LV, 1989, THESIS U GOTHENBURG
   Donath K., 1988, PRAPARATOR, V34, P197
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HETSON G, 1988, MAR IADR M MONTR
   Johansson C, 1987, Int J Oral Maxillofac Implants, V2, P69
   KALEBO P, 1986, ARCH ORTHOP TRAUM SU, V105, P321, DOI 10.1007/BF00449935
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
NR 11
TC 14
Z9 15
U1 0
U2 1
PU SWEDISH DENTAL JOURNAL
PI STOCKHOLM
PA BOX 5843, S102 48 STOCKHOLM, SWEDEN
SN 0347-9994
J9 SWED DENT J
JI Swed. Dent. J.
PY 1991
VL 15
IS 2
BP 95
EP 101
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FK775
UT WOS:A1991FK77500005
PM 2063266
DA 2018-10-20
ER

PT J
AU NAYLOR, PT
   MYRVIK, QN
   GRISTINA, A
AF NAYLOR, PT
   MYRVIK, QN
   GRISTINA, A
TI ANTIBIOTIC-RESISTANCE OF BIOMATERIAL-ADHERENT COAGULASE-NEGATIVE AND
   COAGULASE-POSITIVE STAPHYLOCOCCI
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article; Proceedings Paper
CT 18TH OPEN SCIENTIFIC MEETING OF THE HIP SOC
CY FEB   11, 1990
CL NEW ORLEANS, LA
SP HIP SOC
C1 WAKE FOREST UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,WINSTON SALEM,NC 27103.
   NATL HOSP ORTHOPED & REHABIL,MUSCULOSKELETAL SCI RES INST,ARLINGTON,VA.
RP NAYLOR, PT (reprint author), WAKE FOREST UNIV,MED CTR,ORTHOPED SURG SECT,WINSTON SALEM,NC 27103, USA.
CR CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COSTERTON JW, 1977, MICROBIOLOGY 1977, P151
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518
   NICKEL JC, 1985, EUR J CLIN MICROBIOL, V4, P213, DOI 10.1007/BF02013600
   SHANHOLTZER CJ, 1984, ANTIMICROB AGENTS CH, V26, P214, DOI 10.1128/AAC.26.2.214
   1985, M7A NAT COMM CLIN LA
NR 13
TC 53
Z9 55
U1 0
U2 3
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD DEC
PY 1990
IS 261
BP 126
EP 133
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA EL720
UT WOS:A1990EL72000015
DA 2018-10-20
ER

PT J
AU STEFLIK, DE
   MCKINNEY, RV
   SISK, AL
   PARR, GR
   KOTH, DL
AF STEFLIK, DE
   MCKINNEY, RV
   SISK, AL
   PARR, GR
   KOTH, DL
TI SCANNING ELECTRON-MICROSCOPIC STUDIES OF THE ORAL-TISSUE RESPONSES TO
   DENTAL IMPLANTS
SO SCANNING MICROSCOPY
LA English
DT Article
DE DENTAL IMPLANTS; TISSUE INTERFACE; SCANNING ELECTRON MICROSCOPY;
   EPITHELIAL ATTACHMENT; IMPLANT SUPPORT TISSUES
ID TITANIUM IMPLANTS; POROUS ALUMINA; BONE; INTERFACE; SURFACE;
   OSSEOINTEGRATION; BIOMATERIALS; INVIVO; DOGS
AB Scanning electron microscopy (SEM) and its associated technologies have proven invaluable in elucidating the interfacial oral tissue responses to dental implants.  Since the dental implant must extend from the mandibular or maxillary jaw, through the oral mucosa, and into the oral cavity, these tissue responses include epithelium, connective tissue and bone.  The continual occlusal forces acting upon these tissues reinforce the dynamic character of these tissue responses.  Immediately upon implantation, a healing phase begins as a response to the implanted biomaterial.  Following this immediate response a longer healing phase occurs, beginning approximately 1 week after implantation, resulting in the modeling of bone to the implant as well as the formation of epithelial attachment to the implant.  This later, delayed healing continues throughout the lifetime of the implant since these tissues must die and be replaced by similar tissues.  Current dental research employing scanning electron microscopy is now documenting these tissue responses.  This paper reviews, in detail, SEM observations of these tissue responses.
C1 MED COLL GEORGIA,SCH DENT,DEPT ORAL SURG,AUGUSTA,GA 30912.
   MED COLL GEORGIA,SCH DENT,DEPT PROSTHODONT,AUGUSTA,GA 30912.
   UNIV ALABAMA,DEPT RESTORAT DENT,BIRMINGHAM,AL 35294.
RP STEFLIK, DE (reprint author), MED COLL GEORGIA,SCH DENT,DEPT ORAL PATHOL,AUGUSTA,GA 30912, USA.
CR AGUERO A, 1989, Journal of Dental Research, V68, P277
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   BABBUSH CA, 1974, J ORAL IMPLANTOL, V4, P373
   BAIER R E, 1988, Journal of Oral Implantology, V13, P594
   Baier R E, 1988, J Dent Educ, V52, P788
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1988, J ORAL IMPLANTOL, V14, P208
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P414, DOI 10.1016/0278-2391(87)90009-7
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   BRUNETTE DM, 1990, J DENT RES, V69, P291
   DELANGE GL, 1988, T BIOMAT, V11, P509
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   FUKUYAMA H, 1987, JAP DENT J, V22, P1
   GOLDBERG F, 1982, INT ENDOD J, V15, P77, DOI 10.1111/j.1365-2591.1982.tb01345.x
   GRAFELMAN HL, 1983, J ORAL IMPLANTOL, V10, P552
   Greenfield EJ., 1913, DENT COSMOS, V55, P364
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1986, EUROPEAN C BIOMATERI, V14, P17
   Gross U M, 1988, J Dent Educ, V52, P798
   HANSSON HA, 1983, J PROSTHET DENT, V50, P108, DOI 10.1016/0022-3913(83)90175-0
   HART R, 1986, P SE ELE MICROSC SOC, V9, P32
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HIPP JA, 1987, J DENT RES, V66, P186
   James R A, 1974, Oral Implantol, V4, P294
   JAMES RA, 1986, CLARKS CLIN DENTISTR, pCH48
   JAMES RA, 1974, J BIOMED MATER RES 2, V5, P373
   JAMES RA, 1986, IMPLANTOLOGIST, V3, P35
   JUR TA, 1986, P SE ELE MICROSC SOC, V9, P33
   Karagianes M T, 1982, J Oral Implantol, V10, P189
   KAWAHARA H, 1978, DENTAL OUTLOOK, V51, P1147
   Kirsch A, 1983, J Oral Implantol, V11, P197
   KLAWITTER JJ, 1977, J DENT RES, V56, P768, DOI 10.1177/00220345770560071101
   Lemons J E, 1988, J Dent Educ, V52, P748
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   MANIATOPOULOS C, 1986, J BIOMED MATER RES, V20, P1309, DOI 10.1002/jbm.820200907
   McKinney R V Jr, 1982, J Oral Implantol, V10, P487
   McKinney R V Jr, 1984, J Oral Implantol, V11, P327
   MCKINNEY RV, 1984, J PROSTHET DENT, V51, P372, DOI 10.1016/0022-3913(84)90225-7
   MCKINNEY RV, 1985, J PERIODONTOL, V56, P579, DOI 10.1902/jop.1985.56.10.579
   MEENAGHAN MA, 1974, J PROSTHET DENT, V31, P681, DOI 10.1016/0022-3913(74)90123-1
   Mishima A, 1984, J Oral Implantol, V11, P516
   NAKAGAWA K-I, 1987, Shikwa Gakuho, V87, P1247
   PEARSALL GW, 1986, P SE ELE MICROSC SOC, V9, P33
   ROGGENDORF W, 1986, Z ZAHNARZTL IMLANTOL, V2, P197
   Russell T E, 1977, J Oral Implantol, V7, P415
   SCHOEDER A, 1981, J MAXILLOFAC SURG, V9, P15
   Smith D C, 1988, J Dent Educ, V52, P815
   STANLEY HR, 1976, ORAL SURG ORAL MED O, V42, P339, DOI 10.1016/0030-4220(76)90168-7
   Steflik D E, 1988, Ann N Y Acad Sci, V523, P4, DOI 10.1111/j.1749-6632.1988.tb38497.x
   STEFLIK DE, 1990, J DENT RES, V69, P214
   STEFLIK DE, 1989, J BIOMED MATER RES, V23, P895, DOI 10.1002/jbm.820230807
   STEFLIK DE, 1984, STAIN TECHNOL, V59, P71, DOI 10.3109/10520298409113835
   STEFLIK DE, 1989, 15TH T ANN SOC BIOM, V12, P62
   STEFLIK DE, 1978, THESIS STATE U NEW Y
   STEFLIK DE, 1984, SCANNING ELECTRON MI, V2, P547
   Steinberg B, 1978, J Oral Implantol, V7, P475
   SUTTER F, 1983, J ORAL IMPLANTOL, V11, P166
   VONSTKOHLER, 1980, ZAHN MUND KIERFERHEI, V68, P124
   WEINSTEIN AM, 1981, J BIOMED MATER RES, V15, P749, DOI 10.1002/jbm.820150510
   YAMAGAMI A, 1988, J PROSTHET DENT, V59, P689, DOI 10.1016/0022-3913(88)90384-8
   Zak R, 1977, J Oral Implantol, V7, P393
NR 64
TC 10
Z9 10
U1 0
U2 3
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 0891-7035
J9 SCANNING MICROSCOPY
JI Scanning Microsc.
PD DEC
PY 1990
VL 4
IS 4
BP 1021
EP 1038
PG 18
WC Microscopy
SC Microscopy
GA EY836
UT WOS:A1990EY83600015
PM 2094003
DA 2018-10-20
ER

PT J
AU BOUET, T
   SCHMITT, M
   DESUZINGES, C
   ELOY, R
AF BOUET, T
   SCHMITT, M
   DESUZINGES, C
   ELOY, R
TI QUANTITATIVE INVIVO STUDIES OF HYPEREMIA IN THE COURSE OF THE
   TISSUE-RESPONSE TO BIOMATERIAL IMPLANTATION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 INSERM,U37,18 AV DOYEN LEPINE,F-69500 BRON,FRANCE.
   LAB THERMOREGULAT,CNRS,URA 1341,F-69000 LYONS,FRANCE.
   LAB BIOPHYS & MED NUCL,F-69000 LYONS,FRANCE.
CR ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755
   BECK JS, 1986, IMMUNOLOGY, V58, P209
   BROWN SL, 1988, NUCL MED BIOL, V15, P381
   CASPARY L, 1988, INT J MICROCIRC, V7, P367
   COOK SD, 1986, J BIOMED MATER RES, V20, P1347, DOI 10.1002/jbm.820200909
   DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103
   DULING BR, 1973, MICROVASC RES, V5, P423, DOI 10.1016/0026-2862(73)90059-9
   FAJARDO LF, 1988, LAB INVEST, V58, P718
   FAN TPD, 1981, BRIT J PHARMACOL, V24, pP964
   FOLKMAN J, 1982, ENDOTHELIUM, P212
   GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413
   GOURLAY SJ, 1978, J BIOMED MATER RES, V12, P219, DOI 10.1002/jbm.820120207
   GRIFFITH TM, 1989, MICROVASC RES, V37, P162, DOI 10.1016/0026-2862(89)90035-6
   HARPER EI, 1988, J IMMUNOL METHODS, V133, P255
   HOLLOWAY GA, 1977, J INVEST DERMATOL, V69, P306, DOI 10.1111/1523-1747.ep12507665
   HORSLEVPETERSEN K, 1988, EUR J CLIN INVEST, V18, P352, DOI 10.1111/j.1365-2362.1988.tb01023.x
   LINDSBERG PJ, 1989, AM J PHYSIOL, V257, pH674
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MARION L, 1980, J BIOMED MATER RES, V14, P343, DOI 10.1002/jbm.820140402
   NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P597, DOI 10.1109/TBME.1980.326582
   NOTZLI HP, 1989, J ORTHOPAED RES, V7, P413, DOI 10.1002/jor.1100070314
   Oberg PA, 1984, ACTA MED SCAND S, V687, P17
   ORLANDI C, 1988, CLIN SCI, V74, P119, DOI 10.1042/cs0740119
   PERSHING LK, 1989, J INVEST DERMATOL, V92, P355, DOI 10.1111/1523-1747.ep12277181
   SALTHOUSE TN, 1981, FUNDAMENTAL ASPECTS, P233
   Schmitt M., 1984, RECENT ADV MED THERM, P439, DOI DOI 10.1007/978-1-4684-7697-2_61
   SMITS GJ, 1986, J APPL PHYSIOL, V61, P666
   STERN MD, 1977, AM J PHYSIOL, V232, pH441
   SWAIN ID, 1989, PHYS MED BIOL, V34, P151, DOI 10.1088/0031-9155/34/2/001
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   TENLAND T, 1983, INT J MICROCIRC, V2, P81
NR 31
TC 3
Z9 3
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1990
VL 24
IS 11
BP 1439
EP 1461
DI 10.1002/jbm.820241104
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ED740
UT WOS:A1990ED74000003
PM 2279980
DA 2018-10-20
ER

PT J
AU STEMBERGER, A
AF STEMBERGER, A
TI DRUG CARRIER SYSTEMS BASED ON RESORBABLE POLYESTER COLLAGEN AND OR
   BIOMATERIAL COMBINATIONS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 TECH UNIV MUNICH,INST EXPTL SURG,W-8000 MUNICH 80,GERMANY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 26
PY 1990
VL 200
BP 78
EP PMSE
PN 2
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA DU043
UT WOS:A1990DU04301300
DA 2018-10-20
ER

PT J
AU MINOURA, N
   TSUKADA, M
   NAGURA, M
AF MINOURA, N
   TSUKADA, M
   NAGURA, M
TI PHYSICOCHEMICAL PROPERTIES OF SILK FIBROIN MEMBRANE AS A BIOMATERIAL
SO BIOMATERIALS
LA English
DT Article
C1 NATL INST SERICULTURAL & ENTOMOL SCI,TSUKUBA,IBARAKI 305,JAPAN.
   SHINSHU UNIV,FAC TEXT SCI & TECHNOL,UEDA,NAGANO 386,JAPAN.
RP MINOURA, N (reprint author), IND PROD RES INST,1-1-4 HIGASHI,TSUKUBA,IBARAKI 305,JAPAN.
CR AIBA S, 1985, BIOMATERIALS, V6, P290, DOI 10.1016/0142-9612(85)90084-5
   Asakura T, 1987, BIOINDUSTRY, V4, P878
   Hirotsu T., 1988, SEN-I GAKKAISHI, V44, P72
   KITAMURA A, 1988, SEN-I GAKKAISHI, V44, P193
   KITAMURA A, 1967, J SERICULT SCI JPN, V36, P113
   KUZUHARA A, 1987, J BIOTECHNOL, V5, P199, DOI 10.1016/0168-1656(87)90016-2
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   MAGOSHI J, 1974, KOBUNSHI RONBUNSHU, V31, P648
   MINOURA N, 1982, J APPL POLYM SCI, V27, P1007, DOI 10.1002/app.1982.070270320
   MINOURA N, 1979, J APPL POLYM SCI, V24, P965, DOI 10.1002/app.1979.070240410
   NAGURA M, 1987, J POLYM SCI POL PHYS, V25, P2567, DOI 10.1002/polb.1987.090251211
   NAKABAYASHI N, 1988, IYOU KOUBUNSHI, P18
   NG CO, 1976, BRIT POLYM J, V8, P118, DOI 10.1002/pi.4980080403
   SUGIURA M, 1974, NIPPON NOGEI KAGAKU, V48, P627
NR 14
TC 224
Z9 243
U1 3
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1990
VL 11
IS 6
BP 430
EP 434
DI 10.1016/0142-9612(90)90100-5
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DU618
UT WOS:A1990DU61800012
PM 2207234
DA 2018-10-20
ER

PT J
AU MUSTER, D
   HUMBERT, P
   MOSSER, A
AF MUSTER, D
   HUMBERT, P
   MOSSER, A
TI SURFACE PHYSICS METHODS AND INVITRO BONE BIOMATERIAL INTERFACE CONTROL
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT SYMP ON CALCIFIED TISSUES AND BIOMATERIALS ( BIOMAT 89 )
CY DEC 13-15, 1989
CL BORDEAUX, FRANCE
SP LAB EVALUAT IMPLANTABLE MAT, BIOMAT
C1 UNIV STRASBOURG 1,IPCMS,SURFACES INTERFACES GRP,UM 380046,F-67070 STRASBOURG,FRANCE.
RP MUSTER, D (reprint author), CTR HOSP REG & UNIV STRASBOURG,LEED BIOMAT STOMATOL & CHIRURG MAXILLOFACIALE,F-67091 STRASBOURG,FRANCE.
CR BRIGGS D, 1983, PRACTICAL SURFACE AN
   EBERHART JP, 1976, METHODES PHYSIQUES E
   ESSOUNI M, 1985, J MICROSC SPECT ELEC, V10, P563
   Feldman LE, 1986, FUNDAMENTALS SURFACE
   HUMBERT P, 1988, VIDE COUCHES MINCE S, V243, P243
   MUSTER D, 1988, NATO ASI SERIES A, V158, P341
   MUSTER D, 1987, BIOMATERIALS, V1, P73
   PORTIER R, 1988, VIDE COUCHES MINCE S, V243, P41
   SAIDANI N, 1985, THESIS STRASBOURG
   SOLNICKLEGG H, 1989, MRS B, V14, P27
NR 10
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1990
VL 11
SU S
BP 57
EP 62
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ393
UT WOS:A1990DQ39300017
PM 2168765
DA 2018-10-20
ER

PT J
AU MUTLU, M
   PISKIN, E
AF MUTLU, M
   PISKIN, E
TI BLOOD-PLASMA PROTEINS ON POLYURETHANE AND ALKYLSILOXANE PLASMA-TREATED
   POLYURETHANE SURFACES - DYNAMIC APPROACH BY STIMULUS-RESPONSE TECHNIQUE
   .2. EVALUATION OF ADSORPTION DATA BY MOMENT TECHNIQUE
SO MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
LA English
DT Article
DE BIOMATERIALS; BLOOD PLASMA PROTEINS; MOMENT TECHNIQUE; POLYURETHANE;
   STIMULUS-RESPONSE TECHNIQUE; SURFACE MODIFICATION BY PLASMA
   POLYMERIZATION
ID GAS-CHROMATOGRAPHY; DIFFUSION
AB In this study, interactions of blood proteins (i.e. albumin and fibrinogen) with polyurethane biomaterial surfaces were investigated in an in vitro bead column test circuit using a stimulus-response technique.  The dynamic sorption process of radiolabelled proteins on the surfaces was followed by detecting the radioactivity at the exit stream of the column, which was the response of a pulse stimulus at the inlet.  The mathematical model was described and solved using 'parameter estimation by cybernetic moment technique', and the adsorption rate constants of plasma proteins on different biomaterial surfaces were calculated.  By evaluation of the response curves with standard and cybernetic moment techniques, the following results were obtained.  Albumin and fibrinogen adsorption is competitive, and the competition is strongly dependent upon the surface characteristics of the biomaterial.  Preadsorption or preferential adsorption of albumin decreases the fibrinogen adsorption, and therefore increases the biocompatibility of material surface.  Adsorption of blood plasma proteins are irreversible.  The moment technique can also be used for the evaluation of stimulus-response data of biological systems, to determine the process parameters.
RP MUTLU, M (reprint author), HACETTEPE UNIV,FAC ENGN,DEPT CHEM ENGN,BEYTAPE CAMPUS,GR-06532 ANKARA,TURKEY.
RI MUTLU, MEHMET/B-3240-2013
OI MUTLU, MEHMET/0000-0001-9610-9817; Mutlu, Mehmet/0000-0001-7146-1937
CR BAIER RE, 1977, ANN NY ACAD SCI, V283, P17, DOI 10.1111/j.1749-6632.1977.tb41750.x
   BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P79
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHANG TMS, 1972, ARTIFICIAL CELLS
   CHIMIEL H, 1983, PLASMA SEPARATION PL, P180
   DOGU G, 1975, AICHE J, V21, P58, DOI 10.1002/aic.690210106
   DOGU T, 1986, AICHE J, V32, P743
   Dutton R C, 1969, J Biomed Mater Res, V3, P13, DOI 10.1002/jbm.820030104
   HASHIMOTO N, 1973, IND ENG CHEM FUND, V12, P353, DOI 10.1021/i160047a014
   HAYNES HW, 1973, AICHE J, V19, P1043, DOI 10.1002/aic.690190526
   Hoffman AS, 1982, ADV CHEM SER, V199, P3
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   HSU LKP, 1981, AICHE J, V27, P81, DOI 10.1002/aic.690270113
   IHLENFELD JV, 1978, T AM SOC ART INT ORG, V24, P727
   Kafarov V., 1976, CYBERNETIC METHODS C
   LELAH MD, 1984, J COLL INTERFACE JUN, P47
   Levenspiel O., 1972, CHEM REACTION ENG
   MASON RE, 1980, US NIH802185 PUBL
   MUTLU M, 1988, THESIS HACETTEPE U A
   MUTLU M, 1989, J CLIN MATER, V4, P61
   NOISHIKI Y, 1982, J BIOMED MATER RES, V16, P359, DOI 10.1002/jbm.820160405
   Petersen E. E., 1965, CHEM REACTION ANAL
   PISKIN E, 1976, THESIS HACETTEPE U A
   PISKIN E, 1981, 5TH P NORD M MED BIO, P233
   SCARBOROUGH DE, 1969, LAB INVEST, V20, P164
   SCHNEIDER P, 1968, AICHE J, V14, P762, DOI 10.1002/aic.690140516
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   YOUNG BR, 1984, THESIS U WISCONSIN M
NR 28
TC 11
Z9 11
U1 0
U2 2
PU PETER PEREGRINUS LTD
PI HERTS
PA SOUTHGATE HOUSE STEVENAGE PO BOX 8, HERTS, ENGLAND SG1 1HQ
SN 0140-0118
J9 MED BIOL ENG COMPUT
JI Med. Biol. Eng. Comput.
PD MAY
PY 1990
VL 28
IS 3
BP 232
EP 236
DI 10.1007/BF02442672
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Mathematical & Computational Biology; Medical Informatics
SC Computer Science; Engineering; Mathematical & Computational Biology;
   Medical Informatics
GA FJ928
UT WOS:A1990FJ92800005
PM 2377005
DA 2018-10-20
ER

PT J
AU BAKKER, D
   VANBLITTERSWIJK, CA
   HESSELING, SC
   DAEMS, WT
   GROTE, JJ
AF BAKKER, D
   VANBLITTERSWIJK, CA
   HESSELING, SC
   DAEMS, WT
   GROTE, JJ
TI TISSUE BIOMATERIAL INTERFACE CHARACTERISTICS OF 4 ELASTOMERS - A
   TRANSMISSION ELECTRON MICROSCOPICAL STUDY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 LEIDEN STATE UNIV, ELECTRON MICROSCOPY LAB, 2312 AV LEIDEN, NETHERLANDS.
RP BAKKER, D (reprint author), STATE UNIV LEIDEN HOSP, DEPT EAR NOSE & THROAT, 2333 AA LEIDEN, NETHERLANDS.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   BAKKER D, IN PRESS J BIOMED MA
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOTS JGF, 1986, BIOMATERIALS, V7, P393, DOI 10.1016/0142-9612(86)90011-6
   BOTS JGF, 1988, THESIS TU TWENTE ENS
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   CHAMBERS TJ, 1981, FUNDAMENTAL ASPECTS, V1, P145
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CUDDIHY EF, 1976, J BIOMED MATER RES, V10, P471, DOI 10.1002/jbm.820100314
   DAEMS WT, 1980, RETICULOENDOTHELIAL, P57
   DEWIJN JR, 1981, BIOCOMPATIBILITY CLI, V2, P99
   EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GILDING DK, 1981, FUNDAMENTAL ASPECTS, V1, P43
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   GROTE JJ, 1984, BIOMATERIALS OTOLOGY, P274
   Hench L L, 1973, Med Instrum, V7, P136
   Hench L. L., 1982, BIOMATERIALS INTERFA, P279
   Hench LL, 1981, FUNDAMENTAL ASPECTS, P67
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JARCHO M, 1977, J BIOENG, V1, P79
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KOPECEK J, 1983, PROG POLYM SCI, V9, P1
   KUIJPERS W, 1984, BIOMATERIALS OTOLOGY, P18
   MATLAGA BF, 1983, J BIOMED MATER RES, V17, P185, DOI 10.1002/jbm.820170115
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   MOISEEV YV, 1979, J POLYM SCI PS, V66, P269
   MUNTHEKAAS AC, 1980, RETICULOENDOTHELIAL, P19
   Osborn J. F., 1980, DENT IMPLANTS MAT SY, P111
   PAPADIMITRIOU JM, 1980, J PATHOL, V130, P75, DOI 10.1002/path.1711300203
   PAPADIMITRIOU JM, 1976, J PATHOL, V120, P193, DOI 10.1002/path.1711200402
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   RAE T, 1981, FUNDAMENTAL ASPECTS, V1, P159
   REDLER I, 1962, J BONE JOINT SURG AM, V44, P1621, DOI 10.2106/00004623-196244080-00010
   REED AM, 1981, POLYMER, V22, P499, DOI 10.1016/0032-3861(81)90169-5
   REED AM, 1977, T AM SOC ART INT ORG, V23, P109
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   SCHERFT JP, 1972, J ULTRA MOL STRUCT R, V38, P318, DOI 10.1016/S0022-5320(72)90008-1
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   STOKES KB, 1984, 42ND ANN TECH C SOC, V30, P1073
   Swanson A B, 1973, Orthop Clin North Am, V4, P1097
   SWANSON JW, 1974, J BIOMED MATER RES, V8, P357, DOI 10.1002/jbm.820080603
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P1197, DOI 10.1002/jbm.820200810
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   WAGENER KB, 1982, Patent No. 4350806
   WAGENER KB, 1981, Patent No. 4262114
   WILLIAMS DF, 1976, ANNU REV MATER SCI, V6, P237, DOI 10.1146/annurev.ms.06.080176.001321
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1978, IMPLANTS SURGERY, P203
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
NR 58
TC 42
Z9 42
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1990
VL 24
IS 3
BP 277
EP 293
DI 10.1002/jbm.820240302
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CQ734
UT WOS:A1990CQ73400001
PM 2318896
DA 2018-10-20
ER

PT J
AU ALLMER, K
   HILBORN, J
   LARSSON, PH
   HULT, A
   RANBY, B
AF ALLMER, K
   HILBORN, J
   LARSSON, PH
   HULT, A
   RANBY, B
TI SURFACE MODIFICATION OF POLYMERS .5. BIOMATERIAL APPLICATIONS
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
C1 ROYAL INST TECHNOL,DEPT POLYMER TECHNOL,S-10044 STOCKHOLM 70,SWEDEN.
OI Hilborn, Jons/0000-0001-6947-9601
CR ALLMER K, 1988, J POLYM SCI POL CHEM, V26, P2099, DOI 10.1002/pola.1988.080260809
   ALLMER K, 1989, J POLYM SCI POL CHEM, V27, P1641, DOI 10.1002/pola.1989.080270516
   Andrezik J.A., 1985, RAT NERVOUS SYSTEM, V2, P1
   AVRAMEAS S, 1978, SCAND J IMMUNOL   S7, V8, P7
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   LARSSON PH, 1987, J IMMUNOL METHODS, V98, P129, DOI 10.1016/0022-1759(87)90446-7
   OSHANNESSY DJ, 1987, J IMMUNOL METHODS, V99, P153, DOI 10.1016/0022-1759(87)90120-7
   PLATE NA, 1987, ADV POLYM SCI BIOPOL, V79, P91
   SORENSEN K, 1987, J IMMUNOL METHODS, V99, P153
NR 12
TC 65
Z9 69
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN 15
PY 1990
VL 28
IS 1
BP 173
EP 183
DI 10.1002/pola.1990.080280112
PG 11
WC Polymer Science
SC Polymer Science
GA CF568
UT WOS:A1990CF56800012
DA 2018-10-20
ER

PT J
AU CHANDY, T
   SHARMA, CP
AF CHANDY, T
   SHARMA, CP
TI CHITOSAN - AS A BIOMATERIAL
SO BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS
LA English
DT Article
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV BIOSURFACE TECHNOL,BIOMED TECHNOL WING,TRIVANDRUM 695012,INDIA.
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR AIBA S, 1987, BIOMATERIALS, V8, P481, DOI 10.1016/0142-9612(87)90086-X
   BJORNSSON TD, 1982, THROMB RES, V27, P15, DOI 10.1016/0049-3848(82)90273-0
   CHANDY T, 1989, APPL BIOACTIVE POLYM, P297
   CHANDY T, UNPUB ARTIF ORGANS
   CHANDY T, IN PRESS J COLLOID I
   CLARAMMA CV, 1988, T SOC BIOMAT, V11, P477
   FINE A, 1987, J BIOL CHEM, V262, P3897
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   HAY ED, 1981, J CELL BIOL, V90, P2035
   HEWITT AT, 1984, BIOL GLYCOPROTEINS, P65
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   HIRANO S, 1980, J BIOMED MATER RES, V4, P477
   HIRANO S, 1978, AGR BIOL CHEM TOKYO, V42, P1938
   HIRANO S, 1979, CARBOHYD RES, V71, P344
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   KAMBIC H, 1976, T AM SOC ART INT ORG, V22, P664
   Kifune K, 1988, T SOC BIOMATER, V11, P216
   Kim KY, 1988, T SOC BIOMATER, V11, P558
   KIM TD, 1986, THROMB RES, V43, P603, DOI 10.1016/0049-3848(86)90097-6
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   KON T, 1970, Journal of Biomedical Materials Research, V4, P13, DOI 10.1002/jbm.820040103
   MASON MS, 1968, T AM SOC ART INT ORG, V14, P31
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   MURATA K, 1975, ATHEROSCLEROSIS, V21, P93, DOI 10.1016/0021-9150(75)90096-9
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI RAA, 1986, CHITIN
   NAKAJIMA M, 1986, JPN J SURG, V16, P418, DOI 10.1007/BF02470609
   OUCHI T, 1988, T SOC BIOMED, V11, P232
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   Sharma C P, 1987, J Biomater Appl, V1, P533
   SHARMA CP, 1987, T SOC BIOMAT, V10, P31
   SOLUM NO, 1966, SCAND J CLIN LAB INV, V18, P577, DOI 10.3109/00365516609049041
   TOOLE BP, 1983, ROLE EXTRACELLULAR M, P43
   TYRRELL DA, 1976, BIOCHIM BIOPHYS ACTA, V457, P259, DOI 10.1016/0304-4157(76)90002-2
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1975, J BIOMED MATER RES, V9, P623, DOI 10.1002/jbm.820090608
NR 37
TC 427
Z9 446
U1 2
U2 53
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0890-5533
J9 BIOMATER ARTIF CELL
PY 1990
VL 18
IS 1
BP 1
EP 24
DI 10.3109/10731199009117286
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL252
UT WOS:A1990CL25200001
PM 2185854
DA 2018-10-20
ER

PT J
AU GROTH, T
   VASSILIEFF, C
   WOLF, H
   KUHN, H
AF GROTH, T
   VASSILIEFF, C
   WOLF, H
   KUHN, H
TI INVESTIGATION OF BLOOD-BIOMATERIAL INTERACTION BY MEANS OF A NEW
   QUANTITATIVE DYNAMIC MEASURING PRINCIPLE
SO BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS
LA English
DT Article
C1 UNIV SOFIA,FAC CHEM,BU-1126 SOFIA,BULGARIA.
RP GROTH, T (reprint author), HUMBOLDT UNIV,SCH MED,BIOMAT RES UNIT,O-1040 BERLIN,GERMANY.
OI Groth, Thomas/0000-0001-6647-9657
CR HOCHMUTH RM, 1973, BIOPHYS J, V13, P747, DOI 10.1016/S0006-3495(73)86021-7
   SALZMAN E, 1963, J LAB CLIN MED, V62, P724
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184
   ZAPRYANOV Z, 1980, INT J HEAT MASS TRAN, V23, P873, DOI 10.1016/0017-9310(80)90042-3
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0890-5533
J9 BIOMATER ARTIF CELL
PY 1990
VL 18
IS 4
BP 517
EP 522
DI 10.3109/10731199009119627
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EK417
UT WOS:A1990EK41700009
PM 2285815
DA 2018-10-20
ER

PT J
AU GRAHAM, TR
   DASSE, K
   COUMBE, A
   SALIH, V
   MARRINAN, MT
   FRAZIER, OH
   LEWIS, CT
AF GRAHAM, TR
   DASSE, K
   COUMBE, A
   SALIH, V
   MARRINAN, MT
   FRAZIER, OH
   LEWIS, CT
TI NEOINTIMAL DEVELOPMENT ON TEXTURED BIOMATERIAL SURFACES DURING CLINICAL
   USE OF AN IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICE
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 3RD ANNUAL MEETING OF THE EUROPEAN ASSOC FOR CARDIO-THORACIC SURGERY
CY OCT 09-11, 1989
CL MUNICH, FED REP GER
SP EUROPEAN ASSOC CARDIOTHORAC SURG
RP GRAHAM, TR (reprint author), LONDON HOSP,DEPT CARDIOTHORAC SURG,LONDON E1 1BB,ENGLAND.
NR 0
TC 50
Z9 50
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PY 1990
VL 4
IS 4
BP 182
EP 190
DI 10.1016/1010-7940(90)90002-H
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CZ819
UT WOS:A1990CZ81900002
PM 2334559
DA 2018-10-20
ER

PT J
AU EMCH, R
   CLIVAZ, X
   TAYLORDENES, C
   VAUDAUX, P
   DESCOUTS, P
AF EMCH, R
   CLIVAZ, X
   TAYLORDENES, C
   VAUDAUX, P
   DESCOUTS, P
TI SCANNING TUNNELING MICROSCOPY FOR STUDYING THE BIOMATERIAL BIOLOGICAL
   TISSUE INTERFACE
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS
LA English
DT Article; Proceedings Paper
CT 4TH INTERNATIONAL CONF ON SCANNING TUNNELING MICROSCOPY/SPECTROSCOPY
CY JUL 09-14, 1989
CL OARAI CULTURE CTR, OARAI, JAPAN
SP JAPAN SOC APPL PHYS, AMER VACUUM SOC, COMMORAT ASSOC JAPAN WORLD EXPOSIT, JAPAN IRON & STEEL FEDERAT, HITACHI
HO OARAI CULTURE CTR
RP EMCH, R (reprint author), UNIV GENEVA,APPL PHYS GRP,20 RUE ECOLE MED,CH-1211 GENEVA 4,SWITZERLAND.
CR AMREIN M, 1988, SCIENCE, V240, P514, DOI 10.1126/science.3358130
   AMREIN M, 1989, SCIENCE, V243, P1708, DOI 10.1126/science.2928803
   ARSCOTT PG, 1989, NATURE, V339, P484, DOI 10.1038/339484a0
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   EMCH R, 1988, J MICROSC-OXFORD, V152, P85, DOI 10.1111/j.1365-2818.1988.tb01365.x
   EMCH R, 1988, J MICROSC-OXFORD, V152, P129, DOI 10.1111/j.1365-2818.1988.tb01370.x
   EMCH R, 1989, J APPL PHYS, V65, P79, DOI 10.1063/1.343379
   ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673
   FOSTER JS, 1988, NATURE, V333, P542, DOI 10.1038/333542a0
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   LYDING JW, 1988, REV SCI INSTRUM, V59, P1897, DOI 10.1063/1.1140047
   MIRANDA R, 1985, APPL PHYS LETT, V47, P367, DOI 10.1063/1.96167
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
NR 15
TC 13
Z9 13
U1 0
U2 1
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0734-2101
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A-Vac. Surf. Films
PD JAN-FEB
PY 1990
VL 8
IS 1
BP 655
EP 658
DI 10.1116/1.576366
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA CL594
UT WOS:A1990CL59400150
DA 2018-10-20
ER

PT J
AU THULL, R
AF THULL, R
TI SEMICONDUCTIVE PROPERTIES OF PASSIVATED TITANIUM AND TITANIUM BASED HARD
   COATINGS ON METALS FOR IMPLANTS - AN EXPERIMENTAL APPROACH
SO MEDICAL PROGRESS THROUGH TECHNOLOGY
LA English
DT Article
DE BIOMATERIAL; HIP JOINT IMPLANT; TOOTH IMPLANT; HARD COATING;
   SEMICONDUCTIVE SURFACE LAYERS
ID FILMS
AB Titanium is used in the field of dental implants on account of the fact that they are integrated into body tissue virtually reaction-free.  This integration is made possible by the passivated layers which form within the body electrolyte, and which can be described in the terms of a semiconductive solid body.  A prerequisite, however, is the prevention of relative movement between the implant and the tissue so that the passivated layer is not destroyed.  The low resistance to shearing, and the oxide stoichiometry - which under in vivo conditions cannot be influenced - on repassivation following mechanical destruction strongly suggest that, during fabrication, implants should be provided with wear-resistant coatings having defined solid state properties which are similiar to those of electrochemically passivated titanium surfaces.  In the clinical test are already employed, a (Ti,Nb)ON- and a (Ti,Zr)O-coating on titanium and TiAl5Fe2.5.  One of the most important parameters for the solid body-physical description of semiconductive hard coatings is the energy gap between conduction and valence band of the electronic structure, which are determinative for the physical-chemical behaviour of the implant surface within the body.  The contribution describes the experimental procedure and the results of determinations of the energy gap at singularities in the Brillouin zone for titanium, the titanium alloys in clinical use, and some hard coatings in clinical test.  The experimental method of choice for surfaces in contact with aqueous electrolytes is the electroreflectance spectroscopy.
RP THULL, R (reprint author), BAVARIAN JULIUS MAXIMILIANS UNIV,DEPT ORAL MED,DIV EXPTL DENT MED,PLEICHERWALL 2,W-8700 WURZBURG,GERMANY.
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   BERGMANNSCHAEFER, 1978, LEHRBUCH EXPERIMENTA, V3
   BLONDEAU G, 1979, J ELECTROCHEM SOC, V126, P1592, DOI 10.1149/1.2129337
   BUTLER MA, 1977, J APPL PHYS, V48, P1914, DOI 10.1063/1.323948
   CARDONA M, 1965, PHYS REV, V137, P1467, DOI 10.1103/PhysRev.137.A1467
   Cardona M., 1969, MODULATION SPECTROSC
   CREIGHTON TE, 1989, PROTEINS STRUCTURES
   DANSLAX, 1970, TASCHERBUCH CHEM PHY, V3
   DIQUARTO F, 1986, BER BUNSEN PHYS CHEM, V90, P549
   FORVA A, 1966, PHYS REV, V157, P700
   FRANZ W, 1958, Z NATURFORSCH PT A, V13, P484
   GALLA HJ, 1988, SPEKTORSKOPISCHE MET
   Gerischer H., 1961, Z PHYS CHEM, V27, P48
   GOBRECHT H, 1970, BERICH BUNSEN GESELL, V74, P1234
   Gurney RW, 1931, P R SOC LOND A-CONTA, V134, P137, DOI 10.1098/rspa.1931.0187
   KELDYSH LV, 1958, ZH EKSP TEOR FIZ, V7, P788
   MAKKVILLEN AD, 1958, TITAN MOSKAU METALUR, V18
   MCINTYRE JDT, 1972, SPECULAR REFLECTION
   Morrison S. R., 1980, ELECTROCHEMISTRY SEM
   MOTT NF, 1979, ELECTRONIC PROCESSES
   PAATSCH W, 1975, BER BUNSEN PHYS CHEM, V79, P922, DOI 10.1002/bbpc.19750791016
   PESANT JC, 1980, J ELECTROANAL CHEM, V106, P103, DOI 10.1016/0368-1874(80)80020-7
   SCHULTZE JW, 1985, MATER SCI ENG, V69, P273, DOI 10.1016/0025-5416(85)90323-4
   SIEVERS H, 1991, UNPUB
   SIGURD D, 1981, SOL CELLS, V5, P81, DOI 10.1016/0379-6787(81)90018-1
   THULL R, 1986, P C BRISTOL
   TUMMLER HP, 1986, THESIS U ERLANGEN NU
   Vijh A. K., 1973, ELECTROCHEMISTRY MET
   VOGELZANG E, 1987, J APPL PHYS, V61, P4606, DOI 10.1063/1.338370
NR 29
TC 15
Z9 15
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0047-6552
J9 MED PROG TECHNOL
JI Med. Prog. Technol.
PY 1990
VL 16
IS 4
BP 225
EP 234
PG 10
WC Engineering, Biomedical
SC Engineering
GA FM668
UT WOS:A1990FM66800005
PM 2151668
DA 2018-10-20
ER

PT B
AU GRISTINA, AG
   NAYLOR, PT
   MYRVIK, QN
AF GRISTINA, AG
   NAYLOR, PT
   MYRVIK, QN
BE WADSTROM, T
   ELIASSON, I
   HOLDER, I
   LJUNGH, A
TI BIOMATERIAL-CENTERED INFECTIONS - MICROBIAL ADHESION VERSUS TISSUE
   INTEGRATION
SO PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS
LA English
DT Proceedings Paper
CT WORKSHOP ON PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS
CY AUG 30-SEP 01, 1989
CL HELSINGOR, DENMARK
SP NORD IND FDN, ROYAL PHYSIOG SOC, SWEDISH BOARD TECH DEV, SWEDISH DEFENCE RES ESTABLISHMENT, SWEDISH MED RES COUNCIL, ASTRA LAKEMEDEL, BAYER SWEDEN, BIODISK, BIOGRAM, COLOPLAST
NR 0
TC 17
Z9 17
U1 2
U2 8
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA BERLIN
BN 3-540-19596-3
PY 1990
BP 193
EP 216
PG 24
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental;
   Pathology
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine;
   Pathology
GA BS27G
UT WOS:A1990BS27G00024
DA 2018-10-20
ER

PT B
AU URRY, DW
   JAGGARD, J
   HARRIS, RD
   CHANG, DK
   PRASAD, KU
AF URRY, DW
   JAGGARD, J
   HARRIS, RD
   CHANG, DK
   PRASAD, KU
BE GEBELEIN, CG
   DUNN, RL
TI THE POLY(NONAPEPTIDE) OF ELASTIN - A NEW ELASTOMERIC POLYPEPTIDE
   BIOMATERIAL
SO PROGRESS IN BIOMEDICAL POLYMERS
LA English
DT Proceedings Paper
CT SYMP AT THE 196TH NATIONAL MEETING OF THE AMERICAN CHEMICAL SOC
CY SEP 25-30, 1988
CL LOS ANGELES, CA
SP AMER CHEM SOC, DIV POLYM MAT SCI & ENGN
NR 0
TC 1
Z9 1
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA NEW YORK
BN 0-306-43523-3
PY 1990
BP 171
EP 178
PG 8
WC Engineering, Biomedical; Polymer Science
SC Engineering; Polymer Science
GA BR34U
UT WOS:A1990BR34U00018
DA 2018-10-20
ER

PT J
AU HSIUE, GH
   CHU, HL
AF HSIUE, GH
   CHU, HL
TI BIGRAFT COPOLYMER EVA-G-AA-G-HEMA FOR BIOMATERIAL USAGE
SO ANGEWANDTE MAKROMOLEKULARE CHEMIE
LA English
DT Article
RP HSIUE, GH (reprint author), NATL TSING HUA UNIV,DEPT CHEM ENGN,HSINCHU 30043,TAIWAN.
CR HEMSY CA, 1970, J BIOMED MATER RES, V4, P341
   HSIUE GH, 1985, J APPL POLYM SCI, V30, P1023, DOI 10.1002/app.1985.070300312
   HSIUE GH, IN PRESS J APPL POLY
   HSIUE GM, 1985, J CHINESE I CHEM ENG, V16, P57
   KAIFU K, 1982, J BIOMED MATER RES, V16, P757, DOI 10.1002/jbm.820160602
   KIRALY R J, 1974, Biomaterials Medical Devices and Artificial Organs, V2, P207
   MORI Y, 1982, J BIOMED MATER RES, V16, P16
   Ratner B. D, 1976, HYDROGELS MEDICAL RE, V31, P1
   REFOJO MF, 1967, J APPL POLYM SCI, V11, P407, DOI 10.1002/app.1967.070110308
   REFOJO MF, 1967, J POLYM SCI A1, V5, P3103, DOI 10.1002/pol.1967.150051211
   SEVCIK S, 1967, J POLYM SCI C, V16, P821
   STAMBERG J, 1966, COLLECT CZECH CHEM C, V31, P1009, DOI 10.1135/cccc19661009
   WHITE ML, 1960, J PHYS CHEM-US, V64, P1563, DOI 10.1021/j100839a055
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V125, P108
   YASUDA H, 1968, MAKROMOL CHEM, V118, P19
   YASUDA H, 1967, J POLYM SCI A1, V5, P2952, DOI 10.1002/pol.1967.150051125
   YASUDA H, 1966, J POLYM SCI A1, V4, P1314, DOI 10.1002/pol.1966.150040529
NR 18
TC 7
Z9 7
U1 0
U2 0
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 0003-3146
J9 ANGEW MAKROMOL CHEM
JI Angew. Makromol. Chem.
PD DEC
PY 1989
VL 173
BP 195
EP 204
DI 10.1002/apmc.1989.051730115
PG 10
WC Polymer Science
SC Polymer Science
GA CK156
UT WOS:A1989CK15600015
DA 2018-10-20
ER

PT J
AU LEFEBVRE, F
   DROUILLET, F
   DELARCLAUSE, AMS
   APRAHAMIAN, M
   MIDY, D
   BORDENAVE, L
   RABAUD, M
AF LEFEBVRE, F
   DROUILLET, F
   DELARCLAUSE, AMS
   APRAHAMIAN, M
   MIDY, D
   BORDENAVE, L
   RABAUD, M
TI REPAIR OF EXPERIMENTAL ARTERIOTOMY IN RABBIT AORTA USING A NEW
   RESORBABLE ELASTIN-FIBRIN BIOMATERIAL
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 UNIV BORDEAUX 2,INSERM,U61-3,AVE MOLIERE,F-67200 STRASBOURG,FRANCE.
   UNIV BORDEAUX 2,INSERM,U306,CEEMASI,F-33076 BORDEAUX,FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   BARBIE C, IN PRESS BIOMATERIAL
   BIETH JR, 1985, BIOL EXTRACELLULAR M, P217
   BUSUTTIL RW, 1982, J SURG RES, V32, P214, DOI 10.1016/0022-4804(82)90093-2
   CAMPA JS, 1987, ATHEROSCLEROSIS, V65, P13, DOI 10.1016/0021-9150(87)90003-7
   CAZENAVE JP, 1986, MATERIAUX ORIGINE BI
   COHEN JR, 1987, SURG GYNECOL OBSTET, V164, P355
   COHEN JR, 1987, SURG GYNECOL OBSTET, V165, P301
   DUBICK MA, 1986, CLIN RES, V34, pA28
   GRAVELINE J, 1986, EXPERIENTIA, V42, P830, DOI 10.1007/BF01941542
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   JONAS RA, 1987, ANN THORAC SURG, V44, P283, DOI 10.1016/S0003-4975(10)62075-9
   MARESCAUX J, 1988, 3RD WORLD BIOM C KYO
   MARTIN MT, 1988, BIOMATERIALS, V9, P519, DOI 10.1016/0142-9612(88)90048-8
   RABAUD M, 1984, CONNECT TISSUE RES, V12, P165, DOI 10.3109/03008208408992781
   RABAUD M, 1986, THROMB RES, V43, P205, DOI 10.1016/0049-3848(86)90061-7
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
   ROBERT L, 1980, FRONTIERS MATRIX BIO, V8, P130
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
NR 20
TC 8
Z9 8
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1989
VL 23
IS 12
BP 1423
EP 1432
DI 10.1002/jbm.820231205
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ570
UT WOS:A1989AZ57000004
PM 2621215
DA 2018-10-20
ER

PT J
AU BARBIE, C
   ANGIBAUD, C
   DARNIS, T
   LEFEBVRE, F
   RABAUD, M
   APRAHAMIAN, M
AF BARBIE, C
   ANGIBAUD, C
   DARNIS, T
   LEFEBVRE, F
   RABAUD, M
   APRAHAMIAN, M
TI SOME FACTORS AFFECTING PROPERTIES OF ELASTIN FIBRIN BIOMATERIAL
SO BIOMATERIALS
LA English
DT Article
C1 INSERM,U61,F-67200 STRASBOURG,FRANCE.
RP RABAUD, M (reprint author), UNIV BORDEAUX 2,INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR APRAHAMIAN M, 1985, AM J CLIN NUTR, V41, P578
   APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   CHARLESBY A, 1987, POLYM J, V19, P649, DOI 10.1295/polymj.19.649
   DARBORD JC, 1987, INT J PHARMACEUT, V37, P1, DOI 10.1016/0378-5173(87)90002-0
   GIET A, 1968, RESISTANCE MATERIAUX
   GUIDOIN R, 1987, J BIOMED MATER RES, V21, P65, DOI 10.1002/jbm.820210111
   MARESCAUX J, 1988, 3RD WORLD BIOM C KYO
   MARTIN MT, 1988, BIOMATERIALS, V9, P519, DOI 10.1016/0142-9612(88)90048-8
   POOL JG, 1965, NEW ENGL J MED, V273, P1443, DOI 10.1056/NEJM196512302732701
   RABAUD M, 1987, BIOMATERIALS, V8, P217, DOI 10.1016/0142-9612(87)90067-6
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
NR 11
TC 12
Z9 13
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1989
VL 10
IS 7
BP 445
EP 448
DI 10.1016/0142-9612(89)90084-7
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR988
UT WOS:A1989AR98800003
PM 2508780
DA 2018-10-20
ER

PT J
AU CAPSON, DW
   MALUDZINSKI, RA
   FEUERSTEIN, IA
AF CAPSON, DW
   MALUDZINSKI, RA
   FEUERSTEIN, IA
TI MICROCOMPUTER-BASED INTERACTIVE TRACKING OF BLOOD-CELLS AT BIOMATERIAL
   SURFACES
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Note
C1 MCMASTER UNIV,DEPT CHEM ENGN,HAMILTON L8S 4L7,ONTARIO,CANADA.
   MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L7,ONTARIO,CANADA.
RP CAPSON, DW (reprint author), MCMASTER UNIV,DEPT ELECT & COMP ENGN,HAMILTON L8S 4L7,ONTARIO,CANADA.
CR ABSOLOM DR, 1984, BIOMATER ARTIF CELL, V12, P235, DOI 10.3109/10731198409118834
   ADAMS GA, 1981, AM J PHYSIOL, V240, pH99
   ADAMS GA, 1981, ASAIO J, V4, P90
   BORETOS JW, 1984, CONT BIOMATERIALS MA
   FERRIE FP, 1982, IEEE T PATTERN ANAL, V4, P277, DOI 10.1109/TPAMI.1982.4767244
   FEUERSTEIN IA, 1987, THROMB RES, V46, P751, DOI 10.1016/0049-3848(87)90278-7
   FEUERSTEIN IA, 1986, J BIOMECH ENG-T ASME, V108, P49, DOI 10.1115/1.3138579
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595
   Huang T. S, 1983, IMAGE SEQUENCE PROCE
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LEONARD EF, 1987, ANN NY ACAD SCI, V516
   LEVINE MD, 1980, IEEE T PATTERN ANAL, V2, P444, DOI 10.1109/TPAMI.1980.6592365
   MALUDZINSKI RA, 1987, IEEE T INSTRUM MEAS, V36, P928, DOI 10.1109/TIM.1987.6312584
   MARTIN WN, 1978, COMPUT GRAPH IMAGE P, V7, P365
   NAGEL HH, 1978, 4TH P INT JOINT C PA, P186
   VROMAN L, 1987, ANN NY ACAD SCI, V283
NR 17
TC 12
Z9 12
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD AUG
PY 1989
VL 36
IS 8
BP 860
EP 864
DI 10.1109/10.30814
PG 5
WC Engineering, Biomedical
SC Engineering
GA AF595
UT WOS:A1989AF59500009
PM 2759646
DA 2018-10-20
ER

PT J
AU REYNOLDS, PS
   COUMBE, A
   SALIH, V
   GRAHAM, TR
   LEWIS, CT
   BERRY, CL
AF REYNOLDS, PS
   COUMBE, A
   SALIH, V
   GRAHAM, TR
   LEWIS, CT
   BERRY, CL
TI EVALUATION OF THE BLOOD BIOMATERIAL INTERFACE WITHIN PERFUSION CHAMBERS
   IN AN INVITRO CIRCULATORY LOOP
SO JOURNAL OF PATHOLOGY
LA English
DT Meeting Abstract
C1 LONDON HOSP,DEPT MORBID ANAT,LONDON E1 1BB,ENGLAND.
   LONDON HOSP,DEPT EXPTL SURG,LONDON E1 1BB,ENGLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0022-3417
J9 J PATHOL
JI J. Pathol.
PD AUG
PY 1989
VL 158
IS 4
BP A353
EP A353
PG 1
WC Oncology; Pathology
SC Oncology; Pathology
GA AL388
UT WOS:A1989AL38800191
DA 2018-10-20
ER

PT J
AU FERRARO, FT
   SALCMAN, M
   BROADWELL, RD
   SEWCHAND, W
   NEUBERTH, G
AF FERRARO, FT
   SALCMAN, M
   BROADWELL, RD
   SEWCHAND, W
   NEUBERTH, G
TI ALUMINA CERAMIC AS A BIOMATERIAL FOR USE IN AFTERLOADING RADIATION
   CATHETERS FOR HYPERTHERMIA
SO NEUROSURGERY
LA English
DT Article
C1 NURAD INC, BALTIMORE, MD USA.
   UNIV MARYLAND, DIV NEUROL SURG, NEUROONCOL SERV, BALTIMORE, MD 21201 USA.
   UNIV MARYLAND, DEPT PATHOL NEUROPATHOL, BALTIMORE, MD 21201 USA.
   UNIV MARYLAND, DEPT RADIAT ONCOL, BALTIMORE, MD 21201 USA.
CR BRONK BV, 1973, BIOCHEM BIOPH RES CO, V52, P1064, DOI 10.1016/0006-291X(73)91046-2
   COUGHLIN CT, 1985, INT J RADIAT ONCOL, V11, P1673, DOI 10.1016/0360-3016(85)90220-2
   COUGHLIN CT, 1983, RADIOLOGY, V148, P285, DOI 10.1148/radiology.148.1.6344136
   CRILE G, 1963, CANCER RES, V23, P372
   DESIEYES DC, 1981, MED PHYS, V8, P174, DOI 10.1118/1.594930
   DEWHIRST MW, 1984, CANCER RES, V44, P43
   HAHN GM, 1979, CANCER RES, V39, P2264
   HOFER KG, 1976, CANCER, V38, P272
   ROBERTS DW, 1986, J NEUROSURG, V64, P581, DOI 10.3171/jns.1986.64.4.0581
   SALCMAN M, 1984, PROG EXP TUMOR RES, V28, P220
   SALCMAN M, 1981, NEUROSURGERY, V9, P327, DOI 10.1227/00006123-198109000-00021
   Salcman M, 1983, J Neurooncol, V1, P225, DOI 10.1007/BF00165607
   SALCMAN M, 1986, J NEURO-ONCOL, V4, P141, DOI 10.1007/BF00165374
   SALCMAN M, 1986, IEEE T MICROW THEORY, P771
   SALCMAN M, 1979, NEUROONCOLOGY SERIES, V1, P351
   SAMARAS GM, 1982, NATL CANCER I MONOGR, V61, P477
   SEWCHAND W, 1984, J NEURO-ONCOL, V2, P177
   STROHBEHN JW, 1982, IEEE T BIO-MED ENG, V29, P649, DOI 10.1109/TBME.1982.324938
   TAYLOR LS, 1980, P IEEE, V68, P142, DOI 10.1109/PROC.1980.11594
   TAYLOR LS, 1978, IEEE T BIO-MED ENG, V25, P303, DOI 10.1109/TBME.1978.326349
   TREMBLY BS, 1985, IEEE T BIO-MED ENG, V32, P152, DOI 10.1109/TBME.1985.325436
   WINTER A, 1985, NEUROSURGERY, V17, P387, DOI 10.1227/00006123-198509000-00001
NR 22
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0148-396X
EI 1524-4040
J9 NEUROSURGERY
JI Neurosurgery
PD AUG
PY 1989
VL 25
IS 2
BP 209
EP 213
DI 10.1227/00006123-198908000-00009
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA AG185
UT WOS:A1989AG18500009
PM 2770985
DA 2018-10-20
ER

PT J
AU ORLY, I
   GREGOIRE, M
   MENANTEAU, J
   HEUGHEBAERT, M
   KEREBEL, B
AF ORLY, I
   GREGOIRE, M
   MENANTEAU, J
   HEUGHEBAERT, M
   KEREBEL, B
TI CHEMICAL-CHANGES IN HYDROXYAPATITE BIOMATERIAL UNDER INVIVO AND INVITRO
   BIOLOGICAL CONDITIONS
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
C1 ECOLE NATL SUPER CHIM, PHYSICOCHIM SOLIDES LAB, CNRS, UA 445, TOULOUSE, FRANCE.
RP ORLY, I (reprint author), INSERM, U225, UER ODONTOL, PL ALEXIS RICORDEAU, F-44042 NANTES 01, FRANCE.
RI GREGOIRE, Marc/G-2867-2013
OI GREGOIRE, Marc/0000-0003-3868-0198
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   BLUMENTHAL NC, 1979, CALCIFIED TISSUE INT, V27, P75, DOI 10.1007/BF02441164
   BONEL G, IN PRESS ANN NY ACAD
   BONEL G, 1970, THESIS TOULOUSE
   BORKOWF A, 1987, CALCIFIED TISSUE INT, V40, P173, DOI 10.1007/BF02555703
   BOSKEY AL, 1981, CLIN ORTHOP RELAT R, V157, P225
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P115
   DEROOIJ JF, 1984, J COLLOID INTERF SCI, V100, P350, DOI 10.1016/0021-9797(84)90440-5
   DRIESSENS FCM, 1980, B SOC CHIM BELG, V89, P663
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   EVANS RW, 1984, ARTHRITIS RHEUM, V27, P829, DOI 10.1002/art.1780270717
   EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384
   Feenstra L, 1983, BIOCERAMICS CALCIUM, P131
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P634, DOI 10.1097/00006534-197905000-00005
   FLEISCH H, 1980, FUNDAMENTAL CLIN BON, P268
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GREGOIRE M, 1987, BIOL CELL, V59, P255, DOI 10.1111/j.1768-322X.1987.tb00538.x
   HEIMKE G, 1983, BIOCERAMICS CALCIUM, P79
   Hench LL, 1981, FUNDAMENTAL ASPECTS, P67
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LEGEROS RZ, 1967, THESIS NEW YORK U
   Nancollas G. H., 1984, Phosphate Minerals, P137
   POSNER AS, 1979, SKELETAL RES, P167
   RENOOJI W, 1985, CLIN ORTHOP RELAT R, V197, P272
   SCHAFER H, 1979, ZELLCALCIUM ZELLFUNK
   TERMINE JD, 1980, CALCIFIED TISSUE INT, V31, P247, DOI 10.1007/BF02407188
NR 33
TC 65
Z9 65
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0171-967X
EI 1432-0827
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PD JUL
PY 1989
VL 45
IS 1
BP 20
EP 26
DI 10.1007/BF02556656
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AB356
UT WOS:A1989AB35600006
PM 2504459
DA 2018-10-20
ER

PT J
AU ISSAHAKIAN, S
   OUHAYOUN, JP
   SHABANA, H
   SAWAF, H
AF ISSAHAKIAN, S
   OUHAYOUN, JP
   SHABANA, H
   SAWAF, H
TI EVALUATION OF A NEW BIOMATERIAL IN PERIODONTAL DEFECTS - NATURAL CORAL
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 FAC CHIRURG DENT PARIS,PARIS 7,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 1989
VL 68
IS 4
BP 643
EP 643
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA U3417
UT WOS:A1989U341700854
DA 2018-10-20
ER

PT J
AU WATANABE, M
   ASAHINA, I
   HARADA, K
   MORI, M
   ENOMOTO, S
AF WATANABE, M
   ASAHINA, I
   HARADA, K
   MORI, M
   ENOMOTO, S
TI EXPERIMENTAL-STUDY ON BONE-INDUCTIVE BIOMATERIAL
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 TOKYO MED & DENT UNIV,DEPT ORAL & MAXILLOFACIAL SURG 2,TOKYO 113,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 1989
VL 68
IS 4
BP 668
EP 668
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA U3417
UT WOS:A1989U341701003
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   DENNIS, JW
   ENDEAN, ED
   ELLINGER, J
   FRIESEL, R
   BURGESS, W
AF GREISLER, HP
   DENNIS, JW
   ENDEAN, ED
   ELLINGER, J
   FRIESEL, R
   BURGESS, W
TI MACROPHAGE BIOMATERIAL INTERACTIONS - THE STIMULATION OF
   ENDOTHELIALIZATION
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
C1 VET ADM HOSP,HINES,IL 60141.
   AMER RED CROSS,DEPT MOLEC BIOL,ROCKVILLE,MD.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
CR BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BIANCO C, 1981, METHODS STUDYING MON, P273
   BITTERMAN PB, 1982, J CLIN INVEST, V70, P806, DOI 10.1172/JCI110677
   BRANT AM, 1986, ARTIF ORGANS, V10, P419, DOI 10.1111/j.1525-1594.1986.tb02591.x
   BRANT AM, 1987, J APPL PHYSIOL, V62, P679
   GLENN KC, 1981, CELL, V25, P603, DOI 10.1016/0092-8674(81)90168-9
   GREENBURG GB, 1978, J CELL PHYSIOL, V97, P353, DOI 10.1002/jcp.1040970310
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1986, VASCULAR GRAFT UPDAT, P197
   GREISLER HP, 1987, SURG FORUM, V36, P323
   LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501
   MARTIN BM, 1981, J IMMUNOL, V126, P1510
   MARTINET Y, 1986, NATURE, V319, P158, DOI 10.1038/319158a0
   NATHAN CF, 1980, NEW ENGL J MED, V303, P622, DOI 10.1056/NEJM198009113031106
   PHAM S M, 1988, Surgical Forum (Chicago), V39, P330
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   Sumpio B E, 1987, J Vasc Surg, V6, P252
   SUMPIO BE, 1988, FASEB J, V2, pA419
   THAKRAL KK, 1979, J SURG RES, V24, P430
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
NR 26
TC 36
Z9 36
U1 0
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD APR
PY 1989
VL 9
IS 4
BP 588
EP 593
DI 10.1067/mva.1989.vs0090588
PG 6
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA U4252
UT WOS:A1989U425200013
PM 2523491
DA 2018-10-20
ER

PT B
AU SCHNUR, JM
   CALVERT, J
   PECKERAR, M
   SCHOEN, P
   MARRIAN, C
   PRICE, R
   SINGH, A
   RUDOLPH, A
   GEORGER, J
   STOCKTON, W
   DULCEY, C
   TESTOFF, M
AF SCHNUR, JM
   CALVERT, J
   PECKERAR, M
   SCHOEN, P
   MARRIAN, C
   PRICE, R
   SINGH, A
   RUDOLPH, A
   GEORGER, J
   STOCKTON, W
   DULCEY, C
   TESTOFF, M
BE KIM, Y
   SPELMAN, FA
TI BIO TECHNOLOGICAL AND BIOMATERIAL APPLICATIONS OF SELF ASSEMBLY
SO IMAGES OF THE TWENTY-FIRST CENTURY, PTS 1-6
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 1989 ANNUAL INTERNATIONAL CONF OF THE IEEE ENGINEERING IN MEDICINE AND
   BIOLOGY SOC : IMAGES OF THE TWENTY-FIRST CENTURY
CY NOV 09-12, 1989
CL SEATTLE, WA
SP IEEE, ENGN MED & BIOL SOC
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA NEW YORK
J9 P IEEE EMBS
PY 1989
VL 11
BP 1373
EP 1374
DI 10.1109/IEMBS.1989.96247
PG 2
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BQ05S
UT WOS:A1989BQ05S00701
DA 2018-10-20
ER

PT J
AU HOFFMAN, AS
AF HOFFMAN, AS
TI COMBINING NOVEL BIOMOLECULES AND STIMULI-SENSITIVE BIOMATERIALS INTO NEW
   RECOGNITION RESPONSE BIOMATERIAL SYSTEMS
SO ARTIFICIAL ORGANS
LA English
DT Article
RP HOFFMAN, AS (reprint author), UNIV WASHINGTON,CTR BIOENGN,FL-20,SEATTLE,WA 98195, USA.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD DEC
PY 1988
VL 12
IS 6
BP 504
EP 505
DI 10.1111/j.1525-1594.1988.tb02813.x
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA R2891
UT WOS:A1988R289100009
PM 3214330
DA 2018-10-20
ER

PT J
AU CHINN, JA
   HORBETT, TA
   RATNER, BD
AF CHINN, JA
   HORBETT, TA
   RATNER, BD
TI SHEAR-STRESS INDUCED PLATELET REFRACTORINESS IN BLOOD-BIOMATERIAL
   EVALUATIONS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 25
PY 1988
VL 196
BP 52
EP PMSE
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA P8142
UT WOS:A1988P814203668
DA 2018-10-20
ER

PT J
AU MURTHY, KD
   SIMMONS, SR
   ALBRECHT, RM
   COOPER, SL
AF MURTHY, KD
   SIMMONS, SR
   ALBRECHT, RM
   COOPER, SL
TI IMMUNOGOLD STAINING OF FIBRINOGEN ON BIOMATERIAL SURFACES - THE EFFECT
   OF LABELING CONDITIONS
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
C1 UNIV WISCONSIN,DEPT CHEM ENGN,MADISON,WI 53706.
   UNIV WISCONSIN,DEPT VET SCI,MADISON,WI 53706.
CR ALBRECHT RM, 1986, SCANNING MICROSCOPY, V4, P185
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BARBER TA, 1979, SCANNING ELECTR MICR, V3, P881
   BAUER H, 1975, EXPERIENTIA, V31, P1149, DOI 10.1007/BF02326762
   BENKO B, 1975, J COLLOID INTERFACE, V57, P444
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   BRASH JL, 1971, CHEMISTRY BIOSURFACE, V1, P177
   CHUANG HYK, 1984, J BIOMED MATER RES, V18, P547, DOI 10.1002/jbm.820180508
   COLLER BS, 1979, BLOOD, V53, P325
   DEBAILLOU N, 1984, J COLLOID INTERF SCI, V100, P167, DOI 10.1016/0021-9797(84)90422-3
   Doolittle R F, 1973, Adv Protein Chem, V27, P1, DOI 10.1016/S0065-3233(08)60446-5
   FEDER J, 1980, J COLLOID INTERF SCI, V78, P144, DOI 10.1016/0021-9797(80)90502-0
   GRANT WH, 1977, J BIOMED MATER RES S, V8, P33
   HAMILTON WC, 1972, J COLLOID INTERF SCI, V40, P219, DOI 10.1016/0021-9797(72)90011-2
   HENNINK WE, 1983, T AM SOC ART INT ORG, V29, P200
   Hlady V., 1985, SURFACE INTERFACIAL, V2, P81
   HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295, DOI 10.1177/25.4.323352
   JAKOBSEN E, 1973, Thrombosis Research, V3, P145, DOI 10.1016/0049-3848(73)90065-0
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LELAH MD, 1985, J BIOMED MATER RES, V19, P1101
   MCMILLIN CR, 1974, J COLLOID INTERF SCI, V48, P345, DOI 10.1016/0021-9797(74)90170-2
   MORRISSEY BW, 1978, J COLLOID INTERF SCI, V65, P423, DOI 10.1016/0021-9797(78)90093-0
   MURTHY KD, 1986, THESIS U WISCONSIN M, P139
   MURTHY KD, 1987, SCAN MICROSC, V2, P765
   NORDE W, 1980, ADHESION ADSORPTION, V2, P801
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PARK K, 1987, SCANNING MICROSCOPY, V1, P339
   Park K., COMMUNICATION
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PILZ I, 1970, BIOCHEMISTRY-US, V9, P211, DOI 10.1021/bi00804a004
   RASMUSSEN JR, 1977, J AM CHEM SOC, V99, P4736, DOI 10.1021/ja00456a035
   RICCITELLI SD, 1984, T AM SOC ART INT ORG, V30, P420
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   RUDEE ML, 1981, ULTRAMICROSCOPY, V7, P193, DOI 10.1016/0304-3991(81)90010-3
   VROMAN L, 1983, BIOCOMPATIBLE POLYM, P81
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   YOUNG BR, 1983, T AM SOC ART INT ORG, V29, P442
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
   YOUNG BR, 1982, BIOMATERIALS INTERFA, P317
NR 41
TC 2
Z9 2
U1 0
U2 3
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD SEP
PY 1988
VL 125
IS 1
BP 176
EP 189
DI 10.1016/0021-9797(88)90067-7
PG 14
WC Chemistry, Physical
SC Chemistry
GA Q4310
UT WOS:A1988Q431000020
DA 2018-10-20
ER

PT J
AU MUTLU, M
   ERCAN, MT
AF MUTLU, M
   ERCAN, MT
TI KINETICS OF RADIOLABELED PLASMA-PROTEINS AT INTERFACE WITH BIOMATERIAL
   SURFACES
SO EUROPEAN JOURNAL OF NUCLEAR MEDICINE
LA English
DT Meeting Abstract
C1 HACETTEPE UNIV,DEPT CHEM ENGN,ANKARA,TURKEY.
   HACETTEPE UNIV,DEPT NUCL MED,ANKARA,TURKEY.
RI MUTLU, MEHMET/B-3240-2013
OI MUTLU, MEHMET/0000-0001-9610-9817
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-6997
J9 EUR J NUCL MED
JI Eur. J. Nucl. Med.
PD AUG
PY 1988
VL 14
IS 5-6
BP 288
EP 288
PG 1
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA R0411
UT WOS:A1988R041100396
DA 2018-10-20
ER

PT J
AU KASEMO, B
   LAUSMAA, J
AF KASEMO, B
   LAUSMAA, J
TI BIOMATERIAL AND IMPLANT SURFACES - ON THE ROLE OF CLEANLINESS,
   CONTAMINATION, AND PREPARATION PROCEDURES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH-APPLIED BIOMATERIALS
LA English
DT Article
C1 INST APPL BIOTECHNOL,S-40033 GOTHENBURG,SWEDEN.
RP KASEMO, B (reprint author), CHALMERS UNIV TECHNOL,DEPT PHYS,S-41296 GOTHENBURG,SWEDEN.
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, PHYSICOCHEMICAL ASPE, V2, P895
   BAIER RE, 1970, 176 CALSP REP
   BRANEMARK PI, 1986, Patent No. 447445
   Chapman B., 1980, GLOW DISCHARGE PROCE
   Czanderna AW, 1975, METHODS SURFACE ANAL
   KANE PF, 1974, CHARACTERIZATION SOL
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, IN PRESS PROGR BIOME
   Kasemo B, 1985, TISSUE INTEGRATED PR, P99
   KING DA, 1983, CHEM PHYSICS HETEROG, V1
   Lausmaa J, 1986, MATER RES SOC S P, V55, P351
   LAUSMAA J, UNPUB
   LAUSMAA J, IN PRESS ADV BIOMEDI
   MATTSSON M, 1982, INT J ENVIRON AN CH, V11, P211, DOI 10.1080/03067318208078312
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   VANSTEENBERGHE D, 1986, TISSUE INTEGRATION O, P509
   ZARB GA, 1985, TISSUE INTEGRATED PR
   Zisman W. A, 1964, ADV CHEM SER, P1
   ZORIC I, 1986, CHEM SCRIPTA, V26, P409
NR 22
TC 171
Z9 173
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
J9 J BIOMED MATER RES-A
PD AUG
PY 1988
VL 22
IS A2
SU S
BP 145
EP 158
DI 10.1002/jbm.820221307
PG 14
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA P7253
UT WOS:A1988P725300005
PM 3209600
DA 2018-10-20
ER

PT J
AU JAYABALAN, M
   SREENIVASAN, K
   NAIR, PD
   JALAJAMANI, KN
AF JAYABALAN, M
   SREENIVASAN, K
   NAIR, PD
   JALAJAMANI, KN
TI THERMAL-ANALYSIS OF USED AND RADIATION TREATED POLYCARBONATE (L-MW)
   BIOMATERIAL
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
RP JAYABALAN, M (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TECH EVALUAT BIOMAT,BIOMED TECHNOL WING,TRIVANDRUM 695012,INDIA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD MAY
PY 1988
VL 10
IS 3
BP 257
EP 261
DI 10.1007/BF02744072
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA N8216
UT WOS:A1988N821600011
DA 2018-10-20
ER

PT J
AU HSIUE, GH
   YANG, JM
   WU, RL
AF HSIUE, GH
   YANG, JM
   WU, RL
TI PREPARATION AND PROPERTIES OF A BIOMATERIAL - HEMA GRAFTED SBS BY
   GAMMA-RAY IRRADIATION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
RP HSIUE, GH (reprint author), NATL TSING HUA UNIV,DEPT CHEM ENGN,HSINCHU 300,TAIWAN.
CR ATSUMI K, 1978, KYOLITSU KAGAKU, V66
   BEAMISH A, 1977, POLYMER, V18, P49, DOI 10.1016/0032-3861(77)90261-0
   BRANDRUP J, 1975, POLYM HDB, pR4
   CRANK J, 1963, J POLYM SCI, V11, P97
   Flory P. J., 1953, PRINCIPLES POLYM CHE, P541
   FORT RJ, 1976, EUR POLYM J, V12, P685, DOI 10.1016/0014-3057(76)90036-7
   Holden G., 1969, J POLYM SCI        C, VC26, P37
   HOLLY FJ, 1976, ACS SYM SER, V31, P252
   KUSANO T, 1970, B CHEM RES I NONAQUE, V20, P199
   LEININGER RL, 1968, ANN NY ACAD SCI, V146, P3
   Ratner B. D, 1976, HYDROGELS MEDICAL RE, V31, P1
   SEFTON MV, 1976, J POLYM SCI POL CHEM, V14, P1581, DOI 10.1002/pol.1976.170140702
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 13
TC 50
Z9 51
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1988
VL 22
IS 5
BP 405
EP 415
DI 10.1002/jbm.820220504
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA N1649
UT WOS:A1988N164900003
PM 3397379
DA 2018-10-20
ER

PT J
AU SCHOEN, FJ
   HARASAKI, H
   KIM, KM
   ANDERSON, HC
   LEVY, RJ
AF SCHOEN, FJ
   HARASAKI, H
   KIM, KM
   ANDERSON, HC
   LEVY, RJ
TI BIOMATERIAL-ASSOCIATED CALCIFICATION - PATHOLOGY, MECHANISMS, AND
   STRATEGIES FOR PREVENTION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH-APPLIED BIOMATERIALS
LA English
DT Article
C1 VET ADM MED CTR,SHREVEPORT,LA.
   UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103.
   UNIV MICHIGAN,MED CTR,ANN ARBOR,MI 48109.
   HARVARD UNIV,SCH MED,BOSTON,MA 02115.
   CLEVELAND CLIN,CLEVELAND,OH 44106.
   LOUISIANA STATE UNIV,SHREVEPORT,LA 71105.
RP SCHOEN, FJ (reprint author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,75 FRANCIS ST,BOSTON,MA 02115, USA.
FU NHLBI NIH HHS [HL 38118, HL36574]
CR ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341
   ANDERSON HC, 1984, SCANNING ELECTRON MI, V2, P953
   ARBUSTINI E, 1984, AM J CARDIOL, V53, P1388, DOI 10.1016/0002-9149(84)90099-7
   BARNHART GR, 1982, J THORAC CARDIOV SUR, V83, P618
   BERNHARD WF, 1984, J THORAC CARDIOV SUR, V88, P11
   BOSKEY AL, 1977, CALC TISS RES, V22, P197
   BOSKEY AL, 1981, CLIN ORTHOP RELAT R, V157, P225
   BOYAN BD, 1985, SCAN ELECTRON MICROS, V4, P1793
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   COHN LH, 1985, J THORAC CARDIOV SUR, V90, P872
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   CUMMING RD, 1985, DEC DEV TECHN BRANCH
   ENNEVER J, 1980, ATHEROSCLEROSIS, V35, P209, DOI 10.1016/0021-9150(80)90085-4
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FISHBEIN MC, 1982, J THORAC CARDIOV SUR, V83, P602
   GLIMCHER MJ, 1976, HDB PHYSIOLOGY     7, V7, P25
   GLIMCHER MJ, 1985, CALCIUM BIOL SYSTEMS, P607
   GLIMCHER MJ, 1981, CHEM BIOL MINERALIZE, P617
   GOFFIN YA, 1986, BIOL BIOPROSTHETIC V, P405
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLUMB G, 1987, J PHARM SCI, V76, P271
   GOLUMB G, 1986, J CONTROL REL, V4, P181
   HAMMOND GL, 1987, J THORAC CARDIOV SUR, V93, P182
   HARASAKI H, 1980, T AM SOC ART INT ORG, V26, P470
   Harasaki H, 1985, Trans Am Soc Artif Intern Organs, V31, P489
   HARASAKI H, 1987, T AM SOC ART INT ORG, V33, P643
   HIGHMAN WJ, 1971, ACTA CYTOL, V15, P473
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   ISHIHARA T, 1982, J THORAC CARDIOV SUR, V83, P399
   ISHIHARA T, 1981, CIRCULATION, V63, P718, DOI 10.1161/01.CIR.63.3.718
   JOHNSTON TP, 1987, T SOC BIOMATER, V10, P178
   KHAN SR, 1985, HUM PATHOL, V16, P732, DOI 10.1016/S0046-8177(85)80160-X
   KIM KM, 1983, SURV SYN PATHOL RES, V2, P215
   KIM KM, 1976, HUM PATHOL, V7, P47, DOI 10.1016/S0046-8177(76)80005-6
   LENTZ DJ, 1982, T AM SOC ART INT ORG, V28, P494
   LEVY RJ, 1983, AM J CARDIOL, V52, P629, DOI 10.1016/0002-9149(83)90040-1
   LEVY RJ, 1985, CIRCULATION, V71, P349, DOI 10.1161/01.CIR.71.2.349
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   LEVY RJ, 1987, J THORAC CARDIOV SUR, V94, P551
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   LEVY RJ, 1985, CALCIFICATION CARDIA, P661
   LEVY RJ, 1982, ANN THORAC SURG, V62, P313
   LIAN JB, 1981, T AM SOC ARTIF INTER, V26, P683
   MATSUZAWA T, 1971, J HISTOCHEM CYTOCHEM, V19, P801, DOI 10.1177/19.12.801
   PERRESS NS, 1974, CALCIF TISS RES, V14, P275
   POSNER AS, 1985, CLIN ORTHOP RELAT R, V200, P87
   REUL GJ, 1985, J VASC SURG, V2, P192
   RUBEN M, 1975, BRIT J OPHTHALMOL, V59, P141, DOI 10.1136/bjo.59.3.141
   Schoen F J, 1987, J Card Surg, V2, P65, DOI 10.1111/j.1540-8191.1987.tb00174.x
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SCHOEN FJ, 1987, HUM PATHOL, V18, P568, DOI 10.1016/S0046-8177(87)80356-8
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SCHOEN FJ, 1984, J THORAC CARDIOV SUR, V88, P208
   SCHOEN FJ, 1987, J BIOMED MATER RES-A, V21, P91
   SCHOEN FJ, 1987, CIRCULATION, V76, P1061, DOI 10.1161/01.CIR.76.5.1061
   SCHOEN FJ, 1986, AM J PATHOL, V123, P143
   SHANKAR R, 1984, ATHEROSCLEROSIS, V52, P191, DOI 10.1016/0021-9150(84)90117-5
   SHEMIN RJ, IN PRESS J THORAC CA
   TANIMURA A, 1983, P SOC EXP BIOL MED, V172, P173
   TAYLOR KD, 1987, T SOC BIOMATER, V10, P243
   THOMA RJ, 1987, T SOC BIOMATER, V10, P245
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   TSAO JW, 1987, T SOC BIOMATER, V10, P180
   TSAO JW, 1988, IN PRESS BIOMATERIAL
   VALENTE M, 1985, AM J PATHOL, V119, P12
   WEBB CL, 1987, T AM SOC ARTIF INTER, V33, P592
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WHALEN RL, 1980, T AM SOC ART INT ORG, V26, P487
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
   WISSLER RW, 1984, HEART DISEASE TXB CA, P1183
   WOODWARD SC, 1981, T AM SOC ART INT ORG, V27, P697
NR 76
TC 208
Z9 214
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
J9 J BIOMED MATER RES-A
PD APR
PY 1988
VL 22
IS A1
SU S
BP 11
EP 36
PG 26
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA M9880
UT WOS:A1988M988000003
PM 3286652
DA 2018-10-20
ER

PT J
AU GRISTINA, AG
   DOBBINS, JJ
   GIAMMARA, B
   LEWIS, JC
   DEVRIES, WC
AF GRISTINA, AG
   DOBBINS, JJ
   GIAMMARA, B
   LEWIS, JC
   DEVRIES, WC
TI BIOMATERIAL-CENTERED SEPSIS AND THE TOTAL ARTIFICIAL-HEART - MICROBIAL
   ADHESION VS TISSUE INTEGRATION
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
C1 WAKE FOREST UNIV,MED CTR,DEPT PATHOL,WINSTON SALEM,NC 27103.
   BELLARMINE COLL,DEPT BIOL,LOUISVILLE,KY.
   UNIV LOUISVILLE,GRAD PROGRAMS & RES,LOUISVILLE,KY 40292.
   HUMANA HEART INST INT,LOUISVILLE,KY.
RP GRISTINA, AG (reprint author), WAKE FOREST UNIV,MED CTR,ORTHOPED SURG SECT,300 S HAWTHORNE RD,WINSTON SALEM,NC 27103, USA.
FU NIGMS NIH HHS [R01 GM35939-01]; NIADDK NIH HHS [R01 AM26957-05]
CR BALTIMORE RS, 1980, J INFECT DIS, V141, P238, DOI 10.1093/infdis/141.2.238
   BARTH E, 1985, ACTA ORTHOP SCAND, V56, P491, DOI 10.3109/17453678508993042
   BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325
   BIRDWELL CR, 1978, P NATL ACAD SCI USA, V75, P3273, DOI 10.1073/pnas.75.7.3273
   BIRINYI LK, 1987, J VASC SURG, V5, P193, DOI 10.1067/mva.1987.avs0050193
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, BACTERIAL ADHESION M, P279
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DEVRIES WC, 1988, JAMA-J AM MED ASSOC, V259, P886, DOI 10.1001/jama.259.6.886
   DOBBINS JJ, 1988, JAMA-J AM MED ASSOC, V259, P865, DOI 10.1001/jama.259.6.865
   Fletcher M, 1980, BACTERIAL ADHERENC B, V6, P345
   GRISTINA A G, 1980, Orthopaedic Transactions, V4, P355
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P517
   Gristina AG, 1984, INFECT SURG, V3, P655
   GRISTINA AG, 1981, ORTHOP T, V5, P322
   Gristina AG, 1987, PATHOGENICITY CLIN S, P143
   HAMILL RJ, 1986, INFECT IMMUN, V54, P833
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KUNIN CM, 1988, JAMA-J AM MED ASSOC, V259, P860, DOI 10.1001/jama.259.6.860
   LOWY FD, 1983, ANN INTERN MED, V99, P834, DOI 10.7326/0003-4819-99-6-834
   PULVERER G, 1987, PATHOGENESIS CLIN SI
   RYAN US, 1985, FED P, V44, P13
   SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110
   STERN GA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1221, DOI 10.1001/archopht.1985.01050080133033
   SUGARMAN B, 1984, INFECTIONS ASS PROST
   WEBB LX, 1986, J VASC SURG, V4, P16
NR 29
TC 71
Z9 75
U1 0
U2 6
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610
SN 0098-7484
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD FEB 12
PY 1988
VL 259
IS 6
BP 870
EP 874
DI 10.1001/jama.259.6.870
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA L9223
UT WOS:A1988L922300022
PM 3336200
DA 2018-10-20
ER

PT J
AU CAZENAVE, JP
   BERETZ, A
   KLEINSOYER, C
   MAZZUCOTELLI, JP
AF CAZENAVE, JP
   BERETZ, A
   KLEINSOYER, C
   MAZZUCOTELLI, JP
TI UNDERSTANDING THE STRUCTURE OF AN ARTERY IN ORDER TO DESIGN A
   NONTHROMBOGENIC AND CONTRACTILE VASCULAR BIOMATERIAL
SO BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 CTR REG TRANSFUS SANGUINE,INSERM,U311,F-67085 STRASBOURG,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0890-5533
J9 BIOMATER ARTIF CELL
PY 1988
VL 16
IS 4
BP 842
EP 842
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA Q6872
UT WOS:A1988Q687200022
DA 2018-10-20
ER

PT J
AU BARBUCCI, R
   NOCENTINI, M
AF BARBUCCI, R
   NOCENTINI, M
TI FTIR-ATR CHARACTERIZATION OF A NEW BIOMATERIAL CAPABLE TO ADSORB HIGH
   QUANTITY OF HEPARIN
SO MIKROCHIMICA ACTA
LA English
DT Article
RP BARBUCCI, R (reprint author), UNIV SIENA,DEPT CHEM,PIAN MANTELLINI 44,I-53100 SIENA,ITALY.
CR BARBUCCI R, 1986, Patent No. 19094
NR 1
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0026-3672
J9 MIKROCHIM ACTA
JI Mikrochim. Acta
PY 1988
VL 1
IS 1-6
BP 279
EP 282
PG 4
WC Chemistry, Analytical
SC Chemistry
GA Q0165
UT WOS:A1988Q016500064
DA 2018-10-20
ER

PT B
AU MAINARD, D
   BENICHOUX, R
   LOCHON, P
   DELAGOUTTE, JP
   CUNY, J
AF MAINARD, D
   BENICHOUX, R
   LOCHON, P
   DELAGOUTTE, JP
   CUNY, J
BE Harris, G
   Walker, C
TI OSTEOCHONDRAL DEFECT HEALING BY A POROUS PLASTIC BIOMATERIAL (PORIMID-C)
SO PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4
LA English
DT Proceedings Paper
CT 1989 ANNUAL INTERNATIONAL CONF OF THE IEEE ENGINEERING IN MEDICINE AND
   BIOLOGY SOC : IMAGES OF THE TWENTY-FIRST CENTURY
CY NOV 09-12, 1989
CL SEATTLE, WA
SP IEEE, ENGN MED & BIOL SOC
C1 CHU BRABOIS, INST RECH CHIRURG, F-54511 VANDOEUVRE LES NANCY, FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
PY 1988
BP 726
EP 726
PG 1
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical; Radiology,
   Nuclear Medicine & Medical Imaging
SC Cardiovascular System & Cardiology; Engineering; Radiology, Nuclear
   Medicine & Medical Imaging
GA BP88P
UT WOS:A1988BP88P00374
DA 2018-10-20
ER

PT J
AU MCGRATH, TJ
   SHIVELY, MJ
   HERRON, MR
   GREEN, RW
   WILLIAMS, JD
   AUER, JA
AF MCGRATH, TJ
   SHIVELY, MJ
   HERRON, MR
   GREEN, RW
   WILLIAMS, JD
   AUER, JA
TI THE STABILITY OF THE BONE-EXTERNAL SPLINTAGE PIN INTERFACE AS AFFECTED
   BY PIN INSERTION METHOD AND SURFACE BIOMATERIAL
SO VETERINARY SURGERY
LA English
DT Meeting Abstract
C1 TEXAS AGR EXPT STN,COLLEGE STN,TX 77843.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0161-3499
J9 VET SURG
JI Vet. Surg.
PD JAN-FEB
PY 1988
VL 17
IS 1
BP 36
EP 36
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA L8705
UT WOS:A1988L870500044
DA 2018-10-20
ER

PT J
AU BRASH, JL
AF BRASH, JL
TI THE FATE OF FIBRINOGEN FOLLOWING ADSORPTION AT THE BLOOD-BIOMATERIAL
   INTERFACE
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
C1 MCMASTER UNIV, DEPT PATHOL, HAMILTON L8S 4L7, ONTARIO, CANADA.
RP BRASH, JL (reprint author), MCMASTER UNIV, DEPT CHEM ENGN, HAMILTON L8S 4L7, ONTARIO, CANADA.
CR ADAMS AL, 1984, J BIOMED MATER RES, V18, P643, DOI 10.1002/jbm.820180606
   AUHAGEN E, 1967, INT S DRUGS ANIMAL O, P69
   BOISSON C, 1984, THROMB RES, V34, P269, DOI 10.1016/0049-3848(84)90383-9
   BOISSON C, UNPUB
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BRASH JL, 1976, THROMB RES, V9, P249, DOI 10.1016/0049-3848(76)90214-0
   BRASH JL, 1985, J BIOMED MATER RES, V19, P1017, DOI 10.1002/jbm.820190914
   BRASH JL, 1983, J COLLOID INTERF SCI, V95, P28, DOI 10.1016/0021-9797(83)90068-1
   BRASH JL, 1985, T SOC BIOMATERIALS, V8, P105
   BRASH JL, UNPUB
   BRASH JL, 1987, UNPUB MECHANISM TRAN
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   CHAN BMC, 1981, J COLLOID INTERF SCI, V84, P263, DOI 10.1016/0021-9797(81)90283-6
   CHAN BMC, 1981, J COLLOID INTERF SCI, V82, P217, DOI 10.1016/0021-9797(81)90141-7
   CHENOWETH DE, 1984, ASAIO J, V7, P44
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DEBAILLOU N, 1984, J COLLOID INTERF SCI, V100, P167, DOI 10.1016/0021-9797(84)90422-3
   DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095
   DOOLITTLE RF, 1981, SCI AM, V245, P126, DOI 10.1038/scientificamerican1281-126
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOLDSMITH GH, 1978, J CLIN INVEST, V62, P54, DOI 10.1172/JCI109113
   GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998
   GRIFFIN JH, 1979, SEMIN THROMB HEMOST, V5, P254
   GRIFFIN JH, 1981, INTERACTION BLOOD NA, P134
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   HUDSON CB, 1986, T SOC BIOMATERIALS, V9, P122
   KICHENIN V, 1986, THESIS U PARIS NORD
   KLUFT C, 1978, J LAB CLIN MED, V91, P83
   KUSSEROW BK, 1971, T AM SOC ART INT ORG, V17, P1
   Lawrie JS, 1979, BIOCHEM SOC T, V7, P693, DOI 10.1042/bst0070693
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LIJNEN HR, 1982, SEMIN THROMB HEMOST, V8, P2, DOI 10.1055/s-2007-1005038
   LINDON JN, 1986, BLOOD, V68, P355
   MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   OGSTON D, 1978, BRIT MED BULL, V34, P107, DOI 10.1093/oxfordjournals.bmb.a071479
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   Ratnoff O D, 1969, Adv Immunol, V10, P145, DOI 10.1016/S0065-2776(08)60417-4
   SANTERRE P, UNPUB
   SCHMAIER AH, 1984, THROMB RES, V33, P51, DOI 10.1016/0049-3848(84)90154-3
   SCHMITT A, 1983, J COLLOID INTERF SCI, V92, P25, DOI 10.1016/0021-9797(83)90113-3
   SCOTT CF, 1985, J BIOL CHEM, V260, P856
   SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319
   SENATORE F, 1986, J BIOMED MATER RES, V20, P177, DOI 10.1002/jbm.820200207
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1980, BLOOD, V55, P156
   WHICHER SJ, 1978, J BIOMED MATER RES, V12, P181, DOI 10.1002/jbm.820120205
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   YOUNG BR, 1983, T AM SOC ART INT ORG, V29, P442
NR 57
TC 45
Z9 45
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PD DEC 28
PY 1987
VL 516
BP 206
EP 222
DI 10.1111/j.1749-6632.1987.tb33043.x
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA R6896
UT WOS:A1987R689600018
DA 2018-10-20
ER

PT J
AU FRAME, JW
AF FRAME, JW
TI HYDROXYAPATITE AS A BIOMATERIAL FOR ALVEOLAR RIDGE AUGMENTATION
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Review
RP FRAME, JW (reprint author), UNIV BIRMINGHAM, SCH DENT, DEPT ORAL SURG & ORAL MED, ST CHADS QUEENSWAY, BIRMINGHAM B4 6NN, W MIDLANDS, ENGLAND.
CR BARSAN RE, 1985, ORAL SURG ORAL MED O, V59, P113, DOI 10.1016/0030-4220(85)90001-5
   BELL WH, 1978, J ORAL SURG, V36, P693
   BELL WH, 1977, ORAL SURG ORAL MED O, V43, P485, DOI 10.1016/0030-4220(77)90096-2
   BLIJDORP PA, 1986, 9TH INT C OR MAX SUR
   BLOCK MS, 1984, ORAL SURG ORAL MED O, V57, P123, DOI 10.1016/0030-4220(84)90196-8
   BLOCK MS, 1985, J ORAL MAXIL SURG, V43, P3, DOI 10.1016/S0278-2391(85)80005-7
   BLOCK MS, 1984, J ORAL MAXIL SURG, V42, P793, DOI 10.1016/0278-2391(84)90347-1
   BROOK IM, 1986, BRIT DENT J, V161, P68, DOI 10.1038/sj.bdj.4805889
   CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   CHANG CS, 1983, J ORAL MAXIL SURG, V41, P729, DOI 10.1016/0278-2391(83)90190-8
   CHANG CS, 1984, J AM DENT ASSOC, V108, P54
   COBLE RL, 1956, J AM CERAM SOC, V39, P377, DOI 10.1111/j.1151-2916.1956.tb15608.x
   COHEN HV, 1984, J AM DENT ASSOC, V108, P54, DOI 10.14219/jada.archive.1984.0195
   Davies A S, 1972, Br J Oral Surg, V10, P133, DOI 10.1016/S0007-117X(72)80029-5
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DENISSEN HW, 1979, J PROSTHET DENT, V42, P551, DOI 10.1016/0022-3913(79)90253-1
   DENISSEN HW, 1978, BIOCERAM S KEELE
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P634, DOI 10.1097/00006534-197905000-00005
   FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4
   FINN RA, 1984, COMMUNICATION
   FONSECA R, 1980, J DENT RES, V59, P446
   Frame J W, 1987, Restorative Dent, V3, P84
   FRAME JW, 1987, BRIT DENT J, V162, P185, DOI 10.1038/sj.bdj.4806062
   FRAME JW, 1984, J ORAL MAXIL SURG, V42, P89, DOI 10.1016/0278-2391(84)90317-3
   FRAME JW, 1981, INT J ORAL MAXILLOF, V10, P88
   FRAME JW, 1981, BIOMATERIALS, V2, P19, DOI 10.1016/0142-9612(81)90082-X
   FRAME JW, 1982, J ORAL MAXIL SURG, V40, P407, DOI 10.1016/0278-2391(82)90075-1
   FRAME JW, 1987, IN PRESS J ORAL MAXI
   GONGLOFF RK, 1986, INT J ORAL MAX SURG, V15, P669, DOI 10.1016/S0300-9785(86)80107-7
   HARVEY WK, 1985, J ORAL MAXIL SURG, V43, P277, DOI 10.1016/0278-2391(85)90287-3
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   HUPP JR, 1986, J ORAL MAXIL SURG, V44, pM19
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1978, J DENT RES, V57, P917, DOI 10.1177/00220345780570091801
   KENT JN, 1983, J ORAL MAXIL SURG, V41, P629, DOI 10.1016/0278-2391(83)90016-2
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P37, DOI 10.1016/0278-2391(86)90012-1
   KENT JN, 1982, J AM DENT ASSOC, V105, P993, DOI 10.14219/jada.archive.1982.0405
   KENT JN, 1986, DENT CLIN N AM, V30, P231
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Levin M P, 1974, J Clin Periodontol, V1, P197
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   LEW D, 1985, J ORAL MAXIL SURG, V43, P57, DOI 10.1016/S0278-2391(85)80016-1
   LEW D, 1986, J ORAL MAXIL SURG, V44, P516, DOI 10.1016/S0278-2391(86)80091-X
   MCDAVID PT, 1979, J DENT RES, V58, P1478, DOI 10.1177/00220345790580050901
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   MOOS KF, 1979, BRIT J ORAL SURG, V16, P187, DOI 10.1016/0007-117X(79)90024-6
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Peelen J. G. J., 1978, Ceramurgia International, V4, P71, DOI 10.1016/0390-5519(78)90122-9
   PEELEN JGJ, 1977, SCI CERAM, V9, P226
   PETERSON LJ, 1986, J ORAL MAXIL SURG, V44, pM20
   PHAM H, 1986, J ORAL MAXIL SURG, V44, P80, DOI 10.1016/0278-2391(86)90018-2
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   PIECUCH JF, 1984, J BIOMED MATER RES, V18, P39, DOI 10.1002/jbm.820180106
   PIECUCH JF, 1986, DENT CLIN N AM, V30, P291
   PIECUCH JF, 1983, J ORAL MAXIL SURG, V41, P801, DOI 10.1016/S0278-2391(83)80047-0
   PIECUCH JF, 1983, J DENT RES, V62, P148, DOI 10.1177/00220345830620021301
   PILLIAR RM, 1979, J BIOMED MATER RES, V13, P799, DOI 10.1002/jbm.820130510
   RAO WR, 1974, J DENT RES, V53, P1351, DOI 10.1177/00220345740530061001
   ROOTARE HM, 1978, J DENT RES, V57, P777, DOI 10.1177/00220345780570070401
   ROTHSTEIN SS, 1984, J ORAL MAXIL SURG, V42, P224, DOI 10.1016/0278-2391(84)90453-1
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SILVERBERG M, 1986, J ORAL MAXIL SURG, V44, P877, DOI 10.1016/0278-2391(86)90225-9
   SMALL IA, 1986, J ORAL MAXIL SURG, V44, P60, DOI 10.1016/0278-2391(86)90014-5
   STOELINGA PJW, 1986, J ORAL MAXIL SURG, V44, P353, DOI 10.1016/S0278-2391(86)80030-1
   STOELINGA PJW, 1983, J MAXILLOFAC SURG, V11, P107, DOI 10.1016/S0301-0503(83)80026-5
   TERRY W, 1985, COMMUNICATION
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   WEBER JN, 1971, NATURE, V233, P337, DOI 10.1038/233337a0
   WEBER JN, 1973, MINER SCI ENGNG, V5, P151
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
NR 75
TC 26
Z9 26
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD DEC
PY 1987
VL 16
IS 6
BP 642
EP 655
DI 10.1016/S0901-5027(87)80048-6
PG 14
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA L1926
UT WOS:A1987L192600001
PM 2830349
DA 2018-10-20
ER

PT J
AU WILLIAMS, DF
AF WILLIAMS, DF
TI TISSUE - BIOMATERIAL INTERACTIONS
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
RP WILLIAMS, DF (reprint author), UNIV LIVERPOOL, INST MED & DENT BIOENGN, LIVERPOOL L69 3BX, ENGLAND.
CR AKUTSU T, 1986, ARTIFICIAL HEART
   ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   ALBREKTSSON T, 1983, J PROSTHET DENT, V50, P255, DOI 10.1016/0022-3913(83)90027-6
   ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   ANDERSON JM, 1985, ANN NY ACAD SCI, V446, P67, DOI 10.1111/j.1749-6632.1985.tb18391.x
   ANDERSON JM, IN PRESS BLOOD COMPA
   ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   BAGNALL RD, 1980, BIOMATERIALS, V1, P97, DOI 10.1016/0142-9612(80)90006-X
   BAGOGRANELL J, 1984, J BONE JT SURG, V66, P540
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1982, BIOL SYNTHETIC VASCU, P83
   BAILEY WJ, 1985, ANN NY ACAD SCI, V446, P42, DOI 10.1111/j.1749-6632.1985.tb18389.x
   BAMFORD CH, 1985, ADV POLYM SYNTHESIS, V31
   BEDER OE, 1956, SURGERY, V39, P470
   BENTLEY F, 1974, SCI F SURGERY, P143
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BORETOS JW, 1984, CONT BIOMATERIALS
   BRADLEY CR, 1981, SYSTEMIC ASPECTS BIO, V1, P187
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   BRASH JL, 1976, T AM SOC ART INT ORG, V22, P253
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   BRASH JL, 1979, J POLYM SCI, V66, P66
   BRASH JL, 1981, INTERACTIONS BLOOD N, P37
   BROWN SA, 1981, J BIOMED MATER RES, V15, P479, DOI 10.1002/jbm.820150404
   BRUNE D, 1986, BIOMATERIALS, V7, P163, DOI 10.1016/0142-9612(86)90097-9
   BRUNETTE DM, 1985, CRIT REV BIOCOMPAT, V1, P323
   BUNDY KJ, 1986, J BIOMED MATER RES, V20, P493, DOI 10.1002/jbm.820200406
   CARTER JM, 1984, ARTIF ORGANS, V8, P102, DOI 10.1111/j.1525-1594.1984.tb04252.x
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P9, DOI 10.1016/0142-9612(86)90081-5
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P89, DOI 10.1016/0142-9612(86)90062-1
   CASTILLO EJ, 1984, BIOMATERIALS, V5, P319, DOI 10.1016/0142-9612(84)90029-2
   CHAMBERS TJ, 1981, FUNDAMENTAL ASPECTS, V1, P145
   CHARNLEY J, 1957, P ROY SOC MED, V50, P840
   CHU C C, 1985, Critical Reviews in Biocompatibility, V1, P261
   COHAN BE, 1979, AM J OPHTHALMOL, V88, P982, DOI 10.1016/0002-9394(79)90402-1
   COHEN LM, 1982, CARDIAC BIOPROSTHESE
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   COLEMAN DL, 1986, J BIOMED MATER RES, V20, P416
   CURRAN RC, 1962, NATURE, V193, P494, DOI 10.1038/193494a0
   DAVIDGE RW, 1984, BIOMATERIALS, V5, P37, DOI 10.1016/0142-9612(84)90064-4
   DAVIE EW, 1965, PROTEINS, V3
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEWIJN JR, 1981, BIOCOMPATIBILITY CLI, V2, P99
   DEYME M, 1986, J BIOMED MATER RES, V20, P951, DOI 10.1002/jbm.820200710
   DIDISHEIM P, 1984, CONT BIOMATERIALS MA, P132
   DIEGELMANN RF, 1981, PLAST RECONSTR SURG, V68, P107, DOI 10.1097/00006534-198107000-00025
   DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103
   Dowson D, 1981, INTRO BIOMECHANICS J
   DRUKKER W, 1983, REPLACEMENT RENAL FU
   DUCHEYNE P, 1975, J BIOMED MATER RES, V9, P199, DOI 10.1002/jbm.820090423
   DUCHEYNE P, 1983, ASTM SPECIAL TECHN B, V79, P365
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   ELVES MW, 1981, FUNDAMENTAL ASPECTS, V2, P159
   ESCALAS F, 1975, J BIOMED MATER RES, V9, P303, DOI 10.1002/jbm.820090306
   FEBRESROMAN PR, 1980, AM J CARDIOL, V46, P735, DOI 10.1016/0002-9149(80)90422-1
   FRANCOS GC, 1983, T AM SOC ART INT ORG, V29, P140
   GEBELEIN CG, 1981, BIOMEDICAL DENTAL AP
   GEBELEIN CG, 1985, POLYM MATERIALS MEDI
   GENDREAU RM, 1980, 1ST WORLD C BIOM BAD
   GERET V, 1980, EVALUATION BIOMATERI, P351
   GILDING DK, 1980, FUNDAMENTAL ASPECTS, P43
   GILDING DK, 1979, 5TH T M SOC BIOM CLE, P159
   GOODMAN LS, 1975, PHARMACOL BASIS THER, P590
   GREAVES MF, 1973, T B LYMPHOCYTES THEI
   GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRISS P, 1981, BIOCOMPATIBILITY CLI, V1, P155
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROTE JJ, 1984, BIOMATERIALS OTOLOGY
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HELLER J, 1985, ANN NY ACAD SCI, V446, P51, DOI 10.1111/j.1749-6632.1985.tb18390.x
   HELMUS MN, 1984, J BIOMED MATER RES, V18, P165, DOI 10.1002/jbm.820180207
   HENCH LL, 1980, FUNDAMENTAL ASPECTS, P67
   HENCH LL, 1982, BIOCOMPATIBILITY ORT, V2, P129
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HENNINK WE, 1983, THROMB RES, V29, P1, DOI 10.1016/0049-3848(83)90120-2
   HENSTENPETTERSE.A, 1980, EVALUATION BIOMATERI, P44
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   HOFFMAN AS, 1977, ANN NY ACAD SCI, V283, P372, DOI 10.1111/j.1749-6632.1977.tb41782.x
   HOMSY CA, 1981, BIOCOMPATIBILITY CLI, V2, P59
   HORBETT TA, 1986, J BIOMED MATER RES, V20, P739, DOI 10.1002/jbm.820200608
   HUGHES RD, IN PRESS BLOOD COMPA
   IONESCU MI, 1981, TECHNIQUES EXTRACORP
   JACOBSON JJ, 1986, ORAL SURG ORAL MED O, V61, P413, DOI 10.1016/0030-4220(86)90430-5
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KELLER H, 1983, 1ST P INT C LEUC LOC
   KENT JN, 1986, DENT CLIN N AM, V30, P231
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1985, BIOMATERIALS, V6, P189, DOI 10.1016/0142-9612(85)90008-0
   KOEGEL A, 1984, J BIOMED MATER RES, V18, P513, DOI 10.1002/jbm.820180505
   KORMAN NJ, 1984, J BIOMED MATER RES, V18, P225, DOI 10.1002/jbm.820180210
   LANDRY M, 1964, J BONE JOINT SURG BR, V46, P764
   LEFEMINE AA, 1974, J THORAC CARDIOV SUR, V67, P857
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   LENTZ AJ, 1985, J BIOMED MATER RES, V19, P1101, DOI 10.1002/jbm.820190919
   LEPOW IH, 1972, INFLAMMATION MECHANI
   LEWY RB, 1966, ARCHIV OTOLARYNGOL, V83, P355
   LOEB GE, 1982, BIOCOMPATIBILITY CLI, V2, P123
   MAJNO G, 1967, LANCET, V2, P99
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   Mason R G, 1972, Prog Hemost Thromb, V1, P141
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MCNAMARA A, 1984, J BIOMED MATER RES, V18, P185, DOI 10.1002/jbm.820180208
   MCNAMARA A, 1982, BIOMATERIALS, V3, P160, DOI 10.1016/0142-9612(82)90006-0
   MCNAMARA A, 1981, BIOMATERIALS, V2, P33, DOI 10.1016/0142-9612(81)90085-5
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   MEACHIM G, 1981, FUNDAMENTAL ASPECTS, V1, P107
   MEACHIM G, 1976, BIOCOMPATIBILITY IMP, P120
   MERRITT K, 1984, BIOMATERIALS, V5, P47, DOI 10.1016/0142-9612(84)90066-8
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   MERRITT K, 1986, TECHNIQUES BIOCOMPAT, V2, P123
   MIRKOVITCH V, 1962, T AM SOC ART INT ORG, V8, P79
   MIURA Y, 1980, J BIOMED MATER RES, V14, P619, DOI 10.1002/jbm.820140508
   MJOR IA, 1977, INT DENT J, V27, P333
   MUELLER HJ, 1983, BIOMATERIALS, V4, P66, DOI 10.1016/0142-9612(83)90042-X
   NATELSON S, 1980, PRINCIPLES APPLIED C, V3
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P295, DOI 10.1016/0021-9797(78)90307-7
   NYILAS E, 1974, T AM SOC ART INT ORG, VB 20, P480
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OTA K, 1984, CONT BIOMATERIALS MA, P537
   PEDLEY RB, 1981, FUNDAMENTAL ASPECTS, V2, P175
   PEPPAS NA, 1982, ACS ADV CHEM SER, V194
   PIERCE WS, 1980, NIH802032 PUBL
   PITT CG, 1981, BIOMATERIALS, V2, P215
   POLLER L, 1981, RECENT ADV BLOOD COA
   RAE T, 1981, FUNDAMENTAL ASPECTS, V2, P159
   RAE T, 1981, SYSTEMIC ASPECTS BIO, V1, P21
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   REFOJO MF, 1986, 5TH P EUR C BIOM PAR, P159
   RIGDON RH, 1974, J BIOMED MATER RES, V8, P97, DOI 10.1002/jbm.820080202
   ROSS R, 1975, PHILOS T R SOC B, V271, P247, DOI 10.1098/rstb.1975.0049
   ROSTOKER W, 1974, J BIOMED MATER RES, V8, P407, DOI 10.1002/jbm.820080609
   RYAN GB, 1977, AM J PATHOL, V86, P183
   SALTHOUSE TN, 1983, ADV BIOMATER, P127
   SALTZMAN EW, 1981, INTERACTION BLOOD NA
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SAMET P, 1980, CARDIAC PACING
   SCHULTZ RC, 1984, CONT BIOMATERIALS MA, P332
   SEFTON MV, IN PRESS BLOOD COMPA
   SENN HJ, 1975, SEMIN HEMATOL, V12, P27
   SEVASTIANOV VI, 1984, J BIOMED MATER RES, V18, P969, DOI 10.1002/jbm.820180902
   SMITH R, 1986, POLYM TEST, V6, P243, DOI 10.1016/0142-9418(86)90002-4
   SMITH R, 1985, J MATER SCI LETT, V4, P547, DOI 10.1007/BF00720029
   SMITH R, 1987, IN PRESS J BIOMED MA, V21
   SNYDERMAN R, 1971, J EXP MED, V134, P1131, DOI 10.1084/jem.134.5.1131
   SPAET TH, 1978, PROGR HEMOSTASIS THR
   SPECTOR M, 1982, BIOCOMPATIBILITY ORT, V2, P55
   STANLEY JC, 1982, BIOL SYNTHETIC VASCU
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STOSSEL TP, 1974, NEW ENGL J MED, V290, P717, DOI 10.1056/NEJM197403282901306
   SUGARMAN B, 1984, INFECTIONS ASS PROST
   SURY P, 1977, CORROS SCI, V17, P155, DOI 10.1016/0010-938X(77)90015-4
   SZYCHER M, 1984, CONT BIOMATERIALS, P493
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   Uhthoff H K, 1971, Clin Orthop Relat Res, V81, P165, DOI 10.1097/00003086-197111000-00026
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VROMAN L, 1982, ADV CHEM SER, P265
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   WARD MK, 1981, SYSTEMIC ASPECTS BIO, V2, P187
   WARREN KS, 1976, ANN NY ACAD SCI, V278, P7, DOI 10.1111/j.1749-6632.1976.tb47011.x
   Wilkes G.L., 1975, POLYM MED SURGERY, P45
   Williams D.F., 1981, BIOCOMPATIBILITY CLI, V2
   Williams D.F., 1981, BIOCOMPATIBILITY CLI, V1
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   WILLIAMS DF, 1982, J MATER SCI, V17, P1675, DOI 10.1007/BF00540795
   WILLIAMS DF, 1977, J MED ENG TECHNOL, V1, P266, DOI 10.3109/03091907709162192
   WILLIAMS DF, 1976, ANNU REV MATER SCI, V6, P237, DOI 10.1146/annurev.ms.06.080176.001321
   WILLIAMS DF, 1983, BIOMATERIALS, V4, P285, DOI 10.1016/0142-9612(83)90029-7
   WILLIAMS DF, 1986, J DENT, V14, P185, DOI 10.1016/0300-5712(86)90001-1
   WILLIAMS DF, 1980, PHYS MED BIOL, V25, P611, DOI 10.1088/0031-9155/25/4/001
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1983, BIOCOMPATIBILITY ORT, V1
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V2, P45
   WILLIAMS DF, 1982, BIOCOMPATIBILITY ORT, V1, P1
   WILLIAMS DF, 1986, BIOL BIOMECHANICAL P, P391
   WILLIAMS DF, 1973, IMPLANTS SURGERY
   WILLIAMS DF, IN PRESS BLOOD COMPA
   WILLIAMS DF, 1986, 5TH P EUR C BIOM PAR, P239
   Williams DF., 1985, BIOCOMPATIBILITY TIS, VII, P43
   WILLIAMS DF, 1980, FUNDAMENTAL ASPECTS, V1, P11
   WILLIAMS DF, 1987, IN PRESS P CONSENSUS
   Williamson D H, 1985, Yeast, V1, P1, DOI 10.1002/yea.320010102
   WILLIS AL, 1974, PROSTAGLANDINS, V5, P1, DOI 10.1016/S0090-6980(74)80126-7
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WINTER GD, 1974, J BIOMED MATER RES, V8, P11, DOI 10.1002/jbm.820080304
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   WOO SLY, 1976, J BONE JOINT SURG AM, V58, P190, DOI 10.2106/00004623-197658020-00005
   WYKE BD, 1974, SCI F SURGERY, P242
   ZIGMOND SH, 1978, J CELL BIOL, V77, P269, DOI 10.1083/jcb.77.2.269
   ZURIER RB, 1974, ARCH INTERN MED, V133, P101, DOI 10.1001/archinte.133.1.101
NR 195
TC 186
Z9 189
U1 2
U2 26
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD OCT
PY 1987
VL 22
IS 10
BP 3421
EP 3445
DI 10.1007/BF01161439
PG 25
WC Materials Science, Multidisciplinary
SC Materials Science
GA K9921
UT WOS:A1987K992100001
DA 2018-10-20
ER

PT J
AU GRISTINA, AG
AF GRISTINA, AG
TI BIOMATERIAL-CENTERED INFECTION - MICROBIAL ADHESION VERSUS TISSUE
   INTEGRATION
SO SCIENCE
LA English
DT Article
RP GRISTINA, AG (reprint author), WAKE FOREST UNIV,MED CTR,ORTHOPED SURG SECT,WINSTON SALEM,NC 27103, USA.
FU NIADDK NIH HHS [R01AM26957-05]; NIGMS NIH HHS [R01GM35939-01]
CR ALBERTS B, 1983, MOL BIOL CELL
   ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   ALBREKTSSON T, 1985, 5TH EUR C BIOM, P151
   Andrade JD, 1985, SURFACE INTERFACIAL, VI, P15
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BARTH E, 1985, ACTA ORTHOP SCAND, V56, P491, DOI 10.3109/17453678508993042
   BARTH E, IN PRESS ACTA ORTHOP
   BEACHEY EH, 1980, QUEUES RECEPTORS R B, V6
   BIRINYI LK, 1987, J VASC SURG, V5, P193, DOI 10.1067/mva.1987.avs0050193
   BROWN MRW, 1985, ANNU REV MICROBIOL, V39, P527, DOI 10.1146/annurev.mi.39.100185.002523
   BURWELL RG, 1985, CLIN ORTHOP RELAT R, V197, P141
   CALLEJA GB, 1984, MICROBIAL ADHESION A, P304
   CHRISTENSEN GD, 1985, BACTERIAL ADHESION M, P279
   CIERNY G, 1986, 53 ANN M FEBR 20 25, P86
   COMIZZOLI RB, 1986, SCIENCE, V234, P340, DOI 10.1126/science.234.4774.340
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DHO M, 1984, AVIAN DIS, V28, P1016, DOI 10.2307/1590278
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P269
   ENGEL T, 1986, SCIENCE, V234, P327, DOI 10.1126/science.234.4774.327
   Fletcher M., 1985, BACTERIAL ADHESION M, P339
   GIBBONS RJ, 1980, QUEUES RECEPTORS R B, P63
   GOMER R, 1982, SCI AM, V247, P98, DOI 10.1038/scientificamerican0882-98
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1963, J BONE JOINT SURG AM, V45, P1104
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, IN PRESS INFECTION O
   GRISTINA AG, IN PRESS J AM MED AS
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P3
   Gristina AG, 1987, PATHOGENICITY CLIN S, P143
   GRISTINA AG, 1980, 1ST WORLD BIOM C EUR
   HAMILL RJ, 1986, INFECT IMMUN, V54, P833
   HIRSCH P, 1984, P373
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   HSIEH YL, 1986, J APPL BACTERIOL, V60, P535, DOI 10.1111/j.1365-2672.1986.tb01093.x
   ICHIMAN Y, 1981, J APPL BACTERIOL, V51, P229, DOI 10.1111/j.1365-2672.1981.tb01237.x
   JONES GW, 1983, CRC CR REV MICROBIOL, V10, P229
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   Lehninger AL, 1982, PRINCIPLES BIOCH
   LUDWICKA A, 1983, ZBL BAKT MIK HYG B, V177, P527
   LYKLEMA J, 1985, SURFACE INTERFACIAL, V1, P293
   Mandelbrot B. B, 1982, FRACTAL GEOMETRY NAT
   MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31
   MEAKIN P, 1986, J THEOR BIOL, V118, P101, DOI 10.1016/S0022-5193(86)80011-X
   MEARS DC, 1979, MATERIALS ORTHOPAEDI
   MERRITT K, 1985, 11TH ANN M SOC BIOM
   NOONAN JR, 1986, SCIENCE, V234, P310, DOI 10.1126/science.234.4774.310
   OGA M, UNPUB
   Paerl HW., 1985, BACTERIAL ADHESION M, P363
   PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RYAN US, 1986, ANNU REV PHYSIOL, V48, P263
   SANDER LM, 1987, SCI AM, V256, P94, DOI 10.1038/scientificamerican0187-94
   Savage D. C., 1985, BACTERIAL ADHESION M
   SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110
   SRIYOSACHATI S, 1986, INFECT IMMUN, V52, P885
   STENSTROM TA, 1985, ARCH MICROBIOL, V143, P6, DOI 10.1007/BF00414759
   STERN GA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1221, DOI 10.1001/archopht.1985.01050080133033
   SUGARMAN B, 1984, INFECTIONS ASS PROST
   SUTHERLAND IW, 1978, SURFACE CARBOHYDRATE, P27
   SWITALSKI LM, 1983, INFECT IMMUN, V42, P628
   TROMP RM, 1986, SCIENCE, V234, P304, DOI 10.1126/science.234.4774.304
   VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13
   WEBB LX, 1986, J VASC SURG, V4, P16
   WRANGSTADH M, 1986, ARCH MICROBIOL, V145, P220, DOI 10.1007/BF00443649
NR 69
TC 1229
Z9 1260
U1 10
U2 195
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD SEP 25
PY 1987
VL 237
IS 4822
BP 1588
EP 1595
DI 10.1126/science.3629258
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA K1006
UT WOS:A1987K100600022
PM 3629258
DA 2018-10-20
ER

PT J
AU HORMANN, K
   DONATH, K
AF HORMANN, K
   DONATH, K
TI IS HYDROXYAPATITE CERAMIC AN ADEQUATE BIOMATERIAL IN OSSICULAR CHAIN
   RECONSTRUCTION
SO AMERICAN JOURNAL OF OTOLOGY
LA English
DT Article
C1 UNIV HOSP HAMBURG, INST PATHOL, HAMBURG, GERMANY.
RP HORMANN, K (reprint author), UNIV HOSP HAMBURG, DEPT EAR NOSE & THROAT, MARTINISTR 52, D-2000 HAMBURG 20, GERMANY.
CR CHANG CS, 1983, J ORAL MAXIL SURG, V41, P729, DOI 10.1016/0278-2391(83)90190-8
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K, 1985, Dtsch Z Mund Kiefer Gesichtschir, V9, P438
   DONATH K, IN PRESS ORAL SURG
   GROTE JJ, 1984, ARCH OTOLARYNGOL, V110, P197
   HORMANN K, IN PRESS ARCH OTOR S
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   PLESTER D, 1981, AM J OTOL, V3, P104
   PLESTER D, 1980, HNO HEILK, V6, P27
   Steinbach E, 1972, Z Laryngol Rhinol Otol, V51, P659
NR 10
TC 6
Z9 6
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0192-9763
J9 AM J OTOL
JI Am. J. Otol.
PD SEP
PY 1987
VL 8
IS 5
BP 402
EP 405
PG 4
WC Otorhinolaryngology
SC Otorhinolaryngology
GA K2058
UT WOS:A1987K205800006
PM 2825527
DA 2018-10-20
ER

PT J
AU FERRARO, FT
   SALCMAN, M
   BROADWELL, R
   SEWCHAND, W
   NEWBERT, G
AF FERRARO, FT
   SALCMAN, M
   BROADWELL, R
   SEWCHAND, W
   NEWBERT, G
TI ALUMINA CERAMIC AS A BIOMATERIAL FOR USE IN AFTERLOADING RADIATION
   CATHETERS FOR HYPERTHERMIA
SO NEUROSURGERY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0148-396X
J9 NEUROSURGERY
JI Neurosurgery
PD JUL
PY 1987
VL 21
IS 1
BP 119
EP 119
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA J1313
UT WOS:A1987J131300048
DA 2018-10-20
ER

PT J
AU NIMNI, ME
   CHEUNG, D
   STRATES, B
   KODAMA, M
   SHEIKH, K
AF NIMNI, ME
   CHEUNG, D
   STRATES, B
   KODAMA, M
   SHEIKH, K
TI CHEMICALLY MODIFIED COLLAGEN - A NATURAL BIOMATERIAL FOR TISSUE
   REPLACEMENT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 UNIV SO CALIF,SCH MED,DEPT MED,CONNECT TISSUE BIOCHEM LAB,LOS ANGELES,CA 90033.
   ORTHOPAED HOSP,LOS ANGELES,CA 90007.
RP NIMNI, ME (reprint author), UNIV SO CALIF,SCH MED,DEPT BIOCHEM,CONNECT TISSUE BIOCHEM LAB,LOS ANGELES,CA 90033, USA.
CR ARENDS J, 1977, CALC TISS RES, V24, pR2
   BAJPAI P K, 1980, IRCS (International Research Communications System) Medical Science Library Compendium, V8, P519
   BAJPAI PK, 1980, IRCS MED SCI-BIOCHEM, V8, P642
   BAJPAI PK, 1985, BIOCOMPATIBILITY TIS, V1, P5
   BALLEISEN L, 1975, KLIN WOCHENSCHR, V53, P903, DOI 10.1007/BF01468982
   BARNES MJ, 1976, BIOCHEM J, V160, P647, DOI 10.1042/bj1600647
   BARNES MJ, 1981, CONNECTIVE TISSUE RE, P163
   BIJVOET OLM, 1974, ACTA ORTHOP SCAND, V45, P926, DOI 10.3109/17453677408989703
   BLUMENTHAL NC, 1979, CALCIFIED TISSUE INT, V27, P75, DOI 10.1007/BF02441164
   BORTOLOTTI U, 1984, AM J CARDIOL, V54, P681, DOI 10.1016/0002-9149(84)90279-0
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P353, DOI 10.1016/0005-2795(68)90157-8
   BUCH WS, 1970, J THORAC CARDIOV SUR, V60, P673
   CARPENTIER A, 1972, BIOL TISSUE HEART VA, P515
   CATER CW, 1967, J SOC LEATHER TRADE, V52, P239
   CHAMBERS RW, 1968, ARCH PATHOL, V85, P18
   CHARO IF, 1977, J CLIN INVEST, V60, P866, DOI 10.1172/JCI108841
   CHEN CC, 1984, CALCIFIED TISSUE INT, V36, P285, DOI 10.1007/BF02405332
   CHEUNG DT, 1983, J BIOL CHEM, V258, P7774
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   CHEUNG DT, UNPUB MECHANISM CROS
   CHEUNG DT, 1984, CONNECT TISSUE RES, V13, P109
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   CUNNINGHAM LW, 1976, 1ST P MUN S BIOL CON, P380
   ERICSSON JL, 1967, LAB INVEST, V17, P281
   FERRANS VJ, 1978, AM J CARDIOL, V41, P1159, DOI 10.1016/0002-9149(78)90873-1
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   FLEISCH H, 1968, CALCIF TISSUE RES S, V2, pA10
   FLEISCH H, 1970, INT ENCYCLOPEDIA PHA, P61
   FRANCIS MD, 1972, CALC TISS RES, V9, P109, DOI 10.1007/BF02061949
   GALLUCCI V, 1982, CARDIAC BIOPROSTHESE, P9
   GEHO WB, 1973, CLIN ASPECTS METABOL, P506
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   GOSSELIN RE, 1976, CLIN TOXICOLOGY COMM, P125
   HARDY PM, 1976, J CHEM SOC CHEM COMM, V5, P157
   HAYAT MA, 1981, FIXATION ELECTRON MI, P66
   HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005
   HOWELL DS, 1969, J CLIN INVEST, V48, P630, DOI 10.1172/JCI106021
   HOWELL DS, 1976, CLIN ORTHOP RELAT R, V118, P208
   HUGUES J, 1976, THROMB RES, V9, P223, DOI 10.1016/0049-3848(76)90211-5
   JAMIESON GA, 1971, NATURE-NEW BIOL, V234, P5
   JETHI RK, 1970, CALC TISS RES, V6, P81, DOI 10.1007/BF02196187
   KRONICK PL, 1976, THROMB RES, V9, P553, DOI 10.1016/0049-3848(76)90103-1
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LEVY RJ, 1984, CHEM BIOL MINERALIZE, P375
   LITWACK RS, 1972, ADV CARDIOL, V7, P119
   MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405
   MCINTOSH CL, 1975, SURGERY, V78, P768
   MEYER FA, 1981, THROMB HAEMOSTASIS, V46, P515
   MEYER FA, 1980, PLATELETS CELLULAR R
   MICHAELI D, 1978, PROGR THROMBOSIS HEM, V3, P20
   MONSAN P, 1975, BIOCHIMIE, V57, P1281
   Muir H., 1980, JOINTS SYNOVIAL FLUI, P27
   NIMNI M, 1975, TECHNICAL B, V1, P1
   NIMNI ME, 1983, SEMIN ARTHRITIS RHEU, V13, P1, DOI 10.1016/0049-0172(83)90024-0
   NIMNI ME, 1968, J BIOL CHEM, V243, P1457
   NIMNI ME, 1971, S POL MAT ART ORG CA, P85
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   RAYSSIGUIER Y, 1973, CR ACAD SCI D NAT, V276, P2035
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   ROCCHINI AP, 1981, CIRCULATION, V64, P162
   RUGGIERO F, 1985, J SUBMICR CYTOL PATH, V17, P11
   SHEIKH KM, 1980, FED PROC, V39, P472
   SILVER FH, 1979, J BIOMED MATER RES, V13, P701, DOI 10.1002/jbm.820130504
   SLANCZKA D J, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P421
   SLANCZKA DJ, 1979, 7TH P NEW ENGL NE BI, P197
   SLESINSKI RS, 1983, FOOD CHEM TOXICOL, V21, P621, DOI 10.1016/0278-6915(83)90150-3
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPENCER PS, 1978, TOXICOL APPL PHARM, V44, P17, DOI 10.1016/0041-008X(78)90280-6
   STRATES B, 1958, P SOC EXP BIOL MED, V97, P688
   STRATES BS, 1957, J PHYS CHEM-US, V61, P279, DOI 10.1021/j150549a005
   STRAWICH E, 1975, BIOMATER ARTIF CELL, V3, P309, DOI 10.3109/10731197509118629
   TOMIMATSU Y, 1971, J COLLOID INTERF SCI, V36, P51, DOI 10.1016/0021-9797(71)90239-6
   VILLA ML, 1980, TISSUE ANTIGENS, V16, P62
   WADKINS CL, 1968, CALC TISS RES, V2, P214, DOI 10.1007/BF02279209
   WADKINS CL, 1978, CALC TISS RES, V26, P51, DOI 10.1007/BF02013234
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WOODROOF EA, 1978, J BIOENG, V2, P1
NR 79
TC 264
Z9 268
U1 5
U2 40
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1987
VL 21
IS 6
BP 741
EP 771
DI 10.1002/jbm.820210606
PG 31
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA H4239
UT WOS:A1987H423900005
PM 3036880
DA 2018-10-20
ER

PT J
AU SUN, YH
   HOFFMAN, AS
   GOMBOTZ, WR
AF SUN, YH
   HOFFMAN, AS
   GOMBOTZ, WR
TI NON-FOULING BIOMATERIAL SURFACES .2. PROTEIN ADSORPTION ON RADIATION
   GRAFTED POLYETHYLENE-GLYCOL METHACRYLATE COPOLYMERS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 5
PY 1987
VL 193
BP 33
EP POLY
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA G2896
UT WOS:A1987G289602833
DA 2018-10-20
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI ESCA NONDESTRUCTIVE DEPTH PROFILES OF POLYMERIC BIOMATERIAL SURFACES
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 5
PY 1987
VL 193
BP 66
EP ANYL
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA G2896
UT WOS:A1987G289600199
DA 2018-10-20
ER

PT J
AU RATNR, BD
   JOHNSTON, AB
   LENK, TJ
AF RATNR, BD
   JOHNSTON, AB
   LENK, TJ
TI BIOMATERIAL SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH-APPLIED BIOMATERIALS
LA English
DT Review
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
RP RATNR, BD (reprint author), UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195, USA.
FU NHLBI NIH HHS [HL25951]; NCRR NIH HHS [RR01296]
CR ABSOLOM DR, 1985, J COLLOID INTERF SCI, V104, P51, DOI 10.1016/0021-9797(85)90008-6
   ABSOLOM DR, 1979, T AM SOC ART INT ORG, V25, P152
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Andrade J D, 1973, Med Instrum, V7, P110
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   ANDRADE JD, 1980, MAKROMOL CHEM-RAPID, V1, P101
   ANDRADE JD, 1980, MD DI            JUN, P22
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAIER RE, 1977, 51ST COLL SURF SCI S
   BARENBERG SA, 1979, T AM SOC ART INT ORG, V25, P159
   BARTLE KD, 1981, CHROMATOGRAPHIA, V14, P387, DOI 10.1007/BF02262872
   BASZKIN A, 1978, J BIOENG, V2, P527
   BENNETT JM, 1976, APPL OPTICS, V15, P2705, DOI 10.1364/AO.15.002705
   BENNINGHOVEN A, 1983, SPRINGER SERIES CHEM, V25, P64
   BIRDI KS, 1979, J DENT, V3, P230
   BISCHOFF KB, 1968, J BIOMED MATER RES, V2, P80
   BLACK J, 1981, BIOL PERFORMANCE MAT
   BRIGGS D, 1985, SPECTROCHIM ACTA B, V40, P707, DOI 10.1016/0584-8547(85)80120-8
   BRIGGS D, 1984, SURF INTERFACE ANAL, V6, P184, DOI 10.1002/sia.740060407
   BRIGGS D, 1982, SURF INTERFACE ANAL, V4, P151, DOI 10.1002/sia.740040405
   BRIGGS D, 1984, POLYMER, V25, P1379, DOI 10.1016/0032-3861(84)90097-1
   BRIGGS D, 1983, PRACTICAL SURFACE AN
   BROWN A, 1984, SURF INTERFACE ANAL, V6, P1, DOI 10.1002/sia.740060102
   BRUCK SD, 1974, BLOOD COMPATIBLE SYN
   BRYSON CE, 1979, SURFACE CONTAMINATIO, V2, P687
   BURNS MS, 1981, ANAL CHEM, V53, P2149, DOI 10.1021/ac00236a051
   CARLES JE, 1973, J APPL POLYM SCI, V17, P1855, DOI 10.1002/app.1973.070170618
   CASPER LA, 1982, IND APPLICATIONS SUR
   CHANG FY, 1973, J APPL POLYM SCI, V17, P2915, DOI 10.1002/app.1973.070170929
   CHANG SK, 1977, MED PROG TECHNOL, V5, P57
   CHAWLA AS, 1979, T AM SOC ART INT ORG, V25, P287
   CHINN JA, 1986, THESIS U WASHINGTON
   CHOI S, 1977, J COLLOID INTERF SCI, V61, P1, DOI 10.1016/0021-9797(77)90410-6
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   Clark D. T., 1978, POLYM SURFACES
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   COLTER KD, 1977, BIOMATER ARTIF CELL, V5, P1
   COOKE R, 1974, ANNU REV BIOPHYS BIO, V3, P95, DOI 10.1146/annurev.bb.03.060174.000523
   CULLER SR, 1984, APPL SPECTROSC, V38, P791, DOI 10.1366/0003702844554512
   Czanderna A.W., 1975, METHODS SURFACE ANAL, V1
   CZANDERNA AW, 1978, SCANNING ELECTRON MI, V1, P259
   DACOSTA VS, 1981, J COLLOID INTERF SCI, V80, P445
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   DIDISHEIM P, 1983, T AM SOC ARTIF INT O, V24, P169
   DROSTHANSEN W, 1965, ANN NY ACAD SCI, V125, P471, DOI 10.1111/j.1749-6632.1965.tb45410.x
   Echlin P., 1984, ANAL ORGANIC BIOL SU
   FLEMING WW, 1979, J POLYM SCI POL PHYS, V17, P199, DOI 10.1002/pol.1979.180170202
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   FURUSAWA K, 1977, KOBUNSHI RONBUNSHU, V34, P309, DOI 10.1295/koron.34.309
   GALLE P, 1983, SCANNING ELECTRON MI, V2, P827
   GALLE P, 1979, SPRINGER SERIES CHEM, V9, P238
   GARCIA C, 1980, T AM SOC ART INT ORG, V26, P294
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GARRISON BJ, 1982, SCIENCE, V216, P805, DOI 10.1126/science.216.4548.805
   GERSON DF, 1980, BIOCHIM BIOPHYS ACTA, V602, P506, DOI 10.1016/0005-2736(80)90329-6
   Ghosh P.K., 1983, INTRO PHOTOELECTRON
   GILDING DK, 1980, BIOMATERIALS, V1, P163, DOI 10.1016/0142-9612(80)90040-X
   GOLDEN WG, 1985, FOURIER TRANSFORM IN, V4, P315
   GOOD RJ, 1975, ADHESION SCI TECHNOL, P107
   Graham J. A., 1985, FOURIER TRANSFORM IN, V4, P345
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P349, DOI 10.1002/jbm.820150307
   GRIFFITHS PR, 1986, FOURIER TRANSFORM IN
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1982, ADV BIOMATER, V3, P519
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   Harrick N. J, 1967, INTERNAL REFLECTION
   HASEGAWA H, 1985, MACROMOLECULES, V18, P589, DOI 10.1021/ma00145a051
   HECKER JF, 1981, J BIOMED MATER RES, V15, P1, DOI 10.1002/jbm.820150104
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1982, ACS S SERIES, V199, P204
   HENCH LL, 1979, SURFACE CONTAMINATIO, P313
   Hepburn C, 1982, POLYURETHANE ELASTOM
   HIRSCHFELD T, 1977, APPL SPECTROSC, V31, P289, DOI 10.1366/000370277774463553
   HOEVE CAJ, 1980, ACS S SERIES, V127, P136
   HOFFMAN AS, 1986, VASCULAR GRAFT UPDAT, V898
   HOLLAHAN JR, 1974, TECHNIQUES APPLICATI
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   HOLLY FJ, 1976, ACS SYM SER, V31, P252
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KANE PF, 1974, CHARACTERIZATION SOL
   KATAOKA K, 1982, BIOMATERIALS, V3, P237, DOI 10.1016/0142-9612(82)90026-6
   KATZ W, 1984, SCANNING ELECTRON MI, V4, P1557
   KENWAYJACKSON C, 1984, VACUUM, V34, P479, DOI 10.1016/0042-207X(84)90085-X
   KITAHARA A, 1984, ELECTRICAL PHENOMENA
   KLOTZ IM, 1970, MEMBRANES ION TRANSP, V1, P93
   KO YC, 1981, J COLLOID INTERF SCI, V82, P25, DOI 10.1016/0021-9797(81)90120-X
   KOESTNER RJ, 1983, J PHYS CHEM-US, V87, P203, DOI 10.1021/j100225a007
   LAMB RN, 1982, J CHEM SOC FARAD T 1, V78, P61, DOI 10.1039/f19827800061
   LANGE W, 1983, SPRINGER SERIES CHEM, V25, P124
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LEE HB, 1975, J COLLOID INTERF SCI, V51, P225, DOI 10.1016/0021-9797(75)90107-1
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1979, AM CERAM SOC BULL, V58, P1121
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LING G N, 1970, International Journal of Neuroscience, V1, P129, DOI 10.3109/00207457009147626
   LYKLEMA J, 1985, SURFACE INTERFACIAL, V1, P293
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   LYMAN DJ, 1970, THROMB DIATH HAEMOST, V23, P120, DOI 10.1055/s-0038-1654126
   MACKENZIE AP, 1972, WATER STRUCTURE WATE, P146
   MCINTIRE LV, 1985, NIH852185 US DEP HLT
   MCKENZIE MT, 1985, APPL SPECTROSC, V39, P408, DOI 10.1366/0003702854248755
   MILLER DR, 1983, ACS POLYM PREPR, V24, P12
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   MOORE G, 1982, J ENVIRON SCI, V25, P33
   MORRISON GH, 1975, ANAL CHEM, V47, pA932, DOI 10.1021/ac60361a006
   NAKASHIMA T, 1977, J BIOMED MATER RES, V11, P787, DOI 10.1002/jbm.820110512
   NEUMANN AW, 1980, J BIOMED MATER RES, V14, P499, DOI 10.1002/jbm.820140416
   NEUMANN AW, 1983, BIOCOMPATIBLE POLYM, P53
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   NEUMANN AW, 1979, J POLY SCI        PS, V66, P391
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   OGSTON AG, 1966, FED PROC, V25, P986
   OHTA K, 1985, APPL SPECTROSC, V39, P418, DOI 10.1366/0003702854248719
   PANTANO CG, 1977, J TEST EVAL, V5, P66
   PANTANO CG, 1976, J VAC SCI TECHNOL, V13, P414, DOI 10.1116/1.568934
   PARINS DJ, 1981, IN VIVO DEGRADATION
   PICHA GJ, 1978, J BIOENG, V2, P301
   PLANCK H, 1984, 1983 P INT C POL MED
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   RAPPAPORT C, 1972, CHEM BIOSURFACES, V2, P449
   RASIGNI M, 1981, J OPT SOC AM, V71, P1124, DOI 10.1364/JOSA.71.001124
   Ratner B. D., 1984, CONT BIOMATERIALS MA, P193
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   RATNER BD, 1986, SPECTROSC-BIOMED APP, P107
   RATNER BD, 1982, ACS SYM SER, V199, P9
   RATNER BD, 1979, SURFACE CONTAMINATIO, V2, P669
   RATNER BD, 1984, PROGR BIOMEDICAL ENG, V1, P41
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   REEDHILL RE, 1973, PHYSICAL METALLURGY
   Refojo M., 1979, J POLYM SCI POLYM S, V66, P227
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   RYND JP, 1975, SURF SCI, V48, P22
   SAWYER PN, 1983, ANN NY ACAD SCI, V416, P561, DOI 10.1111/j.1749-6632.1983.tb35212.x
   SCHERRER H, 1984, J NON-CRYST SOLIDS, V65, P311, DOI 10.1016/0022-3093(84)90055-3
   SPARROW GR, 1977, ASTM SPECIAL TECHNIC, V643, P164
   SPRAGG RC, 1971, P I MECH ENG, V185, P697
   SRINIVASAN S, 1975, ACS S SERIES, V9, P322
   STOKES K, 1982, STIMUCOEUR MED, V10, P205
   STOKES KB, 1985, A C S POLYM MATER SC, V53, P6
   STOKES KB, 1985, ACS POLYM MAT SCI EN, V53, P1
   Sung CSP, 1984, CHEM ENG COMMUN, V30, P229, DOI 10.1080/00986448408911130
   TAIT MJ, 1971, NATURE, V230, P91, DOI 10.1038/230091a0
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TANIGUCHI Y, 1975, J APPL POLYM SCI, V19, P2743, DOI 10.1002/app.1975.070191009
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   VANOSS CJ, 1977, THROMB RES, V11, P183, DOI 10.1016/0049-3848(77)90037-8
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   VONHIPPE.PH, 1973, BIOCHEMISTRY-US, V12, P1256, DOI 10.1021/bi00731a003
   WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506
   Werner H. W., 1980, Surface and Interface Analysis, V2, P56, DOI 10.1002/sia.740020205
   WHICHER SJ, 1983, PHYSICOCHEMICAL ASPE, V2, P985
   WHITEHOUSE DJ, 1974, CHARACTERIZATION SOL, P49
   Wu S., 1971, J POLYM SCI C, V34, P19, DOI DOI 10.1002/POLC.5070340105
   Wu S, 1982, POLYM INTERFACE ADHE
   YASUDA H, 1982, J APPL POLYM SCI, V27, P1735, DOI 10.1002/app.1982.070270530
   Yasuda H., 1981, Journal of Polymer Science, Polymer Physics Edition, V19, P1285, DOI 10.1002/pol.1981.180190901
   YASUDA H, 1978, J BIOMED MATER RES, V12, P701, DOI 10.1002/jbm.820120510
   YASUDA H, 1976, BIOMATER ARTIF CELL, V4, P307, DOI 10.3109/10731197609118656
   Yasuda H., 1985, PLASMA POLYM
   YOON SC, 1986, MACROMOLECULES, V19, P1068, DOI 10.1021/ma00158a023
NR 172
TC 151
Z9 156
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
J9 J BIOMED MATER RES-A
PD APR
PY 1987
VL 21
IS A1
SU S
BP 59
EP 89
PG 31
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA H1513
UT WOS:A1987H151300005
PM 3571303
DA 2018-10-20
ER

PT J
AU JOHNSON, RJ
   NAZIMEK, C
   CHENOWETH, DE
AF JOHNSON, RJ
   NAZIMEK, C
   CHENOWETH, DE
TI COMPLEMENT ACTIVATION BY BIOMATERIAL - IMMUNODETECTION OF SURFACE-BOUND
   C3B AND FLUID PHASE ANAPHYLATOXINS
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 TRAVENOL LABS INC,ROUND LAKE,IL 60073.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0014-9446
J9 FASEB J
PD MAR 1
PY 1987
VL 46
IS 3
BP 983
EP 983
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA G3234
UT WOS:A1987G323403891
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI SYMPOSIUM - BIOMATERIAL SURFACES AND INTERFACES
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 1987
VL 66
SI SI
BP 95
EP 95
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA G1485
UT WOS:A1987G148500001
DA 2018-10-20
ER

PT J
AU NISHIOKA, GJ
   TRIPLETT, RG
   JONES, JK
   AUFDEMORTE, TB
AF NISHIOKA, GJ
   TRIPLETT, RG
   JONES, JK
   AUFDEMORTE, TB
TI BACTERIAL ADHERENCE IN MAXILLOFACIAL BIOMATERIAL INFECTIONS
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 1987
VL 66
SI SI
BP 193
EP 193
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA G1485
UT WOS:A1987G148500764
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   KLOSAK, JJ
   DENNIS, JW
   KARESH, SM
   ELLINGER, J
   KIM, DU
AF GREISLER, HP
   KLOSAK, JJ
   DENNIS, JW
   KARESH, SM
   ELLINGER, J
   KIM, DU
TI BIOMATERIAL PRETREATMENT WITH ECGF TO AUGMENT ENDOTHELIAL-CELL
   PROLIFERATION
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
C1 LOYOLA UNIV, MED CTR, DEPT NUCL MED, MAYWOOD, IL 60153 USA.
   ST BARNABAS MED CTR, DEPT PATHOL, LIVINGSTON, NJ 07039 USA.
RP GREISLER, HP (reprint author), LOYOLA UNIV, MED CTR, DEPT SURG, 2160 S 1ST AVE, MAYWOOD, IL 60153 USA.
CR BURGESS WH, 1985, J BIOL CHEM, V260, P1389
   CLOWES AW, 1986, FASEB J, V45, P473
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1986, T AM SOC ART INT ORG, V32, P346
   GREISLER HP, IN PRESS ARCH SURG
   GREISLER HP, 1986, VASCULAR GRAFT UPDAT, P197
   MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607
   MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674
   MACIAG T, 1982, J BIOL CHEM, V257, P5333
   SCHREIBER AB, 1985, P NATL ACAD SCI USA, V82, P6138, DOI 10.1073/pnas.82.18.6138
   SCHREIBER AB, 1985, J CELL BIOL, V101, P1623, DOI 10.1083/jcb.101.4.1623
   THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659
NR 14
TC 17
Z9 17
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD FEB
PY 1987
VL 5
IS 2
BP 393
EP 399
DI 10.1067/mva.1987.avs0050393
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA G1048
UT WOS:A1987G104800023
PM 2950245
DA 2018-10-20
ER

PT J
AU GOMBOTZ, WR
   HOFFMAN, AS
AF GOMBOTZ, WR
   HOFFMAN, AS
TI GAS-DISCHARGE TECHNIQUES FOR BIOMATERIAL MODIFICATION
SO CRC CRITICAL REVIEWS IN BIOCOMPATIBILITY
LA English
DT Review
RP GOMBOTZ, WR (reprint author), UNIV WASHINGTON,DEPT BIOENGN,SEATTLE,WA 98195, USA.
NR 0
TC 85
Z9 85
U1 0
U2 9
PU CRC PRESS INC
PI BOCA RATON
PA 2000 CORPORATE BLVD NW, JOURNALS CUSTOMER SERVICE, BOCA RATON, FL 33431
SN 0748-5204
J9 CRIT REV BIOCOMPAT
PY 1987
VL 4
IS 1
BP 1
EP 42
PG 42
WC Engineering, Biomedical
SC Engineering
GA L2614
UT WOS:A1987L261400001
DA 2018-10-20
ER

PT J
AU COHN, D
   HOFFMAN, AS
   RATNER, BD
AF COHN, D
   HOFFMAN, AS
   RATNER, BD
TI RADIATION-GRAFTED POLYMERS FOR BIOMATERIAL APPLICATIONS .2. THE
   MORPHOLOGY AND STRUCTURE OF 2-HYDROXYETHYL METHACRYLATE AND
   ETHYL-METHACRYLATE HOMOPOLYMER GRAFTS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
C1 UNIV WASHINGTON,DEPT CHEM ENGN,FL-20,SEATTLE,WA 98195.
   UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
CR AKERS CK, 1977, J COLLOID INTERF SCI, V59, P461, DOI 10.1016/0021-9797(77)90041-8
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   HOFFMAN AS, 1981, RADIAT PHYS CHEM, V18, P323, DOI 10.1016/0146-5724(81)90085-6
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   RATNER BD, 1978, J BIOENG, V2, P313
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Sasaki T., 1976, ACS SYM SER, V31, P283
NR 9
TC 18
Z9 18
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN
PY 1987
VL 33
IS 1
BP 1
EP 20
DI 10.1002/app.1987.070330101
PG 20
WC Polymer Science
SC Polymer Science
GA F3768
UT WOS:A1987F376800001
DA 2018-10-20
ER

PT J
AU HOFFMAN, AS
AF HOFFMAN, AS
TI A GENERAL CLASSIFICATION SCHEME FOR HYDROPHILIC AND HYDROPHOBIC
   BIOMATERIAL SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Letter
RP HOFFMAN, AS (reprint author), UNIV WASHINGTON,CTR BIOENGN,FL-20,SEATTLE,WA 98195, USA.
NR 0
TC 26
Z9 26
U1 1
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV-DEC
PY 1986
VL 20
IS 9
BP R9
EP R11
DI 10.1002/jbm.820200903
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA E5722
UT WOS:A1986E572200002
PM 3782182
DA 2018-10-20
ER

PT J
AU GENDLER, E
AF GENDLER, E
TI PERFORATED DEMINERALIZED BONE-MATRIX - A NEW FORM OF OSTEOINDUCTIVE
   BIOMATERIAL
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
RP GENDLER, E (reprint author), ORTHOPAED HOSP,2400 S FLOWER ST,LOS ANGELES,CA 90007, USA.
CR BASSETT CAL, 1962, J BONE JOINT SURG AM, V44, P1217, DOI 10.2106/00004623-196244060-00020
   BURSTONE MS, 1962, ENZYME HISTOCHEMISTR
   GENDLER E, NATO ADV SCI I SERIE
   MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150
   PECK WA, 1981, OSTEOPOROSIS, P191
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   REDDI AH, 1976, BIOCH COLLAGEN, P449
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
NR 9
TC 49
Z9 55
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL-AUG
PY 1986
VL 20
IS 6
BP 687
EP 697
DI 10.1002/jbm.820200603
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA C9237
UT WOS:A1986C923700003
PM 3522592
DA 2018-10-20
ER

PT J
AU WILSON, RS
   MARMUR, A
   COOPER, SL
AF WILSON, RS
   MARMUR, A
   COOPER, SL
TI A MODEL OF DEPOSITION AND EMBOLIZATION OF PROTEINS AND PLATELETS ON
   BIOMATERIAL SURFACES
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
C1 UNIV WISCONSIN,DEPT CHEM ENGN,1415 JOHNSON DR,MADISON,WI 53706.
   TECHNION ISRAEL INST TECHNOL,DEPT CHEM ENGN,HAIFA,ISRAEL.
FU NHLBI NIH HHS [HL-24046, HL-21001]
CR BEISSINGER RL, 1980, ASAIO J, V3, P160
   BRASH JL, 1978, J COLLOID INTERF SCI, V65, P495, DOI 10.1016/0021-9797(78)90101-7
   BUTRUILLE YA, 1975, T AM SOC ART INT ORG, V21, P609
   CHRISTENSON JT, 1981, T AM SOC ART INT ORG, V27, P188
   FRIEDMAN LI, 1971, FED PROC, V30, P1641
   HAHN GJ, 1967, STATISTICAL MODELS E, P130
   HAMPTON JR, 1972, HUMAN BLOOD COAGULAT, P476
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   IHLENFELD JV, 1979, THROMB RES, V14, P953, DOI 10.1016/0049-3848(79)90013-6
   KIM SW, 1975, ADV CHEM SER, V145, P218
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   MARMUR A, 1982, J COLLOID INTERF SCI, V89, P458, DOI 10.1016/0021-9797(82)90196-5
   MUSTARD JF, 1969, THROMBOSIS, P496
   PITT WG, 1985, T SOC BIOMATER, V8, P28
   RICHARDSON PD, 1973, NATURE, V245, P103, DOI 10.1038/245103a0
   RODVIEN R, 1982, ADV CHEM SER, V199, P25
   RUCKENSTEIN E, 1977, J THEOR BIOL, V66, P147, DOI 10.1016/0022-5193(77)90317-4
   SCHAFFNIT RL, 1978, THESIS U WASHINGTON
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   STRONG AB, 1982, ANN BIOMED ENG, V10, P71, DOI 10.1007/BF02366999
   Young BR, 1982, ADV CHEM SER, V199, P317
NR 21
TC 9
Z9 9
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PY 1986
VL 14
IS 4
BP 383
EP 400
DI 10.1007/BF02367410
PG 18
WC Engineering, Biomedical
SC Engineering
GA D6536
UT WOS:A1986D653600006
PM 3752641
DA 2018-10-20
ER

PT J
AU COMBRIER, E
   RONOT, X
   ADOLPHE, M
AF COMBRIER, E
   RONOT, X
   ADOLPHE, M
TI FLOW CYTOMETRIC ASSESSMENT OF VIABILITY IN CULTURED-CELLS - AN INVITRO
   VALIDATION FOR BIOMATERIAL CYTOTOXICITY TESTING
SO BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 ECOLE PRAT HAUTES ETUD,PHARMACOL CELLULAIRE LAB,F-75006 PARIS,FRANCE.
RI RONOT, Xavier/B-8412-2014
NR 0
TC 0
Z9 0
U1 0
U2 1
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE
SN 0248-4900
J9 BIOL CELL
JI Biol. Cell
PY 1986
VL 57
IS 2
BP A32
EP A32
PG 1
WC Cell Biology
SC Cell Biology
GA F0815
UT WOS:A1986F081500102
DA 2018-10-20
ER

PT J
AU JARCHO, M
AF JARCHO, M
TI BIOMATERIAL ASPECTS OF CALCIUM PHOSPHATES - PROPERTIES AND APPLICATIONS
SO DENTAL CLINICS OF NORTH AMERICA
LA English
DT Review
RP JARCHO, M (reprint author), CALCITEK INC,SAN DIEGO,CA, USA.
NR 0
TC 162
Z9 163
U1 0
U2 8
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0011-8532
J9 DENT CLIN N AM
PD JAN
PY 1986
VL 30
IS 1
BP 25
EP 47
PG 23
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA A1256
UT WOS:A1986A125600003
PM 3514291
DA 2018-10-20
ER

PT J
AU WHITE, E
   SHORS, EC
AF WHITE, E
   SHORS, EC
TI BIOMATERIAL ASPECTS OF INTERPORE-200 POROUS HYDROXYAPATITE
SO DENTAL CLINICS OF NORTH AMERICA
LA English
DT Article
RP WHITE, E (reprint author), PENN STATE UNIV,SOLID STATE TECHNOL,ROSSITER,PA 15772, USA.
NR 0
TC 173
Z9 178
U1 3
U2 10
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0011-8532
J9 DENT CLIN N AM
PD JAN
PY 1986
VL 30
IS 1
BP 49
EP 67
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA A1256
UT WOS:A1986A125600004
PM 3514293
DA 2018-10-20
ER

PT J
AU LI, ST
AF LI, ST
TI COLLAGEN AS A BIOMATERIAL - A ROLE IN ARTERIAL VESSEL RECONSTRUCTIONS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 MEADOX MED INC,RES & DEV,OAKLAND,NJ 07436.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1985
VL 190
IS SEP
BP 7
EP PME
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA APH03
UT WOS:A1985APH0303267
DA 2018-10-20
ER

PT J
AU PFALTZ, CR
   GRIESEMER, C
AF PFALTZ, CR
   GRIESEMER, C
TI PERICARD - A NEW BIOMATERIAL FOR TYMPANOPLASTY - PRELIMINARY-REPORT
SO AMERICAN JOURNAL OF OTOLOGY
LA English
DT Article
RP PFALTZ, CR (reprint author), UNIV HOSP BASEL,DEPT OTORHINOLARYNGOL,CH-4031 BASEL,SWITZERLAND.
CR BEALES PH, 1979, S BROWNS DISEASES EA, V2, P259
   Kup W, 1967, Arch Klin Exp Ohren Nasen Kehlkopfheilkd, V188, P593, DOI 10.1007/BF00302318
   PALVA T, 1978, ORL J OTO-RHINO-LARY, V40, P129, DOI 10.1159/000275397
   PFALTZ CR, 1975, ORL J OTO-RHINO-LARY, V37, P257, DOI 10.1159/000275234
   ZINI C, 1979, 76 CR C FRANC ORL PA, P83
   ZINI C, 1980, IL POLICLINICO CHIRU, V83, P653
NR 6
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0192-9763
J9 AM J OTOL
JI Am. J. Otol.
PY 1985
VL 6
IS 3
BP 266
EP 268
PG 3
WC Otorhinolaryngology
SC Otorhinolaryngology
GA AGZ77
UT WOS:A1985AGZ7700015
PM 4003539
DA 2018-10-20
ER

PT J
AU BERTRAM, JEA
AF BERTRAM, JEA
TI TOUGHNESS IN HORSE HOOF KERATIN - A KEY PROPERTY IN THIS STRUCTURAL
   BIOMATERIAL
SO AMERICAN ZOOLOGIST
LA English
DT Meeting Abstract
C1 UNIV CHICAGO,CHICAGO,IL 60637.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC ZOOLOGISTS
PI LAWRENCE
PA 1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044
SN 0003-1569
J9 AM ZOOL
JI Am. Zool.
PY 1985
VL 25
IS 4
BP A12
EP A12
PG 1
WC Zoology
SC Zoology
GA AUX17
UT WOS:A1985AUX1700051
DA 2018-10-20
ER

PT J
AU HOGT, AH
   DANKERT, J
   FEIJEN, J
AF HOGT, AH
   DANKERT, J
   FEIJEN, J
TI ADHESION OF COAGULASE-NEGATIVE STAPHYLOCOCCI WITH DIFFERENT SURFACE
   CHARACTERISTICS ONTO A HYDROPHOBIC BIOMATERIAL
SO ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY
LA English
DT Meeting Abstract
C1 TWENTE UNIV TECHNOL,DEPT CHEM TECHNOL,BIOMAT SECT,7500 AE ENSCHEDE,NETHERLANDS.
   STATE UNIV GRONINGEN HOSP,DEPT HOSP INFECT,9700 RB GRONINGEN,NETHERLANDS.
CR DUGUID JP, 1951, J PATHOL BACTERIOL, V63, P673, DOI 10.1002/path.1700630413
   FEIJEN J, 1979, ADV CARDIOVASCULAR P, V3, P100
   GARVEY G, 1980, INFECTIONS ABNORMAL, P693
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82
   PEDERSEN K, 1981, FEMS MICROBIOL LETT, V12, P365
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   SUGARMAN B, 1982, INFECTION, V10, P9, DOI 10.1007/BF01640828
NR 10
TC 5
Z9 5
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0003-6072
J9 A VAN LEEUW J MICROB
PY 1985
VL 51
IS 5-6
BP 510
EP 512
DI 10.1007/BF00404506
PG 3
WC Microbiology
SC Microbiology
GA C1863
UT WOS:A1985C186300014
DA 2018-10-20
ER

PT J
AU VONDERBRINK, JP
   SERNKA, TJ
   BAJPAI, PK
AF VONDERBRINK, JP
   SERNKA, TJ
   BAJPAI, PK
TI GASTRIC BIOMATERIAL PATCHES
SO IRCS MEDICAL SCIENCE-BIOCHEMISTRY
LA English
DT Article
C1 WRIGHT STATE UNIV,DEPT PHYSIOL & BIOPHYS,DAYTON,OH 45435.
RP VONDERBRINK, JP (reprint author), UNIV DAYTON,DEPT BIOL,DAYTON,OH 45469, USA.
CR NGUYEN DA, 1985, GEN PHYSIOL BIOPHYS, V4, P337
   PAREKH AC, 1970, BIOCHEM MED METAB B, V4, P446, DOI 10.1016/0006-2944(70)90074-8
   SALGALLER ML, 1985, J BIOMED MATER RES, V19, P1, DOI 10.1002/jbm.820190103
   SHEEHAN DC, 1980, THEORY PRACTICE HIST, P130
   SIMPSON RL, 1983, BIOMATERIALS RECONST, P109
   WOODROOF EA, 1984, BURN WOUND COVERINGS, V2, P1
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER-IRCS LTD
PI LANCASTER
PA ST LEONARDS HOUSE ST LEONARDGATE, LANCASTER, LANCS, ENGLAND LA1 1PF
J9 IRCS MED SCI-BIOCHEM
PY 1985
VL 13
IS 12
BP 1170
EP 1171
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AWG35
UT WOS:A1985AWG3500006
DA 2018-10-20
ER

PT J
AU WILLIAMS, DF
AF WILLIAMS, DF
TI BIOMATERIAL AND BIOMECHANICAL CONSIDERATIONS IN THE DEVELOPMENT OF
   COMPOSITES FOR THE RESTORATION OF POSTERIOR TEETH
SO JOURNAL OF BIOMECHANICS
LA English
DT Meeting Abstract
C1 UNIV LIVERPOOL,SCH DENT SURG,LIVERPOOL L69 3BX,ENGLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PY 1985
VL 18
IS 7
BP 517
EP 517
DI 10.1016/0021-9290(85)90674-8
PG 1
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA ANY63
UT WOS:A1985ANY6300014
DA 2018-10-20
ER

PT J
AU HOGT, AH
   DANKERT, J
   FEIJEN, J
AF HOGT, AH
   DANKERT, J
   FEIJEN, J
TI ADHESION OF STAPHYLOCOCCUS-EPIDERMIDIS AND STAPHYLOCOCCUS-SAPROPHYTICUS
   TO A HYDROPHOBIC BIOMATERIAL
SO JOURNAL OF GENERAL MICROBIOLOGY
LA English
DT Article
C1 UNIV HOSP GRONINGEN,MED MICROBIOL LAB,OOSTERSINGEL 59,19700 RB GRONINGEN,NETHERLANDS.
   UNIV HOSP GRONINGEN,DEPT HOSP EPIDEMIOL,9700 RB GRONINGEN,NETHERLANDS.
   TWENTE UNIV TECHNOL,DEPT CHEM TECHNOL,BIOMAT SECT,7500 AE ENSCHEDE,NETHERLANDS.
CR ADAMSON AW, 1967, PHYSICAL CHEM SURFAC, P352
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   DOYLE RJ, 1982, FEMS MICROBIOL LETT, V15, P1
   DUGUID JP, 1951, J PATHOL BACTERIOL, V63, P673, DOI 10.1002/path.1700630413
   FEIJEN J, 1979, ADV CARDIOVASCULAR P, V3, P100
   FISHER RA, 1957, STATISTICAL METHODS
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   GARVEY G, 1980, INFECTIONS ABNORMAL, P693
   GIBBONS RJ, 1983, INFECTION IMMUNITY, V41, P1191
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   ICHIMAN Y, 1981, J APPL BACTERIOL, V51, P229, DOI 10.1111/j.1365-2672.1981.tb01237.x
   KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82
   LOCCI R, 1981, ZBL BAKT MIK HYG B, V173, P300
   OFEK I, 1983, J BACTERIOL, V154, P139
   Ofek I, 1980, BACTERIAL ADHERENC B, V6, P1, DOI 10.1007%2F978-94-009-5863-0_1
   OLSSON J, 1982, FEMS MICROBIOL LETT, V15, P319
   PEDERSEN K, 1981, FEMS MICROBIOL LETT, V12, P365
   REYNOLDS EC, 1983, INFECT IMMUN, V39, P1285
   ROSENBERG E, 1983, FEMS MICROBIOL LETT, V17, P157
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   ROSENBERG M, 1984, FEMS MICROBIOL LETT, V22, P289
   Rutter P. R., 1980, MICROBIAL ADHESION S, P79
   VANOSS CJ, 1972, J RETICULOENDOTH SOC, V12, P497
   WOOD JM, 1980, MICROBIAL ADHESION S, P163
   YOSHIDA K, 1979, J APPL BACTERIOL, V47, P299, DOI 10.1111/j.1365-2672.1979.tb01758.x
NR 26
TC 99
Z9 100
U1 1
U2 11
PU SOC GENERAL MICROBIOLOGY
PI READING
PA HARVEST HOUSE 62 LONDON ROAD, READING, BERKS, ENGLAND RG1 5AS
SN 0022-1287
J9 J GEN MICROBIOL
JI J. Gen. Microbiol.
PY 1985
VL 131
IS SEP
BP 2485
EP 2491
PG 7
WC Microbiology
SC Microbiology
GA AQY53
UT WOS:A1985AQY5300046
PM 4067581
DA 2018-10-20
ER

PT J
AU BROWN, SK
   BROWN, GS
   PRENTICE, CRM
   LOWE, GDO
   FORBES, CD
   COURTNEY, JM
   TRAVERS, M
AF BROWN, SK
   BROWN, GS
   PRENTICE, CRM
   LOWE, GDO
   FORBES, CD
   COURTNEY, JM
   TRAVERS, M
TI BIOMATERIAL ASSESSMENT - MEASUREMENT OF CIRCULATING PLATELET AGGREGATES
SO ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 GLASGOW ROYAL INFIRM,DEPT MED,GLASGOW G4 0SF,SCOTLAND.
   UNIV STRATHCLYDE,BIOENGN UNIT,GLASGOW G1 1XW,SCOTLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PY 1984
VL 8
IS 1
BP 124
EP 124
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA SF358
UT WOS:A1984SF35800090
DA 2018-10-20
ER

PT J
AU ANDERSON, JM
   MILLER, KM
AF ANDERSON, JM
   MILLER, KM
TI BIOMATERIAL BIOCOMPATIBILITY AND THE MACROPHAGE
SO BIOMATERIALS
LA English
DT Article
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
RP ANDERSON, JM (reprint author), CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106, USA.
FU NHLBI NIH HHS [HL-00779, HL-27277, HL-25239]
CR ABRAMSON SB, 1983, ARTHRITIS RHEUM-US, V26, P630, DOI 10.1002/art.1780260509
   ALLISON AC, 1982, CLIN ASPECTS IMMUNOL, V1, P101
   ANDERSON JT, UNPUB
   ATKINSON JP, 1980, CLIN IMMUNOLOGY, V1, P219
   AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BARACOS V, 1983, NEW ENGL J MED, V308, P553, DOI 10.1056/NEJM198303103081002
   BECKER EL, 1980, CLIN IMMUNOLOGY, V1, P272
   BOGGS DR, 1983, WHITE CELL MANUAL, P46
   CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3
   COHEN L, 1983, J IMMUNOL, V131, P373
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   COLEMAN DL, 1983, J IMMUNOL, V130, P2195
   COLEMAN DL, 1974, J BIOMEDICAL MATERIA, V5, P65
   CRADDOCK PR, 1977, J CLIN INVEST, V60, P260, DOI 10.1172/JCI108763
   FARRAR JJ, 1982, FED PROC, V41, P263
   GOODMAN MG, 1982, J EXP MED, V156, P912, DOI 10.1084/jem.156.3.912
   GORDON S, 1978, HDB EXPT IMMUNOLOGY, V2
   GOURLAY SJ, 1978, J BIOMED MATER RES, V12, P219, DOI 10.1002/jbm.820120207
   GRINNELL F, 1982, AM J DERMATOPATH, V4, P185, DOI 10.1097/00000372-198204000-00014
   HIBBS MS, 1983, J EXP MED, V157, P47, DOI 10.1084/jem.157.1.47
   HILL RB, 1980, PRINCIPLES PATHOBIOL
   JALKANEN M, 1981, CONNECT TISSUE RES, V9, P19, DOI 10.3109/03008208109160236
   JIMENEZ SA, 1979, J EXP MED, V150, P1421, DOI 10.1084/jem.150.6.1421
   JOHNSTON RB, 1978, FED PROC, V37, P2759
   KAPLAN G, 1982, J EXP MED, V156, P1101, DOI 10.1084/jem.156.4.1101
   LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501
   LIEBERT TC, 1976, J BIOMED MATER RES, V10, P939, DOI 10.1002/jbm.820100611
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, UNPUB
   MARION L, 1980, J BIOMED MATER RES, V14, P343, DOI 10.1002/jbm.820140402
   MICHL J, 1983, J EXP MED, V157, P2121, DOI 10.1084/jem.157.6.2121
   MICHL J, 1983, J EXP MED, V157, P1746, DOI 10.1084/jem.157.6.1746
   NORRIS DA, 1982, J IMMUNOL, V129, P1612
   OPPENHEIM JJ, 1982, FED PROC, V41, P257
   OPPENHEIM JJ, 1982, IMMUNOL TODAY, V3, P113, DOI 10.1016/S0167-5699(82)80027-3
   POMMIER CG, 1983, J EXP MED, V157, P1844, DOI 10.1084/jem.157.6.1844
   POSTLETHWAITE AE, 1983, J EXP MED, V157, P801, DOI 10.1084/jem.157.2.801
   REMOLD HG, 1981, CELL IMMUNOL, V58, P175, DOI 10.1016/0008-8749(81)90159-3
   RENNARD SI, 1981, P NATL ACAD SCI-BIOL, V78, P7147, DOI 10.1073/pnas.78.11.7147
   RIGDON RH, 1975, CRIT REV FOOD SCI NU, V7, P435
   ROBBINS SL, 1979, PATHOLOGIC BASIS DIS, P55
   ROUVEIX B, 1981, AGENTS ACTIONS, V11, P622, DOI 10.1007/BF01978767
   ROUZER CA, 1982, J EXP MED, V156, P1077, DOI 10.1084/jem.156.4.1077
   RUTHERFORD B, 1983, J IMMUNOL, V130, P874
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SERHAN CN, 1983, ADV PROSTAG THROMB L, V11, P53
   SHIKITA M, 1981, J CELL PHYSIOL, V109, P161, DOI 10.1002/jcp.1041090118
   SIPE JD, 1982, ANN NY ACAD SCI, V389, P137, DOI 10.1111/j.1749-6632.1982.tb22132.x
   SNYDER OS, 1982, J IMMUNOL, V129, P1803
   STENSON WF, 1980, J IMMUNOL, V125, P1
   SUNDSMO JS, 1981, J EXP MED, V154, P763, DOI 10.1084/jem.154.3.763
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   TAUSSIG MJ, 1979, PROCESSES PATHOLOGY
   TSUKAMOTO Y, 1981, J IMMUNOL, V127, P673
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   WEISSMANN G, COMMUNICATION
   WERB Z, 1980, J EXP MED, V152, P1340, DOI 10.1084/jem.152.5.1340
NR 57
TC 270
Z9 273
U1 1
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1984
VL 5
IS 1
BP 5
EP 10
DI 10.1016/0142-9612(84)90060-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RW553
UT WOS:A1984RW55300002
PM 6375747
DA 2018-10-20
ER

PT J
AU BREEMHAAR, W
   BRINKMAN, E
   ELLENS, DJ
   BEUGELING, T
   BANTJES, A
AF BREEMHAAR, W
   BRINKMAN, E
   ELLENS, DJ
   BEUGELING, T
   BANTJES, A
TI PREFERENTIAL ADSORPTION OF HIGH-DENSITY LIPOPROTEIN FROM BLOOD-PLASMA
   ONTO BIOMATERIAL SURFACES
SO BIOMATERIALS
LA English
DT Article
C1 ORGANON TEKN BV,BOXTEL,NETHERLANDS.
RP BREEMHAAR, W (reprint author), TWENTE UNIV TECHNOL,BIOMAT SECT,DEPT CHEM TECHNOL,ENSCHEDE,NETHERLANDS.
CR BAGDADE JD, 1977, NEW ENGL J MED, V296, P1436, DOI 10.1056/NEJM197706232962504
   Bos E S, 1981, J Immunoassay, V2, P187, DOI 10.1080/15321818108056977
   BRASH JL, 1981, ARTIFICIAL ORGANS S, V5, P475
   BREEMHAAR W, 1982, LIFE SUPPORT SYST, P295
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   FEIJEN J, 1979, ADV CARDIOVASCULAR P, V3, P100
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KIM SW, 1975, ADV CHEM SER, V145, P218
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   LEVINE J, 1978, T AM SOC ART INT ORG, V24, P43
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1
NR 12
TC 78
Z9 78
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1984
VL 5
IS 5
BP 269
EP 274
DI 10.1016/0142-9612(84)90071-1
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TK781
UT WOS:A1984TK78100004
PM 6386064
DA 2018-10-20
ER

PT J
AU MATTIE, DR
   MCFALL, FB
   BAJPAI, PK
   GRIDLEY, J
AF MATTIE, DR
   MCFALL, FB
   BAJPAI, PK
   GRIDLEY, J
TI ALCAP CERAMIC - A NONTOXIC ALUMINUM, CALCIUM AND PHOSPHORUS OXIDE
   BIOMATERIAL
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 UNIV DAYTON,DAYTON,OH 45469.
   MONSANTO RES CORP,DAYTON,OH 45418.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0014-9446
J9 FED PROC
PY 1984
VL 43
IS 3
BP 327
EP 327
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA SF052
UT WOS:A1984SF05200249
DA 2018-10-20
ER

PT J
AU COHN, D
   HOFFMAN, AS
   RATNER, BD
AF COHN, D
   HOFFMAN, AS
   RATNER, BD
TI RADIATION-GRAFTED POLYMERS FOR BIOMATERIAL APPLICATIONS .1.
   2-HYDROXYETHYL METHACRYLATE - ETHYL METHACRYLATE GRAFTING ONTO
   LOW-DENSITY POLYETHYLENE FILMS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
   UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
CR AKERS CK, 1977, J COLLOID INTERF SCI, V59, P461, DOI 10.1016/0021-9797(77)90041-8
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   COHN D, UNPUB
   GREER RT, 1978, SCANNING ELECTRON MI, V1, P633
   HOFFMAN AS, 1981, RADIAT PHYS CHEM, V18, P323, DOI 10.1016/0146-5724(81)90085-6
   HOFFMAN AS, 1959, J POLYM SCI, V34, P461, DOI 10.1002/pol.1959.1203412734
   HOFFMAN AS, 1974, J BIOMED MATER RES S, V5, P77
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   LEE HB, 1972, POLYM PREPR, V13, P729
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   Ratner B. D, 1976, HYDROGELS MEDICAL RE, V31, P1
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   RATNER BD, 1978, J BIOENG, V2, P313
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Sasaki T., 1976, ACS SYM SER, V31, P283
   VACIK J, 1977, COLLECT CZECH CHEM C, V42, P2786, DOI 10.1135/cccc19772786
   WEATHERSBY PK, 1977, J BIOENG, V1, P381
   YAMAUCHI A, 1979, AM CHEM SOC POLYM PR, V20, P575
NR 24
TC 41
Z9 41
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PY 1984
VL 29
IS 8
BP 2645
EP 2663
DI 10.1002/app.1984.070290819
PG 19
WC Polymer Science
SC Polymer Science
GA TC776
UT WOS:A1984TC77600019
DA 2018-10-20
ER

PT J
AU GRUEN, TA
   SARMIENTO, A
AF GRUEN, TA
   SARMIENTO, A
TI KEY REFERENCES IN BIOMATERIALS - BONE BIOMATERIAL INTERFACE IN
   ORTHOPEDIC JOINT IMPLANTS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
RP GRUEN, TA (reprint author), UNIV SO CALIF, ORTHOPAED HOSP, SCH MED & ORTHOPAED BIOMECHAN, DEPT ORTHOPAED, LOS ANGELES, CA 90007 USA.
CR AGLIETTI P, 1982, ITAL J ORTHOP TRAUMA, V7, P321
   AHLBERG A, 1977, ACTA ORTHOP SCAND, V48, P687, DOI 10.3109/17453677708994818
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1981, CLIN ORTHOP RELAT R, P269
   AMSTUTZ HC, 1979, J BONE JOINT SURG AM, V61, P1161, DOI 10.2106/00004623-197961080-00004
   AMSTUTZ HC, 1973, CLIN ORTHOP RELAT R, P158
   ANAND SC, 1977, ANN BIOMED ENG, V5, P410, DOI 10.1007/BF02367319
   Andersson G B, 1972, J Bone Joint Surg Br, V54, P590
   ANDERSSON GBJ, 1978, J BONE JOINT SURG AM, V60, P31, DOI 10.2106/00004623-197860010-00005
   ANDERSSON GBJ, 1981, ARCH ORTHOP TRAUM SU, V99, P47, DOI 10.1007/BF00400909
   Andrade J D, 1973, Med Instrum, V7, P110
   ASKEW MJ, 1981, J BIOMECH ENG-T ASME, V103, P239, DOI 10.1115/1.3138287
   BALLINTYN NJ, 1979, BIOMATER ARTIF CELL, V7, P23, DOI 10.3109/10731197909119369
   BARB W, 1982, J BIOMED MATER RES, V16, P447, DOI 10.1002/jbm.820160412
   BARGREN JH, 1978, J BONE JOINT SURG BR, V60, P256
   BEAUMONT PWR, 1977, J MATER SCI, V12, P1853, DOI 10.1007/BF00566246
   BEAUMONT PWR, 1975, PLASTICS MED SURGERY
   BECKENBAUGH RD, 1978, J BONE JOINT SURG AM, V60, P306, DOI 10.2106/00004623-197860030-00005
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   BEDER OE, 1956, SURGERY, V39, P470
   BENUM P, 1976, ACTA ORTHOP SCAND, V47, P158, DOI 10.3109/17453677608989711
   BENUM P, 1977, ACTA ORTHOP SCAND, V48, P150, DOI 10.3109/17453677708985126
   BERGENDAHL G., 1960, ACTA PATHOL ET MICROBIOL SCAND, V49, P30
   BERGMANN G, 1977, ARCH ORTHOP TRAUM SU, V87, P223, DOI 10.1007/BF00415210
   BERGSTROM B, 1974, CLIN ORTHOP RELAT R, V99, P95
   BIEHL G, 1974, ARCH ORTHOP TRAUM SU, V78, P62, DOI 10.1007/BF00417083
   BLACK J, 1981, BIOMEDICAL ENG INSTR, V8
   BLAHA JD, 1982, J BONE JOINT SURG BR, V64, P326
   BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   BLENCKE BA, 1975, LEITZ-MITT WISS TECH, V6, P198
   BLENCKE BA, 1975, Z MED ORTHOP TECHNOL, V6, P144
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOBYN JD, 1981, ACTA ORTHOP SCAND, V52, P145, DOI 10.3109/17453678108991775
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   BOBYN JD, 1982, CLIN ORTHOP RELAT R, V166, P301
   BOUTIN P, 1972, REV CHIR ORTHOP, V58, P229
   Boutin P, 1974, Acta Orthop Belg, V40, P744
   BOWES DN, 1975, STAIN TECHNOL, V50, P355, DOI 10.3109/10520297509117087
   BREED AL, 1974, CLIN ORTHOP RELAT R, V102, P227
   BROWN SA, 1979, J BIOMED MATER RES, V13, P337, DOI 10.1002/jbm.820130212
   BRYAN WJ, 1981, CLIN ORTHOP RELAT R, V157, P125
   Cameron H, 1972, S Afr J Surg, V10, P63
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CAMERON HU, 1981, ARCH ORTHOP TRAUM SU, V98, P135, DOI 10.1007/BF00460801
   CAMERON HU, 1981, J ROY SOC MED, V74, P887
   CAMERON HU, 1980, CLIN ORTHOP RELAT R, P154
   CAMERON HU, 1974, J BIOMED MATER RES, V8, P283, DOI 10.1002/jbm.820080510
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   CAMERON HU, 1974, CLIN ORTHOP RELAT R, V100, P309
   CAMERON HU, 1982, CLIN ORTHOP RELAT R, V165, P188
   CARLSSON AS, 1980, CLIN ORTHOP RELAT R, V147, P262
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   CHANDLER HP, 1981, J BONE JOINT SURG AM, V63, P1426, DOI 10.2106/00004623-198163090-00008
   CHAO EY, 1976, CLOSED LOOP, V6, P3
   CHARNLEY J, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P228
   CHARNLEY J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P340
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P354
   Charnley J, 1968, J Bone Joint Surg Br, V50, P822
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P56
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   Charnley J, 1979, LOW FRICTION ARTHROP, P25
   CHARNLEY J, 1970, ACRYLIC CEMENT ORTHO
   CHEN SC, 1974, ACTA ORTHOP SCAND, V45, P429, DOI 10.3109/17453677408989165
   CHIARI K, 1977, ARCH ORTHOP TRAUM SU, V89, P305, DOI 10.1007/BF00416958
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CLARKE IC, 1979, BIOMATER ARTIF CELL, V7, P111, DOI 10.3109/10731197909119378
   CLATTENBURG R, 1975, J BIOMED MATER RES, V9, P169
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COLELLA SM, 1981, J BIOMED MATER RES, V15, P37, DOI 10.1002/jbm.820150108
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P65, DOI 10.1002/jbm.820080308
   COLLIER JP, 1976, J BIOMED MATER RES, V10, P485, DOI 10.1002/jbm.820100403
   COOK SD, 1982, BIOMATER ARTIF CELL, V10, P21, DOI 10.3109/10731198209118769
   COTTERILL P, 1982, CLIN ORTHOP RELAT R, P120
   DANCKWARDTLILLI.G, 1969, ACTA ORTHOP SCAND S, V128
   DAVIS CM, 1981, BIOMATER ARTIF CELL, V9, P47, DOI 10.3109/10731198109117600
   DEBRUNNER HU, 1974, ARCH ORTHOP TRAUM SU, V78, P309, DOI 10.1007/BF00415811
   DEBRUNNER HU, 1976, ADV ARTIFICIAL HIP K, P294
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   DESMET AA, 1977, AM J ROENTGENOL, V129, P279, DOI 10.2214/ajr.129.2.279
   DIFFORD J, 1974, MED LAB TECHNOL, V31, P79
   DiPisa J A, 1976, Clin Orthop Relat Res, P95
   DORRE E, 1976, J BIOMED MATER RES, V10, P493, DOI 10.1002/jbm.820100404
   Draenert K, 1981, Hip, P71
   DRAENERT K, 1978, CHIRURG, V49, P276
   DRAENERT K, 1977, SCANNING ELECTRON MI, V2, P229
   DUCHEYNE P, 1978, J BIOMECH, V11, P297, DOI 10.1016/0021-9290(78)90063-5
   DUCHEYNE P, 1978, J BONE JOINT SURG AM, V60, P384, DOI 10.2106/00004623-197860030-00021
   DUCHEYNE P, 1979, ARCH ORTHOP TRAUM SU, V94, P155, DOI 10.1007/BF00618439
   DUCHEYNE P, 1977, J BIOMED MATER RES, V11, P811, DOI 10.1002/jbm.820110603
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   DUCHEYNE P, 1979, POWDER METALL INT, V11, P115
   Ducheyne P, 1974, Acta Orthop Belg, V40, P799
   DUNN EJ, 1974, JOHNS HOPKINS MED J, V135, P106
   DUNN EJ, 1974, CALC TISS RES, V15, P329, DOI 10.1007/BF02059068
   DUSTOOR MR, 1977, MODERN DEV POWDER ME, V11, P247
   DUSTOOR MR, 1977, THESIS U WISCONSIN
   DUSTOOR MR, 1973, POWDER METALL INT, V5, P183
   EITENMUELLER J, 1979, 30 VER NIED W GAEL C
   EITENMULLER J, 1981, ARCH ORTHOP TRAUM SU, V98, P61, DOI 10.1007/BF00389713
   EITENMULLER J, 1978, LEITZ-MITT WISS TECH, V7, P104
   ESSLINGER JO, 1973, J BIOMED MATER RES, V7, P187, DOI 10.1002/jbm.820070312
   Eulenberger J, 1978, SSO Schweiz Monatsschr Zahnheilkd, V88, P378
   FEITH R, 1975, ACTA ORTHOP SCAND S, V161
   FORNASIER VL, 1976, CLIN ORTHOP RELAT R, V116, P249
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   FRIEDENBERG ZB, 1963, SURG GYNECOL OBSTET, V116, P588
   FRIEND J. V., 1964, J MED LAB TECHNOL, V21, P51
   FROST H. M., 1960, HENRY FORD HOSP MED BULL, V8, P239
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   FROST HM, 1959, STAIN TECHNOL, V34, P135, DOI 10.3109/10520295909114665
   FROST HM, 1958, STAIN TECHNOL, V33, P273, DOI 10.3109/10520295809111862
   FROST HM, 1963, CAN J BIOCHEM PHYS, V41, P31
   FROST HM, 1960, STAIN TECHNOL, V35, P135, DOI 10.3109/10520296009114729
   FUCHS GA, 1981, ARCH ORTHOP TRAUM SU, V98, P121, DOI 10.1007/BF00460799
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GALANTE J, 1973, J BIOMED MATER RES, V7, P43, DOI 10.1002/jbm.820070305
   GALANTE J, 1973, INTERNAL STRUCTURAL, P58
   GILBERTSON EMM, 1977, MED LAB SCI, V34, P89
   GITELIS S, 1982, CLIN ORTHOP RELAT R, P291
   GITELIS S, 1979, HIP, P188
   GORE L. F., 1964, J MED LAB TECHNOL, V21, P293
   GORE LF, 1976, MED LAB SCI, V33, P305
   GRAVES GA, 1975, J BIOMED MATER RES, V9, P17, DOI 10.1002/jbm.820090405
   GRAVES GA, 1971, J BIOMED MATER RES S, V2, P91
   GREENBERG AR, 1978, J BIOMED MATER RES, V12, P929, DOI 10.1002/jbm.820120612
   GREENLEE TK, 1972, J BIOMED MATER RES, V6, P235, DOI 10.1002/jbm.820060312
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   GREENWALD AS, 1978, J BONE JOINT SURG BR, V60, P107
   GRIFFITH MJ, 1978, CLIN ORTHOP RELAT R, V137, P24
   GRISS P, 1981, ARCH ORTHOP TRAUM SU, V98, P157, DOI 10.1007/BF00632972
   GRISS P, 1975, Z ORTHOP GRENZGEB, V113, P756
   GRISS P, 1977, ARCH ORTHOP TRAUM SU, V87, P73, DOI 10.1007/BF00416141
   GRISS P, 1976, J BIOMED MATER RES, V10, P519, DOI 10.1002/jbm.820100407
   GRISS P, 1977, ARCH ORTHOP TRAUM SU, V90, P15, DOI 10.1007/BF00415891
   GRISS P, 1978, ARCH ORTHOP TRAUM SU, V92, P199, DOI 10.1007/BF00397960
   GRISS P, 1974, J BIOMED MATER RES, V8, P39, DOI 10.1002/jbm.820080306
   GRISS P, 1976, J BIOMED MATER RES, V10, P511, DOI 10.1002/jbm.820100406
   GRISS P, 1975, J BIOMED MATER RES, V9, P177, DOI 10.1002/jbm.820090421
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   GROSS UM, 1977, STAIN TECHNOL, V52, P217, DOI 10.3109/10520297709116778
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, V141, P17
   GRUEN TA, 1976, CLIN ORTHOP RELAT R, V119, P250
   GSCHWEND N, 1976, TOTAL HIP PROSTHESIS
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   HALAWA M, 1978, ARCH ORTHOP TRAUM SU, V92, P19, DOI 10.1007/BF00381636
   HALLIN G, 1974, UPSALA J MED SCI, V79, P51, DOI 10.3109/03009737409178390
   HALSTEAD A, 1979, J BIOMED MATER RES, V13, P121, DOI 10.1002/jbm.820130113
   HAMPTON SJ, 1980, J BIOMECH, V13, P443, DOI 10.1016/0021-9290(80)90038-X
   HANSSON KI, 1967, ACTA ORTHOP SCAND S, V101
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   HARRIS WH, 1982, J BONE JOINT SURG AM, V64, P745, DOI 10.2106/00004623-198264050-00013
   HARRIS WH, 1982, J BONE JOINT SURG AM, V64, P1063, DOI 10.2106/00004623-198264070-00017
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HARRIS WH, 1960, NATURE, V188, P1038, DOI 10.1038/1881038a0
   HARRIS WH, 1968, J BONE JOINT SURG AM, VA 50, P1118, DOI 10.2106/00004623-196850060-00003
   HARRIS WH, 1964, J BONE JOINT SURG AM, V46, P493, DOI 10.2106/00004623-196446030-00003
   HARRIS WH, 1962, J BONE JOINT SURG AM, V44, P1308, DOI 10.2106/00004623-196244070-00003
   HART BL, 1982, CALCIFIED TISSUE INT, V34, P29, DOI 10.1007/BF02411204
   HASTINGS GW, 1980, ADV BIOMATERIALS, V2
   HEDLEY AK, 1979, HIP, P160
   HEDLEY AK, 1980, HIP, P329
   HEDLEY AK, 1982, CLIN ORTHOP RELAT R, V163, P300
   HEIMKE G, 1978, ARCH ORTHOP TRAUM SU, V91, P267, DOI 10.1007/BF00389609
   HEIMKE G, 1979, J BIOMED MATER RES, V13, P57, DOI 10.1002/jbm.820130108
   Heimke G., 1973, Berichte der Deutschen Keramischen Gesellschaft, V50, P4
   HENCH LL, 1980, J BIOMED MATER RES, V14, P803, DOI 10.1002/jbm.820140611
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1977, J BIOMED MATER RES, V11, P267, DOI 10.1002/jbm.820110211
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1983, BIOMATERIALS INTERFA
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HENTRICH R L, 1971, Journal of Biomedical Materials Research, V5, P25, DOI 10.1002/jbm.820050104
   HILL BD, 1973, AUST J MED TECHNOL, V4, P9
   Hirschhorn J.S., 1969, RES DENTAL MED MATER, P137
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   Homsy C A, 1973, Orthop Clin North Am, V4, P295
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   HOMSY CA, 1979, J BIOMED MATER RES, V13, P987, DOI 10.1002/jbm.820130615
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P317, DOI 10.1097/00003086-197203000-00052
   HOMSY CA, 1976, BIOCOMPATIBILITY IMP, P85
   HOMSY CA, 1973, HIP, P156
   HOWE DF, 1974, J BIOMED MATER RES, V8, P399, DOI 10.1002/jbm.820080608
   HOY ALS, 1981, CLIN ORTHOP RELAT R, P231
   Huiskes R, 1980, Acta Orthop Belg, V46, P711
   HUISKES R, 1981, T ORTHOP RES SOC, V6, P134
   HUISKES R, 1980, ACTA ORTHOP SCAND S, V185
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   HULBERT SF, 1975, J BIOMED MATER RES, V9, P189, DOI 10.1002/jbm.820090422
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   HULBERT SF, 1974, J BIOMED MATER RES, V8, P85, DOI 10.1002/jbm.820080310
   HUPFAUER W, 1972, ARCH ORTHOPAD UNFALL, V72, P174, DOI 10.1007/BF00416531
   Hupfauer W, 1971, Arch Orthop Unfallchir, V70, P70, DOI 10.1007/BF00416359
   INSALL J, 1976, CLIN ORTHOP RELAT R, V120, P149
   INSALL JN, 1982, J BONE JOINT SURG AM, V64, P1317, DOI 10.2106/00004623-198264090-00006
   ITAMI Y, 1982, ARCH ORTHOP TRAUM SU, V100, P11, DOI 10.1007/BF00381537
   ITAMI Y, 1982, ARCH ORTHOP TRAUM SU, V100, P183, DOI 10.1007/BF00442732
   JAEGER M, 1974, BIOPOLYMERS BIOMECHA, P421
   JAWORSKI ZFG, 1973, 1ST P WORKSH BON MOR
   JEE WSS, 1981, 3RD BON HIST INT WOR
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   JOBBINS B, 1973, BIOMED ENG, V8, P380
   JOHNSTONE JC, 1973, MED LAB TECHNOL, V30, P355
   JOWSEY J, 1965, J BONE JOINT SURG AM, VA 47, P785, DOI 10.2106/00004623-196547040-00014
   JOWSEY J, 1955, J SCI INSTRUM, V32, P159, DOI 10.1088/0950-7671/32/5/302
   JOWSEY J, 1972, Seminars in Nuclear Medicine, V2, P3, DOI 10.1016/S0001-2998(72)80003-5
   JUDET R, 1978, CLIN ORTHOP RELAT R, V137, P76
   KAGAN A, 1977, J BIOMECH, V10, P387, DOI 10.1016/0021-9290(77)90014-8
   KARAGIANES M T, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P171
   KARAGIANES MT, 1975, ARCH PATHOL, V99, P398
   KARNOVSKY MJ, 1965, J CELL BIOL A, V37, P27
   KELLER JC, 1980, J BIOMED MATER RES, V14, P639, DOI 10.1002/jbm.820140510
   KENESI C, 1973, REV CHIR ORTHOP, V59, P469
   KENNER GH, 1982, STAIN TECHNOL, V57, P121, DOI 10.3109/10520298209066540
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLAWITTER JJ, 1971, 1 WORKSH BIOEV HARD
   KNAHR K, 1981, BIOMATERIALS, V2, P98, DOI 10.1016/0142-9612(81)90006-5
   KOELBEL R, 1974, BIOPOLYMERS BIOMECHA, P409
   KOLBEL R, 1974, ARCH ORTHOP TRAUM SU, V80, P31, DOI 10.1007/BF00416539
   KOLBEL R, 1973, ARCH ORTHOP TRAUM SU, V77, P339, DOI 10.1007/BF00418919
   KOLBEL R, 1972, ARCH ORTHOPAD UNFALL, V73, P89, DOI 10.1007/BF00419075
   KOSTER K, 1977, Z ORTHOP GRENZGEB, V115, P693
   KRAUSE WR, 1982, CLIN ORTHOP RELAT R, V163, P290
   Krempien B, 1974, Acta Orthop Belg, V40, P624
   KWAK BM, 1979, INT ORTHOP, V2, P315
   LABITZKE R, 1974, ARCH ORTHOP TRAUM SU, V79, P341, DOI 10.1007/BF00418804
   LANGE DR, 1979, J BONE JOINT SURG AM, V61, P254, DOI 10.2106/00004623-197961020-00016
   LEE AJC, 1982, ADV BIOMATERIALS, V4
   LEMBERT E, 1972, CLIN ORTHOP RELAT R, P303
   LEWIS JL, 1982, J BONE JOINT SURG AM, V64, P129, DOI 10.2106/00004623-198264010-00018
   LINDER L, 1976, CLIN ORTHOP RELAT R, P303
   LINDER L, 1976, ACTA ORTHOP SCAND, V47, P3, DOI 10.3109/17453677608998965
   LINDER L, 1977, ARCH ORTHOP TRAUM SU, V89, P179, DOI 10.1007/BF00415342
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   LINDER L, 1977, J BONE JOINT SURG AM, V59, P82, DOI 10.2106/00004623-197759010-00015
   LINDER L, 1975, INJURY, V6, P277, DOI 10.1016/0020-1383(75)90174-6
   LINDER L, 1982, BIOCOMPATIBILITY ORT, V2, P1
   LINDWER J, 1975, ACTA ORTHOP SCAND, V46, P657, DOI 10.3109/17453677508989249
   LORD GA, 1979, CLIN ORTHOP RELAT R, P2
   LOUDON JR, 1980, J BONE JOINT SURG BR, V62, P450
   LUNDSKOG J, 1972, SCAND J PLAST RECO S, V9
   LYNG S, 1973, ACTA ORTHOP SCAND, V44, P694, DOI 10.3109/17453677308989109
   MARKOLF KL, 1980, J BONE JOINT SURG AM, V62, P1315, DOI 10.2106/00004623-198062080-00011
   MARKOLF KL, 1976, CLIN ORTHOP RELAT R, V121, P60
   MARTENS M, 1980, ARCH ORTHOP TRAUM SU, V97, P111, DOI 10.1007/BF00450933
   MATTHEWS LS, 1972, J BONE JOINT SURG AM, VA 54, P297, DOI 10.2106/00004623-197254020-00008
   McCarthy T C, 1977, Biomed Sci Instrum, V13, P41
   MCCARTHY TC, 1977, AM J VET RES, V38, P75
   MCQUEEN CM, 1972, CALC TISS RES, V10, P23, DOI 10.1007/BF02012532
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   MEUNIER PJ, 1977, 2ND BON HIST INT WOR
   MEYER PR, 1973, J BONE JOINT SURG AM, VA 55, P149, DOI 10.2106/00004623-197355010-00015
   MILCH RA, 1957, J NATL CANCER I, V19, P87
   MILLER J, 1978, HIP, P64
   MITTELMEIER H, 1979, UNFALLHEILKUNDE, V82, P67
   MITTELMEIER H, 1979, Z ORTHOP GRENZGEB, V117, P478
   MODIG J, 1975, ACTA ANAESTH SCAND, V19, P28, DOI 10.1111/j.1399-6576.1975.tb05219.x
   MODIS L, 1969, ACTA MORPHOL HUNG, V17, P157
   MORELAND JR, 1980, HIP, P281
   MORSCHER E, 1981, ARCH ORTHOP TRAUM SU, V98, P93, DOI 10.1007/BF00460795
   MORSCHER E, 1975, Z ORTHOP GRENZGEB, V113, P745
   MORSCHER EW, 1982, ARCH ORTHOP TRAUM SU, V99, P223, DOI 10.1007/BF00381397
   MOTTA A, 1979, Italian Journal of Orthopaedics and Traumatology, V5, P65
   MOYLE DD, 1973, J BIOMED MATER RES, V7, P363, DOI 10.1002/jbm.820070323
   MUHR G, 1976, ARCH ORTHOP TRAUM SU, V86, P115, DOI 10.1007/BF00415309
   MURRAY DG, 1975, J BIOMED MATER RES, V9, P699, DOI 10.1002/jbm.820090614
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   MUSTER D, 1982, ANAT CLIN, V4, P183, DOI 10.1007/BF01798887
   NATHANSON D, 1978, J BIOMED MATER RES, V12, P13, DOI 10.1002/jbm.820120103
   NIEDERER PG, 1978, UNFALLHEILKUNDE, V81, P205
   NILLES JL, 1974, J BIOMED MATER RES, V8, P319, DOI 10.1002/jbm.820080411
   NILLES JL, 1973, J BIOMED MATER RES, V7, P63, DOI 10.1002/jbm.820070306
   NILLES JL, 1973, J BIOMED MATER RES, V7, P231, DOI 10.1002/jbm.820070211
   OEST O, 1975, KNOCHENZEMENTE
   OH I, 1978, J BONE JOINT SURG AM, V60, P608, DOI 10.2106/00004623-197860050-00004
   Ohnsorge J, 1970, Z Orthop Ihre Grenzgeb, V107, P683
   Ohnsorge J, 1969, Z Orthop Ihre Grenzgeb, V106, P476
   OHNSORGE J, 1969, ARCH ORTHOPAD UNFALL, V67, P89, DOI 10.1007/BF00416830
   OKEEFE P, 1976, MICROSTRUCT SCI, V4, P169
   OLERUD S, 1970, J BONE JOINT SURG AM, VA 52, P274, DOI 10.2106/00004623-197052020-00008
   Oonishi H., 1981, ORTHOPAEDIC CERAMIC, VI
   PAGE K, 1977, THEORY PRACTICE HIST, P223
   PARK JB, 1982, J BIOMED MATER RES, V16, P459, DOI 10.1002/jbm.820160413
   PARK JB, 1975, BIOMATER ARTIF CELL, V3, P233, DOI 10.3109/10731197509118624
   PARK JB, 1979, BIOMATER ARTIF CELL, V7, P41, DOI 10.3109/10731197909119371
   PARK JB, 1980, ANN BIOMED ENG, V8, P93, DOI 10.1007/BF02363173
   PARK JB, 1976, BIOMATER ARTIF CELL, V4, P225, DOI 10.3109/10731197609118652
   PEDLEY RB, 1979, ANN BIOMED ENG, V7, P319
   PETTY W, 1980, J BIOMED MATER RES, V14, P427, DOI 10.1002/jbm.820140409
   PETTY W, 1980, B PROSTHET RES, V17, P80
   PILLIAR RM, 1980, J BIOMED ENG, V2, P49, DOI 10.1016/0141-5425(80)90092-8
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, V156, P249
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   PLENK H, 1978, CLIN ORTHOP RELAT R, P252
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P401, DOI 10.1002/jbm.820060507
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   PUGH JW, 1972, MICROSTRUCTURES, V3, P23
   RAAB S, 1981, J BIOMED MATER RES, V15, P159, DOI 10.1002/jbm.820150205
   RAAB S, 1982, J BIOMED MATER RES, V16, P679, DOI 10.1002/jbm.820160515
   RADIN EL, 1982, J BONE JOINT SURG AM, V64, P1188, DOI 10.2106/00004623-198264080-00009
   RAHN BA, 1970, EXPERIENTIA, V26, P519, DOI 10.1007/BF01898484
   RAHN BA, 1971, STAIN TECHNOL, V46, P125, DOI 10.3109/10520297109067836
   RAHN BA, 1970, EUR SURG RES, V2, P137
   RAHN BA, 1977, ZEISS INFORM, V22, P36
   RAMAN A, 1969, ACTA ORTHOP SCAND, V40, P193, DOI 10.3109/17453676908989498
   RAYAN GM, 1980, ORTHOPEDICS, V3, P660, DOI 10.3928/0147-7447-19800701-08
   RECKLING FW, 1977, J BONE JOINT SURG AM, V59, P80, DOI 10.2106/00004623-197759010-00014
   RECKLING FW, 1977, J BONE JOINT SURG AM, V59, P355, DOI 10.2106/00004623-197759030-00011
   REILLY D, 1982, CLIN ORTHOP RELAT R, V165, P273
   Rhinelander F, 1979, SKELETAL RES EXPT AP, P367
   Rhinelander F W, 1974, Acta Orthop Belg, V40, P771
   RHINELANDER F W, 1971, Journal of Biomedical Materials Research, V5, P81, DOI 10.1002/jbm.820050107
   RHINELANDER FW, 1977, INT ORTHOP, V1, P77, DOI 10.1007/BF00576308
   RHINELANDER FW, 1982, CLIN ORTHOP RELAT R, P293
   RHINELANDER FW, 1962, J BONE JOINT SURG AM, V44, P1273, DOI 10.2106/00004623-196244070-00001
   RHINELANDER FW, 1979, HIP, P127
   RHINELANDER FW, 1979, CLIN ORTHOP RELAT R, V141, P74
   RIETZ KA, 1968, ACTA CHIR SCAND S, V388
   RIJKE AM, 1977, J BIOMED MATER RES, V11, P373, DOI 10.1002/jbm.820110306
   RIJKE AM, 1971, AM J CLIN PATHOL, V56, P766
   RIJKE AM, 1978, J BIOENG, V2, P333
   RISKA EB, 1981, ACTA ORTHOP SCAND, V52, P207, DOI 10.3109/17453678108991783
   RITTER MA, 1981, CLIN ORTHOP RELAT R, V160, P149
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   ROSSAK K, 1977, Z ORTHOP GRENZGEB, V115, P290
   SADR B, 1977, INJURY, V8, P234, DOI 10.1016/0020-1383(77)90137-1
   SALVATI EA, 1981, J BONE JOINT SURG AM, V63, P753, DOI 10.2106/00004623-198163050-00010
   SALVATI EA, 1976, CLIN ORTHOP RELAT R, V121, P74
   SALZER M, 1976, J BIOMED MATER RES, V10, P847, DOI 10.1002/jbm.820100604
   SALZER M, 1978, CLIN ORTHOP RELAT R, V134, P80
   SALZER M, 1976, ADV ARTIFICIAL HIP K, P459
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   SAVINO AW, 1982, ACTA ORTHOP SCAND, V53, P23, DOI 10.3109/17453678208992174
   SCHALDACH M, 1976, ADV ARTIFICIAL HIP K
   SCHATZKER J, 1975, CAN J SURG, V18, P172
   SCHNEIDER R, 1982, CLIN ORTHOP RELAT R, V170, P156
   SEIDEL H, 1977, ARCH ORTHOP TRAUM SU, V90, P251, DOI 10.1007/BF00415478
   SELIGER WG, 1968, STAIN TECHNOL, V43, P269, DOI 10.3109/10520296809115080
   SELTING WJ, 1973, J DENT RES, V52, P91, DOI 10.1177/00220345730520014201
   SEVITT S, 1982, BONE REPAIR FRACTURE
   SEYFARTH M, 1975, ORTHOP TRAUMAT, V22, P662
   SKINNER AB, 1979, BIOMAT MED DEV ARTIF, V7, P133
   SKINNER HB, 1979, BIOMATER ARTIF CELL, V7, P141, DOI 10.3109/10731197909119381
   SLOOF TJJH, 1971, ACTA ORTHOP SCAND, V42, P465, DOI 10.3109/17453677108989064
   SLOOFF TJJ, 1970, THESIS KATHOLIEKE U
   SMITH LG, 1974, CALC TISS RES, V14, P333, DOI 10.1007/BF02060308
   SOGNNAES RF, 1947, ANAT REC, V99, P133, DOI 10.1002/ar.1090990202
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   SPECTOR M, 1975, J BIOMED MATER RES, V9, P537, DOI 10.1002/jbm.820090514
   SPECTOR M, 1981, CLIN ORTHOP RELAT R, P242
   SPECTOR M, 1976, J BIOMED MATER RES, V10, P595, DOI 10.1002/jbm.820100416
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P991, DOI 10.1002/jbm.820130616
   SPINELLI R, 1976, Italian Journal of Orthopaedics and Traumatology, V2, P103
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   STAUFFER RN, 1982, J BONE JOINT SURG AM, V64, P983, DOI 10.2106/00004623-198264070-00003
   STEFLIK DE, 1982, STAIN TECHNOL, V57, P91, DOI 10.3109/10520298209066534
   STROMQVIST B, 1981, ARCH ORTHOP TRAUM SU, V99, P1, DOI 10.1007/BF00400903
   STURMER KM, 1979, ACTA ANAT, V103, P100
   SULLIVAN B, 1978, CLIN ORTHOP RELAT R, P136
   SUZUKI HK, 1966, STAIN TECHNOL, V41, P57, DOI 10.3109/10520296609116280
   SVENSSON NL, 1977, J BIOMECH, V10, P581
   TAOKA H, 1980, Tokushima Journal of Experimental Medicine, V27, P89
   TAYLOR D F, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P467
   TAYLOR GR, 1971, J SURG RES, V11, P401, DOI 10.1016/0022-4804(71)90147-8
   TREHARNE RW, 1979, CLIN ORTHOP RELAT R, P240
   VANDERHOEFT PATRICK J., 1962, PROC STAFF MEETINGS MAYO CLIN, V37, P229
   VANDERHOEFT PJ, 1962, LAB INVEST, V11, P714
   Vernon-Roberts B, 1977, SCI BASIS JOINT REPL, P86
   VOLZ RG, 1977, J BONE JOINT SURG AM, V59, P501, DOI 10.2106/00004623-197759040-00014
   VOLZ RG, 1980, CONT ORTHOP, V2, P340
   Walker P S, 1982, Eng Med, V11, P83
   WALKER PS, 1981, J BONE JOINT SURG AM, V63, P258, DOI 10.2106/00004623-198163020-00012
   WALKER PS, 1976, J BIOMECH, V9, P269, DOI 10.1016/0021-9290(76)90013-0
   WATTS RH, 1981, STAIN TECHNOL, V56, P155, DOI 10.3109/10520298109067303
   WEIGAND AJ, 1977, NASA TMX3533 TECHN M
   WEINSTEIN AM, 1976, J BIOMED MATER RES, V10, P231, DOI 10.1002/jbm.820100205
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WELSH RP, 1971, J BIOMED MATER RES 1, V2, P231
   WERNER F, 1978, J BONE JOINT SURG AM, V60, P342
   WHEELER KR, 1973, BIOMAT MED EV ARTIF, V1, P337
   WILLERT HG, 1979, Z ORTHOP GRENZGEB, V117, P674
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   WILLIAMS D, 1978, MICROSC ACTA, V81, P1
   WILLIAMS D, 1973, New Scientist, V58, P221
   WILLIAMS DF, 1976, J CLIN PATHOL, V29, P657, DOI 10.1136/jcp.29.7.657
   WILLIAMS DF, 1977, J MED ENG TECHNOL, V1, P266, DOI 10.3109/03091907709162192
   WILLIAMS DF, 1982, CRC SERIES BIOCOMPAT, V2
   WILLIAMS DF, 1982, CRC SERIES BIOCOMPAT, V1
   WILLIAMS DF, 1976, BIOCOMPATIBILITY IMP
   WILLIS AL, 1974, PROSTAGLANDINS, V5, P1, DOI 10.1016/S0090-6980(74)80126-7
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILTSE LL, 1957, J BONE JOINT SURG AM, V39, P961, DOI 10.2106/00004623-195739040-00019
   WINTER GD, 1973, BIOMED ENG, V8, P390
   WINTER GD, 1980, ADV BIOMATERIALS, V1
   WINTER GD, 1982, ADV BIOMATERIALS, V3
   WITT AN, 1972, Z ORTHOP GRENZGEB, V110, P292
   WRIGHT TM, 1979, J BONE JOINT SURG AM, V61, P661, DOI 10.2106/00004623-197961050-00004
   WROBLEWSKI TJ, 1981, VET SURG, V10, P106, DOI 10.1111/j.1532-950X.1981.tb00641.x
   XIPELL J, 1974, STAIN TECHNOL, V49, P69, DOI 10.3109/10520297409116944
   Yettram A L, 1979, J Biomed Eng, V1, P281, DOI 10.1016/0141-5425(79)90167-5
   YPMA JFA, 1981, THESIS NIJMEGEN
   ZWEYMUELLER K, 1978, KNOCHEN GELENKERSATZ
   1977, SOC BIOMATERIALS T A, V1
   1976, ORTHOPAEDIC RES SOC, V1
   CM102LCI ROHM HAAS P
NR 412
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1984
VL 18
IS 5
BP 577
EP 599
DI 10.1002/jbm.820180511
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA SP445
UT WOS:A1984SP44500010
PM 6376515
DA 2018-10-20
ER

PT J
AU DOI, K
   KUWATA, N
   KAWAI, S
AF DOI, K
   KUWATA, N
   KAWAI, S
TI ALUMINA CERAMIC FINGER IMPLANTS - A PRELIMINARY BIOMATERIAL AND
   CLINICAL-EVALUATION
SO JOURNAL OF HAND SURGERY-AMERICAN VOLUME
LA English
DT Article
RP DOI, K (reprint author), YAMAGUCHI UNIV,SCH MED,DEPT ORTHOPAED SURG,UBE,YAMAGUCHI 755,JAPAN.
NR 0
TC 25
Z9 25
U1 0
U2 4
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011
SN 0363-5023
J9 J HAND SURG-AM
JI J. Hand Surg.-Am. Vol.
PY 1984
VL 9A
IS 5
BP 740
EP 749
DI 10.1016/S0363-5023(84)80027-1
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA TH374
UT WOS:A1984TH37400026
PM 6491224
DA 2018-10-20
ER

PT J
AU MINNS, RJ
AF MINNS, RJ
TI CLINICAL USE OF CARBON-FIBER AS A BIOMATERIAL
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Meeting Abstract
C1 DRYBURN HOSP,REG MED PHYS DEPT,DURHAM UNIT,DURHAM DH1 5TW,SCOTLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL, ENGLAND BS1 6BE
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PY 1984
VL 29
IS 2
BP 173
EP 173
PG 1
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA SE508
UT WOS:A1984SE50800057
DA 2018-10-20
ER

PT J
AU STEFLIK, DE
   MCKINNEY, RV
   KOTH, DL
   SINGH, BB
AF STEFLIK, DE
   MCKINNEY, RV
   KOTH, DL
   SINGH, BB
TI THE BIOMATERIAL-TISSUE INTERFACE - A MORPHOLOGICAL-STUDY UTILIZING
   CONVENTIONAL AND ALTERNATIVE ULTRASTRUCTURAL MODALITIES
SO SCANNING ELECTRON MICROSCOPY
LA English
DT Article
C1 UNIV N CAROLINA,SCH DENT,DEPT FIXED PROSTHET,CHAPEL HILL,NC 27514.
RP STEFLIK, DE (reprint author), MED COLL GEORGIA,SCH DENT,DEPT ORAL PATHOL,AUGUSTA,GA 30912, USA.
CR BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   HAMILTON A I, 1982, Journal of Dental Research, V61, P339
   HUMPHREYS WJ, 1979, SCANNING ELECTRON MI, V2, P345
   James R A, 1974, Oral Implantol, V4, P294
   Karagianes M T, 1982, J Oral Implantol, V10, P189
   KOTH D L, 1983, Journal of Oral Implantology, V11, P10
   LISTGARTEN MA, 1972, J PERIODONTAL RES, V7, P68, DOI 10.1111/j.1600-0765.1972.tb00633.x
   McKinney R V Jr, 1983, J Oral Implantol, V10, P619
   MCKINNEY RV, 1982, J ORAL IMPLANTOL, V10, P485
   PETERSON LJ, 1980, J DENT RES, V59, P99, DOI 10.1177/00220345800590022001
   SCHROEDER HE, 1969, HELV ODONTOL ACTA, V13, P65
   STEFLIK D E, 1982, Journal of Dental Research, V61, P231
   STEFLIK DE, 1983, STAIN TECHNOL, V58, P59, DOI 10.3109/10520298309066751
   STEFLIK DE, 1982, STAIN TECHNOL, V57, P91, DOI 10.3109/10520298209066534
   STEFLIK DE, 1983, J DENT RES, V62, P1212, DOI 10.1177/00220345830620120701
   TAYLOR AC, 1972, J PERIODONTOL, V48, P281
   Thomas R. S., 1974, Scanning Electron Microscopy 1974, P83
   TOTO PD, 1965, J DENT RES, V44, P451, DOI 10.1177/00220345650440022801
NR 18
TC 2
Z9 2
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 0891-7035
J9 SCAN ELECTRON MICROS
PY 1984
BP 547
EP 555
PN 2
PG 9
WC Microscopy
SC Microscopy
GA TE877
UT WOS:A1984TE87700008
PM 6484493
DA 2018-10-20
ER

PT J
AU HAFSTEINSSON, H
   RIZVI, SSH
AF HAFSTEINSSON, H
   RIZVI, SSH
TI ACOUSTIC MICROSCOPY - PRINCIPLES AND APPLICATIONS IN THE STUDIES OF
   BIOMATERIAL MICROSTRUCTURE
SO SCANNING ELECTRON MICROSCOPY
LA English
DT Article
RP HAFSTEINSSON, H (reprint author), CORNELL UNIV, INST FOOD SCI, ITHACA, NY 14853 USA.
CR ADAMS T, 1982, HIGH TECHNOL, V2, P78
   ADLER R, 1968, IEEE T SON ULTRASON, VSU15, P157, DOI 10.1109/T-SU.1968.29465
   ATTAL J, 1981, IEEE ULTRASONIC S, P557
   AULD BA, 1972, ACOUSTICAL HOLOGRAPH, V4, P73
   BENNETT SD, 1982, IEEE T SON ULTRASON, V29, P316, DOI 10.1109/T-SU.1982.31360
   BENNETT SD, 1981, IEEE T SON ULTRASON, V28, P59, DOI 10.1109/T-SU.1981.31221
   BORN M, 1975, PRINCIPLES OPTICS, P419
   Brillouin L., 1922, Annales de Physique, V17, P88
   Debye P, 1932, P NATL ACAD SCI USA, V18, P409, DOI 10.1073/pnas.18.6.409
   DEVEY GB, 1978, SCI AM, V238, P98, DOI 10.1038/scientificamerican0578-98
   DUNN F, 1959, J ACOUST SOC AM, V31, P632, DOI 10.1121/1.1907767
   FIRESTONE FA, 1942, Patent No. 2280226
   FOSTER JS, 1983, APPL PHYS LETT, V42, P869, DOI 10.1063/1.93796
   FRIZZELL LA, 1981, ULTRASOUND MED BIOL, V7, P385, DOI 10.1016/0301-5629(81)90049-1
   GOSS SA, 1979, J ACOUST SOC AM, V65, P507, DOI 10.1121/1.382351
   GRAFF KF, 1981, PHYS ACOUSTICS, V15, P1
   GRANT DR, 1981, J ACOUST SOC AM, V69, P866, DOI 10.1121/1.385544
   HEISERMAN J, 1980, J ACOUST SOC AM, V67, P1629, DOI 10.1121/1.384285
   HEISERMAN JE, 1982, PHYSICA B & C, V109, P1978
   HILDEBRAND JA, 1981, P NATL ACAD SCI-BIOL, V78, P1656, DOI 10.1073/pnas.78.3.1656
   HUNT FV, 1972, J ACOUST SOC AM, V51, P992, DOI 10.1121/1.1912949
   HUNT FV, 1954, ELECTROACOUSTICS, P44
   ISRAEL HW, 1980, P NATL ACAD SCI-BIOL, V77, P2046, DOI 10.1073/pnas.77.4.2046
   JAKOBS JE, 1967, MATER EVAL, V25, P41
   JIPSON V, 1978, APPL PHYS LETT, V32, P789, DOI 10.1063/1.89931
   KESSLER L W, 1974, Journal of Clinical Ultrasound, V2, P317, DOI 10.1002/jcu.1870020414
   KESSLER LW, 1979, P IEEE, V67, P526, DOI 10.1109/PROC.1979.11281
   KESSLER LW, 1978, IND RES, V20, P52
   KESSLER LW, 1972, NATURE, V239, P111, DOI 10.1038/239111a0
   KESSLER LW, 1973, J ACOUST SOC AM, V53, P1759, DOI 10.1121/1.1913539
   KESSLER LW, 1974, J ACOUST SOC AM, V55, P909, DOI 10.1121/1.1914661
   KESSLER LW, 1976, NBS SPEC PUBL, V453, P261
   KESSLER LW, 1974, INT C SERIES, V309, P250
   KESSLER LW, 1972, ACOUSTICAL HOLOGRAPH, V4, P51
   KESSLER LW, 1978, SCANNING ELECTRON MI, V1, P555
   KORPEL A, 1966, APPL OPTICS, V5, P1667, DOI 10.1364/AO.5.001667
   KORPEL A, 1971, NATURE, V232, P110, DOI 10.1038/232110a0
   KORPEL A, 1971, ACOUSTICAL HOLOGRAPH, V3, P23
   KRAUTKRAMER J, 1983, ULTRASONIC TESTING M, P245
   LEES S, 1983, IEEE T SON ULTRASON, V30, P85, DOI 10.1109/T-SU.1983.31391
   LEMONS RA, 1974, APPL PHYS LETT, V24, P163, DOI 10.1063/1.1655136
   LEMONS RA, 1979, PHYS ACOUSTICS, V14, P1
   Lucas R, 1932, J PHYS-PARIS, V3, P464, DOI 10.1051/jphysrad:01932003010046400
   MUELLER RK, 1982, IEEE SPECTRUM, V19, P28, DOI 10.1109/MSPEC.1982.6366794
   QUATE CF, 1979, P IEEE, V67, P1092, DOI 10.1109/PROC.1979.11406
   RUGAR D, 1982, IEEE T SON ULTRASON, V29, P172
   RUGAR D, 1980, J MICROSC-OXFORD, V120, P193, DOI 10.1111/j.1365-2818.1980.tb04135.x
   SINCLAIR DA, 1982, J I ELECTRON RAD ENG, V52, P479, DOI 10.1049/ree.1982.0070
   Sokoloff S.J., 1929, Elektrische Nachrichten-Technik, V6, P454
   SOKOLOV S, 1937, Patent No. 477139
   SOKOLOV SJ, 1939, Patent No. 2164125
   STEGEMAN GI, 1976, IEEE T SON ULTRASON, V23, P33, DOI 10.1109/T-SU.1976.30837
   VORRES CL, 1982, RES DEV, V24, P158
   WELLS PNT, 1977, PHYS MED BIOL, V22, P629, DOI 10.1088/0031-9155/22/4/001
   WHITE DN, 1976, ULTRASOUND MED DIAGN, P6
   WHITMAN RL, 1969, APPL OPTICS, V8, P1567, DOI 10.1364/AO.8.001567
   WICKRAMASINGHE HK, 1976, ELECTRON LETT, V12, P637, DOI 10.1049/el:19760489
   WICKRAMASINGHE HK, 1983, J MICROSC-OXFORD, V129, P63, DOI 10.1111/j.1365-2818.1983.tb04161.x
   YUHAS DE, 1980, RES DEV, V22, P108
   YUHAS DE, 1978, SPIE, V152, P46
   YUHAS DE, 1979, NBS SPEC PUBL, V525, P73
NR 61
TC 4
Z9 4
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 0891-7035
J9 SCAN ELECTRON MICROS
PY 1984
BP 1237
EP 1247
PN 3
PG 11
WC Microscopy
SC Microscopy
GA TM347
UT WOS:A1984TM34700024
PM 6438787
DA 2018-10-20
ER

PT J
AU GOUPIL, D
   MAHAR, B
   BRONSTEIN, M
   BAIER, R
AF GOUPIL, D
   MAHAR, B
   BRONSTEIN, M
   BAIER, R
TI THIN-LAYER IMMUNOASSAY (TIA) AS A SURFACE ANALYTICAL TOOL FOR PROTEIN
   BIOMATERIAL INTERACTIONS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 AMER CYANAMID CO,STAMFORD,CT 06904.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1983
VL 185
IS MAR
BP 60
EP COLL
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA QG980
UT WOS:A1983QG98000608
DA 2018-10-20
ER

PT J
AU CARTER, BK
   WILKES, GL
AF CARTER, BK
   WILKES, GL
TI SOME MORPHOLOGICAL INVESTIGATIONS ON AN ABSORBABLE COPOLYESTER
   BIOMATERIAL BASED ON GLYCOLIC AND LACTIC-ACID
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 DEPT CHEM ENGN & POLYMER MAT,BLACKSBURG,VA 24061.
   INTERFACES LAB,BLACKSBURG,VA 24061.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1983
VL 185
IS MAR
BP 163
EP POLY
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA QG980
UT WOS:A1983QG98002556
DA 2018-10-20
ER

PT J
AU NEUMANN, AW
   FRANCIS, DW
   ZINGG, W
   VANOSS, CJ
   ABSOLOM, DR
AF NEUMANN, AW
   FRANCIS, DW
   ZINGG, W
   VANOSS, CJ
   ABSOLOM, DR
TI COMMENTS ON THE ORIGIN OF PLATELET DEPOSITION AND ON CELL-ADHESION TO
   BIOMATERIAL SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Letter
C1 UNIV TORONTO,INST BIOMED ENGN,TORONTO M5S 1A4,ONTARIO,CANADA.
   HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.
   SUNY BUFFALO,DEPT MICROBIOL,BUFFALO,NY 14260.
   SUNY BUFFALO,DEPT CHEM ENGN,BUFFALO,NY 14260.
RP NEUMANN, AW (reprint author), UNIV TORONTO,DEPT MECH ENGN,TORONTO M5S 1A4,ONTARIO,CANADA.
CR ABSOLOM DR, 1980, CELL BIOPHYS, V2, P113, DOI 10.1007/BF02795838
   ABSOLOM DR, 1982, J COLLOID INTERF SCI, V85, P168, DOI 10.1016/0021-9797(82)90245-4
   ABSOLOM DR, 1979, T AM SOC ART INT ORG, V25, P152
   ABSOLOM DR, 1982, J RETICULOENDOTH SOC, V31, P59
   ABSOLOM DR, 1981, TRANSFUSION, V21, P663, DOI 10.1046/j.1537-2995.1981.21682085752.x
   ABSOLOM DR, 1982, 183RD NAT M AM CHEM
   ABSOLOM DR, UNPUB SURFACE MORPHO
   ABSOLOM DR, 1981, AUG NAT M AM CHEM SO
   BAIER RE, 1982, J BIOMED MATER RES, V16, P173, DOI 10.1002/jbm.820160210
   GILLMAN CF, 1971, BIOPHYS J, V11, pA96
   GONZALEZ G, 1980, 182ND NAT M AM CHEM
   HOVANEC DL, 1980, J CLIN MICROBIOL, V12, P608
   MITCHELL DJ, 1978, J CHEM SOC FARAD T 2, V74, P1116, DOI 10.1039/f29787401116
   NEUMANN AW, 1982, J PHYS CHEM-US, V86, P1267, DOI 10.1021/j100397a012
   NEUMANN AW, 1980, J BIOMED MATER RES, V14, P499, DOI 10.1002/jbm.820140416
   NEUMANN AW, 1979, COLLOID POLYM SCI, V257, P413, DOI 10.1007/BF01521578
   Nir S., 1976, PROGR SURF SCI, V8, P1
   OMENYI SN, 1980, J COLLOID INTERF SCI, V75, P117, DOI 10.1016/0021-9797(80)90355-0
   OMENYI SN, 1982, J DISPER SCI TECHNOL, V3, P307, DOI 10.1080/01932698208943644
   OMENYI SN, 1981, J APPL PHYS, V52, P796, DOI 10.1063/1.328765
   OMENYI SN, 1981, J APPL PHYS, V52, P789, DOI 10.1063/1.328764
   OMENYI SN, 1981, J COLLOID INTERF SCI, V81, P402, DOI 10.1016/0021-9797(81)90422-7
   RUCKENSTEIN E, 1982, J BIOMED MATER RES, V16, P169, DOI 10.1002/jbm.820160209
   RUCKENSTEIN E, 1976, THROMB HAEMOSTASIS, V36, P334
   SPELT JK, 1982, CELL BIOPHYS, V4, P117, DOI 10.1007/BF02918308
   SRINIVASAN R, 1981, J COLLOID INTERF SCI, V79, P390, DOI 10.1016/0021-9797(81)90090-4
   SRINIVASAN R, 1980, SEPAR PURIF METHOD, V9, P267, DOI 10.1080/03602548008066002
   VANOSS CJ, 1979, SEPAR SCI TECHNOL, V14, P305, DOI 10.1080/01496397908057149
   VANOSS CJ, 1980, COLLOID SURFACE, V1, P45, DOI 10.1016/0166-6622(80)80037-0
   VANOSS CJ, 1979, COLLOID POLYM SCI, V257, P737, DOI 10.1007/BF01474103
   VANOSS CJ, 1981, BIOCHIM BIOPHYS ACTA, V670, P64, DOI 10.1016/0005-2795(81)90049-0
   VANOSS CJ, 1981, VOX SANG, V40, P367
   VANOSS CJ, 1979, IMMUNOL COMMUN, V8, P11, DOI 10.3109/08820137909044703
   VANOSS CJ, 1979, SEP PURIF METHODS, V7, P245
   VANOSS CJ, 1978, PHAGOCYTIC ENGULFMEN
   VANOSS CJ, RETICULOENDOTHELIAL, V4
   VERWEY EJW, 1948, THEORY STABILITY LYP
   VISSER J, 1981, ADV COLLOID INTERFAC, V15, P157, DOI 10.1016/0001-8686(81)80007-3
   WEISS L, 1972, J THEOR BIOL, V37, P169, DOI 10.1016/0022-5193(72)90123-3
   ZINGG W, 1981, BIOMATERIALS, V2, P156, DOI 10.1016/0142-9612(81)90042-9
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 41
TC 8
Z9 8
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1983
VL 17
IS 2
BP 375
EP 381
DI 10.1002/jbm.820170213
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QE714
UT WOS:A1983QE71400012
PM 6841374
DA 2018-10-20
ER

PT J
AU VANDERSTEENHOVEN, JJ
   SPECTOR, M
AF VANDERSTEENHOVEN, JJ
   SPECTOR, M
TI HISTOLOGICAL INVESTIGATION OF BONE INDUCTION BY DEMINERALIZED ALLOGENEIC
   BONE-MATRIX - A NATURAL BIOMATERIAL FOR OSSEOUS RECONSTRUCTION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 MED UNIV S CAROLINA, DEPT PHYS SCI, CHARLESTON, SC 29425 USA.
   MED UNIV S CAROLINA, DEPT PATHOL, CHARLESTON, SC 29425 USA.
RP VANDERSTEENHOVEN, JJ (reprint author), MED UNIV S CAROLINA, DEPT BIOL SCI, CHARLESTON, SC 29425 USA.
OI Spector, Myron/0000-0003-3328-4858
FU NIDCR NIH HHS [DE00067]
CR ANDERSON HC, 1964, AM J PATHOL, V44, P507
   BACHRA BN, 1972, CALC TISS RES, V8, P287
   BASSETT CAL, 1964, BONE BIODYNAMICS
   EIDELMAN A, 1973, ARCH SURG-CHICAGO, V107, P87
   FIRSCHEIN HE, 1972, CLIN ORTHOP RELAT R, V84, P262
   GLOWACKI J, 1981, LANCET, V1, P959
   HANAMURA H, 1980, CLIN ORTHOP RELAT R, V148, P281
   Huggins CB, 1931, ARCH SURG-CHICAGO, V22, P377, DOI 10.1001/archsurg.1931.01160030026002
   Huggins CB, 1933, J EXP MED, V58, P393, DOI 10.1084/jem.58.4.393
   INDYK J S, 1957, Med J Aust, V44, P9
   KABAN LB, 1981, J DENT RES, V60, P1356, DOI 10.1177/00220345810600071201
   LINDEN GJ, 1975, J ANAT, V119, P359
   MULLIKEN JB, 1978, PLAST RECONSTR SURG, V62, P173, DOI 10.1097/00006534-197808000-00004
   NARANG R, 1974, ORAL SURG ORAL MED O, V37, P153, DOI 10.1016/0030-4220(74)90172-8
   Narang R, 1971, Clin Orthop Relat Res, V80, P174, DOI 10.1097/00003086-197110000-00025
   NATH M, 1978, CLIN ORTHOP RELAT R, P179
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   SPECTOR M, 1978, BRIT J UROL, V50, P12, DOI 10.1111/j.1464-410X.1978.tb02757.x
   URIST MR, 1952, J BONE JOINT SURG AM, V34-A, P443, DOI 10.2106/00004623-195234020-00015
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   URIST MR, 1977, ARCH SURG-CHICAGO, V112, P612
   URIST MR, 1968, CLIN ORTHOP RELAT R, P59
   Urist MR, 1976, AM ACAD ORTHOP SURG, P1
   WLODARSKI K, 1970, CALC TISS RES, V5, P70
NR 25
TC 32
Z9 33
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1983
VL 17
IS 6
BP 1003
EP 1014
DI 10.1002/jbm.820170610
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RT592
UT WOS:A1983RT59200009
PM 6654924
DA 2018-10-20
ER

PT J
AU COOK, SD
   THOMAS, KA
   WEINSTEIN, AM
AF COOK, SD
   THOMAS, KA
   WEINSTEIN, AM
TI DESIGN VARIABLES AFFECTING BONE-BIOMATERIAL ATTACHMENT STRENGTH
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 TULANE UNIV,SCH MED,BIOMAT LAB,NEW ORLEANS,LA 70112.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PY 1983
VL 62
SI SI
BP 239
EP 239
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA QD438
UT WOS:A1983QD43800667
DA 2018-10-20
ER

PT J
AU FANG, YE
   JI, YL
   FU, JJ
   HAN, P
AF FANG, YE
   JI, YL
   FU, JJ
   HAN, P
TI RADIATION-GRAFTED HYDROGELS ON POLYETHYLENE AND POLYPROPYLENE SURFACE -
   A NEW BIOMATERIAL
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Meeting Abstract
C1 UNIV SCI & TECHNOL CHINA,HEFEI,PEOPLES R CHINA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PY 1983
VL 22
IS 6
BP 1069
EP 1069
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA RQ823
UT WOS:A1983RQ82300080
DA 2018-10-20
ER

PT J
AU HATTON, MWC
   ROLLASON, G
   SEFTON, MV
AF HATTON, MWC
   ROLLASON, G
   SEFTON, MV
TI FATE OF THROMBIN AND THROMBIN-ANTITHROMBIN-III COMPLEX ADSORBED TO A
   HEPARINIZED BIOMATERIAL - ANALYSIS OF THE ENZYME-INHIBITOR COMPLEXES
   DISPLACED BY PLASMA
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A1,ONTARIO,CANADA.
RP HATTON, MWC (reprint author), MCMASTER UNIV,HLTH SCI CTR,DEPT PATHOL,HAMILTON L8N 3Z5,ONTARIO,CANADA.
FU NHLBI NIH HHS [HL-24020]
CR BASMADJIAN D, 1983, J BIOMED MATER RES, V17, P509, DOI 10.1002/jbm.820170310
   BINDER B, 1973, THROMB DIATH HAEMOST, V30, P280, DOI 10.1055/s-0038-1649075
   CHOLAKIS CH, 1983, ACS DIV POLYM CHEM P, V24, P64
   COLLEN D, 1977, EUR J CLIN INVEST, V7, P407, DOI 10.1111/j.1365-2362.1977.tb01627.x
   DANIELSSON A, 1980, FEBS LETT, V119, P241, DOI 10.1016/0014-5793(80)80262-6
   FISH WW, 1979, FEBS LETT, V98, P103, DOI 10.1016/0014-5793(79)80162-3
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   GOOSEN MFA, 1983, J BIOMED MATER RES, V17, P359, DOI 10.1002/jbm.820170212
   GOOSEN MFA, 1979, J BIOMED MATER RES, V13, P347, DOI 10.1002/jbm.820130302
   GOOSEN MFA, 1982, ADV CHEM, V199, P147
   Harpel P C, 1976, Methods Enzymol, V45, P639
   HATTON MWC, 1977, THROMB RES, V10, P645, DOI 10.1016/0049-3848(77)90047-0
   HATTON MWC, 1977, BIOCHEM SOC T, V5, P1443, DOI 10.1042/bst0051443
   HATTON MWC, 1978, THROMB RES, V13, P655, DOI 10.1016/0049-3848(78)90155-X
   HATTON MWC, 1973, BIOCHEM J, V131, P799, DOI 10.1042/bj1310799
   HATTON MWC, 1974, BIOCHIM BIOPHYS ACTA, V359, P55, DOI 10.1016/0005-2795(74)90131-7
   LAM LSL, 1979, BRIT J EXP PATHOL, V60, P151
   LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7
   MARCINIAK E, 1983, THROMB HAEMOSTASIS, V49, P32
   MARCINIAK E, 1981, BRIT J HAEMATOL, V48, P325, DOI 10.1111/j.1365-2141.1981.tb08466.x
   MERRILL EW, 1970, J APPL PHYSIOL, V29, P723
   MILLERANDERSSON M, 1974, THROMB RES, V5, P439, DOI 10.1016/0049-3848(74)90001-2
   MITCHELL GA, 1978, THROMB RES, V12, P219, DOI 10.1016/0049-3848(78)90293-1
   PEPPER DS, 1977, THROMB HAEMOSTASIS, V38, P494, DOI 10.1055/s-0038-1651855
   SHAPIRO SS, 1977, CHEM BIOL THROMBIN, P361
NR 25
TC 17
Z9 17
U1 0
U2 0
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PY 1983
VL 50
IS 4
BP 873
EP 877
PG 5
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA RY333
UT WOS:A1983RY33300026
PM 6198746
DA 2018-10-20
ER

PT J
AU HOFFMAN, AS
AF HOFFMAN, AS
TI BLOOD BIOMATERIAL INTERACTIONS - AN OVERVIEW
SO ADVANCES IN CHEMISTRY SERIES
LA English
DT Review
C1 UNIV WASHINGTON,COLL CHEM ENGN,SEATTLE,WA 98195.
RP HOFFMAN, AS (reprint author), UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195, USA.
CR VROMAN L, 1977, ANN NY ACAD SCI, V283
   1980, 1979 P DEV TECHN BRA
   1980, NHLBI NIH802185 US D
   1980, NHLBI NIH802186 US D
NR 4
TC 27
Z9 27
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-2393
J9 ADV CHEM SER
PY 1982
IS 199
BP 3
EP 8
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA PX642
UT WOS:A1982PX64200001
DA 2018-10-20
ER

PT J
AU BAIER, RE
   MEYER, AE
   AKERS, CK
   NATIELLA Jr
   MEENAGHAN, M
   CARTER, JM
AF BAIER, RE
   MEYER, AE
   AKERS, CK
   NATIELLA, JR
   MEENAGHAN, M
   CARTER, JM
TI DEGRADATIVE EFFECTS OF CONVENTIONAL STEAM STERILIZATION ON BIOMATERIAL
   SURFACES
SO BIOMATERIALS
LA English
DT Article
C1 SUNY Buffalo, DEPT ORAL PATHOL, BUFFALO, NY 14214 USA.
   ARVIN CALSPAN CORP, CTR ADV TECHNOL, BUFFALO, NY 14225 USA.
RP BAIER, RE (reprint author), SUNY Buffalo, DEPT DENT MAT, BUFFALO, NY 14214 USA.
FU NIDCR NIH HHS [DE-04226]
CR Baier R.E., 1975, ADV CHEM SERIES
   BAIER RE, 1978, ACTA ODONTOL SCAND, V36, P289, DOI 10.3109/00016357809029079
   BAIER RE, 1973, SURFACE CHEM DENTAL, P337
   BAIER RE, 1970, 176 CALSP REP
   BAIER RE, J BIOMED MATER RES
   CARTER JM, 1981, J BIOMED MATER RES, V15, P843
   FLYNN HE, 1982, J PROSTH DENT
   MCGOWAN BD, 1979, THESIS STATE U NEW Y
   NATIELLA JR, 1982, J PROSTH DENT
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 10
TC 49
Z9 49
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1982
VL 3
IS 4
BP 241
EP 245
DI 10.1016/0142-9612(82)90027-8
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PP118
UT WOS:A1982PP11800010
PM 7171685
DA 2018-10-20
ER

PT J
AU BOROVETZ, HS
   MOLEK, GE
   LEVINE, G
   HARDESTY, RL
   HAUBOLD, AD
AF BOROVETZ, HS
   MOLEK, GE
   LEVINE, G
   HARDESTY, RL
   HAUBOLD, AD
TI PROTEIN ADSORPTION INVITRO ONTO BIOMATERIAL SURFACES COVERED WITH MULTI
   CARBON
SO BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS
LA English
DT Article
C1 UNIV PITTSBURGH,SCH ENGN,PITTSBURGH,PA 15261.
RP BOROVETZ, HS (reprint author), UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261, USA.
CR BAIER RE, 1977, ANN NY ACAD SCI, V283, P17, DOI 10.1111/j.1749-6632.1977.tb41750.x
   BOKROS JC, 1977, CARBON, V15, P355
   BOROVETZ HS, 1978, SCANNING ELECTRON MI, V2, P85
   BOROVETZ HS, 1980, J BIOMEDICAL MAT RES, V2, P145
   BOROVETZ HS, 1980, 8TH P INT C XRAY OPT, P501
   CHIU TH, 1976, T AM SOC ART INT ORG, V22, P498
   CHIU TH, 1978, T AM SOC ART INT ORG, V24, P384
   DEBSKI RF, 1982, BIOMATERIALS, P499
   HAUBOLD AD, 1977, B TEX HEART I, V4, P369
   KIM SW, 1975, UNPUB
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P457, DOI 10.1111/j.1749-6632.1977.tb41790.x
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SHIM HS, 1978, J BIOENG, V2, P341
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P1, DOI 10.1111/j.1749-6632.1977.tb41747.x
NR 14
TC 5
Z9 5
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0090-5488
J9 BIOMATER ARTIF CELL
PY 1982
VL 10
IS 3
BP 187
EP 203
DI 10.3109/10731198209118780
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PW359
UT WOS:A1982PW35900003
PM 7159668
DA 2018-10-20
ER

PT J
AU RUCKENSTEIN, E
   SRINIVASAN, R
AF RUCKENSTEIN, E
   SRINIVASAN, R
TI COMMENTS ON CELL-ADHESION TO BIOMATERIAL SURFACES - THE ORIGIN OF
   SATURATION IN PLATELET DEPOSITION - IS IT KINETIC OR THERMODYNAMIC
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Note
RP RUCKENSTEIN, E (reprint author), SUNY BUFFALO,DEPT CHEM ENGN,BUFFALO,NY 14260, USA.
CR MARMUR A, 1976, B MATH BIOL, V38, P713, DOI 10.1016/S0092-8240(76)80011-0
   MARMUR A, 1980, PHYSICOCHEMICAL AS 2, P341
   NEUMANN AW, 1980, J BIOMED MATER RES, V14, P499, DOI 10.1002/jbm.820140416
   RUCKENSTEIN E, 1976, J THEOR BIOL, V58, P439, DOI 10.1016/S0022-5193(76)80130-0
   RUCKENSTEIN E, 1975, J THEOR BIOL, V51, P429, DOI 10.1016/0022-5193(75)90072-7
   RUCKENSTEIN E, 1976, THROMB HAEMOSTASIS, V36, P334
   SRINIVASAN R, 1981, J COLLOID INTERF SCI, V79, P390, DOI 10.1016/0021-9797(81)90090-4
   WEISS L, 1972, J THEOR BIOL, V37, P169, DOI 10.1016/0022-5193(72)90123-3
NR 8
TC 16
Z9 16
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 2
BP 169
EP 172
DI 10.1002/jbm.820160209
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ND582
UT WOS:A1982ND58200008
PM 7061535
DA 2018-10-20
ER

PT J
AU BAIER, RE
AF BAIER, RE
TI COMMENTS ON CELL-ADHESION TO BIOMATERIAL SURFACES - CONFLICTS AND
   CONCERNS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Note
RP BAIER, RE (reprint author), ARVIN CALSPAN ADV TECHNOL CTR,POB 400,BUFFALO,NY 14225, USA.
CR RUCKENSTEIN E, 1982, J BIOMED MATER RES, V16, P169, DOI 10.1002/jbm.820160209
NR 1
TC 30
Z9 30
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 2
BP 173
EP 175
DI 10.1002/jbm.820160210
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ND582
UT WOS:A1982ND58200009
PM 7061536
DA 2018-10-20
ER

PT J
AU SEITZ, TL
   NOONAN, KD
   HENCH, LL
   NOONAN, NE
AF SEITZ, TL
   NOONAN, KD
   HENCH, LL
   NOONAN, NE
TI EFFECT OF FIBRONECTIN ON THE ADHESION OF AN ESTABLISHED CELL-LINE TO A
   SURFACE REACTIVE BIOMATERIAL
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 UNIV FLORIDA,J HILLIS MILLER HLTH CTR,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610.
   UNIV FLORIDA,DEPT MAT SCI & ENGN,GAINESVILLE,FL 32611.
   UNIV FLORIDA,COLL VET MED,DEPT METAB,GAINESVILLE,FL 32611.
FU NIGMS NIH HHS [GM 23227, GM 24858-02]
CR ALITALO K, 1980, CELL, V19, P1053, DOI 10.1016/0092-8674(80)90096-3
   CULP LA, 1979, J SUPRAMOL STR CELL, V11, P401, DOI 10.1002/jss.400110314
   CULP LA, 1978, CURR TOP MEMBR TRANS, V11, P327
   GAHMBERG CG, 1973, P NATL ACAD SCI USA, V70, P3329, DOI 10.1073/pnas.70.12.3329
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1980, BIOCOMPATIBILITY ORT
   HENCH LL, 1980, SCIENCE, P826
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HYNES RO, 1976, BIOCHIM BIOPHYS ACTA, V458, P73, DOI 10.1016/0304-419X(76)90015-9
   HYNES RO, 1974, CELL, V3, P113, DOI 10.1016/0092-8674(74)90114-7
   KESSLER SW, 1975, J IMMUNOL, V115, P1617
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORRISON PR, 1948, J AM CHEM SOC, V70, P3103, DOI 10.1021/ja01189a080
   MOSESSON MW, 1970, J BIOL CHEM, V245, P5728
   NOONAN KD, 1973, EXP CELL RES, V80, P405, DOI 10.1016/0014-4827(73)90313-3
   PHILLIPS DR, 1970, BIOCHEM BIOPH RES CO, V40, P284, DOI 10.1016/0006-291X(70)91007-7
   STARLING JJ, 1979, J SUPRAMOL STR CELL, V11, P563, DOI 10.1002/jss.400110414
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   WAGNER DD, 1979, J BIOL CHEM, V254, P6746
   WALKER MM, 1977, THESIS U FLORIDA
   WEISS RE, 1980, P NATL ACAD SCI-BIOL, V77, P2074, DOI 10.1073/pnas.77.4.2074
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   YAMADA KM, 1974, P NATL ACAD SCI USA, V71, P3492, DOI 10.1073/pnas.71.9.3492
   YAMADA KM, 1978, J CELL BIOL, V78, P520, DOI 10.1083/jcb.78.2.520
NR 25
TC 66
Z9 66
U1 1
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 3
BP 195
EP 207
DI 10.1002/jbm.820160303
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NM074
UT WOS:A1982NM07400002
PM 7085684
DA 2018-10-20
ER

PT J
AU AOSHIMA, R
   KANDA, Y
   TAKADA, A
   YAMASHITA, A
AF AOSHIMA, R
   KANDA, Y
   TAKADA, A
   YAMASHITA, A
TI SULFONATED POLY(VINYLIDENE FLUORIDE) AS A BIOMATERIAL - IMMOBILIZATION
   OF UROKINASE AND BIOCOMPATIBILITY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 HAMAMATSU UNIV,SCH MED,DEPT PHYSIOL,HAMAMATSU,SHIZUOKA 43131,JAPAN.
   HAMAMATSU UNIV,SCH MED,DEPT ANAT,HAMAMATSU,SHIZUOKA 43131,JAPAN.
RP AOSHIMA, R (reprint author), HAMAMATSU UNIV,SCH MED,DEPT PHYS,HAMAMATSU,SHIZUOKA 43131,JAPAN.
CR BLACK MM, 1958, SURG GYNECOL OBSTET, V106, P163
   BOLLMAN JL, 1948, J LAB CLIN MED, V33, P1349
   CAPETANTONINI FC, 1975, CAN J BIOCHEM CELL B, V53, P890, DOI 10.1139/o75-121
   GOTT VL, 1964, T AM SOC ART INT ORG, V10, P213
   HARADA Y, 1980, JINKO ZOKI, V9, P102
   HESTRIN S, 1949, J BIOL CHEM, V180, P249
   KANDA Y, 1980, JINKO ZOKI, V9, P251
   KJELDGAARD NO, 1957, BIOCHIM BIOPHYS ACTA, V24, P283
   KUSSEROW BK, 1971, T AM SOC ART INT ORG, V17, P1
   Mason R G, 1972, Prog Hemost Thromb, V1, P141
   RICHARDS GN, 1964, J APPL POLYM SCI, V8, P2269
   ROBERTS PS, 1958, J BIOL CHEM, V232, P285
   SHERRY S, 1964, J LAB CLIN MED, V64, P145
   SHERRY S, 1954, J BIOL CHEM, V208, P95
   TROLL W, 1953, J BIOL CHEM, V208, P85
NR 15
TC 13
Z9 13
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 3
BP 289
EP 299
DI 10.1002/jbm.820160309
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NM074
UT WOS:A1982NM07400008
PM 7045128
DA 2018-10-20
ER

PT J
AU CHAWLA, AS
AF CHAWLA, AS
TI TOXICITY EVALUATION OF A NOVEL FILLER FREE SILICONE-RUBBER BIOMATERIAL
   BY CELL-CULTURE TECHNIQUES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
RP CHAWLA, AS (reprint author), HLTH & WELF CANADA,BUR MED DEVICES,OTTAWA K1A 0L2,ONTARIO,CANADA.
CR AUTIAN JOHN, 1967, J BIOMED MAT RES, V1, P433, DOI 10.1002/jbm.820010408
   CHAWLA A, 1977, ACS ORG COAT POLY P, V37, P291
   CHAWLA AS, 1978, J BIOENG, V2, P231
   CHAWLA AS, 1976, J BIOENG, V1, P51
   CHAWLA AS, 1978, BIOMATER ARTIF CELL, V6, P89, DOI 10.3109/10731197809118695
   CHAWLA AS, 1978, TRENDS BIOMEDICAL EN, P126
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   Johnsson R I, 1968, Ann N Y Acad Sci, V146, P66, DOI 10.1111/j.1749-6632.1968.tb20271.x
   Johnsson-Hegyeli R I, 1969, J Biomed Mater Res, V3, P115, DOI 10.1002/jbm.820030111
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   OBANNON SA, 1970, J MACROMOL SCI CHE A, V4, P615
   POWELL D, 1970, Journal of Biomedical Materials Research, V4, P583, DOI 10.1002/jbm.820040409
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   TOLLAR M, 1969, Journal of Biomedical Materials Research, V3, P305, DOI 10.1002/jbm.820030210
   Wilsnack R E, 1973, Biomater Med Devices Artif Organs, V1, P543
NR 16
TC 8
Z9 8
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 4
BP 501
EP 508
DI 10.1002/jbm.820160415
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NV730
UT WOS:A1982NV73000014
PM 7050127
DA 2018-10-20
ER

PT J
AU BLACK, J
   SHOLTES, V
AF BLACK, J
   SHOLTES, V
TI BIOMATERIAL ASPECTS OF SURFACE REPLACEMENT ARTHROPLASTY OF THE HIP
SO ORTHOPEDIC CLINICS OF NORTH AMERICA
LA English
DT Review
C1 UNIV PENN,DEPT ORTHOPAED SURG,PHILADELPHIA,PA 19104.
   UNIV PENN,DEPT BIOENGN,PHILADELPHIA,PA 19104.
   UNIV PENN,DEPT CHEM ENGN,PHILADELPHIA,PA 19104.
CR ADAMS JC, 1953, J BONE JOINT SURG BR, V35, P199
   AMSTUTZ HC, 1978, CLIN ORTHOP RELAT R, P87
   AMSTUTZ HC, 1977, CLIN ORTHOP RELAT R, V128, P261
   AMSTUTZ HC, 1981, J BONE JOINT SURG AM, V63, P1069
   ANDRY N, 1793, ORTHOPAEDIA
   AUFRANC OE, 1957, J BONE JOINT SURG AM, V39, P237, DOI 10.2106/00004623-195739020-00001
   Baer WS, 1909, B JOHNS HOPKINS HOSP, V20, P271
   BICK EM, 1968, SOURCE BOOK ORTHOPAE
   BICK M, 1976, CLASSICS ORTHOPAEDIC
   BICKEL WH, 1948, J BONE JOINT SURG AM, V30-A, P647, DOI 10.2106/00004623-194830030-00012
   BOHLMAN HR, 1952, AM J SURG, V84, P268, DOI 10.1016/0002-9610(52)90053-6
   BURMAN MS, 1943, AM J SURG, V62, P124
   BUXTON JD, 1954, J BONE JOINT SURG BR, V36, P50, DOI 10.1302/0301-620X.36B1.50
   CAMPBELL WC, 1924, JAMA, V832, P976
   CAPELLO WN, 1978, CLIN ORTHOP RELAT R, V134, P59
   CHARNLEY J, 1963, LANCET, V2, P1379
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHARNLEY J, 1961, LANCET, V1, P1129
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COLLINS DH, 1954, J BONE JOINT SURG BR, V36, P458
   COLONNA PC, 1947, J BONE JOINT SURG, V29, P711
   CSERHATI MD, 1979, ARCH ORTHOP TRAUM SU, V94, P233, DOI 10.1007/BF00383406
   DAUBIGNE RM, 1952, J BONE JOINT SURG BR, V34, P22
   DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001
   DUCHEYNE P, 1978, J BIOMECH, V11, P297, DOI 10.1016/0021-9290(78)90063-5
   Dumbleton J. H., 1981, TRIBOLOGY NATURAL AR
   Evarts C M, 1971, Orthop Clin North Am, V2, P93
   Freeman MA, 1975, J BONE JOINT SURG BR, V57, P114
   FREEMAN MAR, 1978, ARCH ORTHOP TRAUM SU, V92, P191, DOI 10.1007/BF00397959
   FREEMAN MAR, 1978, CLIN ORTHOP RELAT R, V134, P45
   FREEMAN MAR, 1978, CLIN ORTHOP RELAT R, V134, P19
   FREEMAN MAR, 1978, CLIN ORTHOP RELAT R, V134, P2
   GERARD Y, 1978, CLIN ORTHOP RELAT R, V134, P25
   GOLDIE IF, 1979, ARCH ORTHOP TRAUM SU, V95, P149, DOI 10.1007/BF00460112
   HARMON PH, 1943, SURG GYNECOL OBSTET, V76, P347
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   HARRIS WH, 1965, J BONE JOINT SURG AM, VA 47, P31, DOI 10.2106/00004623-196547010-00002
   HEAD WC, 1981, J BONE JOINT SURG AM, V63, P420, DOI 10.2106/00004623-198163030-00017
   HECK CV, 1954, J BONE JOINT SURG AM, V36-A, P1059, DOI 10.2106/00004623-195436050-00013
   HEDLEY AK, 1979, T ORS, V4, P163
   HEYGROVES EW, 1926, BR J SURG, V14, P486
   HUETTNER W, 1981, 15TH P BIENN C CARB
   JUDET J, 1950, J BONE JOINT SURG BR, V32, P166
   KALLIO E, 1958, ACTA ORTHOP SCAND S, V30
   KELLY PJ, 1958, J BONE JOINT SURG AM, V40, P675, DOI 10.2106/00004623-195840030-00016
   KETTUNEN KO, 1958, ACTA ORTHOP SCAND S, V31
   LAMBERT CN, 1956, J BONE JOINT SURG AM, V38, P407
   LANG AG, 1977, J BONE JOINT SURG AM, V59, P444, DOI 10.2106/00004623-197759040-00002
   LAW AW, 1962, J BONE JOINT SURG AM, V44, P1497
   LEVY LJ, 1954, J BONE JOINT SURG AM, V36-A, P1175, DOI 10.2106/00004623-195436060-00006
   LIPPMANN RK, 1967, J BONE JOINT SURG AM, VA 49, P876, DOI 10.2106/00004623-196749050-00004
   LIPSCOMB PR, 1965, J BONE JOINT SURG AM, VA 47, P1
   LUNCEFORD E, 1981, COMMUNICATION   1120
   MACAUSLAND WR, 1951, SURG GYNECOL OBSTET, V92, P513
   MACAUSLAND WR, 1923, MOBILIZATION ANKYLOS
   MATCHETT F, 1965, J BONE JOINT SURG AM, VA 47, P43, DOI 10.2106/00004623-196547010-00003
   MCBRIDE ED, 1952, J BONE JOINT SURG AM, V34-A, P989, DOI 10.2106/00004623-195234040-00026
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKEEVER D C, 1955, Clin Orthop, V6, P17
   MOORE AT, 1957, J BONE JOINT SURG AM, V39, P811, DOI 10.2106/00004623-195739040-00005
   Moore AT, 1943, J BONE JOINT SURG, V25, P688
   NEWMAN PH, 1951, J BONE JOINT SURG BR, V33, P392
   OSGOOD RB, 1925, EVOLUTION ORTHOPAEDI
   PETERSON LT, 1951, J BONE JOINT SURG AM, V33-A, P65, DOI 10.2106/00004623-195133010-00004
   Rang M., 1966, ANTHOLOGY ORTHOPAEDI
   RIGDON RH, 1974, J BIOMED MATER RES, V8, P97, DOI 10.1002/jbm.820080202
   SALVATI EA, 1973, J BONE JOINT SURG AM, VA 55, P516, DOI 10.2106/00004623-197355030-00007
   SALVATI EA, 1981, J BONE JOINT SURG AM, V63, P753, DOI 10.2106/00004623-198163050-00010
   SALZER M, 1978, CLIN ORTHOP RELAT R, V134, P80
   SCALES JT, 1958, ACTA ORTHOP SCAND, V27, P13
   SCHWARTZMANN JR, 1959, J BONE JOINT SURG AM, V41, P705, DOI 10.2106/00004623-195941040-00013
   SHANDS AR, 1970, EARLY ORTHOPAEDIC SU
   SIMON SR, 1975, JBJS A, V57, P216
   Smith-Petersen MN, 1939, J BONE JOINT SURG, V21, P269
   SMITHPETERSEN MN, 1978, CLIN ORTHOP RELAT R, V134, P5
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502
   STEIN AH, 1962, J BONE JOINT SURG AM, V44, P1155, DOI 10.2106/00004623-196244060-00010
   STINCHFIELD FE, 1966, J BONE JOINT SURG AM, VA 48, P564, DOI 10.2106/00004623-196648030-00017
   STINCHFIELD FE, 1949, J BONE JOINT SURG AM, V31-A, P628, DOI 10.2106/00004623-194931030-00022
   STREET D M, 1955, Clin Orthop, V6, P72
   SWANSON SA, 1977, J MED ENG TECH, V1, P253
   SWANSON SAV, 1977, J MED ENG TECHNOL, V1, P335, DOI 10.3109/03091907709162055
   SWANSON SAV, 1978, CLIN ORTHOP RELAT R, V134, P12
   THOMPSON FR, 1954, J BONE JOINT SURG AM, V36-A, P489, DOI 10.2106/00004623-195436030-00003
   THOMSON JEM, 1952, J BONE JOINT SURG AM, V34-A, P175, DOI 10.2106/00004623-195234010-00021
   TRENTANI C, 1978, CLIN ORTHOP RELAT R, P36
   URIST MR, 1957, J BONE JOINT SURG AM, V39, P786, DOI 10.2106/00004623-195739040-00004
   Venable CS, 1938, J AMER MED ASSOC, V111, P1349, DOI 10.1001/jama.1938.02790410005002
   VERNONROBERTS V, 1977, SCI BASIS JOINT REPL
   VOLKOV MV, 1972, ARTHROPLASTY HIP, P53
   WAGNER H, 1978, CLIN ORTHOP RELAT R, V134, P102
   WAGNER H, 1980, PROG ORTHOP SURG, V4
   WAGNER H, 1978, P HIP SOC ST LOUIS
   WALKER PS, 1977, HUMAN JOINTS THEIR
   WARING TL, 1961, J BONE JOINT SURG AM, V43, P431, DOI 10.2106/00004623-196143030-00011
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WILES P, 1957, BRIT J SURG, V45, P488
   WILES P, 1955, ESSENTIALS ORTHOPAED
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WROBLEWSKI BM, 1979, J BONE JOINT SURG BR, V61, P498
   1980, U GRONERTWEIGERT HIP
   AESCULAP RESURFACE P
   TARA ARTICULAR REPLA
   1953, JBJS A, V35, P489
NR 104
TC 8
Z9 8
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0030-5898
J9 ORTHOP CLIN N AM
JI Orthop. Clin. North Am.
PY 1982
VL 13
IS 4
BP 709
EP 728
PG 20
WC Orthopedics
SC Orthopedics
GA QC347
UT WOS:A1982QC34700005
PM 6755338
DA 2018-10-20
ER

PT J
AU MONTERO, CG
   EZESPADA, FD
   KREISLER, M
   CASTILLOOLIVARES, JL
   FIGUERA, D
AF MONTERO, CG
   EZESPADA, FD
   KREISLER, M
   CASTILLOOLIVARES, JL
   FIGUERA, D
TI IMMUNOLOGICAL RESPONSE IN BEAGLE DOGS TO A NEW BIOMATERIAL FOR
   CARDIAC-VALVE PROSTHESES - XENOGENIC CERVICAL DURA
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Meeting Abstract
C1 CLIN PUERTA HIERRO,EXPTL SURG UNIT,MADRID 35,SPAIN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 1981
VL 13
IS 1
BP 55
EP 55
PG 1
WC Surgery
SC Surgery
GA LN811
UT WOS:A1981LN81100081
DA 2018-10-20
ER

PT J
AU RODVIEN, R
   ROBINSON, J
   LITWAK, P
   MITCHELL, RR
AF RODVIEN, R
   ROBINSON, J
   LITWAK, P
   MITCHELL, RR
TI AN INVIVO MODEL TO ASSESS BIOMATERIAL THROMBORESISTANCE
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 INST MED SCI,SAN FRANCISCO,CA 94115.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PY 1981
VL 46
IS 1
BP 100
EP 100
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA ML165
UT WOS:A1981ML16500303
DA 2018-10-20
ER

PT J
AU FIGUERA, D
   MONTERO, CG
   MORA, NP
   BARREIRO, JJ
   RODRIGUEZMONTES, JA
   ABASCAL, J
   CIENFUEGOS, JA
   CASTILLOOLIVARES, JL
AF FIGUERA, D
   MONTERO, CG
   MORA, NP
   BARREIRO, JJ
   RODRIGUEZMONTES, JA
   ABASCAL, J
   CIENFUEGOS, JA
   CASTILLOOLIVARES, JL
TI XENOGENIC CERVICAL DURA - A NEW BIOMATERIAL FOR THE CONSTRUCTION OF
   VALVULAR BIOPROSTHESES - EXPERIMENTAL-STUDY OF ITS PHYSICAL AND
   MECHANICAL-PROPERTIES
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Meeting Abstract
RP FIGUERA, D (reprint author), CLIN PUERTA HIERRO,EXPTL SURG UNIT,SAN MARTIN PORRES 4,MADRID 35,SPAIN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 1980
VL 12
SU 1
BP 107
EP 108
PG 2
WC Surgery
SC Surgery
GA JQ809
UT WOS:A1980JQ80900118
DA 2018-10-20
ER

PT J
AU WEISS, M
   PLANCHE, C
   BINET, JP
AF WEISS, M
   PLANCHE, C
   BINET, JP
TI ON THE RELEVANCE OF ANIMAL-MODELS IN CARDIOVASCULAR BIOMATERIAL RESEARCH
   - SIMILAR EVOLUTION OF AORTO-VALVULAR HETEROGRAFTS AFTER MORE THAN
   7-YEAR FOLLOW-UP IN A PATIENT AND IN A DOG
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Meeting Abstract
RP WEISS, M (reprint author), CTR CHIRURG MARIE LANNELONGUE,133 AVE RESISTANCE,F-92350 LE PLESSIS ROBINS,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 1980
VL 12
SU 1
BP 110
EP 111
PG 2
WC Surgery
SC Surgery
GA JQ809
UT WOS:A1980JQ80900121
DA 2018-10-20
ER

PT J
AU MANTOVANI, F
   MARCONI, W
   CAPRINO, L
   GOGLIA, G
   TOGNA, G
AF MANTOVANI, F
   MARCONI, W
   CAPRINO, L
   GOGLIA, G
   TOGNA, G
TI A SIMPLE METHOD FOR EXVIVO EVALUATION OF BIOMATERIAL INTERACTION WITH
   BLOOD-PLATELETS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
C1 UNIV CATTOLICA SACRO CUORE, ROME, ITALY.
RP MANTOVANI, F (reprint author), ASSORENI, MICROBIOL PROC LABS, VIA E RAMARINI 32, I-00015 MONTEROTONDO, ITALY.
CR DANIELS AU, 1971, BIOMAT MED EV ARTIF, V2, P365
   DUTTON RC, 1968, T AM SOC ART INT ORG, V14, P57
   GOTT VL, 1971, FED PROC, V30, P1679
   GRABOWSKI EF, 1975, ANN BIOMED ENG, V3, P322, DOI 10.1007/BF02390977
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P457, DOI 10.1111/j.1749-6632.1977.tb41790.x
   MARCONI W, 1979, T AM SOC ARTIF INT O, V25
   MASON R G, 1969, Journal of Biomedical Materials Research, V3, P615
   MASON R G, 1974, Biomaterials Medical Devices and Artificial Organs, V2, P21
   SAWYER PN, 1977, ANN NY ACAD SCI, V283, P536, DOI 10.1111/j.1749-6632.1977.tb41795.x
   SCHULTZ JS, 1977, ANN NY ACAD SCI, V283, P494, DOI 10.1111/j.1749-6632.1977.tb41793.x
NR 11
TC 6
Z9 6
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PY 1980
VL 3
IS 5
BP 305
EP 310
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA KM621
UT WOS:A1980KM62100014
PM 7461864
DA 2018-10-20
ER

PT J
AU PHARRISS, BB
AF PHARRISS, BB
TI COLLAGEN AS A BIOMATERIAL
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
RP PHARRISS, BB (reprint author), COLLAGEN CORP,PALO ALTO,CA 94303, USA.
CR CHAVPIL M, 1973, INT REV CONNECTIVE T, V6, P1
   HARRINGTON WF, 1971, ENCY POLYMER SCI TEC, V15, P1
   JAFFE R, 1974, J CLIN INVEST, V53, P875, DOI 10.1172/JCI107628
   PIKKARAINEN J, 1964, ACTA CHEM SCAND, V18, P2011, DOI 10.3891/acta.chem.scand.18-2011
   ROGERS R, 1979, MONOGRAPH COLLAGEN, P12
   SCHMITT FO, 1964, P NATL ACAD SCI USA, V51, P493, DOI 10.1073/pnas.51.3.493
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
NR 7
TC 22
Z9 22
U1 0
U2 1
PU AMER LEATHER CHEMISTS ASSN
PI CINCINNATI
PA ROOM 5 CAMPUS STATION-14 TANNER RES LAB, CINCINNATI, OH 45221
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PY 1980
VL 75
IS 11
BP 474
EP 480
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA KY765
UT WOS:A1980KY76500008
DA 2018-10-20
ER

PT J
AU GOOSEN, MFA
   SEFTON, MV
   HATTON, MWC
AF GOOSEN, MFA
   SEFTON, MV
   HATTON, MWC
TI INACTIVATION OF THROMBIN BY ANTI-THROMBIN-III ON A HEPARINIZED
   BIOMATERIAL
SO THROMBOSIS RESEARCH
LA English
DT Article
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A4,ONTARIO,CANADA.
   MCMASTER UNIV,HLTH SCI CTR,DEPT PATHOL,PLASMA PROT RES LAB,HAMILTON L8N 3Z5,ONTARIO,CANADA.
FU NHLBI NIH HHS [1RO1HL25020]
CR BAUGHMAN DJ, 1967, J BIOL CHEM, V242, P5252
   BETHELL GS, 1979, J BIOL CHEM, V254, P2572
   BOFFA MC, 1979, THROMB HAEMOSTASIS, V41, P346
   DANISHEFSKY I, 1976, THROMB RES, V8, P131, DOI 10.1016/0049-3848(76)90256-5
   DINCER A, 1977, THESIS MASSACHUSETTS
   GALLETTI PM, 1978, ARTIF ORGANS, V2, P189
   GOOSEN MFA, 1979, J BIOMED MATER RES, V13, P347, DOI 10.1002/jbm.820130302
   GOOSEN MFA, UNPUBLISHED
   GRIFFITH MJ, 1979, ARCH BIOCHEM BIOPHYS, V195, P378, DOI 10.1016/0003-9861(79)90363-1
   GRIFFITH MJ, 1980, THROMB RES, V17, P83, DOI 10.1016/0049-3848(80)90296-0
   GRIFFITH MJ, 1980, CHEM BIOL HEPARIN
   GRODE G, 1969, JUN ART HEART PROG C
   HATTON MWC, 1977, THROMB RES, V10, P645, DOI 10.1016/0049-3848(77)90047-0
   HATTON MWC, 1977, BIOCHEM SOC T, V5, P1443, DOI 10.1042/bst0051443
   HATTON MWC, 1978, THROMB RES, V13, P655, DOI 10.1016/0049-3848(78)90155-X
   IDEZUKI Y, 1975, T AM SOC ART INT ORG, V21, P436
   KEZDY FJ, 1965, BIOCHEMISTRY-US, V4, P2302, DOI 10.1021/bi00887a007
   LAM LSL, 1979, BRIT J EXP PATHOL, V60, P151
   LI EHH, 1976, ARCH BIOCHEM BIOPHYS, V175, P153, DOI 10.1016/0003-9861(76)90494-X
   LINDON J, 1978, J LAB CLIN MED, V91, P47
   LONGAS MO, 1980, ARCH BIOCHEM BIOPHYS, V200, P595, DOI 10.1016/0003-9861(80)90392-6
   LUNDBLAD RL, 1971, BIOCHEMISTRY-US, V10, P2501, DOI 10.1021/bi00789a012
   MACHOVICH R, 1975, BIOCHIM BIOPHYS ACTA, V379, P193, DOI 10.1016/0005-2795(75)90022-7
   MACHOVICH R, 1979, THROMB RES, V15, P821, DOI 10.1016/0049-3848(79)90191-9
   MERRILL EW, 1972, Patent No. 3658745
   MERRILL EW, 1970, J APPL PHYSL, P723
   MIURA Y, 1980, J BIOMED MATER RES, V14, P619, DOI 10.1002/jbm.820140508
   NORDENMAN B, 1978, THROMB RES, V12, P755, DOI 10.1016/0049-3848(78)90269-4
   ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490
   ROSENBERG RD, 1980, CHEM BIOL HEPARIN
   SALZMAN E, 1980, CHEM BIOL HEPARIN
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   SCHMER G, 1976, T AM SOC ART INT ORG, V22, P654
   SEFTON MV, 1980, CHEM BIOL HEPARIN
   SEFTON MV, UNPUBLISHED
   SMITH GF, 1977, BIOCHEM BIOPH RES CO, V77, P111, DOI 10.1016/S0006-291X(77)80171-X
   STURZEBECHER J, 1977, THROMB RES, V11, P835, DOI 10.1016/0049-3848(77)90112-8
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P1, DOI 10.1111/j.1749-6632.1977.tb41747.x
   WILCHEK M, 1975, P NATL ACAD SCI USA, V72, P1055, DOI 10.1073/pnas.72.3.1055
NR 39
TC 45
Z9 45
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PY 1980
VL 20
IS 5-6
BP 543
EP 554
DI 10.1016/0049-3848(80)90142-5
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA LD721
UT WOS:A1980LD72100008
PM 7233384
DA 2018-10-20
ER

PT J
AU TARR, RR
AF TARR, RR
TI SEM FRACTOGRAPHY STUDIES OF POROUS VITREOUS CARBON - CANDIDATE
   BIOMATERIAL
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
RP TARR, RR (reprint author), UNIV SO CALIF,DEPT ORTHOPAED,LOS ANGELES,CA 90007, USA.
CR Andersson G B, 1972, J Bone Joint Surg Br, V54, P590
   BENSON J, 1971, J BIOMED MATER RES S, V2, P41
   BOKROS JC, 1972, CHEM PHYS CARBON, P103
   CESTERO HJ, 1973, J BIOMED MATER RES S, V4, P33
   FIELD JE, 1971, CONTEMP PHYS, V12, P1, DOI 10.1080/00107517108205103
   GUNSTON FH, 1976, CLIN ORTHOP RELAT R, V120, P11
   HULBERT SF, 1973, J BIOMED MATER RES S, V4, P1
   HULBERT SF, 1970, J BIOMED MATER RES, V4, P443
   INSALL JN, 1976, J BONE JOINT SURG AM, V58, P754, DOI 10.2106/00004623-197658060-00003
   KAAE JL, 1971, J AM CERAM SOC, V54, P605, DOI 10.1111/j.1151-2916.1971.tb16014.x
   KAAE JL, 1974, J BIOMED MATER RES S, V5, P209
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KROUSKOP TA, 1978, T SOC BIOMAT, V4, P107
   LAWN BR, 1975, FRACTURE BRITTLE SOL
   MARMOR L, 1976, CLIN ORTHOPAEDICS, V121, P116
   OLCOTT EL, 1974, J BIOMED MAT RES S, V5, P209
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   SHIVELY JC, 1977, J AM ANIM HOSP ASSOC, V13, P589
   SKOLNICK MD, 1976, J BONE JOINT SURG AM, V58, P749, DOI 10.2106/00004623-197658060-00002
   WILSON FC, 1976, CLIN ORTHOP, V120, P33
NR 20
TC 0
Z9 0
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1979
VL 13
IS 5
BP 717
EP 727
DI 10.1002/jbm.820130505
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HH836
UT WOS:A1979HH83600004
PM 479218
DA 2018-10-20
ER

PT J
AU RATNER, BD
   WEATHERSBY, PK
   HOFFMAN, AS
   KELLY, MA
   SCHARPEN, LH
AF RATNER, BD
   WEATHERSBY, PK
   HOFFMAN, AS
   KELLY, MA
   SCHARPEN, LH
TI RADIATION-GRAFTED HYDROGELS FOR BIOMATERIAL APPLICATIONS AS STUDIED BY
   ESCA TECHNIQUE
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
C1 HEWLETT PACKARD CO,PALO ALTO,CA 94304.
   UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
RP RATNER, BD (reprint author), UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195, USA.
CR Andrade J D, 1973, Med Instrum, V7, P110
   BAIER RE, 1971, FED PROC, V30, P1523
   BRASH JL, 1973, J BIOMED MATER RES, V7, P313, DOI 10.1002/jbm.820070405
   BRASH JL, 1974, T AM SOC ART INT ORG, VA 20, P69
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   CLARK DT, 1975, J MACROMOL SCI R M C, VC 12, P191
   HALPERN BD, 1976, N01HB611248 NIH NAT
   HOFFMAN AS, 1972, POLYM PREPR, V13, P740
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   HORBETT TA, 1975, ADV CHEM SER, V145, P230
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   LEE HB, 1975, J COLLOID INTERF SCI, V51, P225, DOI 10.1016/0021-9797(75)90107-1
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   MICHAELS AS, 1975, AICHE J, V21, P1073, DOI 10.1002/aic.690210605
   MURRAY DG, 1975, J BIOMED MATER RES, V9, P699, DOI 10.1002/jbm.820090614
   RATNER B, UNPUBLISHED
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   RATNER BD, 1975, BIOMATER ARTIF CELL, V3, P115, DOI 10.3109/10731197509118616
   RATNER BD, 1976, ACS SYM SER, P1
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   RATNER BD, 1975, BIOMEDICAL APPLICATI, P159
   REFOJO M F, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P179
   Robb W L, 1968, Ann N Y Acad Sci, V146, P119, DOI 10.1111/j.1749-6632.1968.tb20277.x
   SASAKI T, 1976, ACS SYM SER, P283
   SCOFIELD JH, 1973, UCRL51326 REP
   VROMAN L, 1971, J POLYM SCI POL SYM, P159
   WEATHERSBY PK, 1976, T AM SOC ART INT ORG, V22, P242
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 29
TC 215
Z9 220
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PY 1978
VL 22
IS 3
BP 643
EP 664
DI 10.1002/app.1978.070220306
PG 22
WC Polymer Science
SC Polymer Science
GA FK381
UT WOS:A1978FK38100006
DA 2018-10-20
ER

PT J
AU CHAWLA, AS
AF CHAWLA, AS
TI NOVEL FILLER FREE SILICONE-RUBBER BIOMATERIAL .2. RADIATION CHEMICAL AND
   PHYSICAL EVALUATION
SO JOURNAL OF BIOENGINEERING
LA English
DT Article
RP CHAWLA, AS (reprint author), MCGILL UNIV,DEPT PHYSIOL,ARTIFICIAL ORGANS RES UNIT,MONTREAL H3C 3G1,QUEBEC,CANADA.
CR BRALEY S, 1970, J MACROMOL SCI CHEM, VA  4, P529, DOI 10.1080/00222337008074361
   BUECHE AM, 1957, J POLYM SCI, V25, P139, DOI 10.1002/pol.1957.1202510902
   BUECHE AM, 1955, J POLYM SCI, V15, P105, DOI 10.1002/pol.1955.120157909
   CHAHAL RC, 1968, THESIS MCGILL U
   CHAPIRO A, 1962, RAD CHEM POLYMERIC S, P475
   CHAWLA A, 1977, ACS ORG COAT POLY P, V37, P291
   CHAWLA AS, 1972, J POLYM SCI A1, V10, P2691, DOI 10.1002/pol.1972.150100915
   CHAWLA AS, 1976, J BIOENG, V1, P51
   CHAWLA AS, UNPUBLISHED
   Flory P. J., 1953, PRINCIPLES POLYM CHE, P432
   Flory P.J., 1953, PRINCIPLES POLYM CHE, P579
   FLORY PJ, 1950, J CHEM PHYS, V18, P108, DOI 10.1063/1.1747424
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   GIFFORD GH, 1976, J BIOMED MATER RES, V10, P857, DOI 10.1002/jbm.820100605
   KOLOBOW T, 1974, T AM SOC ART INT ORG, VA 20, P269
   NYILAS E, 1970, Journal of Biomedical Materials Research, V4, P369, DOI 10.1002/jbm.820040308
   STPIERRE LE, 1959, J POLYM SCI, V36, P105, DOI 10.1002/pol.1959.1203613009
   ZAPOL WM, 1975, T AM SOC ART INT ORG, V21, P587
NR 18
TC 5
Z9 5
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 J BIOENG
PY 1978
VL 2
IS 3-4
BP 231
EP 240
PG 10
WC Engineering, Biomedical
SC Engineering
GA FH468
UT WOS:A1978FH46800006
PM 711716
DA 2018-10-20
ER

PT J
AU LIPTON, M
   LANE, JM
   BRIGHTON, CT
   IRWIN, J
   SHADLE, C
AF LIPTON, M
   LANE, JM
   BRIGHTON, CT
   IRWIN, J
   SHADLE, C
TI JOINT ALLOTRANSPLANTATION - METABOLIC AND BIOMATERIAL STUDY
SO ARTHRITIS AND RHEUMATISM
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0004-3591
J9 ARTHRITIS RHEUM
JI Arthritis Rheum.
PY 1977
VL 20
IS 1
BP 125
EP 126
PG 2
WC Rheumatology
SC Rheumatology
GA CV439
UT WOS:A1977CV43900073
DA 2018-10-20
ER

PT J
AU HANSON, SR
   HARKER, LA
   HOFFMAN, AS
AF HANSON, SR
   HARKER, LA
   HOFFMAN, AS
TI INVIVO EVALUATION OF BIOMATERIAL THROMBOGENESIS
SO CIRCULATION
LA English
DT Meeting Abstract
C1 UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PY 1977
VL 56
IS 4
BP 119
EP 119
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA DX484
UT WOS:A1977DX48400466
DA 2018-10-20
ER

PT J
AU CANNON, SL
   STATTON, WO
AF CANNON, SL
   STATTON, WO
TI SPRINGY POLYPROPYLENE - NOVEL ELASTOMERIC BIOMATERIAL
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS
LA English
DT Article
C1 UNIV UTAH,DEPT MAT SCI & ENGN,SALT LAKE CITY,UT 84112.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GORDON BREACH SCI PUBL LTD
PI READING
PA C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL
SN 0091-4037
J9 INT J POLYM MATER
JI Int. J. Polym. Mater.
PY 1977
VL 5
IS 3
BP 165
EP 176
DI 10.1080/00914037708075204
PG 12
WC Polymer Science
SC Polymer Science
GA DV309
UT WOS:A1977DV30900002
DA 2018-10-20
ER

PT J
AU WARD, CA
   FOREST, TW
AF WARD, CA
   FOREST, TW
TI RELATION BETWEEN PLATELET-ADHESION AND ROUGHNESS OF A SYNTHETIC
   BIOMATERIAL
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
C1 UNIV TORONTO,DEPT MECH ENGN,TORONTO,ONTARIO,CANADA.
CR CALLEN H, 1970, THERMODYNAMICS
   DEPALMA VA, 1972, J BIOMED MATER RES, V6, P37, DOI 10.1002/jbm.820060406
   Gibbs J.W, 1961, SCI PAPERS JW GIBBS, V1
   LANDAU LD, 1969, STATISTICAL PHYSICS
   RODMAN NF, 1970, THROMB HAEMORRH DI S, V42, P61
   SHAFRIN EG, 1963, 5985 US NAV RES LAB
   TUCKER AS, 1975, J APPL PHYS, V46, P4801, DOI 10.1063/1.321506
   WARD CA, 1974, T AM SOC ART INT ORG, VA 20, P77
   WARD CA, 1974, J COLLOID INTERFACIA, V49, P296
   WARD CA, 1973, P ANN C ENG BIOL MED, V15, P202
NR 10
TC 35
Z9 35
U1 1
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PY 1976
VL 4
IS 2
BP 184
EP 207
DI 10.1007/BF02363646
PG 24
WC Engineering, Biomedical
SC Engineering
GA BY333
UT WOS:A1976BY33300006
PM 937783
DA 2018-10-20
ER

PT J
AU ZIMMERMAN, RL
AF ZIMMERMAN, RL
TI INDUCED PIEZOELECTRICITY IN ISOTROPIC BIOMATERIAL
SO BIOPHYSICAL JOURNAL
LA English
DT Article
C1 UNIV SAO PAULO,INST FIS & QUIM SAO CARLOS,SAO CARLOS 13560,SP,BRAZIL.
CR FUKADA E, 1974, ADV BIOPHYS, V6, P121
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716
   NETTO TG, 1975, BIOPHYS J, V15, P573
   NYE JF, 1964, PHYSICAL PROPERTIES
   PERLMAN MM, 1971, J APPL PHYS, V42, P2645, DOI 10.1063/1.1660602
   REILLY DT, 1974, J BIOMECH, V7, P271, DOI 10.1016/0021-9290(74)90018-9
   ZIMMERMAN RL, 1975, J APPL POLYM SCI, V19, P1373, DOI 10.1002/app.1975.070190517
NR 7
TC 11
Z9 11
U1 0
U2 2
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PY 1976
VL 16
IS 12
BP 1341
EP 1348
DI 10.1016/S0006-3495(76)85778-5
PG 8
WC Biophysics
SC Biophysics
GA CP175
UT WOS:A1976CP17500001
PM 990389
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU PLANCHE, C
   MARRE, P
   IZRAEL, MT
   BATISSE, A
   WEISS, M
AF PLANCHE, C
   MARRE, P
   IZRAEL, MT
   BATISSE, A
   WEISS, M
TI LONG-TERM EVALUATION OF MODIFIED PORCINE AORTAS AS A BIOMATERIAL
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Meeting Abstract
C1 CTR CHIRURG MARIE-LANNELONGUE,F-75013 PARIS,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 1976
VL 8
SU 2
BP 197
EP 197
PG 1
WC Surgery
SC Surgery
GA CJ344
UT WOS:A1976CJ34400201
DA 2018-10-20
ER

PT J
AU ZVANUT, CW
   RODRIGUEZ, F
AF ZVANUT, CW
   RODRIGUEZ, F
TI COLLAGEN AS A BIOMATERIAL - MODULUS JUMP AND DEGRADATION OF COLLAGEN
   GELS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
C1 CORNELL UNIV,SCH CHEM ENGN,ITHACA,NY 14853.
CR AMDUR I, 1966, CHEMICAL KINETICS
   Ferry J. D., 1970, VISCOELASTIC PROPERT
   GRASSIE N, 1956, CHEMISTRY HIGH POLYM
   HAMED G, 1975, J APPL POLYM SCI, V19, P3299, DOI 10.1002/app.1975.070191215
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   Ramachandran G., 1967, TREATISE COLLAGEN, V1
   Scatchard G, 1944, J AM CHEM SOC, V66, P1980, DOI 10.1021/ja01239a058
   STAINSBY G, 1952, NATURE, V169, P662, DOI 10.1038/169662a0
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   WEAVER ES, 1959, THESIS CORNELL U
NR 10
TC 5
Z9 5
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PY 1976
VL 20
IS 10
BP 2871
EP 2878
DI 10.1002/app.1976.070201021
PG 8
WC Polymer Science
SC Polymer Science
GA CG612
UT WOS:A1976CG61200021
DA 2018-10-20
ER

PT J
AU CHAWLA, AS
AF CHAWLA, AS
TI PURE AND FILLER FREE SILICONE-RUBBER BIOMATERIAL - NEW CONCEPT IN
   PREPARING SILICONE-RUBBER
SO JOURNAL OF BIOENGINEERING
LA English
DT Note
C1 MCGILL UNIV,DEPT PHYSIOL,ARTIFICIAL ORGANS RES UNIT,MONTREAL 101,QUEBEC,CANADA.
CR BRALEY S, 1970, J MACROMOL SCI CHEM, VA  4, P529, DOI 10.1080/00222337008074361
   BUECHE AM, 1957, J POLYM SCI, V25, P139, DOI 10.1002/pol.1957.1202510902
   CHAWLA AS, 1972, J POLYM SCI A1, V10, P2691, DOI 10.1002/pol.1972.150100915
   KOLOBOW T, 1974, T AM SOC ART INT ORG, VA 20, P269
   NYILAS E, 1970, Journal of Biomedical Materials Research, V4, P369, DOI 10.1002/jbm.820040308
   WARD CA, 1974, T AM SOC ART INT ORG, VA 20, P77
   ZAPOL WM, 1975, T AM SOC ART INT ORG, V21, P587
NR 7
TC 5
Z9 5
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 J BIOENG
PY 1976
VL 1
IS 1
BP 51
EP 53
PG 3
WC Engineering, Biomedical
SC Engineering
GA DR839
UT WOS:A1976DR83900007
PM 210159
DA 2018-10-20
ER

PT J
AU AHN, BK
   WOLFSON, SK
   YAO, SJ
   LIU, CC
   TODD, RC
   WEINER, SB
AF AHN, BK
   WOLFSON, SK
   YAO, SJ
   LIU, CC
   TODD, RC
   WEINER, SB
TI HYALURONIDASE-BOUND MEMBRANE AS A BIOMATERIAL FOR IMPLANTABLE FUEL-CELLS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 UNIV PITTSBURGH,DEPT NEUROL SURG,PITTSBURGH,PA 15213.
   UNIV PITTSBURGH,DEPT CHEM ENGN,PITTSBURGH,PA 15213.
   MONTEFIORE HOSP,SURG RES LABS,PITTSBURGH,PA 15213.
CR BRIMACOMBE JS, 1964, BBA, V6, pCH3
   DOHAN LA, 1971, T AM SOC ART INT ORG, V17, P411
   MOSBACH K, 1971, SCI AM          0326
   PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0
   WOLFSON SK, 1970, T AM SOC ART INT ORG, V16, P193
   YAO SJ, 1969, NATURE, V224, P921, DOI 10.1038/224921a0
   YAO SJ, 1972, ELECTROCATALYSIS FUE, P291
NR 7
TC 7
Z9 7
U1 1
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1976
VL 10
IS 2
BP 283
EP 294
DI 10.1002/jbm.820100209
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BL971
UT WOS:A1976BL97100008
PM 1254616
DA 2018-10-20
ER

PT J
AU NATHAN, P
   LAW, EJ
   MACMILLAN, BG
   MURPHY, DF
   RONEL, SH
   DANDREA, MJ
   ABRAHAMS, RA
AF NATHAN, P
   LAW, EJ
   MACMILLAN, BG
   MURPHY, DF
   RONEL, SH
   DANDREA, MJ
   ABRAHAMS, RA
TI NEW BIOMATERIAL FOR CONTROL OF INFECTION IN BURN WOUND
SO TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS
LA English
DT Article
C1 UNIV CINCINNATI, MED CTR, SHRINERS BURNS INST, DEPT PHYSIOL, CINCINNATI, OH 45221 USA.
   UNIV CINCINNATI, MED CTR, DEPT SURG, CINCINNATI, OH 45221 USA.
   HYDRO MED SCI INC, NEW BRUNSWICK, NJ USA.
CR ABRAHAMS RA, 1975, J BIOMED MATER RES, V9, P355, DOI 10.1002/jbm.820090310
   ABRAHAMS RA, IN PRESS
   ANDERSON JM, 1975, AM CHEM SOC POLY PRE, V16, P376
   ARLEN M, 1972, ARCH SURG-CHICAGO, V105, P100
   FALCETTA JJ, 1974, POLY NEWS, V1, P3
   KROHN DL, 1975, INVEST OPHTH VISUAL, V14, P152
   LEVOWITZ BS, 1969, ARCH SURG-CHICAGO, V98, P251
   MILLER JM, 1975, J UROLOGY, V113, P530, DOI 10.1016/S0022-5347(17)59518-X
   MURRAY DG, 1975, J BIOMED MATER RES, V9, P699, DOI 10.1002/jbm.820090614
   NATHAN P, 1974, APPL MICROBIOL, V28, P465
   NATHAN P, 1975, INFECT IMMUN, V12, P257
   NOSE Y, 1974, INVITRO TEST COMPATI, P87
   OBRIEN WJ, 1972, J BIOMED MATER RES, V6, P15, DOI 10.1002/jbm.820060204
   RATNER BD, 1975, BIOMATER ARTIF CELL, V3, P115, DOI 10.3109/10731197509118616
   SINGH MP, 1971, BIOMED ENG, V6, P157
   SMYTH HF, 1950, J AM PHARM ASSOC SCI, V39, P349, DOI 10.1002/jps.3030390615
   VOLDRICH Z, 1975, J BIOMED MATER RES, V9, P675, DOI 10.1002/jbm.820090612
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 18
TC 25
Z9 25
U1 0
U2 1
PU GEORGETOWN UNIV MED CENTER
PI WASHINGTON
PA DR GEORGE SCHREINER ROOM 2212 GEORGETOWN UNIV HOSP, WASHINGTON, DC 20007
   USA
SN 0066-0078
J9 T AM SOC ART INT ORG
PY 1976
VL 22
BP 30
EP 41
PG 12
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA BZ601
UT WOS:A1976BZ60100005
PM 781984
DA 2018-10-20
ER

PT J
AU WEATHERSBY, PK
   HORBETT, TA
   HOFFMAN, AS
AF WEATHERSBY, PK
   HORBETT, TA
   HOFFMAN, AS
TI NEW METHOD FOR ANALYSIS OF ADSORBED PLASMA-PROTEIN LAYER ON BIOMATERIAL
   SURFACES
SO TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS
LA English
DT Article
C1 UNIV WASHINGTON, DEPT CHEM ENGN, SEATTLE, WA 98105 USA.
   UNIV WASHINGTON, CTR BIOENGN, SEATTLE, WA 98105 USA.
CR ARDAILLOU N, 1974, THROMB RES, V5, P327, DOI 10.1016/0049-3848(74)90171-6
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1975, CHAPTER POLYMERS MED, P139
   DAVIE EW, 1975, ANNU REV BIOCHEM, V44, P729
   Doolittle R F, 1973, Adv Protein Chem, V27, P1, DOI 10.1016/S0065-3233(08)60446-5
   EDELSTEIN C, 1972, J BIOL CHEM, V247, P5842
   HARWIG SSL, 1975, THROMB RES, V6, P375, DOI 10.1016/0049-3848(75)90154-1
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   HORBETT TA, 1975, ADV CHEM SER, P230
   HORBETT TA, UNPUBLISHED DATA
   HUNG LT, 1974, J LABELLED COMPD, V10, P3
   JACOBSSON KJELL, 1955, SCAND JOUR CLIN AND LAB INVEST, V7, P1
   JAKOBSEN E, 1973, Thrombosis Research, V3, P145, DOI 10.1016/0049-3848(73)90065-0
   KIM SW, 1975, ADV CHEM SER, P218
   LIMBER GK, 1974, THROMB RES, V5, P735, DOI 10.1016/0049-3848(74)90117-0
   LIMBER GK, 1975, THROMB RES, V6, P421, DOI 10.1016/0049-3848(75)90158-9
   LY B, 1975, THROMB RES, V6, P387, DOI 10.1016/0049-3848(75)90155-3
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   MCFARLANE AS, 1963, J CLIN INVEST, V42, P346, DOI 10.1172/JCI104721
   MIHALYI E, 1964, ARCH BIOCHEM BIOPHYS, V106, P229, DOI 10.1016/0003-9861(64)90181-X
   PERLMAN RL, 1967, J BIOL CHEM, V242, P2416
   REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161
   SASAKI T, 1975, POLYMER PREPRINTS, V16, P435
   SCHMER G, 1975, COMMUNICATION
   STEVENSON GT, 1974, STRUCTURE FUNCTION P, P223
   SWANK RT, 1971, ANAL BIOCHEM, V39, P462, DOI 10.1016/0003-2697(71)90436-2
   VROMAN L, 1975, ADV CHEM SER, P255
   VROMAN L, 1971, FED PROC, V30, P1494
   WEBER K, 1969, J BIOL CHEM, V244, P4406
NR 29
TC 43
Z9 43
U1 0
U2 3
PU GEORGETOWN UNIV MED CENTER
PI WASHINGTON
PA DR GEORGE SCHREINER ROOM 2212 GEORGETOWN UNIV HOSP, WASHINGTON, DC 20007
   USA
SN 0066-0078
J9 T AM SOC ART INT ORG
PY 1976
VL 22
BP 242
EP 252
PG 11
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA BZ601
UT WOS:A1976BZ60100034
PM 951840
DA 2018-10-20
ER

PT J
AU BAUM, G
   LYNN, M
AF BAUM, G
   LYNN, M
TI INORGANIC BIOMATERIAL SUPPORTS
SO PROCESS BIOCHEMISTRY
LA English
DT Article
C1 CORNING GLASS WORKS, TECH STAFF DIV, CORNING, NY 14830 USA.
CR AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0
   BARKER SA, 1971, PROCESS BIOCHEM, V5, P11
   BAUM G, 1972, BIOCHIM BIOPHYS ACTA, V268, P411, DOI 10.1016/0005-2744(72)90336-1
   BROCKMAN HL, 1973, J BIOL CHEM, V248, P4965
   CHARLES M, 1974, IMMOBILIZED BIOCHEMI, P213
   COBB JT, 1974, 77TH AICHE NAT M PIT
   CUATRECASAS P, 1971, ANNU REV BIOCHEM, V40, P259, DOI 10.1146/annurev.bi.40.070171.001355
   DEAN K, UNPUBLISHED RESULTS
   EMERY AN, 1972, CHEMICAL ENG     FEB
   EREL Z, 1972, BIOCHEM BIOPH RES CO, V49, P383, DOI 10.1016/0006-291X(72)90422-6
   GUILFORD H, 1973, CHEM SOC REV, V2, P249, DOI 10.1039/cs9730200249
   HAYNES R, 1969, BIOCHEM BIOPH RES CO, V36, P235, DOI 10.1016/0006-291X(69)90320-9
   LYNN M, 1973, CHIM IND, V106, P601
   MCLAREN AD, 1956, ARCH BIOCHEM BIOPHYS, V61, P158, DOI 10.1016/0003-9861(56)90328-9
   MESSING R, 1970, Patent No. 3519538
   MESSING RA, 1969, J AM CHEM SOC, V91, P2370, DOI 10.1021/ja01037a030
   MESSING RA, 1974, RES DEV, V25, P32
   MESSING RA, 1974, IMMOBILISED ENZYMES, P149
   MESSING RA, 1971, Patent No. 3556945
   MILLER RE, 1972, Patent No. 3669841
   MONSAN P, 1971, FEBS LETT, V16, P39, DOI 10.1016/0014-5793(71)80679-8
   MONSAN P, 1971, CR HEBD ACAD SCI, V273, P33
   Nelson JM, 1916, J AM CHEM SOC, V38, P1109, DOI 10.1021/ja02262a018
   NEWIRTH TL, 1972, BIOTECHNOL BIOENG, V15, P1089
   OCARRA P, 1974, INDUSTRIAL ASPECTS B, P107
   ONEILL SP, 1972, 164TH ACS NAT M
   ROBBERSON DL, 1972, BIOCHEMISTRY-US, V11, P533, DOI 10.1021/bi00754a008
   ROBINSON PJ, 1971, BIOCHIM BIOPHYS ACTA, V242, P659, DOI 10.1016/0005-2744(71)90160-4
   SCOUTEN WH, IN PRESS
   TRAUB A, 1969, ANAL BIOCHEM, V28, P469, DOI 10.1016/0003-2697(69)90201-2
   USAMI S, 1970, J FERMENT TECHNOL, V48, P506
   VANLEEMP.E, 1974, BIOTECHNOL BIOENG, V16, P385, DOI 10.1002/bit.260160308
   VELIKANOV LL, 1971, CA 135651M, V74
   VENTER JC, 1973, P NATL ACAD SCI USA, V70, P1214, DOI 10.1073/pnas.70.4.1214
   WEETAL HH, 1972, CHEM BIOSURFACES, P597
   WEETALL HH, 1972, ENZYME ENG, P241
   WEETALL HH, 1974, IMMOBILIZED BIOCH AF, P191
   WEETALL HH, 1974, SEPARATION PURIFICAT, P199
   WEETALL HH, TO BE PUBLISHED
   WEETALL HH, 1972, CHEMISTRY BIOSURFACE, P563
   WEIBEL MK, 1971, BIOCHEM BIOPH RES CO, V44, P347, DOI 10.1016/0006-291X(71)90606-1
   WOYCHIK JH, 1972, BIOCHIM BIOPHYS ACTA, V289, P347, DOI 10.1016/0005-2744(72)90085-X
   ZABORSKY O, 1973, IMMOBILISED ENZYMES
   1974, PIERCE PREVIEWS  JUN
   1969, CORNING GLASS WORKS
NR 45
TC 9
Z9 10
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
J9 PROCESS BIOCHEM
JI Process Biochem.
PY 1975
VL 10
IS 2
BP 14
EP 17
PG 4
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA AA386
UT WOS:A1975AA38600002
DA 2018-10-20
ER

PT J
AU KLAWITTE.JJ
AF KLAWITTE.JJ
TI POROUS ALUMINUM-OXIDE BIOMATERIAL
SO AMERICAN CERAMIC SOCIETY BULLETIN
LA English
DT Meeting Abstract
C1 CLEMSON UNIV,CLEMSON,SC.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, PO BOX 6136, WESTERVILLE, OH 43081-6136
SN 0002-7812
J9 AM CERAM SOC BULL
JI Am. Ceram. Soc. Bull.
PY 1974
VL 53
IS 4
BP 384
EP 384
PG 1
WC Materials Science, Ceramics
SC Materials Science
GA S6821
UT WOS:A1974S682100444
DA 2018-10-20
ER

PT J
AU STENZEL, KH
   MIYATA, T
   RUBIN, AL
AF STENZEL, KH
   MIYATA, T
   RUBIN, AL
TI COLLAGEN AS A BIOMATERIAL
SO ANNUAL REVIEW OF BIOPHYSICS AND BIOENGINEERING
LA English
DT Review
C1 CORNELL UNIV, NEW YORK HOSP, MED CTR, NEW YORK, NY 10021 USA.
   JAPAN LEATHER CO, TOKYO, JAPAN.
CR Abbenhaus J I, 1965, Surg Forum, V16, P477
   ABBENHAUS JI, 1971, LARYNGOSCOPE, V81, P1650
   ADELMANN BC, 1972, IMMUNOLOGY, V23, P739
   ADELMANN BC, 1972, IMMUNOLOGY, V23, P723
   APARRAY MB, 1969, SURG FORUM, V20, P483
   Bailey A., 1968, COMPREHENSIVE BIOC B, V26B, P297
   BAILEY AJ, 1970, CHEMISTRY MOLECULAR, V2
   BAUMGART.HR, 1967, THROMB DIATH HAEMOST, V18, P592, DOI 10.1055/s-0038-1655068
   BEAR RS, 1942, OEMCMR286 CONTR
   BECKER U, 1972, EUR J BIOCHEM, V28, P221, DOI 10.1111/j.1432-1033.1972.tb01905.x
   BERGMANN M, 1923, Z PHYSL CHEM, V131, P18
   BORNSTEI.P, 1966, BIOCHEMISTRY-US, V5, P3460, DOI 10.1021/bi00875a012
   BORNSTEIN P, 1970, ARCH BIOCHEM BIOPHYS, V138, P443, DOI 10.1016/0003-9861(70)90367-X
   BORNSTEIN P, 1970, CHEMISTRY MOLECULAR
   BOTHWELL JW, 1965, BIOPHYSICAL MECHANIS
   BRAUN RM, 1966, SURG GYNECOL OBSTETR, V122, P15
   BRUNNER H, 1971, Z IMMUNITATSFORSCH, V141, P460
   BUTLER WT, 1967, BIOCHEMISTRY-US, V6, P3771, DOI 10.1021/bi00864a022
   CALLAHAN A, 1965, ARCH OPHTHALMOL-CHIC, V73, P800, DOI 10.1001/archopht.1965.00970030802009
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   CARPENTIER A, 1971, J THORAC CARDIOV SUR, V62, P707
   Cater C. W., 1963, J SOC LEATHER TRADES, V47, P259
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Chvapil M, 1969, J Biomed Mater Res, V3, P315, DOI 10.1002/jbm.820030211
   CHVAPIL M, 1970, MOD TRENDS VASC SURG, V1, P120
   CLICK EM, 1970, BIOCHEMISTRY-US, V9, P4699
   CREECH O, 1954, SURGERY, V36, P431
   CUCIN RL, 1972, J SURG RES, V12, P318, DOI 10.1016/0022-4804(72)90028-5
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P144, DOI 10.1016/0030-4220(73)90109-6
   DAVISON PF, 1967, J EXP MED, V126, P331, DOI 10.1084/jem.126.2.331
   DEFALCO RJ, 1970, J SURG RES, V10, P95, DOI 10.1016/0022-4804(70)90016-8
   DOUGLAS J F, 1956, Surg Forum, V6, P242
   DRAKE MP, 1966, BIOCHEMISTRY-US, V5, P301, DOI 10.1021/bi00865a039
   DUNN M, 1971, T AM SOC ART INT ORG, V17, P421
   DUNN MW, 1969, ARCH OPHTHALMOL-CHIC, V82, P840
   DUNN MW, 1971, J OPHTHALMOL SURG, V2, P7
   Einhorn A, 1905, LIEBIGS ANN CHEM, V343, P207
   EISEN AZ, 1968, BIOCHIM BIOPHYS ACTA, V151, P637, DOI 10.1016/0005-2744(68)90010-7
   EPSTEIN EH, 1971, J BIOL CHEM, V246, P1718
   EVERSON JM, 1967, SCIENCE, V158, P499
   FIETZEK PP, 1970, FEBS LETT, V9, P229, DOI 10.1016/0014-5793(70)80362-3
   FIETZEK PP, 1969, BIOCHEMISTRY-US, V8, P2129, DOI 10.1021/bi00833a052
   FRANZBLAU C, 1968, Brookhaven Symposia in Biology, V21, P358
   FURTHMAYR H, 1972, BIOCHEM BIOPH RES CO, V47, P944, DOI 10.1016/0006-291X(72)90584-0
   FURTHMAYR H, 1971, FEBS LETT, V12, P341, DOI 10.1016/0014-5793(71)80010-8
   GALLOP PM, 1972, ANNU REV BIOCHEM, V41, P617, DOI 10.1146/annurev.bi.41.070172.003153
   GRANT ME, 1972, NEW ENGL J MED, V286, P242, DOI 10.1056/NEJM197202032860505
   GRANT ME, 1972, NEW ENGL J MED, V286, P291, DOI 10.1056/NEJM197202102860604
   GRANT ME, 1972, NEW ENGL J MED, V286, P194, DOI 10.1056/NEJM197201272860406
   GREEN RW, 1953, BIOCHEM J, V54, P181, DOI 10.1042/bj0540181
   GRILLO HC, 1968, DEV BIOL, V17, P571, DOI 10.1016/0012-1606(68)90006-7
   GRILLO HC, 1967, DEV BIOL, V15, P300, DOI 10.1016/0012-1606(67)90029-2
   GROSS J, 1965, P NATL ACAD SCI USA, V54, P1197, DOI 10.1073/pnas.54.4.1197
   GROSS J, 1970, COLLAGENASE
   GUSTAVSON KH, 1961, ARK KEMI, V17, P541
   GUSTAVSON KH, 1956, CHEMISTRY TANNING PR
   HANNIG K, 1967, TREATISE COLLAGEN, V1, P73
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   HARPER E, 1970, COLLAGENASE
   HIGHBERGER JH, 1939, J AM LEATHER CHEM AS, V34, P131
   HIGHBERGER JH, 1940, J AM LEATHER CHEM AS, V35, P11
   HILEL N, 1972, INT SURG, V57, P26
   HISA S, 1959, ACTA PATHOL JAPON, V9, P499
   HODGE AJ, 1960, P NATL ACAD SCI USA, V46, P197, DOI 10.1073/pnas.46.2.197
   HODGE AJ, 1960, P NATL ACAD SCI USA, V46, P186, DOI 10.1073/pnas.46.2.186
   HODGE AJ, 1958, P NATL ACAD SCI USA, V44, P418, DOI 10.1073/pnas.44.5.418
   HOSABE H, 1959, JAP J UROL, V3, P188
   HOVIG T, 1968, J LAB CLIN MED, V71, P29
   HOVIG T, 1963, THROMB DIATH HAEMOST, V9, P248
   HUGUES J, 1962, THROMB DIATH HAEMOST, V8, P241
   IONESCU MI, 1968, THORAX, V23, P221, DOI 10.1136/thx.23.3.221
   KANG AH, 1969, BIOCHEMISTRY-US, V8, P3648, DOI 10.1021/bi00837a023
   KANG AH, 1967, BIOCHEMISTRY-US, V6, P788, DOI 10.1021/bi00855a019
   KARUBE I, 1972, BIOCHEM BIOPH RES CO, V47, P51, DOI 10.1016/S0006-291X(72)80008-1
   KEFALIDES NA, 1971, BIOCHEM BIOPH RES CO, V45, P226, DOI 10.1016/0006-291X(71)90073-8
   KLINE DG, 1965, ARCH SURG-CHICAGO, V91, P924
   KON T, 1970, Journal of Biomedical Materials Research, V4, P13, DOI 10.1002/jbm.820040103
   LINDSLEY H, 1971, J EXP MED, V133, P1309, DOI 10.1084/jem.133.6.1309
   LYMAN B, 1971, J CLIN INVEST, V50, P1854, DOI 10.1172/JCI106677
   MANDL I, 1970, COLLAGENASE
   MECHANIC G, 1970, CHEMISTRY MOLECULAR, V1
   MILLER EJ, 1969, P NATL ACAD SCI USA, V64, P1264, DOI 10.1073/pnas.64.4.1264
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   MOEYS E J, 1954, Arch Chir Neerl, V6, P333
   NAGEOTTE J, 1922, ORGANISATION MATIERE
   NISHIHAR.T, 1967, T AM SOC ART INT ORG, V13, P243
   NISHIHARA T, 1962, COLLAGEN S, V3, P66
   NOSSEL HL, 1971, J CLIN INVEST, V50, P2168, DOI 10.1172/JCI106711
   OBRIEN MF, 1967, J THORAC CARDIOV SUR, V53, P392
   OLCOTT HS, 1947, CHEM REV, V41, P151, DOI 10.1021/cr60128a004
   OLIVER RF, 1972, BRIT J EXP PATHOL, V53, P540
   PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871
   PIEZ K A, 1968, Brookhaven Symposia in Biology, V21, P345
   PIEZ KA, 1968, ANNU REV BIOCHEM, V37, P547, DOI 10.1146/annurev.bi.37.070168.002555
   PIEZ KA, 1967, TREATISE COLLAGEN, V1, P207
   PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708
   PONTZ B, 1970, EUR J BIOCHEM, V16, P50, DOI 10.1111/j.1432-1033.1970.tb01051.x
   POSTLETHWAIT RW, 1969, REPAIR REGENERATION
   PRUDDEN JF, 1967, SURG GYNECOL OBSTETR, V125, P109
   PRUETT RC, 1972, ARCH OPHTHALMOL-CHIC, V88, P540, DOI 10.1001/archopht.1972.01000030542015
   Ramachandran G.N., 1967, TREATISE COLLAGEN
   RAUTERBE.J, 1971, EUR J BIOCHEM, V19, P398, DOI 10.1111/j.1432-1033.1971.tb01329.x
   RICHARDSON JP, 1970, J THORAC CARDIOV SUR, V59, P489
   RITTS RE, 1960, FED PROC, V19, P201
   ROJKIND M, 1964, BIOCHEM BIOPH RES CO, V17, P320, DOI 10.1016/0006-291X(64)90004-X
   ROJKIND M, 1968, J BIOL CHEM, V243, P2266
   ROJKIND M, 1970, CHEMISTRY MOLECULAR, V1
   ROSENBER.N, 1970, SURGERY, V67, P951
   ROSENBERG N, 1962, ARCH SURG-CHICAGO, V85, P192, DOI 10.1001/archsurg.1962.01310020022006
   ROSENBERG N, 1957, ARCH SURG-CHICAGO, V74, P89, DOI 10.1001/archsurg.1957.01280070093011
   ROSENBERG N, 1965, BIOPHYSICAL MECHANIC
   ROTHBARD S, 1965, J EXP MED, V122, P441, DOI 10.1084/jem.122.3.441
   ROTHBARD S, 1962, J EXP MED, V116, P337, DOI 10.1084/jem.116.3.337
   ROTHBARD S, 1956, J EXP MED, V103, P57, DOI 10.1084/jem.103.1.57
   RUBIN AL, 1968, T AM SOC ART INT ORG, V14, P169
   RUBIN AL, 1963, SCIENCE, V139, P37, DOI 10.1126/science.139.3549.37
   RUBIN AL, 1965, BIOCHEMISTRY-US, V4, P181, DOI 10.1021/bi00878a001
   RUBIN AL, 1973, J CLIN PHARMACOL, V13, P309, DOI 10.1002/j.1552-4604.1973.tb00217.x
   RUBIN AL, 1971, NATURE, V230, P120, DOI 10.1038/230120a0
   RUDERMAN RJ, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070213
   Samohyl J, 1969, Acta Chir Orthop Traumatol Cech, V36, P352
   SCHMITT FO, 1964, P NATL ACAD SCI USA, V51, P493, DOI 10.1073/pnas.51.3.493
   SCHMITT FRANCIS O., 1955, EXPTL CELL RES SUPPL, V3, P326
   SHOSHAN S, 1970, J SURG RES, V10, P485, DOI 10.1016/0022-4804(70)90074-0
   SMITH A, 1970, BRIT J OPHTHALMOL, V54, P522, DOI 10.1136/bjo.54.8.522
   SPIRO RG, 1969, J BIOL CHEM, V244, P602
   STARK M, 1972, EUR J BIOCHEM, V27, P192, DOI 10.1111/j.1432-1033.1972.tb01825.x
   STARK M, 1971, FEBS LETT, V13, P101, DOI 10.1016/0014-5793(71)80209-0
   STEFFEN C, 1968, IMMUNOLOGY, V15, P135
   STEFFEN C, 1964, J IMMUNOL, V93, P656
   STEMERMAN MB, 1971, LAB INVEST, V24, P179
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   STENZEL KH, 1971, T AM SOC ART INT ORG, V17, P293
   STENZEL RH, 1969, T AM SOC ART INT ORG, V15, P114
   SUMMERLIN WT, 1973, TRANSPL P, V5, P707
   Thilander B L, 1970, Cleft Palate J, V7, P540
   TIMPL R, 1968, J IMMUNOL, V101, P725
   TRANZER JP, 1967, NATURE, V216, P1126, DOI 10.1038/2161126a0
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   TRAUB W, 1969, NATURE, V221, P914, DOI 10.1038/221914a0
   VEIS A, 1958, J PHYS CHEM-US, V62, P459, DOI 10.1021/j150562a022
   VEIS A, 1956, J AM CHEM SOC, V78, P6238, DOI 10.1021/ja01605a007
   VEIS A, 1965, J BIOL CHEM, V240, P3899
   VIETH WR, 1972, T NEW YORK ACAD SCI, V34, P454, DOI 10.1111/j.2164-0947.1972.tb02697.x
   WATSON RF, 1954, J EXP MED, V99, P535, DOI 10.1084/jem.99.6.535
   WIDERHORN NW, 1955, J AM LEATHER CHEM AS, V48, P7
   WILNER GD, 1968, J CLIN INVEST, V47, P2616, DOI 10.1172/JCI105944
   WILNER GD, 1971, AM J PHYSIOL, V220, P1074
   WILNER GD, 1968, J CLIN INVEST, V47, P2608, DOI 10.1172/JCI105943
   WRIGHT BA, 1951, J POLYM SCI, V7, P105, DOI 10.1002/pol.1951.120070202
   YANNAS AV, 1967, NATURE, V215, P509
   Yannas IV, 1972, REVS MACROMOL CHEM C, VC7, P49
   ZUCKER MB, 1962, P SOC EXP BIOL MED, V109, P779
NR 153
TC 221
Z9 224
U1 4
U2 29
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0084-6589
J9 ANNU REV BIOPHYS BIO
PY 1974
VL 3
BP 231
EP 253
DI 10.1146/annurev.bb.03.060174.001311
PG 23
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA T3141
UT WOS:A1974T314100010
PM 4607533
DA 2018-10-20
ER

PT J
AU EDLICH, RF
   PANEK, PH
   RODEHEAVER, GT
   KURTZ, LD
   EDGERTON, MT
AF EDLICH, RF
   PANEK, PH
   RODEHEAVER, GT
   KURTZ, LD
   EDGERTON, MT
TI SURGICAL SUTURES AND INFECTION - BIOMATERIAL EVALUATION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 UNIV VIRGINIA, MED CTR, DEPT PLAST SURG, CHARLOTTESVILLE, VA 22903 USA.
CR CARPENDALE MT, 1965, SURGERY, V58, P672
   DOUGLAS DM, 1949, LANCET, V257, P499
   EDLICH RF, 1968, J SURG RES, V8, P585, DOI 10.1016/0022-4804(68)90013-9
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   HARRISON JH, 1956, SURG GYNECOL OBSTET, V103, P613
   Herrmann J B, 1971, Am Surg, V37, P209
   MOLONEY GE, 1961, BRIT J SURG, V48, P528, DOI 10.1002/bjs.18004821114
   ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P911
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   POSTLETHWAIT RW, 1970, ARCH SURG-CHICAGO, V101, P489
   USHER FC, 1962, JAMA-J AM MED ASSOC, V179, P780, DOI 10.1001/jama.1962.03050100034006b
   WILLIAMS DF, 1971, BIOMED ENG, V6, P152
NR 12
TC 21
Z9 23
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1974
VL 8
IS 3
BP 115
EP 126
DI 10.1002/jbm.820080312
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA T7363
UT WOS:A1974T736300011
PM 4281781
DA 2018-10-20
ER

PT J
AU LEAKE, DL
AF LEAKE, DL
TI DACRON-URETHANE COMPOSITE - NEW BIOMATERIAL FOR OSSEOUS CONTOUR
   RECONSTRUCTION
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Article
C1 UNIV CALIF,SCH DENT,LOS ANGELES,CA.
   UNIV CALIF,SCH MED,LOS ANGELES,CA.
   HARBOR GEN HOSP,DEPT SURG,DIV ORAL SURG,1000 W CARSON ST,TORRANCE,CA 90509.
CR BLOCH B, 1972, PLASTICS MATERIALS S
   BORETOS JW, 1973, CONCISE GUIDE BIOMED
   BOYNE PJ, 1970, CLIN ORTHOPAEDICS, V73, P199
   CARMODY JTB, 1946, NEW ENGL J MED, V234, P393, DOI 10.1056/NEJM194603212341201
   KRATOCHVIL FJ, 1972, J PROSTHET DENT, V27, P645, DOI 10.1016/0022-3913(72)90312-5
   LEAKE DL, 1974, J ORAL SURG, V32, P23
   LEAKE DL, 1972, SURGERY, V72, P332
   LEAKE DL, 1974, J CALIF DENT ASSOC, V1, P50
   Mowlem R, 1944, LANCET, V2, P746
   Rappoport M, 1973, Br J Oral Surg, V10, P326
   RICHTER HE, 1968, ORAL SURG ORAL MED O, V26, P396, DOI 10.1016/0030-4220(68)90413-1
NR 11
TC 5
Z9 5
U1 0
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-3913
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PY 1974
VL 32
IS 2
BP 182
EP 187
DI 10.1016/S0022-3913(74)80024-7
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA T7832
UT WOS:A1974T783200009
PM 4276283
DA 2018-10-20
ER

PT J
AU MOYLE, DD
   KLAWITTER, JJ
   HULBERT, SF
AF MOYLE, DD
   KLAWITTER, JJ
   HULBERT, SF
TI MECHANICAL PROPERTIES OF BONE-POROUS BIOMATERIAL INTERFACE - ELASTIC
   BEHAVIOR
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
C1 CLEMSON UNIV, COLL ENGN, DIV INTERDISCIPLINARY STUDIES, CLEMSON, SC 29631 USA.
CR BAHN SL, 1966, ORAL SURG ORAL MED O, V21, P672, DOI 10.1016/0030-4220(66)90045-4
   BIGGS WD, 1966, COMPOSITE MATERIALS
   BONFIELD W, 1966, J APPL PHYS, V37, P869, DOI 10.1063/1.1708274
   BOWMAN LS, 1971, THESIS CLEMSON U
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P354
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P56
   COLETTE JM, 1971, J BONE JOINT SURG AM, VA 53, P799
   EDBERG E, 1930, ACTA CHIR SCAND, V67, P313
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GALANTE J, 1970, J BONE JOINT SURG AM, VA 52, P834
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7
   HASHIN Z, 1962, J MECH PHYS SOLIDS, V10, P343, DOI 10.1016/0022-5096(62)90005-4
   Hashin Z, 1962, J APPL MECH, V29, P143, DOI DOI 10.1115/1.3636446
   HENEFER EP, 1968, J ORAL SURG, V26, P577
   HENTRICH R L, 1971, Journal of Biomedical Materials Research, V5, P25, DOI 10.1002/jbm.820050104
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   HILLE GH, 1966, J MATER, V1, P373
   HIRSCHHORN JS, 1969, RESEARCH DENTAL MEDI
   HIRSCHHORN JS, 1971, J BIOMED MATER RES, V6, P49
   HOLLIDAY L, 1966, COMPOSITE MATERIALS
   HOMSY CA, 1971, BIOMATERIALS BIOENGI
   Jaeger J. C., 1962, ELASTICITY FRACTURE
   JOHNSON JF, 1967, MODERN PRACTICE DENT
   KATZ JL, 1970, ASME70WABHF3 PAP
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KRIEGEL WW, 1971, CERAMICS SEVERE ENVI
   LAZANSKY MG, 1970, J BONE JOINT SURG AM, VA 52, P834
   MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231
   MORRAL FR, 1966, J MATER, V1, P384
   NYSTROM G, 1928, ACTA CHIR SCAND, V63, P296
   PAGANO NJ, 1969, PROGR MATERIALS SCIE, V1
   PARKER EB, 1967, MATERIALS DATA BOOK
   PAUL B, 1960, T AM I MIN MET ENG, V218, P36
   PELTIER LF, 1957, ANN SURG, V146, P61, DOI 10.1097/00000658-195707000-00007
   PETERS RL, 1965, MATERIALS DATA NOMOG
   PETERSEN CD, 1969, J BONE JOINT SURG AM, VA 51, P805
   PREDECKI P, IN PRESS
   Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104
   SKINNER EW, 1967, SCIENCE DENTAL MATER
   SMITH L, 1963, ARCH SURG-CHICAGO, V87, P653
   STRUTHERS AM, 1955, PLASTIC RECONSTRUCTI, V15
   Voigt W, 1910, LEHRBUCH KRISTALLPHY
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WELSH RP, 1971, J BIOMED MATER RES, V6, P231
   Woodforde John, 1968, STRANGE STORY FALSE
NR 46
TC 8
Z9 8
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1973
VL 7
IS 3
BP 363
EP 382
DI 10.1002/jbm.820070323
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA Q1469
UT WOS:A1973Q146900021
PM 4717960
DA 2018-10-20
ER

PT J
AU ANDRADE, JD
   LEE, HB
   JHON, MS
   KIM, SW
   HIBBS, JB
AF ANDRADE, JD
   LEE, HB
   JHON, MS
   KIM, SW
   HIBBS, JB
TI WATER AS A BIOMATERIAL
SO TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS
LA English
DT Article
C1 UNIV UTAH,COLL ENGN,SALT LAKE CITY,UT 84112.
CR ABDULLA YH, 1967, J ATHEROSCLER RES, V7, P415, DOI 10.1016/S0368-1319(67)80020-6
   ANDRADE JD, IN PRESS
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAIER RE, 1970, MANAGEMENT ARTERIAL
   BEHNKE O, 1968, J ULTRA MOL STRUCT R, V24, P51, DOI 10.1016/S0022-5320(68)80016-4
   BERENDSEN H. J. C, 1965, ANN N Y ACAD SCI, V125, P365, DOI 10.1111/j.1749-6632.1965.tb45403.x
   BISCHOFF KENNETH B., 1968, J BIOMED MAT RES, V2, P89, DOI 10.1002/jbm.820020107
   BOSSNABB H, 1972, BIOCH BIOPHYS ACTA, V279, P456
   BRANDT PW, 1962, CIRCULATION, V26, P1075, DOI 10.1161/01.CIR.26.5.1075
   BRANDTS J, 1969, STRUCTURE STABILITY
   BRASH JL, 1971, CHEMISTRY BIOSURFACE, V1
   BROWN F, 1964, CYTOLOGY CELL PHYSIO
   BRUCK SD, 1972, J BIOMED MATER RES, V6, P173, DOI 10.1002/jbm.820060306
   CATCHPOOL JF, 1966, FED PROC, V25, P979
   CURTIS ASG, 1967, CELL SURFACE
   DAMADIAN R, 1971, SCIENCE, V171, P1151, DOI 10.1126/science.171.3976.1151
   DANIELLI JF, 1938, COLD SPRING HARB SYM, V6, P190
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P302, DOI 10.1016/0021-9797(70)90054-8
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P321, DOI 10.1016/0021-9797(70)90055-X
   Davies J.T., 1963, INTERFACIAL PHENOMEN
   DROSTHANSEN W, 1971, CHEMISTRY CELL SUR B
   Eisenberg D., 1969, STRUCTURE PROPERTIES
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   FRANK HS, 1965, ANN NY ACAD SCI, V125, P737
   FRANKS F, 1968, HYDROGEN BONDED SOLV
   FRENCH JE, 1963, EVOLUTION ATHEROSCLE
   FREYWYSSLING A, 1953, SUBMICROSCOPIC MORPH
   FRIEDMAN LI, 1970, T AM SOC ART INT ORG, V16, P63
   GOOD RJ, 1970, IND ENG CHEM, V62, P54, DOI 10.1021/ie50723a009
   GORDON R, 1972, J THEOR BIOL, V37, P43, DOI 10.1016/0022-5193(72)90114-2
   GOTT VL, 1972, PB213110 US GOV REP
   GRAY WR, PERSONAL COMMUNICATI
   HAMILTON WC, 1972, J COLLOID INTERF SCI, V40, P219, DOI 10.1016/0021-9797(72)90011-2
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   ITO S, 1969, FED PROC, V28, P12
   JHON MS, IN PRESS
   Kaelble DH, 1970, J ADHESION, V2, P66
   LEE H, IN PRESS
   LEE HB, 1972, POLYM PREPR, V13, P729
   LENTZ D, IN PRESS
   LING GN, 1962, PHYSICAL THEORY LIVI
   LYMAN DJ, 1965, T AM SOC ART INT ORG, V11, P301
   MADOFF MA, 1964, J CLIN INVEST, V43, P870, DOI 10.1172/JCI104972
   MARTINEZPALOMO A, 1970, INT REV CYTOL, V29, P29
   MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1
   MILLER IR, 1971, PROGRESS SURFACE MEM, V4, P299
   PAK CYC, 1967, NATURE, V214, P888, DOI 10.1038/214888a0
   PARKER J, 1972, CRYOBIOLOGY, V9, P247, DOI 10.1016/0011-2240(72)90042-9
   PARSONS DF, 1972, BIOCHIM BIOPHYS ACTA, V265, P85, DOI 10.1016/0304-4157(72)90020-2
   PETHICA B. A., 1961, EXPTL CELL RES SUPPL, V8, P123, DOI 10.1016/0014-4827(61)90344-5
   POSTE G, 1973, CYTOBIOS, V3, P5
   Rambourg A, 1971, Int Rev Cytol, V31, P57
   RASMUSSEN DH, 1972, WATER STRUCTURE WATE
   SAUNDERS JF, 1965, ANN NY ACAD SCI, V125, P251, DOI 10.1111/j.1749-6632.1965.tb45395.x
   SAWYER PN, 1972, B NEW YORK ACAD MED, V48, P235
   SAWYER PN, 1964, T AM SOC ART INT ORG, V10, P316
   Schleich T, 1969, STRUCTURE STABILITY
   SCHULTZ RD, 1970, RECENT PROGRESS SURF, V3, P291, DOI 10.1016/B978-0-12-571803-5.50016-X
   SZENTGYORGYI A, 1971, PERSPECT BIOL MED, V14, P239
   TAIT MJ, 1971, NATURE, V230, P91, DOI 10.1038/230091a0
   TONER PG, 1971, CELL STRUCTURE
   TROSHIN AS, 1966, PROBLEMS CELL PERMEA
   Vroman L, 1967, BLOOD
   WARNER DT, 1965, ANN NY ACAD SCI, V125, P605, DOI 10.1111/j.1749-6632.1965.tb45417.x
   WARNER DT, 1970, J THEOR BIOL, V26, P289, DOI 10.1016/S0022-5193(70)80019-4
   WARNER DT, 1962, NATURE, V196, P1055, DOI 10.1038/1961055a0
   WEBB SJ, 1967, CAN J MICROBIOL, V13, P303, DOI 10.1139/m67-039
   WEISS L, 1967, CELL PERIPHERY
   WHITE JG, 1971, PLATELET
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Winzler R J, 1970, Int Rev Cytol, V29, P77, DOI 10.1016/S0074-7696(08)60033-9
   WINZLER RJ, 1969, RED CELL MEMBRANE
NR 72
TC 104
Z9 105
U1 1
U2 12
PU GEORGETOWN UNIV MED CENTER
PI WASHINGTON
PA DR GEORGE SCHREINER ROOM 2212 GEORGETOWN UNIV HOSP, WASHINGTON, DC 20007
SN 0066-0078
J9 T AM SOC ART INT ORG
PY 1973
VL 19
BP 1
EP 7
PG 7
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA Q3277
UT WOS:A1973Q327700001
PM 4579026
DA 2018-10-20
ER

PT J
AU HOFFMAN, AS
   KRAFT, WG
AF HOFFMAN, AS
   KRAFT, WG
TI RADIATION-GRAFTED HYDROGELS ON POLYURETHANE SURFACES - NEW BIOMATERIAL
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT BIOENGN,SEATTLE,WA 98195.
   BATTELLE MEM INST,SEATTLE RES CTR,SEATTLE,WA 98195.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1972
VL 164
IS AUG-S
BP 33
EP &
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA YY913
UT WOS:A1972YY91300376
DA 2018-10-20
ER

PT J
AU HOFFMAN, AS
   HARRIS, C
AF HOFFMAN, AS
   HARRIS, C
TI RADIATION-GRAFTED HYDROGELS ON SILICONE-RUBBER SURFACES - NEW
   BIOMATERIAL
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV WASHINGTON,DEPT BIOENGN,SEATTLE,WA 98195.
   BATTELLE MEM INST,RES CTR,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1972
VL 164
IS AUG-S
BP 36
EP &
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA YY913
UT WOS:A1972YY91300379
DA 2018-10-20
ER

EF